Citrus Sinensis ID: 029154
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 198 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.661 | 0.335 | 0.478 | 7e-31 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.651 | 0.140 | 0.413 | 2e-23 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.621 | 0.131 | 0.424 | 7e-23 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.641 | 0.095 | 0.430 | 7e-23 | |
| Q66HA1 | 850 | Mitogen-activated protein | yes | no | 0.661 | 0.154 | 0.394 | 3e-22 | |
| Q80XI6 | 850 | Mitogen-activated protein | yes | no | 0.661 | 0.154 | 0.394 | 3e-22 | |
| Q16584 | 847 | Mitogen-activated protein | yes | no | 0.661 | 0.154 | 0.394 | 4e-22 | |
| Q8VDG6 | 1002 | Mitogen-activated protein | no | no | 0.601 | 0.118 | 0.390 | 2e-21 | |
| Q95UN8 | 1161 | Mitogen-activated protein | yes | no | 0.636 | 0.108 | 0.391 | 2e-21 | |
| Q5TCX8 | 1036 | Mitogen-activated protein | no | no | 0.595 | 0.113 | 0.395 | 2e-21 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 133 bits (335), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 67/140 (47%), Positives = 89/140 (63%), Gaps = 9/140 (6%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K +NLLL D+ +K+ADFG + ET GTYRWMAPE+ ++K Y
Sbjct: 213 LKSNNLLLN-DEMRVKVADFGTSCLETQCREAKGNMGTYRWMAPEMI--------KEKPY 263
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
KVDVYSFGIVLWEL T LPF+GM+ +QAA+A A K+ RP LP P LA +++ CW
Sbjct: 264 TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALAHLIKRCW 323
Query: 125 VEDPNLRPSFSQIIRMLNAF 144
E+P+ RP FS I+ +L +
Sbjct: 324 SENPSKRPDFSNIVAVLEKY 343
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 108 bits (270), Expect = 2e-23, Method: Composition-based stats.
Identities = 57/138 (41%), Positives = 85/138 (61%), Gaps = 9/138 (6%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K NLLL + ++K+ DFGL++ ++ + MT G+ WM+PEL GE Y
Sbjct: 785 IKSLNLLLD-EHMNVKICDFGLSKLKSKSTEMTKSIGSPIWMSPELL------MGED--Y 835
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
KVDVY+FGI+LWEL T LP+ G+ ++Q A A K RP +P L+ ++Q+CW
Sbjct: 836 TEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACW 895
Query: 125 VEDPNLRPSFSQIIRMLN 142
+DP RPSF++I+ +LN
Sbjct: 896 HQDPLKRPSFTEILNLLN 913
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 107 bits (266), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 56/132 (42%), Positives = 82/132 (62%), Gaps = 9/132 (6%)
Query: 11 LLTPDQKSLKLADFGLAREETVTEMMTAET-GTYRWMAPELYSTVTLRQGEKKHYNNKVD 69
LL + ++K+ DFGL+R + T + + T GT WMAPE+ LR + N K D
Sbjct: 798 LLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEV-----LRN---EPSNEKCD 849
Query: 70 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPN 129
VYSFG++LWEL T RLP+ GM+ +Q A F++ R +P+++ P + I+ CW DPN
Sbjct: 850 VYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVVGRIILECWQTDPN 909
Query: 130 LRPSFSQIIRML 141
LRPSF+Q+ +L
Sbjct: 910 LRPSFAQLTEVL 921
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 107 bits (266), Expect = 7e-23, Method: Composition-based stats.
Identities = 59/137 (43%), Positives = 80/137 (58%), Gaps = 10/137 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K NLL+ ++K+AD G+ARE + T+ MT GT W APE+ LR + Y
Sbjct: 1201 LKSSNLLMD-KHFNIKIADLGIARETSFTQTMTT-IGTVAWTAPEI-----LRH---ESY 1250
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
N K DVYS+ IVL+ELLT P++G+ + A A K RP LP++ P+ +V CW
Sbjct: 1251 NQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASKGLRPELPDNCDPNWKKLVVWCW 1310
Query: 125 VEDPNLRPSFSQIIRML 141
EDPN RPSF +I L
Sbjct: 1311 SEDPNKRPSFEEITNYL 1327
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q66HA1|M3K11_RAT Mitogen-activated protein kinase kinase kinase 11 OS=Rattus norvegicus GN=Map3k11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 104 bits (260), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 58/147 (39%), Positives = 80/147 (54%), Gaps = 16/147 (10%)
Query: 5 MKEDN-LLLTP------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 57
+K +N LLL P + K+LK+ DFGLARE T M+A GTY WMAPE+ T
Sbjct: 243 LKSNNILLLQPIEGDDMEHKTLKITDFGLAREWHKTTQMSA-AGTYAWMAPEVIKASTFS 301
Query: 58 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 117
+G DV+SFG++LWELLT +P+ G+ L AY A +P A
Sbjct: 302 KGS--------DVWSFGVLLWELLTGEVPYRGIDCLAVAYGVAVNKLTLPIPSTCPEPFA 353
Query: 118 FIVQSCWVEDPNLRPSFSQIIRMLNAF 144
++ CW +DP+ RP F+ I++ L A
Sbjct: 354 QLMADCWAQDPHRRPDFASILQQLEAL 380
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q80XI6|M3K11_MOUSE Mitogen-activated protein kinase kinase kinase 11 OS=Mus musculus GN=Map3k11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 104 bits (260), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 58/147 (39%), Positives = 80/147 (54%), Gaps = 16/147 (10%)
Query: 5 MKEDN-LLLTP------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 57
+K +N LLL P + K+LK+ DFGLARE T M+A GTY WMAPE+ T
Sbjct: 243 LKSNNILLLQPIEGDDMEHKTLKITDFGLAREWHKTTQMSA-AGTYAWMAPEVIKASTFS 301
Query: 58 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 117
+G DV+SFG++LWELLT +P+ G+ L AY A +P A
Sbjct: 302 KGS--------DVWSFGVLLWELLTGEVPYRGIDCLAVAYGVAVNKLTLPIPSTCPEPFA 353
Query: 118 FIVQSCWVEDPNLRPSFSQIIRMLNAF 144
++ CW +DP+ RP F+ I++ L A
Sbjct: 354 QLMADCWAQDPHRRPDFASILQQLEAL 380
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q16584|M3K11_HUMAN Mitogen-activated protein kinase kinase kinase 11 OS=Homo sapiens GN=MAP3K11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 104 bits (259), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 58/147 (39%), Positives = 80/147 (54%), Gaps = 16/147 (10%)
Query: 5 MKEDN-LLLTP------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 57
+K +N LLL P + K+LK+ DFGLARE T M+A GTY WMAPE+ T
Sbjct: 242 LKSNNILLLQPIESDDMEHKTLKITDFGLAREWHKTTQMSA-AGTYAWMAPEVIKASTFS 300
Query: 58 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 117
+G DV+SFG++LWELLT +P+ G+ L AY A +P A
Sbjct: 301 KGS--------DVWSFGVLLWELLTGEVPYRGIDCLAVAYGVAVNKLTLPIPSTCPEPFA 352
Query: 118 FIVQSCWVEDPNLRPSFSQIIRMLNAF 144
++ CW +DP+ RP F+ I++ L A
Sbjct: 353 QLMADCWAQDPHRRPDFASILQQLEAL 379
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q8VDG6|M3KL4_MOUSE Mitogen-activated protein kinase kinase kinase MLK4 OS=Mus musculus GN=Mlk4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 102 bits (254), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 50/128 (39%), Positives = 74/128 (57%), Gaps = 9/128 (7%)
Query: 17 KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76
K+LK+ DFGLARE T M+A GTY WMAPE+ + +G D++S+G++
Sbjct: 267 KTLKITDFGLAREWHRTTRMSA-AGTYAWMAPEVIRSSLFSKGS--------DIWSYGVL 317
Query: 77 LWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 136
LWELLT +P+ G+ L AY A +P A +++ CW +DP++RPSF+
Sbjct: 318 LWELLTGEVPYRGIDGLAVAYGVAVNKLTLPIPSTCPEPFAKLMKECWEQDPHIRPSFAL 377
Query: 137 IIRMLNAF 144
I++ L A
Sbjct: 378 ILQQLTAI 385
|
Activates the JUN N-terminal pathway. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q95UN8|M3KSL_DROME Mitogen-activated protein kinase kinase kinase OS=Drosophila melanogaster GN=slpr PE=1 SV=1 | Back alignment and function description |
|---|
Score = 102 bits (254), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 54/138 (39%), Positives = 77/138 (55%), Gaps = 12/138 (8%)
Query: 16 QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75
QK+LK+ DFGLARE T+ M+A GTY WM PE+ S T Y+ DV+S+G+
Sbjct: 283 QKTLKITDFGLAREMYNTQRMSA-AGTYAWMPPEVISVST--------YSKFSDVWSYGV 333
Query: 76 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 135
+LWEL+T P++G L AY A +P+ +++SCW DP+ RP F
Sbjct: 334 LLWELITGETPYKGFDPLSVAYGVAVNTLTLPIPKTCPETWGALMKSCWQTDPHKRPGFK 393
Query: 136 QIIRMLNAFL---FTLRP 150
+I++ L + FTL P
Sbjct: 394 EILKQLESIACSKFTLTP 411
|
Activates the JUN N-terminal pathway during dorsal closure. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q5TCX8|M3KL4_HUMAN Mitogen-activated protein kinase kinase kinase MLK4 OS=Homo sapiens GN=MLK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 102 bits (253), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 51/129 (39%), Positives = 74/129 (57%), Gaps = 11/129 (8%)
Query: 17 KSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75
K+LK+ DFGLARE T+M TA GTY WMAPE+ + +G D++S+G+
Sbjct: 283 KTLKITDFGLAREWHRTTKMSTA--GTYAWMAPEVIKSSLFSKGS--------DIWSYGV 332
Query: 76 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 135
+LWELLT +P+ G+ L AY A +P A +++ CW +DP++RPSF+
Sbjct: 333 LLWELLTGEVPYRGIDGLAVAYGVAVNKLTLPIPSTCPEPFAKLMKECWQQDPHIRPSFA 392
Query: 136 QIIRMLNAF 144
I+ L A
Sbjct: 393 LILEQLTAI 401
|
Activates the JUN N-terminal pathway. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 198 | ||||||
| 255584255 | 367 | protein kinase atn1, putative [Ricinus c | 0.969 | 0.523 | 0.895 | 3e-98 | |
| 225439671 | 374 | PREDICTED: serine/threonine-protein kina | 0.979 | 0.518 | 0.830 | 9e-92 | |
| 297735553 | 337 | unnamed protein product [Vitis vinifera] | 0.979 | 0.575 | 0.830 | 2e-91 | |
| 224139346 | 356 | predicted protein [Populus trichocarpa] | 0.969 | 0.539 | 0.855 | 5e-91 | |
| 356532165 | 370 | PREDICTED: serine/threonine-protein kina | 0.969 | 0.518 | 0.850 | 3e-89 | |
| 449439809 | 373 | PREDICTED: serine/threonine-protein kina | 0.979 | 0.520 | 0.827 | 1e-88 | |
| 449521717 | 373 | PREDICTED: serine/threonine-protein kina | 0.979 | 0.520 | 0.827 | 2e-88 | |
| 388513773 | 360 | unknown [Medicago truncatula] | 0.949 | 0.522 | 0.821 | 1e-87 | |
| 357506575 | 363 | Protein kinase, putative [Medicago trunc | 0.969 | 0.528 | 0.829 | 1e-86 | |
| 297810213 | 337 | hypothetical protein ARALYDRAFT_324798 [ | 0.934 | 0.548 | 0.812 | 1e-86 |
| >gi|255584255|ref|XP_002532865.1| protein kinase atn1, putative [Ricinus communis] gi|223527377|gb|EEF29519.1| protein kinase atn1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 363 bits (931), Expect = 3e-98, Method: Compositional matrix adjust.
Identities = 172/192 (89%), Positives = 181/192 (94%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K DNLLLT +QKS+KLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY
Sbjct: 175 LKPDNLLLTANQKSVKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 234
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK RP LPED SPDLAFI+QSCW
Sbjct: 235 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKQERPSLPEDTSPDLAFIIQSCW 294
Query: 125 VEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSNGAMTEFSARARGKFAF 184
VEDPNLRPSFSQIIRMLNAFLFTL PPS SVPES T+EAAA+SNG ++EFSARARGKFAF
Sbjct: 295 VEDPNLRPSFSQIIRMLNAFLFTLSPPSTSVPESSTHEAAASSNGTVSEFSARARGKFAF 354
Query: 185 LRQLFTAKRTKN 196
LRQLFTAKR +N
Sbjct: 355 LRQLFTAKRARN 366
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439671|ref|XP_002270753.1| PREDICTED: serine/threonine-protein kinase HT1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 341 bits (875), Expect = 9e-92, Method: Compositional matrix adjust.
Identities = 162/195 (83%), Positives = 174/195 (89%), Gaps = 1/195 (0%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K DNLLLT +QKS+KLADFGLAREE+VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY
Sbjct: 180 LKPDNLLLTANQKSVKLADFGLAREESVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 239
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
NNKVDVYSFGIV WELLTNR+PFEGMSNLQAAYAAAFK RP LPEDISPDLAFI+QSCW
Sbjct: 240 NNKVDVYSFGIVFWELLTNRMPFEGMSNLQAAYAAAFKQERPSLPEDISPDLAFIIQSCW 299
Query: 125 VEDPNLRPSFSQIIRMLNAFLFTLRPPSPS-VPESDTNEAAATSNGAMTEFSARARGKFA 183
VEDPN+RPSFSQIIRMLN F F + PP S + ESDTN AA +SNG MTE SAR RGKF+
Sbjct: 300 VEDPNMRPSFSQIIRMLNTFHFKVTPPPSSLLEESDTNGAAMSSNGTMTELSARTRGKFS 359
Query: 184 FLRQLFTAKRTKNLQ 198
FLRQLF AKRT+N Q
Sbjct: 360 FLRQLFAAKRTRNSQ 374
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297735553|emb|CBI18047.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 340 bits (873), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 162/195 (83%), Positives = 174/195 (89%), Gaps = 1/195 (0%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K DNLLLT +QKS+KLADFGLAREE+VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY
Sbjct: 143 LKPDNLLLTANQKSVKLADFGLAREESVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 202
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
NNKVDVYSFGIV WELLTNR+PFEGMSNLQAAYAAAFK RP LPEDISPDLAFI+QSCW
Sbjct: 203 NNKVDVYSFGIVFWELLTNRMPFEGMSNLQAAYAAAFKQERPSLPEDISPDLAFIIQSCW 262
Query: 125 VEDPNLRPSFSQIIRMLNAFLFTLRPPSPS-VPESDTNEAAATSNGAMTEFSARARGKFA 183
VEDPN+RPSFSQIIRMLN F F + PP S + ESDTN AA +SNG MTE SAR RGKF+
Sbjct: 263 VEDPNMRPSFSQIIRMLNTFHFKVTPPPSSLLEESDTNGAAMSSNGTMTELSARTRGKFS 322
Query: 184 FLRQLFTAKRTKNLQ 198
FLRQLF AKRT+N Q
Sbjct: 323 FLRQLFAAKRTRNSQ 337
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139346|ref|XP_002323067.1| predicted protein [Populus trichocarpa] gi|222867697|gb|EEF04828.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 339 bits (869), Expect = 5e-91, Method: Compositional matrix adjust.
Identities = 166/194 (85%), Positives = 182/194 (93%), Gaps = 2/194 (1%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K DNLLLT +QKS+KLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY
Sbjct: 161 LKPDNLLLTANQKSVKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 220
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
NNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RP LPED+SPDLAFI+QSCW
Sbjct: 221 NNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPALPEDVSPDLAFIMQSCW 280
Query: 125 VEDPNLRPSFSQIIRMLNAFLF--TLRPPSPSVPESDTNEAAATSNGAMTEFSARARGKF 182
VEDPNLRPSF+QIIRMLNAFLF + P+PS+PESDTNEAA++SNG +TEFS+R RGKF
Sbjct: 281 VEDPNLRPSFNQIIRMLNAFLFTLSPPSPTPSLPESDTNEAASSSNGTITEFSSRTRGKF 340
Query: 183 AFLRQLFTAKRTKN 196
AFLRQLFTAK+T+N
Sbjct: 341 AFLRQLFTAKKTRN 354
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532165|ref|XP_003534644.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 333 bits (853), Expect = 3e-89, Method: Compositional matrix adjust.
Identities = 165/194 (85%), Positives = 177/194 (91%), Gaps = 2/194 (1%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K DNLLLT DQKS+KLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY
Sbjct: 177 LKPDNLLLTADQKSVKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 236
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
NNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RPG+P+DISP+LAF++QSCW
Sbjct: 237 NNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPGIPDDISPELAFVIQSCW 296
Query: 125 VEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTN--EAAATSNGAMTEFSARARGKF 182
VEDPNLRPSFSQIIRMLNAFLFTL PPSP +P N E A TSNG +TEFSAR RGKF
Sbjct: 297 VEDPNLRPSFSQIIRMLNAFLFTLSPPSPPLPVPPDNEPEVATTSNGTITEFSARNRGKF 356
Query: 183 AFLRQLFTAKRTKN 196
FLRQLF++KRTKN
Sbjct: 357 GFLRQLFSSKRTKN 370
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439809|ref|XP_004137678.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 330 bits (847), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 163/197 (82%), Positives = 176/197 (89%), Gaps = 3/197 (1%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K DNLLLT +Q+S+KLADFGLAREE+VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY
Sbjct: 177 LKPDNLLLTANQRSVKLADFGLAREESVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 236
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
NNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RP +P DISP+LAFIVQSCW
Sbjct: 237 NNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPSIPGDISPELAFIVQSCW 296
Query: 125 VEDPNLRPSFSQIIRMLNAFLFTL---RPPSPSVPESDTNEAAATSNGAMTEFSARARGK 181
VEDPN+RPSFSQIIRMLNA+LFTL SPS P+SDT E A TSN A+TEFS+RARGK
Sbjct: 297 VEDPNMRPSFSQIIRMLNAYLFTLPPPSQSSPSSPKSDTTETATTSNSAITEFSSRARGK 356
Query: 182 FAFLRQLFTAKRTKNLQ 198
F FLRQLF AKR KN Q
Sbjct: 357 FGFLRQLFAAKRAKNSQ 373
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449521717|ref|XP_004167876.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 330 bits (847), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 163/197 (82%), Positives = 176/197 (89%), Gaps = 3/197 (1%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K DNLLLT +Q+S+KLADFGLAREE+VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY
Sbjct: 177 LKPDNLLLTANQRSVKLADFGLAREESVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 236
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
NNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RP +P DISP+LAFIVQSCW
Sbjct: 237 NNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPSIPGDISPELAFIVQSCW 296
Query: 125 VEDPNLRPSFSQIIRMLNAFLFTL---RPPSPSVPESDTNEAAATSNGAMTEFSARARGK 181
VEDPN+RPSFSQIIRMLNA+LFTL SPS P+SDT E A TSN A+TEFS+RARGK
Sbjct: 297 VEDPNMRPSFSQIIRMLNAYLFTLPPPSQSSPSSPKSDTTETATTSNSAITEFSSRARGK 356
Query: 182 FAFLRQLFTAKRTKNLQ 198
F FLRQLF AKR KN Q
Sbjct: 357 FGFLRQLFAAKRAKNSQ 373
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388513773|gb|AFK44948.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 328 bits (840), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 156/190 (82%), Positives = 171/190 (90%), Gaps = 2/190 (1%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K DNLLLT +QKS+KLADFGLAREE+VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY
Sbjct: 170 LKPDNLLLTANQKSVKLADFGLAREESVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 229
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
NNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RP +P+DISPDLAF++QSCW
Sbjct: 230 NNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPKIPDDISPDLAFVIQSCW 289
Query: 125 VEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATS--NGAMTEFSARARGKF 182
VEDPNLRPSFSQIIRMLN FLFTL P P +PE D AAT+ NGA+TEFSAR +GKF
Sbjct: 290 VEDPNLRPSFSQIIRMLNEFLFTLSPLFPPLPEPDNEPKAATTSNNGAITEFSARNKGKF 349
Query: 183 AFLRQLFTAK 192
AF RQLF++K
Sbjct: 350 AFFRQLFSSK 359
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357506575|ref|XP_003623576.1| Protein kinase, putative [Medicago truncatula] gi|355498591|gb|AES79794.1| Protein kinase, putative [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 324 bits (831), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 161/194 (82%), Positives = 176/194 (90%), Gaps = 2/194 (1%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K DNLLLT +QKS+KLADFGLAREE+VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY
Sbjct: 170 LKPDNLLLTANQKSVKLADFGLAREESVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 229
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
NNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RP +P+DISPDLAF++QSCW
Sbjct: 230 NNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPKIPDDISPDLAFVIQSCW 289
Query: 125 VEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATS--NGAMTEFSARARGKF 182
VEDPNLRPSFSQIIRMLN FLFTL P SP +PE D AAT+ NGA+TEFSAR +GKF
Sbjct: 290 VEDPNLRPSFSQIIRMLNEFLFTLSPLSPPLPEPDNEPKAATTSNNGAITEFSARNKGKF 349
Query: 183 AFLRQLFTAKRTKN 196
AFLRQLF++KR KN
Sbjct: 350 AFLRQLFSSKRIKN 363
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297810213|ref|XP_002872990.1| hypothetical protein ARALYDRAFT_324798 [Arabidopsis lyrata subsp. lyrata] gi|297318827|gb|EFH49249.1| hypothetical protein ARALYDRAFT_324798 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 324 bits (830), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 156/192 (81%), Positives = 169/192 (88%), Gaps = 7/192 (3%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K DNLLLT + KS+KLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY
Sbjct: 152 LKPDNLLLTENHKSVKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 211
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
NNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RPG+PE ISP LAFIVQSCW
Sbjct: 212 NNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQQRPGMPEGISPSLAFIVQSCW 271
Query: 125 VEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSNGAMTEFSARARGKFAF 184
VEDPN+RPSFSQIIR+LN FL TL PP PE+DTN T+ A+TEFS+RA+GKFAF
Sbjct: 272 VEDPNMRPSFSQIIRLLNEFLLTLTPP----PETDTNR---TNGRAITEFSSRAKGKFAF 324
Query: 185 LRQLFTAKRTKN 196
+RQLF AKR N
Sbjct: 325 IRQLFAAKRNIN 336
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 198 | ||||||
| TAIR|locus:2180992 | 333 | AT5G01850 [Arabidopsis thalian | 0.954 | 0.567 | 0.725 | 5.5e-70 | |
| TAIR|locus:2091423 | 356 | ATN1 [Arabidopsis thaliana (ta | 0.737 | 0.410 | 0.639 | 1.1e-46 | |
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.767 | 0.439 | 0.607 | 2.7e-45 | |
| TAIR|locus:2168778 | 353 | AT5G40540 [Arabidopsis thalian | 0.722 | 0.405 | 0.638 | 3.4e-45 | |
| TAIR|locus:2173674 | 405 | AT5G66710 [Arabidopsis thalian | 0.838 | 0.409 | 0.464 | 4.6e-34 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.656 | 0.316 | 0.446 | 8.2e-28 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.656 | 0.315 | 0.446 | 2.2e-27 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.666 | 0.231 | 0.404 | 5.4e-24 | |
| TAIR|locus:2101689 | 377 | AT3G50720 [Arabidopsis thalian | 0.676 | 0.355 | 0.416 | 4.8e-23 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.646 | 0.222 | 0.423 | 1.5e-22 |
| TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 709 (254.6 bits), Expect = 5.5e-70, P = 5.5e-70
Identities = 140/193 (72%), Positives = 153/193 (79%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHY 64
+K DNLLLT + KS+KLADFGLAR YRWMAPELYSTVTLRQGEKKHY
Sbjct: 143 LKPDNLLLTENHKSVKLADFGLAREESVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 202
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
NNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RP +PE ISP LAFIVQSCW
Sbjct: 203 NNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPVMPEGISPSLAFIVQSCW 262
Query: 125 VEDPNLRPSFSQIIRMLNAFLFTLRPPSPS-VPESDTNEAAATSNGAMTEFSARARGKFA 183
VEDPN+RPSFSQIIR+LN FL TL PP P +PE+ TN T+ A+TEFS R +GKFA
Sbjct: 263 VEDPNMRPSFSQIIRLLNEFLLTLTPPPPQPLPETATNR---TNGRAITEFSIRPKGKFA 319
Query: 184 FLRQLFTAKRTKN 196
F+RQLF AKR N
Sbjct: 320 FIRQLFAAKRNIN 332
|
|
| TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 489 (177.2 bits), Expect = 1.1e-46, P = 1.1e-46
Identities = 94/147 (63%), Positives = 111/147 (75%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHY 64
+K +NL+L+ D K++KLADFGLAR YRWMAPELYSTVTLRQGEKKHY
Sbjct: 151 LKPENLILSADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 210
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
N+KVD YSF IVLWEL+ N+LPFEGMSNLQAAYAAAFK+ RP ED+ DL IV SCW
Sbjct: 211 NHKVDAYSFAIVLWELILNKLPFEGMSNLQAAYAAAFKNLRPSA-EDLPGDLEMIVTSCW 269
Query: 125 VEDPNLRPSFSQIIRMLNAFLFTLRPP 151
EDPN RP+F++II+ML +L T+ P
Sbjct: 270 KEDPNERPNFTEIIQMLLRYLTTVSAP 296
|
|
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 476 (172.6 bits), Expect = 2.7e-45, P = 2.7e-45
Identities = 93/153 (60%), Positives = 110/153 (71%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHY 64
+K +NLLLT D K++KLADFGLAR YRWMAPELYSTVTLR GEKKHY
Sbjct: 145 LKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRLGEKKHY 204
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
N+KVD YSF IVLWELL N+LPFEGMSNLQAAYAAAFK+ RP E + +L IV SCW
Sbjct: 205 NHKVDAYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ESLPEELGDIVTSCW 263
Query: 125 VEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPE 157
EDPN RP+F+ II +L +L + P ++P+
Sbjct: 264 NEDPNARPNFTHIIELLLNYLSKVGSPISAIPQ 296
|
|
| TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 475 (172.3 bits), Expect = 3.4e-45, P = 3.4e-45
Identities = 92/144 (63%), Positives = 109/144 (75%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHY 64
+K ++L+LT D K++KLADFGLAR YRWMAPELYSTVTLR GEKKHY
Sbjct: 151 LKPESLILTADYKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRHGEKKHY 210
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
N+KVD YSF IVLWEL+ N+LPFEGMSNLQAAYAAAFK+ RP +D+ DLA IV SCW
Sbjct: 211 NHKVDAYSFAIVLWELIHNKLPFEGMSNLQAAYAAAFKNVRPSA-DDLPKDLAMIVTSCW 269
Query: 125 VEDPNLRPSFSQIIRMLNAFLFTL 148
EDPN RP+F++II+ML L T+
Sbjct: 270 KEDPNDRPNFTEIIQMLLRCLSTI 293
|
|
| TAIR|locus:2173674 AT5G66710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 370 (135.3 bits), Expect = 4.6e-34, P = 4.6e-34
Identities = 79/170 (46%), Positives = 105/170 (61%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHY 64
+K N+LLT DQK +KLADFGLAR YRWMAPEL+S TL GEKKHY
Sbjct: 197 LKPSNMLLTGDQKHVKLADFGLAREETKGFMTFEAGT-YRWMAPELFSYDTLEIGEKKHY 255
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
++KVDVYSF IV WELLTN+ PF+G +N+ AYAA+ K+ RP + E++ + I+QSCW
Sbjct: 256 DHKVDVYSFAIVFWELLTNKTPFKGKNNIFVAYAAS-KNQRPSV-ENLPEGVVSILQSCW 313
Query: 125 VEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPE-SDTNEAAATSNGAMTE 173
E+P+ RP F +I L L +L + + S N A S ++ +
Sbjct: 314 AENPDARPEFKEITYSLTNLLRSLSSDTDATSSNSKANIATEDSTSSLVQ 363
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 311 (114.5 bits), Expect = 8.2e-28, P = 8.2e-28
Identities = 62/139 (44%), Positives = 87/139 (62%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHY 64
+K DNLL++ D KS+K+ADFG+AR YRWMAPE+ + + Y
Sbjct: 257 LKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI--------QHRAY 307
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
N KVDVYSFGIVLWEL+T LPF+ M+ +QAA+A + RP +P D P L+ I+ CW
Sbjct: 308 NQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPNDCLPVLSDIMTRCW 367
Query: 125 VEDPNLRPSFSQIIRMLNA 143
+P +RP F +++++L A
Sbjct: 368 DANPEVRPCFVEVVKLLEA 386
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 307 (113.1 bits), Expect = 2.2e-27, P = 2.2e-27
Identities = 62/139 (44%), Positives = 85/139 (61%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHY 64
+K DNLL++ D +S+K+ADFG+AR YRWMAPE+ + + Y
Sbjct: 258 LKSDNLLISAD-RSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI--------QHRPY 308
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
KVDVYSFGIVLWEL+T LPF+ M+ +QAA+A + RP +P D P L I+ CW
Sbjct: 309 TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPADCLPVLGEIMTRCW 368
Query: 125 VEDPNLRPSFSQIIRMLNA 143
DP +RP F++I+ +L A
Sbjct: 369 DADPEVRPCFAEIVNLLEA 387
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 282 (104.3 bits), Expect = 5.4e-24, P = 5.4e-24
Identities = 57/141 (40%), Positives = 84/141 (59%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHY 64
+K NLL+ + + +K+ADFG+AR YRWMAPE+ E K Y
Sbjct: 414 LKTANLLMD-EHEVVKVADFGVARVQTESGVMTAETGTYRWMAPEVI--------EHKPY 464
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
+++ DV+S+ IVLWELLT LP+ ++ LQAA K RP +P++ P L +++ CW
Sbjct: 465 DHRADVFSYAIVLWELLTGELPYSYLTPLQAAVGVVQKGLRPKIPKETHPKLTELLEKCW 524
Query: 125 VEDPNLRPSFSQIIRMLNAFL 145
+DP LRP+F++II MLN +
Sbjct: 525 QQDPALRPNFAEIIEMLNQLI 545
|
|
| TAIR|locus:2101689 AT3G50720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 266 (98.7 bits), Expect = 4.8e-23, P = 4.8e-23
Identities = 57/137 (41%), Positives = 76/137 (55%)
Query: 9 NLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKV 68
N+L+T D K +KLADFGLAR YRWMAPE+ S LR GEKKHY+ K+
Sbjct: 178 NVLVTGDMKHVKLADFGLAREKTLGGMTCEAGT-YRWMAPEVCSREPLRIGEKKHYDQKI 236
Query: 69 DVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDP 128
DVYSF ++ W LLTN+ PF + ++ Y + RP L +I ++ I++ CW D
Sbjct: 237 DVYSFALIFWSLLTNKTPFSEIPSISIPYFVN-QGKRPSL-SNIPDEVVPILECCWAADS 294
Query: 129 NLRPSFSQIIRMLNAFL 145
R F I L + L
Sbjct: 295 KTRLEFKDITISLESLL 311
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 269 (99.8 bits), Expect = 1.5e-22, P = 1.5e-22
Identities = 58/137 (42%), Positives = 80/137 (58%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHY 64
+K NLL+ + + +K+ADFG+AR YRWMAPE+ E K Y
Sbjct: 412 LKAANLLMD-ENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVI--------EHKPY 462
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
++K DV+S+GIVLWELLT +LP+E M+ LQAA K RP +P++ P LA +++ W
Sbjct: 463 DHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTIPKNTHPKLAELLERLW 522
Query: 125 VEDPNLRPSFSQIIRML 141
D RP FS+II L
Sbjct: 523 EHDSTQRPDFSEIIEQL 539
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 198 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-33 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-30 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-23 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-23 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-17 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-16 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-16 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-15 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-14 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-14 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-13 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-12 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-10 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-09 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-09 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-09 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-08 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-04 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.001 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.001 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 0.001 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 0.001 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.002 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.003 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 9e-34
Identities = 46/136 (33%), Positives = 75/136 (55%), Gaps = 13/136 (9%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETG--TYRWMAPELYSTVTLRQGEKKHYNN 66
N L+ + +K++DFGL+R+ + G RWMAPE +L++G+ + +
Sbjct: 132 NCLVG-ENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE-----SLKEGK---FTS 182
Query: 67 KVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 125
K DV+SFG++LWE+ T P+ GMSN + R P + P+L ++ CW
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK-NGYRLPQPPNCPPELYDLMLQCWA 241
Query: 126 EDPNLRPSFSQIIRML 141
EDP RP+FS+++ +L
Sbjct: 242 EDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 1e-33
Identities = 47/136 (34%), Positives = 77/136 (56%), Gaps = 13/136 (9%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETG--TYRWMAPELYSTVTLRQGEKKHYNN 66
N L+ + +K++DFGL+R+ + + G RWMAPE +L++G+ + +
Sbjct: 133 NCLVG-ENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE-----SLKEGK---FTS 183
Query: 67 KVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 125
K DV+SFG++LWE+ T P+ GMSN + K R P + P+L ++ CW
Sbjct: 184 KSDVWSFGVLLWEIFTLGEEPYPGMSNAEV-LEYLKKGYRLPKPPNCPPELYKLMLQCWA 242
Query: 126 EDPNLRPSFSQIIRML 141
EDP RP+FS+++ +L
Sbjct: 243 EDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-33
Identities = 48/138 (34%), Positives = 72/138 (52%), Gaps = 11/138 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K +N+LL D +KLADFGLAR+ E +T GT +MAPE+ K Y
Sbjct: 123 LKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL--------GKGY 173
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQS 122
VD++S G++L+ELLT + PF G L + K P P DISP+ +++
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233
Query: 123 CWVEDPNLRPSFSQIIRM 140
V+DP R + + ++
Sbjct: 234 LLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-31
Identities = 48/137 (35%), Positives = 74/137 (54%), Gaps = 14/137 (10%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYN 65
N L+ D +K++DFGL+R+ + +TG RWMAPE +L+ G +
Sbjct: 135 NCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE-----SLKDG---IFT 185
Query: 66 NKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
+K DV+SFG++LWE+ T P+ G+SN + K R PE +L ++ SCW
Sbjct: 186 SKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-LEYLRKGYRLPKPEYCPDELYELMLSCW 244
Query: 125 VEDPNLRPSFSQIIRML 141
DP RP+FS+++ L
Sbjct: 245 QLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-30
Identities = 45/137 (32%), Positives = 72/137 (52%), Gaps = 14/137 (10%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYN 65
N L+T + +K++DFGL+R+ + G +WMAPE L+ G+ +
Sbjct: 132 NCLVT-ENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES-----LKDGK---FT 182
Query: 66 NKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
+K DV+SFG++LWE+ T P+ GMSN + R PE+ +L ++ CW
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV-LELLEDGYRLPRPENCPDELYELMLQCW 241
Query: 125 VEDPNLRPSFSQIIRML 141
DP RP+FS+++ L
Sbjct: 242 AYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-28
Identities = 46/140 (32%), Positives = 73/140 (52%), Gaps = 16/140 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K +N+LL + +K+ADFGLA++ + +T GT +MAPE+ L G
Sbjct: 124 LKPENILLDENG-VVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEV-----LLGG--NG 175
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED------ISPDLA 117
Y KVDV+S G++L+ELLT + PF G N+ + P L D S +
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234
Query: 118 FIVQSCWVEDPNLRPSFSQI 137
+++ C +DP+ RP+ +I
Sbjct: 235 DLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (232), Expect = 3e-23
Identities = 45/137 (32%), Positives = 72/137 (52%), Gaps = 11/137 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K N+ LT + +KL DFG+++ + ++ GT +++PEL + K
Sbjct: 129 IKPQNIFLTSNGL-VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC--------QNKP 179
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
YN K D++S G VL+EL T + PFEG + L+ A P +P S +L +V S
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP-IPSQYSSELRNLVSSL 238
Query: 124 WVEDPNLRPSFSQIIRM 140
+DP RPS +QI++
Sbjct: 239 LQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 8e-23
Identities = 41/135 (30%), Positives = 63/135 (46%), Gaps = 13/135 (9%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
K N+L+ D +KLADFG A+ + E + GT WMAPE+ +R E
Sbjct: 128 KGANILVDSDGV-VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-----IRGEE-- 179
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA-YAAAFKHARPGLPEDISPDLAFIVQ 121
Y D++S G + E+ T + P+ + N AA Y P +PE +S + ++
Sbjct: 180 -YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238
Query: 122 SCWVEDPNLRPSFSQ 136
C DP RP+ +
Sbjct: 239 KCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 9e-23
Identities = 37/137 (27%), Positives = 60/137 (43%), Gaps = 41/137 (29%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-GTYRWMAPELYSTVTLRQGEKKHY 64
K +N+LL D +KLADFGL++ T + + GT +MAPE+ K +Y
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLL-------GKGYY 171
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
+ K D++S G++L+EL P+L +++
Sbjct: 172 SEKSDIWSLGVILYEL---------------------------------PELKDLIRKML 198
Query: 125 VEDPNLRPSFSQIIRML 141
+DP RPS +I+ L
Sbjct: 199 QKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-20
Identities = 42/129 (32%), Positives = 68/129 (52%), Gaps = 15/129 (11%)
Query: 18 SLKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 74
++K+ DFG+ R+ T+ RWMAPE +L+ G + K DV+SFG
Sbjct: 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE-----SLKDG---VFTTKSDVWSFG 208
Query: 75 IVLWELLT-NRLPFEGMSNLQA-AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP 132
+VLWE+ T P++G+SN + + H LPE+ L +++ CW +P +RP
Sbjct: 209 VVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD--LPENCPDKLLELMRMCWQYNPKMRP 266
Query: 133 SFSQIIRML 141
+F +I+ L
Sbjct: 267 TFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 4e-19
Identities = 47/140 (33%), Positives = 69/140 (49%), Gaps = 19/140 (13%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
K DN+LL+ D S+KLADFG A + T + GT WMAPE+ +K Y
Sbjct: 143 KSDNILLSKD-GSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK--------RKDY 193
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-----EDISPDLAFI 119
KVD++S GI+ E+ P+ L+A + K G+P E SP+
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK----GIPPLKNPEKWSPEFKDF 249
Query: 120 VQSCWVEDPNLRPSFSQIIR 139
+ C V+DP RPS ++++
Sbjct: 250 LNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-18
Identities = 48/140 (34%), Positives = 69/140 (49%), Gaps = 21/140 (15%)
Query: 12 LTPDQKSLKLADFGLAREETVTEMMTAETGT----YRWMAPELYSTVTLRQGEKKHYNNK 67
L + LK++DFG++REE + T G +W APE L G Y ++
Sbjct: 125 LVGENNVLKISDFGMSREEE-GGIYTVSDGLKQIPIKWTAPE-----ALNYGR---YTSE 175
Query: 68 VDVYSFGIVLWELLT-NRLPFEGMSNLQA--AYAAAFKHARPGL-PEDISPDLAFIVQSC 123
DV+S+GI+LWE + P+ GMSN Q + ++ P L PE+I ++ C
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYR----LMLQC 231
Query: 124 WVEDPNLRPSFSQIIRMLNA 143
W DP RPSFS+I L
Sbjct: 232 WAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-18
Identities = 40/136 (29%), Positives = 73/136 (53%), Gaps = 18/136 (13%)
Query: 12 LTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKV 68
L + +K++DFGLAR + + T+ GT +W PE++ +++K
Sbjct: 132 LVGEDNVVKVSDFGLARY-VLDDQYTSSQGTKFPVKWAPPEVFD--------YSRFSSKS 182
Query: 69 DVYSFGIVLWELLT-NRLPFEGMSNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWV 125
DV+SFG+++WE+ + ++P+E SN + +A ++ RP L ++ I+ SCW
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKL---APTEVYTIMYSCWH 239
Query: 126 EDPNLRPSFSQIIRML 141
E P RP+F +++ L
Sbjct: 240 EKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-17
Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 25/136 (18%)
Query: 20 KLADFGLAREETVTEMMTAETGTY---------RWMAPELYSTVTLRQGEKKHYNNKVDV 70
K++DFGL+R +E TY RW APE + R + + DV
Sbjct: 146 KVSDFGLSRRLEDSE------ATYTTKGGKIPIRWTAPE---AIAYR-----KFTSASDV 191
Query: 71 YSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPN 129
+SFGIV+WE+++ P+ MSN Q A R P D L ++ CW +D N
Sbjct: 192 WSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRN 250
Query: 130 LRPSFSQIIRMLNAFL 145
RP+FSQI+ L+ +
Sbjct: 251 ERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 7e-17
Identities = 50/138 (36%), Positives = 72/138 (52%), Gaps = 17/138 (12%)
Query: 6 KEDNLLLTPDQKSLKLADFGLA-REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
K N+L T D +KLADFG+A + V++ + GT WMAPE V G
Sbjct: 126 KAANILTTKDG-VVKLADFGVATKLNDVSKDDASVVGTPYWMAPE----VIEMSG----A 176
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA---RPGLPEDISPDLAFIVQ 121
+ D++S G + ELLT P+ +L AA F+ P LPE ISP+L +
Sbjct: 177 STASDIWSLGCTVIELLTGNPPY---YDLNPM-AALFRIVQDDHPPLPEGISPELKDFLM 232
Query: 122 SCWVEDPNLRPSFSQIIR 139
C+ +DPNLRP+ Q+++
Sbjct: 233 QCFQKDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-16
Identities = 40/141 (28%), Positives = 66/141 (46%), Gaps = 17/141 (12%)
Query: 6 KEDNLLLTPDQKSLKLADFG----LAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGE 60
K N+ L +KL DFG L T E + + GT +MAPE+ G+
Sbjct: 126 KPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI-----TGGK 179
Query: 61 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHARPGLPE--DISPD-L 116
K + D++S G V+ E+ T + P+ + N Q + H +P +P+ +SP+
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPPIPDSLQLSPEGK 238
Query: 117 AFIVQSCWVEDPNLRPSFSQI 137
F+ + C DP RP+ S++
Sbjct: 239 DFLDR-CLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-16
Identities = 39/137 (28%), Positives = 66/137 (48%), Gaps = 13/137 (9%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKH 63
K N+ L ++KL DFGLA+ + A+T GT +M+PE +
Sbjct: 137 KPANIFLD-ANNNVKLGDFGLAKILG-HDSSFAKTYVGTPYYMSPEQLN--------HMS 186
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
Y+ K D++S G +++EL PF + LQ A R +P S +L +++S
Sbjct: 187 YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR-IPYRYSSELNEVIKSM 245
Query: 124 WVEDPNLRPSFSQIIRM 140
DP+ RPS +++++
Sbjct: 246 LNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-16
Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 44 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFK 102
RW+APE +++ + ++ K DV+SFG+++WE+ T LPF G+S+ +
Sbjct: 183 RWLAPE-----AVQEDD---FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG 234
Query: 103 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141
+PE L ++ CW +P RPSFS+++ L
Sbjct: 235 KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-16
Identities = 44/139 (31%), Positives = 74/139 (53%), Gaps = 17/139 (12%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNN 66
N+L++ + K++DFGLA+E + + ++G +W APE LR +K ++
Sbjct: 132 NVLVS-EDLVAKVSDFGLAKEASQGQ----DSGKLPVKWTAPE-----ALR---EKKFST 178
Query: 67 KVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 125
K DV+SFGI+LWE+ + R+P+ + L+ K R PE P++ +++ CW
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWE 237
Query: 126 EDPNLRPSFSQIIRMLNAF 144
DP RP+F Q+ L
Sbjct: 238 LDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-16
Identities = 41/130 (31%), Positives = 63/130 (48%), Gaps = 14/130 (10%)
Query: 4 FMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEK 61
+K +N+LL +KL DFGLA+E +E T GT ++APE V L +G
Sbjct: 118 DLKPENILLD-ADGHIKLTDFGLAKEL-SSEGSRTNTFCGTPEYLAPE----VLLGKG-- 169
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQ 121
Y VD +S G++L+E+LT + PF + + Y PE +SP+ ++
Sbjct: 170 --YGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIY-EKILKDPLRFPEFLSPEARDLIS 225
Query: 122 SCWVEDPNLR 131
+DP R
Sbjct: 226 GLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 2e-16
Identities = 48/135 (35%), Positives = 65/135 (48%), Gaps = 15/135 (11%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKH 63
K N+LL + KLADFG++ + M T GT WMAPE V G
Sbjct: 126 KAGNILLNEE-GQAKLADFGVS-GQLTDTMAKRNTVIGTPFWMAPE----VIQEIG---- 175
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQ 121
YNNK D++S GI E+ + P+ + ++A + K P L PE SP+ V+
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPP-PTLSDPEKWSPEFNDFVK 234
Query: 122 SCWVEDPNLRPSFSQ 136
C V+DP RPS Q
Sbjct: 235 KCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-16
Identities = 41/135 (30%), Positives = 69/135 (51%), Gaps = 16/135 (11%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 68
N+L+ + +KLADFG+A++ + G+ WMAPE V +QG Y
Sbjct: 132 NILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE----VIAQQGG---YGLAA 183
Query: 69 DVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR----PGLPEDISPDLAFIVQSCW 124
D++S G + E+ T + P+ S L+ AA FK R P +P+ +S + + C
Sbjct: 184 DIWSLGCTVLEMATGKPPW---SQLEG-VAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239
Query: 125 VEDPNLRPSFSQIIR 139
DP+LRP+ ++++
Sbjct: 240 QRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-16
Identities = 44/130 (33%), Positives = 66/130 (50%), Gaps = 18/130 (13%)
Query: 11 LLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYN 65
+L + K+ADFGLAR ++ A G +W APE LY+ ++
Sbjct: 134 VLVGENNICKVADFGLARV-IKEDIYEAREGAKFPIKWTAPEAALYNRFSI--------- 183
Query: 66 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
K DV+SFGI+L E++T R+P+ GM+N + + P P +L I+ CW
Sbjct: 184 -KSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP-CPPGCPKELYDIMLDCW 241
Query: 125 VEDPNLRPSF 134
EDP+ RP+F
Sbjct: 242 KEDPDDRPTF 251
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 74.8 bits (182), Expect = 5e-16
Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 19/161 (11%)
Query: 6 KEDNLLLTPDQKSLKLADFGLARE-------ETVTEMMTAETGTYRWMAPELYSTVTLRQ 58
K +N+LL D + +KL DFGLA+ ++ + + GT +MAPE+ L
Sbjct: 128 KPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV-----LLG 182
Query: 59 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 118
+ ++ D++S GI L+ELLT PFEG N A + K ++ L+
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS-ATSQTLKIILELPTPSLASPLSP 241
Query: 119 IVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESD 159
+ + S +++ L A R S S D
Sbjct: 242 SNP------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
|
Length = 384 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-16
Identities = 48/141 (34%), Positives = 75/141 (53%), Gaps = 18/141 (12%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR-----WMAPELYSTVTLRQGEKKH 63
N L+T ++ LK++DFG++REE + + A TG + W APE L G
Sbjct: 124 NCLVT-EKNVLKISDFGMSREEE--DGVYASTGGMKQIPVKWTAPE-----ALNYGR--- 172
Query: 64 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
Y+++ DV+SFGI+LWE + +P+ +SN Q A + R PE + +++
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMER 231
Query: 123 CWVEDPNLRPSFSQIIRMLNA 143
CW DP RPSFS + + L +
Sbjct: 232 CWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 7e-16
Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 12/133 (9%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
K N+LLT D + +KL DFGL+ + + T+ GT WMAPE+ + K Y+
Sbjct: 125 KAANILLTSDGE-VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN--------GKPYD 175
Query: 66 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSC 123
K D++S GI EL + P+ + ++A + A PGL PE S + ++ C
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP-PGLRNPEKWSDEFKDFLKKC 234
Query: 124 WVEDPNLRPSFSQ 136
++P RP+ Q
Sbjct: 235 LQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 7e-16
Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 15/140 (10%)
Query: 10 LLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNN 66
L+ TP +K+ DFGLA+ + + AE G +WMA E ++ Y +
Sbjct: 141 LVKTPQH--VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE-----SILHRI---YTH 190
Query: 67 KVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 125
K DV+S+G+ +WEL+T P+EG+ K R P + D+ ++ CW+
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWM 249
Query: 126 EDPNLRPSFSQIIRMLNAFL 145
D RP+F ++I +
Sbjct: 250 IDAESRPTFKELINEFSKMA 269
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-15
Identities = 40/135 (29%), Positives = 71/135 (52%), Gaps = 21/135 (15%)
Query: 17 KSLKLADFGLAREETVTEMMTAETG---TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 73
+ +K+ DFGLAR+ ++ E RWMAPE +L G+ + + DV+SF
Sbjct: 148 RVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPE-----SLLDGK---FTTQSDVWSF 199
Query: 74 GIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDP 128
G+++WE+LT + P+ ++N + +H G PE+ + ++ +CW +DP
Sbjct: 200 GVLMWEILTLGQQPYPALNNQEV-----LQHVTAGGRLQKPENCPDKIYQLMTNCWAQDP 254
Query: 129 NLRPSFSQIIRMLNA 143
+ RP+F +I +L
Sbjct: 255 SERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-15
Identities = 42/125 (33%), Positives = 65/125 (52%), Gaps = 12/125 (9%)
Query: 19 LKLADFGLA-REETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 74
+KL DFG + R +T+ M + TGT WM+PE+ S GE Y K DV+S G
Sbjct: 143 VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS------GEG--YGRKADVWSVG 194
Query: 75 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 134
+ E+LT + P+ + A + A + P LP +SPD ++ +VE+ RPS
Sbjct: 195 CTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSA 254
Query: 135 SQIIR 139
+++R
Sbjct: 255 EELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-15
Identities = 44/144 (30%), Positives = 73/144 (50%), Gaps = 19/144 (13%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR----WMAPE-LYSTVTLRQGEKKH 63
N+LL+ + +K+ DFGLAR+ + G R WMAPE ++ V
Sbjct: 203 NILLS-ENNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPESIFDKV--------- 251
Query: 64 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQ 121
Y + DV+SFG++LWE+ + P+ G+ + + K R PE +P++ I+
Sbjct: 252 YTTQSDVWSFGVLLWEIFSLGASPYPGV-QIDEEFCRRLKEGTRMRAPEYATPEIYSIML 310
Query: 122 SCWVEDPNLRPSFSQIIRMLNAFL 145
CW +P RP+FS+++ +L L
Sbjct: 311 DCWHNNPEDRPTFSELVEILGDLL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-15
Identities = 38/143 (26%), Positives = 77/143 (53%), Gaps = 16/143 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREE----TVTEMMTAETGTYRWMAPELYSTVTLRQGE 60
+K DNLL+ D K++DFG++++ + M+ + G+ WMAPE+ +
Sbjct: 134 LKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPEVIHS------Y 185
Query: 61 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI- 119
+ Y+ KVD++S G V+ E+ R P+ + A + K + P +P D+S +L+ +
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVA 245
Query: 120 ---VQSCWVEDPNLRPSFSQIIR 139
+ +C+ +P+ RP+ ++++
Sbjct: 246 LDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-15
Identities = 42/129 (32%), Positives = 65/129 (50%), Gaps = 15/129 (11%)
Query: 20 KLADFGLAR--EETVTEMMTAETGT-YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76
K+ADFGLAR +E V ++++ Y+W APE S ++ K DV+SFGI+
Sbjct: 144 KVADFGLARLIKEDV--YLSSDKKIPYKWTAPEAAS--------HGTFSTKSDVWSFGIL 193
Query: 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 135
L+E+ T ++P+ GM+N Y R P ++ I+ CW +P RPSF
Sbjct: 194 LYEMFTYGQVPYPGMNN-HEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFK 252
Query: 136 QIIRMLNAF 144
+ L+
Sbjct: 253 ALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 5e-15
Identities = 45/139 (32%), Positives = 66/139 (47%), Gaps = 18/139 (12%)
Query: 12 LTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNN 66
L + K+ADFGLAR E TA G +W APE Y T+
Sbjct: 135 LVGENLVCKIADFGLARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTI---------- 183
Query: 67 KVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 125
K DV+SFGI+L E++T R+P+ GM+N + + P P + +L ++ CW
Sbjct: 184 KSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP-RPPNCPEELYDLMLQCWD 242
Query: 126 EDPNLRPSFSQIIRMLNAF 144
+DP RP+F + L +
Sbjct: 243 KDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 6e-15
Identities = 47/146 (32%), Positives = 76/146 (52%), Gaps = 24/146 (16%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHY 64
N+L+T D +K+ADFGLAR+ + T +WMAPE L+ V Y
Sbjct: 162 NVLVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV---------Y 211
Query: 65 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFI 119
++ DV+SFG++LWE+ T P+ G+ FK + G P++ + +L +
Sbjct: 212 THQSDVWSFGVLLWEIFTLGGSPYPGI-----PVEELFKLLKEGYRMEKPQNCTQELYHL 266
Query: 120 VQSCWVEDPNLRPSFSQIIRMLNAFL 145
++ CW E P+ RP+F Q++ L+ L
Sbjct: 267 MRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 6e-15
Identities = 34/133 (25%), Positives = 60/133 (45%), Gaps = 12/133 (9%)
Query: 5 MKEDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K DN+LL D++ + + DF +A + T + T+ +GT +MAPE+ +
Sbjct: 126 IKPDNILL--DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR--------QG 175
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
Y+ VD +S G+ +E L + P+ G S ++ A + A P S + +
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINK 235
Query: 123 CWVEDPNLRPSFS 135
DP R +
Sbjct: 236 LLERDPQKRLGDN 248
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 6e-15
Identities = 39/135 (28%), Positives = 71/135 (52%), Gaps = 16/135 (11%)
Query: 12 LTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNNKVD 69
L +K++DFG+ R E ++ + +W PE+++ Y++K D
Sbjct: 132 LVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF--------SKYSSKSD 183
Query: 70 VYSFGIVLWELLTN-RLPFEGMSNLQA--AYAAAFKHARPGLPEDISPDLAFIVQSCWVE 126
V+SFG+++WE+ T ++PFE SN + + F+ RP L S + ++ SCW E
Sbjct: 184 VWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLA---SMTVYEVMYSCWHE 240
Query: 127 DPNLRPSFSQIIRML 141
P RP+F++++R +
Sbjct: 241 KPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 9e-15
Identities = 40/150 (26%), Positives = 67/150 (44%), Gaps = 23/150 (15%)
Query: 3 KFMKED----NLLLTPDQKSLKLADFGLAREETV-TEMMTAETG---TYRWMAPEL--YS 52
F+ D N+LL ++ K++DFG++R ++ A T +W APE Y
Sbjct: 115 HFVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 53 TVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPED 111
+++K DV+S+G+ LWE + P+ M + A R PE+
Sbjct: 174 K----------FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-AMLESGERLPRPEE 222
Query: 112 ISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141
++ I+ SCW P RP+FS++
Sbjct: 223 CPQEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-14
Identities = 45/143 (31%), Positives = 69/143 (48%), Gaps = 28/143 (19%)
Query: 12 LTPDQKSLKLADFGLAREETVTEMMTAETGTY----------RWMAPELYSTVTLRQGEK 61
L + LK++DFG++R+E + G Y +W APE L G
Sbjct: 125 LVGENNVLKISDFGMSRQE--------DDGIYSSSGLKQIPIKWTAPE-----ALNYGR- 170
Query: 62 KHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 120
Y+++ DV+S+GI+LWE + P+ GM+N QA K R P+ D+ ++
Sbjct: 171 --YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVM 227
Query: 121 QSCWVEDPNLRPSFSQIIRMLNA 143
Q CW P RP FS++ + L A
Sbjct: 228 QRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-14
Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 10/136 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K N+ L+ + KL DFG+AR+ E+ GT +++PE+ + +
Sbjct: 127 IKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC--------QNRP 178
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
YNNK D++S G VL+EL T + PFEG + Q + P P + S DL ++
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISP-NFSRDLRSLISQL 237
Query: 124 WVEDPNLRPSFSQIIR 139
+ P RPS + I++
Sbjct: 238 FKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-14
Identities = 43/136 (31%), Positives = 74/136 (54%), Gaps = 18/136 (13%)
Query: 12 LTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKV 68
L + + +K++DFG+ R + + T+ TGT +W +PE++S Y++K
Sbjct: 132 LVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVFSF--------SKYSSKS 182
Query: 69 DVYSFGIVLWELLTN-RLPFEGMSNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWV 125
DV+SFG+++WE+ + + P+E SN + A F+ +P L S + ++Q CW
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRL---ASQSVYELMQHCWK 239
Query: 126 EDPNLRPSFSQIIRML 141
E P RPSFS ++ L
Sbjct: 240 ERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-14
Identities = 44/141 (31%), Positives = 73/141 (51%), Gaps = 21/141 (14%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPE-LYSTVTLRQGEKKHY 64
N+LLT K +K+ DFGLAR+ + +WMAPE +++ V Y
Sbjct: 171 NVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV---------Y 220
Query: 65 NNKVDVYSFGIVLWELLTNRL-PFEGM---SNLQAAYAAAFKHARPGLPEDISPDLAFIV 120
+ DV+S+GI+LWE+ + P+ GM S ++ A+P E ++ I+
Sbjct: 221 TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP---EHAPAEIYDIM 277
Query: 121 QSCWVEDPNLRPSFSQIIRML 141
++CW DP RP+F QI++++
Sbjct: 278 KTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-14
Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFG----LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGE 60
+K DN+L+ +K++DFG LA TE T GT ++MAPE+ + +G
Sbjct: 134 IKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEV-----IDKGP 185
Query: 61 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA-YAAAFKHARPGLPEDISPDLAFI 119
+ Y D++S G + E+ T + PF + QAA + P +PE +S +
Sbjct: 186 RG-YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244
Query: 120 VQSCWVEDPNLRPSFSQIIR 139
+ C+ DP+ R S +++
Sbjct: 245 ILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-14
Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 38/159 (23%)
Query: 12 LTPDQKSLKLADFGLAREETVTEMMTAETGTYR----------WMAPELYSTVTLRQGEK 61
+ ++K+ DFG+ R+ ET YR WMAPE +L+ G
Sbjct: 151 MVAHDFTVKIGDFGMTRD-------IYETDYYRKGGKGLLPVRWMAPE-----SLKDGVF 198
Query: 62 KHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDL 116
+ D++SFG+VLWE+ + P++G+SN Q K G P++ +
Sbjct: 199 TTSS---DMWSFGVVLWEITSLAEQPYQGLSNEQV-----LKFVMDGGYLDQPDNCPERV 250
Query: 117 AFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSV 155
+++ CW +P +RP+F +I+ +L L P P V
Sbjct: 251 TDLMRMCWQFNPKMRPTFLEIVNLLKD---DLHPSFPEV 286
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-14
Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K N+L+T +KL DFG+A + + GT WMAPE+ + E K+
Sbjct: 127 IKAANILVTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT-------EGKY 178
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED-ISPDLAFIVQS 122
Y+ K D++S GI ++E+ T P+ + +A K P L ++ S L V +
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP-KSKPPRLEDNGYSKLLREFVAA 237
Query: 123 CWVEDPNLRPSFSQIIRM 140
C E+P R S ++++
Sbjct: 238 CLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-14
Identities = 47/145 (32%), Positives = 70/145 (48%), Gaps = 28/145 (19%)
Query: 11 LLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPEL--YSTVTLRQGEKKHYNN 66
+L + K+ADFGLAR E E + +W APE Y T T+
Sbjct: 133 ILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI---------- 182
Query: 67 KVDVYSFGIVLWELLT-NRLPFEGMSN------LQAAYAAAFKHARPGLPEDISPDLAFI 119
K DV+SFGI+L E++T R+P+ GM+N L+ Y R P++ +L +
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY-------RMPRPDNCPEELYEL 235
Query: 120 VQSCWVEDPNLRPSFSQIIRMLNAF 144
++ CW E P RP+F + +L F
Sbjct: 236 MRLCWKEKPEERPTFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-14
Identities = 46/139 (33%), Positives = 72/139 (51%), Gaps = 17/139 (12%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR----WMAPE-LYSTVTLRQGEKKH 63
N+LLT + + K+ DFGLAR+ + G R WMAPE +++ V
Sbjct: 244 NILLTHGRIT-KICDFGLARDIR-NDSNYVVKGNARLPVKWMAPESIFNCV--------- 292
Query: 64 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
Y + DV+S+GI+LWE+ + P+ GM Y + R PE ++ I++S
Sbjct: 293 YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKS 352
Query: 123 CWVEDPNLRPSFSQIIRML 141
CW DP RP+F QI++++
Sbjct: 353 CWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 5e-14
Identities = 45/143 (31%), Positives = 69/143 (48%), Gaps = 17/143 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-------ETVTEMMTAETGTYRWMAPELYSTVTLR 57
+K +N++L P+ +KL DFG AR T + M+ + GT WMAPE+ +
Sbjct: 128 IKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN----- 181
Query: 58 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA-AAFKHARPGLPEDISPDL 116
+ Y K D++S G ++E+ T + P M L A + A + P LP+ S
Sbjct: 182 ---ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238
Query: 117 AFIVQSCWVEDPNLRPSFSQIIR 139
V SC D + RPS Q++R
Sbjct: 239 IDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-14
Identities = 45/144 (31%), Positives = 72/144 (50%), Gaps = 22/144 (15%)
Query: 11 LLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPE-----LYSTVTLRQGEKK 62
+L + K +K+ DFGLAR+ ++ T+ +WMAPE LY+T++
Sbjct: 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS------- 322
Query: 63 HYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQ 121
DV+SFGI+LWE+ T P+ + + Y A + R P S ++ I+Q
Sbjct: 323 ------DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQ 376
Query: 122 SCWVEDPNLRPSFSQIIRMLNAFL 145
CW E +RP FSQ++ ++ L
Sbjct: 377 KCWEEKFEIRPDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 5e-14
Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 16/133 (12%)
Query: 20 KLADFGLAR---EETVTEMMTAETG---TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 73
K++DFGL+R ++T T+ G RW APE + R+ + + DV+S+
Sbjct: 146 KVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE---AIAYRK-----FTSASDVWSY 197
Query: 74 GIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP 132
GIV+WE+++ P+ MSN Q A + R P D L ++ CW +D N RP
Sbjct: 198 GIVMWEVMSYGERPYWDMSN-QDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARP 256
Query: 133 SFSQIIRMLNAFL 145
F QI+ L+ +
Sbjct: 257 KFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-14
Identities = 39/142 (27%), Positives = 74/142 (52%), Gaps = 19/142 (13%)
Query: 11 LLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPE-LYSTVTLRQGEKKHYNN 66
+L + + +K++DFGL+R EE + +WMA E L+ + Y
Sbjct: 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI---------YTT 208
Query: 67 KVDVYSFGIVLWELLT-NRLPFEGMS--NLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
+ DV+SFG++LWE++T P+ G++ L ++ RP E+ S ++ ++ +C
Sbjct: 209 QSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERP---ENCSEEMYNLMLTC 265
Query: 124 WVEDPNLRPSFSQIIRMLNAFL 145
W ++P+ RP+F+ I + L +
Sbjct: 266 WKQEPDKRPTFADISKELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-14
Identities = 40/138 (28%), Positives = 68/138 (49%), Gaps = 13/138 (9%)
Query: 11 LLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNK 67
+L +Q +K++D GL+RE + + + RWM PE + G+ +++
Sbjct: 155 ILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPE-----AIMYGK---FSSD 206
Query: 68 VDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVE 126
D++SFG+VLWE+ + L P+ G SN + + P ED P + ++ CW E
Sbjct: 207 SDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLP-CSEDCPPRMYSLMTECWQE 265
Query: 127 DPNLRPSFSQIIRMLNAF 144
P+ RP F I L ++
Sbjct: 266 GPSRRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 8e-14
Identities = 42/144 (29%), Positives = 61/144 (42%), Gaps = 26/144 (18%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR----------WMAPELYSTVTLRQ 58
N+LL D K +K+ DFGL R E Y W APE T T
Sbjct: 127 NILLASDDK-VKIGDFGLMRALPQNEDH------YVMEEHLKVPFAWCAPESLRTRT--- 176
Query: 59 GEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 117
+++ DV+ FG+ LWE+ T P+ G+S Q + R PE D+
Sbjct: 177 -----FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIY 231
Query: 118 FIVQSCWVEDPNLRPSFSQIIRML 141
++ CW +P RP+F+ + L
Sbjct: 232 NVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-14
Identities = 43/137 (31%), Positives = 70/137 (51%), Gaps = 13/137 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K N+ LT D ++KL DFG+AR TV E+ GT +++PE+ E +
Sbjct: 127 IKSQNIFLTKD-GTIKLGDFGIARVLNSTV-ELARTCIGTPYYLSPEIC--------ENR 176
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
YNNK D+++ G VL+E+ T + FE N++ + + P + S DL +V
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQ 235
Query: 123 CWVEDPNLRPSFSQIIR 139
+ +P RPS + I+
Sbjct: 236 LFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-14
Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 11/136 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K NL L ++K+ D G+A+ T GT +++PEL E K
Sbjct: 127 IKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC--------EDKP 177
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
YN K DV++ G+VL+E T + PF+ +N A + P + + S LA ++ C
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDA-NNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236
Query: 124 WVEDPNLRPSFSQIIR 139
+D RP Q++R
Sbjct: 237 LTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 9e-14
Identities = 41/134 (30%), Positives = 66/134 (49%), Gaps = 9/134 (6%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+LL + +K+ DFG+++ + GT +++PEL E K Y
Sbjct: 127 LKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC--------EGKPY 178
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
N K D+++ G VL+EL + + FE +NL A + + SPDL ++ S
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFEA-ANLPALVLKIMSGTFAPISDRYSPDLRQLILSML 237
Query: 125 VEDPNLRPSFSQII 138
DP+ RP SQI+
Sbjct: 238 NLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-13
Identities = 42/135 (31%), Positives = 70/135 (51%), Gaps = 24/135 (17%)
Query: 12 LTPDQKSLKLADFGLAREETVTEMMTAETGT--------YRWMAPELYSTVTLRQGEKKH 63
L + +K+ADFGL+R +MT +T T +W APE +
Sbjct: 136 LVGENHLVKVADFGLSR------LMTGDTYTAHAGAKFPIKWTAPESLAYNK-------- 181
Query: 64 YNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
++ K DV++FG++LWE+ T + P+ G+ +L Y K R PE P + ++++
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKGYRMERPEGCPPKVYELMRA 240
Query: 123 CWVEDPNLRPSFSQI 137
CW +P+ RPSF++I
Sbjct: 241 CWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-13
Identities = 52/149 (34%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+LLT + ++KLADFG A ++ + GT WMAPE V L E Y
Sbjct: 141 IKAGNILLT-EPGTVKLADFGSA---SLVSPANSFVGTPYWMAPE----VILAMDEG-QY 191
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL-PEDISPDLAFIVQSC 123
+ KVDV+S GI EL + P M+ + A Y A ++ P L D S V SC
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSPTLSSNDWSDYFRNFVDSC 250
Query: 124 WVEDPNLRPSFSQIIRMLNAFLFTLRPPS 152
+ P RPS ++++ + F+ RPP+
Sbjct: 251 LQKIPQDRPSSEELLK--HRFVLRERPPT 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-13
Identities = 40/137 (29%), Positives = 68/137 (49%), Gaps = 14/137 (10%)
Query: 6 KEDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
K N+LL+ ++ +KLADFG++ + T+++ T GT WMAPE+ ++Q
Sbjct: 125 KAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTF-VGTPFWMAPEV-----IKQSG--- 174
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED-ISPDLAFIVQS 122
Y+ K D++S GI EL P + ++ + K+ P L + S V
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-KNNPPSLEGNKFSKPFKDFVSL 233
Query: 123 CWVEDPNLRPSFSQIIR 139
C +DP RPS ++++
Sbjct: 234 CLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-13
Identities = 44/151 (29%), Positives = 66/151 (43%), Gaps = 21/151 (13%)
Query: 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGE 60
M + +K N+L+ + +KL DFG++ E + + GT +M+PE QG
Sbjct: 126 MHRDIKPSNILVN-SRGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERI------QGG 177
Query: 61 KKHYNNKVDVYSFGIVLWELLTNRLPF---EGMSNLQAAYAAAF-------KHARPGLP- 109
K Y K DV+S GI + EL + PF + Q + P LP
Sbjct: 178 K--YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235
Query: 110 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 140
D DL V +C ++DP RP+ Q+ M
Sbjct: 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-13
Identities = 46/146 (31%), Positives = 75/146 (51%), Gaps = 23/146 (15%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR----WMAPE-LYSTVTLRQGEKKH 63
N+LLT D + K+ DFGLAR+ + + G R WMAPE ++ V
Sbjct: 242 NVLLT-DGRVAKICDFGLARD-IMNDSNYVVKGNARLPVKWMAPESIFDCV--------- 290
Query: 64 YNNKVDVYSFGIVLWELLT-NRLPFEGM---SNLQAAYAAAFKHARPGLPEDISPDLAFI 119
Y + DV+S+GI+LWE+ + + P+ G+ S ++ +RP P++ I
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFA---PPEIYSI 347
Query: 120 VQSCWVEDPNLRPSFSQIIRMLNAFL 145
++ CW +P RP+FSQI +++ L
Sbjct: 348 MKMCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-13
Identities = 40/133 (30%), Positives = 69/133 (51%), Gaps = 18/133 (13%)
Query: 12 LTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNN 66
L DQ +K++DFGL+R + + T+ G+ RW PE LYS +++
Sbjct: 132 LVDDQGCVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLLYSK----------FSS 180
Query: 67 KVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 125
K DV++FG+++WE+ + ++P+E +N + + R P S + I+ SCW
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL-RLYRPHLASEKVYAIMYSCWH 239
Query: 126 EDPNLRPSFSQII 138
E RP+F Q++
Sbjct: 240 EKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-13
Identities = 36/136 (26%), Positives = 63/136 (46%), Gaps = 6/136 (4%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
K N+L+ +KL DFG++ + T + G +MAPE + + +K Y+
Sbjct: 131 KPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINP----ELNQKGYD 185
Query: 66 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED-ISPDLAFIVQSCW 124
K DV+S GI + EL T R P++ + P LP + SP+ V C
Sbjct: 186 VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCL 245
Query: 125 VEDPNLRPSFSQIIRM 140
++ RP++ ++++
Sbjct: 246 KKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-13
Identities = 43/139 (30%), Positives = 72/139 (51%), Gaps = 10/139 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K N+LLT D +KLADFG++ + + + +T GT WMAPE+ + T +
Sbjct: 129 LKAGNILLTLD-GDVKLADFGVSAKNK-STLQKRDTFIGTPYWMAPEVVACETFKD---N 183
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIV 120
Y+ K D++S GI L EL P ++ ++ K P L P S +
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL-KSEPPTLDQPSKWSSSFNDFL 242
Query: 121 QSCWVEDPNLRPSFSQIIR 139
+SC V+DP+ RP+ +++++
Sbjct: 243 KSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-13
Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 27/161 (16%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE---TGTYRWMAPELYSTVTLRQGEK 61
+K D++LLT D + +KL+DFG + V++ + GT WMAPE+ S +
Sbjct: 141 IKSDSILLTSDGR-VKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPEVIS--------R 189
Query: 62 KHYNNKVDVYSFGIVLWELLT------NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 115
Y +VD++S GI++ E++ N P + M ++ K+ +SP
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKN-----LHKVSPR 244
Query: 116 LAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 156
L + V DP R + ++++ + FL PPS VP
Sbjct: 245 LRSFLDRMLVRDPAQRATAAELLN--HPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-13
Identities = 41/128 (32%), Positives = 65/128 (50%), Gaps = 12/128 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKH 63
+K DN+LL D +K+ADFG+ +E E + GT ++APE+ +G+K
Sbjct: 122 LKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL------KGQK-- 172
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
YN VD +SFG++L+E+L + PF G + + + RP P IS + +
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD--SILNDRPHFPRWISKEAKDCLSKL 230
Query: 124 WVEDPNLR 131
+ DP R
Sbjct: 231 FERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-13
Identities = 44/139 (31%), Positives = 70/139 (50%), Gaps = 16/139 (11%)
Query: 11 LLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPEL--YSTVTLRQGEKKHYNN 66
+L + K+ADFGLAR E E + +W APE + + T+
Sbjct: 134 VLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI---------- 183
Query: 67 KVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 125
K DV+SFGI+L+E++T ++P+ GMSN A + P E+ +L I+++CW
Sbjct: 184 KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP-RMENCPDELYDIMKTCWK 242
Query: 126 EDPNLRPSFSQIIRMLNAF 144
E RP+F + +L+ F
Sbjct: 243 EKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-13
Identities = 45/142 (31%), Positives = 75/142 (52%), Gaps = 16/142 (11%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHY 64
N+L+T D +K+ADFGLAR+ + T +WMAPE L+ V Y
Sbjct: 164 NVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV---------Y 213
Query: 65 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
++ DV+SFG++LWE+ T P+ G+ ++ + + R P + + +L I++ C
Sbjct: 214 THQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTHELYMIMREC 272
Query: 124 WVEDPNLRPSFSQIIRMLNAFL 145
W P+ RP+F Q++ L+ L
Sbjct: 273 WHAVPSQRPTFKQLVEDLDRVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-13
Identities = 43/136 (31%), Positives = 70/136 (51%), Gaps = 17/136 (12%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNN 66
N+L++ D + K++DFGLAR M + +W APE L+ + +++
Sbjct: 130 NILVSEDGVA-KVSDFGLAR----VGSMGVDNSKLPVKWTAPE-----ALKHKK---FSS 176
Query: 67 KVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 125
K DV+S+G++LWE+ + R P+ MS L+ K R PE D+ ++ SCW
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVEKGYRMEPPEGCPADVYVLMTSCWE 235
Query: 126 EDPNLRPSFSQIIRML 141
+P RPSF ++ L
Sbjct: 236 TEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-13
Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 14/136 (10%)
Query: 10 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNNK 67
L+ +PD +KL DFGL+R A G +WMAPE ++ R+ + +
Sbjct: 139 LVSSPD--CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE---SINFRR-----FTSA 188
Query: 68 VDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVE 126
DV+ FG+ +WE+L PF+G+ N R +P + P L ++ CW
Sbjct: 189 SDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 247
Query: 127 DPNLRPSFSQIIRMLN 142
DP+ RP F+++ L+
Sbjct: 248 DPSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 3e-13
Identities = 43/141 (30%), Positives = 62/141 (43%), Gaps = 23/141 (16%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR-QGEKKHY 64
K N+L+ + +KL DFG++ + V + GT +MAPE R QG Y
Sbjct: 128 KPSNILVN-SRGQIKLCDFGVSGQ-LVNSLAKTFVGTSSYMAPE-------RIQGN--DY 176
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF-------KHARPGLPEDI-SPDL 116
+ K D++S G+ L EL T R P+ F P LP SPD
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPY---PPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233
Query: 117 AFIVQSCWVEDPNLRPSFSQI 137
V C ++DP RPS+ ++
Sbjct: 234 QDFVNLCLIKDPRERPSYKEL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-13
Identities = 40/133 (30%), Positives = 68/133 (51%), Gaps = 25/133 (18%)
Query: 19 LKLADFGLAREETVTEMMTAETGTY---RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSF 73
+K+ADFGL+R + A RWM PE Y+ Y + DV+++
Sbjct: 169 VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN----------RYTTESDVWAY 218
Query: 74 GIVLWELLTNRL-PFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDP 128
G+VLWE+ + + P+ GM++ + Y + R G P++ +L +++ CW + P
Sbjct: 219 GVVLWEIFSYGMQPYYGMAHEEVIY-----YVRDGNVLSCPDNCPLELYNLMRLCWSKLP 273
Query: 129 NLRPSFSQIIRML 141
+ RPSF+ I R+L
Sbjct: 274 SDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-13
Identities = 43/139 (30%), Positives = 68/139 (48%), Gaps = 13/139 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K N+ LT +KL DFG+++ +E AET GT +M+PEL QG K
Sbjct: 127 IKTLNIFLTKAG-LIKLGDFGISKILG-SEYSMAETVVGTPYYMSPELC------QGVK- 177
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
YN K D+++ G VL+ELLT + F+ +N + + S +L +V S
Sbjct: 178 -YNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTPVVSVYSSELISLVHS 235
Query: 123 CWVEDPNLRPSFSQIIRML 141
+DP RP+ +++
Sbjct: 236 LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-13
Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 11/131 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K +N+LL + + L DFGL++E E A + GT +MAPE+ +R G
Sbjct: 131 IKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV-----IRGGSGG 184
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 120
H + VD +S G++ +ELLT PF +G N Q+ + ++P P+ +S + +
Sbjct: 185 H-DKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFI 243
Query: 121 QSCWVEDPNLR 131
Q +DP R
Sbjct: 244 QKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-13
Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 19/144 (13%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR----WMAPE-LYSTVTLRQGEKKH 63
N+LL+ + +K+ DFGLAR+ + G+ R WMAPE ++ V
Sbjct: 204 NILLS-ENNVVKICDFGLARD-IYKDPDYVRKGSARLPLKWMAPESIFDKV--------- 252
Query: 64 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQ 121
Y + DV+SFG++LWE+ + P+ G+ + + K R PE+ +P++ I+
Sbjct: 253 YTTQSDVWSFGVLLWEIFSLGASPYPGV-QINEEFCQRLKDGTRMRAPENATPEIYRIML 311
Query: 122 SCWVEDPNLRPSFSQIIRMLNAFL 145
+CW DP RP+FS ++ +L L
Sbjct: 312 ACWQGDPKERPTFSALVEILGDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-13
Identities = 46/145 (31%), Positives = 75/145 (51%), Gaps = 13/145 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEK 61
+K N+LL + +KL DFG ++ T ++ GT ++APE++ +
Sbjct: 169 IKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW--------RR 219
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQ 121
K Y+ K D++S G++L+ELLT + PF+G N++ LP ISP++ IV
Sbjct: 220 KPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGRYDPLPPSISPEMQEIVT 278
Query: 122 SCWVEDPNLRPSFSQIIRMLNAFLF 146
+ DP RPS S+++ M LF
Sbjct: 279 ALLSSDPKRRPSSSKLLNMPICKLF 303
|
Length = 496 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 8e-13
Identities = 48/130 (36%), Positives = 65/130 (50%), Gaps = 18/130 (13%)
Query: 11 LLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYN 65
+L D K+ADFGLAR E TA G +W APE LY T+
Sbjct: 133 ILVGDGLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTI--------- 182
Query: 66 NKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
K DV+SFGI+L EL+T R+P+ GM+N + + P P+D L ++ CW
Sbjct: 183 -KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP-CPQDCPISLHELMLQCW 240
Query: 125 VEDPNLRPSF 134
+DP RP+F
Sbjct: 241 KKDPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-12
Identities = 38/134 (28%), Positives = 56/134 (41%), Gaps = 25/134 (18%)
Query: 20 KLADFGLAREETVTEMMTAETGTY---RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFG 74
K+ DFG++R+ T+ T RWM PE +Y T DV+SFG
Sbjct: 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTES----------DVWSFG 211
Query: 75 IVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPN 129
+VLWE+ T + P+ G+SN + + G P ++ I+ CW DP
Sbjct: 212 VVLWEIFTYGKQPWYGLSNEE-----VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQ 266
Query: 130 LRPSFSQIIRMLNA 143
R + I L
Sbjct: 267 QRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-12
Identities = 45/131 (34%), Positives = 65/131 (49%), Gaps = 18/131 (13%)
Query: 20 KLADFGLAREETVTEMMTAETGTYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVL 77
K+ADFGL+R + V T RWMA E YS Y DV+S+G++L
Sbjct: 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV----------YTTNSDVWSYGVLL 213
Query: 78 WELLT-NRLPFEGMS--NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 134
WE+++ P+ GM+ L ++ +P +D DL ++ CW E P RPSF
Sbjct: 214 WEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDL---MRQCWREKPYERPSF 270
Query: 135 SQIIRMLNAFL 145
+QI+ LN L
Sbjct: 271 AQILVSLNRML 281
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-12
Identities = 42/131 (32%), Positives = 70/131 (53%), Gaps = 11/131 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +N+LL + + L DFGL++E E E + GT +MAP++ +R G+
Sbjct: 131 IKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI-----VRGGDGG 184
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 120
H + VD +S G++++ELLT PF +G N QA + + P P+++S I+
Sbjct: 185 H-DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDII 243
Query: 121 QSCWVEDPNLR 131
Q ++DP R
Sbjct: 244 QRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-12
Identities = 40/106 (37%), Positives = 60/106 (56%), Gaps = 18/106 (16%)
Query: 44 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ-AAY-AAA 100
+WMA E +L K Y++ DV+SFG++LWEL+T + P+ + + AAY
Sbjct: 184 KWMALE-----SL---VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG 235
Query: 101 FKHARPGLPEDIS-PDLAFIVQS-CWVEDPNLRPSFSQIIRMLNAF 144
++ A+P I+ PD F V + CW DP RPSFSQ+++ L F
Sbjct: 236 YRLAQP-----INCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-12
Identities = 43/142 (30%), Positives = 75/142 (52%), Gaps = 16/142 (11%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHY 64
N+L+T D +K+ADFGLAR+ + T +WMAPE L+ + Y
Sbjct: 170 NVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI---------Y 219
Query: 65 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
++ DV+SFG++LWE+ T P+ G+ ++ + + R P + + +L +++ C
Sbjct: 220 THQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDC 278
Query: 124 WVEDPNLRPSFSQIIRMLNAFL 145
W P+ RP+F Q++ L+ L
Sbjct: 279 WHAVPSQRPTFKQLVEDLDRIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-12
Identities = 43/132 (32%), Positives = 72/132 (54%), Gaps = 17/132 (12%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNN 66
N+L++ D + K++DFGL +E + T+ +TG +W APE LR+ K ++
Sbjct: 132 NVLVSEDNVA-KVSDFGLTKEASSTQ----DTGKLPVKWTAPE-----ALRE---KKFST 178
Query: 67 KVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 125
K DV+SFGI+LWE+ + R+P+ + L+ K + P+ P + +++ CW
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWH 237
Query: 126 EDPNLRPSFSQI 137
D RPSF Q+
Sbjct: 238 LDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-12
Identities = 40/138 (28%), Positives = 68/138 (49%), Gaps = 11/138 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+ +N++L D K + + DFGLA+++ +T+ GT + PE+ + E Y
Sbjct: 140 LTPNNIMLGEDDK-VTITDFGLAKQKQPESKLTSVVGTILYSCPEIV------KNEP--Y 190
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI-SPDLAFIVQSC 123
K DV++FG +L+++ T + PF + L A P LPE + S D+ ++ SC
Sbjct: 191 GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-LPEGMYSEDVTDVITSC 249
Query: 124 WVEDPNLRPSFSQIIRML 141
D RP Q+ M+
Sbjct: 250 LTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-12
Identities = 45/130 (34%), Positives = 68/130 (52%), Gaps = 23/130 (17%)
Query: 18 SLKLADFGLAREETVTEMMTAETG-----TYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 72
++K+ DFG+ R+ + E G RWM+PE +L+ G + DV+S
Sbjct: 157 TVKIGDFGMTRD--IYETDYYRKGGKGLLPVRWMSPE-----SLKDGV---FTTYSDVWS 206
Query: 73 FGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAF-IVQSCWVEDP 128
FG+VLWE+ T P++GMSN Q GL + D PD+ F +++ CW +P
Sbjct: 207 FGVVLWEIATLAEQPYQGMSNEQVLRFVM----EGGLLDKPDNCPDMLFELMRMCWQYNP 262
Query: 129 NLRPSFSQII 138
+RPSF +II
Sbjct: 263 KMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-12
Identities = 38/147 (25%), Positives = 63/147 (42%), Gaps = 23/147 (15%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAET---GTYRWMAPELYSTVTLRQG 59
+K N+LL D S+K+ADFG++ + GT WMAPE+
Sbjct: 128 IKAGNILLGED-GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME------- 179
Query: 60 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA--YAAAFKHARPGLPEDISPDL- 116
+ Y+ K D++SFGI EL T P+ S ++ P L
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPY---SKYPPMKVLMLTLQNDPPSLETGADYKKY 236
Query: 117 --AF--IVQSCWVEDPNLRPSFSQIIR 139
+F ++ C +DP+ RP+ ++++
Sbjct: 237 SKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-12
Identities = 40/136 (29%), Positives = 68/136 (50%), Gaps = 11/136 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K N+ LT +K+ D G+AR E +M + GT +M+PEL+S K
Sbjct: 128 LKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN--------KP 178
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
YN K DV++ G ++E+ T + F ++ + + P +P+D SP+L ++ +
Sbjct: 179 YNYKSDVWALGCCVYEMATLKHAFNA-KDMNSLVYRIIEGKLPPMPKDYSPELGELIATM 237
Query: 124 WVEDPNLRPSFSQIIR 139
+ P RPS I+R
Sbjct: 238 LSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-12
Identities = 46/140 (32%), Positives = 69/140 (49%), Gaps = 18/140 (12%)
Query: 11 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL--YSTVTLRQGEKKHYNNKV 68
+L + + K+ADFGL+R E V T RWMA E YS Y K
Sbjct: 150 VLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV----------YTTKS 199
Query: 69 DVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVED 127
DV+SFG++LWE+++ P+ GM+ + Y + R P + ++ +++ CW +
Sbjct: 200 DVWSFGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDR 258
Query: 128 PNLRPSFSQII----RMLNA 143
P RP F+QI RML A
Sbjct: 259 PYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-12
Identities = 44/137 (32%), Positives = 60/137 (43%), Gaps = 18/137 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-----TGTYRWMAPELYSTVTLRQG 59
+K NLL+ + L++ADFG A E GT +MAPE+ LR G
Sbjct: 129 VKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV-----LR-G 182
Query: 60 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR----PGLPEDISPD 115
E+ Y DV+S G V+ E+ T + P+ A FK A P +PE +SP
Sbjct: 183 EQ--YGRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFKIASATTAPSIPEHLSPG 239
Query: 116 LAFIVQSCWVEDPNLRP 132
L + C P RP
Sbjct: 240 LRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-12
Identities = 46/139 (33%), Positives = 67/139 (48%), Gaps = 16/139 (11%)
Query: 11 LLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPE--LYSTVTLRQGEKKHYNN 66
+L D K+ADFGLAR E + + +W APE LY T+
Sbjct: 133 ILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI---------- 182
Query: 67 KVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 125
K DV+SFGI+L EL+T R+P+ GM N + + P P+ L +++ CW
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP-CPQGCPESLHELMKLCWK 241
Query: 126 EDPNLRPSFSQIIRMLNAF 144
+DP+ RP+F I L +
Sbjct: 242 KDPDERPTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 4e-12
Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 21/142 (14%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELYSTVTLR-QGEKK 62
K NLL+ +K+ADFG+++ E T+ + T GT +M+PE R QGE
Sbjct: 127 KPSNLLINSKG-EVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE-------RIQGE-- 175
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH----ARPGLPED-ISPDLA 117
Y+ D++S G+ L E + PF Q ++ + P LP + SP+
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFL--PPGQPSFFELMQAICDGPPPSLPAEEFSPEFR 233
Query: 118 FIVQSCWVEDPNLRPSFSQIIR 139
+ +C +DP RPS +++++
Sbjct: 234 DFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-12
Identities = 40/141 (28%), Positives = 75/141 (53%), Gaps = 13/141 (9%)
Query: 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLR 57
M + +K N+ L P +KL DFG +++ + + ++ ++ GT ++APEL+
Sbjct: 191 MHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELW------ 243
Query: 58 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 117
E+K Y+ K D++S G++L+ELLT PF+G S + + P P +S +
Sbjct: 244 --ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP-FPCPVSSGMK 300
Query: 118 FIVQSCWVEDPNLRPSFSQII 138
++ ++P LRP+ Q++
Sbjct: 301 ALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-12
Identities = 46/146 (31%), Positives = 72/146 (49%), Gaps = 24/146 (16%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHY 64
N+L+T D +K+ADFGLAR + + +WMAPE L+ V Y
Sbjct: 164 NVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV---------Y 213
Query: 65 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFI 119
++ DV+SFGI++WE+ T P+ G+ FK R G P + + +L +
Sbjct: 214 THQSDVWSFGILMWEIFTLGGSPYPGIP-----VEELFKLLREGHRMDKPSNCTHELYML 268
Query: 120 VQSCWVEDPNLRPSFSQIIRMLNAFL 145
++ CW P RP+F Q++ L+ L
Sbjct: 269 MRECWHAVPTQRPTFKQLVEALDKVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-12
Identities = 42/142 (29%), Positives = 75/142 (52%), Gaps = 16/142 (11%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHY 64
N+L+T + +K+ADFGLAR+ + T +WMAPE L+ V Y
Sbjct: 167 NVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV---------Y 216
Query: 65 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
++ DV+SFG+++WE+ T P+ G+ ++ + + R P + + +L +++ C
Sbjct: 217 THQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDC 275
Query: 124 WVEDPNLRPSFSQIIRMLNAFL 145
W P+ RP+F Q++ L+ L
Sbjct: 276 WHAIPSHRPTFKQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-12
Identities = 46/155 (29%), Positives = 70/155 (45%), Gaps = 20/155 (12%)
Query: 3 KFMKED----NLLLTPDQK-SLKLADFGLAREETVTEMMTAETGT-----YRWMAPELYS 52
KF+ D N +L D+ ++K+ADFGLAR+ E + T +WMA E
Sbjct: 118 KFVHRDLAARNCML--DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 53 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 112
T + K DV+SFG++LWEL+T P + + R PE
Sbjct: 176 TQK--------FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYC 227
Query: 113 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147
L ++ SCW P +RP+FS+++ + T
Sbjct: 228 PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-11
Identities = 43/131 (32%), Positives = 66/131 (50%), Gaps = 14/131 (10%)
Query: 20 KLADFGLAR--EETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75
K++DFGL+R E+ T G RW APE + R+ + + DV+S+GI
Sbjct: 146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE---AIAYRK-----FTSASDVWSYGI 197
Query: 76 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 134
V+WE+++ P+ MSN Q A + R P D L ++ CW +D N RP F
Sbjct: 198 VMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKF 256
Query: 135 SQIIRMLNAFL 145
QI+ +L+ +
Sbjct: 257 EQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-11
Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 23/146 (15%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPE-----LYSTVTLRQGE 60
N+LL K +K+ DFGLAR+ ++ T+ +WMAPE LY+T++
Sbjct: 267 NVLLA-QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLS----- 320
Query: 61 KKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 119
DV+S+GI+LWE+ + P+ GM Y R P+ + ++ I
Sbjct: 321 --------DVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDI 372
Query: 120 VQSCWVEDPNLRPSFSQIIRMLNAFL 145
+ CW +P RPSF + ++ + L
Sbjct: 373 MVKCWNSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-11
Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 23/159 (14%)
Query: 5 MKEDNLLLTPDQKSLKLADFGL-AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K D++LLT D + +KL+DFG A+ + GT WMAPEL S +
Sbjct: 142 IKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-------- 192
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP------EDISPDLA 117
Y +VD++S GI++ E++ P+ L+ A K R LP +SP L
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMIRDNLPPKLKNLHKVSPSLK 247
Query: 118 FIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 156
+ V DP R + +++++ + FL PPS VP
Sbjct: 248 GFLDRLLVRDPAQRATAAELLK--HPFLAKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-11
Identities = 40/132 (30%), Positives = 61/132 (46%), Gaps = 17/132 (12%)
Query: 12 LTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPE--LYSTVTLRQGEKKHYNN 66
L + ++K++DFGL+R+ + + + RWM PE LY T
Sbjct: 156 LVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTES-------- 207
Query: 67 KVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 125
D++SFG+VLWE+ + L P+ G SN + + P PED + ++ CW
Sbjct: 208 --DIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPC-PEDCPARVYALMIECWN 264
Query: 126 EDPNLRPSFSQI 137
E P RP F I
Sbjct: 265 EIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-11
Identities = 37/130 (28%), Positives = 64/130 (49%), Gaps = 14/130 (10%)
Query: 10 LLLTPDQKSLKLADFGLAREETVTEMMT-AETGTYRWMAPELYSTVTLRQGEKKHYNNKV 68
LL+ D +K+ D G+++ + + M + GT +MAPE++ + Y+ K
Sbjct: 135 LLVANDL--VKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWK--------GRPYSYKS 182
Query: 69 DVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDP 128
D++S G +L+E+ T PFE S +Q + P +P S DL ++S P
Sbjct: 183 DIWSLGCLLYEMATFAPPFEARS-MQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKP 241
Query: 129 NLRPSFSQII 138
LRP+ +I+
Sbjct: 242 KLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-11
Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 14/138 (10%)
Query: 11 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL--YSTVTLRQGEKKHYNNKV 68
+L + K+ADFGL+R + V T RWMA E YS Y
Sbjct: 143 ILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV----------YTTNS 192
Query: 69 DVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVED 127
DV+S+G++LWE+++ P+ GM+ + Y + R P + ++ +++ CW E
Sbjct: 193 DVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREK 251
Query: 128 PNLRPSFSQIIRMLNAFL 145
P RPSF+QI+ LN L
Sbjct: 252 PYERPSFAQILVSLNRML 269
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-11
Identities = 41/140 (29%), Positives = 63/140 (45%), Gaps = 14/140 (10%)
Query: 11 LLTPDQKSLKLADFGLAR--EETVTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNN 66
+L K++DFGL+R E+ T G RW APE + + + +
Sbjct: 138 ILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY--------RKFTS 189
Query: 67 KVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 125
DV+SFGIV+WE+++ P+ MSN A R P D + ++ CW
Sbjct: 190 ASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQ 248
Query: 126 EDPNLRPSFSQIIRMLNAFL 145
+D RP F I+ +L+ L
Sbjct: 249 QDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-11
Identities = 46/136 (33%), Positives = 71/136 (52%), Gaps = 12/136 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K N+ L LK+ DFG++R + ++ T TGT +M+PE QG
Sbjct: 132 LKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK----HQG---- 181
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
Y++K D++S G +L+E+ FEG N + + P LPE S L I+QS
Sbjct: 182 YDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSM 240
Query: 124 WVEDPNLRPSFSQIIR 139
+DP+LRPS ++I+R
Sbjct: 241 LNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-11
Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 15/148 (10%)
Query: 3 KFMKEDNLLLTPDQK----------SLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 52
KF+KE++ ++ D K +KL DFG++ V + G +MAPE
Sbjct: 116 KFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIK 174
Query: 53 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLPE 110
+ Q Y + DV+S G+ + E+ R P+ E +N+ A +A P LP
Sbjct: 175 SGGPNQ--NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS 232
Query: 111 DISPDLAFIVQSCWVEDPNLRPSFSQII 138
S D V C + PN RP+++Q++
Sbjct: 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 4e-11
Identities = 45/166 (27%), Positives = 67/166 (40%), Gaps = 39/166 (23%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWM-APELYSTVTLRQGEKK 62
+K +NLL+ + LKLADFGLAR + T T RW APEL + +
Sbjct: 124 LKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVT-RWYRAPEL--LLGDKG---- 175
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEG------------------------MSNLQAAYA 98
Y+ VD++S G + ELL+ R F G ++L Y
Sbjct: 176 -YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234
Query: 99 AAFKH-ARPGLPE---DISPDLAFIVQSCWVEDPNLRPSFSQIIRM 140
+F A LP+ + SP ++ DP+ R + Q +
Sbjct: 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-11
Identities = 42/144 (29%), Positives = 72/144 (50%), Gaps = 19/144 (13%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR----WMAPE-LYSTVTLRQGEKKH 63
N+LL+ + +K+ DFGLAR+ + G R WMAPE ++ V
Sbjct: 209 NILLS-ENNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPETIFDRV--------- 257
Query: 64 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQ 121
Y + DV+SFG++LWE+ + P+ G+ + + K R P+ +P++ +
Sbjct: 258 YTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 316
Query: 122 SCWVEDPNLRPSFSQIIRMLNAFL 145
CW +P+ RP+FS+++ L L
Sbjct: 317 DCWHGEPSQRPTFSELVEHLGNLL 340
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-11
Identities = 37/143 (25%), Positives = 73/143 (51%), Gaps = 20/143 (13%)
Query: 11 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYR--------WMAPELYSTVTLRQGEKK 62
+L ++ +K++DFG++++ + T T R WMAPE+ ++
Sbjct: 137 ILVDNKGGIKISDFGISKKLEANSLSTK-TNGARPSLQGSVFWMAPEVV--------KQT 187
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
Y K D++S G ++ E+LT + PF + LQA + ++A P +P +IS + ++
Sbjct: 188 SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNISSEAIDFLEK 246
Query: 123 CWVEDPNLRPSFSQIIRMLNAFL 145
+ D N RP+ +++ + + FL
Sbjct: 247 TFEIDHNKRPTAAEL--LKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 5e-11
Identities = 43/167 (25%), Positives = 70/167 (41%), Gaps = 42/167 (25%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWM-APELYSTVTLRQGEK 61
+K +NLL++ + +K+ADFGLARE + T T RW APE + LR
Sbjct: 125 LKPENLLVSGPE-VVKIADFGLARE--IRSRPPYTDYVST-RWYRAPE----ILLRST-- 174
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL--------------QAAYAAAFKHAR-- 105
Y++ VD+++ G ++ EL T R F G S + + + +K A
Sbjct: 175 -SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 106 -------PGLPED-----ISPDLAFIVQSCWVEDPNLRPSFSQIIRM 140
SP+ +++ DP RP+ SQ ++
Sbjct: 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-11
Identities = 40/136 (29%), Positives = 70/136 (51%), Gaps = 11/136 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKH 63
+K N+LL+ +Q +KLADFG+A + T T++ GT WMAPE+ ++
Sbjct: 127 IKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--------QQSA 177
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
Y++K D++S GI EL P M ++ + K+ P L + S + +C
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDAC 236
Query: 124 WVEDPNLRPSFSQIIR 139
+DP+ RP+ ++++
Sbjct: 237 LNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-11
Identities = 47/143 (32%), Positives = 71/143 (49%), Gaps = 27/143 (18%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K N+ LT + K +KL DFG AR T + A T GT ++ PE++ E
Sbjct: 126 IKSKNIFLTQNGK-VKLGDFGSARLLT-SPGAYACTYVGTPYYVPPEIW--------ENM 175
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMS--NL-----QAAYAAAFKHARPGLPEDISPD 115
YNNK D++S G +L+EL T + PF+ S NL Q +Y LP S +
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP--------LPSHYSYE 227
Query: 116 LAFIVQSCWVEDPNLRPSFSQII 138
L +++ + +P RPS + I+
Sbjct: 228 LRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 8e-11
Identities = 50/155 (32%), Positives = 75/155 (48%), Gaps = 15/155 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K DN+LL D S+KL DFG + T + + GT WMAPE+ VT +K
Sbjct: 141 IKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV---VT-----RKA 191
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQ 121
Y KVD++S GI+ E++ P+ + L+A Y A + P L PE +S +
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLN 250
Query: 122 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 156
C D R S ++++ + FL +P S P
Sbjct: 251 RCLEMDVEKRGSAKELLQ--HPFLKIAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 9e-11
Identities = 40/136 (29%), Positives = 69/136 (50%), Gaps = 11/136 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMM-TAETGTYRWMAPELYSTVTLRQGEKKH 63
+K N+LL+ +Q +KLADFG+A + T T++ GT WMAPE+ ++
Sbjct: 127 IKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--------KQSA 177
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
Y+ K D++S GI EL P + ++ + K++ P L S V++C
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEAC 236
Query: 124 WVEDPNLRPSFSQIIR 139
+DP RP+ ++++
Sbjct: 237 LNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-10
Identities = 46/148 (31%), Positives = 73/148 (49%), Gaps = 13/148 (8%)
Query: 5 MKEDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K N+LLT P Q +KLADFG A + + + GT WMAPE+ + + +G+
Sbjct: 147 IKAGNILLTEPGQ--VKLADFGSA---SKSSPANSFVGTPYWMAPEV--ILAMDEGQ--- 196
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
Y+ KVDV+S GI EL + P M+ + A Y A + + + V C
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYC 256
Query: 124 WVEDPNLRPSFSQIIRMLNAFLFTLRPP 151
+ P RP+ ++++R + F+ RP
Sbjct: 257 LQKIPQERPASAELLR--HDFVRRDRPA 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-10
Identities = 40/144 (27%), Positives = 67/144 (46%), Gaps = 31/144 (21%)
Query: 15 DQKSLKLADFGLAREETVTEMMTAETGTY-----------RWMAPE-LYSTVTLRQGEKK 62
+ ++ +ADFGL++ +G Y +W+A E L V
Sbjct: 148 EDMTVCVADFGLSK--------KIYSGDYYRQGRIAKMPVKWIAIESLADRV-------- 191
Query: 63 HYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQ 121
Y +K DV++FG+ +WE+ T + P+ G+ N + Y R PED +L ++
Sbjct: 192 -YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI-YDYLRHGNRLKQPEDCLDELYDLMY 249
Query: 122 SCWVEDPNLRPSFSQIIRMLNAFL 145
SCW DP RP+F+++ +L L
Sbjct: 250 SCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-10
Identities = 40/133 (30%), Positives = 68/133 (51%), Gaps = 12/133 (9%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKH 63
K N+LLT + +KLADFG++ + T T + ++ GT WMAPE+ + V + G
Sbjct: 128 KGANILLT-EDGDVKLADFGVSAQLTAT-IAKRKSFIGTPYWMAPEVAA-VERKGG---- 180
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED---ISPDLAFIV 120
Y+ K D+++ GI EL + P + ++A + + + P +D SP +
Sbjct: 181 YDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFI 240
Query: 121 QSCWVEDPNLRPS 133
+ C +DP RP+
Sbjct: 241 KKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-10
Identities = 38/154 (24%), Positives = 69/154 (44%), Gaps = 28/154 (18%)
Query: 1 MG-KFMKEDN-----------LLLTPDQKSLKLADFGLAREETVTEMMTAETGT----YR 44
MG K+++E N LL+T Q K++DFGL++ E +
Sbjct: 106 MGMKYLEETNFVHRDLAARNVLLVT--QHYAKISDFGLSKALGADENYYKAKTHGKWPVK 163
Query: 45 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKH 103
W APE + +++K DV+SFG+++WE + + P++GM +
Sbjct: 164 WYAPECMNYYK--------FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT-QMIESG 214
Query: 104 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 137
R P+ P++ +++ CW + RP F+ +
Sbjct: 215 ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-10
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 15/167 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKH 63
+K DN+LL D S+KL DFG + T + + GT WMAPE+ + +K
Sbjct: 142 IKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT--------RKA 192
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQ 121
Y KVD++S GI+ E++ P+ + L+A Y A + P L PE +S +
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLN 251
Query: 122 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSN 168
C D R S ++++ + FL +P S P + A +N
Sbjct: 252 RCLDMDVEKRGSAKELLQ--HQFLKIAKPLSSLTPLIAAAKEATKNN 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-10
Identities = 27/83 (32%), Positives = 45/83 (54%)
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
Y K D+YS G+VLWE+ T ++PFE ++ + K+ LP D ++ IV++C
Sbjct: 199 YTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEAC 258
Query: 124 WVEDPNLRPSFSQIIRMLNAFLF 146
D RP+ +I+ L+ + F
Sbjct: 259 TSHDSIKRPNIKEILYNLSLYKF 281
|
Length = 283 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-10
Identities = 41/131 (31%), Positives = 63/131 (48%), Gaps = 12/131 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +N+LL + + L DFGL++E E + GT +MAPE+ +G+
Sbjct: 131 IKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII------RGKGG 183
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 120
H VD +S GI+++ELLT PF EG N Q+ + P P I P+ ++
Sbjct: 184 H-GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLL 242
Query: 121 QSCWVEDPNLR 131
+DP R
Sbjct: 243 HKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-10
Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 12/129 (9%)
Query: 20 KLADFGLAREETVTEMMTAETG--TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77
K++ F +E+ + T +G W APE ++ H+++ DV+SFGIV+
Sbjct: 147 KISGFRRLQEDKSEAIYTTMSGKSPVLWAAPE-----AIQYH---HFSSASDVWSFGIVM 198
Query: 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 136
WE+++ P+ MS Q A R P + L ++ CW ++ RP FSQ
Sbjct: 199 WEVMSYGERPYWDMSG-QDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQ 257
Query: 137 IIRMLNAFL 145
I +L+ +
Sbjct: 258 IHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-10
Identities = 46/130 (35%), Positives = 66/130 (50%), Gaps = 16/130 (12%)
Query: 20 KLADFGLAREETVTEMMTAETGTY--RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGI 75
K+ADFGLAR E E + +W APE + + T+ K DV+SFGI
Sbjct: 142 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI----------KSDVWSFGI 191
Query: 76 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 134
+L E++T R+P+ GMSN + A + P PE+ +L I+ CW P RP+F
Sbjct: 192 LLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-RPENCPEELYNIMMRCWKNRPEERPTF 250
Query: 135 SQIIRMLNAF 144
I +L+ F
Sbjct: 251 EYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-10
Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 13/149 (8%)
Query: 5 MKEDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K N+LLT P Q +KLADFG A ++ + GT WMAPE+ + + +G+
Sbjct: 151 IKAGNILLTEPGQ--VKLADFGSA---SIASPANSFVGTPYWMAPEV--ILAMDEGQ--- 200
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
Y+ KVDV+S GI EL + P M+ + A Y A + + S V SC
Sbjct: 201 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC 260
Query: 124 WVEDPNLRPSFSQIIRMLNAFLFTLRPPS 152
+ P RP+ ++++ + F+ RP +
Sbjct: 261 LQKIPQDRPTSEELLKHM--FVLRERPET 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-10
Identities = 46/140 (32%), Positives = 65/140 (46%), Gaps = 20/140 (14%)
Query: 11 LLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPE--LYSTVTLRQGEKKHYNN 66
+L + K+ADFGLAR E + + +W APE LY T+
Sbjct: 133 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI---------- 182
Query: 67 KVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 125
K DV+SFGI+L EL T R+P+ GM N + + P P + L ++ CW
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWR 241
Query: 126 EDPNLRPSFSQIIRMLNAFL 145
++P RP+F L AFL
Sbjct: 242 KEPEERPTF----EYLQAFL 257
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-10
Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 15/167 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K DN+LL S+KL DFG + T + + GT WMAPE+ + +K
Sbjct: 141 IKSDNVLLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT--------RKA 191
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQ 121
Y KVD++S GI+ E++ P+ + L+A Y A + P L PE +SP +
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSPIFRDFLN 250
Query: 122 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSN 168
C D R S ++++ + FL +P S P + A SN
Sbjct: 251 RCLEMDVEKRGSAKELLQ--HPFLKLAKPLSSLTPLILAAKEAMKSN 295
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (138), Expect = 6e-10
Identities = 35/92 (38%), Positives = 48/92 (52%), Gaps = 13/92 (14%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGT--YRWMAPELYSTVTLRQGEK 61
+K N+L+ D LKLADFGLAR + T E T YR APE+ G K
Sbjct: 124 LKPQNILINRDG-VLKLADFGLARAFGIPLRTYTHEVVTLWYR--APEIL------LGSK 174
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 93
HY+ VD++S G + E++T + F G S +
Sbjct: 175 -HYSTAVDIWSVGCIFAEMITGKPLFPGDSEI 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 7e-10
Identities = 38/144 (26%), Positives = 61/144 (42%), Gaps = 35/144 (24%)
Query: 18 SLKLADFGLAREETVTEMMTAETGTY-----------RWMAPELYSTVTLRQGEKKHYNN 66
++K+ADFG++R + Y RWMA E ++ G+ +
Sbjct: 168 TIKIADFGMSRN--------LYSSDYYRVQGRAPLPIRWMAWE-----SVLLGK---FTT 211
Query: 67 KVDVYSFGIVLWELLT--NRLPFEGMSNLQAAYAAAFKHARPGLPE-----DISP-DLAF 118
K DV++FG+ LWE+LT P+E +++ Q A G P D+
Sbjct: 212 KSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYE 271
Query: 119 IVQSCWVEDPNLRPSFSQIIRMLN 142
++ CW D RP+F +I L
Sbjct: 272 LMLECWRRDEEDRPTFREIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-10
Identities = 39/136 (28%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKH 63
+K N+LL+ + +KLADFG+A + T T++ GT WMAPE+ ++
Sbjct: 127 IKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--------KQSA 177
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
Y++K D++S GI EL P + ++ + K+ P L + S L V++C
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEAC 236
Query: 124 WVEDPNLRPSFSQIIR 139
++P+ RP+ ++++
Sbjct: 237 LNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-09
Identities = 39/146 (26%), Positives = 63/146 (43%), Gaps = 25/146 (17%)
Query: 9 NLLLTPD--QKSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQ 58
N LLT + K+ADFG+AR+ M+ +WM PE +
Sbjct: 146 NCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI-----KWMPPEAFLDGI--- 197
Query: 59 GEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 117
+ +K DV+SFG++LWE+ + +P+ G +N Q R P+ +
Sbjct: 198 -----FTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTGGGRLDPPKGCPGPVY 251
Query: 118 FIVQSCWVEDPNLRPSFSQIIRMLNA 143
I+ CW P RP+F+ I+ +
Sbjct: 252 RIMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 1e-09
Identities = 54/186 (29%), Positives = 74/186 (39%), Gaps = 51/186 (27%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWM-APEL-YSTVTLRQGEK 61
+K +NLL+ D LKLADFGLAR + MT + T RW APEL +
Sbjct: 128 LKPNNLLIASDGV-LKLADFGLARSFGSPNRKMTHQVVT-RWYRAPELLFGA-------- 177
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPF-------------------------EGMSNLQAA 96
+HY VD++S G + ELL R+PF G+++L
Sbjct: 178 RHYGVGVDMWSVGCIFAELL-LRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP-- 234
Query: 97 YAAAFKHARPGLPED-----ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 151
FK P P S D ++Q +PN R + Q L F+ P
Sbjct: 235 DYVEFKP-FPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ---ALEHPYFSNDPA 290
Query: 152 SPSVPE 157
P+ P
Sbjct: 291 -PTPPS 295
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-09
Identities = 34/92 (36%), Positives = 48/92 (52%), Gaps = 10/92 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K NLL+ + LK+ DFGLAR E E MT E T + APE+ +
Sbjct: 129 IKPGNLLVNSNCV-LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG-------SR 180
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
HY + VD++S G + ELL R+ F+ S +Q
Sbjct: 181 HYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 1e-09
Identities = 48/155 (30%), Positives = 75/155 (48%), Gaps = 15/155 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K DN+LL D S+KL DFG + T + + GT WMAPE+ + +K
Sbjct: 141 IKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT--------RKA 191
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQ 121
Y KVD++S GI+ E++ P+ + L+A Y A + P L PE +S +
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQNPERLSAVFRDFLN 250
Query: 122 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 156
C D + R S ++++ + FL +P S P
Sbjct: 251 RCLEMDVDRRGSAKELLQ--HPFLKLAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-09
Identities = 41/137 (29%), Positives = 68/137 (49%), Gaps = 8/137 (5%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K N+LLT D +KLADFG++ + T + + GT WMAPE+ T++
Sbjct: 136 LKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP--- 191
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQ 121
Y+ K D++S GI L E+ P ++ ++ A K P L P S + ++
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLSQPSKWSMEFRDFLK 250
Query: 122 SCWVEDPNLRPSFSQII 138
+ + P RPS +Q++
Sbjct: 251 TALDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-09
Identities = 36/139 (25%), Positives = 63/139 (45%), Gaps = 10/139 (7%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
K N+LL ++KL DFG++ + + T + G +MAPE R G Y+
Sbjct: 135 KPSNILLD-RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA-RDG----YD 188
Query: 66 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI----SPDLAFIVQ 121
+ DV+S GI L+E+ T + P+ +++ K P L SP +
Sbjct: 189 VRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFIN 248
Query: 122 SCWVEDPNLRPSFSQIIRM 140
C ++D + RP + +++
Sbjct: 249 LCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-09
Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 12/136 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKH 63
+K DN+LL D +K+ADFG+ +E + + T GT ++APE+ G+K
Sbjct: 122 LKLDNILLDTD-GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL------LGQK-- 172
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
YN VD +SFG++L+E+L + PF G + + + P P ++ + I+
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHD--EEELFQSIRMDNPCYPRWLTREAKDILVKL 230
Query: 124 WVEDPNLRPSFSQIIR 139
+V +P R IR
Sbjct: 231 FVREPERRLGVKGDIR 246
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-09
Identities = 40/127 (31%), Positives = 65/127 (51%), Gaps = 15/127 (11%)
Query: 18 SLKLADFGLARE-ETV----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 72
++KL DFG ++ +T+ T M + TGT WM+PE+ S GE Y K D++S
Sbjct: 144 NVKLGDFGASKRLQTICLSGTGMKSV-TGTPYWMSPEVIS------GEG--YGRKADIWS 194
Query: 73 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP 132
G + E+LT + P+ + A + A + P LP +S ++ +VE LRP
Sbjct: 195 VGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFVE-AKLRP 253
Query: 133 SFSQIIR 139
S +++R
Sbjct: 254 SADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-09
Identities = 38/133 (28%), Positives = 63/133 (47%), Gaps = 17/133 (12%)
Query: 11 LLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPE--LYSTVTLRQGEKKHYN 65
+L D+ ++K++D GL RE + +M RWM+PE +Y ++
Sbjct: 155 VLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDS------- 207
Query: 66 NKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
D++S+G+VLWE+ + L P+ G SN + P P+D + ++ CW
Sbjct: 208 ---DIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP-CPDDCPAWVYTLMLECW 263
Query: 125 VEDPNLRPSFSQI 137
E P+ RP F I
Sbjct: 264 NEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 2e-09
Identities = 40/144 (27%), Positives = 60/144 (41%), Gaps = 22/144 (15%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE---------TGTYRWMAPELYSTVT 55
+K DN+L+ + LKL DFGL++ V + GT ++APE V
Sbjct: 119 LKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE----VI 173
Query: 56 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA--AAFKHARPGLPEDIS 113
L QG ++ VD +S G +L+E L PF G + + K P E +S
Sbjct: 174 LGQG----HSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVE-VS 227
Query: 114 PDLAFIVQSCWVEDPNLRPSFSQI 137
+ ++ V DP R I
Sbjct: 228 DEAIDLISKLLVPDPEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-09
Identities = 38/130 (29%), Positives = 61/130 (46%), Gaps = 15/130 (11%)
Query: 19 LKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75
+K+ DFG++R+ T+ T RWM PE ++ R+ + + D++SFG+
Sbjct: 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE---SILYRK-----FTTESDIWSFGV 212
Query: 76 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPS 133
VLWE+ T + P+ +SN +A R P P++ I+Q CW +P R
Sbjct: 213 VLWEIFTYGKQPWYQLSNTEA--IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMV 270
Query: 134 FSQIIRMLNA 143
I L A
Sbjct: 271 IKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 3e-09
Identities = 31/154 (20%), Positives = 58/154 (37%), Gaps = 38/154 (24%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET---------------------GTY 43
+K +N+LL D +K+ DFG A+ + GT
Sbjct: 128 LKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTA 186
Query: 44 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAA 100
+++PEL + +K D+++ G +++++LT + PF G + Q
Sbjct: 187 EYVSPELLN--------EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238
Query: 101 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 134
+ P + PD +++ V DP R
Sbjct: 239 YS-----FPPNFPPDAKDLIEKLLVLDPQDRLGV 267
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-09
Identities = 38/139 (27%), Positives = 67/139 (48%), Gaps = 27/139 (19%)
Query: 10 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---------RWMAPELYSTVTLRQGE 60
L+ TP +K+ DFGLA+ ++ A+ Y +WMA L
Sbjct: 141 LVKTPQH--VKITDFGLAK------LLGADEKEYHAEGGKVPIKWMA--------LESIL 184
Query: 61 KKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 119
+ Y ++ DV+S+G+ +WEL+T P++G+ + + + K R P + D+ I
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTIDVYMI 243
Query: 120 VQSCWVEDPNLRPSFSQII 138
+ CW+ D + RP F ++I
Sbjct: 244 MVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-09
Identities = 38/142 (26%), Positives = 64/142 (45%), Gaps = 16/142 (11%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPE-LYSTVTLRQGEKKHY 64
N +L + ++ +ADFGL+++ + A +W+A E L V Y
Sbjct: 143 NCMLNENM-TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV---------Y 192
Query: 65 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
DV++FG+ +WE++T + P+ G+ N + Y K R P D D+ ++ C
Sbjct: 193 TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI-YNYLIKGNRLKQPPDCLEDVYELMCQC 251
Query: 124 WVEDPNLRPSFSQIIRMLNAFL 145
W +P RPSF + L
Sbjct: 252 WSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 4e-09
Identities = 44/167 (26%), Positives = 71/167 (42%), Gaps = 40/167 (23%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPE-LYSTVTLRQGEK 61
+K NLL++ D LK+ADFGLAR E + + + T + APE LY
Sbjct: 125 LKPANLLISADG-VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG--------A 175
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEG------------------------MSNLQAAY 97
+ Y+ VD+++ G + ELL F G +++L
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235
Query: 98 AAAFKHARPGLPEDISPDL---AF-IVQSCWVEDPNLRPSFSQIIRM 140
F ++P E+I PD A +++ V DP+ R S ++ +R
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 4e-09
Identities = 40/140 (28%), Positives = 62/140 (44%), Gaps = 14/140 (10%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMT-AETGTYRWMAPELYSTVTLRQGEKKHY 64
K N+LLT +KL DFG++ + T GT WMAPE+ + + Y
Sbjct: 140 KGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV---IACDEQPDASY 195
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR---PGL--PEDISPDLAFI 119
+ + DV+S GI EL + P M ++ A FK R P L PE+ S
Sbjct: 196 DARSDVWSLGITAIELADGKPPLCDMHPMR----ALFKIPRNPPPTLKSPENWSKKFNDF 251
Query: 120 VQSCWVEDPNLRPSFSQIIR 139
+ C +++ RP +++
Sbjct: 252 ISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-09
Identities = 41/141 (29%), Positives = 65/141 (46%), Gaps = 11/141 (7%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTY--RWMAPELYSTVTLRQGEKKHYN 65
N LT D S+K+ D+GLA E+ + +T + RW+APEL K
Sbjct: 130 NCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQ-T 187
Query: 66 NKVDVYSFGIVLWELLTN-RLPFEGMSNLQA-AYAAA---FKHARPGLPEDISPDLAFIV 120
K +++S G+ +WEL T P+ +S+ Q K +P L S ++
Sbjct: 188 KKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVM 247
Query: 121 QSCWVEDPNLRPSFSQIIRML 141
Q CW+ DP RP+ ++ +L
Sbjct: 248 QFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-09
Identities = 40/138 (28%), Positives = 68/138 (49%), Gaps = 8/138 (5%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMM-TAETGTYRWMAPELYSTVTLRQGEKKH 63
+K +N+LLT + +KL DFG++ + T T + GT WMAPE+ + Q
Sbjct: 150 VKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV---IACEQQLDST 205
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQ 121
Y+ + DV+S GI EL P + ++A + ++ P L PE S + ++
Sbjct: 206 YDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP-RNPPPTLHQPELWSNEFNDFIR 264
Query: 122 SCWVEDPNLRPSFSQIIR 139
C +D RP+ S +++
Sbjct: 265 KCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-09
Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 23/159 (14%)
Query: 5 MKEDNLLLTPDQKSLKLADFGL-AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K D++LLT D + +KL+DFG A+ + GT WMAPE+ S +
Sbjct: 144 IKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP-------- 194
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP------EDISPDLA 117
Y +VD++S GI++ E++ P+ LQ A + R LP +S L
Sbjct: 195 YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-----AMRRIRDNLPPRVKDSHKVSSVLR 249
Query: 118 FIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 156
+ V +P+ R + ++++ + FL PPS VP
Sbjct: 250 GFLDLMLVREPSQRATAQELLQ--HPFLKLAGPPSCIVP 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-09
Identities = 43/141 (30%), Positives = 65/141 (46%), Gaps = 14/141 (9%)
Query: 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQ 58
M + +K N+ +T +KL D GL R + ++ A + GT +M+PE
Sbjct: 128 MHRDIKPANVFITAT-GVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI------- 178
Query: 59 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKHARPGLPEDI-SPDL 116
+ YN K D++S G +L+E+ + PF G NL + K P LP D S +L
Sbjct: 179 -HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237
Query: 117 AFIVQSCWVEDPNLRPSFSQI 137
+V C DP RP S +
Sbjct: 238 RDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-09
Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 8/137 (5%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMM-TAETGTYRWMAPELYSTVTLRQGEKKH 63
+K +N+LLT + +KL DFG++ + T T + GT WMAPE+ + Q
Sbjct: 154 VKGNNILLTT-EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV---IACEQQYDYS 209
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQ 121
Y+ + DV+S GI EL P M ++ + ++ P L PE +
Sbjct: 210 YDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP-RNPPPTLLHPEKWCRSFNHFIS 268
Query: 122 SCWVEDPNLRPSFSQII 138
C ++D RPS + ++
Sbjct: 269 QCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-09
Identities = 40/128 (31%), Positives = 71/128 (55%), Gaps = 12/128 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKH 63
+K +N+LL ++ +KL DFGL++E E GT +MAPE V R+G
Sbjct: 124 LKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE----VVNRRG---- 174
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
+ D +SFG++++E+LT LPF+G + + K A+ G+P+ +SP+ ++++
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILK-AKLGMPQFLSPEAQSLLRAL 232
Query: 124 WVEDPNLR 131
+ +P R
Sbjct: 233 FKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-09
Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 13/126 (10%)
Query: 18 SLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 73
++KL DFG ++ M + + TGT WM+PE+ S GE Y K DV+S
Sbjct: 144 NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS------GEG--YGRKADVWSL 195
Query: 74 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 133
G + E+LT + P+ + A + A + P LP IS + +VE + RPS
Sbjct: 196 GCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARH-RPS 254
Query: 134 FSQIIR 139
+++R
Sbjct: 255 AEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 7e-09
Identities = 32/85 (37%), Positives = 44/85 (51%), Gaps = 11/85 (12%)
Query: 6 KEDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
K +NLLL D +KL DFG A++ + GT ++APE+ K Y
Sbjct: 120 KPENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEII--------LNKGY 169
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEG 89
+ VD +S GI+L+ELLT R PF
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-08
Identities = 35/132 (26%), Positives = 60/132 (45%), Gaps = 13/132 (9%)
Query: 11 LLTPDQKSLKLADFGLAREETVTEMMTAETG---TYRWMAPELYSTVTLRQGEKKHYNNK 67
+L +K+ DFGLAR + E G +WMA L + + ++
Sbjct: 140 VLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA--------LESILHRRFTHQ 191
Query: 68 VDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVE 126
DV+S+G+ +WEL+T P++G+ + K R P + D+ I+ CW+
Sbjct: 192 SDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICTIDVYMIMVKCWMI 250
Query: 127 DPNLRPSFSQII 138
D RP F +++
Sbjct: 251 DSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-08
Identities = 37/129 (28%), Positives = 64/129 (49%), Gaps = 14/129 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K +NL+L D +K+ DFGL +E +T+ T +T GT ++APE+ E
Sbjct: 121 LKLENLMLDKD-GHIKITDFGLCKE-GITDAATMKTFCGTPEYLAPEVL--------EDN 170
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
Y VD + G+V++E++ RLPF + + + + P +S D ++
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK--FPRTLSADAKSLLSG 228
Query: 123 CWVEDPNLR 131
++DPN R
Sbjct: 229 LLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-08
Identities = 38/135 (28%), Positives = 58/135 (42%), Gaps = 7/135 (5%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
K N+LL ++KL DFG++ ++ T G +MAPE Y+
Sbjct: 142 KPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDP----PDPNPKYD 196
Query: 66 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSC 123
+ DV+S GI L EL T + P++ + P LP E SPD V C
Sbjct: 197 IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLC 256
Query: 124 WVEDPNLRPSFSQII 138
+D RP + +++
Sbjct: 257 LTKDHRKRPKYRELL 271
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-08
Identities = 40/142 (28%), Positives = 63/142 (44%), Gaps = 21/142 (14%)
Query: 9 NLLLT--PDQKS-----LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
N+LL D+K+ +KL+D G++ E++ W+ PE
Sbjct: 130 NVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI---PWVPPECIE-------NP 179
Query: 62 KHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 120
++ + D +SFG LWE+ + P +S L + F R LP +LA ++
Sbjct: 180 QNLSLAADKWSFGTTLWEIFSGGDKP---LSALDSQKKLQFYEDRHQLPAPKWTELANLI 236
Query: 121 QSCWVEDPNLRPSFSQIIRMLN 142
C +P+ RPSF IIR LN
Sbjct: 237 NQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-08
Identities = 36/129 (27%), Positives = 64/129 (49%), Gaps = 14/129 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K DN+LL + +K+ADFG+ +E + +T T GT ++APE+ +
Sbjct: 122 LKLDNVLLDSE-GHIKIADFGMCKE-GILGGVTTSTFCGTPDYIAPEIL------SYQP- 172
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
Y VD ++ G++L+E+L + PFEG + + R P +S + I++S
Sbjct: 173 -YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR--YPRWLSKEAKSILKS 229
Query: 123 CWVEDPNLR 131
++P R
Sbjct: 230 FLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-08
Identities = 40/138 (28%), Positives = 69/138 (50%), Gaps = 8/138 (5%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K N+L T D +KLADFG++ + T T + + GT WMAPE+ V + +
Sbjct: 129 LKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV---VMCETSKDRP 184
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQ 121
Y+ K DV+S GI L E+ P ++ ++ A K P L P S + ++
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLAQPSRWSSEFKDFLK 243
Query: 122 SCWVEDPNLRPSFSQIIR 139
C ++ + R + +Q+++
Sbjct: 244 KCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-08
Identities = 40/151 (26%), Positives = 72/151 (47%), Gaps = 25/151 (16%)
Query: 9 NLLLTPDQKSLKLADFGLA-------REETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
N+LL D +++ADFG+A ++ +E T +WMA E ++ +
Sbjct: 139 NILLKSDSI-VQIADFGVADLLYPDDKKYFYSEHKTP----IKWMALE---SILFGR--- 187
Query: 62 KHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 120
Y ++ DV+S+G+ +WE+++ P+ GM K R P+ + D+ ++
Sbjct: 188 --YTHQSDVWSYGVTVWEMMSYGAEPYAGM-RPHEVPDLLEKGERLAQPQICTIDVYMVM 244
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 151
CW+ D N+RP+F + + N F R P
Sbjct: 245 VKCWMIDENVRPTFKE---LANEFTRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-08
Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 13/126 (10%)
Query: 18 SLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 73
++KL DFG ++ M + + TGT WM+PE+ S GE Y K DV+S
Sbjct: 144 NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS------GEG--YGRKADVWSV 195
Query: 74 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 133
+ E+LT + P+ + A + A + +P LP+ +S ++ +VE+ RP+
Sbjct: 196 ACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFVEE-KRRPT 254
Query: 134 FSQIIR 139
++R
Sbjct: 255 AEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-08
Identities = 46/148 (31%), Positives = 71/148 (47%), Gaps = 15/148 (10%)
Query: 5 MKEDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K N+LL+ P +KL DFG A ++ GT WMAPE+ + + +G+
Sbjct: 141 VKAGNILLSEPGL--VKLGDFGSA---SIMAPANXFVGTPYWMAPEV--ILAMDEGQ--- 190
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED-ISPDLAFIVQS 122
Y+ KVDV+S GI EL + P M+ + A Y A ++ P L S V S
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPALQSGHWSEYFRNFVDS 249
Query: 123 CWVEDPNLRPSFSQIIRMLNAFLFTLRP 150
C + P RP+ +++ + F+ RP
Sbjct: 250 CLQKIPQDRPTSEVLLK--HRFVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-08
Identities = 37/159 (23%), Positives = 66/159 (41%), Gaps = 39/159 (24%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY----------RWMAPELYSTVTLRQ 58
N+L+ + +K++DFGLA+ ++ + Y W APE T
Sbjct: 139 NILVESE-DLVKISDFGLAK------VLPEDKDYYYVKEPGESPIFWYAPECLRTSK--- 188
Query: 59 GEKKHYNNKVDVYSFGIVLWELLT----NRLPFEGMSNLQAAYAAAFKHAR--------P 106
+++ DV+SFG+ L+EL T ++ P + R
Sbjct: 189 -----FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243
Query: 107 GLPE-DISPDLAF-IVQSCWVEDPNLRPSFSQIIRMLNA 143
LP PD + +++ CW +P RPSF+ +I +++
Sbjct: 244 RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-08
Identities = 38/128 (29%), Positives = 65/128 (50%), Gaps = 12/128 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K DN++L D +K+ADFG+ +E + + GT ++APE+ QG K
Sbjct: 122 LKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL------QGLK-- 172
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
Y VD +SFG++L+E+L + PF G + + + + P P I+ + I++
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHG--DDEDELFESIRVDTPHYPRWITKESKDILEKL 230
Query: 124 WVEDPNLR 131
+ DP R
Sbjct: 231 FERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 5e-08
Identities = 29/92 (31%), Positives = 41/92 (44%), Gaps = 16/92 (17%)
Query: 9 NLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKK 62
N+L+ + LK+ DFGLAR +E +T T YR APEL
Sbjct: 133 NILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR--APELL-------LSSS 182
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
Y +D++S G + ELLT + F G +
Sbjct: 183 RYTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 6e-08
Identities = 32/89 (35%), Positives = 43/89 (48%), Gaps = 14/89 (15%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGT--YRWMAPELYSTVTLRQGE 60
+K N+L+ + LKLADFGLAR T T T YR PEL G
Sbjct: 126 IKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVITLWYR--PPELL------LGA 176
Query: 61 KKHYNNKVDVYSFGIVLWELLTNRLPFEG 89
+ Y +VD++S G +L EL + F+G
Sbjct: 177 TR-YGPEVDMWSVGCILAELFLGKPIFQG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-08
Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 5 MKEDNLLLTPDQKSLKLADFGL-AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K D++LLT D + +KL+DFG A+ + GT WMAPE+ S +
Sbjct: 143 IKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS--------RTP 193
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP------EDISPDLA 117
Y +VD++S GI++ E++ P+ S +Q A K R P ISP L
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-----AMKRLRDSPPPKLKNAHKISPVLR 248
Query: 118 FIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 156
++ +P R + +++ + FL P VP
Sbjct: 249 DFLERMLTREPQERATAQELLD--HPFLLQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 8e-08
Identities = 29/85 (34%), Positives = 45/85 (52%), Gaps = 15/85 (17%)
Query: 5 MKEDNLLLTPDQK-SLKLADFGLA-REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +NLLL D +K+ DFG A R + T + GT ++APE + L +G
Sbjct: 127 LKPENLLL--DSDGYIKITDFGFAKRVKGRTYTLC---GTPEYLAPE----IILSKG--- 174
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPF 87
Y VD ++ GI+++E+L PF
Sbjct: 175 -YGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-07
Identities = 28/84 (33%), Positives = 44/84 (52%), Gaps = 10/84 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K +NL+L D +K+ DFGL +E + M GT ++APE+ E
Sbjct: 121 LKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL--------EDND 171
Query: 64 YNNKVDVYSFGIVLWELLTNRLPF 87
Y VD + G+V++E++ RLPF
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-07
Identities = 34/85 (40%), Positives = 46/85 (54%), Gaps = 12/85 (14%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR-QGEKKH 63
+K N+LLT + +KL DFG++ E V + TGT +MAPE R QG K
Sbjct: 131 IKPSNILLT-RKGQVKLCDFGVS-GELVNSLAGTFTGTSFYMAPE-------RIQG--KP 179
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFE 88
Y+ DV+S G+ L E+ NR PF
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-07
Identities = 49/156 (31%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K NLLLT D+ LK+ADFGLAR + MT + T + APEL T
Sbjct: 134 LKVSNLLLT-DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCT-------T 185
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP---DLAFIV 120
Y +D+++ G +L ELL ++ G S ++ P E I P DL +
Sbjct: 186 YTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN--ESIWPGFSDLPLVG 243
Query: 121 QSCWVEDP--NLRPSFSQI----IRMLNAFLFTLRP 150
+ + P NL+ F + +R+LN FL P
Sbjct: 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLN-FLLMYDP 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-07
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K NLL+ +LKLADFGLAR + T E T + APE+ +H
Sbjct: 128 LKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG-------SRH 180
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNL 93
Y+ VD++S G + E++ + F G S +
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210
|
Length = 294 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 1e-07
Identities = 37/98 (37%), Positives = 48/98 (48%), Gaps = 20/98 (20%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR------EETVTEMMTAETGTYRWM-APE--LYSTVT 55
+K N+LL D + +KLADFGLAR E ++T T RW APE L ST
Sbjct: 133 LKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVAT-RWYRAPEILLGST-- 188
Query: 56 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 93
Y VD++S G +L E+L + F G S L
Sbjct: 189 -------RYTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-07
Identities = 40/154 (25%), Positives = 66/154 (42%), Gaps = 29/154 (18%)
Query: 11 LLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
+L + +K+ DFGL + +E E+ + W APE + E K ++
Sbjct: 139 ILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF-WYAPESLT-------ESK-FS 189
Query: 66 NKVDVYSFGIVLWELLT----NRLP----FEGMSNLQAAYAAAF-------KHARPGLPE 110
DV+SFG+VL+EL T + P M N + + + R P
Sbjct: 190 VASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPP 249
Query: 111 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144
++ I++ CW DP+ RPSFS++ + A
Sbjct: 250 GCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-07
Identities = 39/146 (26%), Positives = 60/146 (41%), Gaps = 29/146 (19%)
Query: 9 NLLLTPD------QKSLKLADFGLAREETVTEMMTAETGTYR-----WMAPELYSTVTLR 57
N+L+ +KL+D G+ +T + R W+APE
Sbjct: 131 NILVARYGLNEGYVPFIKLSDPGIP--------ITVLSREERVERIPWIAPECI------ 176
Query: 58 QGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDL 116
+ + D +SFG L E+ +N P +S L ++ F + LP +L
Sbjct: 177 RNGQASLTIAADKWSFGTTLLEICSNGEEP---LSTLSSSEKERFYQDQHRLPMPDCAEL 233
Query: 117 AFIVQSCWVEDPNLRPSFSQIIRMLN 142
A ++ CW DP RPSF I+R LN
Sbjct: 234 ANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-07
Identities = 38/146 (26%), Positives = 62/146 (42%), Gaps = 21/146 (14%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQG-----E 60
N LT D ++K+ D+G+ + + E RW+APEL V G E
Sbjct: 129 NCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL---VGEFHGGLITAE 184
Query: 61 KKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNL----QAAYAAAFKHARPGLPEDISPD 115
+ +N V++ G+ LWEL N P+ +S+ K +P L S
Sbjct: 185 QTKPSN---VWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSER 241
Query: 116 LAFIVQSCWVEDPNLRPSFSQIIRML 141
++Q CW+ P R + ++ R+L
Sbjct: 242 WYEVLQFCWLS-PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-07
Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 12/86 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW-MAPELYSTVTLRQGEKKH 63
+K N+ + D + LK+ DFGLAR + MT T RW APE + L H
Sbjct: 144 LKPSNIAVNEDCE-LKILDFGLARH--TDDEMTGYVAT-RWYRAPE----IML---NWMH 192
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEG 89
YN VD++S G ++ ELLT + F G
Sbjct: 193 YNQTVDIWSVGCIMAELLTGKTLFPG 218
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-07
Identities = 35/92 (38%), Positives = 45/92 (48%), Gaps = 18/92 (19%)
Query: 5 MKEDNLLL--TPDQKSLKLADFGLAR----EETVTEMMTAETGTYRWM-APELYSTVTLR 57
+K NLLL D LK+ DFGLAR E T +T T RW APE+
Sbjct: 132 LKPSNLLLNTNCD---LKICDFGLARIADPEHDHTGFLTEYVAT-RWYRAPEIMLN---- 183
Query: 58 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 89
K Y +D++S G +L E+L+NR F G
Sbjct: 184 ---SKGYTKAIDIWSVGCILAEMLSNRPLFPG 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-07
Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 25/138 (18%)
Query: 18 SLKLADFGLA---------REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 68
++ +ADFGL+ R+ + +M +W+A E + + Y K
Sbjct: 150 NVCVADFGLSKKIYNGDYYRQGRIAKM------PVKWIAIESLA--------DRVYTTKS 195
Query: 69 DVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVED 127
DV+SFG+ +WE+ T + P+ G+ N + Y + R P D L ++ SCW+ +
Sbjct: 196 DVWSFGVTMWEIATRGQTPYPGVENSE-IYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLN 254
Query: 128 PNLRPSFSQIIRMLNAFL 145
P RPSF + L L
Sbjct: 255 PKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-07
Identities = 28/86 (32%), Positives = 45/86 (52%), Gaps = 10/86 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKH 63
+K DNLLL + +K+ADFGL +E T+ GT ++APE+ + +
Sbjct: 127 LKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT--------ETS 177
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEG 89
Y VD + G++++E+L PF G
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-07
Identities = 37/111 (33%), Positives = 55/111 (49%), Gaps = 9/111 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K DN+LL LKLADFG + T M+ +T GT +++PE+ + QG
Sbjct: 168 VKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS----QGGDG 222
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-GLPEDI 112
+Y + D +S G+ L+E+L PF S L Y+ H PED+
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTPFYADS-LVGTYSKIMDHKNSLNFPEDV 272
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-07
Identities = 32/89 (35%), Positives = 45/89 (50%), Gaps = 10/89 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K NL + D + LK+ DFGLAR + MT T + APE+ HY
Sbjct: 146 LKPSNLAVNEDCE-LKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM-------HY 195
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNL 93
N VD++S G ++ ELLT R F G ++
Sbjct: 196 NQTVDIWSVGCIMAELLTGRTLFPGTDHI 224
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-07
Identities = 29/87 (33%), Positives = 53/87 (60%), Gaps = 12/87 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K DN++L + +K+ADFG+ +E + + +T +T GT ++APE+ + +
Sbjct: 127 LKLDNVMLD-SEGHIKIADFGMCKE-NMWDGVTTKTFCGTPDYIAPEIIAY--------Q 176
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEG 89
Y VD ++FG++L+E+L + PFEG
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-07
Identities = 37/131 (28%), Positives = 54/131 (41%), Gaps = 28/131 (21%)
Query: 19 LKLADFG-----LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 73
+KL+D G L+REE V + W+APE + D +SF
Sbjct: 163 IKLSDPGVSFTALSREERVERI--------PWIAPECVPGGN-------SLSTAADKWSF 207
Query: 74 GIVLWELLTNRLPFEGMSNLQAAYAAA---FKHARPGLPEDISPDLAFIVQSCWVEDPNL 130
G L E+ F+G L+ + F + LPE +LA ++ C +P
Sbjct: 208 GTTLLEIC-----FDGEVPLKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQ 262
Query: 131 RPSFSQIIRML 141
RPSF I+R L
Sbjct: 263 RPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-07
Identities = 35/101 (34%), Positives = 50/101 (49%), Gaps = 25/101 (24%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR---------------EETVTEMMTAET-GTYRWMAP 48
+K DNLL+T +KL DFGL++ E+ E + + GT ++AP
Sbjct: 127 LKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAP 185
Query: 49 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 89
E V LRQG Y VD ++ GI+L+E L +PF G
Sbjct: 186 E----VILRQG----YGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-07
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 9/83 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K +N+LL D +++++D GLA E + + GT +MAPE+ + + Y
Sbjct: 121 LKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVL--------QGEVY 171
Query: 65 NNKVDVYSFGIVLWELLTNRLPF 87
+ VD ++ G L+E++ R PF
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-07
Identities = 28/84 (33%), Positives = 48/84 (57%), Gaps = 9/84 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
MK +N+LL DQ + +L+D GLA E + +T GT +MAPE+ +++ Y
Sbjct: 121 MKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEIL--------KEEPY 171
Query: 65 NNKVDVYSFGIVLWELLTNRLPFE 88
+ VD ++ G ++E++ R PF+
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-07
Identities = 36/129 (27%), Positives = 63/129 (48%), Gaps = 14/129 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K +NL+L D +K+ DFGL +E +++ T +T GT ++APE+ E
Sbjct: 121 IKLENLMLDKD-GHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEVL--------EDN 170
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
Y VD + G+V++E++ RLPF + + + R P +SP+ ++
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAG 228
Query: 123 CWVEDPNLR 131
+DP R
Sbjct: 229 LLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-07
Identities = 35/131 (26%), Positives = 62/131 (47%), Gaps = 13/131 (9%)
Query: 11 LLTPDQKSLKLADFGLARE-ETVTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNNK 67
+L +K+ DFGLAR E + A+ G +WMA E + + ++
Sbjct: 140 VLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI--------HYRKFTHQ 191
Query: 68 VDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVE 126
DV+S+G+ +WEL+T P++G+ + K R P + D+ ++ CW+
Sbjct: 192 SDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQPPICTIDVYMVMVKCWMI 250
Query: 127 DPNLRPSFSQI 137
D + RP F ++
Sbjct: 251 DADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-07
Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 15/131 (11%)
Query: 19 LKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75
+K+ DFG++R+ T+ T RWM PE ++ R+ + + DV+SFG+
Sbjct: 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE---SIMYRK-----FTTESDVWSFGV 213
Query: 76 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF-IVQSCWVEDPNLRPS 133
+LWE+ T + P+ +SN + R + P + I+ CW +P R +
Sbjct: 214 ILWEIFTYGKQPWFQLSNTEV--IECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLN 271
Query: 134 FSQIIRMLNAF 144
+I ++L+A
Sbjct: 272 IKEIYKILHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-07
Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 11/140 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEK 61
+K NLL+ K++K+ADFG++R + + M + GT +M+PE +T L G
Sbjct: 194 IKPSNLLIN-SAKNVKIADFGVSR--ILAQTMDPCNSSVGTIAYMSPERINT-DLNHGAY 249
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFE-GMSNLQAAYAAAFKHAR-PGLPEDISPDLAFI 119
Y D++S G+ + E R PF G A+ A ++ P P S +
Sbjct: 250 DGYAG--DIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHF 307
Query: 120 VQSCWVEDPNLRPSFSQIIR 139
+ C +P R S Q+++
Sbjct: 308 ISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 7e-07
Identities = 30/86 (34%), Positives = 41/86 (47%), Gaps = 9/86 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K NLLL + LK+ DFGLAR + + MT T + APEL +
Sbjct: 134 LKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCS-------E 185
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEG 89
Y +DV+S G + ELL + F G
Sbjct: 186 YTTAIDVWSVGCIFAELLGRKPLFPG 211
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-07
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQG 59
M + +K NLL+ + LK+AD GL R ++ + T E T + APE+ T
Sbjct: 132 MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST---- 187
Query: 60 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
HY+ VD++S G + E+ + F G S LQ
Sbjct: 188 ---HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 7e-07
Identities = 35/92 (38%), Positives = 49/92 (53%), Gaps = 13/92 (14%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT--YRWMAPELYSTVTLRQGEK 61
+K NLLL ++ LK+ DFGLARE + + T T YR APEL G K
Sbjct: 132 LKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVTLWYR--APELL------LGAK 182
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 93
+ Y+ +D++S G + ELLT + F G S +
Sbjct: 183 E-YSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-07
Identities = 38/155 (24%), Positives = 64/155 (41%), Gaps = 29/155 (18%)
Query: 9 NLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
N+LL D + +K+ DFGLA+ E ++ + W A E E K
Sbjct: 137 NVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-WYAVECLK-------ENKF 187
Query: 64 YNNKVDVYSFGIVLWELLTN-------RLPFEGMSNLQAAYAAAF-------KHARPGLP 109
DV+SFG+ L+ELLT+ FE M + + R P
Sbjct: 188 SYAS-DVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCP 246
Query: 110 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144
++ ++ ++++CW + RP+F +I +L
Sbjct: 247 KNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-07
Identities = 28/87 (32%), Positives = 52/87 (59%), Gaps = 12/87 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K DN++L + +K+ADFG+ +E V + +T T GT ++APE+ + +
Sbjct: 127 LKLDNVMLD-SEGHIKIADFGMCKEHMV-DGVTTRTFCGTPDYIAPEIIAY--------Q 176
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEG 89
Y VD +++G++L+E+L + PF+G
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 9e-07
Identities = 37/112 (33%), Positives = 53/112 (47%), Gaps = 9/112 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K DN+LL LKLADFG + M+ +T GT +++PE V QG
Sbjct: 168 VKPDNMLLD-KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE----VLKSQGGDG 222
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-GLPEDIS 113
+Y + D +S G+ L+E+L PF S L Y+ H P+DI
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKIMDHKNSLTFPDDIE 273
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-06
Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 10/142 (7%)
Query: 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQG 59
M + +K N+LLT D +KLADFG+A + T T + GT WMAPE+ + V G
Sbjct: 128 MHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV-AAVEKNGG 185
Query: 60 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED---ISPDL 116
YN D+++ GI EL + P + ++A + + + +P +D S
Sbjct: 186 ----YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241
Query: 117 AFIVQSCWVEDPNLRPSFSQII 138
V+ ++P RP+ +++
Sbjct: 242 HNFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-06
Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 14/129 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K +NL+L D +K+ DFGL +E + + T +T GT ++APE+ E
Sbjct: 122 LKLENLMLDKD-GHIKITDFGLCKE-GIKDGATMKTFCGTPEYLAPEVL--------EDN 171
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
Y VD + G+V++E++ RLPF + + + R P +SP+ ++
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEAKSLLSG 229
Query: 123 CWVEDPNLR 131
+DP R
Sbjct: 230 LLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-06
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 12/87 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K DN++L + +K+ADFG+ +E + T T GT ++APE+ + +
Sbjct: 127 LKLDNVMLDAE-GHIKIADFGMCKEN-IFGGKTTRTFCGTPDYIAPEIIAY--------Q 176
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEG 89
Y VD ++FG++L+E+L + PF+G
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 26/72 (36%), Positives = 37/72 (51%), Gaps = 8/72 (11%)
Query: 18 SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77
+LK+ DFGLAR + MMT T + APE V L G Y VD++S G ++
Sbjct: 156 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIM 207
Query: 78 WELLTNRLPFEG 89
E++ + F G
Sbjct: 208 GEMIRGTVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-06
Identities = 38/137 (27%), Positives = 65/137 (47%), Gaps = 7/137 (5%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K N+LLT + +KL DFG++ + TV T GT WMAPE+ + +
Sbjct: 137 IKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAPEV---IACDENPDA 191
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
Y+ K D++S GI E+ P M ++A + A + S ++S
Sbjct: 192 TYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIES 251
Query: 123 CWVEDPNLRPSFSQIIR 139
C V++ + RP+ Q+++
Sbjct: 252 CLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-06
Identities = 37/141 (26%), Positives = 59/141 (41%), Gaps = 19/141 (13%)
Query: 12 LTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKV 68
L + ++K+ADFG++R + + RWMA E + G+ +
Sbjct: 170 LVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWE-----CILMGK---FTTAS 221
Query: 69 DVYSFGIVLWELLT--NRLPFEGMSNLQAAYAAA--FKHARP----GLPEDISPDLAFIV 120
DV++FG+ LWE+L P+ +++ Q A F+ P L ++
Sbjct: 222 DVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELM 281
Query: 121 QSCWVEDPNLRPSFSQIIRML 141
CW D RPSFS I L
Sbjct: 282 LQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 1e-06
Identities = 34/93 (36%), Positives = 47/93 (50%), Gaps = 15/93 (16%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKK 62
+K N+L+T D + +K+ADFGLAR + +T+ T YR APE V L+
Sbjct: 133 LKPQNILVTSDGQ-VKIADFGLARIYSFEMALTSVVVTLWYR--APE----VLLQS---- 181
Query: 63 HYNNKVDVYSFGIVLWELLTNRLP-FEGMSNLQ 94
Y VD++S G + EL R P F G S
Sbjct: 182 SYATPVDMWSVGCIFAELF-RRRPLFRGTSEAD 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-06
Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 10/85 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKH 63
+K DN+LL + KLADFG+ +E T+ GT ++APE+ ++
Sbjct: 122 LKLDNVLLDHEGHC-KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL--------QEML 172
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFE 88
Y VD ++ G++L+E+L PFE
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-06
Identities = 37/132 (28%), Positives = 57/132 (43%), Gaps = 28/132 (21%)
Query: 19 LKLADFG-----LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 73
+KL+D G L+R+E V + W+APE + K+ + D +SF
Sbjct: 151 IKLSDPGIPITVLSRQECVERI--------PWIAPECVE-------DSKNLSIAADKWSF 195
Query: 74 GIVLWELLTN-RLPFEG--MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNL 130
G LWE+ N +P + ++ + Y P E LA ++ C DPN
Sbjct: 196 GTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCKE-----LADLMTHCMNYDPNQ 250
Query: 131 RPSFSQIIRMLN 142
RP F I+R +N
Sbjct: 251 RPFFRAIMRDIN 262
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-06
Identities = 36/140 (25%), Positives = 66/140 (47%), Gaps = 19/140 (13%)
Query: 19 LKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75
+K+ DFG++R+ T+ T RWM PE ++ R+ + + DV+S G+
Sbjct: 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE---SIMYRK-----FTTESDVWSLGV 210
Query: 76 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPS 133
VLWE+ T + P+ +SN + R P ++ ++ CW +P++R +
Sbjct: 211 VLWEIFTYGKQPWYQLSNNEV--IECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLN 268
Query: 134 FSQIIRMLNAFLFTLRPPSP 153
I+ +++ L L SP
Sbjct: 269 ----IKEIHSLLQNLAKASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-06
Identities = 29/86 (33%), Positives = 44/86 (51%), Gaps = 10/86 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKH 63
+K +N+LL Q +KL DFGL +E +T GT +MAPE+ R G
Sbjct: 126 LKPENILLDA-QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM----RSG---- 176
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEG 89
+ VD +S G +++++LT PF
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-06
Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 12/143 (8%)
Query: 1 MGKFMKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQG 59
M + +K N+ +T +KL D GL R + T + GT +M+PE +
Sbjct: 128 MHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE--------RI 178
Query: 60 EKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKHARPGLPED-ISPDLA 117
+ YN K D++S G +L+E+ + PF G NL + + P LP D S +L
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238
Query: 118 FIVQSCWVEDPNLRPSFSQIIRM 140
+V C DP RP + + +
Sbjct: 239 QLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-06
Identities = 36/132 (27%), Positives = 51/132 (38%), Gaps = 20/132 (15%)
Query: 5 MKEDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K +NLL+ DQ LKL DFGL+R GT ++APE
Sbjct: 123 IKPENLLI--DQTGHLKLTDFGLSR---NGLENKKFVGTPDYLAPETI--------LGVG 169
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED----ISPDLAFI 119
+ D +S G V++E L PF + A R PE+ SP+ +
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFH--AETPDAVFDNILSRRINWPEEVKEFCSPEAVDL 227
Query: 120 VQSCWVEDPNLR 131
+ DP R
Sbjct: 228 INRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-06
Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 9/90 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K NLL+ + +KLADFGLAR V T E T + APE+ K+
Sbjct: 126 LKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC-------KY 177
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNL 93
Y+ VD++S G + E++T R F G S +
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 4e-06
Identities = 32/101 (31%), Positives = 46/101 (45%), Gaps = 20/101 (19%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGT---Y------RWM-APELYS 52
+K N+L+ +Q LK+ADFGLAR + G Y RW PEL
Sbjct: 141 IKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL 199
Query: 53 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 93
GE++ Y VD++ G V E+ T R +G S++
Sbjct: 200 ------GERR-YTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-06
Identities = 29/85 (34%), Positives = 44/85 (51%), Gaps = 9/85 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+++ D +LK+ DFGLAR + MMT T + APE V L G Y
Sbjct: 152 LKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE----VILGMG----Y 202
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEG 89
VD++S G ++ E++ + F G
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPG 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-06
Identities = 32/143 (22%), Positives = 74/143 (51%), Gaps = 15/143 (10%)
Query: 9 NLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
N+LL +Q K++DFGL++ +++ + +A +W APE + R+ +
Sbjct: 125 NVLLV-NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE---CINFRK-----F 175
Query: 65 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
+++ DV+S+GI +WE + + P++ M + + + R P + P++ +++ C
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-SFIEQGKRLDCPAECPPEMYALMKDC 234
Query: 124 WVEDPNLRPSFSQIIRMLNAFLF 146
W+ RP+F+++ + + +
Sbjct: 235 WIYKWEDRPNFAKVEERMRTYYY 257
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-06
Identities = 41/166 (24%), Positives = 58/166 (34%), Gaps = 60/166 (36%)
Query: 40 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA--- 96
T W++PEL LRQ + YN K D+YS GI EL T R+PF+ M Q
Sbjct: 169 TSVLPWLSPEL-----LRQ-DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK 222
Query: 97 ---------YAAAF-------KHARPGL--------------------------PEDISP 114
F K+++ G+ + SP
Sbjct: 223 LKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSP 282
Query: 115 DLAFIVQSCWVEDPNLRPS---------FSQIIRMLNAFLFTLRPP 151
+V+ C +DP RPS F Q+ + +L PP
Sbjct: 283 AFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQGSILSLLPP 328
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-06
Identities = 35/110 (31%), Positives = 53/110 (48%), Gaps = 9/110 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K DN+LL LKLADFG + M+ +T GT +++PE+ + QG
Sbjct: 168 VKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS----QGGDG 222
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-GLPED 111
+Y + D +S G+ L+E+L PF S L Y+ H P+D
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKIMNHKNSLTFPDD 271
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 6e-06
Identities = 32/88 (36%), Positives = 45/88 (51%), Gaps = 9/88 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K NLL+ + +LKLADFGLAR V T E T + APE + L +
Sbjct: 125 LKPQNLLID-REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPE----ILLGS---RQ 176
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMS 91
Y+ VD++S G + E++ R F G S
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRPLFPGDS 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-06
Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+++ D +LK+ DFGLAR MMT T + APE V L G Y
Sbjct: 149 LKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPE----VILGMG----Y 199
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNL 93
VD++S G ++ EL+ + F+G ++
Sbjct: 200 KENVDIWSVGCIMGELVKGSVIFQGTDHI 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-06
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 7/87 (8%)
Query: 5 MKEDNLLLTPDQKS-LKLADFGLAREETVTEMMTAE--TGTYRWMAPELYSTVTLRQGEK 61
+K +N+L+ D+ +KLADFG A T +M+ ++ GT ++APE+ +T + K
Sbjct: 128 IKPENVLI--DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT--MNGDGK 183
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFE 88
Y + D +S G++ +E++ R PF
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-06
Identities = 29/86 (33%), Positives = 47/86 (54%), Gaps = 9/86 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K NLL+ ++ LKLADFGLAR ++V T+ + E T + P++ T
Sbjct: 129 LKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST-------E 180
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEG 89
Y+ +D++ G +L+E+ T R F G
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 9e-06
Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 15/91 (16%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTYRWM-APELYSTVTLRQ 58
+K NLL+ D + LK+ DFGLAR MT T RW APE+ +
Sbjct: 131 LKPGNLLVNADCE-LKICDFGLARGFSENPGENAGFMTEYVAT-RWYRAPEIMLSF---- 184
Query: 59 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 89
+ Y +DV+S G +L ELL + F+G
Sbjct: 185 ---QSYTKAIDVWSVGCILAELLGRKPVFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-05
Identities = 26/85 (30%), Positives = 47/85 (55%), Gaps = 10/85 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKH 63
+K DN+LL + KLADFG+ +E + + T GT ++APE+ ++
Sbjct: 122 LKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL--------QELE 172
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFE 88
Y VD ++ G++++E++ + PFE
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-05
Identities = 32/120 (26%), Positives = 59/120 (49%), Gaps = 9/120 (7%)
Query: 20 KLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79
K+ DFGL++ + M + GT + +PEL E K Y++K D+++ G +++E
Sbjct: 182 KIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLH------ETKSYDDKSDMWALGCIIYE 235
Query: 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQII 138
L + + PF +N + + K P LP + S +L ++++ RPS Q +
Sbjct: 236 LCSGKTPFHKANNF-SQLISELKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-05
Identities = 39/143 (27%), Positives = 68/143 (47%), Gaps = 10/143 (6%)
Query: 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQG 59
M + +K N+LLT D +KLADFG++ + T T + GT WMAPE+ +
Sbjct: 128 MHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV-----E 181
Query: 60 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED---ISPDL 116
K YN D+++ GI EL + P + ++A + + +P +D S
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241
Query: 117 AFIVQSCWVEDPNLRPSFSQIIR 139
V+ ++P RP+ ++++
Sbjct: 242 HHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-05
Identities = 27/86 (31%), Positives = 47/86 (54%), Gaps = 9/86 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K NLL+ ++ LKLADFGLAR +++ T+ + E T + P++ T
Sbjct: 130 LKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST-------D 181
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEG 89
Y+ ++D++ G + +E+ T R F G
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-05
Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 10/85 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+ + D + L++ DFGLAR+ + MT T + APE+ HY
Sbjct: 144 LKPSNVAVNEDCE-LRILDFGLARQ--ADDEMTGYVATRWYRAPEIMLNWM-------HY 193
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEG 89
N VD++S G ++ ELL + F G
Sbjct: 194 NQTVDIWSVGCIMAELLKGKALFPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-05
Identities = 47/168 (27%), Positives = 71/168 (42%), Gaps = 44/168 (26%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWM-APELYSTVTLRQGE 60
+K +N+L++ +KL DFG AR T+ E+ T T RW APEL G+
Sbjct: 126 IKPENILVSQS-GVVKLCDFGFAR--TLAAPGEVYTDYVAT-RWYRAPELLV------GD 175
Query: 61 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMS-------------NLQAAYAAAFKHARPG 107
K Y VD+++ G ++ E+LT F G S NL + F+
Sbjct: 176 TK-YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234
Query: 108 ----LPE------------DISPDLAFIVQSCWVEDPNLRPSFSQIIR 139
LPE +S + + + C DP+ RPS SQ++
Sbjct: 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-05
Identities = 29/85 (34%), Positives = 46/85 (54%), Gaps = 9/85 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+++ D +LK+ DFGLAR + MMT T + APE V L G Y
Sbjct: 145 LKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE----VILGMG----Y 195
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEG 89
VD++S G ++ E++ +++ F G
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-05
Identities = 26/84 (30%), Positives = 44/84 (52%), Gaps = 13/84 (15%)
Query: 5 MKEDNLLLTPDQK-SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K +NLLL D K +K+ DFG A++ V + GT ++APE+ + K
Sbjct: 144 LKPENLLL--DNKGHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVI--------QSKG 191
Query: 64 YNNKVDVYSFGIVLWELLTNRLPF 87
+ VD ++ G++L+E + PF
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 14/95 (14%)
Query: 5 MKEDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K +N L+ D +KL DFGL++ + + G+ +MAPE+ +G+
Sbjct: 127 LKPENFLI--DASGHIKLTDFGLSKG--IVTYANSVVGSPDYMAPEVL------RGKG-- 174
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 98
Y+ VD +S G +L+E L PF G S +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWE 208
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-05
Identities = 32/85 (37%), Positives = 44/85 (51%), Gaps = 10/85 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K NL + D + LK+ DFGLAR MT T + APE V L HY
Sbjct: 143 LKPGNLAVNEDCE-LKILDFGLARHADAE--MTGYVVTRWYRAPE----VILNW---MHY 192
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEG 89
N VD++S G ++ E+LT + F+G
Sbjct: 193 NQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-05
Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 12/143 (8%)
Query: 1 MGKFMKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQG 59
M + +K N+ +T +KL D GL R + T + GT +M+PE +
Sbjct: 128 MHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE--------RI 178
Query: 60 EKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKHARPGLP-EDISPDLA 117
+ YN K D++S G +L+E+ + PF G NL + + P LP E S L
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238
Query: 118 FIVQSCWVEDPNLRPSFSQIIRM 140
+V C DP+ RP + ++
Sbjct: 239 ELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-05
Identities = 29/84 (34%), Positives = 48/84 (57%), Gaps = 10/84 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMT-AETGTYRWMAPELYSTVTLRQGEKKH 63
+K +N+LL + +++++D GLA E + T GT +MAPEL QGE+
Sbjct: 123 LKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL------QGEE-- 173
Query: 64 YNNKVDVYSFGIVLWELLTNRLPF 87
Y+ VD ++ G+ L+E++ R PF
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-05
Identities = 34/116 (29%), Positives = 54/116 (46%), Gaps = 12/116 (10%)
Query: 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGE 60
M + +K N+L+ + +KL DFG++ + + M + GT +M+PE QG
Sbjct: 126 MHRDVKPSNILVN-SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL------QG- 176
Query: 61 KKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLPEDISP 114
HY+ + D++S G+ L EL R P L+A + G P ISP
Sbjct: 177 -THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 231
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-05
Identities = 30/84 (35%), Positives = 44/84 (52%), Gaps = 10/84 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKH 63
+K +N+LL Q + L DFGL +E T+ GT ++APE+ LR K+
Sbjct: 122 LKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV-----LR---KQP 172
Query: 64 YNNKVDVYSFGIVLWELLTNRLPF 87
Y+ VD + G VL+E+L PF
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 33/93 (35%), Positives = 44/93 (47%), Gaps = 9/93 (9%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM-APELYSTVTLRQGEKKHY 64
K +N+L+T Q +KL DFG AR T + RW APEL T Y
Sbjct: 127 KPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT-------QY 178
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 97
VDV++ G V ELLT + + G S++ Y
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-05
Identities = 38/138 (27%), Positives = 66/138 (47%), Gaps = 9/138 (6%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K N+LLT + +KL DFG++ + TV T GT WMAPE+ + +
Sbjct: 147 IKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAPEV---IACDENPDA 201
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL-PEDISPDLAFIVQ 121
Y+ + D++S GI E+ P M ++A + ++ P L + S ++
Sbjct: 202 TYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP-RNPPPKLKSKKWSKKFIDFIE 260
Query: 122 SCWVEDPNLRPSFSQIIR 139
C V++ RPS Q+++
Sbjct: 261 GCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-05
Identities = 23/77 (29%), Positives = 38/77 (49%), Gaps = 9/77 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K +N+ + D + + D G A+ V GT APE+ + + Y
Sbjct: 183 VKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLA--------RDKY 233
Query: 65 NNKVDVYSFGIVLWELL 81
N+K D++S GIVL+E+L
Sbjct: 234 NSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-05
Identities = 29/93 (31%), Positives = 52/93 (55%), Gaps = 13/93 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPE--LYSTVTLRQGEK 61
+K NLL++ ++ LKLADFGLAR ++V ++ + E T + P+ L ST
Sbjct: 129 LKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST-------- 179
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
Y+ +D++ G + +E+ T R F G ++++
Sbjct: 180 -EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-05
Identities = 40/140 (28%), Positives = 64/140 (45%), Gaps = 17/140 (12%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTV---TLRQGEKK 62
N LLT D ++K+ D+GL+ + + + RW+APEL V L + K
Sbjct: 130 NCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTK 188
Query: 63 HYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA-AYAA---AFKHARPGLPEDISPDLA 117
N V+S G+ +WEL P+ +S+ Q Y K +P L +S
Sbjct: 189 ESN----VWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWY 244
Query: 118 FIVQSCWVEDPNLRPSFSQI 137
++Q CW++ P RPS ++
Sbjct: 245 EVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-05
Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 11/85 (12%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K +N+LL + +KL DFG A++ + + GT ++APE+ + K +
Sbjct: 127 LKPENILLDKE-GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVI--------QSKGH 175
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEG 89
N VD ++ GI+++E+L PF
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-05
Identities = 37/136 (27%), Positives = 55/136 (40%), Gaps = 17/136 (12%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+L+ + +KL DFG++ + V + GT +MAPE S GE+ Y
Sbjct: 121 VKPSNMLVN-TRGQVKLCDFGVSTQ-LVNSIAKTYVGTNAYMAPERIS------GEQ--Y 170
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA------AAFKHARPGLPE-DISPDLA 117
DV+S GI EL R P+ + Q + P LP S
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230
Query: 118 FIVQSCWVEDPNLRPS 133
+ C + P RP+
Sbjct: 231 HFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-05
Identities = 29/84 (34%), Positives = 44/84 (52%), Gaps = 10/84 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K +N+LL Q + L DFGL +E ++ T GT ++APE+ K+
Sbjct: 122 LKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI--------RKQP 172
Query: 64 YNNKVDVYSFGIVLWELLTNRLPF 87
Y+N VD + G VL+E+L PF
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-05
Identities = 31/91 (34%), Positives = 52/91 (57%), Gaps = 12/91 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKH 63
+K DN+LL + +KL D+G+ +E T+ GT ++APE+ LR GE
Sbjct: 122 LKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEI-----LR-GED-- 172
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFE--GMSN 92
Y VD ++ G++++E++ R PF+ GMS+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGMSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 8e-05
Identities = 34/89 (38%), Positives = 47/89 (52%), Gaps = 11/89 (12%)
Query: 5 MKEDNLLLTPDQKSL-KLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K NLL+ D K + KLADFGLAR + + T E T + APE V L G +
Sbjct: 127 LKPQNLLI--DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPE----VLL--GSPR 178
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMS 91
Y+ VD++S G + E+ T + F G S
Sbjct: 179 -YSTPVDIWSIGTIFAEMATKKPLFHGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 8e-05
Identities = 29/85 (34%), Positives = 40/85 (47%), Gaps = 11/85 (12%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM-APELYSTVTLRQGEKKHY 64
K +N+L+ LKLADFG R T T RW APE L G +Y
Sbjct: 127 KPENILI--KDDILKLADFGSCRGIYSKPPYTEYIST-RWYRAPE----CLLTDG---YY 176
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEG 89
K+D+++ G V +E+L+ F G
Sbjct: 177 GPKMDIWAVGCVFFEILSLFPLFPG 201
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 1e-04
Identities = 30/90 (33%), Positives = 40/90 (44%), Gaps = 22/90 (24%)
Query: 15 DQKSLKLADFGLAR---------------EETVTEMMTAETGTYRWMAPELYSTVTLRQG 59
+ K+ADFGLAR E MT++ T + APEL L
Sbjct: 154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPEL-----LMGA 208
Query: 60 EKKHYNNKVDVYSFGIVLWELLTNRLPFEG 89
EK Y+ VD++S G + ELLT + F G
Sbjct: 209 EK--YHFAVDMWSVGCIFAELLTGKPLFPG 236
|
Length = 335 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 1e-04
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 7/90 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K NLL++ D LKLADFGLAR ++V + W P V L E Y
Sbjct: 129 LKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRP---PDVLLGSTE---Y 181
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
+ +D++ G + E++ F GM ++Q
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 1e-04
Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 10/89 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K NL + D + LK+ DFGLAR+ T +EM T T + APE V L HY
Sbjct: 144 LKPGNLAVNEDCE-LKILDFGLARQ-TDSEM-TGYVVTRWYRAPE----VILNW---MHY 193
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNL 93
VD++S G ++ E+LT + F+G +L
Sbjct: 194 TQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 1e-04
Identities = 31/84 (36%), Positives = 45/84 (53%), Gaps = 10/84 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKH 63
+K +N+LL Q + L DFGL +E E T+ GT ++APE+ LR K+
Sbjct: 122 LKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEV-----LR---KEP 172
Query: 64 YNNKVDVYSFGIVLWELLTNRLPF 87
Y+ VD + G VL+E+L PF
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 1e-04
Identities = 31/96 (32%), Positives = 44/96 (45%), Gaps = 14/96 (14%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWM-APELYSTVTLRQGEK 61
K +N+L++ LKL DFG AR + + Y RW APEL T
Sbjct: 127 KPENILVSESGV-LKLCDFGFAR--ALRARPASPLTDYVATRWYRAPELLVGDT------ 177
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 97
+Y VDV++ G ++ ELL F G S++ Y
Sbjct: 178 -NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLY 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 1e-04
Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 9/86 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K NLL+ ++ LKLADFGLAR ++V T+ + E T + P+ V L E
Sbjct: 130 LKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD----VLLGSSE--- 181
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEG 89
Y+ ++D++ G + +E+ + R F G
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 29/91 (31%), Positives = 41/91 (45%), Gaps = 15/91 (16%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-----ETVTEMMTAETGTYRWM-APELYSTVTLRQ 58
+K NLL+ D L++ DFG+AR MT T RW APEL ++
Sbjct: 133 LKPSNLLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEYVAT-RWYRAPELLLSL---- 186
Query: 59 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 89
Y +D++S G + E+L R F G
Sbjct: 187 ---PEYTTAIDMWSVGCIFAEMLGRRQLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 45/192 (23%), Positives = 64/192 (33%), Gaps = 53/192 (27%)
Query: 6 KEDNLLLTPDQKSLKLADFGLA-------------REETVTEMMTAET------------ 40
K DN+L+ D +KLADFGL +
Sbjct: 128 KPDNILIDAD-GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVR 186
Query: 41 -----GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 95
GT ++APE V Y + D +S G++L+E+L PF LQ
Sbjct: 187 ANSTVGTPDYIAPE----VLRGTP----YGLECDWWSLGVILYEMLYGFPPFYS-DTLQE 237
Query: 96 AYAAAFKHARP-GLPED--ISPDLAFIVQSCWVEDPNLR-PSFSQIIRMLNAFLFT---- 147
Y P D +SP+ ++ + DP R SF +I + F
Sbjct: 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRL-LCDPEDRLGSFEEIKS--HPFFKGIDWE 294
Query: 148 --LRPPSPSVPE 157
P VPE
Sbjct: 295 NLRETKPPFVPE 306
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 2e-04
Identities = 27/85 (31%), Positives = 48/85 (56%), Gaps = 10/85 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKH 63
+K DN+LL D +KL D+G+ +E T+ GT ++APE+ +GE+
Sbjct: 122 LKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL------RGEE-- 172
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFE 88
Y VD ++ G++++E++ R PF+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 2e-04
Identities = 28/83 (33%), Positives = 40/83 (48%), Gaps = 13/83 (15%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTYRWMAPELYSTVTLRQG 59
MK N+L+T D LKLADFGLAR + + T T + PEL G
Sbjct: 145 MKAANILITKD-GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELL------LG 197
Query: 60 EKKHYNNKVDVYSFGIVLWELLT 82
E + Y +D++ G ++ E+ T
Sbjct: 198 E-RDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 36/150 (24%), Positives = 50/150 (33%), Gaps = 52/150 (34%)
Query: 45 WMAPELYSTVTLRQ---GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ------- 94
W++PE+ L+Q G YN K D+YS GI EL +PF+ M Q
Sbjct: 174 WLSPEV-----LQQNLQG----YNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR 224
Query: 95 -------------------AAYAAAFKHARPGLPEDI------SPDLAFIVQSCWVEDPN 129
+ ++ +H D S V+ C DP
Sbjct: 225 GTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPE 284
Query: 130 LRPSFSQI--------IRMLNAFLFTLRPP 151
RPS SQ+ + N L L P
Sbjct: 285 SRPSASQLLNHSFFKQCKRRNTSLLDLLKP 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 3e-04
Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 43/147 (29%)
Query: 18 SLKLADFGLAREETVTEMMTAETGTY-----------RWMAPELYSTVTLRQGEKKHYNN 66
++K+ADFG++R +G Y RWM+ E ++ L + +
Sbjct: 168 TIKIADFGMSR--------NLYSGDYYRIQGRAVLPIRWMSWE---SILLGK-----FTT 211
Query: 67 KVDVYSFGIVLWELLT--NRLPFEGMSNLQAAYAAA--FKHA-------RPGLPEDISPD 115
DV++FG+ LWE+LT P+ +S+ Q F+ +P L PD
Sbjct: 212 ASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPAL----CPD 267
Query: 116 LAF-IVQSCWVEDPNLRPSFSQIIRML 141
+ ++ SCW + RPSF +I L
Sbjct: 268 SLYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 3e-04
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 11/90 (12%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPE-LYSTVTLRQGEKK 62
+K NLL+ + LKLADFGLAR + + E T + AP+ L + T
Sbjct: 126 LKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT------- 177
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSN 92
Y+ +D++S G ++ E++T R F G +N
Sbjct: 178 -YSTSIDIWSVGCIMAEMITGRPLFPGTNN 206
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 4e-04
Identities = 30/110 (27%), Positives = 40/110 (36%), Gaps = 15/110 (13%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
K N+LLT D LKL + + Y +MAPE+ + +
Sbjct: 38 KSGNILLTWD-GLLKLDGSVAFKTPE-----QSRPDPY-FMAPEVIQGQSYTE------- 83
Query: 66 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 115
K D+YS GI L+E L LP+ L A P D S
Sbjct: 84 -KADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNL 132
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 4e-04
Identities = 25/89 (28%), Positives = 44/89 (49%), Gaps = 7/89 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K NLL+ P+ +LKL DFG A+ + + + + APEL T +Y
Sbjct: 196 LKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGAT-------NY 248
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNL 93
+D++S G ++ E++ F G S++
Sbjct: 249 TTHIDLWSLGCIIAEMILGYPIFSGQSSV 277
|
Length = 440 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 4e-04
Identities = 25/98 (25%), Positives = 45/98 (45%), Gaps = 19/98 (19%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR--------EETVTEMMTAETGTYRWMAPELYSTVTL 56
+K N+ + + LK+ DFGLAR + ++E + T YR +P L +
Sbjct: 140 LKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV--TKWYR--SPRLLLSPN- 194
Query: 57 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
+Y +D+++ G + E+LT + F G L+
Sbjct: 195 ------NYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 4e-04
Identities = 37/174 (21%), Positives = 60/174 (34%), Gaps = 46/174 (26%)
Query: 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGE 60
M + +K N+L+ + +KL DFG++ + + M + GT +M+PE QG
Sbjct: 122 MHRDVKPSNILVNSRGE-IKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL------QGT 173
Query: 61 KKHYNNKVDVYSFGIVLWELLTNRLP--------FEGMSNLQA-AYAAAFKHARPG---- 107
HY + D++S G+ L E+ R P E M A H
Sbjct: 174 --HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231
Query: 108 ----------------------LPEDI-SPDLAFIVQSCWVEDPNLRPSFSQII 138
LP S + V C ++P R ++
Sbjct: 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 5e-04
Identities = 30/89 (33%), Positives = 44/89 (49%), Gaps = 11/89 (12%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWM-APELYSTVTLRQGE 60
+K N+L D K LK+ DFGLAR +T T + + RW APEL + +
Sbjct: 129 LKPKNILANADCK-LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK--- 184
Query: 61 KKHYNNKVDVYSFGIVLWELLTNRLPFEG 89
Y +D++S G + E+LT + F G
Sbjct: 185 ---YTPAIDIWSIGCIFAEVLTGKPLFPG 210
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 6e-04
Identities = 36/135 (26%), Positives = 65/135 (48%), Gaps = 17/135 (12%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKH 63
+K DN+LL + +KL D+G+ +E T+ GT ++APE+ +GE
Sbjct: 122 LKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL------RGED-- 172
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFE--GMS-----NLQAAYAAAFKHARPGLPEDISPDL 116
Y VD ++ G++++E++ R PF+ G S N + + +P +S
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 232
Query: 117 AFIVQSCWVEDPNLR 131
A +++S +DP R
Sbjct: 233 ASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 6e-04
Identities = 26/90 (28%), Positives = 50/90 (55%), Gaps = 9/90 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K NLL++ LKLADFGLAR +++ ++ ++E T + P++ T
Sbjct: 129 LKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGAT-------D 180
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNL 93
Y++ +D++ G + E+L + F G+S++
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 6e-04
Identities = 28/84 (33%), Positives = 42/84 (50%), Gaps = 10/84 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKH 63
+K +N+LL Q + L DFGL +E T+ GT ++APE+ K+
Sbjct: 122 LKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL--------HKQP 172
Query: 64 YNNKVDVYSFGIVLWELLTNRLPF 87
Y+ VD + G VL+E+L PF
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 6e-04
Identities = 29/89 (32%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+L+T + +KLADFGLAR + +T+ T + APE+ L Q Y
Sbjct: 136 LKPQNILVTSSGQ-IKLADFGLARIYSFQMALTSVVVTLWYRAPEV-----LLQSS---Y 186
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNL 93
VD++S G + E+ + F G S++
Sbjct: 187 ATPVDLWSVGCIFAEMFRRKPLFRGSSDV 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 7e-04
Identities = 23/85 (27%), Positives = 42/85 (49%), Gaps = 9/85 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K +N+LL D ++++D GLA E E + GT +MAPE+ + + Y
Sbjct: 128 LKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV--------KNERY 178
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEG 89
D + G +++E++ + PF
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 7e-04
Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 10/85 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+L+ + LK+ DFGLAR + MT T + APE+ T + Y
Sbjct: 134 LKPSNILIN-ENCDLKICDFGLARIQD--PQMTGYVSTRYYRAPEIMLTW-------QKY 183
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEG 89
+ +VD++S G + E+L + F G
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPG 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 7e-04
Identities = 39/153 (25%), Positives = 61/153 (39%), Gaps = 26/153 (16%)
Query: 11 LLTPDQKSLKLADFGLARE-ETVTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHYNN 66
+L + +K+ DFGL + ET E T + W APE + K Y
Sbjct: 140 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI-------QSKFYIA 192
Query: 67 KVDVYSFGIVLWELLT----------NRLPFEGMSNLQAAYAAAFKHARPG----LPEDI 112
DV+SFG+ L+ELLT L G ++ Q + G P +
Sbjct: 193 S-DVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNC 251
Query: 113 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145
++ +++ CW P+ R +F +I A L
Sbjct: 252 PEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 7e-04
Identities = 33/123 (26%), Positives = 56/123 (45%), Gaps = 11/123 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFG--LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K DN+LL + ++LADFG L + T + GT +++PE+ + G+
Sbjct: 128 IKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGK-- 184
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR----PGLPEDISPDLAF 118
Y + D +S G+ ++E+L PF S L Y H P D+S +
Sbjct: 185 -YGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHEERFQFPSHITDVSEEAKD 242
Query: 119 IVQ 121
++Q
Sbjct: 243 LIQ 245
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 7e-04
Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 10/87 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K N+LL ++ +KLADFGLAR + T + T + PEL GE++
Sbjct: 142 IKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELL------LGEER 194
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEG 89
Y +DV+S G +L EL T + F+
Sbjct: 195 -YGPAIDVWSCGCILGELFTKKPIFQA 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 7e-04
Identities = 27/94 (28%), Positives = 42/94 (44%), Gaps = 18/94 (19%)
Query: 5 MKEDNLLLT---PDQKSLKLADFGLAR------EETVTEMMTAETGTYRWMAPELYSTVT 55
+K N+L+ P++ +K+ D GLAR + T YR APEL
Sbjct: 134 LKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYR--APELLLGA- 190
Query: 56 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 89
+HY +D+++ G + ELLT F+G
Sbjct: 191 ------RHYTKAIDIWAIGCIFAELLTLEPIFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 8e-04
Identities = 23/85 (27%), Positives = 43/85 (50%), Gaps = 9/85 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K +N+LL D ++++D GLA + E + GT +MAPE+ + + Y
Sbjct: 128 LKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN--------QRY 178
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEG 89
D + G +++E++ + PF G
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 9e-04
Identities = 29/101 (28%), Positives = 48/101 (47%), Gaps = 7/101 (6%)
Query: 5 MKEDNLLLTPDQKSLKLADFG--LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K DN+L+ + ++LADFG L E T + GT +++PE+ + + K
Sbjct: 128 IKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM---EDGKG 183
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 103
Y + D +S G+ ++E+L PF S L Y H
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNH 223
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.001
Identities = 28/85 (32%), Positives = 46/85 (54%), Gaps = 11/85 (12%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K +N+LL + L DFGL++ +T+ T T GT ++APE V L ++K
Sbjct: 122 LKPENILLDAT-GHIALCDFGLSKAN-LTDNKTTNTFCGTTEYLAPE----VLL---DEK 172
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPF 87
Y VD +S G++++E+ PF
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.001
Identities = 36/135 (26%), Positives = 62/135 (45%), Gaps = 24/135 (17%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+LL + ++++D GLA + + + A GT+ +MAPE+ L++G Y
Sbjct: 123 LKPANILLD-EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEV-----LQKGVA--Y 173
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH--------ARPGLPEDISPDL 116
++ D +S G +L++LL PF KH LP+ SP+L
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------KHEIDRMTLTMAVELPDSFSPEL 226
Query: 117 AFIVQSCWVEDPNLR 131
+++ D N R
Sbjct: 227 RSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.001
Identities = 22/84 (26%), Positives = 43/84 (51%), Gaps = 9/84 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K +N+LL D ++++D GLA + + GT +MAPE+ + + Y
Sbjct: 128 LKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--------KNERY 178
Query: 65 NNKVDVYSFGIVLWELLTNRLPFE 88
D ++ G +L+E++ + PF+
Sbjct: 179 TFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.001
Identities = 25/85 (29%), Positives = 41/85 (48%), Gaps = 6/85 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFG--LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K DN+LL ++LADFG L T GT +++PE+ + + K
Sbjct: 128 IKPDNVLLDK-NGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM---EDGKG 183
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPF 87
Y + D +S G+ ++E+L PF
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.001
Identities = 24/83 (28%), Positives = 43/83 (51%), Gaps = 9/83 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K +N+LL D+ ++++D GLA + E + GT +MAPE+ EK Y
Sbjct: 128 LKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI------NNEK--Y 178
Query: 65 NNKVDVYSFGIVLWELLTNRLPF 87
D + G +++E++ + PF
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.001
Identities = 26/86 (30%), Positives = 45/86 (52%), Gaps = 10/86 (11%)
Query: 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGE 60
M + +K N+L+ + +KL DFG++ + + M + GT +M+PE QG
Sbjct: 126 MHRDVKPSNILVN-SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL------QG- 176
Query: 61 KKHYNNKVDVYSFGIVLWELLTNRLP 86
HY+ + D++S G+ L E+ R P
Sbjct: 177 -THYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.002
Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 9/77 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K NLL+ LKLADFGLAR + +AE T + P++ L
Sbjct: 125 LKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL------- 176
Query: 64 YNNKVDVYSFGIVLWEL 80
Y+ +D++S G + EL
Sbjct: 177 YSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.003
Identities = 26/83 (31%), Positives = 47/83 (56%), Gaps = 9/83 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+LL + ++++D GLA + + + A GT+ +MAPE+ L++G Y
Sbjct: 123 LKPANILLD-EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEV-----LQKGTA--Y 173
Query: 65 NNKVDVYSFGIVLWELLTNRLPF 87
++ D +S G +L++LL PF
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 36.9 bits (85), Expect = 0.004
Identities = 28/87 (32%), Positives = 42/87 (48%), Gaps = 9/87 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K +N+L+T +KLADFGLAR + +T T + APE+ T Y
Sbjct: 134 LKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST--------Y 184
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMS 91
VD++S G + E+ + F G S
Sbjct: 185 ATPVDMWSVGCIFAEMFRRKPLFCGNS 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 198 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.98 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.98 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.97 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.97 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.97 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.97 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.96 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.96 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.96 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.96 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.96 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.96 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.96 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.96 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.96 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.95 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.95 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.95 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.95 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.95 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.95 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.94 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.94 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.94 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.94 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.94 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.94 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.94 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.94 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.94 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.94 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.94 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.94 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.94 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.94 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.94 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.94 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.94 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.94 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.94 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.94 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.94 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.94 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.94 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.94 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.94 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.94 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.94 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.94 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.94 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.94 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.93 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.93 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.93 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.93 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.93 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.93 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.93 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.93 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.93 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.93 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.93 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.93 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.93 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.93 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.93 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.93 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.93 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.93 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.93 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.93 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.93 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.93 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.93 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.93 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.93 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.93 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.93 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.93 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.93 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.93 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.93 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.93 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.92 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.92 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.92 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.92 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.92 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.92 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.92 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.92 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.92 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.92 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.92 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.92 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.92 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.92 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.92 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.92 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.92 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.92 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.92 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.92 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.92 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.92 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.92 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.91 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.91 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.91 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.91 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.91 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.91 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.91 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.91 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.91 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.91 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.91 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.91 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.91 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.91 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.91 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.91 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.91 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.91 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.91 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.91 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.91 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.91 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.91 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.91 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.91 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.91 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.91 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.91 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.91 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.91 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.91 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.91 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.91 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.91 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.91 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.91 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.9 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.9 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.9 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.9 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.9 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.9 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.9 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.9 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.9 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.9 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.9 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.9 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.9 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.9 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.9 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.9 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.9 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.9 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.9 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.9 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.9 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.9 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.9 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.9 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.9 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.9 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.9 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.9 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.9 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.9 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.89 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.89 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.89 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.89 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.89 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.89 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.89 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.89 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.89 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.89 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.89 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.89 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.89 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.89 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.89 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.88 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.88 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.88 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.88 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.88 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.88 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.88 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.88 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.88 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.87 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.87 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.87 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.87 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.87 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.87 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.87 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.87 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.87 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.86 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.86 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.86 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.86 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.86 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.85 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.84 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.84 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.84 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.83 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.83 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.83 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.83 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.81 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.81 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.78 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.75 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.75 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.74 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.63 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.63 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.62 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.58 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.56 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.53 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.52 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.5 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.48 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.46 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.45 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.37 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.2 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.12 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.1 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 98.91 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 98.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 98.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.81 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 98.64 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.52 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.46 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.33 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.02 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.02 | |
| smart00090 | 237 | RIO RIO-like kinase. | 97.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 97.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 97.62 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 97.56 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 97.54 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 97.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 97.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 97.18 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 97.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 96.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 96.92 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 95.79 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 95.62 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 95.47 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 95.1 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.07 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.9 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 94.89 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.75 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.53 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 94.44 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 94.42 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.4 | |
| PLN02236 | 344 | choline kinase | 94.27 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.22 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 94.18 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 93.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 93.88 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 93.87 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.77 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.75 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 92.94 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 92.41 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 91.99 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 91.55 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 91.09 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 90.78 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 90.78 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 90.76 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 90.71 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 90.5 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 90.12 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 90.11 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 90.09 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 89.93 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 88.85 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 88.68 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 87.99 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 87.61 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 87.25 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 86.87 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 85.78 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 85.72 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 83.1 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 82.91 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 82.33 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=229.47 Aligned_cols=139 Identities=29% Similarity=0.539 Sum_probs=119.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.. +.+||||||+++...++ ...+++||..||+||.+.+ ..|+.++||||||++++|+
T Consensus 201 IHRDIKPsNlLvNsk-GeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g--------~~Ys~~sDIWSLGLsllE~ 270 (364)
T KOG0581|consen 201 IHRDIKPSNLLVNSK-GEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISG--------ESYSVKSDIWSLGLSLLEL 270 (364)
T ss_pred eeccCCHHHeeeccC-CCEEeccccccHHhhhh-hcccccccccccChhhhcC--------CcCCcccceecccHHHHHH
Confidence 799999999999976 78999999999876665 5678999999999999965 6789999999999999999
Q ss_pred HcCCCCCCCC----CcHHHHHHHHHccCCCCCCCC-CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCC
Q 029154 81 LTNRLPFEGM----SNLQAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 81 ~~g~~p~~~~----~~~~~~~~~~~~~~~~~~p~~-~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
++|+.||... ......+.......+|.+|.. +++++++|+.+||.+||.+||++.++++ |.|+.....+
T Consensus 271 a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~--Hpfi~~~~~~ 344 (364)
T KOG0581|consen 271 AIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ--HPFIKKFEDP 344 (364)
T ss_pred hhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc--CHHHhhcccc
Confidence 9999998763 234445566667788889987 9999999999999999999999999999 8887655533
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=216.59 Aligned_cols=144 Identities=44% Similarity=0.830 Sum_probs=123.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+..++||+|||+++....+ ...+...||..|||||++... ...|+.|+||||||+++||
T Consensus 165 IHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~------~~~~~~K~DvySFgIvlWE 238 (362)
T KOG0192|consen 165 IHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGE------KSPYTEKSDVYSFGIVLWE 238 (362)
T ss_pred eecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCC------CCcCCccchhhhHHHHHHH
Confidence 799999999999977338999999999865543 333447899999999999631 3579999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
++||..||.+...............++.+|..+++.+..++.+||..||..||++.+++..|+.+......
T Consensus 239 l~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 239 LLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred HHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 99999999998886666666678888999999999999999999999999999999999999988775443
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=203.09 Aligned_cols=138 Identities=29% Similarity=0.533 Sum_probs=118.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
||||+||+|||+|.. +++|+||||++....++...+...|++.|||||.+.... ...|+.++||||||++++|+
T Consensus 214 iHRDvKPSNILlDe~-GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~-----~~kYDiRaDVWSlGITlveL 287 (391)
T KOG0983|consen 214 IHRDVKPSNILLDER-GNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPD-----KPKYDIRADVWSLGITLVEL 287 (391)
T ss_pred eecccCccceEEccC-CCEEeecccccceeecccccccccCCccccCccccCCCC-----CCccchhhhhhhhccchhhh
Confidence 799999999999976 789999999998777777667788999999999986421 45688999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCC--CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPED--ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~--~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+||+.||.+.+.......+.....+|.+|.. +++++.+|+..||..|+.+||...++++ |.+..
T Consensus 288 aTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~--h~Fi~ 353 (391)
T KOG0983|consen 288 ATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE--HPFIK 353 (391)
T ss_pred hcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc--Cccee
Confidence 9999999997766666666666666766654 7999999999999999999999999998 55543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=203.79 Aligned_cols=129 Identities=32% Similarity=0.491 Sum_probs=106.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc-ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||.||+|+.+ +.+||+|||+++....... ..+.+|||.||+||++.. ..|+.++||||+||++||
T Consensus 150 mHRDIKPaNIFl~~~-gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~--------~~Y~~kSDiWslGCllyE 220 (375)
T KOG0591|consen 150 MHRDIKPANIFLTAN-GVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHE--------SGYNFKSDIWSLGCLLYE 220 (375)
T ss_pred eeccCcchheEEcCC-CceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhc--------CCCCcchhHHHHHHHHHH
Confidence 699999999999977 7899999999997655443 456799999999999964 789999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCC-CCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
|+.-++||.+.+ ...+........-+++| +.++.++..++..|+..||..||+.-.+++
T Consensus 221 McaL~~PF~g~n-~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 221 MCALQSPFYGDN-LLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred HHhcCCCccccc-HHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 999999999874 33333333344555677 668999999999999999999998544444
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-33 Score=216.96 Aligned_cols=138 Identities=33% Similarity=0.549 Sum_probs=118.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
||||||.+|||++.+ +.+||+|||++....... ...+.+||++|||||++. ...|++++||||||++.+|
T Consensus 391 iHrDIKSDnILL~~~-g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvt--------rk~YG~KVDIWSLGIMaIE 461 (550)
T KOG0578|consen 391 IHRDIKSDNILLTMD-GSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVT--------RKPYGPKVDIWSLGIMAIE 461 (550)
T ss_pred eeeccccceeEeccC-CcEEEeeeeeeeccccccCccccccCCCCccchhhhh--------hcccCccccchhhhhHHHH
Confidence 799999999999988 679999999998654433 456789999999999985 4789999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCC-CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHAR-PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
|+.|.+||..+.+..+.+.+...+.+ ...++.+++.+++|+.+||+.|+.+|+++.|+|+ |.++....
T Consensus 462 MveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~--HpFl~~a~ 530 (550)
T KOG0578|consen 462 MVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE--HPFLKMAK 530 (550)
T ss_pred HhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc--ChhhhhcC
Confidence 99999999998888888776544322 3557889999999999999999999999999999 77774433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-34 Score=215.43 Aligned_cols=140 Identities=28% Similarity=0.397 Sum_probs=111.5
Q ss_pred CCCCCCCCCeEEcCC--CCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~--~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+||||..+ ...+||+|||+|+..+....+.+.|||+.|.|||++.+.. ...+..++|+||+||++|
T Consensus 298 ~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg-----~~~~~~kVDiWSlGcvLf 372 (475)
T KOG0615|consen 298 IHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKG-----VEYYPSKVDIWSLGCVLF 372 (475)
T ss_pred ccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCC-----eecccchheeeeccceEE
Confidence 699999999999754 2468999999999888778889999999999999986521 233345899999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHcc---CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKH---ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
-+++|.+||++.........+...+ .-+.....++++..+||.+||..||++||+++|+|+ |.|+..
T Consensus 373 vcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~--hpW~~~ 442 (475)
T KOG0615|consen 373 VCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN--HPWFKD 442 (475)
T ss_pred EEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc--Chhhhc
Confidence 9999999998766433222222211 223345568999999999999999999999999999 777763
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=216.99 Aligned_cols=139 Identities=27% Similarity=0.463 Sum_probs=119.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|+||+.. +++||+|||+|..........+.||++.|++||++.+ ..+.+.++||||+|+++|.+
T Consensus 134 cHRDLKpENlLLd~~-~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G-------~pYdG~~sDVWSCGVILfAL 205 (786)
T KOG0588|consen 134 CHRDLKPENLLLDVK-NNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSG-------RPYDGRPSDVWSCGVILFAL 205 (786)
T ss_pred eeccCCchhhhhhcc-cCEeeeccceeecccCCccccccCCCcccCCchhhcC-------CCCCCCccccchhHHHHHHH
Confidence 599999999999977 5599999999998888888999999999999999976 34446799999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
++|+.||.+.+ ...++ .........+|..+++++++|+.+|+..||+.|.|.+||++ |.|+......
T Consensus 206 LtG~LPFdDdN-ir~LL-lKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k--HP~l~g~~~~ 272 (786)
T KOG0588|consen 206 LTGKLPFDDDN-IRVLL-LKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK--HPFLSGYTSL 272 (786)
T ss_pred HhCCCCCCCcc-HHHHH-HHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhh--CchhhcCCCC
Confidence 99999998644 34433 33456678889999999999999999999999999999999 8887755443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=212.89 Aligned_cols=137 Identities=26% Similarity=0.436 Sum_probs=115.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
||||||-.|++|+.+ .++||+|||||.... ......+.|||+.|.|||++.. ...+..+||||+||++|.
T Consensus 140 iHRDLKLGNlfL~~~-~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k--------~gHsfEvDiWSlGcvmYt 210 (592)
T KOG0575|consen 140 IHRDLKLGNLFLNEN-MNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNK--------SGHSFEVDIWSLGCVMYT 210 (592)
T ss_pred eecccchhheeecCc-CcEEecccceeeeecCcccccceecCCCcccChhHhcc--------CCCCCchhhhhhhhHHHh
Confidence 799999999999976 789999999997654 3356678999999999999863 667899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
++.|++||+... ... ....+......+|..++.++.+||..+|..||.+|||+++++. +.++.....
T Consensus 211 LL~G~PPFetk~-vke-ty~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~--h~Ff~~g~~ 277 (592)
T KOG0575|consen 211 LLVGRPPFETKT-VKE-TYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD--HPFFKSGFT 277 (592)
T ss_pred hhhCCCCcccch-HHH-HHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc--CHhhhCCCc
Confidence 999999998643 222 2334456667788999999999999999999999999999999 888854433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=201.53 Aligned_cols=129 Identities=30% Similarity=0.456 Sum_probs=104.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccC-cccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
||||||||||||+.+ ++++|+|||+++.. .......+.|||+.|||||++.. ..|+..+|+||+|+++||
T Consensus 147 iyRDlKPENILLd~~-GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~--------~gy~~~vDWWsLGillYe 217 (357)
T KOG0598|consen 147 IYRDLKPENILLDEQ-GHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLG--------KGYDKAVDWWSLGILLYE 217 (357)
T ss_pred eeccCCHHHeeecCC-CcEEEeccccchhcccCCCccccccCCccccChHHHhc--------CCCCcccchHhHHHHHHH
Confidence 799999999999977 89999999999844 33344566899999999999864 689999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP----SFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp----s~~~~l~ 139 (198)
|++|.+||.+.+...-. ........+..|..++.+.++++.++|..||.+|. ++.++..
T Consensus 218 ML~G~pPF~~~~~~~~~-~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 218 MLTGKPPFYAEDVKKMY-DKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred HhhCCCCCcCccHHHHH-HHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 99999999987643322 22222333555666999999999999999999995 4666555
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=204.44 Aligned_cols=141 Identities=26% Similarity=0.475 Sum_probs=112.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc----cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.+++.+||+|||+++.... ........||+.|||||++.. ......++||||+||+
T Consensus 139 vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~-------g~~~~~~sDiWSlGCt 211 (313)
T KOG0198|consen 139 VHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRN-------GEVARRESDIWSLGCT 211 (313)
T ss_pred eccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcC-------CCcCCccchhhhcCCE
Confidence 79999999999997346899999999875442 112234689999999999852 1122358999999999
Q ss_pred HHHHHcCCCCCCC-CCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 77 LWELLTNRLPFEG-MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 77 l~e~~~g~~p~~~-~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
+.||+||..||.. ................|.+|..+++++.+|+.+|+..||.+||||.++++ +.++.....
T Consensus 212 VvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~--hpf~~~~~~ 284 (313)
T KOG0198|consen 212 VVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE--HPFLKQNSI 284 (313)
T ss_pred EEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh--Chhhhcccc
Confidence 9999999999987 44445555666566667899999999999999999999999999999999 666655443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=208.68 Aligned_cols=129 Identities=23% Similarity=0.403 Sum_probs=108.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--------------cccCCCCccceecccccccccccccccCCCCc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNN 66 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 66 (198)
||||||||||||+.| +++||.|||-++...... ...+++||..|.+||++.. ...++
T Consensus 196 IHRDlKPENILLd~d-mhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--------~~~~~ 266 (604)
T KOG0592|consen 196 IHRDLKPENILLDKD-GHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--------SPAGP 266 (604)
T ss_pred eeccCChhheeEcCC-CcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC--------CCCCc
Confidence 799999999999987 889999999998442211 1145789999999999863 67788
Q ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 029154 67 KVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 140 (198)
Q Consensus 67 ~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~ 140 (198)
.+|+|+|||++|+|+.|.+||.+.++.... +.+......+|+.+++.+.+|+.++|..||.+|.+.++|.++
T Consensus 267 ~sDiWAlGCilyQmlaG~PPFra~NeyliF--qkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 267 SSDLWALGCILYQMLAGQPPFRAANEYLIF--QKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ccchHHHHHHHHHHhcCCCCCccccHHHHH--HHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 999999999999999999999987754332 233456677899999999999999999999999999999884
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=205.16 Aligned_cols=134 Identities=32% Similarity=0.546 Sum_probs=112.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc-ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
||||||+.|||+..+ +.+||+|||++........ ..+.+||+.|||||++.+ ..|+.++||||||++.+|
T Consensus 133 iHrDIKaanil~s~~-g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~--------~~Y~~KADIWSLGITaiE 203 (467)
T KOG0201|consen 133 IHRDIKAANILLSES-GDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQ--------SGYDTKADIWSLGITAIE 203 (467)
T ss_pred ecccccccceeEecc-CcEEEEecceeeeeechhhccccccccccccchhhhcc--------ccccchhhhhhhhHHHHH
Confidence 799999999999987 7899999999986654433 367899999999999964 679999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|++|.+|+....++...+. .-+..+|.+...+++.+.+|+..||.+||+.||+|.++++ |.++.
T Consensus 204 la~GePP~s~~hPmrvlfl-Ipk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK--h~FIk 267 (467)
T KOG0201|consen 204 LAKGEPPHSKLHPMRVLFL-IPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK--HKFIK 267 (467)
T ss_pred HhcCCCCCcccCcceEEEe-ccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh--hHHHH
Confidence 9999999988776443322 2234555566678999999999999999999999999998 55554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=205.63 Aligned_cols=137 Identities=34% Similarity=0.630 Sum_probs=115.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccccc--CCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||...|||++.+ ..+||+|||+++...++.... ...-...|.|||.+. .+.|+.++||||||+++|
T Consensus 325 IHRDLAARNiLV~~~-~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~--------~~~FS~kSDVWSFGVlL~ 395 (468)
T KOG0197|consen 325 IHRDLAARNILVDED-LVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALN--------YGKFSSKSDVWSFGVLLW 395 (468)
T ss_pred cchhhhhhheeeccC-ceEEEcccccccccCCCceeecCCCCCCceecCHHHHh--------hCCcccccceeehhhhHH
Confidence 899999999999977 789999999999554433211 123357899999986 377999999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|++| |+.||.++.. ......+..+.+.+.|+.+++++.++|..||..+|++||||+.+...|+++...
T Consensus 396 E~fT~G~~py~~msn-~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 396 ELFTYGRVPYPGMSN-EEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHhccCCCCCCCCCH-HHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 9997 8889888765 445567778899999999999999999999999999999999999988887543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=193.19 Aligned_cols=131 Identities=31% Similarity=0.449 Sum_probs=108.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
||||||||||||..+ +.+||||||+|+... ....++.++.|.+|.|||.+.+ ...|+..+|||+.||++.|
T Consensus 123 IHRDIKPENILit~~-gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvG-------DtqYG~pVDiWAiGCv~aE 194 (396)
T KOG0593|consen 123 IHRDIKPENILITQN-GVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVG-------DTQYGKPVDIWAIGCVFAE 194 (396)
T ss_pred ecccCChhheEEecC-CcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcc-------cCcCCCcccchhhhHHHHH
Confidence 799999999999987 789999999999765 5566778899999999999875 5678999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHcc-------------------CCCCCC----------CCCcHHHHHHHHHhcccCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKH-------------------ARPGLP----------EDISPDLAFIVQSCWVEDPNL 130 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~-------------------~~~~~p----------~~~~~~~~~l~~~~l~~dp~~ 130 (198)
|++|.+.|.|....++.+.+...- ...+.| ..++.-+.+|+.+||..||++
T Consensus 195 l~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~ 274 (396)
T KOG0593|consen 195 LLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDD 274 (396)
T ss_pred HhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccc
Confidence 999999999988887776543311 111111 123556889999999999999
Q ss_pred CCCHHHHHH
Q 029154 131 RPSFSQIIR 139 (198)
Q Consensus 131 Rps~~~~l~ 139 (198)
|++.++++.
T Consensus 275 R~sc~qll~ 283 (396)
T KOG0593|consen 275 RLSCEQLLH 283 (396)
T ss_pred cccHHHHhc
Confidence 999999887
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=191.68 Aligned_cols=132 Identities=25% Similarity=0.459 Sum_probs=112.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
||||+||+|||++.. +.+||||||++....++-..+...|+..|||||.+.. ....|+.++|+||+|+++||+
T Consensus 190 IHRDvKPSNILldr~-G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p------~~~gyDiRSDvWSLGITL~Ev 262 (361)
T KOG1006|consen 190 IHRDVKPSNILLDRH-GDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDP------SDKGYDIRSDVWSLGITLYEV 262 (361)
T ss_pred hhccCChhheEEecC-CCEeeecccchHhHHHHHHhhhccCCccccChhccCC------ccCCcchhhhhhhhcceEeee
Confidence 799999999999987 6799999999988776666667789999999999865 234689999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCC--C---CCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLP--E---DISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p--~---~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
.||..||.+.............+.++.+. . .++..+..++..||..|-++||++.++++
T Consensus 263 AtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 263 ATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 99999999888766666666555555442 2 26788999999999999999999999987
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=189.64 Aligned_cols=141 Identities=21% Similarity=0.335 Sum_probs=113.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ .++||+|||++............|||++|+|||.+.+.+.- ....|+..+|.|++|+++|.+
T Consensus 145 VHRDLKpENILlddn-~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e--~~pGYs~EVD~Wa~GVImyTL 221 (411)
T KOG0599|consen 145 VHRDLKPENILLDDN-MNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYE--NHPGYSKEVDEWACGVIMYTL 221 (411)
T ss_pred hhcccChhheeeccc-cceEEeccceeeccCCchhHHHhcCCCcccChhheeeeccc--CCCCccchhhHHHHHHHHHHH
Confidence 699999999999966 78999999999887777777889999999999999775532 235678899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCC--CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+.|.+||.....+.-...++..... .+...+++.+..+|+.+||+.||.+|.|++|.+. |.|+.
T Consensus 222 LaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La--Hpff~ 287 (411)
T KOG0599|consen 222 LAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA--HPFFI 287 (411)
T ss_pred HcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc--ChHHH
Confidence 9999999754433323333322222 3345668999999999999999999999999998 66553
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=200.66 Aligned_cols=136 Identities=28% Similarity=0.533 Sum_probs=114.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccC-cccccccCCCCccceecccccccccccccccCCC-CchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY-NNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~Dvws~G~~l~ 78 (198)
+||||||+|||++.+.+.+||+|||++... .......+.+||+.|+|||++.+ ...| +.++||||+|+++|
T Consensus 142 ~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~-------~~~Y~g~~aDvWS~GViLy 214 (370)
T KOG0583|consen 142 VHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSG-------KGTYSGKAADVWSLGVILY 214 (370)
T ss_pred eeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCC-------CCCcCCchhhhhhhHHHHH
Confidence 699999999999976467999999999876 45566788999999999999964 2214 57899999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCC-cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI-SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~-~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
.|++|..||..... ...+. .+......+|..+ ++++..|+.+||..||.+|+++.+++. +.|+..
T Consensus 215 ~ml~G~~PF~d~~~-~~l~~-ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~--h~w~~~ 280 (370)
T KOG0583|consen 215 VLLCGRLPFDDSNV-PNLYR-KIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE--HPWFQK 280 (370)
T ss_pred HHHhCCCCCCCccH-HHHHH-HHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh--Chhhcc
Confidence 99999999987443 22222 3556677888888 999999999999999999999999995 788775
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-30 Score=197.17 Aligned_cols=136 Identities=28% Similarity=0.444 Sum_probs=114.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
.||||||||||+... ..+||+|||+||.......++.++.|.+|.|||++.. ...|+.+.|+|++||+++|+
T Consensus 132 FHRDlKPENiLi~~~-~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLr-------s~~Ys~pvD~wA~GcI~aEl 203 (538)
T KOG0661|consen 132 FHRDLKPENILISGN-DVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLR-------SGYYSSPVDMWAVGCIMAEL 203 (538)
T ss_pred ccccCChhheEeccc-ceeEecccccccccccCCCcchhhhcccccchHHhhh-------ccccCCchHHHHHHHHHHHH
Confidence 499999999999954 6799999999998887778889999999999999874 57899999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCC-----------------C-----------CCCCcHHHHHHHHHhcccCCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPG-----------------L-----------PEDISPDLAFIVQSCWVEDPNLRP 132 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------~-----------p~~~~~~~~~l~~~~l~~dp~~Rp 132 (198)
.+-++.|.|..+.++.+.++..-..|. + -...++++..++.+||..||.+||
T Consensus 204 ~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp 283 (538)
T KOG0661|consen 204 YSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRP 283 (538)
T ss_pred HHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCc
Confidence 999999999988887766544322221 1 122578899999999999999999
Q ss_pred CHHHHHHHHHHHHh
Q 029154 133 SFSQIIRMLNAFLF 146 (198)
Q Consensus 133 s~~~~l~~l~~~~~ 146 (198)
||.+.++ +.+..
T Consensus 284 TA~~al~--~pffq 295 (538)
T KOG0661|consen 284 TASQALQ--HPFFQ 295 (538)
T ss_pred cHHHHhc--Ccccc
Confidence 9999999 44443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=190.78 Aligned_cols=135 Identities=24% Similarity=0.400 Sum_probs=108.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|||++.+ +.+||+|||+++...... ....|+..|+|||++.+ ....++.++|||||||++||+
T Consensus 145 ~Hrdlkp~nill~~~-~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~------~~~~~~~k~Di~SlGvil~el 215 (283)
T PHA02988 145 PYKNLTSVSFLVTEN-YKLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLND------IFSEYTIKDDIYSLGVVLWEI 215 (283)
T ss_pred CCCcCChhhEEECCC-CcEEEcccchHhhhcccc--ccccCcccccCHHHhhh------ccccccchhhhhHHHHHHHHH
Confidence 599999999999976 689999999987543221 23568899999999743 124688999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
++|..||.+................+..|..+++.+.+++.+||+.||.+||++.++++.|+.+
T Consensus 216 ~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 216 FTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred HHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 9999999876644333332234455566767899999999999999999999999999998865
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=188.39 Aligned_cols=142 Identities=27% Similarity=0.378 Sum_probs=113.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc---cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|+|++.+ ..+||+|||+|+.... ....+..+.|.+|.|||++.. ...|+...||||.||++
T Consensus 147 iHRDLKPsNll~n~~-c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~-------~~~Yt~aiDiWSvGCI~ 218 (359)
T KOG0660|consen 147 IHRDLKPSNLLLNAD-CDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLN-------SSEYTKAIDIWSVGCIL 218 (359)
T ss_pred cccccchhheeeccC-CCEEeccccceeeccccCcccchhcceeeeeecCHHHHhc-------cccccchhhhhhhhHHH
Confidence 799999999999977 6799999999997643 334566788999999999864 57899999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccC------------------------CCCC-----CCCCcHHHHHHHHHhcccCC
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHA------------------------RPGL-----PEDISPDLAFIVQSCWVEDP 128 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~------------------------~~~~-----p~~~~~~~~~l~~~~l~~dp 128 (198)
.||++|++.|.|.+...+......... .+.. ....++.+.+|+.+||..||
T Consensus 219 AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP 298 (359)
T KOG0660|consen 219 AEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDP 298 (359)
T ss_pred HHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCc
Confidence 999999999998776554433221111 1111 13468999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCC
Q 029154 129 NLRPSFSQIIRMLNAFLFTLRPPS 152 (198)
Q Consensus 129 ~~Rps~~~~l~~l~~~~~~~~~~~ 152 (198)
.+|+|++|.++ |..++....+.
T Consensus 299 ~kRita~eAL~--hPYl~~~hdp~ 320 (359)
T KOG0660|consen 299 KKRITAEEALA--HPYLAPYHDPE 320 (359)
T ss_pred cccCCHHHHhc--ChhhhhhcCCc
Confidence 99999999999 77877766553
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=193.13 Aligned_cols=137 Identities=30% Similarity=0.534 Sum_probs=107.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc----c-cccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT----E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~----~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
||||||+.||||+.+ |.|||+|||++.....+ . .+.+.+||++|||||++.. ....|+.|+||||||+
T Consensus 148 IHRdvKAgnILi~~d-G~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q------~~~GYdfKaDIwSfGI 220 (516)
T KOG0582|consen 148 IHRDVKAGNILIDSD-GTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQ------QLHGYDFKADIWSFGI 220 (516)
T ss_pred eecccccccEEEcCC-CcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhh------cccCccchhhhhhhhH
Confidence 799999999999977 78999999987633211 1 1256799999999999654 4578999999999999
Q ss_pred HHHHHHcCCCCCCCCCcHHHHHHHHHccCCC-----CCC----CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 76 VLWELLTNRLPFEGMSNLQAAYAAAFKHARP-----GLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~p----~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+..|+.+|..||....++.-+...+. ..+| .++ ..++..++.++..||+.||.+|||++++++ +.|+.
T Consensus 221 TA~ELA~G~aPf~k~pPmkvLl~tLq-n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk--h~FFk 297 (516)
T KOG0582|consen 221 TACELAHGHAPFSKYPPMKVLLLTLQ-NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK--HAFFK 297 (516)
T ss_pred HHHHHhcCCCCcccCChHHHHHHHhc-CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc--cHHHh
Confidence 99999999999998877666555443 2222 111 114567889999999999999999999999 66665
Q ss_pred h
Q 029154 147 T 147 (198)
Q Consensus 147 ~ 147 (198)
.
T Consensus 298 ~ 298 (516)
T KOG0582|consen 298 K 298 (516)
T ss_pred h
Confidence 3
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=181.37 Aligned_cols=174 Identities=22% Similarity=0.382 Sum_probs=127.6
Q ss_pred CCCCCCCCCeEEcCCC--CceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~--~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
||||+||+|+||.... -.+||+|||++............+||+.||+||++. ...|+..+|||++|+++|
T Consensus 132 vHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvr--------kdpy~kpvDiW~cGViLf 203 (355)
T KOG0033|consen 132 VHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLK--------KDPYSKPVDIWACGVILY 203 (355)
T ss_pred eeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhh--------cCCCCCcchhhhhhHHHH
Confidence 7999999999996432 348999999998776655566789999999999985 368899999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHcc---CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKH---ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSV 155 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~~~~ 155 (198)
-++.|.+||.+..... .+...... .+++..+.+++++.+|+++||..||++|.|+.|.++ |.|+.....-....
T Consensus 204 iLL~G~~PF~~~~~~r-lye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~--HpWi~~r~~~As~~ 280 (355)
T KOG0033|consen 204 ILLVGYPPFWDEDQHR-LYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK--HPWICNRERVASAI 280 (355)
T ss_pred HHHhCCCCCCCccHHH-HHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC--CchhcchHHHHHHh
Confidence 9999999999865433 33332222 222344568999999999999999999999999999 77776544322111
Q ss_pred CCCcchhhhccCCCccchhhHhhhhhHHHHHHHHHHh
Q 029154 156 PESDTNEAAATSNGAMTEFSARARGKFAFLRQLFTAK 192 (198)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (198)
... ..-.-+..+.++.+-+.+.|......+
T Consensus 281 H~~-------dtvd~lrkfNarRKLKgavLtav~s~r 310 (355)
T KOG0033|consen 281 HRQ-------DTVDCLKKFNARRKLKGAILTTVIATR 310 (355)
T ss_pred hhH-------HHHHHHHHhhHHHHHHHHHHHHHHhcc
Confidence 110 011124556677777777776665544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=193.80 Aligned_cols=137 Identities=31% Similarity=0.609 Sum_probs=108.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++....... .....++..|+|||++.+ ..++.++|||||||++
T Consensus 196 vHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~il 266 (338)
T cd05102 196 IHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD--------KVYTTQSDVWSFGVLL 266 (338)
T ss_pred ECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccCCCCCccccCcHHhhc--------CCCCcccCHHHHHHHH
Confidence 699999999999976 6799999999975432211 122345678999998753 5678999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|||++ |..||.+...................+..+++++.+++.+||..||.+||++.++++.|+.++.
T Consensus 267 ~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 267 WEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99996 9999987554333333334444555677889999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=200.56 Aligned_cols=141 Identities=22% Similarity=0.323 Sum_probs=108.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+++.+||+|||+++...........+||+.|+|||++.+ ...++.++||||+||++|||
T Consensus 192 iHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~el 264 (440)
T PTZ00036 192 CHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG-------ATNYTTHIDLWSLGCIIAEM 264 (440)
T ss_pred ecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcC-------CCCCCcHHHHHHHHHHHHHH
Confidence 69999999999987655799999999986543333345678999999998753 24678999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCC---------------------------CCCCCCCcHHHHHHHHHhcccCCCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHAR---------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPS 133 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~---------------------------~~~p~~~~~~~~~l~~~~l~~dp~~Rps 133 (198)
++|.+||.+................ ..+|...++++.+|+.+||..||.+|||
T Consensus 265 ltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t 344 (440)
T PTZ00036 265 ILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN 344 (440)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC
Confidence 9999999887654433222110000 0123456789999999999999999999
Q ss_pred HHHHHHHHHHHHhhcCC
Q 029154 134 FSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 134 ~~~~l~~l~~~~~~~~~ 150 (198)
+.++++ +.|+.....
T Consensus 345 a~e~l~--hp~f~~~~~ 359 (440)
T PTZ00036 345 PIEALA--DPFFDDLRD 359 (440)
T ss_pred HHHHhC--ChhHHhhhc
Confidence 999998 777766544
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=203.42 Aligned_cols=133 Identities=30% Similarity=0.642 Sum_probs=113.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
||||||.-||||..+ ..|||+|||-++...+....-.++||..|||||++. +...+.|+||||||+++|||
T Consensus 234 IHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIr--------nePcsEKVDIwSfGVVLWEm 304 (904)
T KOG4721|consen 234 IHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIR--------NEPCSEKVDIWSFGVVLWEM 304 (904)
T ss_pred hhhccCCCceEeecc-ceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhh--------cCCcccccceehhHHHHHHH
Confidence 799999999999977 679999999998655544445689999999999995 47789999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
+||..||.........+.........++|..+++.+.-|++.||.-.|..||+|.+++.+|.
T Consensus 305 LT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 305 LTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred HhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 99999998766544444333334556778999999999999999999999999999999885
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=184.80 Aligned_cols=118 Identities=26% Similarity=0.438 Sum_probs=102.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|+|||||||||||.+ +++||.|||+|+..... ..+.|||+.|+|||++.. ..|+.++|+|+||+++|||
T Consensus 166 iYRDLKPENiLlD~~-G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~s--------k~ynkavDWWalGVLIYEM 234 (355)
T KOG0616|consen 166 IYRDLKPENLLLDQN-GHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQS--------KGYNKAVDWWALGVLIYEM 234 (355)
T ss_pred eeccCChHHeeeccC-CcEEEEeccceEEecCc--EEEecCCccccChHHhhc--------CCCCcchhHHHHHHHHHHH
Confidence 579999999999987 78999999999876543 457899999999999864 7889999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
+.|.+||....+.... ..+......+|..+++++.+|+.++|+.|-.+|
T Consensus 235 laG~pPF~~~~~~~iY--~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 235 LAGYPPFYDDNPIQIY--EKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HcCCCCCcCCChHHHH--HHHHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 9999999987774432 334456677899999999999999999999999
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=190.14 Aligned_cols=137 Identities=29% Similarity=0.461 Sum_probs=110.6
Q ss_pred CCCCCCCCCeEEcCC--C---CceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD--Q---KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~--~---~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
|||||||+||||... . -.+||+|||+|+.........+.||++.|||||++. .+.|+.|+|+||.|+
T Consensus 131 iHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~--------~~~YdAKADLWSiG~ 202 (429)
T KOG0595|consen 131 IHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIM--------SQQYDAKADLWSIGT 202 (429)
T ss_pred eeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHH--------hccccchhhHHHHHH
Confidence 799999999999864 1 248999999999888777778899999999999985 378999999999999
Q ss_pred HHHHHHcCCCCCCCCCcHHHHHHHHHc-cCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 76 VLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
++|+|++|+.||............... ...+..+...+..+.+++...+..++.+|-++.+... +.++..
T Consensus 203 Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~--~~~l~~ 273 (429)
T KOG0595|consen 203 ILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD--HPFLAA 273 (429)
T ss_pred HHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhh--hhhccc
Confidence 999999999999987754443322222 2334455667888889999999999999998887766 555543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=195.59 Aligned_cols=135 Identities=24% Similarity=0.395 Sum_probs=104.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc---------------c---------c----------------------
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV---------------T---------E---------------------- 34 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~---------------~---------~---------------------- 34 (198)
|||||||+|+|||.. |++||+||||+..... . .
T Consensus 263 IHRDIKPdNlLiD~~-GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nr 341 (550)
T KOG0605|consen 263 IHRDIKPDNLLIDAK-GHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNR 341 (550)
T ss_pred ccccCChhheeecCC-CCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhh
Confidence 799999999999987 8999999999851100 0 0
Q ss_pred --cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCC--C
Q 029154 35 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--E 110 (198)
Q Consensus 35 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p--~ 110 (198)
.....+|||-|+|||++.+ ..|+..+|+||+||++|||+.|.+||.+...................| .
T Consensus 342 r~~a~StVGTPDYiAPEVll~--------kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~ 413 (550)
T KOG0605|consen 342 RQLAYSTVGTPDYIAPEVLLG--------KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV 413 (550)
T ss_pred hhhhhcccCCccccchHHHhc--------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC
Confidence 0012379999999999975 668999999999999999999999999988766554443333334444 3
Q ss_pred CCcHHHHHHHHHhcccCCCCCC---CHHHHHHHHHHHHhh
Q 029154 111 DISPDLAFIVQSCWVEDPNLRP---SFSQIIRMLNAFLFT 147 (198)
Q Consensus 111 ~~~~~~~~l~~~~l~~dp~~Rp---s~~~~l~~l~~~~~~ 147 (198)
.+++++++||.+||. ||.+|. .++||.+ |.|+..
T Consensus 414 ~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~--HPfF~~ 450 (550)
T KOG0605|consen 414 DLSDEAKDLITRLLC-DPENRLGSKGAEEIKK--HPFFKG 450 (550)
T ss_pred cccHHHHHHHHHHhc-CHHHhcCcccHHHHhc--CCcccc
Confidence 478999999999998 999995 5778877 666543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=184.11 Aligned_cols=143 Identities=27% Similarity=0.349 Sum_probs=117.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
.||||||+|||+|.+.+.+||||||.|+....+....+.++|..|.|||.+.+ ...|+.+.||||.||++.||
T Consensus 147 cHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifg-------a~~Yt~~IDiWSaGCV~aEL 219 (364)
T KOG0658|consen 147 CHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFG-------ATEYTTSIDIWSAGCVMAEL 219 (364)
T ss_pred ccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcC-------ccccCceeEEhhhhHHHHHH
Confidence 59999999999999989999999999997766666667789999999999876 46799999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCC------------------C---------CCCCCcHHHHHHHHHhcccCCCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARP------------------G---------LPEDISPDLAFIVQSCWVEDPNLRPS 133 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~------------------~---------~p~~~~~~~~~l~~~~l~~dp~~Rps 133 (198)
+.|++.|.|.....+...+..--..| . +....+++..+|+.++|.++|.+|.+
T Consensus 220 l~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~ 299 (364)
T KOG0658|consen 220 LKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS 299 (364)
T ss_pred hcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC
Confidence 99999999987766554332211110 0 12346899999999999999999999
Q ss_pred HHHHHHHHHHHHhhcCCCC
Q 029154 134 FSQIIRMLNAFLFTLRPPS 152 (198)
Q Consensus 134 ~~~~l~~l~~~~~~~~~~~ 152 (198)
+.|++. +.+...+..+.
T Consensus 300 ~~~~l~--h~fFdelr~~~ 316 (364)
T KOG0658|consen 300 ALEALA--HPFFDELRDPN 316 (364)
T ss_pred HHHHhc--chhhHHhhCcC
Confidence 999999 78877776653
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=191.85 Aligned_cols=141 Identities=22% Similarity=0.397 Sum_probs=120.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|+.+-..-+-+||.|||++-.+.......+.||+..|-|||++.+ ..+..+++||||+|+++|-+
T Consensus 140 VHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLG-------DsYDAPAVDiWSLGVILyML 212 (864)
T KOG4717|consen 140 VHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLG-------DSYDAPAVDIWSLGVILYML 212 (864)
T ss_pred hcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhc-------CccCCcchhhhHHHHHHHHH
Confidence 79999999998876667899999999987777777889999999999999976 34446789999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 152 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~ 152 (198)
++|++||+..+....+ .++..+...+|..++.++++||..||..||.+|.+.+++.. ..|+.....+.
T Consensus 213 VCGq~PFqeANDSETL--TmImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s--~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 213 VCGQPPFQEANDSETL--TMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS--TSWLQAGDRGL 280 (864)
T ss_pred HhCCCccccccchhhh--hhhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc--cccccCCCCCc
Confidence 9999999876654443 34456788889999999999999999999999999999998 77877665543
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-29 Score=200.84 Aligned_cols=138 Identities=30% Similarity=0.556 Sum_probs=118.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc-cCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
||||||.+|+|++.-.+.+||+|||-++ ..+.+.+..++.||..|||||++.. ....|+.++|||||||++.|
T Consensus 697 VHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDq------G~RGYG~aADIWS~GCT~vE 770 (1226)
T KOG4279|consen 697 VHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQ------GPRGYGKAADIWSFGCTMVE 770 (1226)
T ss_pred eeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhcc------CCcCCCchhhhhhccceeEe
Confidence 7999999999999777889999999986 4456667778899999999999976 35789999999999999999
Q ss_pred HHcCCCCCCCCCcHHHH-HHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAA-YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|.||++||......+.. +...+-...|++|+.++.++.+++.+|+..||.+||++.++++ ..++.
T Consensus 771 MATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~--DpFlq 836 (1226)
T KOG4279|consen 771 MATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ--DPFLQ 836 (1226)
T ss_pred eccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc--Ccccc
Confidence 99999999876655544 3444455678899999999999999999999999999999998 66654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=173.02 Aligned_cols=141 Identities=28% Similarity=0.383 Sum_probs=111.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||.|+|++.+ +.+||+|||+++.... +......+-|.+|.|||.+.+ .+.|+..+|+||.||++.|
T Consensus 123 lHRDlKPnNLLis~~-g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfG-------sr~Yg~~VDmWavGCI~AE 194 (318)
T KOG0659|consen 123 LHRDLKPNNLLISSD-GQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFG-------SRQYGTGVDMWAVGCIFAE 194 (318)
T ss_pred hcccCCccceEEcCC-CcEEeecccchhccCCCCcccccceeeeeccChHHhcc-------chhcCCcchhhhHHHHHHH
Confidence 699999999999977 7899999999996653 333444578999999999876 5789999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC--C------------------------CCCCCcHHHHHHHHHhcccCCCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP--G------------------------LPEDISPDLAFIVQSCWVEDPNLRPS 133 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~--~------------------------~p~~~~~~~~~l~~~~l~~dp~~Rps 133 (198)
++-|.+-|.|....++.......-..| . +....+.++.+|+.++|..||.+|.+
T Consensus 195 Lllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit 274 (318)
T KOG0659|consen 195 LLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRIT 274 (318)
T ss_pred HHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhccc
Confidence 999999999988777654432211111 1 11224677899999999999999999
Q ss_pred HHHHHHHHHHHHhhcCCC
Q 029154 134 FSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 134 ~~~~l~~l~~~~~~~~~~ 151 (198)
+.|+++ +.++...+.+
T Consensus 275 a~qaL~--~~yf~~~P~p 290 (318)
T KOG0659|consen 275 ASQALK--HPYFKSLPLP 290 (318)
T ss_pred HHHHhc--chhhhcCCCC
Confidence 999999 7777665444
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=193.79 Aligned_cols=138 Identities=30% Similarity=0.535 Sum_probs=114.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
||||||..|||+..+ |.++|+|||++...... ....+++||++|||||+..+.++ ...+|++++||||||+++.|
T Consensus 152 IHRDLKAGNiL~Tld-GdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~---KD~PYDykaDiWSlGITLIE 227 (1187)
T KOG0579|consen 152 IHRDLKAGNILLTLD-GDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETF---KDQPYDYKADIWSLGITLIE 227 (1187)
T ss_pred hhhhccccceEEEec-CcEeeecccccccchhHHhhhccccCCcccccchheeeccc---cCCCchhhhhHHhhhhHHHH
Confidence 799999999999988 67999999998644322 23456899999999999877553 46899999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC--CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
|..+.+|....+.+....... ...+| -.|..++..+.+|+.+||..||..||+++++++ |.|+
T Consensus 228 MAqiEPPHhelnpMRVllKia-KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~--Hpfv 292 (1187)
T KOG0579|consen 228 MAQIEPPHHELNPMRVLLKIA-KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK--HPFV 292 (1187)
T ss_pred HhccCCCccccchHHHHHHHh-hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh--Cccc
Confidence 999999998888776654443 23333 457789999999999999999999999999998 4444
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=191.56 Aligned_cols=133 Identities=30% Similarity=0.498 Sum_probs=110.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|||+||.||||+.. +.+|+||||+++.+..+. ..+...||+.|||||++. .+.|+..+|+||+||++||
T Consensus 122 lhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~--------e~pyd~~sDlWslGcilYE 192 (808)
T KOG0597|consen 122 LHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVE--------EQPYDHTSDLWSLGCILYE 192 (808)
T ss_pred ccccCCcceeeecCC-CceeechhhhhhhcccCceeeeeccCcccccCHHHHc--------CCCccchhhHHHHHHHHHH
Confidence 599999999999976 789999999999665443 345578999999999985 4889999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++.|++||....-.. . ...+...++..|..++.++.+|+..+|.+||.+|.+..+++. |.+..
T Consensus 193 ~~~G~PPF~a~si~~-L-v~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~--HpF~k 255 (808)
T KOG0597|consen 193 LYVGQPPFYARSITQ-L-VKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG--HPFWK 255 (808)
T ss_pred HhcCCCCchHHHHHH-H-HHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc--ChHHh
Confidence 999999998644322 2 223344555667789999999999999999999999999998 55543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=194.14 Aligned_cols=128 Identities=27% Similarity=0.452 Sum_probs=109.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|+||||-+|||||.+ |++||+|||+++... .....++.|||+.|||||++.+ ..|+..+|+|+||+++||
T Consensus 490 IYRDlKLdNiLLD~e-Gh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e--------~~Yt~aVDWW~lGVLlye 560 (694)
T KOG0694|consen 490 IYRDLKLDNLLLDTE-GHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTE--------QSYTRAVDWWGLGVLLYE 560 (694)
T ss_pred eeeecchhheEEccc-CcEEecccccccccCCCCCccccccCChhhcChhhhcc--------CcccchhhHHHHHHHHHH
Confidence 689999999999988 789999999998433 4445678999999999999964 789999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps-----~~~~l~ 139 (198)
|+.|+.||.+.+... ....+....+..|..++.+..++++++|..+|.+|.. +.+|.+
T Consensus 561 ML~Gq~PF~gddEee--~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~ 623 (694)
T KOG0694|consen 561 MLVGESPFPGDDEEE--VFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKK 623 (694)
T ss_pred HHcCCCCCCCCCHHH--HHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhh
Confidence 999999999877533 3344456677789999999999999999999999964 556665
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=184.80 Aligned_cols=135 Identities=21% Similarity=0.363 Sum_probs=105.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||++.............|+..|+|||++.+ ..++.++||||+||++|+|
T Consensus 124 iH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslGvil~el 194 (285)
T cd05631 124 VYRDLKPENILLDDR-GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN--------EKYTFSPDWWGLGCLIYEM 194 (285)
T ss_pred EeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcC--------CCCCcccCchhHHHHHHHH
Confidence 699999999999966 6799999999976443333345678999999999853 5678999999999999999
Q ss_pred HcCCCCCCCCCcHH--HHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQ--AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps-----~~~~l~~l~~~~~ 146 (198)
++|+.||.+..... ..............+..+++++.+|+.+||..||.+||+ ++++++ +.|+.
T Consensus 195 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~--h~~~~ 265 (285)
T cd05631 195 IQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ--HPIFK 265 (285)
T ss_pred HhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc--CHhhc
Confidence 99999998654321 112222233344556778999999999999999999997 788887 55543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=187.99 Aligned_cols=136 Identities=30% Similarity=0.556 Sum_probs=105.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++....... .....++..|+|||++.. ..++.++|||||||++
T Consensus 234 iHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlGvil 304 (374)
T cd05106 234 IHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD--------CVYTVQSDVWSYGILL 304 (374)
T ss_pred EeccCchheEEEeCC-CeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC--------CCCCccccHHHHHHHH
Confidence 699999999999966 6899999999875432221 112234567999998743 5688999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
|+|++ |..||..................+..+...++++.+++.+||+.||.+||++.++++.|+..+
T Consensus 305 ~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 305 WEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 99997 999998755433333333333445556678899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=184.07 Aligned_cols=137 Identities=30% Similarity=0.593 Sum_probs=107.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||+++...... ......++..|+|||++.+ ..++.++||||+||++
T Consensus 195 vHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~SlGv~l 265 (337)
T cd05054 195 IHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD--------KVYTTQSDVWSFGVLL 265 (337)
T ss_pred ecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcC--------CCCCccccHHHHHHHH
Confidence 699999999999976 679999999997542211 1122345678999998753 5688999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
||+++ |..||.+...................+...++++.+++.+||+.+|++||++.+++++|+..+.
T Consensus 266 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 266 WEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99997 9999976543333333333444555567788999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=192.64 Aligned_cols=130 Identities=31% Similarity=0.470 Sum_probs=111.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
||||||..||||... +.|||+|||.+.... ...+++||++|||||++... +.+.|+.++||||+|+++.|+
T Consensus 148 IHRDiKAGNILLse~-g~VKLaDFGSAsi~~---PAnsFvGTPywMAPEVILAM-----DEGqYdgkvDvWSLGITCIEL 218 (948)
T KOG0577|consen 148 IHRDIKAGNILLSEP-GLVKLADFGSASIMA---PANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIEL 218 (948)
T ss_pred HhhhccccceEecCC-CeeeeccccchhhcC---chhcccCCccccchhHheec-----cccccCCccceeeccchhhhh
Confidence 799999999999965 789999999886543 24578999999999998642 468899999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
...++|+.+++.+..++.+.....+.-....++..+.+|+..||..-|.+|||.++++.
T Consensus 219 AERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 219 AERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred hhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 99999999999998888776544433334568999999999999999999999999887
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=191.17 Aligned_cols=143 Identities=27% Similarity=0.438 Sum_probs=103.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc---ccccCCCCccceecccccccccccccc---cCCCCchhhHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGE---KKHYNNKVDVYSFG 74 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~---~~~~~~~~Dvws~G 74 (198)
||.||||.|.|+-+ |.+||+|||+|...... ......+||..||+||.+......+.. .-..+.++||||||
T Consensus 482 VHSDLKPANFLlVk--G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLG 559 (677)
T KOG0596|consen 482 VHSDLKPANFLLVK--GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLG 559 (677)
T ss_pred eecCCCcccEEEEe--eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhh
Confidence 79999999999984 56999999999754332 223456899999999998654322110 12257899999999
Q ss_pred HHHHHHHcCCCCCCCCCcHHHHHHHHHccCC-CCCCCCCcHH-HHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 75 IVLWELLTNRLPFEGMSNLQAAYAAAFKHAR-PGLPEDISPD-LAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 75 ~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~-~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|++|+|+.|+.||....+............. .++|..-... +.++++.||++||.+||+..++|+ +.++..
T Consensus 560 CILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq--hpFl~~ 632 (677)
T KOG0596|consen 560 CILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ--HPFLQI 632 (677)
T ss_pred hHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc--Cccccc
Confidence 9999999999999755443333332222211 2444443333 999999999999999999999999 666554
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=179.66 Aligned_cols=134 Identities=28% Similarity=0.541 Sum_probs=106.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+|+||||+||+++.+ +.+||+|||+++...... ......++..|+|||.+.. ..++.++|+|||||++
T Consensus 146 ~H~dlkp~Nil~~~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDv~slG~il 216 (283)
T cd05048 146 VHRDLAARNCLVGEG-LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY--------GKFTTESDIWSFGVVL 216 (283)
T ss_pred eccccccceEEEcCC-CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc--------CcCchhhhHHHHHHHH
Confidence 699999999999966 679999999987432211 1223456788999998743 5678999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
||+++ |..||.+..... ..........+..+..+++++.+|+.+||+.||.+||++.+++++|+.+
T Consensus 217 ~el~~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 217 WEIFSYGLQPYYGFSNQE-VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHcCCCCCCCCCCHHH-HHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 99997 999998766533 3333334455566778999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=193.36 Aligned_cols=130 Identities=33% Similarity=0.566 Sum_probs=105.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc---ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++..... ......+||+.|+|||++.+ ..++.++|||||||++
T Consensus 165 iHrDLKP~NILl~~~-~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~s~k~DVwSlGvil 235 (496)
T PTZ00283 165 IHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR--------KPYSKKADMFSLGVLL 235 (496)
T ss_pred ecCCCCHHHEEEeCC-CCEEEEecccCeeccccccccccccccCCcceeCHHHhCC--------CCCCcHHHHHHHHHHH
Confidence 699999999999976 68999999999754321 12334679999999999853 5688999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 140 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~ 140 (198)
||+++|..||.+.... .............+|..+++++.+++.+||..||.+||++.+++.+
T Consensus 236 yeLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 236 YELLTLKRPFDGENME-EVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHCCCCCCCCCHH-HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 9999999999875543 2333333444456778899999999999999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=195.43 Aligned_cols=139 Identities=28% Similarity=0.541 Sum_probs=115.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCC---CCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE---TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||-..|+|++.+ ..|||+|||++|..-....++.. .=...||+||.+. .+.|+.++||||||+++
T Consensus 625 VHRDLATRNCLVge~-l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl--------y~kFTteSDVWs~GVvL 695 (774)
T KOG1026|consen 625 VHRDLATRNCLVGEN-LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL--------YGKFTTESDVWSFGVVL 695 (774)
T ss_pred cccchhhhhceeccc-eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh--------cCcccchhhhhhhhhhh
Confidence 799999999999966 78999999999965444433322 2246899999986 47899999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
||+++ |..||.+..+.+..... ..+...+.|+.++.++.+||..||+..|++||+|+||-..|+.+....+
T Consensus 696 WEIFsyG~QPy~glSn~EVIe~i-~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 696 WEIFSYGKQPYYGLSNQEVIECI-RAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred hhhhccccCcccccchHHHHHHH-HcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 99996 89999998876654443 3444578899999999999999999999999999999999998865433
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=184.44 Aligned_cols=135 Identities=26% Similarity=0.392 Sum_probs=101.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++............||..|+|||++.+ ..++.++|+||+||++|+|
T Consensus 145 vHrDlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el 215 (359)
T cd07876 145 IHRDLKPSNIVVKSD-CTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEL 215 (359)
T ss_pred ccCCCCHHHEEECCC-CCEEEecCCCccccccCccCCCCcccCCCCCchhccC--------CCCCcchhhHHHHHHHHHH
Confidence 799999999999976 6799999999976544333445678999999999853 5678899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHH--------------------ccCCCC--------------------CCCCCcHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAF--------------------KHARPG--------------------LPEDISPDLAFIV 120 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~--------------------~~~~~~--------------------~p~~~~~~~~~l~ 120 (198)
++|..||.+............ ....+. .....++++.+|+
T Consensus 216 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 295 (359)
T cd07876 216 VKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLL 295 (359)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHH
Confidence 999999987653221110000 000000 0112357789999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 121 QSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 121 ~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
.+||..||.+|||+.|+++ +.|+.
T Consensus 296 ~~mL~~dP~~R~t~~e~l~--hp~~~ 319 (359)
T cd07876 296 SKMLVIDPDKRISVDEALR--HPYIT 319 (359)
T ss_pred HHHhccCcccCCCHHHHhc--Cchhh
Confidence 9999999999999999999 66654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=182.41 Aligned_cols=130 Identities=26% Similarity=0.343 Sum_probs=99.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|||++.+ +.+||+|||+++............|+..|+|||++.. ..++.++|+||+||++||+
T Consensus 132 iH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 202 (290)
T cd07862 132 VHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEM 202 (290)
T ss_pred eeCCCCHHHEEEcCC-CCEEEccccceEeccCCcccccccccccccChHHHhC--------CCCCCccchHHHHHHHHHH
Confidence 699999999999976 6799999999975544333445678999999998753 5678899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCC-------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARP-------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFS 135 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------~~p~~~~~~~~~l~~~~l~~dp~~Rps~~ 135 (198)
++|.+||.+................+ .....+++.+.+++.+||+.||.+||++.
T Consensus 203 ~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~ 282 (290)
T cd07862 203 FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 282 (290)
T ss_pred HcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHH
Confidence 99999998766543322211100000 01134678889999999999999999999
Q ss_pred HHHH
Q 029154 136 QIIR 139 (198)
Q Consensus 136 ~~l~ 139 (198)
++++
T Consensus 283 ~~l~ 286 (290)
T cd07862 283 SALS 286 (290)
T ss_pred HHhc
Confidence 9987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=177.64 Aligned_cols=140 Identities=31% Similarity=0.538 Sum_probs=108.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||++..............+..|++||++.+ ..++.++|||||||++|||
T Consensus 141 vH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~il~el 211 (297)
T cd05089 141 IHRDLAARNVLVGEN-LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY--------SVYTTKSDVWSFGVLLWEI 211 (297)
T ss_pred ccCcCCcceEEECCC-CeEEECCcCCCccccceeccCCCCcCccccCchhhcc--------CCCCchhhHHHHHHHHHHH
Confidence 699999999999876 6799999999864322111112223557999998743 5678899999999999999
Q ss_pred Hc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 81 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 81 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
++ |..||.+..... .............+..++..+.+++.+||..+|.+||+++++++.|+.+......
T Consensus 212 ~t~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 212 VSLGGTPYCGMTCAE-LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HcCCCCCCCCCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 97 999998765433 2333333444556777899999999999999999999999999999988765543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-28 Score=168.63 Aligned_cols=106 Identities=28% Similarity=0.461 Sum_probs=89.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
||||+||+||||+.+ +++|+||||++....++...+...|+..|||||.+..+. ....|+.++||||+|+++.||
T Consensus 171 IHRDvKPsNiLIn~~-GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~----n~~gY~vksDvWSLGItmiEl 245 (282)
T KOG0984|consen 171 IHRDVKPSNILINYD-GQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPEL----NQKGYSVKSDVWSLGITMIEM 245 (282)
T ss_pred hhccCCcceEEEccC-CcEEEcccccceeehhhhHHHHhcCCCccCChhhcCccc----Ccccceeehhhhhhhhhhhhh
Confidence 799999999999988 789999999999877766555578999999999987633 345799999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPED 111 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~ 111 (198)
.+++.||...........+..+...|.+|.+
T Consensus 246 A~lr~PY~~w~tpF~qLkqvVeep~P~Lp~~ 276 (282)
T KOG0984|consen 246 AILRFPYESWGTPFQQLKQVVEEPSPQLPAD 276 (282)
T ss_pred hhccccccccCCHHHHHHHHhcCCCCCCccc
Confidence 9999999988877777777777777777653
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-28 Score=186.45 Aligned_cols=132 Identities=27% Similarity=0.493 Sum_probs=105.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++... ........+||+.|+|||++.+ ..++.++|+||+||++||
T Consensus 117 vHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~e 187 (323)
T cd05571 117 VYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYE 187 (323)
T ss_pred EeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCcccceecCccccChhhhcC--------CCCCccccCcccchhhhh
Confidence 699999999999976 679999999987432 2222344679999999999853 567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFL 145 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~~l~~~~ 145 (198)
|++|..||.+....... .........+|..+++++.+++.+||..||.+|| ++.++++ +.|+
T Consensus 188 lltg~~Pf~~~~~~~~~--~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~--h~~f 254 (323)
T cd05571 188 MMCGRLPFYNQDHEKLF--ELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME--HRFF 254 (323)
T ss_pred hhcCCCCCCCCCHHHHH--HHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc--CCCc
Confidence 99999999875543322 2223345567788999999999999999999999 7999987 4444
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-29 Score=183.67 Aligned_cols=130 Identities=30% Similarity=0.494 Sum_probs=108.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc-ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
||||||..||||+.+ +++||+|||++....+... ..+.+||+.|||||++. .-.|+.++||||+|++..|
T Consensus 151 IHRDIKAGNILLNT~-G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~--------EIGY~~~ADIWSLGITaIE 221 (502)
T KOG0574|consen 151 IHRDIKAGNILLNTD-GIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIE--------EIGYDTKADIWSLGITAIE 221 (502)
T ss_pred HHhhcccccEEEccc-chhhhhhccccchhhhhHHhhCccccCcccccHHHHH--------HhccchhhhHhhhcchhhh
Confidence 799999999999977 7899999999987665433 45679999999999985 3678999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHcc-CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKH-ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
|..|++||....++...+.+.-.. .....|+.++.++.++++.||...|.+|.|+-++++
T Consensus 222 MAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 222 MAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 999999999888766654432111 112346778999999999999999999999999988
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-28 Score=206.60 Aligned_cols=133 Identities=26% Similarity=0.407 Sum_probs=114.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-----cccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
|||||||+||+|+.+ +.+|++|||.|+....+. ......||+.|||||++.+.. ..+...+.||||+||
T Consensus 1356 VHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~-----~kG~~~A~DiWslGC 1429 (1509)
T KOG4645|consen 1356 VHRDIKPANILLDFN-GLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTK-----GKGHGGAADIWSLGC 1429 (1509)
T ss_pred eecCCCccceeeecC-CcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccc-----cCCCCcchhhhcccc
Confidence 799999999999977 689999999998654432 234568999999999997632 345567899999999
Q ss_pred HHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 76 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
++.||+||+.||...++.-+...++-.+..|++|+.++.+-++|+.+||..||.+|.++.|+++
T Consensus 1430 VVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1430 VVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred eEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 9999999999999888777777777778889999999999999999999999999999999988
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=190.50 Aligned_cols=136 Identities=30% Similarity=0.611 Sum_probs=118.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCC--ccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG--TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||...|||+... .++||+|||++|...+...++...| ...||+||.++ ...++.++|||.||+++|
T Consensus 513 VHRDIAaRNiLVsSp-~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESIN--------fRrFTtASDVWMFgVCmW 583 (974)
T KOG4257|consen 513 VHRDIAARNILVSSP-QCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESIN--------FRRFTTASDVWMFGVCMW 583 (974)
T ss_pred hhhhhhhhheeecCc-ceeeecccchhhhccccchhhccccccceeecCccccc--------hhcccchhhHHHHHHHHH
Confidence 799999999999965 7899999999998887777766655 46899999985 478999999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|++. |..||++..+.+ .......+.+++.|+.+++.+..|+.+||++||.+||.+.++...|++++.
T Consensus 584 EIl~lGvkPfqgvkNsD-VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 584 EILSLGVKPFQGVKNSD-VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred HHHHhcCCccccccccc-eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 9974 999999987644 334455678889999999999999999999999999999999999988876
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=186.38 Aligned_cols=131 Identities=30% Similarity=0.449 Sum_probs=113.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|||||+.||++.+++ .|||+|||+|+...... ...+.+||+.||+||.+. +..|+.|+|+||+||++||
T Consensus 128 LHRDlK~~Nifltk~~-~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~--------d~pYn~KSDiWsLGC~~yE 198 (426)
T KOG0589|consen 128 LHRDLKCANIFLTKDK-KVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILS--------DIPYNEKSDIWSLGCCLYE 198 (426)
T ss_pred hcccchhhhhhccccC-ceeecchhhhhhcCCchhhhheecCCCcccCHHHhC--------CCCCCccCcchhhcchHHH
Confidence 5999999999999884 57999999999776554 567789999999999985 4889999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
|++-+++|.+.+.. ..........-.++|..++.+++.++..|+..+|..||++.+++.+.
T Consensus 199 m~~lk~aF~a~~m~-~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 199 MCTLKPAFKASNMS-ELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred HHhcccccCccchH-HHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 99999999886643 34444445556778899999999999999999999999999999863
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=190.32 Aligned_cols=129 Identities=29% Similarity=0.554 Sum_probs=103.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++...... .....+||+.|+|||++.+ ..++.++||||+||++
T Consensus 191 vHrDlkp~NIll~~~-~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~~l 261 (478)
T PTZ00267 191 MHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER--------KRYSKKADMWSLGVIL 261 (478)
T ss_pred EECCcCHHhEEECCC-CcEEEEeCcCceecCCccccccccccCCCccccCHhHhCC--------CCCCcHHhHHHHHHHH
Confidence 699999999999976 679999999997543321 1234579999999998853 5688999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
|+|++|..||.+...... ..........+.|..++.++.+++.+||..||.+||++.+++.
T Consensus 262 ~el~tg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 262 YELLTLHRPFKGPSQREI-MQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHhCCCCCCCCCHHHH-HHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 999999999987654332 2333333444566778999999999999999999999999875
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-27 Score=177.66 Aligned_cols=134 Identities=28% Similarity=0.505 Sum_probs=105.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||+++....... .....+++.|+|||.+.. ..++.++|+||+|+++
T Consensus 146 ~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l 216 (283)
T cd05091 146 VHKDLATRNVLVFDK-LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY--------GKFSIDSDIWSYGVVL 216 (283)
T ss_pred cccccchhheEecCC-CceEecccccccccccchheeeccCccCCccccCHHHHhc--------CCCCcchhHHHHHHHH
Confidence 699999999999966 6799999999875432221 223455778999998753 4578899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
|||++ |..||.+..... .............+..++..+.+++.+||+.+|.+||++.+++..|+.|
T Consensus 217 ~el~~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 283 (283)
T cd05091 217 WEVFSYGLQPYCGYSNQD-VIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283 (283)
T ss_pred HHHHcCCCCCCCCCCHHH-HHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence 99998 888887765433 3333334444556778999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=183.43 Aligned_cols=134 Identities=32% Similarity=0.561 Sum_probs=104.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccc---cCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++........ ....++..|+|||++.+ ..++.++|+||||+++
T Consensus 236 vH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDi~slG~~l 306 (375)
T cd05104 236 IHRDLAARNILLTHG-RITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGILL 306 (375)
T ss_pred eccCCchhhEEEECC-CcEEEecCccceeccCcccccccCCCCCCcceeChhHhcC--------CCCCCCCCHHHHHHHH
Confidence 699999999999966 67999999999754322211 12234567999999853 5678999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
||+++ |..||.....................|...+.++.+++.+||..||.+||++.++++.|+.
T Consensus 307 ~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 307 WEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 99997 8889977654433333333444455566778999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-27 Score=183.82 Aligned_cols=135 Identities=24% Similarity=0.362 Sum_probs=101.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++............||..|+|||++.+ ..++.++|||||||++|+|
T Consensus 148 vH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el 218 (364)
T cd07875 148 IHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEM 218 (364)
T ss_pred ecCCCCHHHEEECCC-CcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhC--------CCCCchhhHHhHHHHHHHH
Confidence 699999999999976 6899999999986554433445678999999999853 5678899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHc--------------------cCCCC--------------------CCCCCcHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFK--------------------HARPG--------------------LPEDISPDLAFIV 120 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~--------------------~~~~~--------------------~p~~~~~~~~~l~ 120 (198)
++|+.||.+............. ...+. .....+.++.+++
T Consensus 219 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 298 (364)
T cd07875 219 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298 (364)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHH
Confidence 9999999876543322111100 00000 0111346789999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 121 QSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 121 ~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
.+||..||.+|||+.++++ +.|+.
T Consensus 299 ~~mL~~dP~~R~t~~e~L~--hp~~~ 322 (364)
T cd07875 299 SKMLVIDASKRISVDEALQ--HPYIN 322 (364)
T ss_pred HHhcCcCcccCCCHHHHhc--Ccccc
Confidence 9999999999999999999 66654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=182.90 Aligned_cols=135 Identities=25% Similarity=0.375 Sum_probs=108.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc--cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|||||.+|||||.+ +.+||+|||||+.... ...++..+.|.+|.+||.+.+ ...|+...|+||+||++.
T Consensus 240 lHRDIK~SNiLidn~-G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG-------~t~Yg~aVDlWS~GCIl~ 311 (560)
T KOG0600|consen 240 LHRDIKGSNILIDNN-GVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLG-------ATSYGTAVDLWSVGCILA 311 (560)
T ss_pred eeccccccceEEcCC-CCEEeccccceeeccCCCCcccccceEEeeccChHHhcC-------CcccccceeehhhhHHHH
Confidence 699999999999966 7899999999995433 334677788999999999987 467999999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHc--cCC------CCCC-------------------CCCcHHHHHHHHHhcccCCCCC
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFK--HAR------PGLP-------------------EDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~--~~~------~~~p-------------------~~~~~~~~~l~~~~l~~dp~~R 131 (198)
||+.|++.|+|.....+...+... ... ..+| ..++....+|+..+|.+||.+|
T Consensus 312 El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR 391 (560)
T KOG0600|consen 312 ELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKR 391 (560)
T ss_pred HHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccc
Confidence 999999999998877765433211 100 0111 2246778899999999999999
Q ss_pred CCHHHHHHHHHHHH
Q 029154 132 PSFSQIIRMLNAFL 145 (198)
Q Consensus 132 ps~~~~l~~l~~~~ 145 (198)
.|+.++++ +.++
T Consensus 392 ~tA~~aL~--seyF 403 (560)
T KOG0600|consen 392 GTASSALQ--SEYF 403 (560)
T ss_pred ccHHHHhc--Cccc
Confidence 99999998 7766
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=183.56 Aligned_cols=135 Identities=24% Similarity=0.379 Sum_probs=101.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++............||..|+|||++.+ ..++.++|+|||||++|+|
T Consensus 141 vHrDikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 211 (355)
T cd07874 141 IHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEM 211 (355)
T ss_pred ccCCCChHHEEECCC-CCEEEeeCcccccCCCccccCCccccCCccCHHHHcC--------CCCCchhhHHHHHHHHHHH
Confidence 799999999999976 6899999999986554444455678999999999853 5678899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHc--------------------cCCC--------------------CCCCCCcHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFK--------------------HARP--------------------GLPEDISPDLAFIV 120 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~--------------------~~~~--------------------~~p~~~~~~~~~l~ 120 (198)
++|+.||.+............. ...+ ..+...+.++.+++
T Consensus 212 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 291 (355)
T cd07874 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291 (355)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHH
Confidence 9999999875533221110000 0000 01112356789999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 121 QSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 121 ~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
.+||..||.+|||+.++++ +.|+.
T Consensus 292 ~~mL~~dP~~Rps~~ell~--hp~~~ 315 (355)
T cd07874 292 SKMLVIDPAKRISVDEALQ--HPYIN 315 (355)
T ss_pred HHHhcCCchhcCCHHHHhc--Ccchh
Confidence 9999999999999999999 55553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=175.93 Aligned_cols=138 Identities=29% Similarity=0.430 Sum_probs=108.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+|+... ....++..++|..|.|||++.+ ...|+...|+||+||++.|
T Consensus 142 lHRDLKPQNlLi~~~-G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlG-------s~~Ys~~vDiWs~GcIfaE 213 (323)
T KOG0594|consen 142 LHRDLKPQNLLISSS-GVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLG-------STSYSTSVDIWSLGCIFAE 213 (323)
T ss_pred ecccCCcceEEECCC-CcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcC-------CCcCCCCcchHhHHHHHHH
Confidence 699999999999976 789999999999655 3344777899999999999876 4568999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC----------------CCC------------CCCcHHHHHHHHHhcccCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP----------------GLP------------EDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------~~p------------~~~~~~~~~l~~~~l~~dp~~R 131 (198)
|+++++.|.+.....+...+...-..| .++ ...+++..+++.+||+++|.+|
T Consensus 214 m~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R 293 (323)
T KOG0594|consen 214 MFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKR 293 (323)
T ss_pred HHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccC
Confidence 999999999988766654443321111 011 1123578999999999999999
Q ss_pred CCHHHHHHHHHHHHhhc
Q 029154 132 PSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~ 148 (198)
.|++.++. +..+...
T Consensus 294 ~Sa~~al~--h~yf~~~ 308 (323)
T KOG0594|consen 294 ISAKGALT--HPYFSEL 308 (323)
T ss_pred cCHHHHhc--Chhhccc
Confidence 99999998 5444433
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=173.38 Aligned_cols=134 Identities=25% Similarity=0.519 Sum_probs=105.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc----ccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+||||||+||+++.+ +.+||+|||+++....... .....++..|+|||.+.. ..++.++|+||||++
T Consensus 117 ~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~ 187 (257)
T cd05116 117 VHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY--------YKFSSKSDVWSFGVL 187 (257)
T ss_pred eecccchhhEEEcCC-CeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc--------CCcCchhHHHHHHHH
Confidence 699999999999976 6799999999975432221 112234578999998743 457889999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
+||+++ |..||.+..... ..........+..|..+++++.+++.+||..||++||++.+|.+.|+.+
T Consensus 188 l~el~t~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 188 MWEAFSYGQKPYKGMKGNE-VTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 999997 999998765433 2333344455667888999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=180.30 Aligned_cols=138 Identities=24% Similarity=0.385 Sum_probs=101.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||++..... ........|+..|+|||++.+ ...++.++|+||+||++|+
T Consensus 125 vH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ 196 (303)
T cd07869 125 LHRDLKPQNLLISDT-GELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG-------STEYSTCLDMWGVGCIFVE 196 (303)
T ss_pred ecCCCCHHHEEECCC-CCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcC-------CCCCCcHHHHHHHHHHHHH
Confidence 699999999999966 6799999999874322 222334578999999998753 2457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHcc-CCC----------------C-----CC---------CCCcHHHHHHHHHhcccCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKH-ARP----------------G-----LP---------EDISPDLAFIVQSCWVEDP 128 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~-~~~----------------~-----~p---------~~~~~~~~~l~~~~l~~dp 128 (198)
|++|..||.+.............. ..+ . .+ ...+.++.+++.+||+.||
T Consensus 197 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp 276 (303)
T cd07869 197 MIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFP 276 (303)
T ss_pred HHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCc
Confidence 999999998765543322221110 000 0 00 1134678899999999999
Q ss_pred CCCCCHHHHHHHHHHHHhhc
Q 029154 129 NLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 129 ~~Rps~~~~l~~l~~~~~~~ 148 (198)
.+|||+.++++ |.|+...
T Consensus 277 ~~R~s~~~~l~--h~~f~~~ 294 (303)
T cd07869 277 KNRLSAQAALS--HEYFSDL 294 (303)
T ss_pred hhccCHHHHhc--CcccccC
Confidence 99999999998 7776544
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=181.91 Aligned_cols=143 Identities=24% Similarity=0.399 Sum_probs=106.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++...... ......||..|++||++.... ......+.++|||||||++||
T Consensus 190 vHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DvwslGvil~e 265 (353)
T PLN00034 190 VHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL---NHGAYDGYAGDIWSLGVSILE 265 (353)
T ss_pred eecCCCHHHEEEcCC-CCEEEcccccceecccccccccccccCccccCcccccccc---ccCcCCCcchhHHHHHHHHHH
Confidence 699999999999976 679999999987543221 223467999999999874210 011234568999999999999
Q ss_pred HHcCCCCCCCCCc--HHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 80 LLTNRLPFEGMSN--LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 80 ~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
|++|+.||..... .............+..+..++.++.+|+.+||..||++||++.|+++ +.|+....
T Consensus 266 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~--hp~~~~~~ 335 (353)
T PLN00034 266 FYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ--HPFILRAQ 335 (353)
T ss_pred HHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc--CcccccCC
Confidence 9999999974322 12222222233445566778999999999999999999999999999 77766543
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=170.99 Aligned_cols=139 Identities=24% Similarity=0.417 Sum_probs=101.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc----------ccCCCCccceecccccccccccccccCCCCchhhH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM----------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 70 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dv 70 (198)
.||||||.|||+..+ +.++|.|||.+........ .....+|..|.|||.+... .....+.++||
T Consensus 151 AH~DiKP~NILls~~-~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk-----~~~ti~ertDI 224 (302)
T KOG2345|consen 151 AHRDIKPANILLSDS-GLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK-----SHCTITERTDI 224 (302)
T ss_pred cccCCCcceeEecCC-CceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecc-----cCcccccccch
Confidence 499999999999976 6799999998864322110 1123578999999998642 24566889999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCC--CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 71 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 71 ws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
|||||++|+|+.|..||....................+| ..+++.+.+++..||+.||.+||++.+++..+++..
T Consensus 225 WSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 225 WSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred hhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 999999999999999996432211111111111122222 228899999999999999999999999999887653
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=188.08 Aligned_cols=136 Identities=21% Similarity=0.295 Sum_probs=99.2
Q ss_pred CCCCCCCCCeEEcCCCC---------------ceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCC
Q 029154 1 MGKFMKEDNLLLTPDQK---------------SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~---------------~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 65 (198)
|||||||+|||++.++. .+||+|||++..... .....+||..|+|||++.+ ..++
T Consensus 254 iHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~--------~~~~ 323 (467)
T PTZ00284 254 MHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLG--------LGWM 323 (467)
T ss_pred ecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhc--------CCCC
Confidence 79999999999986532 489999998764322 2335689999999999864 5688
Q ss_pred chhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHH--ccC-----------------------CCCC-C----------
Q 029154 66 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF--KHA-----------------------RPGL-P---------- 109 (198)
Q Consensus 66 ~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~--~~~-----------------------~~~~-p---------- 109 (198)
.++|||||||++|||++|+.||.+............ ... .+.. +
T Consensus 324 ~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (467)
T PTZ00284 324 YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARAR 403 (467)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhccc
Confidence 999999999999999999999987664332211100 000 0000 0
Q ss_pred ----CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 110 ----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 110 ----~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
...++.+.+|+.+||..||.+|||+.|+++ |.|+...
T Consensus 404 ~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~--Hp~~~~~ 444 (467)
T PTZ00284 404 PVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT--HPYVLKY 444 (467)
T ss_pred chhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc--Ccccccc
Confidence 011355779999999999999999999999 7776543
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=188.48 Aligned_cols=135 Identities=26% Similarity=0.502 Sum_probs=117.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
||||||.+||+|+.+-|.|||+|+|||.....+. ....+|||.|||||.+- ..|+..+||||||+++.||
T Consensus 167 IHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-aksvIGTPEFMAPEmYE---------E~YnE~VDVYaFGMCmLEM 236 (632)
T KOG0584|consen 167 IHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-AKSVIGTPEFMAPEMYE---------ENYNELVDVYAFGMCMLEM 236 (632)
T ss_pred cccccccceEEEcCCcCceeecchhHHHHhhccc-cceeccCccccChHHHh---------hhcchhhhhhhhhHHHHHH
Confidence 7999999999999888999999999998655444 34479999999999983 5789999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCC-CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPG-LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
+|+..||....+..+.|.++..+..|. +-..-+++++.||.+||.. .++|+++.|+|+ +.|+...
T Consensus 237 vT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~--d~Ff~~d 302 (632)
T KOG0584|consen 237 VTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK--DPFFDED 302 (632)
T ss_pred HhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh--Chhhccc
Confidence 999999999888888888888777663 2333579999999999998 999999999999 7777654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=187.42 Aligned_cols=130 Identities=25% Similarity=0.367 Sum_probs=106.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+.++++|+|||.++..... +.+.+-|..|.|||+.. ...|+..+|+||||+++|+|
T Consensus 437 vhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~--------~~~yt~acD~WSLGvlLy~M 506 (612)
T KOG0603|consen 437 VHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLA--------IQEYTEACDWWSLGVLLYEM 506 (612)
T ss_pred eecCCChhheeecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhc--------cCCCCcchhhHHHHHHHHHH
Confidence 799999999999544578999999999865544 44556788999999985 37899999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
++|+.||........ .... ...+.....++.++++|+.+||+.||.+|++++++.. +.|+
T Consensus 507 L~G~tp~~~~P~~~e-i~~~--i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~--h~w~ 566 (612)
T KOG0603|consen 507 LTGRTLFAAHPAGIE-IHTR--IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA--HPWF 566 (612)
T ss_pred HhCCCccccCCchHH-HHHh--hcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc--Ccch
Confidence 999999987655422 2222 2233344789999999999999999999999999999 8887
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=178.35 Aligned_cols=136 Identities=26% Similarity=0.475 Sum_probs=101.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++..... ......|+..|+|||++.+ ..++.++|+|||||++||+
T Consensus 126 vH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 195 (331)
T cd06649 126 MHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEL 195 (331)
T ss_pred EcCCCChhhEEEcCC-CcEEEccCccccccccc-ccccCCCCcCcCCHhHhcC--------CCCCchHhHHHHHHHHHHH
Confidence 699999999999976 67999999998754322 2334578999999999853 5678999999999999999
Q ss_pred HcCCCCCCCCCcHHHH---------------------------------------------HHHHHccCCCCCC-CCCcH
Q 029154 81 LTNRLPFEGMSNLQAA---------------------------------------------YAAAFKHARPGLP-EDISP 114 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~p-~~~~~ 114 (198)
++|+.||......... .........+..+ ..+++
T Consensus 196 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (331)
T cd06649 196 AIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTP 275 (331)
T ss_pred HhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccH
Confidence 9999999654321110 0001111112111 24678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 115 DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 115 ~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
++.+|+.+||..||++||++.++++ +.|+...
T Consensus 276 ~l~~li~~~L~~~P~~Rpt~~ell~--h~~~~~~ 307 (331)
T cd06649 276 DFQEFVNKCLIKNPAERADLKMLMN--HTFIKRS 307 (331)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhc--ChHHhhc
Confidence 9999999999999999999999999 6676543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=182.40 Aligned_cols=138 Identities=26% Similarity=0.422 Sum_probs=107.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccC------cccccccCCCCccceecccccccccccccccCCCCchhhHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREE------TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 74 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G 74 (198)
|||||||+|+||+.+ +++||+|||.+... .....+...+||+.|+|||.+.++. .....+.+.||||+|
T Consensus 232 iHRDIKPsNLLl~~~-g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~----~~~~~g~a~DiWalG 306 (576)
T KOG0585|consen 232 IHRDIKPSNLLLSSD-GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN----SFSYSGFALDIWALG 306 (576)
T ss_pred eccccchhheEEcCC-CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCC----Cccccchhhhhhhhh
Confidence 799999999999977 88999999998643 2222344568999999999986522 012235689999999
Q ss_pred HHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCC--CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 75 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED--ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 75 ~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~--~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
+++|.++.|+.||.+...... ...+...+..+|.. +.+++.+||.++|.+||.+|.+..+|.. |.|...
T Consensus 307 VTLYCllfG~~PF~~~~~~~l--~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~--Hpwvt~ 377 (576)
T KOG0585|consen 307 VTLYCLLFGQLPFFDDFELEL--FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL--HPWVTR 377 (576)
T ss_pred hhHHHhhhccCCcccchHHHH--HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee--cceecc
Confidence 999999999999987664433 33344555566654 7899999999999999999999999988 555543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=182.61 Aligned_cols=129 Identities=28% Similarity=0.496 Sum_probs=103.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++... ........+||+.|+|||++.+ ..++.++|+||+||++|+
T Consensus 117 vHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~e 187 (328)
T cd05593 117 VYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYE 187 (328)
T ss_pred EecccCHHHeEECCC-CcEEEecCcCCccCCCcccccccccCCcCccChhhhcC--------CCCCccCCccccchHHHH
Confidence 699999999999976 679999999987532 2222344679999999999853 567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRM 140 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~~ 140 (198)
+++|..||.+....... .........+|..+++++.+++.+||..||.+|+ ++.+++++
T Consensus 188 lltG~~Pf~~~~~~~~~--~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 188 MMCGRLPFYNQDHEKLF--ELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HhhCCCCCCCCCHHHHH--HHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 99999999876543322 2223344567788999999999999999999997 89999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=172.64 Aligned_cols=134 Identities=28% Similarity=0.516 Sum_probs=104.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||+++....... .....++..|++||.+.. ..++.++|+||||+++
T Consensus 134 ~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Di~slG~il 204 (272)
T cd05075 134 IHRDLAARNCMLNEN-MNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD--------RVYTTKSDVWSFGVTM 204 (272)
T ss_pred eccccchhheEEcCC-CCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC--------CCcChHHHHHHHHHHH
Confidence 699999999999866 6799999999975433221 112245678999998743 5678999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
|++++ |..||.+..... .............+..++..+.+++.+||..||.+||++.++++.|+..
T Consensus 205 ~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 205 WEIATRGQTPYPGVENSE-IYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHcCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99998 889998755432 3333334444455667889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=173.07 Aligned_cols=137 Identities=28% Similarity=0.349 Sum_probs=110.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
||||||++|+|+... +.+||+|||+||..+.. ..++..+-|.+|.|||.+.+ ...|+...|+||+||++.|
T Consensus 199 lHRDLK~SNLLm~~~-G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG-------~~tyst~iDMWSvGCI~aE 270 (419)
T KOG0663|consen 199 LHRDLKTSNLLLSHK-GILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLG-------AKTYSTAVDMWSVGCIFAE 270 (419)
T ss_pred EecccchhheeeccC-CcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcC-------CcccCcchhhhhHHHHHHH
Confidence 699999999999966 78999999999976654 33556778999999999986 4678999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCC-----------------------------CCCC-CcHHHHHHHHHhcccCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPG-----------------------------LPED-ISPDLAFIVQSCWVEDPN 129 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------~p~~-~~~~~~~l~~~~l~~dp~ 129 (198)
++.+++.|.|.....+...+...-..|. ++.. +++...+|+..+|.+||.
T Consensus 271 ~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~ 350 (419)
T KOG0663|consen 271 LLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPG 350 (419)
T ss_pred HHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcc
Confidence 9999999999887776655433211110 0111 357788999999999999
Q ss_pred CCCCHHHHHHHHHHHHhh
Q 029154 130 LRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 130 ~Rps~~~~l~~l~~~~~~ 147 (198)
+|.|+++.|+ +.|+..
T Consensus 351 kR~tA~~~L~--h~~F~e 366 (419)
T KOG0663|consen 351 KRITAEDGLK--HEYFRE 366 (419)
T ss_pred ccccHHHhhc--cccccc
Confidence 9999999999 777664
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=196.33 Aligned_cols=139 Identities=29% Similarity=0.526 Sum_probs=114.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCC---CCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE---TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||...|+||+.. ..+||+|||+|+.......+... .-...|||||.+. .+.|+.|+||||||+++
T Consensus 824 vHRDLAaRNCLL~~~-r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~--------d~iFtskSDvWsFGVll 894 (1025)
T KOG1095|consen 824 VHRDLAARNCLLDER-RVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLK--------DGIFTSKSDVWSFGVLL 894 (1025)
T ss_pred cCcchhhhheeeccc-CcEEEcccchhHhhhhchheeccCccccceecCCHHHHh--------hcccccccchhhhHHHH
Confidence 799999999999977 78999999999944333332221 1246899999986 37899999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
||+++ |..||.+..+.+. ......+.+.+.|..+++.+.++|..||..+|++||+|..+++.+..++....
T Consensus 895 WEifslG~~PY~~~~n~~v-~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 895 WEIFSLGATPYPSRSNFEV-LLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred HHHHhCCCCCCCCcchHHH-HHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 99997 8899988776544 34345566889999999999999999999999999999999998888776443
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=171.70 Aligned_cols=134 Identities=29% Similarity=0.553 Sum_probs=105.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccc--cCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+||+++.+ +.+||+|||++......... ....++..|++||.+.+ ..++.++|+||||+++|
T Consensus 126 ~H~dlkp~nil~~~~-~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~ 196 (263)
T cd05052 126 IHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLW 196 (263)
T ss_pred eecccCcceEEEcCC-CcEEeCCCccccccccceeeccCCCCCccccCCHHHhcc--------CCCCchhHHHHHHHHHH
Confidence 699999999999866 67999999998754332211 11234567999998753 56788999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
|+++ |..||.+... ............+..+..++.++.+++.+||..||++||++.++++.|+.+
T Consensus 197 el~t~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 197 EIATYGMSPYPGIDL-SQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHcCCCCCCCCCCH-HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 9998 8999987553 333334444455667788999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=176.63 Aligned_cols=131 Identities=11% Similarity=0.195 Sum_probs=98.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--------cccCCCCccceecccccccccccccccCCCCchhhHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 72 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws 72 (198)
|||||||+|||++.+ +.++|+|||+++....+. ......||+.|+|||+..+ ..++.++||||
T Consensus 148 iHrDiKp~Nill~~~-~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--------~~~~~~~DiwS 218 (294)
T PHA02882 148 SHGDIKPENIMVDGN-NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--------ACVTRRGDLES 218 (294)
T ss_pred ecCCCCHHHEEEcCC-CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC--------CCCCcHHHHHH
Confidence 699999999999866 679999999997432111 1123468999999998753 56789999999
Q ss_pred HHHHHHHHHcCCCCCCCCCcHHHHHH-------HHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 73 FGIVLWELLTNRLPFEGMSNLQAAYA-------AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 73 ~G~~l~e~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
+||++||+++|..||.+......... ....... .....++..+.+++..||..+|.+||++.++.+.+
T Consensus 219 lG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 219 LGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGK-IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhh-hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 99999999999999987632211110 1111111 12344678999999999999999999999998865
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=181.14 Aligned_cols=128 Identities=25% Similarity=0.405 Sum_probs=101.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|||++.+ ..++.++|+||+||++|+
T Consensus 115 ~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~e 185 (312)
T cd05585 115 IYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG--------HGYTKAVDWWTLGVLLYE 185 (312)
T ss_pred EeCCCCHHHeEECCC-CcEEEEECcccccCccCCCccccccCCcccCCHHHHcC--------CCCCCccceechhHHHHH
Confidence 699999999999976 6799999999875322 222334679999999999853 567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS---FSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps---~~~~l~ 139 (198)
|++|..||.+...... .. ........+|..+++++.+++.+||..||.+||+ +.+++.
T Consensus 186 l~tg~~pf~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 186 MLTGLPPFYDENVNEM-YR-KILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHhCCCCcCCCCHHHH-HH-HHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 9999999987654322 22 2234455677889999999999999999999975 566665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=179.69 Aligned_cols=141 Identities=24% Similarity=0.331 Sum_probs=102.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.+ +.+||+|||+++...... .....+|+..|+|||++.+ ....++.++|||||||+
T Consensus 125 vH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~~DvwSlGvv 197 (338)
T cd07859 125 FHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS------FFSKYTPAIDIWSIGCI 197 (338)
T ss_pred ecCCCCHHHeEECCC-CcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhc------cccccCchhHHHHHHHH
Confidence 699999999999976 689999999997432211 1234578999999998743 12467889999999999
Q ss_pred HHHHHcCCCCCCCCCcHHHHHHH--------------------------HHccCCCCC---CCCCcHHHHHHHHHhcccC
Q 029154 77 LWELLTNRLPFEGMSNLQAAYAA--------------------------AFKHARPGL---PEDISPDLAFIVQSCWVED 127 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~~~~~~~--------------------------~~~~~~~~~---p~~~~~~~~~l~~~~l~~d 127 (198)
+|+|++|+.||.+.......... ......... ....++.+.+++.+||..|
T Consensus 198 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 277 (338)
T cd07859 198 FAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFD 277 (338)
T ss_pred HHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcC
Confidence 99999999999765532211000 000000000 1236788999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHhhcCC
Q 029154 128 PNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 128 p~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
|.+||+++++++ +.|+.....
T Consensus 278 P~~Rpt~~e~l~--hp~f~~~~~ 298 (338)
T cd07859 278 PKDRPTAEEALA--DPYFKGLAK 298 (338)
T ss_pred cccCCCHHHHhc--CchhhhcCc
Confidence 999999999999 777765443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=172.72 Aligned_cols=135 Identities=32% Similarity=0.561 Sum_probs=103.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|||++.+ +.+||+|||++..............+..|++||++.. ..++.++|+||||+++||+
T Consensus 134 ~H~dikp~nili~~~-~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~el 204 (270)
T cd05047 134 IHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEI 204 (270)
T ss_pred eecccccceEEEcCC-CeEEECCCCCccccchhhhccCCCCccccCChHHHcc--------CCCCchhhHHHHHHHHHHH
Confidence 699999999999976 6799999999863322111112233567999998743 5678899999999999999
Q ss_pred Hc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 81 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 81 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
++ |..||.+.... ..............+..++.++.+++.+||..+|.+||++.+++..|+.++
T Consensus 205 ~~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 205 VSLGGTPYCGMTCA-ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HcCCCCCccccCHH-HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 96 99999765532 223333333444556678899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=175.64 Aligned_cols=131 Identities=25% Similarity=0.372 Sum_probs=98.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++..... .......++..|+|||++.+ ...++.++|+||+||++|+
T Consensus 125 vH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~ 196 (288)
T cd07871 125 LHRDLKPQNLLINEK-GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG-------STEYSTPIDMWGVGCILYE 196 (288)
T ss_pred ccCCCCHHHEEECCC-CCEEECcCcceeeccCCCccccCceecccccChHHhcC-------CcccCcHHHHHHHHHHHHH
Confidence 699999999999976 67999999998743321 22334568899999998753 3457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCC--------------------C--------CCCCCCcHHHHHHHHHhcccCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHAR--------------------P--------GLPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~--------------------~--------~~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
|++|+.||.+................ + .....+++++.+++.+||..||.+|
T Consensus 197 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R 276 (288)
T cd07871 197 MATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSR 276 (288)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccC
Confidence 99999999876543332211110000 0 0012367889999999999999999
Q ss_pred CCHHHHHH
Q 029154 132 PSFSQIIR 139 (198)
Q Consensus 132 ps~~~~l~ 139 (198)
||++|+++
T Consensus 277 ~t~~~~l~ 284 (288)
T cd07871 277 ISAEAALR 284 (288)
T ss_pred CCHHHHhc
Confidence 99999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=173.43 Aligned_cols=136 Identities=25% Similarity=0.488 Sum_probs=107.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||++....... ......++..|++||.+.+ ..++.++|+||||+++
T Consensus 145 ~H~dlkp~Nil~~~~-~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 215 (291)
T cd05094 145 VHRDLATRNCLVGAN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSFGVIL 215 (291)
T ss_pred eecccCcceEEEccC-CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc--------CCCCchhhHHHHHHHH
Confidence 699999999999976 689999999987443221 1223456788999998753 5678899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|++++ |..||....... ..........+..+...+..+.+++.+||..||.+||++.+++++|+.+..
T Consensus 216 ~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 216 WEIFTYGKQPWFQLSNTE-VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHhCCCCCCCCCCHHH-HHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 99998 999987655432 223333344445566688999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=182.41 Aligned_cols=131 Identities=30% Similarity=0.430 Sum_probs=101.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc--ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++..... ......+||..|+|||++.+ ...++.++|||||||++|
T Consensus 127 vHrDlkp~Nili~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ 198 (332)
T cd05614 127 VYRDIKLENILLDSE-GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG-------KGGHGKAVDWWSLGILIF 198 (332)
T ss_pred EecCCCHHHeEECCC-CCEEEeeCcCCccccccCCCccccccCCccccCHHHhcC-------CCCCCCccccccchhhhh
Confidence 699999999999976 67999999998753222 12234579999999999753 234678999999999999
Q ss_pred HHHcCCCCCCCCCc--HHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 029154 79 ELLTNRLPFEGMSN--LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 139 (198)
Q Consensus 79 e~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~ 139 (198)
||++|..||..... .............+.++..+++.+.+++.+||..||.+|| +++++++
T Consensus 199 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 199 ELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 99999999964321 1122222233455667778999999999999999999999 6778887
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-27 Score=180.37 Aligned_cols=128 Identities=28% Similarity=0.463 Sum_probs=102.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++... .........||+.|+|||++.+ ..++.++|+||+||++|+
T Consensus 118 vH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 188 (320)
T cd05590 118 IYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE--------MLYGPSVDWWAMGVLLYE 188 (320)
T ss_pred EeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcC--------CCCCCccchhhhHHHHHH
Confidence 699999999999976 679999999987432 2222334679999999999853 567889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF------SQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~------~~~l~ 139 (198)
|++|..||.+...... . ..........|..++.++.+++.+||..||.+|+++ +++++
T Consensus 189 l~~g~~Pf~~~~~~~~-~-~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 189 MLCGHAPFEAENEDDL-F-EAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred HhhCCCCCCCCCHHHH-H-HHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 9999999987664332 2 223344455677799999999999999999999998 66666
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=180.53 Aligned_cols=128 Identities=26% Similarity=0.474 Sum_probs=102.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++... .........||+.|+|||++.+ ..++.++|+|||||++||
T Consensus 117 vH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~e 187 (323)
T cd05595 117 VYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYE 187 (323)
T ss_pred EecCCCHHHEEEcCC-CCEEecccHHhccccCCCCccccccCCcCcCCcccccC--------CCCCchhchhhhHHHHHH
Confidence 699999999999976 679999999987432 2222334679999999999853 567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~ 139 (198)
+++|..||.+......... .......+|..+++++.+++.+||..||.+|+ ++.++++
T Consensus 188 ll~g~~Pf~~~~~~~~~~~--~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 188 MMCGRLPFYNQDHERLFEL--ILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHhCCCCCCCCCHHHHHHH--HhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 9999999987654332222 22334456778999999999999999999998 8888887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=179.99 Aligned_cols=128 Identities=23% Similarity=0.422 Sum_probs=102.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||+++.... ........|++.|+|||++.+ ..++.++||||+|+++||
T Consensus 122 vH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 192 (323)
T cd05584 122 IYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR--------SGHGKAVDWWSLGALMYD 192 (323)
T ss_pred ecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCcccccCCCccccChhhccC--------CCCCCcceecccHHHHHH
Confidence 699999999999976 6799999999874322 222334578999999999853 456889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~ 139 (198)
|++|..||.+........ . .......+|..+++++.+++.+||..||.+|| ++.++++
T Consensus 193 ll~G~~pf~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 193 MLTGAPPFTAENRKKTID-K-ILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HhcCCCCCCCCCHHHHHH-H-HHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 999999998766433222 2 22344567788999999999999999999999 7888887
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-26 Score=169.86 Aligned_cols=136 Identities=30% Similarity=0.546 Sum_probs=104.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-----cccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
+||||||+|||++.+ +.+||+|||+++...... ......++..|+|||.+.. ..++.++|+||||+
T Consensus 120 ~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~ 190 (262)
T cd05058 120 VHRDLAARNCMLDES-FTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGV 190 (262)
T ss_pred cccccCcceEEEcCC-CcEEECCccccccccCCcceeecccccCcCCccccChhHhcc--------CccchHHHHHHHHH
Confidence 699999999999976 679999999987433211 1112345678999998743 56788999999999
Q ss_pred HHHHHHcC-CCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 76 VLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 76 ~l~e~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++||+++| .+||...... ...........+..+..+++.+.+++.+||..+|++||++.++++.|+.+..
T Consensus 191 ~l~el~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 191 LLWELMTRGAPPYPDVDSF-DITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHHcCCCCCCCCCCHH-HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 99999994 5667655433 2333334444455566788999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=181.35 Aligned_cols=139 Identities=24% Similarity=0.338 Sum_probs=99.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc--cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|||++.+ ..++.++|+||+||++|
T Consensus 204 vHrDiKP~NIll~~~-~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ 274 (391)
T PHA03212 204 IHRDIKAENIFINHP-GDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR--------DPYGPAVDIWSAGIVLF 274 (391)
T ss_pred ccCCCChHhEEEcCC-CCEEEEeCCcccccccccccccccccCccCCCChhhhcC--------CCCCcHHHHHHHHHHHH
Confidence 799999999999976 6799999999864322 122334579999999999853 56889999999999999
Q ss_pred HHHcCCCCCCCCCcH------HHHHH--------------------------HHHcc--CCC-CCC-----CCCcHHHHH
Q 029154 79 ELLTNRLPFEGMSNL------QAAYA--------------------------AAFKH--ARP-GLP-----EDISPDLAF 118 (198)
Q Consensus 79 e~~~g~~p~~~~~~~------~~~~~--------------------------~~~~~--~~~-~~p-----~~~~~~~~~ 118 (198)
|+++|..||...... ..... ..... ..+ ..+ ..++.++.+
T Consensus 275 elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 354 (391)
T PHA03212 275 EMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEY 354 (391)
T ss_pred HHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHH
Confidence 999999876532210 00000 00000 000 001 124568899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 119 IVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 119 l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
|+.+||..||.+|||+.|+++ +.|+.....
T Consensus 355 Li~~mL~~dP~~Rpta~elL~--hp~f~~~~~ 384 (391)
T PHA03212 355 LICKMLAFDAHHRPSAEALLD--FAAFQDIPD 384 (391)
T ss_pred HHHHHhcCChhhCCCHHHHhc--ChhhccCCC
Confidence 999999999999999999999 777765443
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=179.76 Aligned_cols=128 Identities=28% Similarity=0.489 Sum_probs=101.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||+++... ........+||..|+|||++.+ ..++.++|+||+||++|+
T Consensus 118 vHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~e 188 (316)
T cd05620 118 IYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG--------LKYTFSVDWWSFGVLLYE 188 (316)
T ss_pred EecCCCHHHeEECCC-CCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcC--------CCCCcccchhhhHHHHHH
Confidence 699999999999976 679999999987432 1222345679999999999853 567889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS-QIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~-~~l~ 139 (198)
|++|..||.+...... . .......+..|..++.++.+++.+||..||.+|+++. ++++
T Consensus 189 l~~g~~Pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 189 MLIGQSPFHGDDEDEL-F-ESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred HHhCCCCCCCCCHHHH-H-HHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 9999999987654322 2 2223345566778999999999999999999999974 6664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=186.96 Aligned_cols=134 Identities=23% Similarity=0.286 Sum_probs=103.8
Q ss_pred CCCCCCCCCeEEcCC-CCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~-~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
||+|||||||||..- ...+||+|||.|........ +.+-+..|.|||++.+ ..|+.+.|+|||||++.|
T Consensus 311 IHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILG--------lpY~~~IDmWSLGCIlAE 380 (586)
T KOG0667|consen 311 IHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILG--------LPYDTAIDMWSLGCILAE 380 (586)
T ss_pred eeccCChhheeeccCCcCceeEEecccccccCCcce--eeeeccccccchhhcc--------CCCCCccceeehhhhHHh
Confidence 899999999999642 23599999999987665433 6677899999999976 789999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC--------------------------------------------------CCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP--------------------------------------------------GLP 109 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------------------------------~~p 109 (198)
|++|.+.|.|....++...+......| ..|
T Consensus 381 L~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P 460 (586)
T KOG0667|consen 381 LFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGP 460 (586)
T ss_pred HhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCC
Confidence 999999999887766554332210000 011
Q ss_pred -C----------CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 110 -E----------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 110 -~----------~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
. .-...+.+++.+||..||..|+|..++++ |.|+.
T Consensus 461 ~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~--Hpfl~ 506 (586)
T KOG0667|consen 461 PGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN--HPFLT 506 (586)
T ss_pred CCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc--Ccccc
Confidence 0 01234789999999999999999999999 77776
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-26 Score=173.17 Aligned_cols=134 Identities=29% Similarity=0.573 Sum_probs=105.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ ..+||+|||+++...... ......++..|++||.+.+ ..++.++|+||||+++
T Consensus 146 ~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il 216 (283)
T cd05090 146 VHKDLAARNILIGEQ-LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY--------GKFSSDSDIWSFGVVL 216 (283)
T ss_pred ehhccccceEEEcCC-CcEEeccccccccccCCcceecccCCCccceecChHHhcc--------CCCCchhhhHHHHHHH
Confidence 699999999999976 679999999997543221 1223445678999998753 5578899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
|||++ |..||.+..... .............+..+++.+.+++.+||..||.+||++.++++.|..|
T Consensus 217 ~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 217 WEIFSFGLQPYYGFSNQE-VIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHcCCCCCCCCCCHHH-HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 99998 889997765422 2333333444556777899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=171.07 Aligned_cols=136 Identities=25% Similarity=0.517 Sum_probs=105.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||+++...... ......++..|++||.+.+ ..++.++|+||||+++
T Consensus 131 iH~dlkp~nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il 201 (279)
T cd05111 131 VHRNLAARNILLKSD-SIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF--------GRYTHQSDVWSYGVTV 201 (279)
T ss_pred eccccCcceEEEcCC-CcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc--------CCcCchhhHHHHHHHH
Confidence 699999999999966 679999999997542211 1223456778999998753 5678999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
||+++ |..||.+..... ..........+..+..++.++..++.+||..||++||++.++++.|..+..
T Consensus 202 ~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 202 WEMMSYGAEPYAGMRPHE-VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHcCCCCCCCCCCHHH-HHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 99998 999998765432 222233344455566678899999999999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=183.62 Aligned_cols=128 Identities=27% Similarity=0.488 Sum_probs=103.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++... ........+||..|+|||++.+ ..++.++|+||+||++|+
T Consensus 118 vHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 188 (325)
T cd05594 118 VYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYE 188 (325)
T ss_pred EecCCCCCeEEECCC-CCEEEecCCCCeecCCCCcccccccCCcccCCHHHHcc--------CCCCCccccccccceeee
Confidence 699999999999976 679999999987432 2222344679999999999853 567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~ 139 (198)
|++|..||.+....... .........+|..+++++.+++.+||..||.+|+ ++.++++
T Consensus 189 l~tG~~Pf~~~~~~~~~--~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 189 MMCGRLPFYNQDHEKLF--ELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred eccCCCCCCCCCHHHHH--HHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 99999999876543322 2223345566788999999999999999999996 8999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=164.20 Aligned_cols=132 Identities=25% Similarity=0.473 Sum_probs=111.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|+|++.. +.+||+|||.+.... .....+.|||.-|.+||... ...++..+|+|++|++.||+
T Consensus 146 IhRdiKpenlLlg~~-~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~--------~~~hd~~Vd~w~lgvl~yef 215 (281)
T KOG0580|consen 146 IHRDIKPENLLLGSA-GELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVE--------GRGHDKFVDLWSLGVLCYEF 215 (281)
T ss_pred ccCCCCHHHhccCCC-CCeeccCCCceeecC-CCCceeeecccccCCHhhcC--------CCCccchhhHHHHHHHHHHH
Confidence 799999999999977 679999999997655 33456789999999999985 47789999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+.|.+||..... ...+ ..+......+|..++.++.++|.+|+..+|.+|....|++. +.|+.
T Consensus 216 lvg~ppFes~~~-~etY-krI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~--hpwI~ 277 (281)
T KOG0580|consen 216 LVGLPPFESQSH-SETY-KRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMD--HPWIV 277 (281)
T ss_pred HhcCCchhhhhh-HHHH-HHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhh--hHHHH
Confidence 999999987663 2223 33445566778999999999999999999999999999998 66654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=177.31 Aligned_cols=131 Identities=22% Similarity=0.350 Sum_probs=104.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|||++.+ +.+||+|||+++..... ....+|++.|+|||++.+ ..++.++||||+||++|+|
T Consensus 123 ~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~~l 191 (291)
T cd05612 123 VYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQS--------KGHNKAVDWWALGILIYEM 191 (291)
T ss_pred eecCCCHHHeEECCC-CCEEEEecCcchhccCC--cccccCChhhcCHHHHcC--------CCCCchhhHHHHHHHHHHH
Confidence 699999999999976 67999999998754322 224578999999998753 5578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps-----~~~~l~~l~~~~~ 146 (198)
++|..||.+....... .. .......+|..+++.+.+++.+||..||.+|++ ++++++ +.|+.
T Consensus 192 ~~g~~pf~~~~~~~~~-~~-i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~--h~~~~ 258 (291)
T cd05612 192 LVGYPPFFDDNPFGIY-EK-ILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN--HRWFK 258 (291)
T ss_pred HhCCCCCCCCCHHHHH-HH-HHhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc--Ccccc
Confidence 9999999876543322 22 223445667778999999999999999999995 888888 55543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=179.09 Aligned_cols=128 Identities=25% Similarity=0.422 Sum_probs=101.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++.... .......+|++.|+|||.+.+ ..++.++|+|||||++|+
T Consensus 123 vHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 193 (324)
T cd05589 123 VYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTE--------TSYTRAVDWWGLGVLIYE 193 (324)
T ss_pred EecCCCHHHeEECCC-CcEEeCcccCCccCCCCCCcccccccCccccCHhHhcC--------CCCCcccchhhHHHHHHH
Confidence 699999999999977 6799999999874322 222345679999999999853 567889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~ 139 (198)
|++|..||.+......... ........|..+++++.+++.+||..||.+|| ++.++++
T Consensus 194 l~~G~~pf~~~~~~~~~~~--i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 194 MLVGESPFPGDDEEEVFDS--IVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHhCCCCCCCCCHHHHHHH--HHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 9999999987654333222 22334556778999999999999999999999 5777776
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=178.34 Aligned_cols=138 Identities=25% Similarity=0.357 Sum_probs=102.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|||++.+ +.+||+|||+++..... ....+||..|+|||++.+ ...++.++||||+||++|+|
T Consensus 140 vHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el 209 (343)
T cd07878 140 IHRDLKPSNVAVNED-CELRILDFGLARQADDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred ecccCChhhEEECCC-CCEEEcCCccceecCCC--cCCccccccccCchHhcC-------CccCCchhhhHhHHHHHHHH
Confidence 699999999999976 67999999999754332 234578999999998753 24578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHcc---------------------CCCCC--------CCCCcHHHHHHHHHhcccCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKH---------------------ARPGL--------PEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~---------------------~~~~~--------p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
++|..||.+.............. ..+.. ....++.+.+|+.+||..||.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R 289 (343)
T cd07878 210 LKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKR 289 (343)
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhC
Confidence 99999997655332221110000 00001 12356678899999999999999
Q ss_pred CCHHHHHHHHHHHHhhcCC
Q 029154 132 PSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~~~ 150 (198)
||+.++++ +.|+.....
T Consensus 290 ~s~~ell~--hp~~~~~~~ 306 (343)
T cd07878 290 ISASEALA--HPYFSQYHD 306 (343)
T ss_pred CCHHHHhc--CcchhccCC
Confidence 99999998 777765443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=171.70 Aligned_cols=134 Identities=28% Similarity=0.571 Sum_probs=105.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccc---cCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+||+++.+ +.+||+|||+++........ ....++..|++||.+. ...++.++|+|||||++
T Consensus 135 ~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--------~~~~~~~~Dv~SlG~il 205 (273)
T cd05035 135 IHRDLAARNCMLRED-MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA--------DRVYTSKSDVWAFGVTM 205 (273)
T ss_pred eccccchheEEECCC-CeEEECCccceeeccccccccccccccCCccccCHhhcc--------cCCCCcccchHHHHHHH
Confidence 699999999999976 67999999998754322211 1123456899999874 35678899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
||+++ |..||.+..... .............+..++.++.+++.+||..||++||++.++++.|+.+
T Consensus 206 ~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 206 WEIATRGQTPYPGVENHE-IYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99998 889997765433 3334444455667788999999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-26 Score=174.89 Aligned_cols=136 Identities=26% Similarity=0.505 Sum_probs=106.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccc---cCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++........ ....++..|++||.+.. ..++.++|+||||+++
T Consensus 131 iH~dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slGv~l 201 (316)
T cd05108 131 VHRDLAARNVLVKTP-QHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTV 201 (316)
T ss_pred eccccchhheEecCC-CcEEEccccccccccCCCcceeccCCccceeecChHHhcc--------CCCCchhhhHHHHHHH
Confidence 699999999999976 67999999999854322211 12234668999998753 5678999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
||+++ |..||.+..... .............+..++.++.+++.+||..+|.+||++.+++..+.....
T Consensus 202 ~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 202 WELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred HHHHcCCCCCCCCCCHHH-HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 99997 999998755332 223333444555567788999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=174.81 Aligned_cols=130 Identities=25% Similarity=0.306 Sum_probs=97.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc--ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+||+++.+ +.+||+|||++...... .......|+..|+|||++.+ ..++.++|+||+||++|
T Consensus 122 ~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslGvil~ 192 (287)
T cd07848 122 VHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG--------APYGKAVDMWSVGCILG 192 (287)
T ss_pred ecCCCCHHHEEEcCC-CcEEEeeccCcccccccccccccccccccccCCcHHHcC--------CCCCCchhHHhHHHHHH
Confidence 699999999999976 67999999999754322 12234578999999999853 45788999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccC-----------------CCCC-------------CCCCcHHHHHHHHHhcccCC
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHA-----------------RPGL-------------PEDISPDLAFIVQSCWVEDP 128 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~-----------------~~~~-------------p~~~~~~~~~l~~~~l~~dp 128 (198)
|+++|+.||.+............... .... ...++.++.+|+.+||..||
T Consensus 193 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P 272 (287)
T cd07848 193 ELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNP 272 (287)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCc
Confidence 99999999987654333221110000 0000 12367789999999999999
Q ss_pred CCCCCHHHHHH
Q 029154 129 NLRPSFSQIIR 139 (198)
Q Consensus 129 ~~Rps~~~~l~ 139 (198)
.+|||++++++
T Consensus 273 ~~R~s~~~~l~ 283 (287)
T cd07848 273 TDRYLTEQCLN 283 (287)
T ss_pred ccCCCHHHHhc
Confidence 99999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-26 Score=172.33 Aligned_cols=136 Identities=24% Similarity=0.479 Sum_probs=106.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||+++...... ......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 142 ~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~il 212 (288)
T cd05093 142 VHRDLATRNCLVGEN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSLGVVL 212 (288)
T ss_pred eecccCcceEEEccC-CcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc--------CCCCchhhHHHHHHHH
Confidence 699999999999976 679999999987543221 1123345778999998753 5678899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|+|++ |..||....... .............+..++.++.+++.+||..||.+||++.+++..|+.+..
T Consensus 213 ~~l~t~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 213 WEIFTYGKQPWYQLSNNE-VIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHHhCCCCCCCCCCHHH-HHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 99998 899997765433 223333334445566788999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-27 Score=181.28 Aligned_cols=126 Identities=22% Similarity=0.345 Sum_probs=102.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|||++.+ +.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|+|||||++|+|
T Consensus 140 vH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 208 (329)
T PTZ00263 140 IYRDLKPENLLLDNK-GHVKVTDFGFAKKVPDR--TFTLCGTPEYLAPEVIQS--------KGHGKAVDWWTMGVLLYEF 208 (329)
T ss_pred eecCCCHHHEEECCC-CCEEEeeccCceEcCCC--cceecCChhhcCHHHHcC--------CCCCCcceeechHHHHHHH
Confidence 699999999999976 68999999999754332 224578999999999853 5578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 139 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps-----~~~~l~ 139 (198)
++|..||.+....... .. .......+|..++..+.+|+.+||..||.+|++ +.+++.
T Consensus 209 ltg~~pf~~~~~~~~~-~~-i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 209 IAGYPPFFDDTPFRIY-EK-ILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred HcCCCCCCCCCHHHHH-HH-HhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 9999999876543322 22 233455677789999999999999999999986 688887
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=171.13 Aligned_cols=132 Identities=28% Similarity=0.522 Sum_probs=103.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+||+++.+ +.+||+|||+++...... ......++..|+|||++.+ ..++.++|+||||+++
T Consensus 144 ~h~dlkp~nili~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 214 (280)
T cd05049 144 VHRDLATRNCLVGYD-LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSFGVVL 214 (280)
T ss_pred eccccccceEEEcCC-CeEEECCcccceecccCcceecCCCCcccceecChhhhcc--------CCcchhhhHHHHHHHH
Confidence 699999999999977 789999999987432211 1123345778999998853 5678899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
|||++ |..||.+....... ...........+..++..+.+++.+||..||.+||++.|+++.|+
T Consensus 215 ~e~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 215 WEIFTYGKQPWYGLSNEEVI-ECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHhcCCCCCCCCCHHHHH-HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 99998 99999776543322 223333444556678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=174.62 Aligned_cols=130 Identities=25% Similarity=0.306 Sum_probs=98.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++............|+..|+|||++.+ ..++.++|+||+||++|+|
T Consensus 130 vH~dikp~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~l 200 (288)
T cd07863 130 VHRDLKPENILVTSG-GQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ--------STYATPVDMWSVGCIFAEM 200 (288)
T ss_pred ecCCCCHHHEEECCC-CCEEECccCccccccCcccCCCccccccccCchHhhC--------CCCCCcchhhhHHHHHHHH
Confidence 699999999999976 6799999999976543333344578999999998853 5678999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHcc-------CC-----------C-------CCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKH-------AR-----------P-------GLPEDISPDLAFIVQSCWVEDPNLRPSFS 135 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~-------~~-----------~-------~~p~~~~~~~~~l~~~~l~~dp~~Rps~~ 135 (198)
++|.+||.+.............. .+ . .....++..+.+++.+||+.||.+||++.
T Consensus 201 ~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 280 (288)
T cd07863 201 FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAF 280 (288)
T ss_pred HhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHH
Confidence 99999997765433221111000 00 0 01124677889999999999999999999
Q ss_pred HHHH
Q 029154 136 QIIR 139 (198)
Q Consensus 136 ~~l~ 139 (198)
+++.
T Consensus 281 ~~l~ 284 (288)
T cd07863 281 RALQ 284 (288)
T ss_pred HHhc
Confidence 9987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=179.83 Aligned_cols=128 Identities=26% Similarity=0.468 Sum_probs=101.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||+++... ........+||+.|+|||++.+ ..++.++|+|||||++||
T Consensus 123 vHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~e 193 (323)
T cd05616 123 IYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYE 193 (323)
T ss_pred EecCCCHHHeEECCC-CcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcC--------CCCCCccchhchhHHHHH
Confidence 699999999999976 689999999987432 2222335679999999999853 567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-----SQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~-----~~~l~ 139 (198)
|++|..||.+....... .. ........|..++.++.+++.+||..||.+|++. .++++
T Consensus 194 lltg~~Pf~~~~~~~~~-~~-i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 194 MLAGQAPFEGEDEDELF-QS-IMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred HHhCCCCCCCCCHHHHH-HH-HHhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 99999999876643332 22 2234456677899999999999999999999974 55654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=177.81 Aligned_cols=128 Identities=30% Similarity=0.513 Sum_probs=101.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|||++.+ ..++.++|+||+||++|+
T Consensus 118 vH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~e 188 (316)
T cd05592 118 IYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG--------QKYNESVDWWSFGVLLYE 188 (316)
T ss_pred EeCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCccccccCCccccCHHHHcC--------CCCCCcccchhHHHHHHH
Confidence 699999999999976 6799999999974322 222344679999999999853 567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS-QIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~-~~l~ 139 (198)
|++|..||.+....... . ......+..|..++.++.+++.+||..||.+||++. ++++
T Consensus 189 ll~G~~Pf~~~~~~~~~-~-~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 189 MLIGQSPFHGEDEDELF-D-SILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHhCCCCCCCCCHHHHH-H-HHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 99999999876643322 2 223445667788999999999999999999999865 5655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=193.38 Aligned_cols=141 Identities=23% Similarity=0.400 Sum_probs=106.5
Q ss_pred CCCCCCCCCeEEcCC----------------CCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCC
Q 029154 1 MGKFMKEDNLLLTPD----------------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64 (198)
Q Consensus 1 iH~dlKp~NIll~~~----------------~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 64 (198)
|||||||+||||+.+ ...+||+|||++............+||+.|+|||++.+ ....+
T Consensus 147 VHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~g------e~~~~ 220 (1021)
T PTZ00266 147 LHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLH------ETKSY 220 (1021)
T ss_pred eeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhc------cCCCC
Confidence 799999999999642 13489999999986544333445679999999998753 23457
Q ss_pred CchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 65 ~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
+.++|||||||++|+|++|..||................. .......+.++.+||.+||..+|.+||++.+++. +.+
T Consensus 221 s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~--h~~ 297 (1021)
T PTZ00266 221 DDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG--YQI 297 (1021)
T ss_pred CchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc--cHH
Confidence 8899999999999999999999987665544433332222 1112347899999999999999999999999997 556
Q ss_pred HhhcCC
Q 029154 145 LFTLRP 150 (198)
Q Consensus 145 ~~~~~~ 150 (198)
+....+
T Consensus 298 ik~i~~ 303 (1021)
T PTZ00266 298 IKNVGP 303 (1021)
T ss_pred HhhcCC
Confidence 554443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=183.99 Aligned_cols=141 Identities=30% Similarity=0.552 Sum_probs=109.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc---cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
||||||..||+|..+ ..|||+|||++..... ...+....|...|||||++.. .+...|+..+|||+||+++
T Consensus 510 IHrDLKSnNIFl~~~-~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRm-----qd~nPfS~qSDVYaFGiV~ 583 (678)
T KOG0193|consen 510 IHRDLKSNNIFLHED-LKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRM-----QDDNPFSFQSDVYAFGIVW 583 (678)
T ss_pred hhhhccccceEEccC-CcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhh-----cccCCCCcccchhhhhHHH
Confidence 799999999999966 7899999999863221 222344568899999999863 3567899999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCCCCC---CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHARPGL---PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|||++|..||......+..+........+.. -..++.++..|+..||..++++||.+.+|+..|+.++..
T Consensus 584 YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 584 YELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred HHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 9999999999954444333333322222222 244677999999999999999999999999988887664
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-26 Score=170.55 Aligned_cols=130 Identities=32% Similarity=0.553 Sum_probs=104.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc----ccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+|+||||+||+++.+ +.++|+|||+++....... .....|+..|+|||.+.+ ..++.++|+||+|++
T Consensus 126 ~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~i 196 (263)
T cd06625 126 VHRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG--------EGYGRKADVWSVGCT 196 (263)
T ss_pred ecCCCCHHHEEEcCC-CCEEEeecccceeccccccccccccCCCcCccccCcceecc--------CCCCchhhhHHHHHH
Confidence 699999999999966 6799999999864322111 123457889999999854 457889999999999
Q ss_pred HHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 77 LWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+|++++|+.||.....................+..++..+.+++.+||..+|.+||++.++++
T Consensus 197 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 197 VVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred HHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 999999999998766554444444444556677889999999999999999999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=179.42 Aligned_cols=128 Identities=27% Similarity=0.424 Sum_probs=102.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||++..... .......+|+..|+|||++.+ ..++.++|+||+||++|+
T Consensus 118 vHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~e 188 (321)
T cd05591 118 IYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE--------LEYGPSVDWWALGVLMYE 188 (321)
T ss_pred eccCCCHHHeEECCC-CCEEEeecccceecccCCccccccccCccccCHHHHcC--------CCCCCccceechhHHHHH
Confidence 699999999999976 6899999999874322 222334578999999998753 567889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-------CHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-------SFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-------s~~~~l~ 139 (198)
|++|..||.+....... .. ........|..++.++.+++.+||..||.+|+ ++.++++
T Consensus 189 l~tg~~Pf~~~~~~~~~-~~-i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 189 MMAGQPPFEADNEDDLF-ES-ILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HhcCCCCCCCCCHHHHH-HH-HHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 99999999876643332 22 22334456677899999999999999999999 7888887
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.2e-26 Score=179.56 Aligned_cols=136 Identities=29% Similarity=0.553 Sum_probs=107.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||+++....... .....++..|+|||.+.+ ..++.++||||||+++
T Consensus 259 vH~dikp~Nill~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwSlGvil 329 (400)
T cd05105 259 VHRDLAARNVLLAQG-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD--------NLYTTLSDVWSYGILL 329 (400)
T ss_pred eCCCCChHhEEEeCC-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC--------CCCCchhhHHHHHHHH
Confidence 699999999999976 6799999999875432211 122356778999998753 5678899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
||+++ |..||..................+..+..++.++.+++.+||..||++||++.++.++|..++
T Consensus 330 ~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 330 WEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 99996 889997655433333344444555667778999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=179.55 Aligned_cols=137 Identities=30% Similarity=0.437 Sum_probs=101.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc--ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+|||++.+ +.+||+|||+++..... .......++..|+|||++.+ ...++.++|+||+||++|
T Consensus 125 vH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ 196 (372)
T cd07853 125 LHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG-------SRHYTSAVDIWSVGCIFA 196 (372)
T ss_pred eCCCCChHHEEECCC-CCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcC-------CCCCCcHHHHHhHHHHHH
Confidence 699999999999976 68999999999754322 12234567899999998753 245788999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHH-----------------------ccCCC-------CCCCCCcHHHHHHHHHhcccCC
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAF-----------------------KHARP-------GLPEDISPDLAFIVQSCWVEDP 128 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~-----------------------~~~~~-------~~p~~~~~~~~~l~~~~l~~dp 128 (198)
||++|+.||.+............ ....+ ......++++.+|+.+||..||
T Consensus 197 el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP 276 (372)
T cd07853 197 ELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDP 276 (372)
T ss_pred HHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCCh
Confidence 99999999987654332211100 00000 1223467899999999999999
Q ss_pred CCCCCHHHHHHHHHHHHhh
Q 029154 129 NLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 129 ~~Rps~~~~l~~l~~~~~~ 147 (198)
.+|||+.++++ +.|+..
T Consensus 277 ~~R~t~~e~l~--hp~~~~ 293 (372)
T cd07853 277 DKRISAADALA--HPYLDE 293 (372)
T ss_pred hhCcCHHHHhc--CHhhCC
Confidence 99999999998 666554
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=170.47 Aligned_cols=134 Identities=26% Similarity=0.535 Sum_probs=103.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++....... .....++..|++||.+.+ ..++.++|+|||||++
T Consensus 131 iH~dlkp~Nil~~~~-~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l 201 (279)
T cd05109 131 VHRDLAARNVLVKSP-NHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH--------RRFTHQSDVWSYGVTV 201 (279)
T ss_pred eccccccceEEEcCC-CcEEECCCCceeecccccceeecCCCccchhhCCHHHhcc--------CCCCchhHHHHHHHHH
Confidence 699999999999866 6799999999975432221 111234678999998753 5678899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
||+++ |..||....... ..........+..+..++.++.+++.+||..||.+||++.++++.|+..
T Consensus 202 ~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 202 WELMTFGAKPYDGIPARE-IPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred HHHHcCCCCCCCCCCHHH-HHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 99998 889987655322 2223333444555667889999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=178.42 Aligned_cols=128 Identities=25% Similarity=0.466 Sum_probs=101.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||+++... ........+||..|+|||++.+ ..++.++|+||+||++|+
T Consensus 123 vH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~e 193 (324)
T cd05587 123 IYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYE 193 (324)
T ss_pred EecCCCHHHeEEcCC-CCEEEeecCcceecCCCCCceeeecCCccccChhhhcC--------CCCCcccchhhhHHHHHH
Confidence 699999999999976 679999999986432 1222334578999999999853 567889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-----SQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~-----~~~l~ 139 (198)
|++|+.||.+....... . .........|..++.++.+++.+||..||.+|++. .++++
T Consensus 194 lltG~~pf~~~~~~~~~-~-~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 194 MLAGQPPFDGEDEDELF-Q-SIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred HHhCCCCCCCCCHHHHH-H-HHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 99999999876643322 2 22344556677899999999999999999999976 56655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=169.02 Aligned_cols=131 Identities=30% Similarity=0.587 Sum_probs=102.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+ +.+||+|||+++...... ....++..|++||++.. ..++.++|+|||||++|++
T Consensus 124 ~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~i~~~l 192 (256)
T cd05082 124 VHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEI 192 (256)
T ss_pred eccccchheEEEcCC-CcEEecCCccceeccccC--CCCccceeecCHHHHcc--------CCCCchhhhHHHHHHHHHH
Confidence 699999999999976 679999999987433221 23345678999998743 5678899999999999999
Q ss_pred Hc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 81 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 81 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
++ |..||..... ............+..+..+++.+.+++.+||..+|.+||++.++++.|+.
T Consensus 193 ~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 193 YSFGRVPYPRIPL-KDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HhCCCCCCCCCCH-HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 97 9999876543 22222333344555667789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=178.98 Aligned_cols=129 Identities=23% Similarity=0.353 Sum_probs=100.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++.... .....+||+.|+|||++.+ ..++.++||||+||++|||
T Consensus 123 vH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el 191 (333)
T cd05600 123 IHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRG--------KGYDFTVDYWSLGCMLYEF 191 (333)
T ss_pred cccCCCHHHEEECCC-CCEEEEeCcCCccccc--ccCCcccCccccChhHhcC--------CCCCCccceecchHHHhhh
Confidence 799999999999976 6899999999975433 2345679999999999853 4678999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCC------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 140 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p------~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~ 140 (198)
++|..||.+...................| ..+++++.+++.+||..+|.+||++.+++++
T Consensus 192 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 192 LCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred hhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 99999998765433222211111111111 1468999999999999999999999999983
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=169.97 Aligned_cols=132 Identities=30% Similarity=0.572 Sum_probs=103.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+|+||||+||+++.+ +.+||+|||+++....... .....++..|+|||.+.+ ..++.++|+||||+++
T Consensus 141 vH~dlkp~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l 211 (277)
T cd05062 141 VHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVL 211 (277)
T ss_pred ccCCcchheEEEcCC-CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc--------CCcCchhHHHHHHHHH
Confidence 699999999999976 6799999999874432211 112345778999998753 5678999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
||+++ |..||.+..... .............+..++..+.+++.+||..||.+||++.++++.|+
T Consensus 212 ~el~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 212 WEIATLAEQPYQGMSNEQ-VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHcCCCCCCCCCCHHH-HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 99998 688987765432 22333344445567778899999999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=178.90 Aligned_cols=137 Identities=28% Similarity=0.416 Sum_probs=112.3
Q ss_pred CCCCCCCCCeEEcCCC---CceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQ---KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~---~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|+|+.... ..+|++|||++............+||+.|+|||++.. ..|+..+|+||.|+++
T Consensus 157 vHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~--------~~y~~~~DiWS~Gvi~ 228 (382)
T KOG0032|consen 157 VHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG--------RPYGDEVDVWSIGVIL 228 (382)
T ss_pred eeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcC--------CCCCcccchhHHHHHH
Confidence 6999999999997542 3699999999987666556778899999999999853 6789999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCC--CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|.|++|.+||.+................ .+..+.++..+.+++.+++..||..|+++.++++ |.|+..
T Consensus 229 yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~--HpWi~~ 298 (382)
T KOG0032|consen 229 YILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ--HPWIKS 298 (382)
T ss_pred HHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc--CccccC
Confidence 9999999999988765554433333222 2334568999999999999999999999999999 677554
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=173.46 Aligned_cols=139 Identities=31% Similarity=0.540 Sum_probs=105.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|||++.+ +.+||+|||++.............++..|++||.+.+ ..++.++|+||||+++|++
T Consensus 146 ~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el 216 (303)
T cd05088 146 IHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEI 216 (303)
T ss_pred cccccchheEEecCC-CcEEeCccccCcccchhhhcccCCCcccccCHHHHhc--------cCCcccccchhhhhHHHHH
Confidence 699999999999976 6799999999864321111111234567999998743 4578899999999999999
Q ss_pred Hc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 81 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 81 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
++ |..||.+..... .............+..+++++.+++.+||..+|.+||++.++++.|+.++....
T Consensus 217 lt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 217 VSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HhcCCCCcccCChHH-HHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 98 999997655432 222222333444566688999999999999999999999999999988766543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=179.19 Aligned_cols=130 Identities=24% Similarity=0.461 Sum_probs=101.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||+++... ........+||..|+|||++.+ ..++.++|+||+||++|+
T Consensus 118 vH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~~l~e 188 (329)
T cd05588 118 IYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFE 188 (329)
T ss_pred EecCCCHHHeEECCC-CCEEECcCccccccccCCCccccccCCccccCHHHHcC--------CCCCCccceechHHHHHH
Confidence 699999999999976 679999999987422 2222345679999999999853 567889999999999999
Q ss_pred HHcCCCCCCCCC-------cHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 029154 80 LLTNRLPFEGMS-------NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS------FSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps------~~~~l~ 139 (198)
+++|..||.... ................+|..++.++.+++.+||..||.+|++ +.++++
T Consensus 189 l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 189 MMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 999999996311 111112223334555678889999999999999999999987 677776
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=178.63 Aligned_cols=130 Identities=21% Similarity=0.356 Sum_probs=106.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|-|||||+|||||.. ++++|+|+|+|............+||.+|||||++.. ..|+...|+||+||++|||
T Consensus 309 VYRDLKPeNILLDd~-GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~n--------e~Y~~s~Dwf~lGCllYem 379 (591)
T KOG0986|consen 309 VYRDLKPENILLDDH-GHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQN--------EVYDFSPDWFSLGCLLYEM 379 (591)
T ss_pred eeccCChhheeeccC-CCeEeeccceEEecCCCCccccccCcccccCHHHHcC--------CcccCCccHHHHHhHHHHH
Confidence 469999999999966 8999999999987777777777799999999999863 5699999999999999999
Q ss_pred HcCCCCCCCCCcHHH--HHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 029154 81 LTNRLPFEGMSNLQA--AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 139 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps-----~~~~l~ 139 (198)
+.|+.||........ .............++.+++++.++...+|..||.+|.. ++++.+
T Consensus 380 i~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 380 IAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred HcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 999999975443222 12233334455677889999999999999999999964 556665
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=177.20 Aligned_cols=128 Identities=27% Similarity=0.456 Sum_probs=102.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||+++.... .......+|+..|+|||++.+ ..++.++|+||+||++|+
T Consensus 118 vH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslGvil~~ 188 (318)
T cd05570 118 IYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY--------QPYGPAVDWWALGVLLYE 188 (318)
T ss_pred EccCCCHHHeEECCC-CcEEecccCCCeecCcCCCcccceecCccccCHHHhcC--------CCCCcchhhhhHHHHHHH
Confidence 699999999999976 6799999999874322 222234578999999999853 567889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-----SQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~-----~~~l~ 139 (198)
+++|..||.+....... . .........|..++.++.+++.+||..||.+||++ .++++
T Consensus 189 l~~G~~pf~~~~~~~~~-~-~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 189 MLAGQSPFEGDDEDELF-Q-SILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HhhCCCCCCCCCHHHHH-H-HHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 99999999876543322 2 22334455677889999999999999999999999 88876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=172.03 Aligned_cols=135 Identities=32% Similarity=0.639 Sum_probs=106.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+||+++.+ +.+||+|||+++....... .....++..|++||.+.+ ..++.++|+|||||++
T Consensus 154 vH~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 224 (293)
T cd05053 154 IHRDLAARNVLVTED-HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLL 224 (293)
T ss_pred cccccceeeEEEcCC-CeEEeCccccccccccccceeccCCCCCCccccCHHHhcc--------CCcCcccceeehhhHH
Confidence 699999999999976 6899999999975432211 112234567999998743 5678899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
||+++ |..||.+.... ...........+..+...+.++.+++.+||..||.+|||+.++++.|+.++
T Consensus 225 ~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 225 WEIFTLGGSPYPGIPVE-ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHhcCCCCCCCCCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 99997 88999765533 333334444555667778899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.5e-26 Score=173.96 Aligned_cols=140 Identities=21% Similarity=0.326 Sum_probs=103.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||+++..... .......++..|+|||++.+ ...++.++|+||+|+++|+
T Consensus 126 vH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~e 197 (309)
T cd07872 126 LHRDLKPQNLLINER-GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG-------SSEYSTQIDMWGVGCIFFE 197 (309)
T ss_pred ecCCCCHHHEEECCC-CCEEECccccceecCCCccccccccccccccCCHHHhC-------CCCCCcHHHHHHHHHHHHH
Confidence 699999999999976 67999999998753322 22234567899999998753 2457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHcc---------------------CCC-------CCCCCCcHHHHHHHHHhcccCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKH---------------------ARP-------GLPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~---------------------~~~-------~~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
|++|+.||.+.............. .+. .....+++++.+++.+||..||.+|
T Consensus 198 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 277 (309)
T cd07872 198 MASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKR 277 (309)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhC
Confidence 999999998755432211111000 000 0112467889999999999999999
Q ss_pred CCHHHHHHHHHHHHhhcCC
Q 029154 132 PSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~~~ 150 (198)
||+.++++ +.|+.....
T Consensus 278 ~t~~e~l~--h~~~~~~~~ 294 (309)
T cd07872 278 ISAEEAMK--HAYFRSLGT 294 (309)
T ss_pred CCHHHHhc--Chhhhhccc
Confidence 99999999 777765543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=179.29 Aligned_cols=130 Identities=25% Similarity=0.469 Sum_probs=100.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++.... .......+||..|+|||++.+ ..++.++|+|||||++|+
T Consensus 118 vH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 188 (329)
T cd05618 118 IYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFE 188 (329)
T ss_pred eeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCccccccCCccccCHHHHcC--------CCCCCccceecccHHHHH
Confidence 699999999999977 6799999999874322 222334678999999999853 567889999999999999
Q ss_pred HHcCCCCCCCCC-------cHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 029154 80 LLTNRLPFEGMS-------NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS------FSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps------~~~~l~ 139 (198)
|++|..||.... ................+|..++..+.+++.+||..||.+|++ +.++++
T Consensus 189 l~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 189 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred HhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 999999995211 111112223334555678889999999999999999999998 467776
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=168.60 Aligned_cols=133 Identities=32% Similarity=0.548 Sum_probs=103.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+||+++.+ +.+||+|||++........ .....++..|++||.+.. ..++.++|+||||+++|
T Consensus 125 ~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ 195 (261)
T cd05072 125 IHRDLRAANVLVSES-LMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLY 195 (261)
T ss_pred eccccchhhEEecCC-CcEEECCCccceecCCCceeccCCCccceecCCHHHhcc--------CCCChhhhhhhhHHHHH
Confidence 699999999999976 6799999999975433221 122345678999998753 45788999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
++++ |..||.+...... ..........+.+..++.++.+++.+||..+|++||+++++++.|++
T Consensus 196 ~l~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 196 EIVTYGKIPYPGMSNSDV-MSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHccCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 9998 9999977554332 23333344445556688999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=172.69 Aligned_cols=133 Identities=28% Similarity=0.493 Sum_probs=98.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||+++...... ......++..|+|||++.. ..++.++|+||||+++
T Consensus 160 vH~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l 230 (304)
T cd05096 160 VHRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--------GKFTTASDVWAFGVTL 230 (304)
T ss_pred cccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--------CCCCchhhhHHHHHHH
Confidence 699999999999976 679999999997432211 1123345788999998753 5678999999999999
Q ss_pred HHHHc--CCCCCCCCCcHHHHHHH--HHc----cCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 78 WELLT--NRLPFEGMSNLQAAYAA--AFK----HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 78 ~e~~~--g~~p~~~~~~~~~~~~~--~~~----~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
||+++ +..||.+.......... ... ......+..++..+.+++.+||..||.+||++.++.+.|+
T Consensus 231 ~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 231 WEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 99986 56788765433221111 001 1112335567899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=179.58 Aligned_cols=126 Identities=21% Similarity=0.310 Sum_probs=101.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|+||+||++|||
T Consensus 153 vHrDLkp~NILl~~~-~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~el 221 (340)
T PTZ00426 153 VYRDLKPENLLLDKD-GFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLN--------VGHGKAADWWTLGIFIYEI 221 (340)
T ss_pred EccCCCHHHEEECCC-CCEEEecCCCCeecCCC--cceecCChhhcCHHHHhC--------CCCCccccccchhhHHHHH
Confidence 699999999999966 68999999999754322 234579999999999853 5578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 139 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~ 139 (198)
++|..||.+....... .. ........|..+++.+.+++.+||..||.+|+ +++++++
T Consensus 222 l~G~~Pf~~~~~~~~~-~~-i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 222 LVGCPPFYANEPLLIY-QK-ILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred hcCCCCCCCCCHHHHH-HH-HhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 9999999876643322 22 22334456778899999999999999999995 8999888
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=170.62 Aligned_cols=137 Identities=29% Similarity=0.617 Sum_probs=107.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||+++....... .....++..|+|||++.+ ..++.++|+||||+++
T Consensus 159 vH~dlkp~Nili~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l 229 (304)
T cd05101 159 IHRDLAARNVLVTEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLM 229 (304)
T ss_pred eecccccceEEEcCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhcc--------CCCCchhhHHHHHHHH
Confidence 699999999999966 6799999999975432111 122345678999998753 5678899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|++++ |..||.+... ...............+..++..+.+++.+||..+|.+||++.++++.|+.++..
T Consensus 230 ~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 230 WEIFTLGGSPYPGIPV-EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHcCCCCCcccCCH-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 99998 7888876543 333333444444556677899999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=176.57 Aligned_cols=128 Identities=29% Similarity=0.540 Sum_probs=100.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++.... ........||..|+|||++.+ ..++.++|+||+||++|+
T Consensus 118 vHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~e 188 (316)
T cd05619 118 VYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG--------QKYNTSVDWWSFGVLLYE 188 (316)
T ss_pred EeCCCCHHHEEECCC-CCEEEccCCcceECCCCCCceeeecCCccccCHHHHcC--------CCCCchhhhhhHHHHHHH
Confidence 699999999999976 6799999999874321 122334578999999999853 567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS-QIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~-~~l~ 139 (198)
|++|..||.+...... ... .....+..|..++.++.+++.+||..||.+|+++. ++++
T Consensus 189 l~~G~~pf~~~~~~~~-~~~-i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 189 MLIGQSPFHGHDEEEL-FQS-IRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHhCCCCCCCCCHHHH-HHH-HHhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 9999999987654332 222 22334556777899999999999999999999996 6655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=170.19 Aligned_cols=132 Identities=31% Similarity=0.615 Sum_probs=104.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+||+++.+ +.+||+|||+++...... ......++..|+|||.+.. ..++.++|+||||+++
T Consensus 141 ~H~di~p~nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 211 (277)
T cd05032 141 VHRDLAARNCMVAED-LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--------GVFTTKSDVWSFGVVL 211 (277)
T ss_pred cccccChheEEEcCC-CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc--------CCCCcccchHHHHHHH
Confidence 699999999999977 679999999987543222 1223456788999998743 5578899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
||+++ |..||.+...... ............|..++.++.+++.+||..+|.+|||+.++++.|+
T Consensus 212 ~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 212 WEMATLAEQPYQGLSNEEV-LKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHhhccCCCCCccCCHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 99998 8899977554333 2333344455677788999999999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=170.22 Aligned_cols=132 Identities=27% Similarity=0.528 Sum_probs=102.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||++........ .....+++.|++||.+.+ ..++.++|+|||||++
T Consensus 144 ~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 214 (280)
T cd05092 144 VHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--------RKFTTESDIWSFGVVL 214 (280)
T ss_pred ecccccHhhEEEcCC-CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc--------CCcCchhhHHHHHHHH
Confidence 699999999999966 6799999999874332211 122345678999998753 5678999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
||+++ |..||........ ............+..+++.+.+++.+||..||.+||++.++++.|+
T Consensus 215 ~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 215 WEIFTYGKQPWYQLSNTEA-IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHcCCCCCCccCCHHHH-HHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 99998 8999976554332 2333344445566778999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-26 Score=173.57 Aligned_cols=139 Identities=25% Similarity=0.518 Sum_probs=103.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+ +.+||+|||+++............|+..|++||.+.+. ....++.++|+||+|+++|++
T Consensus 130 ~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el 203 (288)
T cd06616 130 IHRDVKPSNILLDRN-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS-----ARDGYDVRSDVWSLGITLYEV 203 (288)
T ss_pred eccCCCHHHEEEccC-CcEEEeecchhHHhccCCccccccCccCccCHHHhccc-----cccCCcchhhhhHHHHHHHHH
Confidence 699999999999976 67999999998754333323344688899999998531 013578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCC----CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~----p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
++|..||..................+.+ +..++.++.+|+.+||..||++||++.+++. +.|+..
T Consensus 204 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~--~~~~~~ 272 (288)
T cd06616 204 ATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE--HPFIKD 272 (288)
T ss_pred HhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc--Chhhhc
Confidence 9999999765432222222222222222 2347889999999999999999999999998 666543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=170.10 Aligned_cols=136 Identities=26% Similarity=0.566 Sum_probs=106.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++....... .....++..|++||.+.+ ..++.++|+||||+++
T Consensus 149 vH~dikp~nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~~l 219 (290)
T cd05045 149 VHRDLAARNVLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD--------HIYTTQSDVWSFGVLL 219 (290)
T ss_pred ehhhhhhheEEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHcc--------CCcchHhHHHHHHHHH
Confidence 699999999999966 6799999999874322111 112345678999998743 5578899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|++++ |..||.+.... ..............+..++.++.+++.+||+.+|.+||++.++++.|+..+.
T Consensus 220 ~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 220 WEIVTLGGNPYPGIAPE-RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHhcCCCCCCCCCHH-HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 99998 99999775533 2233333344555677789999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=173.70 Aligned_cols=137 Identities=28% Similarity=0.564 Sum_probs=106.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||++........ .....++..|++||.+.+ ..++.++|+||||+++
T Consensus 201 ~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l 271 (343)
T cd05103 201 IHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLL 271 (343)
T ss_pred ecCCCccCeEEEcCC-CcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC--------CCCCchhhHHHHHHHH
Confidence 699999999999966 6799999999875422111 112335667999998743 5678899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|++++ |..||.+...................|...++++.+++.+||..||.+||++.+++++|+.++.
T Consensus 272 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 272 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99996 8999976554333333333444555667788999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=171.17 Aligned_cols=135 Identities=32% Similarity=0.568 Sum_probs=104.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+|+||||+|||++.+ ..+||+|||+++....... .....++..|++||.+.. ..++.++|+||+|+++
T Consensus 163 vH~dlkp~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslGvil 233 (302)
T cd05055 163 IHRDLAARNVLLTHG-KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGILL 233 (302)
T ss_pred ehhhhccceEEEcCC-CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhcc--------CCCCcHhHHHHHHHHH
Confidence 699999999999866 6799999999875432211 122345678999998753 5578899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
|++++ |..||.....................+...++++.+++.+||..+|++||++.++++.|...
T Consensus 234 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 234 WEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 99998 99999876543333333333344455667889999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=176.25 Aligned_cols=136 Identities=32% Similarity=0.576 Sum_probs=107.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||+++...... ......++..|++||.+.. ..++.++|+||||+++
T Consensus 261 vHrdlkp~NiLl~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslGvil 331 (401)
T cd05107 261 VHRDLAARNVLICEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN--------NLYTTLSDVWSFGILL 331 (401)
T ss_pred CcccCCcceEEEeCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC--------CCCCcHhHHHHHHHHH
Confidence 699999999999965 679999999997432211 1123456788999998753 5578899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
||+++ |..||.................++..|..++.++.+++.+||..+|.+||+++++++.|+..+
T Consensus 332 ~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 332 WEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 99998 888987655444333434445556667788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=170.25 Aligned_cols=138 Identities=30% Similarity=0.617 Sum_probs=107.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccc---cCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+||+++.+ +.+||+|||+++........ ....++..|+|||.+.+ ..++.++|+||+|+++
T Consensus 162 ~H~dlkp~Nill~~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l 232 (307)
T cd05098 162 IHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLL 232 (307)
T ss_pred ccccccHHheEEcCC-CcEEECCCcccccccccchhhccccCCCccceeChHHhcc--------CCCCcHHHHHHHHHHH
Confidence 699999999999977 67999999998754321111 11234568999998753 5578899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
|+|++ |..||.+... ...............+..++.++.+++.+||..+|.+||++.++++.|+.++...
T Consensus 233 ~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 233 WEIFTLGGSPYPGVPV-EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHcCCCCCCCcCCH-HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 99998 8888876443 3333333344455667778999999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=167.12 Aligned_cols=134 Identities=22% Similarity=0.540 Sum_probs=104.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc----ccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+||||||+|||++.+ +.+||+|||++........ .....++..|++||.+.. ..++.++|+||||++
T Consensus 117 ~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~ 187 (257)
T cd05115 117 VHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGIT 187 (257)
T ss_pred eecccchheEEEcCC-CcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHcc--------CCCCchhhHHHHHHH
Confidence 699999999999966 6799999999874322211 111223568999998743 457889999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
+|++++ |..||.+...... .........+..+...++++.+++.+||..+|.+||++.++.+.|+.+
T Consensus 188 l~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 188 MWEAFSYGQKPYKKMKGPEV-MSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHhcCCCCCcCcCCHHHH-HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 999996 9999987664332 333344455667778899999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=177.97 Aligned_cols=125 Identities=23% Similarity=0.374 Sum_probs=98.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|||++.+ ..++.++||||+||++|+
T Consensus 118 iHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 188 (325)
T cd05602 118 VYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK--------QPYDRTVDWWCLGAVLYE 188 (325)
T ss_pred EecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCcccccCCccccCHHHHcC--------CCCCCccccccccHHHHH
Confidence 699999999999976 6799999999874322 222344679999999999853 567889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 136 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~ 136 (198)
|++|..||.+....... ... .......+..++..+.+++.+||+.||.+|+++.+
T Consensus 189 l~~g~~pf~~~~~~~~~-~~i-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 189 MLYGLPPFYSRNTAEMY-DNI-LNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HhcCCCCCCCCCHHHHH-HHH-HhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 99999999876543322 222 22344556678999999999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=170.96 Aligned_cols=136 Identities=24% Similarity=0.404 Sum_probs=102.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+||+++.+ +.+||+|||++...... .......|+..|+|||++.+ ..++.++|+||+|+++|+
T Consensus 119 ~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslG~il~e 189 (280)
T cd05608 119 IYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG--------EEYDFSVDYFALGVTLYE 189 (280)
T ss_pred ccCCCCHHHEEECCC-CCEEEeeCccceecCCCCccccccCCCcCccCHHHhcC--------CCCCccccHHHHHHHHHH
Confidence 699999999999966 67999999998743322 22234578999999999853 567889999999999999
Q ss_pred HHcCCCCCCCCCcHHH--HHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHHhh
Q 029154 80 LLTNRLPFEGMSNLQA--AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLFT 147 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~~l~~~~~~ 147 (198)
+++|+.||........ .............+..+++++.+++.+||..||.+|| +++++++ +.|+..
T Consensus 190 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~--h~~~~~ 262 (280)
T cd05608 190 MIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT--HPLFRD 262 (280)
T ss_pred HHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc--Chhhhc
Confidence 9999999976432211 1111122233455677899999999999999999999 6788887 555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=169.06 Aligned_cols=138 Identities=22% Similarity=0.401 Sum_probs=109.0
Q ss_pred CCCCCCCCeEEcCC--CCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 2 GKFMKEDNLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 2 H~dlKp~NIll~~~--~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
||||||+|+|.... +-.+||+|||+++....+....+.|.|++|.|||++- ...|+...|+||+|+++|-
T Consensus 184 HRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg--------~eKydkscdmwSlgVimYI 255 (400)
T KOG0604|consen 184 HRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLG--------PEKYDKSCDMWSLGVIMYI 255 (400)
T ss_pred hccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhC--------chhcCCCCCccchhHHHHH
Confidence 99999999999643 2358999999999766666677889999999999984 3568999999999999999
Q ss_pred HHcCCCCCCCCCcHHH--HHHHHHccCCCCCC----CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 80 LLTNRLPFEGMSNLQA--AYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~--~~~~~~~~~~~~~p----~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
+++|.+||+....... -....+......+| ..++++..++|+++|..+|.+|.|+.+++. +.|+.+..
T Consensus 256 lLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~--hpwi~~~~ 329 (400)
T KOG0604|consen 256 LLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD--HPWINQYE 329 (400)
T ss_pred hhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc--Cchhcccc
Confidence 9999999986654221 12222222333333 347899999999999999999999999999 88876544
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=177.14 Aligned_cols=130 Identities=25% Similarity=0.444 Sum_probs=100.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||+++... ........+||+.|+|||++.+ ..++.++|+||+||++|+
T Consensus 118 vHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~e 188 (327)
T cd05617 118 IYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG--------EEYGFSVDWWALGVLMFE 188 (327)
T ss_pred eccCCCHHHEEEeCC-CCEEEeccccceeccCCCCceecccCCcccCCHHHHCC--------CCCCchheeehhHHHHHH
Confidence 699999999999976 679999999987432 2222345679999999999853 567889999999999999
Q ss_pred HHcCCCCCCCCC-----cHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 029154 80 LLTNRLPFEGMS-----NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF------SQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~------~~~l~ 139 (198)
|++|..||.... .............+...|..++..+.+++.+||..||.+|+++ .++++
T Consensus 189 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 189 MMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred HHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 999999995321 1112222233344556788899999999999999999999984 56766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=161.44 Aligned_cols=179 Identities=23% Similarity=0.286 Sum_probs=127.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-----ccccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
+|||+|++|+||+.+ +.+||+|||+++..... ..++..+-|..|.+||.+.+ ...|+++.|+|.-||
T Consensus 146 lHRDmKaaNvLIt~d-gilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG-------~r~yg~~iDiWgAgC 217 (376)
T KOG0669|consen 146 LHRDMKAANVLITKD-GILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG-------DREYGPPIDIWGAGC 217 (376)
T ss_pred HhhcccHhhEEEcCC-ceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhc-------ccccCCcchhHhHHH
Confidence 699999999999987 78999999999743221 22445567999999999986 678999999999999
Q ss_pred HHHHHHcCCCCCCCCCcHHHHHHH--HHccCCCC------------------CC-------------CCCcHHHHHHHHH
Q 029154 76 VLWELLTNRLPFEGMSNLQAAYAA--AFKHARPG------------------LP-------------EDISPDLAFIVQS 122 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~~~~~~~--~~~~~~~~------------------~p-------------~~~~~~~~~l~~~ 122 (198)
++.||+++.+.+++..+.+....+ +.....++ +| ..-+++..+|+.+
T Consensus 218 imaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ 297 (376)
T KOG0669|consen 218 IMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEK 297 (376)
T ss_pred HHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHH
Confidence 999999999999988776654222 22222211 11 1125678899999
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHhhcCCCCCCCCCCcchhhhccCCCccchhhHhhhhhHHHHHHHHHHhhh
Q 029154 123 CWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSNGAMTEFSARARGKFAFLRQLFTAKRT 194 (198)
Q Consensus 123 ~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (198)
++.+||.+|+++++++. +++++....|. +.......+...++.++.+.++...+.-...-...++
T Consensus 298 ll~~DP~kR~~ad~aln--h~~F~kdp~pq-----anl~~ml~t~~~s~fey~~~~~~~~~~~~~q~~~q~~ 362 (376)
T KOG0669|consen 298 LLKLDPTKRIDADQALN--HDFFWKDPMPQ-----ANLQDMLSTHLQSMFEYLAQPRRSNQMRNYQQQLQTM 362 (376)
T ss_pred HhccCcccCcchHhhhc--hhhhhcCCcch-----hhHHHHHHHhHHHHHHHhcCcchhhhhhhHHHHhcCC
Confidence 99999999999999999 77777655442 2223334445556667666666555544444333333
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=166.21 Aligned_cols=133 Identities=30% Similarity=0.590 Sum_probs=103.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+|+||||+||+++.+ +.+||+|||+++...... ......++..|++||.+.. ..++.++|+||||++
T Consensus 119 ~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Di~slG~~ 189 (257)
T cd05040 119 IHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT--------RTFSHASDVWMFGVT 189 (257)
T ss_pred cccccCcccEEEecC-CEEEeccccccccccccccceecccCCCCCceecCHHHhcc--------cCcCchhhhHHHHHH
Confidence 699999999999977 689999999987543211 1112356788999998753 567889999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
+|+|++ |..||.....................+...+..+.+++.+||..+|++||++.++++.|.
T Consensus 190 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 190 LWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 999998 999997665543322222233344456678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=179.56 Aligned_cols=129 Identities=26% Similarity=0.425 Sum_probs=99.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc------------------------------cccCCCCccceecccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE------------------------------MMTAETGTYRWMAPEL 50 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~------------------------------~~~~~~gt~~y~aPE~ 50 (198)
|||||||+|||++.+ +.+||+|||++....... ......||+.|+|||+
T Consensus 123 iH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 201 (350)
T cd05573 123 IHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEV 201 (350)
T ss_pred eccCCCHHHeEECCC-CCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHH
Confidence 699999999999977 679999999987543222 1234578999999999
Q ss_pred cccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCC--CCcHHHHHHHHHhcccCC
Q 029154 51 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDP 128 (198)
Q Consensus 51 ~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~l~~~~l~~dp 128 (198)
+.+ ..++.++|||||||++|||++|..||.+...................|. .+++++.+++.+||. ||
T Consensus 202 ~~~--------~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp 272 (350)
T cd05573 202 LRG--------TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DP 272 (350)
T ss_pred HcC--------CCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-Ch
Confidence 854 5678999999999999999999999987664333222222112222333 369999999999997 99
Q ss_pred CCCCC-HHHHHH
Q 029154 129 NLRPS-FSQIIR 139 (198)
Q Consensus 129 ~~Rps-~~~~l~ 139 (198)
.+|++ ++++++
T Consensus 273 ~~R~~s~~~ll~ 284 (350)
T cd05573 273 EDRLGSFEEIKS 284 (350)
T ss_pred hhcCCCHHHHhc
Confidence 99999 999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=166.28 Aligned_cols=134 Identities=27% Similarity=0.495 Sum_probs=104.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc-cc---CCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM-MT---AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~-~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+|+||||+|||++.+ +.+||+|||+++....... .. ...++..|++||.+.+ ..++.++|+||||++
T Consensus 117 ~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~ 187 (257)
T cd05060 117 VHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY--------GKFSSKSDVWSYGVT 187 (257)
T ss_pred eccCcccceEEEcCC-CcEEeccccccceeecCCcccccccCccccccccCHHHhcC--------CCCCccchHHHHHHH
Confidence 699999999999976 6799999999875432221 11 1123467999998753 557889999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
+|++++ |..||....... .............+..++..+.+++.+||..+|.+||++.++++.|+..
T Consensus 188 l~~~~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 188 LWEAFSYGAKPYGEMKGAE-VIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHHcCCCCCcccCCHHH-HHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 999997 999997765433 2333334444566777899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=184.84 Aligned_cols=137 Identities=33% Similarity=0.646 Sum_probs=114.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccC--CCC--ccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTA--ETG--TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~--~~g--t~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||-..|||+..+ ..+||+|||+++.......+.. ..| ...|||||.+. ...|+.++||||||++
T Consensus 440 vHRDLAaRNVLi~~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~--------~~~ft~kSDVWSfGI~ 510 (609)
T KOG0200|consen 440 VHRDLAARNVLITKN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF--------DRVFTSKSDVWSFGIL 510 (609)
T ss_pred cchhhhhhhEEecCC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc--------cCcccccchhhHHHHH
Confidence 799999999999977 6899999999996554443321 222 34699999985 3789999999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+||+++ |..||.+.............+.+...|..+++++.++|+.||..+|.+||++.++.+.+...+.
T Consensus 511 L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 511 LWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 999997 8899998664455566677788889999999999999999999999999999999999988543
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-25 Score=165.64 Aligned_cols=135 Identities=30% Similarity=0.519 Sum_probs=104.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||||+||+++.+ +.+||+|||+++....... .....++..|++||.... ..++.++|+||+|+++|
T Consensus 124 ~H~dl~p~Nill~~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DvwslG~~l~ 194 (262)
T cd05071 124 VHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLT 194 (262)
T ss_pred cccccCcccEEEcCC-CcEEeccCCceeeccccccccccCCcccceecCHhHhcc--------CCCCchhhHHHHHHHHH
Confidence 699999999999976 6799999999875432221 112345678999998743 56789999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
++++ |..||.+...... ............+..++..+.+++.+||..||.+||+++++++.|++++
T Consensus 195 ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 195 ELTTKGRVPYPGMVNREV-LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHcCCCCCCCCCChHHH-HHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 9999 8888877654332 2222333334445668899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=173.35 Aligned_cols=136 Identities=25% Similarity=0.453 Sum_probs=100.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||++...... ......|+..|+|||++.+ ..++.++|+|||||++|++
T Consensus 126 vH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l 195 (333)
T cd06650 126 MHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEM 195 (333)
T ss_pred EecCCChhhEEEcCC-CCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcC--------CCCCcHHHHHHHHHHHHHH
Confidence 699999999999976 67999999998744321 2234578999999999853 5578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHH-------------------------------------------HHHHccCCCCCC-CCCcHHH
Q 029154 81 LTNRLPFEGMSNLQAAY-------------------------------------------AAAFKHARPGLP-EDISPDL 116 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~p-~~~~~~~ 116 (198)
++|+.||.......... ........+..+ ..++.++
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (333)
T cd06650 196 AIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEF 275 (333)
T ss_pred HHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHH
Confidence 99999986533211100 001111112222 1357889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 117 AFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 117 ~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
.+|+.+||..||++||++.++++ +.|+...
T Consensus 276 ~~li~~~L~~~P~~Rpt~~ell~--h~~~~~~ 305 (333)
T cd06650 276 QDFVNKCLIKNPAERADLKQLMV--HAFIKRS 305 (333)
T ss_pred HHHHHHhccCCcccCcCHHHHhh--CHHHhcC
Confidence 99999999999999999999998 7777543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=171.32 Aligned_cols=130 Identities=23% Similarity=0.336 Sum_probs=97.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+ +.++|+|||++.............|+..|+|||++.+ ..++.++|+||+||++|++
T Consensus 117 vH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslGv~l~el 187 (277)
T cd05607 117 VYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE--------EPYSYPVDWFAMGCSIYEM 187 (277)
T ss_pred EEccCChHhEEEcCC-CCEEEeeceeeeecCCCceeeccCCCCCccCHHHHcc--------CCCCCchhHHHHHHHHHHH
Confidence 699999999999976 6799999999875443333334578999999999853 4588999999999999999
Q ss_pred HcCCCCCCCCCcHHH---HHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 81 LTNRLPFEGMSNLQA---AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
++|..||........ ................+++++.+++.+||+.||.+||++.|+++
T Consensus 188 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 188 VAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 999999976433211 11111111111122457899999999999999999999966553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=176.50 Aligned_cols=124 Identities=25% Similarity=0.403 Sum_probs=98.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|||++.+ ..++.++|+|||||++|+
T Consensus 118 vH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~e 188 (323)
T cd05575 118 IYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK--------QPYDRTVDWWCLGAVLYE 188 (323)
T ss_pred EeCCCCHHHeEECCC-CcEEEeccCCCcccccCCCccccccCChhhcChhhhcC--------CCCCccccccccchhhhh
Confidence 699999999999976 6799999999874322 222334579999999999853 567889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 135 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~ 135 (198)
|++|..||.+...... .... .......+..++..+.+++.+||..||.+||++.
T Consensus 189 ll~g~~pf~~~~~~~~-~~~i-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 189 MLYGLPPFYSRDTAEM-YDNI-LNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred hhcCCCCCCCCCHHHH-HHHH-HcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 9999999987654322 2222 2334455667899999999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=166.96 Aligned_cols=134 Identities=28% Similarity=0.503 Sum_probs=104.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccccc--CCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+|++|||.+.......... ...++..|+|||.+.+ ..++.++|+|||||++|
T Consensus 129 iH~dikp~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ 199 (266)
T cd05064 129 VHKGLAAHKVLVNSD-LVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY--------HHFSSASDVWSFGIVMW 199 (266)
T ss_pred eeccccHhhEEEcCC-CcEEECCCcccccccccchhcccCCCCceeecCHHHHhh--------CCccchhHHHHHHHHHH
Confidence 699999999999976 679999999876432221111 2234678999998753 56789999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
|+++ |..||.+...... ..........+.|..++..+.+++.+||..+|.+||++.++++.|+..
T Consensus 200 ell~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 200 EVMSYGERPYWDMSGQDV-IKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHhcCCCCCcCcCCHHHH-HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 9775 9999987664332 223334445566778899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=172.95 Aligned_cols=130 Identities=22% Similarity=0.381 Sum_probs=102.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+||+++.+ +.++|+|||++............+|+..|++||++.+ ..++.++|+||+|+++|++
T Consensus 124 vH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Diws~G~~l~el 194 (285)
T cd05605 124 VYRDLKPENILLDDY-GHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN--------ERYTFSPDWWGLGCLIYEM 194 (285)
T ss_pred EecCCCHHHEEECCC-CCEEEeeCCCceecCCCCccccccCCCCccCcHHhcC--------CCCCccccchhHHHHHHHH
Confidence 699999999999966 6799999999876543333345578999999999853 5678899999999999999
Q ss_pred HcCCCCCCCCCcHHHH--HHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 139 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~ 139 (198)
++|..||.+....... ............+..+++.+.+++.+||..||.+|| +++++++
T Consensus 195 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 195 IEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred HHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 9999999875432211 112222334455667899999999999999999999 8888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-25 Score=169.49 Aligned_cols=138 Identities=30% Similarity=0.610 Sum_probs=107.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||+++....... .....++..|++||.+.. ..++.++|+||||+++
T Consensus 156 ~H~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l 226 (314)
T cd05099 156 IHRDLAARNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGILM 226 (314)
T ss_pred eeccccceeEEEcCC-CcEEEccccccccccccccccccccCCCCccccCHHHHcc--------CCcCccchhhHHHHHH
Confidence 699999999999976 6799999999975432211 111234467999998743 5678899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
|++++ |..||.+.... ..............+..++.++.+++.+||..+|.+||++.++++.|..+....
T Consensus 227 ~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 227 WEIFTLGGSPYPGIPVE-ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 99998 88899765532 333333344445567778899999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=165.62 Aligned_cols=131 Identities=34% Similarity=0.587 Sum_probs=105.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc---ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+|+||||+||+++.+ +.+||+|||.+...... .......++..|+|||.+.. ..++.++|+||+|+++
T Consensus 127 ~H~di~p~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 197 (262)
T cd00192 127 VHRDLAARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD--------GIFTSKSDVWSFGVLL 197 (262)
T ss_pred ccCccCcceEEECCC-CcEEEcccccccccccccccccccCCCcCccccCHHHhcc--------CCcchhhccHHHHHHH
Confidence 699999999999977 67999999999754432 11233457889999998753 4678899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
|++++ |..||...... ..............+..++.++.+++.+||..+|.+||++.+++++|
T Consensus 198 ~~l~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 198 WEIFTLGATPYPGLSNE-EVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred HHHHhcCCCCCCCCCHH-HHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 99998 68999876543 33333444555667788899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-25 Score=167.40 Aligned_cols=136 Identities=29% Similarity=0.531 Sum_probs=106.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+|+||||+||+++.+ +.+||+|||+++....... .....++..|+|||++.. ..++.++|+||||+++
T Consensus 139 ~H~di~p~nil~~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~~l 209 (280)
T cd05043 139 IHKDIAARNCVIDEE-LQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN--------KEYSSASDVWSFGVLL 209 (280)
T ss_pred eecccCHhhEEEcCC-CcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc--------CCCCchhhHHHhHHHH
Confidence 699999999999866 6899999999975432211 122345678999998753 5678999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
||+++ |..||....... ..........+..+..+++++.+++.+||..||++||++.++++.|+++..
T Consensus 210 ~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 210 WELMTLGQTPYVEIDPFE-MAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHHhcCCCCCcCcCCHHH-HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99998 999998765433 223333344445556678999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-25 Score=167.94 Aligned_cols=135 Identities=24% Similarity=0.449 Sum_probs=100.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc----ccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+||||||+|||++.+ +.+||+|||+++....... .....++..|++||.+.. ..++.++|+||||++
T Consensus 129 ~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~slG~~ 199 (283)
T cd05080 129 IHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE--------NKFSYASDVWSFGVT 199 (283)
T ss_pred eccccChheEEEcCC-CcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc--------cCCCcccccHHHHHH
Confidence 699999999999976 6799999999875432211 112345667999998743 557889999999999
Q ss_pred HHHHHcCCCCCCCCCcHH--------------HHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 77 LWELLTNRLPFEGMSNLQ--------------AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~~--------------~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
+|++++|..|+....... ............+.+..++..+.+++.+||..+|++||+++++++.|+
T Consensus 200 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~ 279 (283)
T cd05080 200 LYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279 (283)
T ss_pred HHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 999999998875432110 000011112223345668899999999999999999999999999988
Q ss_pred HH
Q 029154 143 AF 144 (198)
Q Consensus 143 ~~ 144 (198)
.+
T Consensus 280 ~~ 281 (283)
T cd05080 280 EM 281 (283)
T ss_pred Hh
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-25 Score=165.72 Aligned_cols=133 Identities=32% Similarity=0.520 Sum_probs=102.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccccc--CCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||||+||+++.+ +.+||+|||++.......... ....+..|++||.+.+ ..++.++|+||||+++|
T Consensus 125 ~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ 195 (261)
T cd05068 125 IHRDLAARNVLVGEN-NICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY--------NRFSIKSDVWSFGILLT 195 (261)
T ss_pred eeccCCcceEEEcCC-CCEEECCcceEEEccCCcccccCCCcCceeccCcccccc--------CCCCchhhHHHHHHHHH
Confidence 699999999999976 679999999987544221111 1122457999998753 56788999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
++++ |+.||.+...... ............+...+..+.+++.+||..+|.+||++.++++.|++
T Consensus 196 el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 196 EIVTYGRMPYPGMTNAEV-LQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHhcCCCCCCCCCHHHH-HHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 9998 9999987654332 23333334445566788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-25 Score=165.61 Aligned_cols=133 Identities=32% Similarity=0.538 Sum_probs=103.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.. ..++.++|+||||+++|
T Consensus 124 ~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ 194 (260)
T cd05070 124 IHRDLRSANILVGDG-LVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLT 194 (260)
T ss_pred ccCCCccceEEEeCC-ceEEeCCceeeeeccCcccccccCCCCCccccChHHHhc--------CCCcchhhhHHHHHHHH
Confidence 699999999999966 6799999999975433221 112235567999998743 56788999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
++++ |..||.+...... ..........+.+...+..+.+++.+||..+|++|||+.++.+.|+.
T Consensus 195 ~l~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 195 ELVTKGRVPYPGMNNREV-LEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHhcCCCCCCCCCHHHH-HHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 9998 8899987654332 23333344556677789999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-25 Score=167.39 Aligned_cols=133 Identities=28% Similarity=0.553 Sum_probs=102.0
Q ss_pred CCCCCCCCCeEEcCCC--CceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQ--KSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~--~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
+||||||+||+++.++ ..+||+|||+++....... ......+..|++||++.+ ..++.++|||||||
T Consensus 138 vH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~ 209 (277)
T cd05036 138 IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD--------GIFTSKTDVWSFGV 209 (277)
T ss_pred eecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhc--------CCcCchhHHHHHHH
Confidence 6999999999998542 3589999999975432211 112233567999999853 56889999999999
Q ss_pred HHHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 76 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 76 ~l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
++||+++ |..||.+...... ............|..++..+.+++.+||..+|++||++.+++++|+
T Consensus 210 il~el~~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 210 LLWEIFSLGYMPYPGRTNQEV-MEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHHcCCCCCCCCCCHHHH-HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 9999996 9999987654332 2333334445567778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=168.95 Aligned_cols=135 Identities=27% Similarity=0.413 Sum_probs=101.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++...... .......|+..|++||++.+... ....++.++|+||+||++||
T Consensus 133 vh~dl~~~nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~~~~~~Dv~slGv~l~e 208 (272)
T cd06637 133 IHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN---PDATYDFKSDLWSLGITAIE 208 (272)
T ss_pred ccCCCCHHHEEECCC-CCEEEccCCCceecccccccCCcccccccccCHhHhccccC---cCCCCCchhhHHHHHHHHHH
Confidence 699999999999976 67999999998754322 12234578899999998753110 12457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+++|..||.................+...+..++.++.+|+.+||..||.+||++.++++
T Consensus 209 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 209 MAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 999999997655444333322222222334457889999999999999999999999987
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=171.41 Aligned_cols=137 Identities=31% Similarity=0.480 Sum_probs=104.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++....... ......|+..|++||.+.+ ..++.++|+|||||++|+
T Consensus 138 ~H~dLkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~s~Gvil~~ 208 (296)
T cd06654 138 IHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIE 208 (296)
T ss_pred ccCCCCHHHEEEcCC-CCEEECccccchhccccccccCcccCCccccCHHHHcC--------CCCCccchHHHHHHHHHH
Confidence 699999999999876 679999999987433221 1233568899999998753 456789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHcc-CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKH-ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
+++|..||................ .....+..++..+.+++.+||..||.+||++.++++ +.|+...
T Consensus 209 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~--~~~~~~~ 276 (296)
T cd06654 209 MIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLKIA 276 (296)
T ss_pred HHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh--Chhhhcc
Confidence 999999998766533332222111 122345668889999999999999999999999998 6665543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=177.39 Aligned_cols=133 Identities=25% Similarity=0.384 Sum_probs=96.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc------------------------------------cccCCCCccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE------------------------------------MMTAETGTYR 44 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~------------------------------------~~~~~~gt~~ 44 (198)
|||||||+|||++.+ +.+||+|||+++...... .....+||+.
T Consensus 123 vHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~ 201 (363)
T cd05628 123 IHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPD 201 (363)
T ss_pred EecCCCHHHeEECCC-CCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCcc
Confidence 699999999999976 689999999986432100 0123579999
Q ss_pred eecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCC--CCcHHHHHHHHH
Q 029154 45 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQS 122 (198)
Q Consensus 45 y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~l~~~ 122 (198)
|+|||++.+ ..++.++|+|||||++|||++|..||.+..................+|. .+++++.+++.+
T Consensus 202 Y~aPE~~~~--------~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~ 273 (363)
T cd05628 202 YIAPEVFMQ--------TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILR 273 (363)
T ss_pred ccCHHHHcC--------CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHH
Confidence 999999853 5678999999999999999999999987664433222222122233343 368899999998
Q ss_pred hcccCCC---CCCCHHHHHHHHHHHH
Q 029154 123 CWVEDPN---LRPSFSQIIRMLNAFL 145 (198)
Q Consensus 123 ~l~~dp~---~Rps~~~~l~~l~~~~ 145 (198)
++. +|. .||+++++++ +.|+
T Consensus 274 l~~-~~~~r~~r~~~~ei~~--hp~f 296 (363)
T cd05628 274 FCC-EWEHRIGAPGVEEIKT--NPFF 296 (363)
T ss_pred HcC-ChhhcCCCCCHHHHhC--CCCC
Confidence 664 444 4589999998 5554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=172.13 Aligned_cols=135 Identities=21% Similarity=0.368 Sum_probs=109.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|||||-+|||||.+ +++||+|||++-...+.....++||++-|.+||++++ ..+-++.+|.||+|+++|.+
T Consensus 175 vHRDLKLENILLD~N-~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG-------~PY~GPEVDsWsLGvLLYtL 246 (668)
T KOG0611|consen 175 VHRDLKLENILLDQN-NNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNG-------TPYKGPEVDSWSLGVLLYTL 246 (668)
T ss_pred eecccchhheeecCC-CCeeeeccchhhhhccccHHHHhcCCcccCCccccCC-------CCCCCCccchhhHHHHHHHH
Confidence 699999999999977 6799999999998888888899999999999999975 22336789999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
+.|..||.|.+......++. .....-|+ .+.++..||++||..+|..|.|+.++.. |.|+...
T Consensus 247 VyGtMPFDG~Dhk~lvrQIs--~GaYrEP~-~PSdA~gLIRwmLmVNP~RRATieDiAs--HWWvNwg 309 (668)
T KOG0611|consen 247 VYGTMPFDGRDHKRLVRQIS--RGAYREPE-TPSDASGLIRWMLMVNPERRATIEDIAS--HWWVNWG 309 (668)
T ss_pred hhcccccCCchHHHHHHHhh--cccccCCC-CCchHHHHHHHHHhcCcccchhHHHHhh--hheeecc
Confidence 99999999877544333322 22222222 4557889999999999999999999998 7776543
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-25 Score=167.75 Aligned_cols=139 Identities=32% Similarity=0.512 Sum_probs=107.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++....... ......++..|++||.+.+ ..++.++|+||||+++|+
T Consensus 137 ~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGvil~~ 207 (296)
T cd06655 137 IHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIE 207 (296)
T ss_pred ccCCCCHHHEEECCC-CCEEEccCccchhcccccccCCCcCCCccccCcchhcC--------CCCCchhhHHHHHHHHHH
Confidence 699999999999976 679999999987433222 1223468889999998753 557889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHcc-CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKH-ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
+++|..||.+.............. .....+..+++.+.+++.+||..||.+||++.++++ +.|+....+
T Consensus 208 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~--~~~~~~~~~ 277 (296)
T cd06655 208 MVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKLAKP 277 (296)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh--ChHhhhccc
Confidence 999999998766544332222111 122345678899999999999999999999999998 888775543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=165.05 Aligned_cols=133 Identities=32% Similarity=0.540 Sum_probs=104.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||||+||+++.+ +.++|+|||++........ .....++..|++||...+ ..++.++|+||||+++|
T Consensus 124 ~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~~l~ 194 (260)
T cd05069 124 IHRDLRAANILVGDN-LVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLT 194 (260)
T ss_pred eecccCcceEEEcCC-CeEEECCCccceEccCCcccccCCCccchhhCCHHHhcc--------CCcChHHHHHHHHHHHH
Confidence 699999999999966 6799999999975432221 112345678999998743 56788999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
++++ |..||.+...... .........+..+...+..+.+++.+||..||.+||+++++++.|+.
T Consensus 195 el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 195 ELVTKGRVPYPGMVNREV-LEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHhCCCCCCCCCCHHHH-HHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 9998 8999987654333 23333344455667789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=177.34 Aligned_cols=138 Identities=23% Similarity=0.355 Sum_probs=103.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||++....... .....+||+.|+|||++.... ....++.++|+||+||++|
T Consensus 164 vHrDLkp~NILl~~~-~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~~DiwSlGvily 238 (370)
T cd05596 164 IHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQG----GDGYYGRECDWWSVGVFLY 238 (370)
T ss_pred eccCCCHHHEEEcCC-CCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCC----CCCCCCCceeeeehhHHHH
Confidence 699999999999976 689999999987543221 123467999999999875310 1234788999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCCCC--CCcHHHHHHHHHhcccCCCC--CCCHHHHHHHHHHHH
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNL--RPSFSQIIRMLNAFL 145 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~l~~~~l~~dp~~--Rps~~~~l~~l~~~~ 145 (198)
||++|..||.+...................|. .++.++.+++.+||..+|.+ |+++.++++ +.|+
T Consensus 239 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~--h~~~ 307 (370)
T cd05596 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS--HPFF 307 (370)
T ss_pred HHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc--Cccc
Confidence 99999999987664333222222222233443 47899999999999999987 999999998 4554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.8e-25 Score=164.72 Aligned_cols=133 Identities=32% Similarity=0.587 Sum_probs=104.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc-ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++........ .....++..|++||.+.. ..++.++|+||||+++|+
T Consensus 126 ~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~DiwslG~~l~~ 196 (261)
T cd05148 126 IHRDLAARNILVGED-LVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH--------GTFSTKSDVWSFGILLYE 196 (261)
T ss_pred eccccCcceEEEcCC-ceEEEccccchhhcCCccccccCCCCceEecCHHHHcc--------CCCCchhhHHHHHHHHHH
Confidence 699999999999976 6799999999875432221 122345678999998743 567889999999999999
Q ss_pred HHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 80 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 80 ~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
+++ |..||.+..... .............+..+++.+.+++.+||..||.+||++.++++.|+.
T Consensus 197 l~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 197 MFTYGQVPYPGMNNHE-VYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHcCCCCCCCcCCHHH-HHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 998 899997765433 223333444556677889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-26 Score=175.42 Aligned_cols=124 Identities=27% Similarity=0.394 Sum_probs=98.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|||++.+ ..++.++|+|||||++||
T Consensus 118 vH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 188 (321)
T cd05603 118 IYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK--------EPYDRTVDWWCLGAVLYE 188 (321)
T ss_pred EeccCCHHHeEECCC-CCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcC--------CCCCCcCcccccchhhhh
Confidence 699999999999976 6799999999875322 222334578999999999853 567889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 135 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~ 135 (198)
|++|..||.+..... .... .......+|...+.++.+++.+||..||.+|+++.
T Consensus 189 l~~g~~pf~~~~~~~-~~~~-i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 189 MLYGLPPFYSRDVSQ-MYDN-ILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred hhcCCCCCCCCCHHH-HHHH-HhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 999999998765332 2222 22344566777899999999999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.8e-25 Score=163.81 Aligned_cols=131 Identities=31% Similarity=0.614 Sum_probs=103.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.+ +.+||+|||+++...... ....++..|++||.+.. ..++.++|+||||+++|++
T Consensus 124 ~H~di~p~Nili~~~-~~~~l~d~g~~~~~~~~~--~~~~~~~~~~ape~~~~--------~~~~~~~Di~slG~il~~l 192 (256)
T cd05039 124 VHRDLAARNVLVSED-LVAKVSDFGLAKEASQGQ--DSGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEI 192 (256)
T ss_pred cchhcccceEEEeCC-CCEEEccccccccccccc--ccCCCcccccCchhhcC--------CcCCcHHHHHHHHHHHHHH
Confidence 699999999999966 679999999997653222 12344567999998753 4578899999999999999
Q ss_pred Hc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 81 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 81 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
++ |..||..... ...............+..+++.+.+++.+||..+|++||++.+++++|+.
T Consensus 193 ~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 193 YSFGRVPYPRIPL-KDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HhcCCCCCCCCCH-HHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 97 9999976543 33333333344555667789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=163.67 Aligned_cols=131 Identities=29% Similarity=0.586 Sum_probs=102.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccc--cCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+||+++.+ +.+||+|||+++........ ....++..|+|||.+.+ ..++.++|+||||+++|
T Consensus 122 ~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~s~G~~l~ 192 (256)
T cd05114 122 IHRDLAARNCLVSST-GVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF--------SKYSSKSDVWSFGVLMW 192 (256)
T ss_pred cccccCcceEEEcCC-CeEEECCCCCccccCCCceeccCCCCCchhhCChhhccc--------CccchhhhhHHHHHHHH
Confidence 699999999999966 67999999998754322211 12234568999999753 46788999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
++++ |+.||........ ............|...+..+.+++.+||..+|.+||+++++++.|
T Consensus 193 el~~~g~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 193 EVFTEGKMPFEKKSNYEV-VEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHcCCCCCCCCCCHHHH-HHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 9999 8999987664433 233333444555667888999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=171.17 Aligned_cols=135 Identities=21% Similarity=0.394 Sum_probs=103.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+ +.++|+|||++.............|+..|+|||++.+ ..++.++|+||+|+++|+|
T Consensus 124 iH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~l 194 (285)
T cd05630 124 VYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN--------ERYTFSPDWWALGCLLYEM 194 (285)
T ss_pred EeCCCCHHHEEECCC-CCEEEeeccceeecCCCccccCCCCCccccChHHHcC--------CCCCCccccHHHHHHHHHH
Confidence 699999999999976 6799999999875443333344578999999999853 5678899999999999999
Q ss_pred HcCCCCCCCCCcHH--HHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQ--AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps-----~~~~l~~l~~~~~ 146 (198)
++|..||....... ..............+..+++++.+++.+||+.||.+||+ +.++++ +.|+.
T Consensus 195 ~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~--h~~~~ 265 (285)
T cd05630 195 IAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE--HPLFK 265 (285)
T ss_pred HhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc--Chhhh
Confidence 99999998654211 111122222233456678899999999999999999999 889988 45543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-25 Score=164.88 Aligned_cols=134 Identities=29% Similarity=0.545 Sum_probs=102.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccC--CCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTA--ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~--~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+|+||||+||+++.+ +.+||+|||++........ ... ...+..|++||++.. ..++.++|+||||++
T Consensus 129 ~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~i 199 (268)
T cd05063 129 VHRDLAARNILVNSN-LECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY--------RKFTSASDVWSFGIV 199 (268)
T ss_pred eccccchhhEEEcCC-CcEEECCCccceecccccccceeccCCCcCceecCHHHhhc--------CCcChHhHHHHHHHH
Confidence 699999999999976 6799999999874432111 111 123457999998753 567889999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
+||+++ |..||....... ...........+.+..++..+.+++.+||..+|++||++.++++.|+++
T Consensus 200 l~ell~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 200 MWEVMSFGERPYWDMSNHE-VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHhCCCCCCCcCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999997 999997655433 2233333344455667889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=174.87 Aligned_cols=135 Identities=25% Similarity=0.400 Sum_probs=115.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|-|||||+|.+|+.+ +-+||.|||+++.........++|||+.|.|||++. ++..+.++|.|++|+++||+
T Consensus 542 IYRDLKPENllLd~~-Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIIL--------nKGHD~avDyWaLGIli~EL 612 (732)
T KOG0614|consen 542 IYRDLKPENLLLDNR-GYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIIL--------NKGHDRAVDYWALGILIYEL 612 (732)
T ss_pred eeccCChhheeeccC-CceEEeehhhHHHhccCCceeeecCCcccccchhhh--------ccCcchhhHHHHHHHHHHHH
Confidence 569999999999987 569999999999888888888999999999999985 36678999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps-----~~~~l~~l~~~~~ 146 (198)
++|.+||++.+++.....++..-....+|..++....+++++++..+|.+|.. +.++-+ |.|+.
T Consensus 613 L~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk--H~Wf~ 681 (732)
T KOG0614|consen 613 LTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK--HRWFE 681 (732)
T ss_pred HcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh--hhhhh
Confidence 99999999988877665555445556788889999999999999999999965 666766 55554
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=165.40 Aligned_cols=129 Identities=30% Similarity=0.520 Sum_probs=102.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.++|+|||++...... .......++..|+|||++.. ..++.++|+||+|+++++
T Consensus 124 ~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~ 194 (257)
T cd08223 124 LHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN--------KPYNYKSDVWALGCCVYE 194 (257)
T ss_pred eccCCCchhEEEecC-CcEEEecccceEEecccCCccccccCCcCccChhHhcC--------CCCCchhhhHHHHHHHHH
Confidence 699999999999976 67999999998754322 22234568889999998753 567889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+++|+.||......... ........+..+..+++.+.+++.+||+.+|.+||++.++++
T Consensus 195 l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 195 MATLKHAFNAKDMNSLV-YRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHcCCCCCCCCCHHHHH-HHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 99999999765543322 223334444566778999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=163.12 Aligned_cols=132 Identities=31% Similarity=0.573 Sum_probs=102.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccc--cCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||||+||+++.+ +.+||+|||++......... ....++..|++||++.+ ..++.++|+||||+++|
T Consensus 115 ~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~ll~ 185 (250)
T cd05085 115 IHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY--------GRYSSESDVWSYGILLW 185 (250)
T ss_pred eecccChheEEEcCC-CeEEECCCccceeccccccccCCCCCCcccccCHHHhcc--------CCCCchhHHHHHHHHHH
Confidence 699999999999966 67999999998753322211 11234567999998753 55788999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
++++ |..||.+..... .............+..++.++.+++.+||..+|.+||++.++++.|.
T Consensus 186 ~~~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 186 ETFSLGVCPYPGMTNQQ-AREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHhcCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 9998 999998765433 22333344445566778999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=172.99 Aligned_cols=123 Identities=25% Similarity=0.479 Sum_probs=97.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++.... ........||..|+|||++.+ ..++.++|+||+||++|+
T Consensus 123 vHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~e 193 (323)
T cd05615 123 IYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY--------QPYGKSVDWWAYGVLLYE 193 (323)
T ss_pred eccCCCHHHeEECCC-CCEEEeccccccccCCCCccccCccCCccccCHHHHcC--------CCCCCccchhhhHHHHHH
Confidence 699999999999976 6799999999874322 122334578999999999853 567889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 134 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~ 134 (198)
|++|..||.+......... ........|..++.++.+++.+||..+|.+|++.
T Consensus 194 lltG~~pf~~~~~~~~~~~--i~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 194 MLAGQPPFDGEDEDELFQS--IMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHhCCCCCCCCCHHHHHHH--HHhCCCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 9999999987664333222 2234445677889999999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=175.26 Aligned_cols=135 Identities=25% Similarity=0.400 Sum_probs=94.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++............||..|+|||++.+ ..++.++|+|||||++|||
T Consensus 179 vHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvvl~el 249 (357)
T PHA03209 179 IHRDVKTENIFINDV-DQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLAR--------DKYNSKADIWSAGIVLFEM 249 (357)
T ss_pred ecCCCCHHHEEECCC-CCEEEecCccccccccCcccccccccccccCCeecCC--------CCCCchhhHHHHHHHHHHH
Confidence 699999999999976 6799999999975433333344678999999999853 5678999999999999999
Q ss_pred HcCCCC-CCCCCcHH---------HHHHH--HHccCCCCCC------------------------------CCCcHHHHH
Q 029154 81 LTNRLP-FEGMSNLQ---------AAYAA--AFKHARPGLP------------------------------EDISPDLAF 118 (198)
Q Consensus 81 ~~g~~p-~~~~~~~~---------~~~~~--~~~~~~~~~p------------------------------~~~~~~~~~ 118 (198)
+++..+ |....... ..... .....+..++ ..++.++.+
T Consensus 250 l~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (357)
T PHA03209 250 LAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEF 329 (357)
T ss_pred HHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHH
Confidence 985544 33211110 00000 0000011111 134567788
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 119 IVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 119 l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++.+||..||.+|||+.|+++ +.|+.
T Consensus 330 li~~mL~~dP~~Rpta~e~l~--hp~f~ 355 (357)
T PHA03209 330 LVHKMLTFDAAMRPSAEEILN--YPMFA 355 (357)
T ss_pred HHHHHHcCCcccCcCHHHHhc--Cchhc
Confidence 999999999999999999998 55543
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=172.53 Aligned_cols=132 Identities=22% Similarity=0.303 Sum_probs=92.6
Q ss_pred CCCCCCCCCeEEcC---CCCceEEecccCcccCccc----ccccCCCCccceecccccccccccccccCCCCchhhHHHH
Q 029154 1 MGKFMKEDNLLLTP---DQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 73 (198)
Q Consensus 1 iH~dlKp~NIll~~---~~~~~kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~ 73 (198)
|||||||+|||+.. ..+.+||+|||+++..... ......+||+.|+|||++.+ ...++.++|+||+
T Consensus 130 vHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~Diwsl 202 (317)
T cd07868 130 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAI 202 (317)
T ss_pred EcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcC-------CCCcCchhhHHHH
Confidence 69999999999942 2357999999999754321 11234578999999998853 2457889999999
Q ss_pred HHHHHHHHcCCCCCCCCCcHH--------HHHHHHHc--c-------------------------CCC----------CC
Q 029154 74 GIVLWELLTNRLPFEGMSNLQ--------AAYAAAFK--H-------------------------ARP----------GL 108 (198)
Q Consensus 74 G~~l~e~~~g~~p~~~~~~~~--------~~~~~~~~--~-------------------------~~~----------~~ 108 (198)
||++|+|++|++||.+..... ........ . ... ..
T Consensus 203 G~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (317)
T cd07868 203 GCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKH 282 (317)
T ss_pred HHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhc
Confidence 999999999999996432100 00000000 0 000 00
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 109 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 109 p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
....+.++.+++.+||..||.+|||++|+++
T Consensus 283 ~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 283 KVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred CCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1123567889999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=164.37 Aligned_cols=134 Identities=32% Similarity=0.567 Sum_probs=104.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-ccccc--CCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+|+||||+|||++.+ +.+||+|||+++.... ..... ...++..|++||.+.+ ..++.++|+||||+++
T Consensus 128 ~H~di~p~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Dv~slG~~l 198 (266)
T cd05033 128 VHRDLAARNILVNSN-LVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY--------RKFTSASDVWSFGIVM 198 (266)
T ss_pred ccCCCCcceEEEcCC-CCEEECccchhhcccccccceeccCCCCCccccChhhhcc--------CCCccccchHHHHHHH
Confidence 699999999999976 6799999999975431 11111 1234578999998753 5678899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
|++++ |..||....... ...........+.+..++..+.+++.+||..+|++||++.+++++|+.+
T Consensus 199 ~~l~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 199 WEVMSYGERPYWDMSNQD-VIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHccCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99997 999997655433 2233333344455677899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=162.92 Aligned_cols=132 Identities=33% Similarity=0.577 Sum_probs=100.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccc---cCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+|+||||+||+++.+ +.+||+|||++......... ....++..|++||.+.+ ..++.++|+||+|+++
T Consensus 116 ~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il 186 (252)
T cd05084 116 IHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY--------GRYSSESDVWSFGILL 186 (252)
T ss_pred cccccchheEEEcCC-CcEEECccccCcccccccccccCCCCCCceeecCchhhcC--------CCCChHHHHHHHHHHH
Confidence 699999999999976 67999999998753322111 11123457999998753 5578899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
|++++ |..||........ ............+..++..+.+++.+||..+|++||++.++++.|.
T Consensus 187 ~e~~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 187 WEAFSLGAVPYANLSNQQT-REAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHhCCCCCccccCHHHH-HHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 99997 8888876554332 2223334455667778999999999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-25 Score=175.81 Aligned_cols=136 Identities=23% Similarity=0.374 Sum_probs=99.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++...... ......||..|+|||++.+ ..++.++||||+||++
T Consensus 207 vHrDlkp~Nill~~~-~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil 277 (392)
T PHA03207 207 IHRDVKTENIFLDEP-ENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL--------DPYCAKTDIWSAGLVL 277 (392)
T ss_pred cccCCCHHHEEEcCC-CCEEEccCccccccCcccccccccccccccCccCHhHhcC--------CCCCchhhHHHHHHHH
Confidence 799999999999976 679999999987543221 1224578999999999853 5678999999999999
Q ss_pred HHHHcCCCCCCCCCcHH--HHHHHH---H-----------------------ccCCC--CCC-----CCCcHHHHHHHHH
Q 029154 78 WELLTNRLPFEGMSNLQ--AAYAAA---F-----------------------KHARP--GLP-----EDISPDLAFIVQS 122 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~--~~~~~~---~-----------------------~~~~~--~~p-----~~~~~~~~~l~~~ 122 (198)
|||++|..||.+..... ...... . ...++ ..+ ..++.++.+++.+
T Consensus 278 ~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 357 (392)
T PHA03207 278 FEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAK 357 (392)
T ss_pred HHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHH
Confidence 99999999997643210 000000 0 00011 011 2346788999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 123 CWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 123 ~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
||..||.+||++.+++. +.++..
T Consensus 358 ml~~dp~~Rpsa~e~l~--~p~f~~ 380 (392)
T PHA03207 358 MLTFDQEFRPSAQDILS--LPLFTK 380 (392)
T ss_pred HhccChhhCCCHHHHhh--Cchhhc
Confidence 99999999999999999 666644
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=168.60 Aligned_cols=137 Identities=31% Similarity=0.620 Sum_probs=106.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||+++....... .....++..|++||++.+ ..++.++|+||||+++
T Consensus 156 vH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 226 (334)
T cd05100 156 IHRDLAARNVLVTED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLL 226 (334)
T ss_pred eccccccceEEEcCC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhcc--------CCcCchhhhHHHHHHH
Confidence 699999999999976 6799999999875432211 112234567999998853 5678899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|||++ |..||.+.... ..............+..++.++.+++.+||..+|.+||++.++++.|..+...
T Consensus 227 ~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 227 WEIFTLGGSPYPGIPVE-ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred HHHHhcCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 99998 88898775533 33333334445556677889999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=166.05 Aligned_cols=132 Identities=27% Similarity=0.503 Sum_probs=102.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.+ +.+||+|||++.............|+..|++||.+.+ ..++.++|+||||+++|++
T Consensus 136 ~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Dv~slG~ll~~l 206 (269)
T cd08528 136 VHRDLTPNNIMLGED-DKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN--------EPYGEKADVWAFGCILYQM 206 (269)
T ss_pred eecCCCHHHEEECCC-CcEEEecccceeecccccccccccCcccCcChhhhcC--------CCCchHHHHHHHHHHHHHH
Confidence 599999999999976 6799999999975544333345578899999998853 4578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCC-CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
++|..||........... .......+.+ ..+++.+.+++.+||..||++||++.++..++.
T Consensus 207 ~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 207 CTLQPPFYSTNMLSLATK-IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HhCCCcccccCHHHHHHH-HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 999999976543332222 2222222222 357899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-25 Score=164.17 Aligned_cols=131 Identities=28% Similarity=0.588 Sum_probs=101.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccccc--CCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+||+++.+ +.+||+|||+++......... ...++..|++||.+.+ ..++.++|+||||+++|
T Consensus 122 ~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~il~ 192 (256)
T cd05059 122 IHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY--------SRFSSKSDVWSFGVLMW 192 (256)
T ss_pred ccccccHhhEEECCC-CcEEECCcccceecccccccccCCCCCCccccCHHHhcc--------CCCCchhhHHHHHHHHH
Confidence 699999999999976 679999999987544322111 1223457999998753 56788999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
++++ |..||........ ............+..++..+.+++.+||..+|++||++.++++.|
T Consensus 193 ~l~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 193 EVFSEGKMPYERFSNSEV-VESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHhccCCCCCCCCCHHHH-HHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 9998 7899976554332 333334445556677899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-26 Score=177.64 Aligned_cols=129 Identities=23% Similarity=0.411 Sum_probs=98.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++.... .......+||..|+|||++.+ ...++.++|+||+||++|+
T Consensus 118 vHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwslGvil~e 189 (330)
T cd05586 118 VYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLD-------EKGYTKHVDFWSLGVLVFE 189 (330)
T ss_pred EeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcC-------CCCCCCccceeccccEEEE
Confidence 699999999999976 6799999999874322 222345679999999998753 2457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCC-CCCcHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRP----SFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~l~~~~l~~dp~~Rp----s~~~~l~ 139 (198)
|++|..||.+...... ..... .....++ ..+++++.+++.+||..||.+|| ++.++++
T Consensus 190 lltG~~Pf~~~~~~~~-~~~i~-~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 190 MCCGWSPFYAEDTQQM-YRNIA-FGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred eccCCCCCCCCCHHHH-HHHHH-cCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 9999999987654332 22222 2223333 34789999999999999999998 5677766
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-25 Score=168.18 Aligned_cols=141 Identities=27% Similarity=0.493 Sum_probs=105.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+ +.+||+|||+++............++..|++||.+.+.. ....++.++|+||+|+++|+|
T Consensus 126 ~h~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~Di~slG~~l~~l 200 (283)
T cd06617 126 IHRDVKPSNVLINRN-GQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPEL----NQKGYDVKSDVWSLGITMIEL 200 (283)
T ss_pred ecCCCCHHHEEECCC-CCEEEeecccccccccccccccccCCccccChhhcCCcc----cccccCccccchhhHHHHHHH
Confidence 699999999999976 679999999987544332223356888999999875311 114567899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCC-CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
++|..||..................+..+ ..++.++.+++.+||..+|.+||++.++++ +.|+...
T Consensus 201 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--~~~~~~~ 267 (283)
T cd06617 201 ATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ--HPFFELH 267 (283)
T ss_pred HhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--Cchhhhc
Confidence 99999997543322222233333344444 347899999999999999999999999998 6665543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=163.29 Aligned_cols=129 Identities=28% Similarity=0.468 Sum_probs=102.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||+++...... ......|+..|++||++.. ..++.++|+||||+++++
T Consensus 123 ~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ 193 (256)
T cd08529 123 LHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED--------KPYNEKSDVWALGVVLYE 193 (256)
T ss_pred ccCCCCcceEEEeCC-CCEEEcccccceeccCccchhhccccCccccCHHHhcC--------CCCCCccchHHHHHHHHH
Confidence 699999999999976 679999999987543322 2234568889999998753 557889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+++|..||....... ..........+..+..++.++.+++.+||+.+|++||++.++++
T Consensus 194 l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 194 CCTGKHPFDANNQGA-LILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HHhCCCCCCCCCHHH-HHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 999999997765332 22333344445566678899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=157.30 Aligned_cols=130 Identities=28% Similarity=0.372 Sum_probs=96.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|..-||+|||++.+ +.+|+ ||+++..... ...|++.|+|||++.+ ..++.++|||||||++|||
T Consensus 33 lH~~~kp~Nil~~~~-~~~~~--fG~~~~~~~~----~~~g~~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el 97 (176)
T smart00750 33 LHRQAKSGNILLTWD-GLLKL--DGSVAFKTPE----QSRVDPYFMAPEVIQG--------QSYTEKADIYSLGITLYEA 97 (176)
T ss_pred HHhcCCcccEeEcCc-cceee--ccceEeeccc----cCCCcccccChHHhcC--------CCCcchhhHHHHHHHHHHH
Confidence 366669999999976 67888 9998754332 2368899999999854 5678999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCC------CCCCCcH--HHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPG------LPEDISP--DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~------~p~~~~~--~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
++|..||.................... .+..++. ++.+++.+||..+|.+||++.++++++....
T Consensus 98 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 98 LDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 999999976544333322222222211 1122333 6899999999999999999999999776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=166.65 Aligned_cols=136 Identities=25% Similarity=0.494 Sum_probs=104.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++....... .....++..|++||.+.+ ..++.++|+||||+++
T Consensus 131 vH~dikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DiwslG~~l 201 (303)
T cd05110 131 VHRDLAARNVLVKSP-NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY--------RKFTHQSDVWSYGVTI 201 (303)
T ss_pred eccccccceeeecCC-CceEEccccccccccCcccccccCCCccccccCCHHHhcc--------CCCChHHHHHHHHHHH
Confidence 699999999999866 6799999999975432211 112345678999998743 5678899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
||+++ |..||.+..... ..........+..+..++.++.+++.+||..+|++||++.++++.|+.+..
T Consensus 202 ~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 202 WELMTFGGKPYDGIPTRE-IPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred HHHHhCCCCCCCCCCHHH-HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 99987 889997654322 222233334445556688999999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=165.97 Aligned_cols=132 Identities=28% Similarity=0.514 Sum_probs=108.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccC-cccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|-||||-+|+||+++ +++||.|||+++.. ......++.|||+.|+|||++. ...|+..+|+|.+|+++||
T Consensus 290 vYRDlKLENLlLDkD-GHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVle--------DnDYgraVDWWG~GVVMYE 360 (516)
T KOG0690|consen 290 VYRDLKLENLLLDKD-GHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLE--------DNDYGRAVDWWGVGVVMYE 360 (516)
T ss_pred eeeechhhhheeccC-CceEeeecccchhcccccceeccccCChhhcCchhhc--------cccccceeehhhhhHHHHH
Confidence 469999999999988 79999999999843 3344567899999999999984 5789999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFL 145 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~~l~~~~ 145 (198)
|++|+.||.+.++... ..++......+|..+++++..|+..+|..||.+|. .+.|+.+ +.++
T Consensus 361 MmCGRLPFyn~dh~kL--FeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~--h~FF 427 (516)
T KOG0690|consen 361 MMCGRLPFYNKDHEKL--FELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR--HRFF 427 (516)
T ss_pred HHhccCcccccchhHH--HHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh--hhhh
Confidence 9999999987765433 23333455677899999999999999999999994 3666666 4444
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-25 Score=164.87 Aligned_cols=134 Identities=28% Similarity=0.404 Sum_probs=102.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.++|+|||++....... ......|+..|+|||.+.+ ..++.++|+||+|+++|+
T Consensus 128 ~H~dl~~~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~e 198 (267)
T cd08228 128 MHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYE 198 (267)
T ss_pred eCCCCCHHHEEEcCC-CCEEECccccceeccchhHHHhcCCCCccccChhhhcc--------CCCCchhhHHHHHHHHHH
Confidence 699999999999976 679999999987543322 1234568889999998753 457889999999999999
Q ss_pred HHcCCCCCCCCCcH-HHHHHHHHccCCCCC-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 80 LLTNRLPFEGMSNL-QAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 80 ~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~-p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
+++|..||...... ............++. +...+..+.+++.+||..+|++||++.++++.|+.
T Consensus 199 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~ 264 (267)
T cd08228 199 MAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264 (267)
T ss_pred HhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence 99999998654422 222222222222233 34577899999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=176.56 Aligned_cols=135 Identities=25% Similarity=0.384 Sum_probs=98.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-----------------------------------------------
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT----------------------------------------------- 33 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~----------------------------------------------- 33 (198)
|||||||+|||++.+ +.+||+|||+++.....
T Consensus 123 vHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (381)
T cd05626 123 IHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQ 201 (381)
T ss_pred eecCCcHHHEEECCC-CCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccc
Confidence 699999999999976 68999999997522100
Q ss_pred -ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCC--C
Q 029154 34 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--E 110 (198)
Q Consensus 34 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p--~ 110 (198)
......+||..|+|||++.+ ..++.++||||+||++|||++|..||.....................| .
T Consensus 202 ~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 273 (381)
T cd05626 202 RCLAHSLVGTPNYIAPEVLLR--------KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQV 273 (381)
T ss_pred ccccccccCCccccCHHHHcC--------CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCC
Confidence 00123479999999999853 567899999999999999999999998766443333322222223333 3
Q ss_pred CCcHHHHHHHHHhc--ccCCCCCCCHHHHHHHHHHHHh
Q 029154 111 DISPDLAFIVQSCW--VEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 111 ~~~~~~~~l~~~~l--~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
.+++++.+++.+++ ..++..|+++.+++. +.|+.
T Consensus 274 ~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~--hp~f~ 309 (381)
T cd05626 274 KLSPEAVDLITKLCCSAEERLGRNGADDIKA--HPFFS 309 (381)
T ss_pred CCCHHHHHHHHHHccCcccccCCCCHHHHhc--CcccC
Confidence 57899999999855 455556999999998 55543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=165.07 Aligned_cols=134 Identities=27% Similarity=0.564 Sum_probs=104.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||+++....... .....++..|++||.+.+ ..++.++|+|||||++
T Consensus 141 ~H~dikp~nili~~~-~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~DvwslG~~l 211 (288)
T cd05061 141 VHRDLAARNCMVAHD-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--------GVFTTSSDMWSFGVVL 211 (288)
T ss_pred cCCCCChheEEEcCC-CcEEECcCCccccccccccccccCCCcccccccCHHHhcc--------CCCChHhHHHHHHHHH
Confidence 699999999999976 6799999999874432111 112245678999998743 5678899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
||+++ |..||.+..... .............+...++.+.+++.+||..||.+||++.++++.|...
T Consensus 212 ~el~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 212 WEITSLAEQPYQGLSNEQ-VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 99998 788887655433 3333334444556777889999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=166.49 Aligned_cols=133 Identities=28% Similarity=0.507 Sum_probs=98.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+|+||||+||+++.+ +.++|+|||+++...... ......++..|++||.+.. ..++.++||||||+++
T Consensus 152 ~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l 222 (296)
T cd05051 152 VHRDLATRNCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--------GKFTTKSDVWAFGVTL 222 (296)
T ss_pred cccccchhceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhc--------CCCCccchhhhhHHHH
Confidence 699999999999976 689999999987432221 1223456778999998753 4578999999999999
Q ss_pred HHHHc--CCCCCCCCCcHHHHHHHHHc------cCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 78 WELLT--NRLPFEGMSNLQAAYAAAFK------HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 78 ~e~~~--g~~p~~~~~~~~~~~~~~~~------~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
||+++ +..||............... ......+..++.++.+++.+||+.||.+||++.++++.|+
T Consensus 223 ~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 223 WEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 99987 66788665433322111111 1112234456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-26 Score=176.21 Aligned_cols=125 Identities=28% Similarity=0.523 Sum_probs=99.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||+++..... .......|+..|++||.+.+ ..++.++|+|||||++|+
T Consensus 120 ~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 190 (318)
T cd05582 120 IYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR--------RGHTQSADWWSFGVLMFE 190 (318)
T ss_pred ecCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcC--------CCCCCccceeccceEeee
Confidence 699999999999976 67999999998754332 22334578999999999853 456889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 136 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~ 136 (198)
|++|+.||.+......... .......+|..+++++.+++.+||..||.+||++.+
T Consensus 191 l~tg~~p~~~~~~~~~~~~--i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 191 MLTGSLPFQGKDRKETMTM--ILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred eccCCCCCCCCCHHHHHHH--HHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 9999999987664333222 223445667789999999999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-25 Score=167.77 Aligned_cols=130 Identities=22% Similarity=0.378 Sum_probs=100.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+||+++.+ +.+||+|||++.............|+..|+|||++.+ ..++.++|+||+|+++|++
T Consensus 124 iH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l 194 (285)
T cd05632 124 VYRDLKPENILLDDY-GHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN--------QRYTLSPDYWGLGCLIYEM 194 (285)
T ss_pred eecCCCHHHEEECCC-CCEEEecCCcceecCCCCcccCCCCCcCccChHHhcC--------CCCCcccchHHHHHHHHHH
Confidence 699999999999976 6799999999865433333344578999999999853 5678899999999999999
Q ss_pred HcCCCCCCCCCcHHHH--HHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 029154 81 LTNRLPFEGMSNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 139 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps-----~~~~l~ 139 (198)
++|..||.+....... ............+..+++++.+|+.+||..||.+||+ +.+++.
T Consensus 195 ~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 195 IEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 9999999876543221 1111222233445668899999999999999999999 677777
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=163.78 Aligned_cols=133 Identities=31% Similarity=0.548 Sum_probs=104.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||||+||+++.+ +.++|+|||++........ .....++..|++||.+.. ..++.++|+||||+++|
T Consensus 124 ~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Di~slG~~l~ 194 (260)
T cd05067 124 IHRDLRAANILVSET-LCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLT 194 (260)
T ss_pred ecccccHHhEEEcCC-CCEEEccCcceeecCCCCcccccCCcccccccCHHHhcc--------CCcCcccchHHHHHHHH
Confidence 699999999999976 6799999999875432211 122345678999998753 45788999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
++++ |..||.+..... .............+...+.++.+++.+||..+|++||++++++..|+.
T Consensus 195 el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 195 EIVTYGRIPYPGMTNPE-VIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHhCCCCCCCCCChHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 9998 999998765433 223333344455667788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=163.95 Aligned_cols=128 Identities=26% Similarity=0.454 Sum_probs=97.5
Q ss_pred CCCCCCCCCeEEcCCCCc-------eEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKS-------LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 73 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~-------~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~ 73 (198)
+||||||+||+++.++.. ++++|||++...... ....++..|++||++.. ...++.++|+|||
T Consensus 122 iH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~Diwsl 191 (258)
T cd05078 122 THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIEN-------PQNLSLAADKWSF 191 (258)
T ss_pred ecCCCccceEEEecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccC-------CCCCCchhhHHHH
Confidence 699999999999866432 699999998644322 23467889999999853 2456889999999
Q ss_pred HHHHHHHHcCC-CCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 74 GIVLWELLTNR-LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 74 G~~l~e~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
|+++|++++|. .|+......... .. ......+|...+.++.+++.+||+.||.+||+++++++.|
T Consensus 192 G~~l~~l~~g~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 192 GTTLWEIFSGGDKPLSALDSQKKL-QF--YEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHHHcCCCCChhhccHHHHH-HH--HHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 99999999985 666554432221 11 1234456666778999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=163.82 Aligned_cols=129 Identities=26% Similarity=0.423 Sum_probs=103.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc-ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++........ .....++..|++||.+.. ..++.++|+||||+++++
T Consensus 132 ~h~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~--------~~~~~~~Dv~slG~il~~ 202 (265)
T cd08217 132 LHRDLKPANIFLDAN-NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH--------MSYDEKSDIWSLGCLIYE 202 (265)
T ss_pred eecCCCHHHEEEecC-CCEEEecccccccccCCcccccccccCCCccChhhhcC--------CCCCchhHHHHHHHHHHH
Confidence 699999999999966 7899999999876543332 334578899999999853 457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+++|..||..... ............+.++..++.++.+++.+||..+|.+||++.++++
T Consensus 203 l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 203 LCALSPPFTARNQ-LQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHHCCCcccCcCH-HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 9999999987653 2223333334444567778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=164.00 Aligned_cols=134 Identities=27% Similarity=0.550 Sum_probs=103.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+||+++.+ ..+||+|||+++....... .....++..|++||.+.. ..++.++|+||||+++
T Consensus 135 ~H~dikp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~sDi~slG~il 205 (273)
T cd05074 135 IHRDLAARNCMLNEN-MTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD--------NVYTTHSDVWAFGVTM 205 (273)
T ss_pred eecccchhhEEEcCC-CCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc--------CccchhhhhHHHHHHH
Confidence 699999999999866 6799999999875432221 122345678999998743 5678899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
|++++ |..||.+.... ..............+...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus 206 ~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 206 WEIMTRGQTPYAGVENS-EIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHhhCCCCCCCCCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99998 88898766543 23333334444455567889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=164.28 Aligned_cols=135 Identities=27% Similarity=0.408 Sum_probs=102.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.++|+|||++....... ......|+..|++||.+.+ ..++.++|+||||+++|+
T Consensus 128 ~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~--------~~~~~~~Dv~slG~il~~ 198 (267)
T cd08229 128 MHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYE 198 (267)
T ss_pred ecCCCCHHHEEEcCC-CCEEECcchhhhccccCCcccccccCCcCccCHHHhcC--------CCccchhhHHHHHHHHHH
Confidence 699999999999976 679999999987543322 1234568889999998753 557889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHH-HHHccCCCCC-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYA-AAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~-p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
+++|..||.+......... .......+.. +..+++.+.+++.+||..||.+|||+.++++.+...
T Consensus 199 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 199 MAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 9999999976543222221 2222222222 345788999999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=166.97 Aligned_cols=139 Identities=28% Similarity=0.529 Sum_probs=103.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+ +.+||+|||++.............++..|++||.+.+.. ....++.++|+||||+++|++
T Consensus 137 ~H~dl~p~nill~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~Di~slG~il~el 211 (296)
T cd06618 137 IHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPD----PNPKYDIRADVWSLGISLVEL 211 (296)
T ss_pred ecCCCcHHHEEEcCC-CCEEECccccchhccCCCcccCCCCCccccCHhhcCCCC----CccccccchhHHHHHHHHHHH
Confidence 699999999999966 689999999987544333233345788999999875310 013477899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCC--CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++|+.||..................+..+ ..++.++.+++.+||..||.+||++.++++ +.|+.
T Consensus 212 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--~~~~~ 277 (296)
T cd06618 212 ATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ--HPFIR 277 (296)
T ss_pred HhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc--Chhhh
Confidence 99999997644322333333333333333 236889999999999999999999999998 55544
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=182.80 Aligned_cols=137 Identities=31% Similarity=0.566 Sum_probs=116.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCC--ccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETG--TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~g--t~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||...|||++.+ -.+|++|||++|...+.. .+++.-| ...|.|||.+. .+.++.++||||||++
T Consensus 753 VHRDLAARNILVNsn-LvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa--------~RKFTsASDVWSyGIV 823 (996)
T KOG0196|consen 753 VHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIA--------YRKFTSASDVWSYGIV 823 (996)
T ss_pred hhhhhhhhheeeccc-eEEEeccccceeecccCCCccccccCCccceeecChhHhh--------hcccCchhhccccceE
Confidence 799999999999976 689999999999553332 2333333 46899999985 5889999999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
+||.++ |..||-.+.+ ++......+..+.+.|-+++..+..||..||++|-..||.|.+|+..|+..+..
T Consensus 824 mWEVmSyGERPYWdmSN-QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 824 MWEVMSYGERPYWDMSN-QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred EEEecccCCCcccccch-HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 999874 9999988776 455666777888888999999999999999999999999999999999988764
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=162.82 Aligned_cols=136 Identities=28% Similarity=0.569 Sum_probs=106.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccccc--CCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||||+||+++.+ +.+||+|||+++......... ...++..|++||.+.. ..++.++|+||||+++|
T Consensus 129 ~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 199 (270)
T cd05056 129 VHRDIAARNVLVSSP-DCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMW 199 (270)
T ss_pred eccccChheEEEecC-CCeEEccCceeeecccccceecCCCCccccccChhhhcc--------CCCCchhhhHHHHHHHH
Confidence 699999999999976 679999999987543322111 2234567999998743 56788999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|+++ |..||.+...... ............+..++..+.+++.+||..+|.+||++.++++.|+.+..
T Consensus 200 el~~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 200 EILMLGVKPFQGVKNNDV-IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHcCCCCCCCCCHHHH-HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 9885 9999987665333 23333444556677889999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=174.76 Aligned_cols=136 Identities=29% Similarity=0.547 Sum_probs=115.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccC--CCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTA--ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||...|.|+..+ ..+||+|||+++.+.......+ ......|.|||.+. ...++.|+|||+||+++|
T Consensus 387 IHRDLAARNCLVgEn-hiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLA--------yNtFSiKSDVWAFGVLLW 457 (1157)
T KOG4278|consen 387 IHRDLAARNCLVGEN-HIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA--------YNTFSIKSDVWAFGVLLW 457 (1157)
T ss_pred hhhhhhhhhcccccc-ceEEeeccchhhhhcCCceecccCccCcccccCccccc--------ccccccchhhHHHHHHHH
Confidence 799999999999976 6799999999998766543221 23467899999884 467899999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|+.| |..||.+.+ ..+.+..+....+...|+.+++.+..||+.||...|++||+|.|+.+.++..+.
T Consensus 458 EIATYGMsPYPGid-lSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 458 EIATYGMSPYPGID-LSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHHhcCCCCCCCcc-HHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 9986 889999866 455677777788889999999999999999999999999999999998877653
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=167.04 Aligned_cols=140 Identities=29% Similarity=0.482 Sum_probs=105.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+||+++.+ +.+||+|||++...... .......|+..|+|||.+.. ..++.++|+||+|+++||
T Consensus 140 vH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGvil~e 210 (292)
T cd06658 140 IHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR--------LPYGTEVDIWSLGIMVIE 210 (292)
T ss_pred eecCCCHHHEEEcCC-CCEEEccCcchhhcccccccCceeecCccccCHHHHcc--------CCCCchhhHHHHHHHHHH
Confidence 699999999999976 67999999998643221 11233568899999998743 457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCC--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 152 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~ 152 (198)
+++|..||.......... ......... .....+..+.+++.+||..||.+||+++++++ +.|+....++.
T Consensus 211 l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~--~~~~~~~~~~~ 282 (292)
T cd06658 211 MIDGEPPYFNEPPLQAMR-RIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ--HPFLKLAGPPS 282 (292)
T ss_pred HHhCCCCCCCCCHHHHHH-HHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhh--ChhhhccCCcc
Confidence 999999998765443322 222222222 22347889999999999999999999999998 77766555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=174.05 Aligned_cols=124 Identities=27% Similarity=0.389 Sum_probs=97.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++.... .......+|+..|+|||++.+ ..++.++|+||+||++|+
T Consensus 118 vH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~e 188 (325)
T cd05604 118 VYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK--------QPYDNTVDWWCLGAVLYE 188 (325)
T ss_pred eecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcC--------CCCCCcCccccccceehh
Confidence 699999999999976 6799999999874322 222334579999999999853 567889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 135 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~ 135 (198)
|++|..||........ ..... ......+...+..+.+++.+||..+|.+||++.
T Consensus 189 l~~G~~pf~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 189 MLYGLPPFYCRDVAEM-YDNIL-HKPLVLRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred hhcCCCCCCCCCHHHH-HHHHH-cCCccCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 9999999987654332 22222 233344556889999999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=165.77 Aligned_cols=129 Identities=29% Similarity=0.513 Sum_probs=100.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc----ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+|+||||+||+++.+ +.+||+|||+++..... .......++..|+|||.+.+ ..++.++|+||+||+
T Consensus 128 ~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~i 198 (266)
T cd06651 128 VHRDIKGANILRDSA-GNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG--------EGYGRKADVWSLGCT 198 (266)
T ss_pred eeCCCCHHHEEECCC-CCEEEccCCCccccccccccCCccccCCccccccCHHHhCC--------CCCCchhhhHHHHHH
Confidence 699999999999966 67999999998743211 11123457889999998853 557889999999999
Q ss_pred HHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 77 LWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+|++++|+.||..................+.+|..+++.+.+++ +||..+|++||+++++++
T Consensus 199 ~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 199 VVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 99999999999876554444333333344566777889999998 677789999999999988
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-25 Score=163.83 Aligned_cols=129 Identities=30% Similarity=0.481 Sum_probs=102.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.++++|||++....... ......|+..|+|||++.+ ..++.++|+||+|+++|+
T Consensus 122 ~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dv~slG~i~~~ 192 (255)
T cd08219 122 LHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN--------MPYNNKSDIWSLGCILYE 192 (255)
T ss_pred ccCCCCcceEEECCC-CcEEEcccCcceeecccccccccccCCccccCHHHHcc--------CCcCchhhhhhhchhhee
Confidence 699999999999976 679999999987543222 2234568889999998753 457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
|++|..||........ ............+..++..+.+++.+||..||.+||++.+++.
T Consensus 193 l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 193 LCTLKHPFQANSWKNL-ILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred hhhccCCCCCCCHHHH-HHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 9999999987554332 2333344444567778999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=163.02 Aligned_cols=130 Identities=28% Similarity=0.454 Sum_probs=104.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.++..+||+|||++.............|+..|++||.+.+ ..++.++|+||+|+++|++
T Consensus 123 ~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~~l 194 (256)
T cd08220 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG--------KPYNQKSDIWALGCVLYEL 194 (256)
T ss_pred ecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccC--------CCCCcccchHHHHHHHHHH
Confidence 69999999999986656789999999976544333334568889999998753 4567899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
++|..||.+...... ............+..+++++.+++.+||..+|.+||++.++++
T Consensus 195 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 195 ASLKRAFEAANLPAL-VLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HhCCCCcccCchHHH-HHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 999999977654332 2333334445567778999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=163.99 Aligned_cols=129 Identities=27% Similarity=0.526 Sum_probs=102.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-------cccCCCCccceecccccccccccccccCCCCchhhHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 73 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~ 73 (198)
+||||||+||+++.+ +.+||+|||+++...... ......|+..|++||.+.+ ..++.++|+||+
T Consensus 128 vH~di~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~sl 198 (267)
T cd06628 128 IHRDIKGANILVDNK-GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--------TSYTRKADIWSL 198 (267)
T ss_pred ccccCCHHHEEEcCC-CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhcc--------CCCCchhhhHHH
Confidence 699999999999866 679999999987543211 1112357889999998753 457889999999
Q ss_pred HHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 74 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 74 G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
|+++|++++|..||.+....... ........+.++..++..+.+++.+||+.||.+||++.++++
T Consensus 199 G~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 199 GCLVVEMLTGKHPFPDCTQLQAI-FKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHHhhCCCCCCCccHHHHH-HHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 99999999999999876543332 233334556677789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=165.26 Aligned_cols=140 Identities=27% Similarity=0.446 Sum_probs=103.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+||+++.+ +.+||+|||++...... .......++..|++||++.... .....++.++|+||+||++|+
T Consensus 125 ~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGvil~e 200 (282)
T cd06643 125 IHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET---SKDRPYDYKADVWSLGITLIE 200 (282)
T ss_pred eecCCCcccEEEccC-CCEEEccccccccccccccccccccccccccCHhhccccC---CCCCCCCccchhhhHHHHHHH
Confidence 699999999999976 67999999998654322 1223456889999999874211 012456789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHcc-CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKH-ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+++|..||................ .....+..++.++.+++.+||..||.+||++.++++ +.++.
T Consensus 201 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~~ 266 (282)
T cd06643 201 MAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ--HPFVT 266 (282)
T ss_pred HccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--CCCEe
Confidence 999999998765443332222111 122345668899999999999999999999999988 55543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=162.45 Aligned_cols=135 Identities=30% Similarity=0.452 Sum_probs=103.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.++|+|||++....... ......++..|++||.+.+ ..++.++|+||||+++|+
T Consensus 128 ~h~dl~p~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~~ 198 (267)
T cd08224 128 MHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYE 198 (267)
T ss_pred ecCCcChhhEEECCC-CcEEEeccceeeeccCCCcccceecCCccccCHHHhcc--------CCCCchhcHHHHHHHHHH
Confidence 699999999999976 679999999987543221 1223467889999998753 557889999999999999
Q ss_pred HHcCCCCCCCCCc-HHHHHHHHHccCCCCCCC-CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 80 LLTNRLPFEGMSN-LQAAYAAAFKHARPGLPE-DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 80 ~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~p~-~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
+++|..||..... .............++.|. .++.++.+++.+||..+|++||++.++++.|+.+
T Consensus 199 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 199 MAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 9999999965442 222222222233334444 6788999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=175.09 Aligned_cols=139 Identities=25% Similarity=0.373 Sum_probs=102.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+|||++.+ +.+||+|||++....... .....+||+.|+|||++... .....++.++|+||+||++|
T Consensus 164 vHrDLKp~NILl~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~~~~~DiwSlG~ily 238 (370)
T cd05621 164 IHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLF 238 (370)
T ss_pred EecCCCHHHEEECCC-CCEEEEecccceecccCCceecccCCCCcccCCHHHHhcc----CCCCCCCcccCEEeehHHHH
Confidence 699999999999976 689999999997543222 22356799999999998531 01134678999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCCCC--CCcHHHHHHHHHhcccCCCC--CCCHHHHHHHHHHHHh
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNL--RPSFSQIIRMLNAFLF 146 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~l~~~~l~~dp~~--Rps~~~~l~~l~~~~~ 146 (198)
+|++|..||.+...................|. .++..+.+++.+||..++.. |+++.++++ +.|+.
T Consensus 239 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~--hp~~~ 308 (370)
T cd05621 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ--HPFFK 308 (370)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc--CcccC
Confidence 99999999987664433322222222334444 46899999999999855543 889999999 56654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-25 Score=166.52 Aligned_cols=135 Identities=25% Similarity=0.399 Sum_probs=100.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.++|+|||++...... .......|+..|+|||.+.... .....++.++|+||||+++|+
T Consensus 143 vH~dl~~~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~---~~~~~~~~~~DvwslG~~l~e 218 (282)
T cd06636 143 IHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDYRSDIWSLGITAIE 218 (282)
T ss_pred ccCCCCHHHEEECCC-CCEEEeeCcchhhhhccccCCCcccccccccCHhhcCccc---CcCcCCCcccchhHHHHHHHH
Confidence 699999999999976 67999999998744321 1223456889999999874210 012456789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+++|..||........................++.++.+++.+||..||.+||++.++++
T Consensus 219 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 219 MAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 999999997655433332222111222223457899999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=160.96 Aligned_cols=132 Identities=32% Similarity=0.566 Sum_probs=100.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccc---cCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+||+++.+ +.+||+|||++......... ....++..|++||.+.+ ..++.++|+||||+++
T Consensus 115 ~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~i~ 185 (251)
T cd05041 115 IHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY--------GRYTSESDVWSYGILL 185 (251)
T ss_pred ehhhcCcceEEEcCC-CcEEEeeccccccccCCcceeccccCcceeccCChHhhcc--------CCCCcchhHHHHHHHH
Confidence 699999999999976 67999999998754321111 11233567999998753 5678899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
|++++ |..||........ ............+..++..+.+++.+||..+|.+||++.++++.|+
T Consensus 186 ~~l~t~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 186 WETFSLGDTPYPGMSNQQT-RERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHhccCCCCccCCHHHH-HHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 99998 7888876654332 2222233344556778999999999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=161.90 Aligned_cols=131 Identities=27% Similarity=0.534 Sum_probs=101.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccc--cCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||||+||+++.+ +.+||+|||+++........ ....++..|++||.+.+ ..++.++|+||||+++|
T Consensus 122 ~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Di~slG~~l~ 192 (256)
T cd05113 122 IHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY--------SKFSSKSDVWAFGVLMW 192 (256)
T ss_pred eccccCcceEEEcCC-CCEEECCCccceecCCCceeecCCCccChhhCCHHHHhc--------CcccchhHHHHHHHHHH
Confidence 699999999999966 67999999998754332211 11234568999998753 45788999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
++++ |..||....... .............+...+..+.+++.+||..+|.+||++.+++..|
T Consensus 193 ~l~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 193 EVYSLGKMPYERFNNSE-TVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HHhcCCCCCcCcCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 9998 999997655432 2233333444455666789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=174.92 Aligned_cols=139 Identities=24% Similarity=0.386 Sum_probs=101.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+|||++.+ +.+||+|||++........ .....||+.|+|||++..... .....++.++|||||||++|
T Consensus 124 ~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~~DiwslG~il~ 200 (330)
T cd05601 124 VHRDIKPENVLIDRT-GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG--DGKGTYGVECDWWSLGVIAY 200 (330)
T ss_pred EcccCchHheEECCC-CCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccc--cccCCCCCcceeecccceee
Confidence 699999999999976 6799999999975432221 223478999999998753110 01245778999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCCC--CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
+|++|..||.+...................| ..+++++.+++.+||. +|.+||++.+++. +.|+
T Consensus 201 el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~--h~~~ 266 (330)
T cd05601 201 EMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC--HPFF 266 (330)
T ss_pred eeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC--CCCc
Confidence 9999999998765433322222111112223 3478999999999997 9999999999987 5444
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=164.29 Aligned_cols=134 Identities=30% Similarity=0.506 Sum_probs=104.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||+|+||+++.+ +.++|+|||+++..... .......++..|++||.+.+ ..++.++|+||||+++|+
T Consensus 120 ~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~sDv~slG~il~~ 190 (274)
T cd06609 120 IHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ--------SGYDEKADIWSLGITAIE 190 (274)
T ss_pred ccCCCCHHHEEECCC-CCEEEcccccceeecccccccccccCCccccChhhhcc--------CCCCchhhHHHHHHHHHH
Confidence 699999999999976 67999999999754432 22234568889999999853 457899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCC-CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~-~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+++|..||......... ........+..+.. +++++.+++.+||..+|.+||+++++++ +.|+.
T Consensus 191 l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~--~~~~~ 255 (274)
T cd06609 191 LAKGEPPLSDLHPMRVL-FLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK--HKFIK 255 (274)
T ss_pred HHhCCCCcccCchHHHH-HHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh--Chhhc
Confidence 99999999765543322 22233344444555 7899999999999999999999999998 66654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=161.99 Aligned_cols=133 Identities=29% Similarity=0.608 Sum_probs=102.2
Q ss_pred CCCCCCCCCeEEcCCC----CceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHH
Q 029154 1 MGKFMKEDNLLLTPDQ----KSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 73 (198)
Q Consensus 1 iH~dlKp~NIll~~~~----~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~ 73 (198)
+|+||||+||+++.++ ..++|+|||+++....... .....++..|++||.+.. ..++.++|+|||
T Consensus 128 ~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~sl 199 (269)
T cd05044 128 IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD--------GKFTTQSDVWSF 199 (269)
T ss_pred ccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHcc--------CCcccchhHHHH
Confidence 6999999999998653 1699999999874432211 122345678999998753 567889999999
Q ss_pred HHHHHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 74 GIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 74 G~~l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
|+++|++++ |..||........ ............+..++..+.+++.+||..+|.+||++.++++.|+
T Consensus 200 G~il~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 200 GVLMWEILTLGQQPYPALNNQEV-LQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHHHHHHHcCCCCCcccCHHHH-HHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 999999997 9999976554332 2222333445566778899999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=164.18 Aligned_cols=133 Identities=26% Similarity=0.498 Sum_probs=101.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+||+++.+.+.+||+|||++..... ........|+..|++||.+.. ....++.++|+||+|+++|+
T Consensus 130 ~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~~Dv~slGvvl~~ 203 (268)
T cd06624 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK------GPRGYGAPADIWSLGCTIVE 203 (268)
T ss_pred eecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhcc------ccccCCchhhhHHHHHHHHH
Confidence 69999999999986556899999999864332 122223467889999998743 12346789999999999999
Q ss_pred HHcCCCCCCCCCcHHHH-HHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAA-YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+++|..||......... .........+.+|..+++++.+++.+||..+|.+||++.+++.
T Consensus 204 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 204 MATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 99999999754432222 2222223445567778999999999999999999999999988
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=174.54 Aligned_cols=133 Identities=24% Similarity=0.440 Sum_probs=98.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---------------------------------------cccCCCC
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---------------------------------------MMTAETG 41 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---------------------------------------~~~~~~g 41 (198)
|||||||+|||++.+ +.+||+|||++....... .....+|
T Consensus 123 vH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 201 (364)
T cd05599 123 IHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVG 201 (364)
T ss_pred EeccCCHHHeEECCC-CCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhccccccccccc
Confidence 699999999999976 679999999986322110 0112468
Q ss_pred ccceecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCC--CCcHHHHHH
Q 029154 42 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFI 119 (198)
Q Consensus 42 t~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~l 119 (198)
|+.|+|||++.. ..++.++|+||+||++|||++|..||.+...................|. .+++++.++
T Consensus 202 t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 273 (364)
T cd05599 202 TPDYIAPEVFLQ--------TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDL 273 (364)
T ss_pred CccccCHHHHcC--------CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHH
Confidence 999999999753 5678999999999999999999999987665433322221122223333 468999999
Q ss_pred HHHhcccCCCCCCC---HHHHHHHHHHHH
Q 029154 120 VQSCWVEDPNLRPS---FSQIIRMLNAFL 145 (198)
Q Consensus 120 ~~~~l~~dp~~Rps---~~~~l~~l~~~~ 145 (198)
+.+|+. +|.+|++ +.++++ +.|+
T Consensus 274 i~~ll~-~p~~R~~~~~~~~ll~--h~~~ 299 (364)
T cd05599 274 IKRLCC-EAERRLGNNGVNEIKS--HPFF 299 (364)
T ss_pred HHHHcc-CHhhcCCCCCHHHHhc--CCCc
Confidence 999996 8999987 998888 4444
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=170.58 Aligned_cols=132 Identities=22% Similarity=0.314 Sum_probs=92.1
Q ss_pred CCCCCCCCCeEEcC---CCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHH
Q 029154 1 MGKFMKEDNLLLTP---DQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 73 (198)
Q Consensus 1 iH~dlKp~NIll~~---~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~ 73 (198)
|||||||+|||+.. +.+.+||+|||+++...... ......||..|+|||++.+ ...++.++||||+
T Consensus 130 vH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSl 202 (317)
T cd07867 130 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAI 202 (317)
T ss_pred EcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcC-------CCccCcHHHHHhH
Confidence 69999999999942 23579999999997543221 1234568899999998753 2457889999999
Q ss_pred HHHHHHHHcCCCCCCCCCcHH--------HHHHHHHc--cC-----------C------------------------CCC
Q 029154 74 GIVLWELLTNRLPFEGMSNLQ--------AAYAAAFK--HA-----------R------------------------PGL 108 (198)
Q Consensus 74 G~~l~e~~~g~~p~~~~~~~~--------~~~~~~~~--~~-----------~------------------------~~~ 108 (198)
||++|||++|.+||....... ........ .. . ...
T Consensus 203 G~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (317)
T cd07867 203 GCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKH 282 (317)
T ss_pred HHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcc
Confidence 999999999999986432110 00000000 00 0 000
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 109 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 109 p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
....+..+.+++.+||..||.+|||+.|+++
T Consensus 283 ~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 283 KVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred cCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 1123566889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=186.41 Aligned_cols=139 Identities=24% Similarity=0.387 Sum_probs=107.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc--cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||||.. |++||+|||.+-.+.. .....+.+|||-|.+||++... ....+.|+..+|+||+|+++|
T Consensus 197 VHRDiKPDNvLld~~-GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~---~~~~g~yG~ecDwWSlGV~~Y 272 (1317)
T KOG0612|consen 197 VHRDIKPDNVLLDKS-GHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQ---GDGKGEYGRECDWWSLGVFMY 272 (1317)
T ss_pred eeccCCcceeEeccc-CcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhh---cCCccccCCccchhhhHHHHH
Confidence 799999999999987 8999999998865442 2234567999999999998541 112377899999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCCC--CCCcHHHHHHHHHhcccCCCCCCC---HHHHHHHHHHHHh
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPS---FSQIIRMLNAFLF 146 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~l~~~~l~~dp~~Rps---~~~~l~~l~~~~~ 146 (198)
||+.|..||+...-....-.++.......+| ..+++++.+||.+.+. +|..|.. ++++.. |.|+.
T Consensus 273 EMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~--HpFF~ 342 (1317)
T KOG0612|consen 273 EMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN--HPFFE 342 (1317)
T ss_pred HHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh--Ccccc
Confidence 9999999998755433333334344455666 4589999999999875 6889987 899888 55554
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-25 Score=171.16 Aligned_cols=136 Identities=34% Similarity=0.536 Sum_probs=98.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCC-CCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
||||||++|||||.+ ..+||+|||+++.... .....+. .||.+|++||++.. +..+.++||||||+++.
T Consensus 199 iHrDiKssNILLD~~-~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~--------g~lt~KsDVySFGVvll 269 (361)
T KOG1187|consen 199 IHRDIKSSNILLDED-FNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST--------GKLTEKSDVYSFGVVLL 269 (361)
T ss_pred ecCCCCHHHeeECCC-CCEEccCccCcccCCccccceeeecCCCCccCChhhhcc--------CCcCcccccccchHHHH
Confidence 799999999999976 7899999999976543 3322233 89999999999853 56789999999999999
Q ss_pred HHHcCCCCCCCCC-----cHHHHHHHHH------ccCCCCCC-CCCc-----HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 79 ELLTNRLPFEGMS-----NLQAAYAAAF------KHARPGLP-EDIS-----PDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 79 e~~~g~~p~~~~~-----~~~~~~~~~~------~~~~~~~p-~~~~-----~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
|+++|+.+..... .......... +...+.+. ...+ ..+..+..+|+..+|.+||+|.+|+++|
T Consensus 270 Elitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 270 ELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred HHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 9999998776322 1111111111 11222222 2233 2255788999999999999999999988
Q ss_pred HHHH
Q 029154 142 NAFL 145 (198)
Q Consensus 142 ~~~~ 145 (198)
+...
T Consensus 350 ~~~~ 353 (361)
T KOG1187|consen 350 EGIL 353 (361)
T ss_pred Hhhc
Confidence 5543
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=163.79 Aligned_cols=132 Identities=28% Similarity=0.552 Sum_probs=101.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++|+|||||++
T Consensus 152 ~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il 222 (288)
T cd05050 152 VHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVL 222 (288)
T ss_pred ecccccHhheEecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhc--------CCCCchhHHHHHHHHH
Confidence 699999999999876 6799999999874332211 112344667999998743 5678999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
|++++ |..||.+..... .............+..++.++.+++.+||..||.+||++.|+++.|+
T Consensus 223 ~el~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 223 WEIFSYGMQPYYGMAHEE-VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHhCCCCCCCCCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 99997 888887665433 22333333444456678899999999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-25 Score=175.49 Aligned_cols=133 Identities=26% Similarity=0.432 Sum_probs=97.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-----------------------------------------------
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT----------------------------------------------- 33 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~----------------------------------------------- 33 (198)
|||||||+|||++.+ +.+||+|||++......
T Consensus 123 vHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (382)
T cd05625 123 IHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQ 201 (382)
T ss_pred ecCCCCHHHEEECCC-CCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccc
Confidence 699999999999976 68999999997421100
Q ss_pred -ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCC--C
Q 029154 34 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--E 110 (198)
Q Consensus 34 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p--~ 110 (198)
......+||+.|+|||++.+ ..++.++|+||+||++|||++|..||.+...................| .
T Consensus 202 ~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 273 (382)
T cd05625 202 RCLAHSLVGTPNYIAPEVLLR--------TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQA 273 (382)
T ss_pred cccccccccCcccCCHHHhcC--------CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcc
Confidence 00113468999999999853 567899999999999999999999998766544333322212222233 4
Q ss_pred CCcHHHHHHHHHhcccCCCCCCC---HHHHHHHHHHHH
Q 029154 111 DISPDLAFIVQSCWVEDPNLRPS---FSQIIRMLNAFL 145 (198)
Q Consensus 111 ~~~~~~~~l~~~~l~~dp~~Rps---~~~~l~~l~~~~ 145 (198)
.+++++.+++.+++ .+|.+|++ +.++++ |.|+
T Consensus 274 ~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~--hp~f 308 (382)
T cd05625 274 KLSPEASDLIIKLC-RGPEDRLGKNGADEIKA--HPFF 308 (382)
T ss_pred cCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc--CCCc
Confidence 57899999999976 59999987 888877 4443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=163.72 Aligned_cols=133 Identities=25% Similarity=0.456 Sum_probs=98.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+|+||||+||+++.+ +.+||+|||++........ .....++..|+|||.+.. ..++.++|+||||+++
T Consensus 151 ~H~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~~l 221 (295)
T cd05097 151 VHRDLATRNCLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--------GKFTTASDVWAFGVTL 221 (295)
T ss_pred eccccChhhEEEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhcc--------CCcCchhhHHHHHHHH
Confidence 699999999999966 6799999999874322211 122345678999998753 5678999999999999
Q ss_pred HHHHc--CCCCCCCCCcHHHHHHHH--H----ccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 78 WELLT--NRLPFEGMSNLQAAYAAA--F----KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 78 ~e~~~--g~~p~~~~~~~~~~~~~~--~----~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
|++++ +..||............. . .......+..+++.+.+++.+||..||.+||+++++++.|+
T Consensus 222 ~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 222 WEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 99987 667887654332211110 0 11112335567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=163.83 Aligned_cols=134 Identities=29% Similarity=0.541 Sum_probs=103.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.+ +.++|+|||++........ ....++..|++||.+.+ ..++.++|+||+|+++|++
T Consensus 123 ~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~~l~~l 192 (265)
T cd06605 123 IHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQG--------NDYSVKSDIWSLGLSLIEL 192 (265)
T ss_pred ecCCCCHHHEEECCC-CCEEEeecccchhhHHHHh-hcccCChhccCHHHHcC--------CCCCchhhHHHHHHHHHHH
Confidence 699999999999976 6799999999864432211 12668889999998753 4678899999999999999
Q ss_pred HcCCCCCCCCC----cHHHHHHHHHccCCCCCCCC-CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMS----NLQAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~----~~~~~~~~~~~~~~~~~p~~-~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++|..||.... ..............+..+.. ++.++.+++.+||..||.+||++.+++. +.|+.
T Consensus 193 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~--~~~~~ 261 (265)
T cd06605 193 ATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE--HPFIK 261 (265)
T ss_pred HhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh--Cchhh
Confidence 99999987542 22222233333444455555 8899999999999999999999999998 56553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=160.50 Aligned_cols=130 Identities=32% Similarity=0.613 Sum_probs=101.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+ +.+||+|||++...... ......+..|++||.+.+ ..++.++|+||+|+++|++
T Consensus 122 ~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~l~el 190 (254)
T cd05083 122 VHRDLAARNILVSED-GVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKH--------KKFSSKSDVWSYGVLLWEV 190 (254)
T ss_pred eccccCcceEEEcCC-CcEEECCCccceecccc--CCCCCCCceecCHHHhcc--------CCcCchhhHHHHHHHHHHH
Confidence 699999999999976 67999999998753321 122334568999998743 5678899999999999999
Q ss_pred Hc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 81 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 81 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
++ |..||........ ............+..+++.+.+++.+||..+|.+||+++++++.|+
T Consensus 191 ~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 191 FSYGRAPYPKMSLKEV-KECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HhCCCCCCccCCHHHH-HHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 97 9999987654332 2233333444556678899999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=163.51 Aligned_cols=130 Identities=33% Similarity=0.571 Sum_probs=102.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-------cccccCCCCccceecccccccccccccccCCCCchhhHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 73 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~ 73 (198)
+|+||||+||+++.+ +.+||+|||++..... ........|+..|++||.+.+ ..++.++|+||+
T Consensus 124 ~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~sl 194 (265)
T cd06631 124 VHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE--------SGYGRKSDIWSI 194 (265)
T ss_pred ccCCcCHHhEEECCC-CeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcC--------CCCcchhhHHHH
Confidence 699999999999966 6899999999864321 111223467889999999853 457889999999
Q ss_pred HHHHHHHHcCCCCCCCCCcHHHHHHHHHc-cCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 74 GIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 74 G~~l~e~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
|+++|++++|..||............... ...+.++..++.++.+++.+||..+|.+||++.++++
T Consensus 195 G~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 195 GCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 99999999999999876654433322222 2344567778999999999999999999999999987
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=170.60 Aligned_cols=135 Identities=24% Similarity=0.383 Sum_probs=100.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+ +.+||+|||+++............++..|+|||.+.+ ..++.++|+||+||++|+|
T Consensus 140 ~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~~l 210 (353)
T cd07850 140 IHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEM 210 (353)
T ss_pred eeCCCCHHHEEECCC-CCEEEccCccceeCCCCCCCCCCcccccccCHHHHhC--------CCCCCchhhHhHHHHHHHH
Confidence 699999999999976 6799999999986544333344568889999998753 5678999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccC--------------------CCC--------------C-------CCCCcHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHA--------------------RPG--------------L-------PEDISPDLAFI 119 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~--------------------~~~--------------~-------p~~~~~~~~~l 119 (198)
++|+.||................. .+. . +...+..+.++
T Consensus 211 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 290 (353)
T cd07850 211 IRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDL 290 (353)
T ss_pred HHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHH
Confidence 999999976553221111000000 000 0 11235678999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 120 VQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 120 ~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+.+||..||.+||++.++++ +.|+.
T Consensus 291 i~~~L~~dP~~R~t~~eiL~--~~~~~ 315 (353)
T cd07850 291 LSKMLVIDPEKRISVDDALQ--HPYIN 315 (353)
T ss_pred HHHHcCCChhhCcCHHHHhc--ChhHh
Confidence 99999999999999999998 66664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=163.88 Aligned_cols=144 Identities=24% Similarity=0.454 Sum_probs=107.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.+ +.+||+|||++...... ......++..|++||.+.+.... ....++.++|+||+||++|++
T Consensus 125 ~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~~DiwslG~il~~l 200 (286)
T cd06622 125 IHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPN--QNPTYTVQSDVWSLGLSILEM 200 (286)
T ss_pred eeCCCCHHHEEECCC-CCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCC--ccCCCCcccchHhHHHHHHHH
Confidence 699999999999976 67999999998754322 22345688899999987531110 113457899999999999999
Q ss_pred HcCCCCCCCCCcHHH--HHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 81 LTNRLPFEGMSNLQA--AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
++|..||........ ..........+.++..+++++.+++.+||..+|.+||++.+++. +.|+.....
T Consensus 201 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~--~~~~~~~~~ 270 (286)
T cd06622 201 ALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE--HPWLVKYKN 270 (286)
T ss_pred HhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc--ChhhhhccC
Confidence 999999976443221 11222334455667779999999999999999999999999998 677655443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-25 Score=173.19 Aligned_cols=136 Identities=26% Similarity=0.378 Sum_probs=98.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++...... .....+||+.|+|||++... .....++.++|+||+||++|
T Consensus 164 vHrDLkp~NIll~~~-~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~~~~DiwSlGvily 238 (371)
T cd05622 164 IHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLY 238 (371)
T ss_pred EeCCCCHHHEEECCC-CCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhcc----CCCccCCCccceeehhHHHH
Confidence 699999999999976 789999999997543221 12356799999999997531 01134788999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCCC--CCCcHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNL--RPSFSQIIRML 141 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~l~~~~l~~dp~~--Rps~~~~l~~l 141 (198)
||++|..||.+..................+| ..++..+.+++.+||..++.+ |+++.+++++.
T Consensus 239 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 239 EMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 9999999998765433322222222222333 358999999999999844432 67999999843
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=163.67 Aligned_cols=130 Identities=25% Similarity=0.308 Sum_probs=97.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++. +.+||+|||++.............++..|++||++.. ...++.++|+||+||++|||
T Consensus 122 ~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slGv~l~el 192 (282)
T cd07831 122 FHRDIKPENILIKD--DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLT-------DGYYGPKMDIWAVGCVFFEI 192 (282)
T ss_pred eecccCHHHEEEcC--CCeEEEecccccccccCCCcCCCCCCcccCChhHhhc-------CCCCCcchhHHHHHHHHHHH
Confidence 69999999999996 6799999999976544333344567889999997643 24567899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHH--cc--------------CCCCC-----------CCCCcHHHHHHHHHhcccCCCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAF--KH--------------ARPGL-----------PEDISPDLAFIVQSCWVEDPNLRPS 133 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~--~~--------------~~~~~-----------p~~~~~~~~~l~~~~l~~dp~~Rps 133 (198)
++|..||.+............ .. ..... ...++..+.+++.+||..+|++||+
T Consensus 193 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 272 (282)
T cd07831 193 LSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT 272 (282)
T ss_pred HcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC
Confidence 999999987654332111100 00 00011 1245789999999999999999999
Q ss_pred HHHHHH
Q 029154 134 FSQIIR 139 (198)
Q Consensus 134 ~~~~l~ 139 (198)
++++++
T Consensus 273 ~~~~l~ 278 (282)
T cd07831 273 AKQALR 278 (282)
T ss_pred HHHHhh
Confidence 999988
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=175.59 Aligned_cols=134 Identities=22% Similarity=0.302 Sum_probs=94.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++...... ......||..|++||++.+ ..++.++|||||||++
T Consensus 282 vHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~~~~sDvwSlGviL 352 (461)
T PHA03211 282 IHRDIKTENVLVNGP-EDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG--------DPYTPSVDIWSAGLVI 352 (461)
T ss_pred EECcCCHHHEEECCC-CCEEEcccCCceecccccccccccccCCCcCCcCHHHHcC--------CCCCchHHHHHHHHHH
Confidence 699999999999976 679999999997543211 1223569999999999853 5688999999999999
Q ss_pred HHHHcCCCCCCCCCc-------HHHHHHHHHccC--CCCC--------------------------C-----CCCcHHHH
Q 029154 78 WELLTNRLPFEGMSN-------LQAAYAAAFKHA--RPGL--------------------------P-----EDISPDLA 117 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~-------~~~~~~~~~~~~--~~~~--------------------------p-----~~~~~~~~ 117 (198)
|||++|..++..... ............ ...+ + ..++.++.
T Consensus 353 ~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (461)
T PHA03211 353 FEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVE 432 (461)
T ss_pred HHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHH
Confidence 999987755432110 011111111000 0000 0 13456889
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 118 FIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 118 ~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
+|+.+||..||.+|||+.|+|+ +.|+
T Consensus 433 dli~~mL~~DP~~RPsa~elL~--hp~f 458 (461)
T PHA03211 433 YLVCRALTFDGARRPSAAELLR--LPLF 458 (461)
T ss_pred HHHHHHcccChhhCcCHHHHhh--Cccc
Confidence 9999999999999999999999 5554
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=164.35 Aligned_cols=142 Identities=28% Similarity=0.474 Sum_probs=103.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+||+++.+ +.+||+|||++...... .......++..|++||.+.+... ....++.++|+|||||++|+
T Consensus 132 ~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Dv~slG~il~e 207 (292)
T cd06644 132 IHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM---KDTPYDYKADIWSLGITLIE 207 (292)
T ss_pred eecCCCcceEEEcCC-CCEEEccCccceeccccccccceecCCccccCceeeccccc---cCCCCCchhhhHhHHHHHHH
Confidence 699999999999866 67999999998643222 11233467889999998743110 12446789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC--CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
+++|..||......... ........+ ..+..++.++.+++.+||..+|++||++.++++ +.++....
T Consensus 208 l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~~~~~ 276 (292)
T cd06644 208 MAQIEPPHHELNPMRVL-LKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE--HPFVSSVT 276 (292)
T ss_pred HhcCCCCCccccHHHHH-HHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc--Cccccccc
Confidence 99999999765543322 222222222 335567889999999999999999999999998 66654433
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-25 Score=165.52 Aligned_cols=131 Identities=33% Similarity=0.647 Sum_probs=100.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc---ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
||+||+++||+++.+ +.+||+|||++...... .......+...|++||.+.. ..++.++||||||+++
T Consensus 125 iH~~l~~~nill~~~-~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~ksDVysfG~~l 195 (259)
T PF07714_consen 125 IHGNLSPSNILLDSN-GQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKD--------GEYTKKSDVYSFGMLL 195 (259)
T ss_dssp EEST-SGGGEEEETT-TEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHH--------SEESHHHHHHHHHHHH
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc--------cccccccccccccccc
Confidence 699999999999976 68999999998755211 11223456778999999854 4478999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
||+++ |..||....... .............+..++..+.+++.+||..||.+||++.++++.|
T Consensus 196 ~ei~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 196 YEILTLGKFPFSDYDNEE-IIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHTTSSGTTTTSCHHH-HHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccccccccccccccc-ccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 99999 678998775433 3334455555667788999999999999999999999999999865
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=164.52 Aligned_cols=131 Identities=26% Similarity=0.385 Sum_probs=96.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++...... .......++..|+|||++.+ ...++.++|+||+|+++|+
T Consensus 123 ~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~~ 194 (285)
T cd07861 123 LHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG-------SPRYSTPVDIWSIGTIFAE 194 (285)
T ss_pred eecCCCHHHEEEcCC-CcEEECcccceeecCCCcccccCCcccccccChHHhcC-------CCCcCcHHHHHHHHHHHHH
Confidence 699999999999976 68999999998744322 12233467889999998753 2456889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccC----------------C-----------CCCCCCCcHHHHHHHHHhcccCCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHA----------------R-----------PGLPEDISPDLAFIVQSCWVEDPNLRP 132 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~----------------~-----------~~~p~~~~~~~~~l~~~~l~~dp~~Rp 132 (198)
+++|+.||.+............... . ......+++++.+++.+||..||.+||
T Consensus 195 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 274 (285)
T cd07861 195 MATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRI 274 (285)
T ss_pred HHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCC
Confidence 9999999987554332221110000 0 001234688999999999999999999
Q ss_pred CHHHHHH
Q 029154 133 SFSQIIR 139 (198)
Q Consensus 133 s~~~~l~ 139 (198)
|+.+++.
T Consensus 275 t~~~ll~ 281 (285)
T cd07861 275 SAKKALN 281 (285)
T ss_pred CHHHHhc
Confidence 9999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=163.46 Aligned_cols=135 Identities=22% Similarity=0.401 Sum_probs=99.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+||||||+||+++.+ +.+||+|||+++...... ......++..|+|||.+.+ ..++.++|+||+|++
T Consensus 131 ~H~dlkp~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~i 201 (284)
T cd05079 131 VHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ--------SKFYIASDVWSFGVT 201 (284)
T ss_pred eecccchheEEEcCC-CCEEECCCccccccccCccceeecCCCCCCccccCHHHhcc--------CCCCccccchhhhhh
Confidence 699999999999976 679999999987543221 1123456778999998743 457889999999999
Q ss_pred HHHHHcCCCCCCCC--------------CcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 77 LWELLTNRLPFEGM--------------SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 77 l~e~~~g~~p~~~~--------------~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
+|+++++..|.... ................+.+..++..+.+|+.+||..+|.+||++.++++.|+
T Consensus 202 l~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 281 (284)
T cd05079 202 LYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE 281 (284)
T ss_pred hhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 99999976553211 1111111122223334456678999999999999999999999999999887
Q ss_pred HH
Q 029154 143 AF 144 (198)
Q Consensus 143 ~~ 144 (198)
.+
T Consensus 282 ~~ 283 (284)
T cd05079 282 AI 283 (284)
T ss_pred hh
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=163.54 Aligned_cols=133 Identities=26% Similarity=0.453 Sum_probs=97.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+|+||||+|||++.+ +.++|+|||+++....... .....++..|++||...+ +.++.++|+|||||++
T Consensus 152 ~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~DiwSlG~~l 222 (296)
T cd05095 152 VHRDLATRNCLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--------GKFTTASDVWAFGVTL 222 (296)
T ss_pred ecccCChheEEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--------CCccchhhhhHHHHHH
Confidence 699999999999866 6799999999875422211 112334678999997643 5678899999999999
Q ss_pred HHHHc--CCCCCCCCCcHHHHHHHH------HccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 78 WELLT--NRLPFEGMSNLQAAYAAA------FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 78 ~e~~~--g~~p~~~~~~~~~~~~~~------~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
||+++ |..||............. ......+.+..+++.+.+++.+||..||.+||++.++++.|+
T Consensus 223 ~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 223 WEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 99997 678887654322211110 011112334567899999999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=165.82 Aligned_cols=139 Identities=22% Similarity=0.335 Sum_probs=101.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++...... .......++..|++||++.+ ...++.++|+||+|+++|+
T Consensus 126 ~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~e 197 (301)
T cd07873 126 LHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLG-------STDYSTQIDMWGVGCIFYE 197 (301)
T ss_pred eCCCCCHHHEEECCC-CcEEECcCcchhccCCCCCcccccceeecccCcHHHhC-------CCCCccHHHHHHHHHHHHH
Confidence 699999999999976 67999999998753322 12233467889999998753 2456789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHcc-----------------CCCCC-----------CCCCcHHHHHHHHHhcccCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKH-----------------ARPGL-----------PEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~-----------------~~~~~-----------p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
|++|..||.+.............. ..... ...+++++.+++.+||..||.+|
T Consensus 198 l~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R 277 (301)
T cd07873 198 MSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKR 277 (301)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccC
Confidence 999999998765432221111000 00001 12467889999999999999999
Q ss_pred CCHHHHHHHHHHHHhhcC
Q 029154 132 PSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~~ 149 (198)
||++++++ +.|+..+.
T Consensus 278 ~t~~eil~--h~~f~~~~ 293 (301)
T cd07873 278 ISAEEAMK--HPYFHCLG 293 (301)
T ss_pred cCHHHHhc--Cccccccc
Confidence 99999999 66665444
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=165.19 Aligned_cols=135 Identities=24% Similarity=0.397 Sum_probs=102.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|||++.+ +.++|+|||++....... .....|+..|++||.+.. ...++.++|+||+||++|++
T Consensus 119 vH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l 189 (279)
T cd05633 119 VYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK-------GTAYDSSADWFSLGCMLFKL 189 (279)
T ss_pred CCCCCCHHHEEECCC-CCEEEccCCcceeccccC-ccCcCCCcCccCHHHhcC-------CCCCCchhhhHHHHHHHHHH
Confidence 699999999999966 679999999986443221 223568999999998742 24578899999999999999
Q ss_pred HcCCCCCCCCCcHH-HHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQ-AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~~l~~~~~ 146 (198)
++|..||....... .............++..+++++.+++.+||..||++|+ +++++++ +.|+.
T Consensus 190 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~--h~~~~ 259 (279)
T cd05633 190 LRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE--HVFFK 259 (279)
T ss_pred HhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh--Ccccc
Confidence 99999996543211 11222222344566778899999999999999999999 5999988 44443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=162.33 Aligned_cols=133 Identities=30% Similarity=0.492 Sum_probs=99.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++....... ......++..|++||.+... ....++.++|+||+|+++|+
T Consensus 123 ~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-----~~~~~~~~~Di~slG~~l~~ 196 (262)
T cd06613 123 IHRDIKGANILLTED-GDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVE-----RKGGYDGKCDIWALGITAIE 196 (262)
T ss_pred eecCCChhhEEECCC-CCEEECccccchhhhhhhhccccccCCccccCchhhccc-----ccCCcCchhhhHHHHHHHHH
Confidence 699999999999976 679999999987543221 22345688899999987531 01257889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC---CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
|++|..||..................+ ..+..++.++.+++.+||..+|.+||++++++.
T Consensus 197 ~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 197 LAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999998766444433322221121 123345788999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=160.93 Aligned_cols=131 Identities=25% Similarity=0.529 Sum_probs=104.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.+ +.+||+|||++.............|+..|++||.+.. ...++.++|+||+|+++|++
T Consensus 124 ~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-------~~~~~~~~D~~slG~~l~~l 195 (258)
T cd06632 124 VHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ-------QGGYGLAADIWSLGCTVLEM 195 (258)
T ss_pred ccCCCCHHHEEECCC-CCEEEccCccceeccccccccccCCCcceeCHHHhcC-------CCCCCchhhhHHHHHHHHHH
Confidence 699999999999976 6799999999875443333345678899999998743 12378899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
++|..||..................+..+..+++++.+++.+||..+|.+||++.+++.
T Consensus 196 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 196 ATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 99999997665444333333223445567778999999999999999999999999987
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-25 Score=174.41 Aligned_cols=133 Identities=22% Similarity=0.369 Sum_probs=97.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----------------------------------------------
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---------------------------------------------- 34 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---------------------------------------------- 34 (198)
|||||||+|||++.+ +.+||+|||+++......
T Consensus 123 vHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (377)
T cd05629 123 IHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNR 201 (377)
T ss_pred eccCCCHHHEEECCC-CCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc
Confidence 699999999999976 689999999985211000
Q ss_pred --cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCC--
Q 029154 35 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE-- 110 (198)
Q Consensus 35 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~-- 110 (198)
.....+||+.|+|||++.+ ..++.++|+||+||++|||++|..||.+..................+|.
T Consensus 202 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 273 (377)
T cd05629 202 RLMAYSTVGTPDYIAPEIFLQ--------QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDI 273 (377)
T ss_pred cccccccCCCccccCHHHHcc--------CCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCC
Confidence 0012468999999999853 5678999999999999999999999987664332222221122233343
Q ss_pred CCcHHHHHHHHHhcccCCCCC---CCHHHHHHHHHHHH
Q 029154 111 DISPDLAFIVQSCWVEDPNLR---PSFSQIIRMLNAFL 145 (198)
Q Consensus 111 ~~~~~~~~l~~~~l~~dp~~R---ps~~~~l~~l~~~~ 145 (198)
.++.++.+++.+||. +|.+| +++.+++. +.|+
T Consensus 274 ~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~--hp~~ 308 (377)
T cd05629 274 HLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS--HPFF 308 (377)
T ss_pred CCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc--CCCc
Confidence 478999999999997 67765 59999988 5444
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-25 Score=179.97 Aligned_cols=134 Identities=22% Similarity=0.373 Sum_probs=102.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cc------c---CCCCccceecccccccccccccccCCCCchhhH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MM------T---AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 70 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~------~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dv 70 (198)
||||||-|||||..+ ++.||||||.+....... .. . ...-|+.|.+||.+.- +.+...+.|+||
T Consensus 168 IHRDLKiENvLls~~-g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDl-----ysg~pI~eKsDI 241 (738)
T KOG1989|consen 168 IHRDLKIENVLLSAD-GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDL-----YSGLPIGEKSDI 241 (738)
T ss_pred chhhhhhhheEEcCC-CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhh-----hcCCCCcchhHH
Confidence 899999999999977 689999999886321111 00 0 0135889999999864 235678999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCC--CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 71 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 71 ws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|+|||++|.++....||........ ......+| +.++..+.+||+.||+.||.+||++-+++..+-.+..
T Consensus 242 WALGclLYkLCy~t~PFe~sg~laI------lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 242 WALGCLLYKLCYFTTPFEESGKLAI------LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred HHHHHHHHHHHHhCCCcCcCcceeE------EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 9999999999999999986543221 12222333 4588999999999999999999999999998766543
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=161.02 Aligned_cols=128 Identities=25% Similarity=0.408 Sum_probs=94.1
Q ss_pred CCCCCCCCCeEEcCCCC------ceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQK------SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 74 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~------~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G 74 (198)
|||||||+|||++.++. .+|++|||++...... ....++..|+|||.+.. ...++.++||||||
T Consensus 127 vH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG 196 (262)
T cd05077 127 VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVED-------SKNLSIAADKWSFG 196 (262)
T ss_pred ECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcC-------CCCCCchhHHHHHH
Confidence 69999999999975531 2899999998644321 23467889999998742 35678899999999
Q ss_pred HHHHHHH-cCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 75 IVLWELL-TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 75 ~~l~e~~-~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
+++||++ .|..||......... ... ..........+.++.+++.+||..||.+||++.++++.+
T Consensus 197 ~~l~el~~~~~~p~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 197 TTLWEICYNGEIPLKDKTLAEKE--RFY-EGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHHHHHhCCCCCCCCcchhHHH--HHH-hcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 9999997 588888754432211 111 111222333567899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=161.00 Aligned_cols=134 Identities=31% Similarity=0.554 Sum_probs=101.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCC---CccceecccccccccccccccCCCCchhhHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAET---GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 74 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~---gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G 74 (198)
+|+||||+||+++.+ ..+||+|||++........ ..... .+..|++||.+.+ ..++.++|+||+|
T Consensus 128 ~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DvwslG 198 (269)
T cd05065 128 VHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY--------RKFTSASDVWSYG 198 (269)
T ss_pred eecccChheEEEcCC-CcEEECCCccccccccCccccccccccCCCcceeecCHhHhcc--------CcccchhhhhhhH
Confidence 699999999999866 6799999999874432111 11111 2457999998753 5678899999999
Q ss_pred HHHHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 75 IVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 75 ~~l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
+++||+++ |..||........ ..........+.+..++..+.+++.+||..+|++||++.+++..|+.+
T Consensus 199 ~~l~e~l~~g~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 199 IVMWEVMSYGERPYWDMSNQDV-INAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHhcCCCCCCCCCCHHHH-HHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99999886 9999977554332 222233334455667889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=166.60 Aligned_cols=140 Identities=31% Similarity=0.490 Sum_probs=105.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+||+++.+ +.++|+|||++....... ......++..|++||.+.+ ..++.++|+||+|+++|+
T Consensus 137 ~H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slGvil~~ 207 (297)
T cd06656 137 IHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIE 207 (297)
T ss_pred ccCCCCHHHEEECCC-CCEEECcCccceEccCCccCcCcccCCccccCHHHHcC--------CCCCcHHHHHHHHHHHHH
Confidence 699999999999966 679999999987543222 1233468889999998753 557889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHH-ccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAF-KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
+++|..||.+............ .......+..++..+.+++.+||..+|.+||++.++++ +.|+....+.
T Consensus 208 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~~~~~~ 278 (297)
T cd06656 208 MVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ--HPFLKLAKPL 278 (297)
T ss_pred HHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--Cchhcccccc
Confidence 9999999976554332221111 11122345668889999999999999999999999999 7776655444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-24 Score=160.64 Aligned_cols=136 Identities=28% Similarity=0.532 Sum_probs=105.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccc---cCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+|+||||+||+++.+ +.+||+|||+++........ ....++..|++||.+. ...++.++|+||||+++
T Consensus 131 ~H~di~p~nil~~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--------~~~~~~~~Di~slG~~l 201 (279)
T cd05057 131 VHRDLAARNVLVKTP-QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL--------HRIYTHKSDVWSYGVTV 201 (279)
T ss_pred EecccCcceEEEcCC-CeEEECCCcccccccCcccceecCCCcccccccCHHHhh--------cCCcCchhhHHHHHHHH
Confidence 699999999999866 67999999999754322211 1122356799999874 35678899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
||+++ |..||.+..... .............|...+.++.+++.+||..||.+||++.++++.|..+..
T Consensus 202 ~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 202 WELMTFGAKPYEGIPAVE-IPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHhcCCCCCCCCCCHHH-HHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99998 999998765432 233333444556677788999999999999999999999999999988744
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=164.03 Aligned_cols=131 Identities=25% Similarity=0.367 Sum_probs=94.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+||+++.+ +.+||+|||+++..... .......++..|+|||++.+ ...++.++|+||+||++|+
T Consensus 121 ~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ 192 (284)
T cd07839 121 LHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAE 192 (284)
T ss_pred ecCCCCHHHEEEcCC-CcEEECccchhhccCCCCCCcCCCccccCCcChHHHhC-------CcccCcHHHHHHHHHHHHH
Confidence 699999999999976 67999999998744322 22334567889999998753 2456889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccC-------------------CC---------CCCCCCcHHHHHHHHHhcccCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHA-------------------RP---------GLPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~-------------------~~---------~~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
|++|..|+................. .+ .....+++++.+++.+||..||.+|
T Consensus 193 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 272 (284)
T cd07839 193 LANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQR 272 (284)
T ss_pred HHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhc
Confidence 9999888644333222211111000 00 0112367889999999999999999
Q ss_pred CCHHHHHH
Q 029154 132 PSFSQIIR 139 (198)
Q Consensus 132 ps~~~~l~ 139 (198)
||++++++
T Consensus 273 ~t~~~il~ 280 (284)
T cd07839 273 ISAEEALQ 280 (284)
T ss_pred CCHHHHhc
Confidence 99999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-24 Score=159.57 Aligned_cols=133 Identities=34% Similarity=0.569 Sum_probs=103.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||||+||+++.+ +.+||+|||++........ .....++..|++||.+.. ..++.++|+||||+++|
T Consensus 124 ~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~ 194 (260)
T cd05073 124 IHRDLRAANILVSAS-LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLM 194 (260)
T ss_pred cccccCcceEEEcCC-CcEEECCCcceeeccCCCcccccCCcccccccCHhHhcc--------CCcCccccchHHHHHHH
Confidence 699999999999966 6899999999864432211 112345677999998753 55788999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
++++ |..||.+...... ............+...+.++.+++.+||..+|++||++.++++.|+.
T Consensus 195 ~l~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 195 EIVTYGRIPYPGMSNPEV-IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHhcCCCCCCCCCHHHH-HHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 9998 8999987654322 22333344445566788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=162.13 Aligned_cols=130 Identities=34% Similarity=0.551 Sum_probs=99.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||+|+||+++.+ +.+||+|||++....... ......++..|++||.+.+ ..++.++|+||||+++|+
T Consensus 121 ~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~s~G~il~~ 191 (256)
T cd06612 121 IHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE--------IGYNNKADIWSLGITAIE 191 (256)
T ss_pred ccCCCCcceEEECCC-CcEEEcccccchhcccCccccccccCCccccCHHHHhc--------CCCCchhhHHHHHHHHHH
Confidence 699999999999976 679999999987544322 2233457889999998753 467889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHc-cCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+++|..||............... ......+..++.++.+++.+||..||.+||++.++++
T Consensus 192 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 192 MAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 99999999865543332221111 1111234457789999999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=181.09 Aligned_cols=140 Identities=23% Similarity=0.318 Sum_probs=102.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-------------------ccccCCCCccceeccccccccccccccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-------------------EMMTAETGTYRWMAPELYSTVTLRQGEK 61 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 61 (198)
|||||||+|||++.+ +.+||+|||+++..... ......+||+.|+|||++.+
T Consensus 135 IHRDLKPeNILLd~d-g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-------- 205 (932)
T PRK13184 135 LHRDLKPDNILLGLF-GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-------- 205 (932)
T ss_pred cccCCchheEEEcCC-CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--------
Confidence 799999999999976 67999999999743100 00112468999999998753
Q ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCC-CCCCCCCcHHHHHHHHHhcccCCCCCC-CHHHHHH
Q 029154 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR-PGLPEDISPDLAFIVQSCWVEDPNLRP-SFSQIIR 139 (198)
Q Consensus 62 ~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~l~~~~l~~dp~~Rp-s~~~~l~ 139 (198)
..++.++|+||+||++|||++|..||.................. ......+++.+.+++.+||..||.+|+ +++++++
T Consensus 206 ~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 206 VPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 56789999999999999999999999764432222211111111 111235788999999999999999995 6788888
Q ss_pred HHHHHHhhcC
Q 029154 140 MLNAFLFTLR 149 (198)
Q Consensus 140 ~l~~~~~~~~ 149 (198)
.|+.++....
T Consensus 286 ~Le~~lq~~p 295 (932)
T PRK13184 286 DLEPHLQGSP 295 (932)
T ss_pred HHHHHHhcCc
Confidence 8888876543
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-24 Score=158.55 Aligned_cols=131 Identities=30% Similarity=0.559 Sum_probs=99.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||||+||+++.+ +.+||+|||+++....... .....++..|++||.+.+ ..++.++|+||+|+++|
T Consensus 122 ~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~--------~~~~~~~Dv~slG~~l~ 192 (256)
T cd05112 122 IHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF--------SKYSSKSDVWSFGVLMW 192 (256)
T ss_pred cccccccceEEEcCC-CeEEECCCcceeecccCcccccCCCccchhhcCHhHhcc--------CCcChHHHHHHHHHHHH
Confidence 699999999999866 6799999999874432211 112234578999998753 55788999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
|+++ |..||....... .............+...+..+.+++.+||..+|++||++.+++++|
T Consensus 193 el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 193 EVFSEGKTPYENRSNSE-VVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHcCCCCCCCcCCHHH-HHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 9998 899997655322 2222233334444566789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=163.64 Aligned_cols=134 Identities=25% Similarity=0.474 Sum_probs=100.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+|||++.+ +.+||+|||++...... .....+|+..|++||++.+ ..++.++|+||+|+++|++
T Consensus 117 ~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~~l 186 (279)
T cd06619 117 LHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISG--------EQYGIHSDVWSLGISFMEL 186 (279)
T ss_pred eeCCCCHHHEEECCC-CCEEEeeCCcceecccc-cccCCCCChhhcCceeecC--------CCCCCcchHHHHHHHHHHH
Confidence 699999999999976 67999999998754322 2334578999999999853 5678899999999999999
Q ss_pred HcCCCCCCCCCcHH------HHHHHHHccCCCCC-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQ------AAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~------~~~~~~~~~~~~~~-p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++|..||....... ...........+.. ....++++.+++.+||..+|.+||++.++++ +.|+.
T Consensus 187 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~--~~~~~ 257 (279)
T cd06619 187 ALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD--HPFIV 257 (279)
T ss_pred HhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc--Ccccc
Confidence 99999986432111 11111111222222 2347889999999999999999999999998 55543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=159.99 Aligned_cols=134 Identities=30% Similarity=0.549 Sum_probs=102.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--c--cCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--M--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+||||||+|||++.+ +.++|+|||++........ . ....++..|++||.+.+ ..++.++|+||||++
T Consensus 128 ~h~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~ 198 (267)
T cd05066 128 VHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIV 198 (267)
T ss_pred eehhhchhcEEECCC-CeEEeCCCCcccccccccceeeecCCCccceeecCHhHhcc--------CccCchhhhHHHHHH
Confidence 699999999999876 6799999999975432211 1 11223568999998853 567899999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
+|++++ |..||........ ..........+.+..+++.+.+++.+||..+|.+||++.++++.|..+
T Consensus 199 l~ell~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 199 MWEVMSYGERPYWEMSNQDV-IKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHhcCCCCCcccCCHHHH-HHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 999886 9999977654332 233333344455566889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=164.11 Aligned_cols=135 Identities=28% Similarity=0.418 Sum_probs=97.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+||+++.+ +.+||+|||++....... ......|+..|++||.+... ....++.++|+||+|+++||
T Consensus 128 ~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~~Dvws~G~il~e 201 (267)
T cd06646 128 MHRDIKGANILLTDN-GDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE-----KNGGYNQLCDIWAVGITAIE 201 (267)
T ss_pred cccCCCHHHEEECCC-CCEEECcCccceeecccccccCccccCccccCHhHcccc-----cCCCCcchhhHHHHHHHHHH
Confidence 699999999999866 679999999987543221 12335688899999986421 12446789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCC---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPG---LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
|++|..||..................+. ....++..+.+++.+||..+|++||++++++++|
T Consensus 202 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 202 LAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 9999999865543322211111111111 1234678999999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=163.82 Aligned_cols=134 Identities=34% Similarity=0.556 Sum_probs=102.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||+|+||+++.+ +.+||+|||++...... ....++..|++||++.+. ....++.++|+||||+++|++
T Consensus 137 ~H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~-----~~~~~~~~sDv~s~G~il~el 207 (307)
T cd06607 137 IHRDIKAGNILLTEP-GTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIEL 207 (307)
T ss_pred eecCCCcccEEECCC-CCEEEeecCcceecCCC---CCccCCccccCceeeecc-----CCCCCCcccchHHHHHHHHHH
Confidence 699999999999976 67999999998654322 245678899999987421 124578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCC-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++|..||.+........... ....+.. +..++..+.+++.+||..+|.+||++.+++. +.|+.
T Consensus 208 ~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~~ 271 (307)
T cd06607 208 AERKPPLFNMNAMSALYHIA-QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK--HRFVL 271 (307)
T ss_pred HcCCCCCCCccHHHHHHHHh-cCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc--Chhhc
Confidence 99999998766544333322 2222222 3447889999999999999999999999998 45544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-25 Score=175.76 Aligned_cols=134 Identities=22% Similarity=0.335 Sum_probs=98.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc--------------------------------------------ccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT--------------------------------------------EMM 36 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~--------------------------------------------~~~ 36 (198)
|||||||+|||++.+ +.+||+|||++...... ...
T Consensus 123 vHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (376)
T cd05598 123 IHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLA 201 (376)
T ss_pred EeCCCCHHHEEECCC-CCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccc
Confidence 699999999999976 67999999997421100 001
Q ss_pred cCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCC--CCCCcH
Q 029154 37 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISP 114 (198)
Q Consensus 37 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--p~~~~~ 114 (198)
...+||+.|+|||++.+ ..++.++||||+||++|||++|..||.+................... ...+++
T Consensus 202 ~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 273 (376)
T cd05598 202 HSLVGTPNYIAPEVLLR--------TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSR 273 (376)
T ss_pred cccCCCccccCHHHHcC--------CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCH
Confidence 13479999999999853 56788999999999999999999999876654332222211112222 235789
Q ss_pred HHHHHHHHhcccCCCCCC---CHHHHHHHHHHHHh
Q 029154 115 DLAFIVQSCWVEDPNLRP---SFSQIIRMLNAFLF 146 (198)
Q Consensus 115 ~~~~l~~~~l~~dp~~Rp---s~~~~l~~l~~~~~ 146 (198)
++.+++.+|+ .+|.+|+ ++.++++ +.|+.
T Consensus 274 ~~~~li~~l~-~~p~~R~~~~t~~ell~--h~~~~ 305 (376)
T cd05598 274 EASDLILRLC-CGAEDRLGKNGADEIKA--HPFFK 305 (376)
T ss_pred HHHHHHHHHh-cCHhhcCCCCCHHHHhC--CCCcC
Confidence 9999999976 5999999 8999988 55543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-24 Score=160.16 Aligned_cols=138 Identities=26% Similarity=0.441 Sum_probs=96.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+||+++.+ +.+||+|||++........ .....++..|+|||++..... ......++.++|+||||+++
T Consensus 122 ~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~~~DiwslG~~l 199 (269)
T cd05087 122 IHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG-NLLVVDQTKESNVWSLGVTI 199 (269)
T ss_pred eccccCcceEEEcCC-CcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccc-cccccCCCccchhHHHHHHH
Confidence 699999999999976 6899999999874332211 122456788999998743100 00012357899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHc-cC---CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFK-HA---RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~-~~---~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
||+++ |..||............... .. .+.+....++.+.+++.+|| .+|++||++++|+..|
T Consensus 200 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 200 WELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred HHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 99996 99999766544332222111 11 11222346788999999999 6899999999999866
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=159.29 Aligned_cols=133 Identities=31% Similarity=0.529 Sum_probs=103.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||||+||+++.+ +.+||+|||++........ .....++..|++||.+.+ ..++.++|+||+|+++|
T Consensus 125 ~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~il~ 195 (261)
T cd05034 125 IHRDLAARNILVGEN-LVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY--------GRFTIKSDVWSFGILLT 195 (261)
T ss_pred ccCCcchheEEEcCC-CCEEECccccceeccchhhhhhhccCCCccccCHHHhcc--------CCcCchhHHHHHHHHHH
Confidence 699999999999977 6799999999875432211 112234568999998753 55788999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
++++ |+.||.+..... .............+...+.++.+++.+||..+|.+||+++++.+.|+.
T Consensus 196 ~l~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 196 EIVTYGRVPYPGMTNRE-VLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 9998 999998765433 233333444455566778999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=158.94 Aligned_cols=131 Identities=34% Similarity=0.668 Sum_probs=101.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccccc--CCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||||+||+++.+ +.++|+|||++.......... ...++..|++||.+. ...++.++|+||+|++++
T Consensus 125 ~h~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~--------~~~~~~~~Di~slG~i~~ 195 (258)
T smart00219 125 IHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLK--------DGKFTSKSDVWSFGVLLW 195 (258)
T ss_pred eecccccceEEEccC-CeEEEcccCCceecccccccccccCCCcccccChHHhc--------cCCCCcchhHHHHHHHHH
Confidence 699999999999976 679999999997544322211 123678899999874 256788999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
++++ |..||..... ...............+..++.++.+++.+||..||.+|||+.++++.|
T Consensus 196 ~l~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 196 EIFTLGESPYPGMSN-EEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHhCCCCCCCCCCH-HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 9998 7888876443 233333344455566777899999999999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=161.67 Aligned_cols=133 Identities=30% Similarity=0.544 Sum_probs=103.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||+|+||+++.+ +.++|+|||++....... ......++..|++||.+.+ ..++.++|+||||+++|+
T Consensus 123 vH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Dv~slG~il~e 193 (277)
T cd06640 123 IHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ--------SAYDSKADIWSLGITAIE 193 (277)
T ss_pred cCcCCChhhEEEcCC-CCEEEcccccceeccCCccccccccCcccccCHhHhcc--------CCCccHHHHHHHHHHHHH
Confidence 699999999999976 679999999987543322 1223467889999998753 457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
|++|..||.......... .......+.++..++.++.+++.+||..+|.+||++.++++ +.++
T Consensus 194 l~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~ 256 (277)
T cd06640 194 LAKGEPPNSDMHPMRVLF-LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK--HKFI 256 (277)
T ss_pred HHHCCCCCCCcChHhHhh-hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh--ChHh
Confidence 999999998766433322 22233345556678889999999999999999999999998 5554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-25 Score=173.37 Aligned_cols=134 Identities=25% Similarity=0.379 Sum_probs=97.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc------------------------------------cccCCCCccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE------------------------------------MMTAETGTYR 44 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~------------------------------------~~~~~~gt~~ 44 (198)
|||||||+|||++.+ +.+||+|||+++...... .....+||+.
T Consensus 123 vHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 201 (360)
T cd05627 123 IHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPD 201 (360)
T ss_pred EccCCCHHHEEECCC-CCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCcc
Confidence 699999999999976 789999999986322100 0113479999
Q ss_pred eecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCC--CCcHHHHHHHHH
Q 029154 45 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQS 122 (198)
Q Consensus 45 y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~l~~~ 122 (198)
|+|||++.+ ..++.++|+||+||++|||++|..||.+...................|. .+++++.+++.+
T Consensus 202 Y~APE~~~~--------~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~ 273 (360)
T cd05627 202 YIAPEVFMQ--------TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILR 273 (360)
T ss_pred ccCHHHHcC--------CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHH
Confidence 999999853 5678999999999999999999999987665433222221112223333 378899999999
Q ss_pred hcccCCCCCCC---HHHHHHHHHHHHh
Q 029154 123 CWVEDPNLRPS---FSQIIRMLNAFLF 146 (198)
Q Consensus 123 ~l~~dp~~Rps---~~~~l~~l~~~~~ 146 (198)
++ .||.+|++ +.++++ |.|+.
T Consensus 274 l~-~~p~~R~~~~~~~ei~~--hp~f~ 297 (360)
T cd05627 274 FC-TDSENRIGSNGVEEIKS--HPFFE 297 (360)
T ss_pred hc-cChhhcCCCCCHHHHhc--CCCCC
Confidence 77 49999985 677777 55543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=176.09 Aligned_cols=134 Identities=19% Similarity=0.302 Sum_probs=94.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++...... .....+||..|++||++.+ ..++.++|||||||++|
T Consensus 289 iHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ 359 (501)
T PHA03210 289 IHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG--------DGYCEITDIWSCGLILL 359 (501)
T ss_pred ecCCCCHHHEEECCC-CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC--------CCCCcHHHHHHHHHHHH
Confidence 799999999999976 679999999997543322 1223579999999999853 56889999999999999
Q ss_pred HHHcCCC-CCCCCC-cHHHHHHHHHccC---CCCC----------------------------CCCCcHHHHHHHHHhcc
Q 029154 79 ELLTNRL-PFEGMS-NLQAAYAAAFKHA---RPGL----------------------------PEDISPDLAFIVQSCWV 125 (198)
Q Consensus 79 e~~~g~~-p~~~~~-~~~~~~~~~~~~~---~~~~----------------------------p~~~~~~~~~l~~~~l~ 125 (198)
||++|.. |+.... ............. ...+ ...++.++.+++.+||.
T Consensus 360 ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~ 439 (501)
T PHA03210 360 DMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLT 439 (501)
T ss_pred HHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhc
Confidence 9999875 443221 1111111111100 0000 01245677888999999
Q ss_pred cCCCCCCCHHHHHHHHHHHH
Q 029154 126 EDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 126 ~dp~~Rps~~~~l~~l~~~~ 145 (198)
.||.+||++.|++. +.|+
T Consensus 440 ~DP~~Rpsa~elL~--hp~f 457 (501)
T PHA03210 440 FDWHLRPGAAELLA--LPLF 457 (501)
T ss_pred cCcccCcCHHHHhh--Chhh
Confidence 99999999999998 5554
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=161.55 Aligned_cols=133 Identities=29% Similarity=0.443 Sum_probs=97.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++....... ......|+..|+|||++... ....++.++|+||+||++|+
T Consensus 128 ~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~DvwSlG~il~~ 201 (267)
T cd06645 128 MHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE-----RKGGYNQLCDIWAVGITAIE 201 (267)
T ss_pred ecCCCCHHHEEECCC-CCEEECcceeeeEccCcccccccccCcccccChhhhccc-----cCCCCCchhhhHHHHHHHHH
Confidence 699999999999976 679999999986433221 12345789999999986310 12457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCC-C--CCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPG-L--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~--p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+++|..||..................+. . ...++..+.+++.+||..+|.+||+++++++
T Consensus 202 l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 202 LAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 9999999876554333222211111111 1 1246788999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-24 Score=161.36 Aligned_cols=129 Identities=29% Similarity=0.514 Sum_probs=99.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc----ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+|+||||+||+++.+ +.++|+|||+++..... .......|+..|+|||.+.+ ..++.++|+||||++
T Consensus 128 ~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~i 198 (265)
T cd06652 128 VHRDIKGANILRDSV-GNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG--------EGYGRKADIWSVGCT 198 (265)
T ss_pred ecCCCCHHHEEecCC-CCEEECcCccccccccccccccccccCCCCccccChhhhcC--------CCCCcchhHHHHHHH
Confidence 699999999999966 67999999998743211 11223468889999998753 457889999999999
Q ss_pred HHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 77 LWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+|++++|+.||..................+..|...+..+.+++.+||. +|.+||+++++++
T Consensus 199 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 199 VVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 9999999999987654443333332333445566778889999999995 8999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=163.22 Aligned_cols=137 Identities=28% Similarity=0.448 Sum_probs=103.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++....... ......|+..|+|||++.+ ..++.++|+||||+++||
T Consensus 139 vH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~e 209 (297)
T cd06659 139 IHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR--------TPYGTEVDIWSLGIMVIE 209 (297)
T ss_pred ecCCCCHHHeEEccC-CcEEEeechhHhhcccccccccceecCccccCHHHHcc--------CCCCchhhHHHHHHHHHH
Confidence 699999999999976 679999999986433221 1233568899999998853 457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccC--CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHA--RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
+++|..||........... ..... ....+..++..+.+++.+||..+|.+||++.++++ +.++....
T Consensus 210 l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~--~~~~~~~~ 278 (297)
T cd06659 210 MVDGEPPYFSDSPVQAMKR-LRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLD--HPFLLQTG 278 (297)
T ss_pred HHhCCCCCCCCCHHHHHHH-HhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh--ChhhccCC
Confidence 9999999986654333222 11111 11223457889999999999999999999999999 55555333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-24 Score=160.30 Aligned_cols=134 Identities=30% Similarity=0.515 Sum_probs=103.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.++|+|||++....... ......|+..|++||.+.+ ..++.++|+||||+++||
T Consensus 123 vH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~e 193 (277)
T cd06642 123 IHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--------SAYDFKADIWSLGITAIE 193 (277)
T ss_pred eccCCChheEEEeCC-CCEEEccccccccccCcchhhhcccCcccccCHHHhCc--------CCCchhhhHHHHHHHHHH
Confidence 699999999999966 679999999987543322 1223467889999999853 457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+++|..|+.......... .......+..+..++.++.+++.+||..+|.+||++.++++ +.++.
T Consensus 194 l~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~~ 257 (277)
T cd06642 194 LAKGEPPNSDLHPMRVLF-LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK--HKFIT 257 (277)
T ss_pred HHhCCCCCcccchhhHHh-hhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH--hHHHH
Confidence 999999987654332221 22223344455668889999999999999999999999999 55543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=158.98 Aligned_cols=130 Identities=28% Similarity=0.429 Sum_probs=102.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++....... ......++..|++||.+.+ ..++.++|+||+|+++|+
T Consensus 123 ~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~--------~~~~~~~Dv~slG~i~~~ 193 (256)
T cd08221 123 LHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG--------VKYNFKSDIWALGCVLYE 193 (256)
T ss_pred cccCCChHhEEEeCC-CCEEECcCcceEEcccccccccccCCCccccCHhhcCC--------CCCCCcchhHHHHHHHHH
Confidence 699999999999976 679999999987543322 2334568999999998753 446788999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 140 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~ 140 (198)
|++|..||........... .........+..++.++.+++.+||..+|.+||++.+++++
T Consensus 194 l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 194 LLTLKRTFDATNPLNLVVK-IVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHCCCCCCCCCHHHHHHH-HHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 9999999987554333322 23333344456688999999999999999999999999884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=159.95 Aligned_cols=138 Identities=28% Similarity=0.481 Sum_probs=97.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++....... .....++..|+|||++...... .....++.++|+||+||++
T Consensus 122 vH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~~DiwslG~~l 199 (269)
T cd05042 122 IHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD-LLPKDQTKKSNIWSLGVTM 199 (269)
T ss_pred ecccccHhheEecCC-CcEEEeccccccccccchheeccCCCCCcccccCHHHHhhcccc-ccccccchhhHHHHHHHHH
Confidence 699999999999976 6799999999864322111 1223456789999986421000 0123567899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccC----CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHA----RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~----~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
||+++ |..||................. .+..+..++..+..++..|| .||.+||++++|++.|
T Consensus 200 ~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 200 WELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred HHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 99998 7888877655443322222211 12234457888999999998 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=162.60 Aligned_cols=135 Identities=27% Similarity=0.462 Sum_probs=100.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+||+++.+ +.+||+|||+++...... ......|+..|+|||++..... ....++.++|+||+||++|+
T Consensus 146 ~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Dv~slGvi~~e 221 (286)
T cd06638 146 IHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQ---LDSTYDARCDVWSLGITAIE 221 (286)
T ss_pred cccCCCHHhEEECCC-CCEEEccCCceeecccCCCccccccCCCcccChhhhchhhh---ccccccchhhhhhHHHHHHH
Confidence 699999999999976 679999999987543221 2234568999999998743110 12446889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccC--CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHA--RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 140 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~ 140 (198)
+++|..||........... ..... ....+..++.++.+++.+||..||++||++.+++++
T Consensus 222 l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 222 LGDGDPPLADLHPMRALFK-IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HhcCCCCCCCCchhHHHhh-ccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 9999999976654333221 11111 122345567899999999999999999999999983
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=164.08 Aligned_cols=140 Identities=26% Similarity=0.369 Sum_probs=101.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-----cccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
+||||||+||+++.+ +.+||+|||+++...... ......|+..|++||.+.+ ...++.++|+||+|+
T Consensus 127 vH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~~Di~slGv 198 (332)
T cd07857 127 LHRDLKPGNLLVNAD-CELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS-------FQSYTKAIDVWSVGC 198 (332)
T ss_pred ccCCCCHHHeEEcCC-CCEEeCcCCCceecccccccccccccCcccCccccCcHHHhC-------CCCCCcHHHHHHHHH
Confidence 699999999999976 679999999987432211 1223468899999998643 245788999999999
Q ss_pred HHHHHHcCCCCCCCCCcHHHHHHHHH-------------------------ccC-CCC---CCCCCcHHHHHHHHHhccc
Q 029154 76 VLWELLTNRLPFEGMSNLQAAYAAAF-------------------------KHA-RPG---LPEDISPDLAFIVQSCWVE 126 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~~~~~~~~~-------------------------~~~-~~~---~p~~~~~~~~~l~~~~l~~ 126 (198)
++|++++|..||.+............ ... ... .....+..+.+++.+||..
T Consensus 199 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 278 (332)
T cd07857 199 ILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAF 278 (332)
T ss_pred HHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccC
Confidence 99999999999976542211100000 000 000 1123578899999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 127 DPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 127 dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
||.+||++.+++. +.|+.....
T Consensus 279 ~P~~R~t~~~ll~--~~~~~~~~~ 300 (332)
T cd07857 279 DPTKRISVEEALE--HPYLAIWHD 300 (332)
T ss_pred CcccCCCHHHHhc--ChhhhhhcC
Confidence 9999999999998 777765543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=162.53 Aligned_cols=137 Identities=30% Similarity=0.498 Sum_probs=103.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+||+++.+ +.++|+|||++....... ......|+..|++||.+.+ ..++.++|+||+|+++|+
T Consensus 137 ~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGv~l~e 207 (285)
T cd06648 137 IHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR--------LPYGTEVDIWSLGIMVIE 207 (285)
T ss_pred ecCCCChhhEEEcCC-CcEEEcccccchhhccCCcccccccCCccccCHHHhcC--------CCCCCcccHHHHHHHHHH
Confidence 699999999999976 679999999876432211 1223468899999998753 457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCC--CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
+++|..||......... ........+.. +..++..+.+++.+||..+|.+||++.++++ +.++....
T Consensus 208 ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~~~~ 276 (285)
T cd06648 208 MVDGEPPYFNEPPLQAM-KRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN--HPFLAKAG 276 (285)
T ss_pred HHhCCCCCcCCCHHHHH-HHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc--CcccccCC
Confidence 99999999765543332 22222222222 3337889999999999999999999999998 66665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=173.90 Aligned_cols=129 Identities=29% Similarity=0.575 Sum_probs=107.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccC----CCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTA----ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~----~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||...|+|+... ..|||+|||+.|....+..+.. ..-...|.|||.+. ...|+.++|+|+||++
T Consensus 234 vHRDLAARNlllasp-rtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLr--------h~kFShaSDvWmyGVT 304 (1039)
T KOG0199|consen 234 VHRDLAARNLLLASP-RTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLR--------HRKFSHASDVWMYGVT 304 (1039)
T ss_pred hhhhhhhhhheeccc-ceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhc--------cccccccchhhhhhhh
Confidence 799999999999865 7899999999996655443222 12345799999985 4789999999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+|||++ |..||.|....+.+. .+....+.+.|..++.++.+++..||..+|++||+|..|.+
T Consensus 305 iWEMFtyGEePW~G~~g~qIL~-~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 305 IWEMFTYGEEPWVGCRGIQILK-NIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred HHhhhccCCCCCCCCCHHHHHH-hccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 999997 889999988765543 33467788889999999999999999999999999999976
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=162.53 Aligned_cols=136 Identities=24% Similarity=0.374 Sum_probs=104.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc----------------------------------ccc------------
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET----------------------------------VTE------------ 34 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~----------------------------------~~~------------ 34 (198)
|-|||||||||+..+ |++.|+||-++.... ...
T Consensus 201 vYRDLKPENILvred-GHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~ 279 (459)
T KOG0610|consen 201 VYRDLKPENILVRED-GHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRS 279 (459)
T ss_pred eeccCCcceeEEecC-CcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccccccc
Confidence 569999999999977 899999999864110 000
Q ss_pred -----------cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHcc
Q 029154 35 -----------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 103 (198)
Q Consensus 35 -----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~ 103 (198)
.....+||-.|+|||++.+ ...+.++|+|+||+++|||+.|..||.|..+.......+...
T Consensus 280 ~p~~~aep~~~RSnSFVGThEYlAPEvI~G--------~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~ 351 (459)
T KOG0610|consen 280 LPELVAEPTGARSNSFVGTHEYLAPEVIRG--------EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP 351 (459)
T ss_pred chhhhcCCCCccccccccccccccceeeec--------CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC
Confidence 0112478999999999975 567889999999999999999999999988877666655433
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCC----HHHHHHHHHHHHhh
Q 029154 104 ARPGLPEDISPDLAFIVQSCWVEDPNLRPS----FSQIIRMLNAFLFT 147 (198)
Q Consensus 104 ~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps----~~~~l~~l~~~~~~ 147 (198)
...+--..++..+++||+++|.+||.+|.. +.||-+ |.++..
T Consensus 352 l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~--HpFF~g 397 (459)
T KOG0610|consen 352 LKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR--HPFFEG 397 (459)
T ss_pred CcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc--CccccC
Confidence 332222346789999999999999999987 888887 665543
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=164.33 Aligned_cols=136 Identities=24% Similarity=0.364 Sum_probs=100.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc------------------------------cccCCCCccceecccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE------------------------------MMTAETGTYRWMAPEL 50 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~------------------------------~~~~~~gt~~y~aPE~ 50 (198)
+|+||||+||+++.+ +.++|+|||++....... ......|+..|++||+
T Consensus 125 ~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 203 (316)
T cd05574 125 VYRDLKPENILLHES-GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV 203 (316)
T ss_pred eccCCChHHeEEcCC-CCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHH
Confidence 699999999999976 679999999986432110 0112367889999999
Q ss_pred cccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCC
Q 029154 51 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNL 130 (198)
Q Consensus 51 ~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~ 130 (198)
+.+ ..++.++|+||||+++|++++|..||.+.......................+.++.+++.+||..||.+
T Consensus 204 ~~~--------~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 275 (316)
T cd05574 204 ISG--------DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSK 275 (316)
T ss_pred HcC--------CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhH
Confidence 853 457889999999999999999999998766543332222122222222236899999999999999999
Q ss_pred CCC----HHHHHHHHHHHHhh
Q 029154 131 RPS----FSQIIRMLNAFLFT 147 (198)
Q Consensus 131 Rps----~~~~l~~l~~~~~~ 147 (198)
||+ +++++. +.|+..
T Consensus 276 R~s~~~~~~~ll~--~~~~~~ 294 (316)
T cd05574 276 RLGSKRGAAEIKQ--HPFFRG 294 (316)
T ss_pred CCCchhhHHHHHc--Cchhhc
Confidence 999 888888 555543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=161.10 Aligned_cols=139 Identities=26% Similarity=0.413 Sum_probs=102.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+++.+||+|||++...... .......++..|++||.+.+ ...++.++|+||+|+++|+
T Consensus 124 ~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~i~~~ 196 (294)
T PLN00009 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG-------SRHYSTPVDIWSVGCIFAE 196 (294)
T ss_pred eCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhC-------CCCCCcHHHHHHHHHHHHH
Confidence 699999999999866567999999999754322 22234567889999998743 2457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCC-------------------CC--------CCCCCcHHHHHHHHHhcccCCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHAR-------------------PG--------LPEDISPDLAFIVQSCWVEDPNLRP 132 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------~~--------~p~~~~~~~~~l~~~~l~~dp~~Rp 132 (198)
+++|..||.................. +. .....++.+.+++.+||..+|.+||
T Consensus 197 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 276 (294)
T PLN00009 197 MVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRI 276 (294)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCc
Confidence 99999999876544333221110000 00 1134678899999999999999999
Q ss_pred CHHHHHHHHHHHHhhc
Q 029154 133 SFSQIIRMLNAFLFTL 148 (198)
Q Consensus 133 s~~~~l~~l~~~~~~~ 148 (198)
++.++++ +.|+...
T Consensus 277 s~~~~l~--~~~~~~~ 290 (294)
T PLN00009 277 TARAALE--HEYFKDL 290 (294)
T ss_pred CHHHHhc--CchHhHH
Confidence 9999998 6665543
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=162.78 Aligned_cols=131 Identities=30% Similarity=0.472 Sum_probs=99.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.+ +.++|+|||++...... ......|+..|++||++.+ ..++.++|+|||||++|++
T Consensus 126 ~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l 195 (284)
T cd06620 126 MHRDIKPSNILVNSR-GQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQG--------GKYTVKSDVWSLGISIIEL 195 (284)
T ss_pred eccCCCHHHEEECCC-CcEEEccCCcccchhhh-ccCccccCcccCCHHHHcc--------CCCCccchHHHHHHHHHHH
Confidence 699999999999966 67999999998643221 1234578999999998753 4678899999999999999
Q ss_pred HcCCCCCCCCCcH----------HHHHHHHHccCCCCCCCC-CcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 81 LTNRLPFEGMSNL----------QAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 81 ~~g~~p~~~~~~~----------~~~~~~~~~~~~~~~p~~-~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
++|..||...... ............+.++.. ++.++.+++.+||..||.+||++.+++++.
T Consensus 196 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 196 ALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 9999999754431 111222222333333333 778999999999999999999999999843
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=157.82 Aligned_cols=138 Identities=22% Similarity=0.419 Sum_probs=96.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||++....... ......++..|++||++....... ....++.++|+||||+++
T Consensus 121 ~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~~~~~~DiwslG~~l 198 (268)
T cd05086 121 LHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGL-ITAEQTKPSNVWALGVTL 198 (268)
T ss_pred eccCCccceEEEcCC-ccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCcc-ccCCCCCcchhHHHHHHH
Confidence 699999999999976 679999999986422211 122346788999999874210000 113457789999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHcc----CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKH----ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~----~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
|||++ |..||................ ..+..+..+++.+.+++.+|| .+|.+||+++++++.|
T Consensus 199 ~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 199 WELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 99986 567887655433222211111 223344557889999999999 6799999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=171.97 Aligned_cols=141 Identities=30% Similarity=0.552 Sum_probs=115.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccccc-CCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMT-AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||-..|+|+..+ +.+||+|||+++....-.... ...-...|+|||.+.. ..|+.++||||||+++||
T Consensus 284 IHRDIAARNcL~~~~-~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~--------~~~s~kTDV~sfGV~~~E 354 (474)
T KOG0194|consen 284 IHRDIAARNCLYSKK-GVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT--------GIFSFKTDVWSFGVLLWE 354 (474)
T ss_pred cchhHhHHHheecCC-CeEEeCccccccCCcceeeccccccCcceecChhhhcc--------CccccccchhheeeeEEe
Confidence 799999999999976 568999999997543111111 1123568999999864 578999999999999999
Q ss_pred HHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 80 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 80 ~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
+++ |..||.+...............+...|...+.++..++.+||..+|++||+|.++.+.|+.+......
T Consensus 355 if~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 355 IFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred eeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 997 88899998876555444466777788888999999999999999999999999999999988766554
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=167.61 Aligned_cols=135 Identities=23% Similarity=0.326 Sum_probs=101.2
Q ss_pred CCCCCCCCCeEEcCCC-------------------CceEEecccCcccCcccccccCCCCccceeccccccccccccccc
Q 029154 1 MGKFMKEDNLLLTPDQ-------------------KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61 (198)
Q Consensus 1 iH~dlKp~NIll~~~~-------------------~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 61 (198)
+|.||||||||+..+. ..+||+|||.+....... ++.+.|..|.|||++.+
T Consensus 214 ~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLg-------- 283 (415)
T KOG0671|consen 214 THTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILG-------- 283 (415)
T ss_pred eecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheec--------
Confidence 6999999999995431 248999999997654332 45678999999999975
Q ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCC-------------------------------
Q 029154 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE------------------------------- 110 (198)
Q Consensus 62 ~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~------------------------------- 110 (198)
-+++.++||||+||+++|+.+|...|++..+.... .+++....++|.
T Consensus 284 LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL--aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v 361 (415)
T KOG0671|consen 284 LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL--AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYV 361 (415)
T ss_pred cCcCCccCceeeeeEEEEeeccceecccCCcHHHH--HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhh
Confidence 67899999999999999999999999877654432 111111111110
Q ss_pred ---------------CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 111 ---------------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 111 ---------------~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
.-..++.+|+.+||..||++|+|+.|++. |.++..+.
T Consensus 362 ~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~--HpFF~~~~ 413 (415)
T KOG0671|consen 362 FEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS--HPFFARLT 413 (415)
T ss_pred hcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc--CHHhhcCC
Confidence 01245889999999999999999999999 77766543
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-24 Score=160.23 Aligned_cols=136 Identities=29% Similarity=0.492 Sum_probs=103.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||+|+||+++.+ +.++|+|||++....... ......|+..|++||.+.. ...++.++|+||||+++|+
T Consensus 123 ~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~ 194 (277)
T cd06917 123 IHRDIKAANILVTNT-GNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE-------GKYYDTKADIWSLGITIYE 194 (277)
T ss_pred ccCCcCHHHEEEcCC-CCEEEccCCceeecCCCccccccccCCcceeCHHHhcc-------CCccccchhHHHHHHHHHH
Confidence 699999999999976 679999999987543322 2233568889999998743 2456889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCC-CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~-~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
+++|..||.+........ .......+.++.. ++.++.+++.+||..||++||++.+++. +.|+..
T Consensus 195 ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~--~~~~~~ 260 (277)
T cd06917 195 MATGNPPYSDVDAFRAMM-LIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK--SKWIKA 260 (277)
T ss_pred HHhCCCCCCCCChhhhhh-ccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh--ChHhhc
Confidence 999999998765433221 1112222333433 7889999999999999999999999998 666643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=158.66 Aligned_cols=133 Identities=27% Similarity=0.566 Sum_probs=100.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+||+++.+ +.++++|||+++...... ......++..|++||.+.+ ..++.++|+||||+++|
T Consensus 139 ~H~dlkp~Nili~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~ 209 (275)
T cd05046 139 VHRDLAARNCLVSSQ-REVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE--------DDFSTKSDVWSFGVLMW 209 (275)
T ss_pred ccCcCccceEEEeCC-CcEEEcccccccccCcccccccCCceeEEeecChhhhcc--------CCCCchhhHHHHHHHHH
Confidence 699999999999976 679999999986432221 1223456778999998743 45678899999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
++++ |..||.....................+..++..+.+++.+||..+|.+||++.+++..|.
T Consensus 210 ~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 210 EVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 9998 788987655433222222122223445678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8e-24 Score=161.16 Aligned_cols=131 Identities=29% Similarity=0.384 Sum_probs=97.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++....... ......++..|++||.+.+ ...++.++|+||+|+++|+
T Consensus 122 ~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~i~~~ 193 (286)
T cd07847 122 IHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG-------DTQYGPPVDVWAIGCVFAE 193 (286)
T ss_pred eecCCChhhEEEcCC-CcEEECccccceecCCCcccccCcccccccCCHHHHhC-------CCCcCchhhhHHHHHHHHH
Confidence 699999999999976 679999999997543322 2234567889999998743 2456789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHH--cc-----------------CCCCC----------CCCCcHHHHHHHHHhcccCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAF--KH-----------------ARPGL----------PEDISPDLAFIVQSCWVEDPNL 130 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~--~~-----------------~~~~~----------p~~~~~~~~~l~~~~l~~dp~~ 130 (198)
+++|..||.+............ .. ...+. ...++..+.+++.+||..+|++
T Consensus 194 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 273 (286)
T cd07847 194 LLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTE 273 (286)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccc
Confidence 9999999987665433221110 00 00000 1235788999999999999999
Q ss_pred CCCHHHHHH
Q 029154 131 RPSFSQIIR 139 (198)
Q Consensus 131 Rps~~~~l~ 139 (198)
||++.+++.
T Consensus 274 Rp~~~eil~ 282 (286)
T cd07847 274 RLSCEELLE 282 (286)
T ss_pred cCCHHHHhc
Confidence 999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.1e-24 Score=159.30 Aligned_cols=133 Identities=26% Similarity=0.438 Sum_probs=100.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc-----ccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
+|+||||+||+++.+ +.+||+|||++........ .....++..|++||.+.+. ....++.++|+||||+
T Consensus 121 ~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~~~~Dv~s~G~ 194 (264)
T cd06626 121 VHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG-----KGKGHGRAADIWSLGC 194 (264)
T ss_pred ccCCCCHHHEEECCC-CCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCC-----CCCCCCcccchHHHHH
Confidence 699999999999976 6799999999875432211 1134578899999998541 0123688999999999
Q ss_pred HHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCC--cHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 76 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI--SPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~--~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
++|++++|..||..................+.+|... ++.+.+++.+||..+|.+||++.+++.
T Consensus 195 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 195 VVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 9999999999997654333332222334444555544 899999999999999999999999887
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=158.33 Aligned_cols=135 Identities=27% Similarity=0.502 Sum_probs=106.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccc-cCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMM-TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||+|+||+++.+ +.++|+|||++......... ....++..|++||.+.. ..++.++|+||||+++|+
T Consensus 122 ~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~ 192 (264)
T cd06623 122 IHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG--------ESYSYAADIWSLGLTLLE 192 (264)
T ss_pred ccCCCCHHHEEECCC-CCEEEccCccceecccCCCcccceeecccccCHhhhCC--------CCCCchhhHHHHHHHHHH
Confidence 699999999999976 67999999998754332222 23467889999998753 467889999999999999
Q ss_pred HHcCCCCCCCCC--cHHHHHHHHHccCCCCCCCC-CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMS--NLQAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~--~~~~~~~~~~~~~~~~~p~~-~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+++|..||.... ..............+..+.. ++..+.+++.+||..+|++||++.++++ +.++.
T Consensus 193 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~--~~~~~ 260 (264)
T cd06623 193 CALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ--HPFIK 260 (264)
T ss_pred HHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh--CHHHH
Confidence 999999997664 33333444444455556666 8899999999999999999999999998 56654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-24 Score=162.40 Aligned_cols=134 Identities=28% Similarity=0.480 Sum_probs=99.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++....... ......|+..|++||.+..... ....++.++|+||+|+++|+
T Consensus 150 vH~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Di~slGvi~~e 225 (291)
T cd06639 150 IHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQ---YDYSYDARCDVWSLGITAIE 225 (291)
T ss_pred eccCCCHHHEEEcCC-CCEEEeecccchhcccccccccCccCCccccChhhhcCCCC---cccccCCccchHHHHHHHHH
Confidence 699999999999976 679999999987543222 1233568889999998743110 01236789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC--CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+++|+.||........... ......+ ..+......+.+++.+||..+|++||++.++++
T Consensus 226 l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 226 LGDGDPPLFDMHPVKTLFK-IPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HhhCCCCCCCCcHHHHHHH-HhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 9999999987654433322 2222222 234557788999999999999999999999998
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.8e-24 Score=165.15 Aligned_cols=139 Identities=27% Similarity=0.431 Sum_probs=100.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+||+++.+ +.+||+|||++....... ......|+..|+|||.+.+ ...++.++|+||+|++
T Consensus 128 vH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslGvi 199 (336)
T cd07849 128 LHRDLKPSNLLLNTN-CDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKAIDIWSVGCI 199 (336)
T ss_pred eccCCCHHHEEECCC-CCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhC-------CCCCCcHHHHHHHHHH
Confidence 699999999999976 679999999987543221 1123468899999998642 2457889999999999
Q ss_pred HHHHHcCCCCCCCCCcHHHHHHHH----------------------HccC--CCC-----CCCCCcHHHHHHHHHhcccC
Q 029154 77 LWELLTNRLPFEGMSNLQAAYAAA----------------------FKHA--RPG-----LPEDISPDLAFIVQSCWVED 127 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~~~~~~~~----------------------~~~~--~~~-----~p~~~~~~~~~l~~~~l~~d 127 (198)
+|+|++|+.||.+........... .... ... .....++++.+++.+||..|
T Consensus 200 l~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 279 (336)
T cd07849 200 LAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFN 279 (336)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCC
Confidence 999999999997654322110000 0000 000 01235778999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHhhcC
Q 029154 128 PNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 128 p~~Rps~~~~l~~l~~~~~~~~ 149 (198)
|.+||++.++++ +.|+....
T Consensus 280 P~~Rpt~~e~l~--hp~~~~~~ 299 (336)
T cd07849 280 PHKRITVEEALA--HPYLEQYH 299 (336)
T ss_pred hhhCcCHHHHhc--CccccccC
Confidence 999999999999 66666544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=161.16 Aligned_cols=132 Identities=31% Similarity=0.481 Sum_probs=101.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.+ +.+||+|||++..... .....|+..|++||.+... ..+.++.++|+||||+++|++
T Consensus 147 ~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Dv~slGvil~el 217 (317)
T cd06635 147 IHRDIKAGNILLTEP-GQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIEL 217 (317)
T ss_pred ccCCCCcccEEECCC-CCEEEecCCCccccCC---cccccCCccccChhhhhcC-----CCCCCCccccHHHHHHHHHHH
Confidence 699999999999876 6799999999864332 2245688899999986321 124578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
++|..||........................++..+.+++.+||..+|.+||++.++++++
T Consensus 218 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 218 AERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred HhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 9999999776544433333322333333456788999999999999999999999999844
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-24 Score=159.13 Aligned_cols=135 Identities=27% Similarity=0.438 Sum_probs=104.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.+ +.++|+|||++.............++..|++||.+.. ..++.++|+||+|+++|++
T Consensus 115 ~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~slG~il~~l 185 (262)
T cd05572 115 IYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN--------KGYDFSVDYWSLGILLYEL 185 (262)
T ss_pred ccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccccccCCcCccChhHhcC--------CCCCChhhhhhhHHHHHHH
Confidence 699999999999976 6799999999876544322234568889999998743 5578899999999999999
Q ss_pred HcCCCCCCCCCc-HHHHHHHHH-ccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSN-LQAAYAAAF-KHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~-~~~~~~~~~-~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps-----~~~~l~~l~~~~~ 146 (198)
++|..||..... ......... ....+..|...+.++.+++.+||..+|.+||+ +.|+++ +.|+.
T Consensus 186 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~--~~~~~ 256 (262)
T cd05572 186 LTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK--HKWFN 256 (262)
T ss_pred HhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc--Chhhh
Confidence 999999976652 122222222 23455667777899999999999999999999 888888 55544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-24 Score=162.32 Aligned_cols=132 Identities=30% Similarity=0.376 Sum_probs=97.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+||+++.+++.+||+|||+++..... .......+++.|+|||.+.+ ...++.++|+||||+++|+
T Consensus 132 ~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~ 204 (295)
T cd07837 132 MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG-------STHYSTPVDIWSVGCIFAE 204 (295)
T ss_pred eecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhC-------CCCCCchHHHHHHHHHHHH
Confidence 699999999999974578999999998743221 11223456788999998743 2456889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC--------------------------CCCCCCcHHHHHHHHHhcccCCCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP--------------------------GLPEDISPDLAFIVQSCWVEDPNLRPS 133 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------~~p~~~~~~~~~l~~~~l~~dp~~Rps 133 (198)
|++|..||.+................+ .....+++++.+++.+||..||.+||+
T Consensus 205 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~ 284 (295)
T cd07837 205 MSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS 284 (295)
T ss_pred HHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC
Confidence 999999998765543322211100000 001346788999999999999999999
Q ss_pred HHHHHH
Q 029154 134 FSQIIR 139 (198)
Q Consensus 134 ~~~~l~ 139 (198)
+.+++.
T Consensus 285 ~~eil~ 290 (295)
T cd07837 285 AKAALT 290 (295)
T ss_pred HHHHhc
Confidence 999987
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=158.91 Aligned_cols=135 Identities=25% Similarity=0.441 Sum_probs=97.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc----ccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+||||||+||+++.+ +.+||+|||+++....... .....++..|++||++.+ ..++.++|+||||++
T Consensus 130 ~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~ 200 (284)
T cd05081 130 VHRDLATRNILVESE-NRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE--------SKFSVASDVWSFGVV 200 (284)
T ss_pred eeccCCHhhEEECCC-CeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc--------CCcChHHHHHHHHHH
Confidence 699999999999976 6799999999975432211 111223456999998753 557889999999999
Q ss_pred HHHHHcCCCCCCCCCcHH---------------HHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 77 LWELLTNRLPFEGMSNLQ---------------AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
+||+++|..++....... ............+.+..++.++.+++.+||..+|++|||+.++++.|
T Consensus 201 l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05081 201 LYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280 (284)
T ss_pred HHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 999999876543221100 00111122233345567889999999999999999999999999988
Q ss_pred HHH
Q 029154 142 NAF 144 (198)
Q Consensus 142 ~~~ 144 (198)
+.+
T Consensus 281 ~~~ 283 (284)
T cd05081 281 EAI 283 (284)
T ss_pred Hhc
Confidence 753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8e-24 Score=163.24 Aligned_cols=136 Identities=29% Similarity=0.451 Sum_probs=102.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+ +.+||+|||++...... ....++..|++||.+.+. ....++.++|+|||||++|++
T Consensus 137 ~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el 207 (308)
T cd06634 137 IHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIEL 207 (308)
T ss_pred ccCCCCHHhEEECCC-CcEEECCcccceeecCc---ccccCCccccCHHHHhhc-----ccCCCCcccchHHHHHHHHHH
Confidence 699999999999976 67999999998653321 234678899999986421 124467899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
++|..||.....................+..++..+.+++.+||..+|.+||++.+++. +.++..
T Consensus 208 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~--~~~~~~ 272 (308)
T cd06634 208 AERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLR 272 (308)
T ss_pred HcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhh--Cccccc
Confidence 99999987655433333222222222234467889999999999999999999999998 455444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.8e-24 Score=165.26 Aligned_cols=139 Identities=27% Similarity=0.375 Sum_probs=102.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+ +.+||+|||+++..... .....++..|+|||.+.+ ...++.++|+||||+++||+
T Consensus 139 ~H~dlkp~NIll~~~-~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slGvil~el 208 (342)
T cd07879 139 IHRDLKPGNLAVNED-CELKILDFGLARHADAE--MTGYVVTRWYRAPEVILN-------WMHYNQTVDIWSVGCIMAEM 208 (342)
T ss_pred ccCCCCHHHEEECCC-CCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcC-------ccccCchHHHHHHHHHHHHH
Confidence 699999999999976 67999999998754321 233467889999998743 23478899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHcc---------------------CCCCC--------CCCCcHHHHHHHHHhcccCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKH---------------------ARPGL--------PEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~---------------------~~~~~--------p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
++|+.||.+.............. ..+.. ....++++.+++.+||+.||.+|
T Consensus 209 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 288 (342)
T cd07879 209 LTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKR 288 (342)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhC
Confidence 99999998765333221111000 00000 12356789999999999999999
Q ss_pred CCHHHHHHHHHHHHhhcCCC
Q 029154 132 PSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~~~~ 151 (198)
|++++++. +.|+......
T Consensus 289 ~~~~e~l~--h~~f~~~~~~ 306 (342)
T cd07879 289 LTATEALE--HPYFDSFRDA 306 (342)
T ss_pred cCHHHHhc--Ccchhhcccc
Confidence 99999998 7777665543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.8e-24 Score=165.01 Aligned_cols=142 Identities=20% Similarity=0.333 Sum_probs=102.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+||||||+||+++.++..+||+|||++....... ......++..|+|||.+.. ...++.++|+||+||+
T Consensus 136 vH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwSlGvi 208 (342)
T cd07854 136 LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-------PNNYTKAIDMWAAGCI 208 (342)
T ss_pred ccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhC-------ccccCchhhHHHHHHH
Confidence 6999999999998665678999999986432111 1122357889999998642 2457789999999999
Q ss_pred HHHHHcCCCCCCCCCcHHHHHHHHHc-----------------------cCCCC-----CCCCCcHHHHHHHHHhcccCC
Q 029154 77 LWELLTNRLPFEGMSNLQAAYAAAFK-----------------------HARPG-----LPEDISPDLAFIVQSCWVEDP 128 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~~~~~~~~~~-----------------------~~~~~-----~p~~~~~~~~~l~~~~l~~dp 128 (198)
+|++++|..||.+............. ..... ....++.++.+++.+||..||
T Consensus 209 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 288 (342)
T cd07854 209 FAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNP 288 (342)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCc
Confidence 99999999999766543322111100 00000 123467889999999999999
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCC
Q 029154 129 NLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 129 ~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
.+||++.+++. +.|+.....+
T Consensus 289 ~~R~t~~ell~--h~~~~~~~~~ 309 (342)
T cd07854 289 MDRLTAEEALM--HPYMSCYSCP 309 (342)
T ss_pred hhccCHHHHhC--CCccccccCC
Confidence 99999999998 7777644433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-24 Score=168.16 Aligned_cols=136 Identities=20% Similarity=0.326 Sum_probs=97.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||++....... .....+||+.|+|||++.... .....++.++|+|||||++|
T Consensus 124 iHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DvwSlGvil~ 199 (332)
T cd05623 124 VHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME---DGKGKYGPECDWWSLGVCMY 199 (332)
T ss_pred EecCCCHHHEEECCC-CCEEEeecchheecccCCcceecccccCccccCHHHHhccc---cCCCCCCCcCCEEeeHHHHH
Confidence 699999999999966 679999999986432211 122357999999999874210 01245788999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCC---CCCCcHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGL---PEDISPDLAFIVQSCWVEDPNL--RPSFSQIIRM 140 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---p~~~~~~~~~l~~~~l~~dp~~--Rps~~~~l~~ 140 (198)
||++|+.||.+................... +..+++++.+++.+|+..++.. |+++.+++++
T Consensus 200 ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 200 EMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 999999999876644433222222222222 3457899999999999765544 5789999883
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-24 Score=161.33 Aligned_cols=135 Identities=24% Similarity=0.390 Sum_probs=103.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+ +.+||+|||++...... ......|+..|++||.+.. ...++.++|+||+|+++|++
T Consensus 119 ~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~s~G~~l~~l 189 (278)
T cd05606 119 VYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKL 189 (278)
T ss_pred EcCCCCHHHEEECCC-CCEEEccCcCccccCcc-CCcCcCCCcCCcCcHHhcC-------CCCCCcccchHhHHHHHHHH
Confidence 699999999999976 67999999998744322 2234578999999999753 23578899999999999999
Q ss_pred HcCCCCCCCCCcHHH-HHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQA-AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~~l~~~~~ 146 (198)
++|..||........ .............|..++.++.+++.+||..+|.+|| ++.++++ +.|+.
T Consensus 190 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~--~~~~~ 259 (278)
T cd05606 190 LRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--HPFFR 259 (278)
T ss_pred HhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh--Ccccc
Confidence 999999976532111 1122223344566777899999999999999999999 9999987 54443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-24 Score=160.95 Aligned_cols=134 Identities=28% Similarity=0.497 Sum_probs=98.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||+|+||+++.+ +.+||+|||++...... .......|+..|+|||.+.... .....++.++|+||+|+++|+
T Consensus 135 ~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slG~il~~ 210 (275)
T cd06608 135 IHRDIKGQNILLTKN-AEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDE---QPDASYDARSDVWSLGITAIE 210 (275)
T ss_pred ccCCCCHHHEEEccC-CeEEECCCccceecccchhhhcCccccccccCHhHhcccc---cccCCccccccHHHhHHHHHH
Confidence 699999999999976 67999999998643322 1223456889999999874311 012456789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCC--CCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+++|..||........... ......+.. +..++.++.+++.+||..||.+|||+.++++
T Consensus 211 l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 211 LADGKPPLCDMHPMRALFK-IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHhCCCCccccchHHHHHH-hhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 9999999976544333222 222222222 2346789999999999999999999999987
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.5e-24 Score=163.10 Aligned_cols=135 Identities=24% Similarity=0.454 Sum_probs=99.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+|||++.+ +.+||+|||++...... ......|+..|++||.+.+ ..++.++|+||||+++|++
T Consensus 122 ~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~--------~~~~~~~DiwslG~~l~~l 191 (308)
T cd06615 122 MHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYTVQSDIWSLGLSLVEM 191 (308)
T ss_pred EECCCChHHEEEecC-CcEEEccCCCccccccc-ccccCCCCcCccChhHhcC--------CCCCccchHHHHHHHHHHH
Confidence 699999999999976 67999999998754322 2244678899999998743 4578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHH-----------------------------------HHHccCCCCCCC-CCcHHHHHHHHHhc
Q 029154 81 LTNRLPFEGMSNLQAAYA-----------------------------------AAFKHARPGLPE-DISPDLAFIVQSCW 124 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~-----------------------------------~~~~~~~~~~p~-~~~~~~~~l~~~~l 124 (198)
++|..||........... .......+..|. .++.++.+++.+||
T Consensus 192 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 271 (308)
T cd06615 192 AIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCL 271 (308)
T ss_pred HhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHc
Confidence 999999865432111100 001111122222 36788999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHHhh
Q 029154 125 VEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 125 ~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
..+|++||++.++++ +.|+..
T Consensus 272 ~~~P~~Rpt~~~ll~--~~~~~~ 292 (308)
T cd06615 272 KKNPKERADLKELTK--HPFIKR 292 (308)
T ss_pred cCChhhCcCHHHHhc--Chhhhh
Confidence 999999999999999 666543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-24 Score=160.86 Aligned_cols=135 Identities=23% Similarity=0.399 Sum_probs=102.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.+ +.+||+|||++.............++..|++||.+.+ ..++.++|+||+|+++|++
T Consensus 117 ~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~il~~l 187 (277)
T cd05577 117 VYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG--------EVYDFSVDWFALGCTLYEM 187 (277)
T ss_pred ccCCCCHHHEEECCC-CCEEEccCcchhhhccCCccccccCCCCcCCHHHhcC--------CCCCchhhhHHHHHHHHHH
Confidence 699999999999976 6799999999875433333344567889999998753 4478899999999999999
Q ss_pred HcCCCCCCCCCcH--HHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNL--QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~~l~~~~~ 146 (198)
++|+.||...... ...............+..+++++.+++.+||..||.+|| ++.+++. +.|+.
T Consensus 188 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~--h~~~~ 258 (277)
T cd05577 188 IAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE--HPLFK 258 (277)
T ss_pred hhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh--Chhhh
Confidence 9999999765431 111111122334455677899999999999999999999 7777776 55553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=160.19 Aligned_cols=131 Identities=24% Similarity=0.381 Sum_probs=94.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+|||++.+ +.+||+|||+++..... .......++..|++||.+.+ ...++.++|+||+|+++|+
T Consensus 125 ~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~ 196 (291)
T cd07870 125 LHRDLKPQNLLISYL-GELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLG-------ATDYSSALDIWGAGCIFIE 196 (291)
T ss_pred ccCCCChHHEEEcCC-CcEEEeccccccccCCCCCCCCCccccccccCCceeec-------CCCCCcHHHHHHHHHHHHH
Confidence 699999999999976 67999999998753321 12233457889999998753 2346789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCC----------------------CCCC---------CCCcHHHHHHHHHhcccCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHAR----------------------PGLP---------EDISPDLAFIVQSCWVEDP 128 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------~~~p---------~~~~~~~~~l~~~~l~~dp 128 (198)
+++|..||.+................ ...+ ...++++.+++.+|+..||
T Consensus 197 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp 276 (291)
T cd07870 197 MLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFP 276 (291)
T ss_pred HHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCc
Confidence 99999999865543222221111000 0000 0125678999999999999
Q ss_pred CCCCCHHHHHH
Q 029154 129 NLRPSFSQIIR 139 (198)
Q Consensus 129 ~~Rps~~~~l~ 139 (198)
.+|||+.+++.
T Consensus 277 ~~R~t~~~~l~ 287 (291)
T cd07870 277 KDRISAQDALL 287 (291)
T ss_pred ccCcCHHHHhc
Confidence 99999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=159.55 Aligned_cols=131 Identities=30% Similarity=0.407 Sum_probs=96.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++...... .......++..|++||.+.+ ...++.++|+||||+++|+
T Consensus 122 ~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~~ 193 (284)
T cd07860 122 LHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-------CKYYSTAVDIWSLGCIFAE 193 (284)
T ss_pred ecCCCCHHHEEECCC-CCEEEeeccchhhcccCccccccccccccccCCeEEec-------CCCCCcHHHHHHHHHHHHH
Confidence 699999999999976 67999999998754322 12233457889999998753 2446788999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC---------------------------CCCCCCcHHHHHHHHHhcccCCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP---------------------------GLPEDISPDLAFIVQSCWVEDPNLRP 132 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~~~~l~~~~l~~dp~~Rp 132 (198)
+++|..||.+................+ .....+++++.+++.+||..||++||
T Consensus 194 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 273 (284)
T cd07860 194 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI 273 (284)
T ss_pred HHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCC
Confidence 999999997655433222211100000 01234678899999999999999999
Q ss_pred CHHHHHH
Q 029154 133 SFSQIIR 139 (198)
Q Consensus 133 s~~~~l~ 139 (198)
++.++++
T Consensus 274 t~~~~l~ 280 (284)
T cd07860 274 SAKAALA 280 (284)
T ss_pred CHHHHhc
Confidence 9999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.8e-24 Score=164.70 Aligned_cols=139 Identities=28% Similarity=0.412 Sum_probs=101.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+||+++.+ +.+||+|||++...... .......++..|++||.+.. ...++.++|+||||+++|+
T Consensus 130 ~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ 201 (337)
T cd07858 130 LHRDLKPSNLLLNAN-CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN-------CSEYTTAIDVWSVGCIFAE 201 (337)
T ss_pred ecCCCCHHHEEEcCC-CCEEECcCccccccCCCcccccccccccCccChHHHhc-------CCCCCCcccHHHHHHHHHH
Confidence 699999999999976 67999999999754332 22234567889999998742 2347889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHH----------------------Hcc--C--CC---CCCCCCcHHHHHHHHHhcccCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAA----------------------FKH--A--RP---GLPEDISPDLAFIVQSCWVEDPNL 130 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~----------------------~~~--~--~~---~~p~~~~~~~~~l~~~~l~~dp~~ 130 (198)
+++|+.||.+........... ... . .. .....+++++.+++.+||..+|.+
T Consensus 202 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 281 (337)
T cd07858 202 LLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSK 281 (337)
T ss_pred HHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhh
Confidence 999999997654321110000 000 0 00 112357888999999999999999
Q ss_pred CCCHHHHHHHHHHHHhhcC
Q 029154 131 RPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 131 Rps~~~~l~~l~~~~~~~~ 149 (198)
||++.++++ +.|+....
T Consensus 282 Rps~~ell~--h~~~~~~~ 298 (337)
T cd07858 282 RITVEEALA--HPYLASLH 298 (337)
T ss_pred ccCHHHHHc--Ccchhhhc
Confidence 999999999 66666543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=162.00 Aligned_cols=136 Identities=27% Similarity=0.363 Sum_probs=100.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+||+++.+ +.+||+|||++...... .......++..|+|||++.+ ...++.++|+||+|+++|+
T Consensus 130 ~H~dl~p~nil~~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~il~e 201 (309)
T cd07845 130 IHRDLKVSNLLLTDK-GCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG-------CTTYTTAIDMWAVGCILAE 201 (309)
T ss_pred ecCCCCHHHEEECCC-CCEEECccceeeecCCccCCCCcccccccccChhhhcC-------CCCcCchHHHHHHHHHHHH
Confidence 699999999999976 67999999998754332 12223345788999998753 2457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccC-----------------CCCCC-----------CCCcHHHHHHHHHhcccCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHA-----------------RPGLP-----------EDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~-----------------~~~~p-----------~~~~~~~~~l~~~~l~~dp~~R 131 (198)
+++|..||.+............... ....+ ...++.+.+++.+||..||.+|
T Consensus 202 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R 281 (309)
T cd07845 202 LLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKR 281 (309)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhC
Confidence 9999999987665443222111000 00000 1247888999999999999999
Q ss_pred CCHHHHHHHHHHHHh
Q 029154 132 PSFSQIIRMLNAFLF 146 (198)
Q Consensus 132 ps~~~~l~~l~~~~~ 146 (198)
|++.+++. +.|+.
T Consensus 282 ~t~~~il~--h~~f~ 294 (309)
T cd07845 282 ATAEEALE--SSYFK 294 (309)
T ss_pred cCHHHHhc--Chhhc
Confidence 99999998 67765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=157.33 Aligned_cols=128 Identities=25% Similarity=0.403 Sum_probs=95.7
Q ss_pred CCCCCCCCCeEEcCCC------CceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQ------KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 74 (198)
Q Consensus 1 iH~dlKp~NIll~~~~------~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G 74 (198)
|||||||+|||++..+ ..+|++|||++...... ....++..|++||.+.. ...++.++|+||||
T Consensus 139 iH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~-------~~~~~~~~Dv~slG 208 (274)
T cd05076 139 VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPG-------GNSLSTAADKWSFG 208 (274)
T ss_pred cCCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcC-------CCCCCcHHHHHHHH
Confidence 7999999999997532 23799999987543221 22357788999998753 24578999999999
Q ss_pred HHHHHHH-cCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 75 IVLWELL-TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 75 ~~l~e~~-~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
+++||++ +|..||.+......... . ......+....+++.+++.+||+.+|++||++.++++.|
T Consensus 209 ~~l~el~~~g~~p~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 209 TTLLEICFDGEVPLKERTPSEKERF-Y--EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHHhCCCCCccccChHHHHHH-H--HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 9999985 78999976554322111 1 122334555678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=163.19 Aligned_cols=137 Identities=23% Similarity=0.433 Sum_probs=96.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--------cccCCCCccceecccccccccccccccCCCCchhhHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 72 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws 72 (198)
|||||||+|||++.+ +.+++.|||......... ......++..|+|||++.+ ....++.++|+||
T Consensus 123 iH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Diws 195 (327)
T cd08227 123 VHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQ------NLQGYDAKSDIYS 195 (327)
T ss_pred ecCCCChhhEEEecC-CcEEEcccchhhccccccccccccccccccccceecccChHHhhc------ccCCCCchhhHHH
Confidence 699999999999976 679999998654221100 0112356778999999853 1245789999999
Q ss_pred HHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCC---------------------------------------------C
Q 029154 73 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP---------------------------------------------G 107 (198)
Q Consensus 73 ~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------------------------~ 107 (198)
+||++||+++|..||............. ....+ +
T Consensus 196 lG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (327)
T cd08227 196 VGITACELANGHVPFKDMPATQMLLEKL-NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHP 274 (327)
T ss_pred HHHHHHHHHHCCCCCCCcchhHHHHHHh-cCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccc
Confidence 9999999999999997644322211111 00000 0
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 108 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 108 ~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
....+++.+.+++.+||..||.+|||++++++ +.|+..
T Consensus 275 ~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~--~p~f~~ 312 (327)
T cd08227 275 YNRTFSPHFHHFVEQCLQRNPDARPSASTLLN--HSFFKQ 312 (327)
T ss_pred cccccCHHHHHHHHHHHhhCchhcCCHHHHhc--Chhhhh
Confidence 11124678999999999999999999999998 666654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-25 Score=173.58 Aligned_cols=133 Identities=27% Similarity=0.453 Sum_probs=111.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
||||||.+||||+.+ .++||+|||++..........+.||++.|+|||++.+ ....++.+|+||+|+++|.+
T Consensus 177 vHrdLk~eNilL~~~-mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g-------~~y~gpe~D~Wslgvvly~L 248 (596)
T KOG0586|consen 177 VHRDLKAENILLDEN-MNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNG-------KKYDGPEVDIWSLGVVLYAL 248 (596)
T ss_pred eccccchhhcccccc-cceeeeccccceeecccccccccCCCCCccChHhhcC-------cccCCcceehhhhhhhheee
Confidence 799999999999977 6799999999987777677788999999999999976 34557899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
+.|..||.+..-... ..........+|..++.++.++++++|..+|.+|++.+++++ +.|.
T Consensus 249 V~GsLPFDG~~lk~L--r~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~--~~W~ 309 (596)
T KOG0586|consen 249 VEGSLPFDGQNLKEL--RPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK--DRWR 309 (596)
T ss_pred eecccccCCcccccc--cchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh--hccc
Confidence 999999997653221 222234456778889999999999999999999999999998 4443
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.9e-24 Score=158.29 Aligned_cols=129 Identities=30% Similarity=0.486 Sum_probs=102.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc-ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||+|+||+++.+ +.++|+|||++........ .....|+..|++||++.+ ..++.++|+||||+++++
T Consensus 123 ~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~i~~~ 193 (256)
T cd08218 123 LHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN--------RPYNNKSDIWALGCVLYE 193 (256)
T ss_pred ecCCCCHHHEEEcCC-CCEEEeeccceeecCcchhhhhhccCCccccCHHHhCC--------CCCCCccchhHHHHHHHH
Confidence 699999999999976 6799999999875433221 223457889999998753 557789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+++|..||........ .........+..+..++.++.+++.+||..+|.+||++.++++
T Consensus 194 l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 194 MCTLKHAFEAGNMKNL-VLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHcCCCCccCCCHHHH-HHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 9999999976554333 2333444555667788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=159.07 Aligned_cols=142 Identities=30% Similarity=0.358 Sum_probs=103.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++...... .......++..|+|||.+.+ ...++.++|+|||||++|+
T Consensus 124 ~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~e 195 (298)
T cd07841 124 LHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG-------ARHYGVGVDMWSVGCIFAE 195 (298)
T ss_pred eecCCChhhEEEcCC-CCEEEccceeeeeccCCCccccccccceeeeCHHHHhC-------CCCCCcHHHHHHHHHHHHH
Confidence 699999999999976 67999999998754332 22233456788999998743 2456889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCC---------------------CC-----CCCCCcHHHHHHHHHhcccCCCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHAR---------------------PG-----LPEDISPDLAFIVQSCWVEDPNLRPS 133 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------~~-----~p~~~~~~~~~l~~~~l~~dp~~Rps 133 (198)
+++|.++|.+................ +. .....+..+.+++.+||..||.+||+
T Consensus 196 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s 275 (298)
T cd07841 196 LLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT 275 (298)
T ss_pred HHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC
Confidence 99998888765543322111100000 00 11234678899999999999999999
Q ss_pred HHHHHHHHHHHHhhcCCCC
Q 029154 134 FSQIIRMLNAFLFTLRPPS 152 (198)
Q Consensus 134 ~~~~l~~l~~~~~~~~~~~ 152 (198)
+.++++ +.|+.....+.
T Consensus 276 ~~e~l~--~~~~~~~~~~~ 292 (298)
T cd07841 276 ARQALE--HPYFSNDPAPT 292 (298)
T ss_pred HHHHhh--CccccCCCCCC
Confidence 999999 77776655443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=155.56 Aligned_cols=129 Identities=26% Similarity=0.403 Sum_probs=94.8
Q ss_pred CCCCCCCCCeEEcCCCC------ceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQK------SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 74 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~------~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G 74 (198)
+||||||+|||++.++. .+||+|||++..... .....++..|++||.+.+ ....++.++|+||||
T Consensus 123 ~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~------~~~~~~~~~Di~slG 193 (259)
T cd05037 123 VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRN------GQASLTIAADKWSFG 193 (259)
T ss_pred ecccCccceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcC------CCCCcchhhHHHHHH
Confidence 69999999999986631 599999999875433 123456778999999754 113678899999999
Q ss_pred HHHHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 75 IVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 75 ~~l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
+++|++++ |..||......... .... .....+......+.+++.+||..+|.+||++.++++.|
T Consensus 194 ~~~~~l~~~~~~p~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 194 TTLLEICSNGEEPLSTLSSSEKE-RFYQ--DQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHHHHHHhCCCCCcccCCchhHH-HHHh--cCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 99999998 57777665432211 1111 12222333348899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=158.99 Aligned_cols=139 Identities=31% Similarity=0.534 Sum_probs=103.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.++|+|||++...... .......++..|++||.+.... .....++.++|+||+|+++|+
T Consensus 125 ~h~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~~~~sDi~slG~il~~ 200 (280)
T cd06611 125 IHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET---FKDNPYDYKADIWSLGITLIE 200 (280)
T ss_pred ccCCCChhhEEECCC-CCEEEccCccchhhcccccccceeecchhhcCHHHHhhcc---cCCCCCCccccHHHHHHHHHH
Confidence 699999999999976 67999999988643221 1223346888999999874211 112456789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC--CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+++|..||.+....... ........+ ..+..++.++.+++.+||..+|.+||++.++++ +.|+.
T Consensus 201 l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~ 266 (280)
T cd06611 201 LAQMEPPHHELNPMRVL-LKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK--HPFVS 266 (280)
T ss_pred HHhCCCCcccCCHHHHH-HHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc--Chhhc
Confidence 99999999876543332 222222222 335568899999999999999999999999998 66654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=160.57 Aligned_cols=122 Identities=26% Similarity=0.479 Sum_probs=102.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccC-cccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|-||||-+||+|+.+ +++||+|||+++.. .......+.|||+.|+|||++. .+.|+..+|+|++|+++||
T Consensus 472 iYRDLKLDNvmLd~e-GHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~--------YqPYgksvDWWa~GVLLyE 542 (683)
T KOG0696|consen 472 IYRDLKLDNVMLDSE-GHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIA--------YQPYGKSVDWWAFGVLLYE 542 (683)
T ss_pred eeeeccccceEeccC-CceEeeecccccccccCCcceeeecCCCcccccceEE--------ecccccchhHHHHHHHHHH
Confidence 569999999999987 79999999999843 3334456789999999999985 5889999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 133 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps 133 (198)
|+.|++||.+.+.... ...+.......|..++.++.++....|...|.+|..
T Consensus 543 mlaGQpPFdGeDE~el--F~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 543 MLAGQPPFDGEDEDEL--FQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHcCCCCCCCCCHHHH--HHHHHHccCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 9999999999775332 223334445678899999999999999999999953
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=158.97 Aligned_cols=131 Identities=27% Similarity=0.426 Sum_probs=98.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||||+||+++.+ +.+||+|||++....... ......++..|++||++.. ...++.++|+||+|+++|
T Consensus 122 ~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~~Dv~slG~~l~ 193 (288)
T cd07833 122 IHRDIKPENILVSES-GVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG-------DTNYGKPVDVWAIGCIMA 193 (288)
T ss_pred ecCCCCHHHeEECCC-CCEEEEeeecccccCCCccccccCcccccCCcCCchhcC-------CCCcCchhhHHHHHHHHH
Confidence 699999999999976 679999999987544332 2334567889999999854 226788999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHc--cCC----------------------------CCCCCCCcHHHHHHHHHhcccCC
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFK--HAR----------------------------PGLPEDISPDLAFIVQSCWVEDP 128 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~--~~~----------------------------~~~p~~~~~~~~~l~~~~l~~dp 128 (198)
++++|..||.+............. ... ...+..++.++.+++.+||..+|
T Consensus 194 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 273 (288)
T cd07833 194 ELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDP 273 (288)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCc
Confidence 999999999765543322211110 000 01123357889999999999999
Q ss_pred CCCCCHHHHHH
Q 029154 129 NLRPSFSQIIR 139 (198)
Q Consensus 129 ~~Rps~~~~l~ 139 (198)
.+||+++++++
T Consensus 274 ~~Rps~~~il~ 284 (288)
T cd07833 274 KERLTCDELLQ 284 (288)
T ss_pred hhcccHHHHhc
Confidence 99999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=155.99 Aligned_cols=129 Identities=32% Similarity=0.588 Sum_probs=99.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||+|+||+++.+ +.++|+|||++.............++..|++||.+.+ ..++.++|+||+|++++++
T Consensus 120 ~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Dv~slG~il~~l 190 (253)
T cd05122 120 IHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING--------KPYDYKADIWSLGITAIEL 190 (253)
T ss_pred ecCCCCHHHEEEccC-CeEEEeeccccccccccccccceecCCcccCHHHHcC--------CCCCccccHHHHHHHHHHH
Confidence 699999999999976 6799999999875443321234567889999998753 4478899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCC--CcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPED--ISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~--~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
++|..||............. ....+..+.. ++..+.+++.+||..||++||++.++++
T Consensus 191 ~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 191 AEGKPPYSELPPMKALFKIA-TNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HhCCCCCCCCchHHHHHHHH-hcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99999998764433332222 1223333333 3889999999999999999999999987
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=161.21 Aligned_cols=141 Identities=28% Similarity=0.375 Sum_probs=102.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc------ccccCCCCccceecccccccccccccccCCCCchhhHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 74 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G 74 (198)
+||||||+||+++.+ +.+||+|||++...... .......|+..|++||.+.+ ...++.++|+||||
T Consensus 129 ~H~dl~p~nill~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi~slG 200 (337)
T cd07852 129 IHRDLKPSNILLNSD-CRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLG-------STRYTKGVDMWSVG 200 (337)
T ss_pred ecCCCCHHHEEEcCC-CcEEEeeccchhccccccccccCcchhcccccccccCceeeec-------cccccccchHHHHH
Confidence 699999999999976 68999999998744321 12233568889999998743 24567899999999
Q ss_pred HHHHHHHcCCCCCCCCCcHHHHHHHHHcc-------------------------CC----CCCCCCCcHHHHHHHHHhcc
Q 029154 75 IVLWELLTNRLPFEGMSNLQAAYAAAFKH-------------------------AR----PGLPEDISPDLAFIVQSCWV 125 (198)
Q Consensus 75 ~~l~e~~~g~~p~~~~~~~~~~~~~~~~~-------------------------~~----~~~p~~~~~~~~~l~~~~l~ 125 (198)
+++|++++|+.||.+.............. .. ......++.++.+++.+||.
T Consensus 201 ~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 280 (337)
T cd07852 201 CILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLV 280 (337)
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhcc
Confidence 99999999999997654332211100000 00 01112367889999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHhhcCCC
Q 029154 126 EDPNLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 126 ~dp~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
.||++||++.++++ +.++.....+
T Consensus 281 ~~P~~Rps~~~il~--~~~~~~~~~~ 304 (337)
T cd07852 281 FNPNKRLTAEEALE--HPYVAQFHNP 304 (337)
T ss_pred CCcccccCHHHHhh--ChhhhhhccC
Confidence 99999999999998 6676655433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=162.29 Aligned_cols=142 Identities=25% Similarity=0.397 Sum_probs=103.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-----cccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
+||||||+||+++.+ +.+||+|||++....... ......|+..|++||.+.. ...++.++|+||+|+
T Consensus 129 vH~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~slG~ 200 (334)
T cd07855 129 IHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS-------LPEYTTAIDMWSVGC 200 (334)
T ss_pred ecCCCCHHHEEEcCC-CcEEecccccceeecccCcCCCcccccccccccccChHHhcC-------CcccccccchHHHHH
Confidence 699999999999976 679999999987443211 1123468889999998743 245788999999999
Q ss_pred HHHHHHcCCCCCCCCCcHHHHHHH----------------------HHc--cCCCCC-----CCCCcHHHHHHHHHhccc
Q 029154 76 VLWELLTNRLPFEGMSNLQAAYAA----------------------AFK--HARPGL-----PEDISPDLAFIVQSCWVE 126 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~~~~~~~----------------------~~~--~~~~~~-----p~~~~~~~~~l~~~~l~~ 126 (198)
++|+|++|+.||.+.......... ... ...... ....++++.+++.+||+.
T Consensus 201 ~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 280 (334)
T cd07855 201 IFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQF 280 (334)
T ss_pred HHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccC
Confidence 999999999999765432211100 000 000111 134678999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHhhcCCCC
Q 029154 127 DPNLRPSFSQIIRMLNAFLFTLRPPS 152 (198)
Q Consensus 127 dp~~Rps~~~~l~~l~~~~~~~~~~~ 152 (198)
+|.+||++++++. +.|+.....+.
T Consensus 281 ~P~~Rpt~~~~l~--~~~~~~~~~~~ 304 (334)
T cd07855 281 DPEERITVEQALQ--HPFLAQYHDPD 304 (334)
T ss_pred ChhhCcCHHHHHh--ChhhhhccCCc
Confidence 9999999999999 78877665543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=160.92 Aligned_cols=141 Identities=28% Similarity=0.420 Sum_probs=103.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+|+||||+|||++.+ +.++|+|||++....... ......++..|++||.+.+ ...++.++|+||+|++
T Consensus 125 ~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi~slG~i 196 (330)
T cd07834 125 IHRDLKPSNILVNSN-CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS-------SSRYTKAIDIWSVGCI 196 (330)
T ss_pred ecCCCCHHHEEEcCC-CCEEEcccCceEeecccccccccccccccccCcCCceeeec-------ccCCCcchhHHHHHHH
Confidence 699999999999977 789999999997543322 2334567889999999864 2267889999999999
Q ss_pred HHHHHcCCCCCCCCCcHHHHHHHHHccCCC-----------------------------CCCCCCcHHHHHHHHHhcccC
Q 029154 77 LWELLTNRLPFEGMSNLQAAYAAAFKHARP-----------------------------GLPEDISPDLAFIVQSCWVED 127 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~p~~~~~~~~~l~~~~l~~d 127 (198)
+|++++|..||.+................+ .....++.++.+++.+||+.+
T Consensus 197 l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 276 (330)
T cd07834 197 FAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFD 276 (330)
T ss_pred HHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCC
Confidence 999999999998765432211111100000 011236788999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHhhcCCC
Q 029154 128 PNLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 128 p~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
|.+||++.++++ +.|+.....+
T Consensus 277 P~~Rpt~~~ll~--~~~~~~~~~~ 298 (330)
T cd07834 277 PKKRITADEALA--HPYLAQLHDP 298 (330)
T ss_pred hhhCCCHHHHHh--CccHHhhccc
Confidence 999999999998 6677655443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=159.03 Aligned_cols=131 Identities=31% Similarity=0.449 Sum_probs=97.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||||+||+++.+ +.++|+|||++....... ......|+..|++||.+.+ ...++.++|+||+|++++
T Consensus 121 ~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~ 192 (286)
T cd07832 121 MHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG-------ARKYDPGVDLWAVGCIFA 192 (286)
T ss_pred ecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCCCccccccCcccccCceeeec-------cccCCchhHHHHHHHHHH
Confidence 699999999999976 679999999987543322 2344578899999998753 345688999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCC----------------------------CCCCCCcHHHHHHHHHhcccCCCC
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARP----------------------------GLPEDISPDLAFIVQSCWVEDPNL 130 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~p~~~~~~~~~l~~~~l~~dp~~ 130 (198)
++++|.++|.+................+ ......+..+.+++.+||..+|.+
T Consensus 193 ~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 272 (286)
T cd07832 193 ELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSK 272 (286)
T ss_pred HHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhh
Confidence 9999988887655433221111100000 011235688999999999999999
Q ss_pred CCCHHHHHH
Q 029154 131 RPSFSQIIR 139 (198)
Q Consensus 131 Rps~~~~l~ 139 (198)
||++++++.
T Consensus 273 R~~~~~~l~ 281 (286)
T cd07832 273 RLSAAEALR 281 (286)
T ss_pred CCCHHHHhh
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=155.84 Aligned_cols=130 Identities=30% Similarity=0.490 Sum_probs=100.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.++..+||+|||.+....... ......|+..|+|||.+.. ..++.++|+||||+++++
T Consensus 123 ~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~--------~~~~~~~Dv~slG~il~~ 194 (257)
T cd08225 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN--------RPYNNKTDIWSLGCVLYE 194 (257)
T ss_pred ccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcC--------CCCCchhhHHHHHHHHHH
Confidence 6999999999998775567999999987543322 1223468889999998743 457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+++|..||........ ............+...+.++.+++.+||..+|++||++.++++
T Consensus 195 l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 195 LCTLKHPFEGNNLHQL-VLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHhCCCCCCCccHHHH-HHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 9999999976553332 2233333344455567889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=159.36 Aligned_cols=131 Identities=30% Similarity=0.372 Sum_probs=97.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++...... .......++..|++||.+.+ ...++.++|+||+|+++|+
T Consensus 128 ~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~ 199 (293)
T cd07843 128 LHRDLKTSNLLLNNR-GILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLG-------AKEYSTAIDMWSVGCIFAE 199 (293)
T ss_pred eeccCCHHHEEECCC-CcEEEeecCceeeccCCccccccccccccccCchhhcC-------CccccchhhHHHHHHHHHH
Confidence 699999999999976 67999999998754432 22334567889999998753 2346789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHc-----------------------------cCCCCCCCC-CcHHHHHHHHHhcccCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFK-----------------------------HARPGLPED-ISPDLAFIVQSCWVEDPN 129 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~-----------------------------~~~~~~p~~-~~~~~~~l~~~~l~~dp~ 129 (198)
+++|..||............... .....++.. +++.+.+++.+||..||+
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 279 (293)
T cd07843 200 LLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPA 279 (293)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCcc
Confidence 99999999865543222111000 000112222 578899999999999999
Q ss_pred CCCCHHHHHH
Q 029154 130 LRPSFSQIIR 139 (198)
Q Consensus 130 ~Rps~~~~l~ 139 (198)
+||++.|++.
T Consensus 280 ~R~t~~ell~ 289 (293)
T cd07843 280 KRISAEDALK 289 (293)
T ss_pred ccCCHHHHhc
Confidence 9999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=160.36 Aligned_cols=137 Identities=32% Similarity=0.521 Sum_probs=103.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++....... ......|+..|++||.+.. ..++.++|+||||+++|+
T Consensus 137 ~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~ll~~ 207 (293)
T cd06647 137 IHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIE 207 (293)
T ss_pred eeccCCHHHEEEcCC-CCEEEccCcceecccccccccccccCChhhcCchhhcc--------CCCCchhhHHHHHHHHHH
Confidence 599999999999976 679999999886443222 2233468889999998743 457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC--CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
+++|..||............. ....+ ..+..++..+.+++.+||..+|.+||++.+++. +.|+....
T Consensus 208 ll~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--h~~~~~~~ 276 (293)
T cd06647 208 MVEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKIAK 276 (293)
T ss_pred HHhCCCCCCCCChhhheeehh-cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--CHHHhcCc
Confidence 999999998765433322111 11222 234457888999999999999999999999999 77766444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=157.10 Aligned_cols=132 Identities=27% Similarity=0.574 Sum_probs=98.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc---ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+|+||||+||+++.+ +.++|+|||+++..... .......|+..|++||.+.. ....++.++|+||+|+++
T Consensus 130 ~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~~Dv~slG~~l 202 (272)
T cd06629 130 LHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS------YSQGYSAKVDIWSLGCVV 202 (272)
T ss_pred eecCCChhhEEEcCC-CeEEEeeccccccccccccccccccccCCccccCHHHhcc------ccCCCCccchhHHHHHHH
Confidence 699999999999966 78999999998754321 11223467889999998753 123478899999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCC----CCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE----DISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
|++++|..||.....................+. .++..+.+++.+||..+|.+||++.++++
T Consensus 203 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 203 LEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 999999999976554433322221222222232 45889999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=176.84 Aligned_cols=130 Identities=31% Similarity=0.515 Sum_probs=93.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-------------------ccccccCCCCccceeccccccccccccccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-------------------VTEMMTAETGTYRWMAPELYSTVTLRQGEK 61 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 61 (198)
|||||||.||+|+.+ ++|||+|||++.... .....+..+||..|+|||++.+.. .
T Consensus 719 IHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~-----~ 792 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS-----S 792 (1351)
T ss_pred eeccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc-----c
Confidence 799999999999966 789999999997411 001234568999999999986521 2
Q ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCC---CCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 029154 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL---PEDISPDLAFIVQSCWVEDPNLRPSFSQII 138 (198)
Q Consensus 62 ~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l 138 (198)
..|+.|+|+||+|++++||+. ||............+.....|.. .....+....+|+++++.||++||||.|+|
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 368999999999999999984 36543332222232222222211 222345668899999999999999999998
Q ss_pred H
Q 029154 139 R 139 (198)
Q Consensus 139 ~ 139 (198)
+
T Consensus 870 ~ 870 (1351)
T KOG1035|consen 870 N 870 (1351)
T ss_pred h
Confidence 7
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=180.47 Aligned_cols=133 Identities=19% Similarity=0.218 Sum_probs=91.0
Q ss_pred CCCCCCCCCeEEcCC------------------CCceEEecccCcccCccc-----------------ccccCCCCccce
Q 029154 1 MGKFMKEDNLLLTPD------------------QKSLKLADFGLAREETVT-----------------EMMTAETGTYRW 45 (198)
Q Consensus 1 iH~dlKp~NIll~~~------------------~~~~kl~DfGla~~~~~~-----------------~~~~~~~gt~~y 45 (198)
|||||||+||||+.. ...+|++|||+++..... ......+||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 799999999999532 235677788877632110 000123578899
Q ss_pred ecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcc
Q 029154 46 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 125 (198)
Q Consensus 46 ~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~ 125 (198)
+|||++.+ ..++.++|||||||++|||++|..|+........ .......+.......+...+++.+||.
T Consensus 182 ~APE~~~~--------~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~L~ 250 (793)
T PLN00181 182 TSPEEDNG--------SSSNCASDVYRLGVLLFELFCPVSSREEKSRTMS---SLRHRVLPPQILLNWPKEASFCLWLLH 250 (793)
T ss_pred EChhhhcc--------CCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHH---HHHHhhcChhhhhcCHHHHHHHHHhCC
Confidence 99999854 5678999999999999999999888754222111 111111111111234567789999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHh
Q 029154 126 EDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 126 ~dp~~Rps~~~~l~~l~~~~~ 146 (198)
.+|.+||++.++++ +.|+.
T Consensus 251 ~~P~~Rps~~eil~--h~~~~ 269 (793)
T PLN00181 251 PEPSCRPSMSELLQ--SEFIN 269 (793)
T ss_pred CChhhCcChHHHhh--chhhh
Confidence 99999999999998 55554
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=156.72 Aligned_cols=129 Identities=27% Similarity=0.478 Sum_probs=102.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc----ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+|+||||+||+++.+ +.++|+|||+++..... .......++..|++||.+.+ ..++.++|+||||++
T Consensus 128 ~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~i 198 (264)
T cd06653 128 VHRDIKGANILRDSA-GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG--------EGYGRKADVWSVACT 198 (264)
T ss_pred ecCCCCHHHEEEcCC-CCEEECccccccccccccccCccccccCCcccccCHhhhcC--------CCCCccccHHHHHHH
Confidence 699999999999966 67999999999743211 11223468889999998753 456789999999999
Q ss_pred HHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 77 LWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+|++++|+.||..................+.+|..+++.+.+++.+||. ++..||++.+++.
T Consensus 199 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 199 VVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 9999999999987665544444433444566788899999999999998 5799999998877
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=160.45 Aligned_cols=140 Identities=24% Similarity=0.412 Sum_probs=99.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--------cccCCCCccceecccccccccccccccCCCCchhhHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 72 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws 72 (198)
+||||||+||+++.+ +.+||+|||.+....... ......++..|++||++.. ....++.++|+||
T Consensus 123 vH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Diws 195 (314)
T cd08216 123 IHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ------NLQGYNEKSDIYS 195 (314)
T ss_pred ecCCCCcceEEEecC-CceEEecCccceeeccccccccccccccccccccccccCHHHhcC------CCCCCCcchhHHH
Confidence 699999999999966 679999999886332111 1123456778999998753 1245788999999
Q ss_pred HHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCC--------------------------------CCCCCCCcHHHHHHH
Q 029154 73 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR--------------------------------PGLPEDISPDLAFIV 120 (198)
Q Consensus 73 ~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~--------------------------------~~~p~~~~~~~~~l~ 120 (198)
+|+++||+++|..||.................. ......+++++.+++
T Consensus 196 ~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 275 (314)
T cd08216 196 VGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFV 275 (314)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHH
Confidence 999999999999999865543322221111000 000112346788999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 121 QSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 121 ~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
.+||..||++||+++++++ +.++....
T Consensus 276 ~~~l~~~P~~Rpt~~~ll~--~p~~~~~~ 302 (314)
T cd08216 276 ELCLQRDPESRPSASQLLN--HSFFKQCK 302 (314)
T ss_pred HHHhhcCCCcCcCHHHHhc--CchHhhhc
Confidence 9999999999999999999 77766544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=159.49 Aligned_cols=135 Identities=30% Similarity=0.493 Sum_probs=102.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.+ +.+||+|||++..... .....|+..|++||++... ....++.++|+||||+++|++
T Consensus 143 ~H~dl~p~nili~~~-~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~-----~~~~~~~~sDv~slGvil~el 213 (313)
T cd06633 143 IHRDIKAGNILLTEP-GQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIEL 213 (313)
T ss_pred ecCCCChhhEEECCC-CCEEEeecCCCcccCC---CCCccccccccChhhcccc-----CCCCCCchhhHHHHHHHHHHH
Confidence 699999999999976 6799999999864321 2345688899999987421 124578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++|..||.................+......++..+.+++.+||+.+|.+||++.+++. +.++.
T Consensus 214 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~--~~~~~ 277 (313)
T cd06633 214 AERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR--HDFVR 277 (313)
T ss_pred HhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--CcccC
Confidence 99999998766544443333222222233457788999999999999999999999998 55544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-24 Score=161.17 Aligned_cols=131 Identities=31% Similarity=0.519 Sum_probs=97.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccC-cccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.++|+|||.+... ..........++..|+|||++.. ...++.++|+||+|+++|+
T Consensus 120 ~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~ 191 (260)
T PF00069_consen 120 VHRDIKPENILLDEN-GEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQ-------GKKYTRKSDIWSLGIILYE 191 (260)
T ss_dssp EESSBSGGGEEESTT-SEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTT-------TSSBSTHHHHHHHHHHHHH
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccccccccccccc-------ccccccccccccccccccc
Confidence 599999999999965 77999999998742 22333455678999999999751 3567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHH--HHHHHc-c--CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAA--YAAAFK-H--ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~--~~~~~~-~--~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
|++|..||......... ...... . ............+.+++.+||..||++||++.++++
T Consensus 192 l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 192 LLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999999876321211 111111 0 001111223489999999999999999999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=157.85 Aligned_cols=131 Identities=23% Similarity=0.403 Sum_probs=100.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+++.++|+|||++...... ....++..|+|||++.+ ..++.++|+||+|+++|++
T Consensus 131 ~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l 199 (267)
T PHA03390 131 IHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKG--------HNYDVSFDWWAVGVLTYEL 199 (267)
T ss_pred eeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccCCCCCcccChhhhcC--------CCCCchhhHHHHHHHHHHH
Confidence 699999999999977448999999998754332 23467889999999853 5678899999999999999
Q ss_pred HcCCCCCCCCCcHHH---HHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC-HHHHHHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQA---AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-FSQIIRMLNAFL 145 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps-~~~~l~~l~~~~ 145 (198)
++|..||........ ...... ......+..+++.+.+++.+||+.+|.+|++ ++++++ +.|+
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~--h~~~ 265 (267)
T PHA03390 200 LTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK--HPFL 265 (267)
T ss_pred HHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc--CCcc
Confidence 999999975432211 111111 2333445578999999999999999999995 699987 5443
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=157.76 Aligned_cols=135 Identities=24% Similarity=0.450 Sum_probs=100.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc----ccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+|+||||+||+++.+ +.++|+|||++........ .....++..|++||.+.. ..++.++|+||||++
T Consensus 131 ~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Di~slG~~ 201 (284)
T cd05038 131 IHRDLAARNILVESE-DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT--------SKFSSASDVWSFGVT 201 (284)
T ss_pred ecCCCCHHhEEEcCC-CCEEEcccccccccccCCcceeccCCCCCcccccCcHHHcc--------CCCCcccchHHHhhh
Confidence 699999999999976 6799999999975442111 112234567999998743 467889999999999
Q ss_pred HHHHHcCCCCCCCCCcHH--------------HHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 77 LWELLTNRLPFEGMSNLQ--------------AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~~--------------~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
++||++|..|+....... ..............+..++.++.+++.+||..+|.+||++.+++++|+
T Consensus 202 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05038 202 LYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281 (284)
T ss_pred hheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence 999999998875432111 111122223333445667889999999999999999999999999987
Q ss_pred HH
Q 029154 143 AF 144 (198)
Q Consensus 143 ~~ 144 (198)
.+
T Consensus 282 ~i 283 (284)
T cd05038 282 RL 283 (284)
T ss_pred hc
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=157.19 Aligned_cols=131 Identities=28% Similarity=0.405 Sum_probs=96.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||+|+||+++.+ +.++|+|||++...... .......++..|++||++.+ ...++.++|+||+|+++|+
T Consensus 121 ~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~ 192 (283)
T cd07835 121 LHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-------SRQYSTPVDIWSIGCIFAE 192 (283)
T ss_pred eCCCCCHHHEEEcCC-CcEEEeecccccccCCCccccCccccccCCCCCceeec-------CcccCcHHHHHHHHHHHHH
Confidence 699999999999976 67999999998754322 12233456889999998753 2346889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccC-----------------------C----CCCCCCCcHHHHHHHHHhcccCCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHA-----------------------R----PGLPEDISPDLAFIVQSCWVEDPNLRP 132 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------~----~~~p~~~~~~~~~l~~~~l~~dp~~Rp 132 (198)
+++|..||.+............... . ......++..+.+++.+||+.||.+||
T Consensus 193 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 272 (283)
T cd07835 193 MVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI 272 (283)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCc
Confidence 9999999987654332222111000 0 011234678899999999999999999
Q ss_pred CHHHHHH
Q 029154 133 SFSQIIR 139 (198)
Q Consensus 133 s~~~~l~ 139 (198)
++.++++
T Consensus 273 t~~~il~ 279 (283)
T cd07835 273 SAKAALQ 279 (283)
T ss_pred CHHHHhc
Confidence 9999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=158.42 Aligned_cols=133 Identities=25% Similarity=0.366 Sum_probs=96.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----------------cccCCCCccceecccccccccccccccCCC
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----------------MMTAETGTYRWMAPELYSTVTLRQGEKKHY 64 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 64 (198)
+||||||+||+++.+ +.+||+|||+++....+. ......++..|++||.+.. ..+
T Consensus 123 ~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~ 193 (305)
T cd05609 123 VHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--------QGY 193 (305)
T ss_pred cccCCchHHEEECCC-CCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC--------CCC
Confidence 699999999999966 679999999986321100 0112357788999998743 567
Q ss_pred CchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccC-CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 65 ~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
+.++|+||||+++|++++|..||.+............... .+.....++.++.+++.+||..||.+||++.++.+.|+
T Consensus 194 ~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 194 GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 8999999999999999999999987654332222222211 12222357899999999999999999998655544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-23 Score=157.32 Aligned_cols=131 Identities=29% Similarity=0.441 Sum_probs=96.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.++|+|||++...... .......++..|++||++.+ ...++.++|+||||+++|+
T Consensus 122 ~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~e 193 (286)
T cd07846 122 IHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG-------DTKYGRAVDIWAVGCLVTE 193 (286)
T ss_pred cccCCCHHHEEECCC-CcEEEEeeeeeeeccCCccccCcccceeeccCcHHhcc-------ccccCchHhHHHHHHHHHH
Confidence 699999999999976 67999999998754322 22334568889999998753 2446789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHH--cc------------------CCC---------CCCCCCcHHHHHHHHHhcccCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAF--KH------------------ARP---------GLPEDISPDLAFIVQSCWVEDPNL 130 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~--~~------------------~~~---------~~p~~~~~~~~~l~~~~l~~dp~~ 130 (198)
+++|.+||.+............ .. ..+ .....++..+.+++.+||..+|.+
T Consensus 194 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 273 (286)
T cd07846 194 MLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDD 273 (286)
T ss_pred HHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCccc
Confidence 9999999976554322111110 00 000 012346788999999999999999
Q ss_pred CCCHHHHHH
Q 029154 131 RPSFSQIIR 139 (198)
Q Consensus 131 Rps~~~~l~ 139 (198)
||++.++++
T Consensus 274 Rp~~~~il~ 282 (286)
T cd07846 274 RPSSSQLLH 282 (286)
T ss_pred chhHHHHhc
Confidence 999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=156.70 Aligned_cols=130 Identities=28% Similarity=0.509 Sum_probs=98.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc-----ccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
+|+||||+||+++.+ +.++|+|||++........ .....|+..|++||.+.. ...++.++|+||||+
T Consensus 124 ~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-------~~~~~~~~Dv~slG~ 195 (267)
T cd06610 124 IHRDIKAGNILLGED-GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ-------VHGYDFKADIWSFGI 195 (267)
T ss_pred ecCCCCHHhEEEcCC-CCEEEcccchHHHhccCccccccccccccCChhhcChHHHcc-------ccCcCcccchHhHhH
Confidence 699999999999976 6799999999864432211 123468889999998753 235788999999999
Q ss_pred HHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCC-----CCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 76 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-----EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p-----~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
++|+|++|..||.......... .......+..+ ..+++.+.+++.+||..||.+||++.++++
T Consensus 196 i~~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 196 TAIELATGAAPYSKYPPMKVLM-LTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHHHHhCCCCccccChhhhHH-HHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 9999999999997665433222 22222222222 246788999999999999999999999988
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=172.58 Aligned_cols=145 Identities=17% Similarity=0.173 Sum_probs=93.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc--cccccCCCCccceecccccccccccccc--------------cCCC
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV--TEMMTAETGTYRWMAPELYSTVTLRQGE--------------KKHY 64 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~--------------~~~~ 64 (198)
|||||||+|||++.+.+.+||+|||+++.... .......++++.|+|||.+......... ...+
T Consensus 277 iHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred EeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 69999999999986556899999999974322 1222456789999999976431100000 0124
Q ss_pred CchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHc----------cCCCCC----------CCCCcHHHHHHHHHhc
Q 029154 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK----------HARPGL----------PEDISPDLAFIVQSCW 124 (198)
Q Consensus 65 ~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~----------~~~~~~----------p~~~~~~~~~l~~~~l 124 (198)
+.++||||+||++|||+++..++.. ........... ...... .+......++|+.+||
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 4567999999999999987665432 11111111000 000000 1112334568999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 125 VEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 125 ~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
..||.+|||+.++++ |.|+....
T Consensus 435 ~~dP~kR~ta~e~L~--Hpff~~~~ 457 (566)
T PLN03225 435 RFKGRQRISAKAALA--HPYFDREG 457 (566)
T ss_pred cCCcccCCCHHHHhC--CcCcCCCC
Confidence 999999999999999 77765433
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.3e-23 Score=157.17 Aligned_cols=139 Identities=30% Similarity=0.507 Sum_probs=104.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.++|+|||++....... ......|+..|++||.+.. ..++.++|+||+|+++|+
T Consensus 138 vH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slGvil~e 208 (292)
T cd06657 138 IHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIE 208 (292)
T ss_pred ecCCCCHHHEEECCC-CCEEEcccccceecccccccccccccCccccCHHHhcC--------CCCCchhhHHHHHHHHHH
Confidence 699999999999976 679999999886433221 1233567889999998743 456889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC--CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
+++|..||.+....... .......+. .....+++.+.+++.+||..+|.+||++.++++ +.|+.....+
T Consensus 209 l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~--~~~~~~~~~~ 279 (292)
T cd06657 209 MVDGEPPYFNEPPLKAM-KMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPP 279 (292)
T ss_pred HHhCCCCCCCCCHHHHH-HHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc--ChHHhccCCC
Confidence 99999999875543322 111111222 123457889999999999999999999999999 7787766643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-23 Score=157.91 Aligned_cols=126 Identities=28% Similarity=0.449 Sum_probs=101.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.+ +.+||+|||+++..... .....|++.|++||.+.. ...+.++|+||+|+++|++
T Consensus 123 ~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l 191 (290)
T cd05580 123 VYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILS--------KGYGKAVDWWALGILIYEM 191 (290)
T ss_pred ecCCCCHHHEEECCC-CCEEEeeCCCccccCCC--CCCCCCCccccChhhhcC--------CCCCccccHHHHHHHHHHH
Confidence 699999999999976 67999999998765433 234568899999998753 4567889999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 139 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~ 139 (198)
++|..||........ ... .......+|..+++.+.+++.+||..||.+|+ +++++++
T Consensus 192 ~~g~~p~~~~~~~~~-~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 192 LAGYPPFFDDNPIQI-YEK-ILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HhCCCCCCCCCHHHH-HHH-HhcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 999999987653222 222 22445567778899999999999999999998 7788876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-23 Score=157.94 Aligned_cols=130 Identities=25% Similarity=0.326 Sum_probs=96.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.+ +.+||+|||++.............++..|++||.+.+ ..++.++|+||+|+++|+|
T Consensus 129 ~h~~l~~~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~s~G~~l~~l 199 (287)
T cd07838 129 VHRDLKPQNILVTSD-GQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQ--------SSYATPVDMWSVGCIFAEL 199 (287)
T ss_pred eeccCChhhEEEccC-CCEEEeccCcceeccCCcccccccccccccChHHhcc--------CCCCCcchhhhHHHHHHHH
Confidence 699999999999977 7899999999876543333334457889999998753 4578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCC------------------C-------CCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHAR------------------P-------GLPEDISPDLAFIVQSCWVEDPNLRPSFS 135 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~------------------~-------~~p~~~~~~~~~l~~~~l~~dp~~Rps~~ 135 (198)
++|.+||.+................ . .....+++.+.+++.+||..||.+||++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~ 279 (287)
T cd07838 200 FRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAF 279 (287)
T ss_pred HhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHH
Confidence 9999999876543322211110000 0 00112457788999999999999999999
Q ss_pred HHHH
Q 029154 136 QIIR 139 (198)
Q Consensus 136 ~~l~ 139 (198)
+++.
T Consensus 280 ~il~ 283 (287)
T cd07838 280 EALQ 283 (287)
T ss_pred HHhc
Confidence 9987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=162.95 Aligned_cols=139 Identities=21% Similarity=0.363 Sum_probs=97.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+|||++.+ +.+||+|||++........ ....+||+.|+|||++.... .....++.++|+||+||++|
T Consensus 124 vH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DiwslG~~l~ 199 (331)
T cd05597 124 VHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME---DGKGRYGPECDWWSLGVCMY 199 (331)
T ss_pred EECCCCHHHEEECCC-CCEEEEECCceeecCCCCCccccceeccccccCHHHHhhcc---ccccCCCCcceeehhhhHHH
Confidence 699999999999876 6799999999864332221 12246899999999975210 01245678999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCCC---CCCcHHHHHHHHHhcccCCCC--CCCHHHHHHHHHHHH
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLP---EDISPDLAFIVQSCWVEDPNL--RPSFSQIIRMLNAFL 145 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p---~~~~~~~~~l~~~~l~~dp~~--Rps~~~~l~~l~~~~ 145 (198)
+|++|+.||.+..................++ ..+++++.+++.+|+..++.. |+++.++++ +.|+
T Consensus 200 el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~--hp~~ 269 (331)
T cd05597 200 EMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD--HPFF 269 (331)
T ss_pred HHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc--CCCC
Confidence 9999999998765433322222112222222 347899999999988654443 789999998 5554
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-23 Score=154.77 Aligned_cols=134 Identities=30% Similarity=0.517 Sum_probs=103.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.++|+|||++....... ......++..|++||.+.. ..++.++|+||+|+++|+
T Consensus 123 ~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~~l~~ 193 (277)
T cd06641 123 IHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--------SAYDSKADIWSLGITAIE 193 (277)
T ss_pred ecCCCCHHhEEECCC-CCEEEeecccceecccchhhhccccCCccccChhhhcc--------CCCCchhhHHHHHHHHHH
Confidence 599999999999966 679999999986543221 1233467889999998743 456789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+++|..||......... ........+.++..++.++.+++.+||..+|.+||++.++++ +.++.
T Consensus 194 l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~--~~~~~ 257 (277)
T cd06641 194 LAKGEPPHSELHPMKVL-FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK--HKFIV 257 (277)
T ss_pred HHcCCCCCCccchHHHH-HHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh--CHHHh
Confidence 99999999765543222 222334445566778999999999999999999999999999 55544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-24 Score=164.84 Aligned_cols=135 Identities=21% Similarity=0.349 Sum_probs=96.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+|||++.+ +.+||+|||+++....... ....+||+.|+|||++.+.. .....++.++|+||+|+++|
T Consensus 124 iHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DiwSlGvil~ 199 (331)
T cd05624 124 VHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAME---DGMGKYGPECDWWSLGVCMY 199 (331)
T ss_pred eeccCchHHEEEcCC-CCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccc---cCCCCCCCcccEEeeehhhh
Confidence 699999999999966 6799999999875432221 12357999999999875310 01135678999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCCC---CCCcHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLP---EDISPDLAFIVQSCWVEDPNL--RPSFSQIIR 139 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p---~~~~~~~~~l~~~~l~~dp~~--Rps~~~~l~ 139 (198)
+|++|+.||.+..................+| ..+++++.+++.+||..++.+ |++++++++
T Consensus 200 ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 200 EMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred hhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 9999999998765443332222222223333 346899999999999876544 357888887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=154.45 Aligned_cols=131 Identities=30% Similarity=0.421 Sum_probs=97.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.+ +.++|+|||++.............++..|++||++.. ...++.++|+||||++++++
T Consensus 121 ~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~s~G~~l~el 192 (283)
T cd07830 121 FHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLR-------STSYSSPVDIWALGCIMAEL 192 (283)
T ss_pred ccCCCChhhEEEcCC-CCEEEeecccceeccCCCCcCCCCCcccccCceeeec-------CcCcCCccchhhHHHHHHHH
Confidence 699999999999976 6799999999976544333445678889999998743 24568899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccC-----------------CCC-----------CCCCCcHHHHHHHHHhcccCCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHA-----------------RPG-----------LPEDISPDLAFIVQSCWVEDPNLRP 132 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~-----------------~~~-----------~p~~~~~~~~~l~~~~l~~dp~~Rp 132 (198)
++|..||................. ... .....+.++.+++.+||..||.+||
T Consensus 193 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 272 (283)
T cd07830 193 YTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP 272 (283)
T ss_pred HhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCC
Confidence 999999976554332211110000 000 0112357899999999999999999
Q ss_pred CHHHHHH
Q 029154 133 SFSQIIR 139 (198)
Q Consensus 133 s~~~~l~ 139 (198)
++.|++.
T Consensus 273 t~~ei~~ 279 (283)
T cd07830 273 TASQALQ 279 (283)
T ss_pred CHHHHhh
Confidence 9999987
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-23 Score=161.41 Aligned_cols=138 Identities=27% Similarity=0.393 Sum_probs=101.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.+ +.+||+|||++...... .....++..|++||.+.+ ...++.++|+||+|+++|++
T Consensus 140 ~H~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslGv~l~el 209 (343)
T cd07851 140 IHRDLKPSNIAVNED-CELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred ecCCCCHHHeEECCC-CCEEEcccccccccccc--ccCCcccccccCHHHHhC-------CCCCCchHhHHHHHHHHHHH
Confidence 699999999999976 67999999998754332 234567889999998743 23567899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCC-----------------------------CCCCCCcHHHHHHHHHhcccCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARP-----------------------------GLPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
++|..||.+................+ ......++++.+++.+||..||.+|
T Consensus 210 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~R 289 (343)
T cd07851 210 LTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKR 289 (343)
T ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhC
Confidence 99999998665433221111100000 0112357889999999999999999
Q ss_pred CCHHHHHHHHHHHHhhcCC
Q 029154 132 PSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~~~ 150 (198)
||+.++++ +.|+.....
T Consensus 290 pt~~ell~--h~~~~~~~~ 306 (343)
T cd07851 290 ITAAEALA--HPYLAEYHD 306 (343)
T ss_pred CCHHHHhc--CCCccccCC
Confidence 99999998 676654433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=152.45 Aligned_cols=128 Identities=29% Similarity=0.493 Sum_probs=103.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.+ +.+||+|||++...... ......++..|++||.+.+ ..++.++|+||+|+++|++
T Consensus 125 ~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~--------~~~~~~~D~~slG~~~~~l 194 (256)
T cd08530 125 LHRDLKSANILLVAN-DLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKG--------RPYSYKSDIWSLGCLLYEM 194 (256)
T ss_pred ccCCCCcceEEEecC-CcEEEeeccchhhhccC-CcccccCCccccCHHHHCC--------CCCCchhhHHHHHHHHHHH
Confidence 699999999999976 67999999998755433 2334567889999999753 5577899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
++|+.||........ .........+.++..++.++.+++.+||..+|.+||++.++++
T Consensus 195 ~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 195 ATFAPPFEARSMQDL-RYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HhCCCCCCCCCHHHH-HHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 999999987664332 2233334445566678899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-23 Score=156.44 Aligned_cols=131 Identities=31% Similarity=0.403 Sum_probs=97.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||.+....... ......++..|++||.+.+ ...++.++|+||+|+++|+
T Consensus 120 ~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~~Di~slG~~l~~ 191 (283)
T cd05118 120 LHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLG-------DKGYSTPVDIWSVGCIFAE 191 (283)
T ss_pred eecCcCHHHEEECCC-CcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhc-------CCCCCchhHHHHHHHHHHH
Confidence 699999999999976 679999999987543322 2333567889999998753 2367889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCC----------------------------CCCCCCCcHHHHHHHHHhcccCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHAR----------------------------PGLPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
+++|+.||.+................ ......++.++.+++.+||..||.+|
T Consensus 192 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 271 (283)
T cd05118 192 LLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKR 271 (283)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccC
Confidence 99999999776543322111110000 00112367889999999999999999
Q ss_pred CCHHHHHH
Q 029154 132 PSFSQIIR 139 (198)
Q Consensus 132 ps~~~~l~ 139 (198)
|++.+++.
T Consensus 272 p~~~~ll~ 279 (283)
T cd05118 272 ITAEQALA 279 (283)
T ss_pred cCHHHHhh
Confidence 99999987
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-23 Score=154.64 Aligned_cols=133 Identities=24% Similarity=0.303 Sum_probs=98.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||+|+||+++.+ +.+||+|||++..... .....++..|++||.+.+ ..++.++|+||+|+++|++
T Consensus 119 ~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~il~~l 186 (260)
T cd05611 119 IHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILG--------VGDDKMSDWWSLGCVIFEF 186 (260)
T ss_pred ecCCCCHHHeEECCC-CcEEEeecccceeccc---cccCCCCcCccChhhhcC--------CCCcchhhhHHHHHHHHHH
Confidence 699999999999976 6799999999875332 223467889999998753 4478899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHcc--CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH-HHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKH--ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML-NAFL 145 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l-~~~~ 145 (198)
++|..||................ ........++.++.+++.+||..+|++||++.++.+.| +.|+
T Consensus 187 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 187 LFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred HHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 99999998765433222211111 12233446789999999999999999999765444433 3443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-23 Score=153.21 Aligned_cols=129 Identities=36% Similarity=0.571 Sum_probs=103.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||+|+||+++.+ +.++|+|||++....... ......|+..|++||.... ..++.++|+||+|+++++
T Consensus 125 ~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~~~~ 195 (258)
T cd08215 125 LHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN--------KPYNYKSDIWSLGCVLYE 195 (258)
T ss_pred ecccCChHHeEEcCC-CcEEECCccceeecccCcceecceeeeecccChhHhcc--------CCCCccccHHHHHHHHHH
Confidence 599999999999966 679999999987543332 2234568889999998743 457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+++|..||...... .............++..++.++.+++.+||..+|++||++.++++
T Consensus 196 l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 196 LCTLKHPFEGENLL-ELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHcCCCCCCCCcHH-HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 99999999765532 223333444555667788999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-23 Score=154.15 Aligned_cols=134 Identities=27% Similarity=0.405 Sum_probs=103.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+||++..+ ..+||.|||+++.....-..+..+.|..|.|||++.+ ..|...+||||.||++.||
T Consensus 140 ihRdLkPsnivv~~~-~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~--------~~~ke~vdiwSvGci~gEl 210 (369)
T KOG0665|consen 140 IHRDLKPSNIVVNSD-CTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEL 210 (369)
T ss_pred eecccCcccceecch-hheeeccchhhcccCcccccCchhheeeccCchheec--------cCCcccchhhhhhhHHHHH
Confidence 699999999999977 7899999999997766545667889999999999875 3488999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCC-----------------------------CCCCC-----------CcHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARP-----------------------------GLPED-----------ISPDLAFIV 120 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~p~~-----------~~~~~~~l~ 120 (198)
++|+..|.|....++-.........+ .+|+. -...+++++
T Consensus 211 i~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll 290 (369)
T KOG0665|consen 211 ILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLL 290 (369)
T ss_pred hhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHH
Confidence 99999998776554432211111110 01111 123478999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 121 QSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 121 ~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
.+||..||++|.+++++|. |..+
T Consensus 291 ~~MLvi~pe~Risv~daL~--HPY~ 313 (369)
T KOG0665|consen 291 SKMLVIDPEKRISVDDALR--HPYI 313 (369)
T ss_pred HHhhccChhhcccHHHHhc--CCee
Confidence 9999999999999999999 5444
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=154.12 Aligned_cols=130 Identities=29% Similarity=0.512 Sum_probs=103.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+|+||+|+||+++.+ +.++|+|||.+........ .....++..|++||.+.. ..++.++|+||+|+++
T Consensus 123 ~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il 193 (260)
T cd06606 123 VHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG--------EEYGRAADIWSLGCTV 193 (260)
T ss_pred cccCCCHHHEEEcCC-CCEEEcccccEEecccccccccccCCCCCccccCHhhhcC--------CCCCchhhHHHHHHHH
Confidence 699999999999976 6799999999875544332 334568889999998753 4478899999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHH-HccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAA-FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+++++|..||............. .....+..+...+..+.+++.+||..+|.+||++.++++
T Consensus 194 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 194 IEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 99999999997765322222222 123445667778999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=158.74 Aligned_cols=139 Identities=26% Similarity=0.315 Sum_probs=100.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc---------------cccccCCCCccceecccccccccccccccCCCC
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV---------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 65 (198)
+|+||||+||+++.+ +.+||+|||++..... ........++..|++||.+.+ ...++
T Consensus 141 ~H~dl~~~nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~ 212 (335)
T PTZ00024 141 MHRDLSPANIFINSK-GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG-------AEKYH 212 (335)
T ss_pred ecccccHHHeEECCC-CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhccc-------CCCCC
Confidence 699999999999976 6799999999874431 111122356788999998753 23468
Q ss_pred chhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHH--ccCCC------------------------CCCCCCcHHHHHH
Q 029154 66 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF--KHARP------------------------GLPEDISPDLAFI 119 (198)
Q Consensus 66 ~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~--~~~~~------------------------~~p~~~~~~~~~l 119 (198)
.++|+||+|+++|++++|..||.+............ ..... ......+.++.++
T Consensus 213 ~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 292 (335)
T PTZ00024 213 FAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDL 292 (335)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHH
Confidence 899999999999999999999987665433211111 00000 0012346788999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 120 VQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 120 ~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
+.+||..+|++||++++++. +.|+....
T Consensus 293 i~~~l~~~P~~R~s~~~~l~--~~~~~~~~ 320 (335)
T PTZ00024 293 LQSLLKLNPLERISAKEALK--HEYFKSDP 320 (335)
T ss_pred HHHHcCCCchhccCHHHHhc--CcccCCCC
Confidence 99999999999999999998 77765443
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-23 Score=159.71 Aligned_cols=141 Identities=27% Similarity=0.449 Sum_probs=97.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc---c--cc---cCCCCccceecccccccccccccccCCCCchhhHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT---E--MM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 72 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~---~--~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws 72 (198)
|||||||+|||++.+ +.++++||+.+...... . .. ....++..|++||++.+ ....++.++|+||
T Consensus 123 vHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Diws 195 (328)
T cd08226 123 IHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQ------DLYGYNVKSDIYS 195 (328)
T ss_pred ecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcC------CCCCCCchhhHHH
Confidence 699999999999976 67999999865321110 0 00 01134567999999753 2245788999999
Q ss_pred HHHHHHHHHcCCCCCCCCCcHHHHHHHHHccC---------------------------------------------CCC
Q 029154 73 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA---------------------------------------------RPG 107 (198)
Q Consensus 73 ~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~---------------------------------------------~~~ 107 (198)
+||++|++++|..||.+............... ...
T Consensus 196 lG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (328)
T cd08226 196 VGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTP 275 (328)
T ss_pred HHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccch
Confidence 99999999999999987654333222111000 001
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 108 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 108 ~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
.+..+++.+.+|+.+||..||.+|||+.++++ +.|+.....
T Consensus 276 ~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~--~~~~~~~~~ 316 (328)
T cd08226 276 SSKTFSPAFQNLVELCLQQDPEKRPSASSLLS--HAFFKQVKE 316 (328)
T ss_pred hhhhhhHHHHHHHHHHccCCcccCCCHHHHhh--CHHHHHHHH
Confidence 12235677899999999999999999999998 767655443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-23 Score=155.42 Aligned_cols=135 Identities=36% Similarity=0.618 Sum_probs=102.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.++|+|||++...... .......++..|++||.+.+ ..++.++|+||||+++|+
T Consensus 138 ~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slGvil~~ 208 (286)
T cd06614 138 IHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR--------KDYGPKVDIWSLGIMCIE 208 (286)
T ss_pred eeCCCChhhEEEcCC-CCEEECccchhhhhccchhhhccccCCcccCCHhHhcC--------CCCCCccccHHHHHHHHH
Confidence 599999999999966 67999999987643221 11223457889999998743 457889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCC--CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
+++|..||............. ....+.. +..++.++.+++.+||+.+|.+||++.++++ +.++..
T Consensus 209 l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~~ 275 (286)
T cd06614 209 MAEGEPPYLREPPLRALFLIT-TKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ--HPFLKK 275 (286)
T ss_pred HHhCCCCCCCCCHHHHHHHHH-hcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh--ChHhhc
Confidence 999999998765543332222 2222222 2337889999999999999999999999998 666554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-23 Score=154.23 Aligned_cols=131 Identities=27% Similarity=0.489 Sum_probs=100.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-----cccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
+|+||||+||+++.++..+||+|||++....... ......|+..|++||.+.+ ..++.++|+||+|+
T Consensus 125 ~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Dv~slG~ 196 (268)
T cd06630 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG--------EQYGRSCDVWSVGC 196 (268)
T ss_pred ecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhcc--------CCCCcccchHHHHH
Confidence 6999999999998664569999999986443211 1123467889999998753 45788999999999
Q ss_pred HHHHHHcCCCCCCCCCcH---HHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 76 VLWELLTNRLPFEGMSNL---QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~---~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+++++++|..||...... ............+..+..+++++.+++.+||..+|++||++.++++
T Consensus 197 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 197 VIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 999999999999644321 1111122223445667778999999999999999999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-23 Score=155.32 Aligned_cols=130 Identities=25% Similarity=0.389 Sum_probs=101.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.+ +.++|+|||++.............|+..|++||.+.. ..++.++|+||+|+++|++
T Consensus 122 ~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l 192 (258)
T cd05578 122 IHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR--------QGYSVAVDWWSLGVTAYEC 192 (258)
T ss_pred eccCCCHHHeEEcCC-CCEEEeecccccccCCCccccccCCChhhcCHHHHcc--------cCCCCcccchhhHHHHHHH
Confidence 699999999999976 6799999999875543333344568889999998753 4478899999999999999
Q ss_pred HcCCCCCCCCCcH-HHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH--HHHHH
Q 029154 81 LTNRLPFEGMSNL-QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF--SQIIR 139 (198)
Q Consensus 81 ~~g~~p~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~--~~~l~ 139 (198)
++|..||...... ...............|..++.++.+++.+||..||.+||++ +++++
T Consensus 193 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 193 LRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 9999999866531 11122222224556677789999999999999999999999 77665
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-23 Score=157.14 Aligned_cols=131 Identities=27% Similarity=0.376 Sum_probs=94.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-----cccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
+|+||||+||+++.+ +.+||+|||++....... ......++..|+|||.+.+ ...++.++|+||+|+
T Consensus 141 ~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~ 212 (310)
T cd07865 141 LHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDMWGAGC 212 (310)
T ss_pred eccCCCHHHEEECCC-CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcC-------CcccCchhhhHHHHH
Confidence 699999999999976 679999999987432211 1223457889999998753 234678999999999
Q ss_pred HHHHHHcCCCCCCCCCcHHHHHH--HHHccCCCC---------------C-------------CCCCcHHHHHHHHHhcc
Q 029154 76 VLWELLTNRLPFEGMSNLQAAYA--AAFKHARPG---------------L-------------PEDISPDLAFIVQSCWV 125 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~~~~~~--~~~~~~~~~---------------~-------------p~~~~~~~~~l~~~~l~ 125 (198)
++|++++|..||.+......... ......++. . +...+..+.+++.+||.
T Consensus 213 ~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~ 292 (310)
T cd07865 213 IMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLV 292 (310)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhc
Confidence 99999999999987654322111 111100000 0 11125677899999999
Q ss_pred cCCCCCCCHHHHHH
Q 029154 126 EDPNLRPSFSQIIR 139 (198)
Q Consensus 126 ~dp~~Rps~~~~l~ 139 (198)
.||.+||+++++++
T Consensus 293 ~~P~~R~t~~e~l~ 306 (310)
T cd07865 293 LDPAKRIDADTALN 306 (310)
T ss_pred CChhhccCHHHHhc
Confidence 99999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=159.01 Aligned_cols=131 Identities=22% Similarity=0.314 Sum_probs=94.2
Q ss_pred CCCCCCCCCeEEcC----CCCceEEecccCcccCccccc----ccCCCCccceecccccccccccccccCCCCchhhHHH
Q 029154 1 MGKFMKEDNLLLTP----DQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 72 (198)
Q Consensus 1 iH~dlKp~NIll~~----~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws 72 (198)
+||||||+||+++. + +.+||+|||++........ .....++..|+|||++.+ ...++.++|+||
T Consensus 130 ~h~dlkp~Nil~~~~~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~s 201 (316)
T cd07842 130 LHRDLKPANILVMGEGPER-GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLG-------ARHYTKAIDIWA 201 (316)
T ss_pred eeCCCCHHHEEEcCCCCcc-ceEEECCCccccccCCCcccccccCCccccccccCHHHHhC-------CCCCCcHHHHHH
Confidence 69999999999987 5 6799999999875432211 223467889999998753 245688999999
Q ss_pred HHHHHHHHHcCCCCCCCCCcHH--------HHHHHHH-------------------------ccCCCCCC----------
Q 029154 73 FGIVLWELLTNRLPFEGMSNLQ--------AAYAAAF-------------------------KHARPGLP---------- 109 (198)
Q Consensus 73 ~G~~l~e~~~g~~p~~~~~~~~--------~~~~~~~-------------------------~~~~~~~p---------- 109 (198)
||++++++++|..||.+..... ....... .......+
T Consensus 202 lG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (316)
T cd07842 202 IGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEK 281 (316)
T ss_pred HHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHh
Confidence 9999999999999997544321 0000000 00000111
Q ss_pred -CCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 110 -EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 110 -~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
...+.++.+++.+||..||.+|||+.++++
T Consensus 282 ~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 282 HKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred ccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 145678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=156.79 Aligned_cols=131 Identities=25% Similarity=0.336 Sum_probs=94.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc------------cccCCCCccceecccccccccccccccCCCCchh
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 68 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 68 (198)
+|+||||+||+++.+ +.+||+|||+++...... ......++..|+|||.+.+ ...++.++
T Consensus 137 ~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~ 208 (311)
T cd07866 137 LHRDIKAANILIDNQ-GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG-------ERRYTTAV 208 (311)
T ss_pred ecCCCCHHHEEECCC-CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC-------CCccCchh
Confidence 699999999999976 689999999987432211 1122356788999998753 24578899
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCC---------------------CC-------CCCCcHHHHHHH
Q 029154 69 DVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP---------------------GL-------PEDISPDLAFIV 120 (198)
Q Consensus 69 Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------~~-------p~~~~~~~~~l~ 120 (198)
|+||+|+++|+|++|.+||.+................+ .. .....+++.+++
T Consensus 209 Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 288 (311)
T cd07866 209 DIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLL 288 (311)
T ss_pred HhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHH
Confidence 99999999999999999998765433221111100000 00 022446788999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 029154 121 QSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 121 ~~~l~~dp~~Rps~~~~l~ 139 (198)
.+||..||.+||++.+++.
T Consensus 289 ~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 289 SKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHcccCcccCcCHHHHhc
Confidence 9999999999999999987
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.6e-23 Score=155.78 Aligned_cols=131 Identities=24% Similarity=0.444 Sum_probs=93.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+||+++.+ +.+||+|||+++..... .......++..|+|||++.+ ...++.++|+||+|+++|+
T Consensus 125 ~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dv~slG~il~~ 196 (291)
T cd07844 125 LHRDLKPQNLLISER-GELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG-------STEYSTSLDMWGVGCIFYE 196 (291)
T ss_pred ecccCCHHHEEEcCC-CCEEECccccccccCCCCccccccccccccCCcHHhhc-------CcccCcHHHHHHHHHHHHH
Confidence 699999999999976 67999999998643221 11223456788999998753 2456889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCC-------------------------C----CCCCCCc--HHHHHHHHHhcccCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHAR-------------------------P----GLPEDIS--PDLAFIVQSCWVEDP 128 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------~----~~p~~~~--~~~~~l~~~~l~~dp 128 (198)
|++|..||.+................ + .....++ .++.+++.+||..+|
T Consensus 197 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 276 (291)
T cd07844 197 MATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEP 276 (291)
T ss_pred HHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCc
Confidence 99999999765522221111110000 0 0001233 788899999999999
Q ss_pred CCCCCHHHHHH
Q 029154 129 NLRPSFSQIIR 139 (198)
Q Consensus 129 ~~Rps~~~~l~ 139 (198)
.+||++.++++
T Consensus 277 ~~Rps~~e~l~ 287 (291)
T cd07844 277 KKRISAAEAMK 287 (291)
T ss_pred ccccCHHHHhc
Confidence 99999999887
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=157.97 Aligned_cols=140 Identities=29% Similarity=0.392 Sum_probs=102.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+ +.+||+|||+++..... .....++..|+|||.+.+ ...++.++|+||+||++|++
T Consensus 142 vH~dlkp~NIll~~~-~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~il~el 211 (345)
T cd07877 142 IHRDLKPSNLAVNED-CELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAEL 211 (345)
T ss_pred eecCCChHHEEEcCC-CCEEEeccccccccccc--ccccccCCCccCHHHHhC-------ccCCCchhhHHHHHHHHHHH
Confidence 699999999999976 67999999998754322 234567889999998742 24578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHc------------------------cCCCC-----CCCCCcHHHHHHHHHhcccCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFK------------------------HARPG-----LPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~------------------------~~~~~-----~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
++|..||.+............. ...+. .....++++.+++.+||..||.+|
T Consensus 212 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 291 (345)
T cd07877 212 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 291 (345)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhc
Confidence 9999999765543321111000 00000 012357889999999999999999
Q ss_pred CCHHHHHHHHHHHHhhcCCCC
Q 029154 132 PSFSQIIRMLNAFLFTLRPPS 152 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~~~~~ 152 (198)
|++.+++. +.++.....+.
T Consensus 292 ~t~~e~l~--h~~f~~~~~~~ 310 (345)
T cd07877 292 ITAAQALA--HAYFAQYHDPD 310 (345)
T ss_pred CCHHHHhc--ChhhhhcCCCC
Confidence 99999998 77776555443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=157.61 Aligned_cols=138 Identities=25% Similarity=0.371 Sum_probs=102.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+ +.+||+|||++...... .....++..|++||.+.+ ...++.++|+||+|+++|++
T Consensus 140 ~H~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~ll~~l 209 (343)
T cd07880 140 IHRDLKPGNLAVNED-CELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILN-------WMHYTQTVDIWSVGCIMAEM 209 (343)
T ss_pred ecCCCCHHHEEEcCC-CCEEEeecccccccccC--ccccccCCcccCHHHHhC-------CCCCCcHHHHHHHHHHHHHH
Confidence 699999999999966 67999999998754322 233467889999998743 23468899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCC-----------------------------CCCCCCCcHHHHHHHHHhcccCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHAR-----------------------------PGLPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
++|..||.+................ ......+++.+.+++.+||..||.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 289 (343)
T cd07880 210 LTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESR 289 (343)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhC
Confidence 9999999865543222111100000 01123567889999999999999999
Q ss_pred CCHHHHHHHHHHHHhhcCC
Q 029154 132 PSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~~~ 150 (198)
|++.+++. +.|+.....
T Consensus 290 ~t~~~~l~--~~~~~~~~~ 306 (343)
T cd07880 290 ITAAEALA--HPYFEEFHD 306 (343)
T ss_pred CCHHHHhc--CccHhhhcC
Confidence 99999998 777765543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=153.67 Aligned_cols=133 Identities=29% Similarity=0.447 Sum_probs=98.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||+|+||+++.+ +.++|+|||++....... .....++..|++||.+.+ ..++.++|+||+|+++|++
T Consensus 127 ~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l 196 (287)
T cd06621 127 IHRDIKPSNILLTRK-GQVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQG--------KPYSITSDVWSLGLTLLEV 196 (287)
T ss_pred ccCCCCHHHEEEecC-CeEEEeeccccccccccc-cccccCCccccCHHHhcC--------CCCCchhhHHHHHHHHHHH
Confidence 699999999999976 679999999986443221 123457889999998743 5678899999999999999
Q ss_pred HcCCCCCCCCC----cHHHHHHHHHccCCCCCC------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 81 LTNRLPFEGMS----NLQAAYAAAFKHARPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 81 ~~g~~p~~~~~----~~~~~~~~~~~~~~~~~p------~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
++|..||.... ..............+.++ ..+++.+.+++.+||..+|.+||++.|+++ +.|+
T Consensus 197 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~--~~~~ 269 (287)
T cd06621 197 AQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE--HPWI 269 (287)
T ss_pred HhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh--Cccc
Confidence 99999997652 111222222221222222 234678999999999999999999999999 5554
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=154.14 Aligned_cols=135 Identities=27% Similarity=0.393 Sum_probs=99.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||||+||+++.+ +.++|+|||+++....... .....|+..|++||.+.+ .....+.++|+||+|+++|
T Consensus 127 ~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Dv~slG~il~ 199 (288)
T cd05583 127 IYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG------GSGGHDKAVDWWSLGVLTF 199 (288)
T ss_pred eccCCCHHHeEECCC-CCEEEEECccccccccccccccccccCCccccCHHHhcC------CCCCCcchhhhHHHHHHHH
Confidence 699999999999976 6799999999875432221 123467889999998753 1123678999999999999
Q ss_pred HHHcCCCCCCCCCcH--HHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 79 ELLTNRLPFEGMSNL--QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 79 e~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
+|++|..||...... ............+..+..++..+.+++.+||+.||++|||+.++.+.|+
T Consensus 200 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 200 ELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred HHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 999999998643221 1111122223334566778999999999999999999999887766554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=154.99 Aligned_cols=131 Identities=27% Similarity=0.317 Sum_probs=95.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||||+||+++.+ +.+||+|||++....... ......++..|++||.+.+ ...++.++|+||+||++|
T Consensus 138 ~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~slG~~~~ 209 (302)
T cd07864 138 LHRDIKCSNILLNNK-GQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLG-------EERYGPAIDVWSCGCILG 209 (302)
T ss_pred ecCCCCHHHEEECCC-CcEEeCcccccccccCCcccccccceeccCccChHHhcC-------CCCCCchhHHHHHHHHHH
Confidence 699999999999966 689999999987543222 1223356778999998743 234678999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHH--ccCCC--------------------------CCCCCCcHHHHHHHHHhcccCCCC
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAF--KHARP--------------------------GLPEDISPDLAFIVQSCWVEDPNL 130 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~--~~~~~--------------------------~~p~~~~~~~~~l~~~~l~~dp~~ 130 (198)
++++|+.||.............. ....+ .....++..+.+++.+||..||.+
T Consensus 210 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 289 (302)
T cd07864 210 ELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSK 289 (302)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhh
Confidence 99999999976554332211111 00000 011236789999999999999999
Q ss_pred CCCHHHHHH
Q 029154 131 RPSFSQIIR 139 (198)
Q Consensus 131 Rps~~~~l~ 139 (198)
||++.+++.
T Consensus 290 Rp~~~~il~ 298 (302)
T cd07864 290 RCTAEEALN 298 (302)
T ss_pred CCCHHHHhc
Confidence 999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=152.86 Aligned_cols=131 Identities=30% Similarity=0.374 Sum_probs=95.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||||+||+++.+ +.+||+|||++....... ......++..|++||.+.+ ...++.++|+||||+++|
T Consensus 122 ~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~ 193 (287)
T cd07840 122 LHRDIKGSNILINND-GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG-------ATRYGPEVDMWSVGCILA 193 (287)
T ss_pred eeccCcHHHeEEcCC-CCEEEccccceeeccCCCcccccccccccccCCceeeEc-------cccCChHHHHHHHHHHHH
Confidence 599999999999976 789999999987543322 1233456788999997643 235688999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCC-----------------------------CCCCCCcHHHHHHHHHhcccCCC
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARP-----------------------------GLPEDISPDLAFIVQSCWVEDPN 129 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~p~~~~~~~~~l~~~~l~~dp~ 129 (198)
++++|..||..................+ .....++..+.+++.+||..+|.
T Consensus 194 el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 273 (287)
T cd07840 194 ELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPK 273 (287)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChh
Confidence 9999999998765432221111000000 00111378899999999999999
Q ss_pred CCCCHHHHHH
Q 029154 130 LRPSFSQIIR 139 (198)
Q Consensus 130 ~Rps~~~~l~ 139 (198)
+||++.++++
T Consensus 274 ~Rp~~~~~l~ 283 (287)
T cd07840 274 KRISADQALQ 283 (287)
T ss_pred hCcCHHHHhh
Confidence 9999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=153.07 Aligned_cols=139 Identities=29% Similarity=0.521 Sum_probs=115.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc--cccc-CCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT--EMMT-AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~--~~~~-~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
||.||...|.+|+.. -++||+|-.++|..... .+.. .......||++|.+. +..|+..+|+||||+++
T Consensus 418 iHkDiAaRNCvIdd~-LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~--------n~~yssasDvWsfGVll 488 (563)
T KOG1024|consen 418 IHKDIAARNCVIDDQ-LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ--------NSHYSSASDVWSFGVLL 488 (563)
T ss_pred ccchhhhhcceehhh-eeEEeccchhccccCcccccccCCCCCCcccccCHHHHh--------hhhhcchhhhHHHHHHH
Confidence 799999999999955 78999999999854321 1221 233467899999985 47789999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
||+++ |+.||...++..- ......+.+...|..+++++..+|..||+.+|++||+++++...|.++..++.
T Consensus 489 WELmtlg~~PyaeIDPfEm-~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 489 WELMTLGKLPYAEIDPFEM-EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred HHHHhcCCCCccccCHHHH-HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 99997 8899988776443 34455778889999999999999999999999999999999999999877654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=150.89 Aligned_cols=128 Identities=34% Similarity=0.538 Sum_probs=100.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++. +.+||+|||++....... ......|+..|++||.+.. ..++.++|+||+|+++|+
T Consensus 128 ~h~~l~~~nili~~--~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~~~~~ 197 (260)
T cd08222 128 LHRDLKAKNIFLKN--NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH--------QGYDSKSDIWSLGCILYE 197 (260)
T ss_pred cccCCChhheEeec--CCEeecccCceeecCCCcccccCCCCCcCccCHHHHcc--------CCCCchhhHHHHHHHHHH
Confidence 69999999999984 459999999987543222 2233567889999998743 556789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+++|..||....... ..........+..+..++.++.+++.+||..+|++||++.++++
T Consensus 198 l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 198 MCCLAHAFEGQNFLS-VVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHhCCCCCCCccHHH-HHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 999999997654332 22333344555667778899999999999999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=149.01 Aligned_cols=129 Identities=34% Similarity=0.596 Sum_probs=102.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc-ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.++|+|||++........ .....++..|++||...+ ..++.++|+|++|+++|+
T Consensus 121 ~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~~lG~~l~~ 191 (254)
T cd06627 121 IHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM--------SGASTASDIWSLGCTVIE 191 (254)
T ss_pred ccCCCCHHHEEECCC-CCEEEeccccceecCCCcccccccccchhhcCHhhhcC--------CCCCcchhHHHHHHHHHH
Confidence 699999999999976 6899999999875433221 233567889999998753 346789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+++|..||........... ......+..+..++..+.+++.+||..+|++||++.+++.
T Consensus 192 l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 192 LLTGNPPYYDLNPMAALFR-IVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHhCCCCCCCccHHHHHHH-HhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 9999999976664333322 2334455667778999999999999999999999999986
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=153.07 Aligned_cols=132 Identities=28% Similarity=0.426 Sum_probs=97.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+|||++.+ +.+||+|||++....... ......|+..|++||.+.. ....++.++|+||||+++|
T Consensus 127 ~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Dv~slG~~l~ 199 (290)
T cd05613 127 IYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG------GDGGHDKAVDWWSMGVLMY 199 (290)
T ss_pred eccCCCHHHeEECCC-CCEEEeeCccceecccccccccccccCCcccCChhhccC------CCCCCCccccHHHHHHHHH
Confidence 699999999999976 679999999987543221 1223568889999998743 1234678899999999999
Q ss_pred HHHcCCCCCCCCCcH--HHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 029154 79 ELLTNRLPFEGMSNL--QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 139 (198)
Q Consensus 79 e~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~ 139 (198)
++++|..||...... ............++.+..+++.+.+++.+||..||.+|+ ++.+++.
T Consensus 200 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 200 ELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 999999998643211 111112222234456777899999999999999999997 6777766
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-22 Score=152.45 Aligned_cols=131 Identities=27% Similarity=0.381 Sum_probs=95.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++....... ......++..|++||++.+ ...++.++|+||+|+++|+
T Consensus 122 ~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~~ 193 (284)
T cd07836 122 LHRDLKPQNLLINKR-GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG-------SRTYSTSIDIWSVGCIMAE 193 (284)
T ss_pred eeCCCCHHHEEECCC-CcEEEeecchhhhhcCCccccccccccccccChHHhcC-------CCCCCcHHHHHHHHHHHHH
Confidence 699999999999966 679999999987443221 1233467889999998753 2456889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHcc----------------CCCC-----------CCCCCcHHHHHHHHHhcccCCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKH----------------ARPG-----------LPEDISPDLAFIVQSCWVEDPNLRP 132 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~----------------~~~~-----------~p~~~~~~~~~l~~~~l~~dp~~Rp 132 (198)
+++|..||.+.............. .... .....+..+.+++.+||+.||.+||
T Consensus 194 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 273 (284)
T cd07836 194 MITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI 273 (284)
T ss_pred HHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCC
Confidence 999999998765433221111000 0000 0123567889999999999999999
Q ss_pred CHHHHHH
Q 029154 133 SFSQIIR 139 (198)
Q Consensus 133 s~~~~l~ 139 (198)
++.++++
T Consensus 274 ~~~~~l~ 280 (284)
T cd07836 274 SAHDALQ 280 (284)
T ss_pred CHHHHhc
Confidence 9999987
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-22 Score=154.24 Aligned_cols=141 Identities=26% Similarity=0.397 Sum_probs=102.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+ +.+||+|||++..... ......++..|++||.+.+ ...++.++|+||+|+++|++
T Consensus 130 iH~dl~p~Nili~~~-~~~~l~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~el 199 (328)
T cd07856 130 VHRDLKPSNILINEN-CDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLT-------WQKYDVEVDIWSAGCIFAEM 199 (328)
T ss_pred ccCCCCHHHEeECCC-CCEEeCccccccccCC--CcCCCcccccccCceeeec-------cCCcCcHHHHHHHHHHHHHH
Confidence 699999999999966 6799999999874322 2234567889999998642 24578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHH--H--------------------Hc--cCCCCC-----CCCCcHHHHHHHHHhcccCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAA--A--------------------FK--HARPGL-----PEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~--~--------------------~~--~~~~~~-----p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
++|..||.+.......... . .. ...... ...+++.+.+++.+||+.+|.+|
T Consensus 200 ~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 279 (328)
T cd07856 200 LEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKR 279 (328)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhC
Confidence 9999999765532211000 0 00 000011 12467889999999999999999
Q ss_pred CCHHHHHHHHHHHHhhcCCCCC
Q 029154 132 PSFSQIIRMLNAFLFTLRPPSP 153 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~~~~~~ 153 (198)
|++.+++. +.|+.....+..
T Consensus 280 ~t~~ell~--~~~~~~~~~~~~ 299 (328)
T cd07856 280 ISAAEALA--HPYLAPYHDPTD 299 (328)
T ss_pred CCHHHHhc--CCccccccCCcc
Confidence 99999998 777765555433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-24 Score=168.04 Aligned_cols=131 Identities=24% Similarity=0.382 Sum_probs=111.3
Q ss_pred CCCCCCCCCeEEcCCC--CceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~--~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||||+||||.... -++||||||++|..+......+.+||+.|+|||++. ++.|...-|+||.|+++|
T Consensus 686 vHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLr--------nkGyNrSLDMWSVGVIiY 757 (888)
T KOG4236|consen 686 VHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLR--------NKGYNRSLDMWSVGVIIY 757 (888)
T ss_pred eeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHh--------hccccccccceeeeEEEE
Confidence 6999999999997542 269999999999988888888899999999999985 478899999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
-.+.|..||.......+..+....-.++.....+++++.+||..+|+..-.+|-+.+.-+.
T Consensus 758 VsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 758 VSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred EEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 9999999998766655555444445556666779999999999999999999999887665
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=150.47 Aligned_cols=117 Identities=22% Similarity=0.263 Sum_probs=90.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+ +.++++|||++...... .....++..|++||.+.. ..++.++|+||+|+++|++
T Consensus 107 ~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el 175 (237)
T cd05576 107 VCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGI--------SEETEACDWWSLGAILFEL 175 (237)
T ss_pred eccCCCHHHEEEcCC-CCEEEecccchhccccc--cccCCcCccccCCcccCC--------CCCCchhhHHHHHHHHHHH
Confidence 699999999999977 67999999987654332 223455778999998743 5578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 134 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~ 134 (198)
++|..|+...... ........+|..+++.+.+++.+||..||++|+++
T Consensus 176 ~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 176 LTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 9999887532211 01112234567789999999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-22 Score=147.77 Aligned_cols=128 Identities=30% Similarity=0.491 Sum_probs=100.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.++|+|||++...... .......++..|++||.+.+ ...+.++|+||||+++|+
T Consensus 115 ~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~D~~slG~~~~~ 185 (250)
T cd05123 115 IYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG--------KGYGKAVDWWSLGVLLYE 185 (250)
T ss_pred eecCCCcceEEEcCC-CcEEEeecCcceecccCCCcccCCcCCccccChHHhCC--------CCCCchhhHHHHHHHHHH
Confidence 599999999999976 67999999998754332 22334567889999998753 446789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH---HHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF---SQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~---~~~l~ 139 (198)
+++|..||..... ....... ......++...+.++.+++.+||..||.+||++ .++++
T Consensus 186 l~~g~~p~~~~~~-~~~~~~~-~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 186 MLTGKPPFYAEDR-KEIYEKI-LKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHHCCCCCCCCCH-HHHHHHH-hcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 9999999976554 2222222 235566778889999999999999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-22 Score=150.88 Aligned_cols=128 Identities=28% Similarity=0.436 Sum_probs=95.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---------cccCCCCccceecccccccccccccccCCCCchhhHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 71 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvw 71 (198)
+|+||+|+||+++.+ +.++|+|||++....... ......++..|++||.... ..++.++|+|
T Consensus 115 ~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Dv~ 185 (265)
T cd05579 115 IHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG--------QGHSKTVDWW 185 (265)
T ss_pred ecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcC--------CCCCcchhhH
Confidence 699999999999976 679999999987432211 1223467889999998753 4467899999
Q ss_pred HHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCC--cHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 72 SFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI--SPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 72 s~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~--~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
|||+++|++++|..||......... .... ......+... +..+.+++.+||+.+|.+||++..+.+
T Consensus 186 slG~~~~~l~~g~~p~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 186 SLGCILYEFLVGIPPFHGETPEEIF-QNIL-NGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEE 253 (265)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHH-HHHh-cCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence 9999999999999999766543322 2222 2223334444 899999999999999999999944433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.9e-22 Score=149.51 Aligned_cols=131 Identities=28% Similarity=0.432 Sum_probs=95.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||+|+||+++.+ +.+||+|||++....... ......++..|+|||.+.. ...++.++|+||+|+++||
T Consensus 120 ~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dv~slG~~l~~ 191 (282)
T cd07829 120 LHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLG-------SKHYSTAVDIWSVGCIFAE 191 (282)
T ss_pred ccCCCChheEEEcCC-CCEEEecCCcccccCCCccccCccccCcCcCChHHhcC-------CcCCCccccHHHHHHHHHH
Confidence 699999999999976 679999999987543322 2233456778999998753 2367889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHc-------------cC---C---C--------CCCCCCcHHHHHHHHHhcccCCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFK-------------HA---R---P--------GLPEDISPDLAFIVQSCWVEDPNLRP 132 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~-------------~~---~---~--------~~p~~~~~~~~~l~~~~l~~dp~~Rp 132 (198)
+++|..||.+............. .. . + ......+..+.+++.+||..||.+||
T Consensus 192 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 271 (282)
T cd07829 192 MITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI 271 (282)
T ss_pred HHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCC
Confidence 99999999775543322111000 00 0 0 00112467899999999999999999
Q ss_pred CHHHHHH
Q 029154 133 SFSQIIR 139 (198)
Q Consensus 133 s~~~~l~ 139 (198)
++.+++.
T Consensus 272 ~~~~~l~ 278 (282)
T cd07829 272 SAKEALK 278 (282)
T ss_pred CHHHHhh
Confidence 9999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-22 Score=147.26 Aligned_cols=137 Identities=26% Similarity=0.355 Sum_probs=96.8
Q ss_pred CCCCCCCCCeEEcCC---CCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHH
Q 029154 1 MGKFMKEDNLLLTPD---QKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 73 (198)
Q Consensus 1 iH~dlKp~NIll~~~---~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~ 73 (198)
+||||||.|||+..+ .+.|||+|||++|...... .....+-|..|.|||.+.+ ...|+.+.|+|+.
T Consensus 154 lHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG-------a~hYT~AiDvWAi 226 (438)
T KOG0666|consen 154 LHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG-------ARHYTKAIDVWAI 226 (438)
T ss_pred eeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcc-------cccccchhhhHHH
Confidence 699999999999755 2579999999999654322 1223467999999999986 4789999999999
Q ss_pred HHHHHHHHcCCCCCCCCCcH---------HHHHHH--HHccCCCC-------CCCC------------------------
Q 029154 74 GIVLWELLTNRLPFEGMSNL---------QAAYAA--AFKHARPG-------LPED------------------------ 111 (198)
Q Consensus 74 G~~l~e~~~g~~p~~~~~~~---------~~~~~~--~~~~~~~~-------~p~~------------------------ 111 (198)
||++.|+++..+.|.+.... .+..++ ........ .|+.
T Consensus 227 GCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~ 306 (438)
T KOG0666|consen 227 GCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKH 306 (438)
T ss_pred HHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHh
Confidence 99999999988887653211 111111 11100000 0110
Q ss_pred --CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 112 --ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 112 --~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
-++...+|+.++|.+||.+|.|+++.++ +.++.
T Consensus 307 k~k~~~a~~LL~klL~yDP~kRIta~qAle--h~yF~ 341 (438)
T KOG0666|consen 307 KVKDPSALDLLQKLLTYDPIKRITAEQALE--HPYFT 341 (438)
T ss_pred cCCCchHHHHHHHHhccCchhhccHHHHhc--ccccc
Confidence 1344789999999999999999999998 44443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=144.47 Aligned_cols=130 Identities=36% Similarity=0.581 Sum_probs=100.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||+|+||+++.+ +.++|+|||++.............++..|++||.... ..++.++|+|++|++++++
T Consensus 109 ~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~--------~~~~~~~Di~slG~~l~~l 179 (244)
T smart00220 109 IHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLG--------KGYGKAVDVWSLGVILYEL 179 (244)
T ss_pred ecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCCCCHHHHcc--------CCCCchhhHHHHHHHHHHH
Confidence 699999999999976 6799999999876544333445678889999998742 4568899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCC--CcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPED--ISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~--~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
++|..||........................ ++.++.+++.+||..+|++||++.++++
T Consensus 180 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 180 LTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 9999999764433333333322222222222 7889999999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-23 Score=162.44 Aligned_cols=130 Identities=28% Similarity=0.394 Sum_probs=98.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|.||||+|||++.+...+||||||.|.....+. .+.+.-+..|.|||++.+ ..|++..|+||.||++||+
T Consensus 558 lHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG--------~~yd~~iD~WSvgctLYEl 628 (752)
T KOG0670|consen 558 LHADIKPDNILVNESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILG--------LPYDYPIDTWSVGCTLYEL 628 (752)
T ss_pred eecccCccceEeccCcceeeeccCcccccccccc-ccHHHHHHhccCcceeec--------CcccCCccceeeceeeEEe
Confidence 6999999999999887789999999987655544 234455789999999976 6789999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCC-----------------------------------------------------
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPG----------------------------------------------------- 107 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------------------------------- 107 (198)
.||+..|.|..+.+-+...+......+
T Consensus 629 YtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~ 708 (752)
T KOG0670|consen 629 YTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAV 708 (752)
T ss_pred eccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhcc
Confidence 999999998776543322111000000
Q ss_pred --CCCC---CcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 108 --LPED---ISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 108 --~p~~---~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+|.+ .-..+.+|+.+||.+||++|.+..++|+
T Consensus 709 q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 709 QRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred CCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0000 0134789999999999999999999888
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=148.93 Aligned_cols=128 Identities=23% Similarity=0.470 Sum_probs=99.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---------------------cccCCCCccceeccccccccccccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---------------------MMTAETGTYRWMAPELYSTVTLRQG 59 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~ 59 (198)
+|+||||+||+++.+ +.++|+|||++....... ......++..|++||++..
T Consensus 124 ~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~------ 196 (280)
T cd05581 124 IHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE------ 196 (280)
T ss_pred eecCCCHHHeEECCC-CCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC------
Confidence 599999999999976 679999999987433211 1123457889999998753
Q ss_pred ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH----H
Q 029154 60 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF----S 135 (198)
Q Consensus 60 ~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~----~ 135 (198)
..++.++|+||+|++++++++|..||........ ... ........+..+++.+.+++.+||..+|.+||++ .
T Consensus 197 --~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 272 (280)
T cd05581 197 --KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-FQK-ILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYD 272 (280)
T ss_pred --CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-HHH-HHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHH
Confidence 4578899999999999999999999986653222 222 2234455677789999999999999999999999 8
Q ss_pred HHHH
Q 029154 136 QIIR 139 (198)
Q Consensus 136 ~~l~ 139 (198)
++++
T Consensus 273 ~ll~ 276 (280)
T cd05581 273 ELKA 276 (280)
T ss_pred HHhc
Confidence 8776
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-22 Score=161.34 Aligned_cols=129 Identities=23% Similarity=0.370 Sum_probs=92.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccC---------ccc------------------c----------------ccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREE---------TVT------------------E----------------MMT 37 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~---------~~~------------------~----------------~~~ 37 (198)
|||||||+|||||.+ +++||.||||+... ... . ...
T Consensus 751 IHRDiKPDNILIDrd-GHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ah 829 (1034)
T KOG0608|consen 751 IHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAH 829 (1034)
T ss_pred eecccCccceEEccC-CceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhh
Confidence 799999999999988 79999999998521 000 0 012
Q ss_pred CCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCC--CCCCcHH
Q 029154 38 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPD 115 (198)
Q Consensus 38 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--p~~~~~~ 115 (198)
..+||+.|+|||++.. ..|+..+|+||.|+++|||+.|++||.........+..........+ ...++.+
T Consensus 830 slvgt~nyiapevl~r--------~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e 901 (1034)
T KOG0608|consen 830 SLVGTPNYIAPEVLAR--------TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKE 901 (1034)
T ss_pred hhcCCCcccChHHhcc--------cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHH
Confidence 2479999999999853 67888999999999999999999999776654433222111122223 3458999
Q ss_pred HHHHHHHhcccCCCCCCC---HHHHHH
Q 029154 116 LAFIVQSCWVEDPNLRPS---FSQIIR 139 (198)
Q Consensus 116 ~~~l~~~~l~~dp~~Rps---~~~~l~ 139 (198)
+.++|.+++. +++.|.. +++|-.
T Consensus 902 ~~~li~kLc~-sad~RLGkng~d~vKa 927 (1034)
T KOG0608|consen 902 ALDLIQKLCC-SADSRLGKNGADQVKA 927 (1034)
T ss_pred HHHHHHHHhc-Chhhhhcccchhhhhc
Confidence 9999988653 5777842 444544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-22 Score=166.89 Aligned_cols=133 Identities=27% Similarity=0.472 Sum_probs=107.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
||||+|-.|||++.+ +.|||+|||++.....+. ...+.+||++|||||++.+.. .....|+..+|+||+|++..|
T Consensus 145 iHRDikG~NiLLT~e-~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e---~~d~tyd~R~D~WsLGITaIE 220 (953)
T KOG0587|consen 145 IHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDE---SPDATYDYRSDLWSLGITAIE 220 (953)
T ss_pred eeecccCceEEEecc-CcEEEeeeeeeeeeecccccccCcCCCcccccceeeeccc---CCCCCcccccchhhccceeeh
Confidence 799999999999987 569999999998655433 245679999999999986522 123456789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC---CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
|..|.+|+..+.+....+.+. .++| ..|..++.++.++|..||..|-.+||+..++++
T Consensus 221 ladG~PPl~DmHPmraLF~Ip--RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 221 MAEGAPPLCDMHPMRALFLIP--RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hcCCCCCccCcchhhhhccCC--CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 999999999988877654432 2222 225668899999999999999999999999887
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-22 Score=154.19 Aligned_cols=135 Identities=24% Similarity=0.404 Sum_probs=98.6
Q ss_pred CCCCCCCCCeEEcCC--CCceEEecccCcccCccccc--------ccCCCCccceecccccccccccccccCCCCchhhH
Q 029154 1 MGKFMKEDNLLLTPD--QKSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 70 (198)
Q Consensus 1 iH~dlKp~NIll~~~--~~~~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dv 70 (198)
||.||||.||||... .+.+||.|||+++.+.+... .+...||.+|++||++.-+. +....+.++||
T Consensus 592 IHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgk----ePPKIsnKVDV 667 (775)
T KOG1151|consen 592 IHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGK----EPPKISNKVDV 667 (775)
T ss_pred eeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCC----CCCccccceee
Confidence 799999999999743 24689999999996654321 22346899999999985321 23456889999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCcHHHHHHH--HHccCCCCCC--CCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 71 YSFGIVLWELLTNRLPFEGMSNLQAAYAA--AFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 71 ws~G~~l~e~~~g~~p~~~~~~~~~~~~~--~~~~~~~~~p--~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
||.|+++|.++.|+.||...-..++.+.. .+..-...+| +.++.++.+||++||++.-.+|....++..
T Consensus 668 WSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 668 WSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred EeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 99999999999999999765444433221 1111112233 458899999999999999999987776655
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-21 Score=153.91 Aligned_cols=134 Identities=25% Similarity=0.491 Sum_probs=103.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccccc---CCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMT---AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||.+.|+|++.+ +++||+|||++|..-....+. ..+-...|||+|.+.- +.++.++|+|+||+++
T Consensus 659 VHrd~a~rNcLv~~e-~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsill--------gkFttaSDvWafgvTl 729 (807)
T KOG1094|consen 659 VHRDLATRNCLVDGE-FTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILL--------GKFTTASDVWAFGVTL 729 (807)
T ss_pred hhccccccceeecCc-ccEEecCcccccccccCCceeeecceeeeeeehhHHHHHh--------ccccchhhhhhhHHHH
Confidence 799999999999977 789999999998443222221 1234679999998853 7899999999999999
Q ss_pred HHHH--cCCCCCCCCCcHHHHHHHH--HccC----CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 78 WELL--TNRLPFEGMSNLQAAYAAA--FKHA----RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 78 ~e~~--~g~~p~~~~~~~~~~~~~~--~~~~----~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
||++ +...||......+...... .... -+..|..++..+..+|.+||.+|..+||+|+++...|++
T Consensus 730 wE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 730 WEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred HHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 9986 4778998766544332221 1111 124577899999999999999999999999999887765
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6e-21 Score=136.38 Aligned_cols=139 Identities=19% Similarity=0.328 Sum_probs=107.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
||||+||.|++|+.....++|+|+|+|........+...+.+..|..||.+.. .+.|+..-|+|||||++.+|
T Consensus 154 mHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVd-------y~~YDYSLD~WS~GcmlA~m 226 (338)
T KOG0668|consen 154 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASM 226 (338)
T ss_pred ccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheee-------chhccccHHHHHHHHHHHHH
Confidence 69999999999998878899999999987766666677788999999999863 57889999999999999999
Q ss_pred HcCCCCC-CCCCcHHHHHHHHHc---------------cCCCCC--------------------CCCCcHHHHHHHHHhc
Q 029154 81 LTNRLPF-EGMSNLQAAYAAAFK---------------HARPGL--------------------PEDISPDLAFIVQSCW 124 (198)
Q Consensus 81 ~~g~~p~-~~~~~~~~~~~~~~~---------------~~~~~~--------------------p~~~~~~~~~l~~~~l 124 (198)
+..+.|| .|..+.++...+... ...+.+ ..-.++++.+|+.++|
T Consensus 227 iFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklL 306 (338)
T KOG0668|consen 227 IFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLL 306 (338)
T ss_pred HhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHH
Confidence 9888776 455554444332110 000000 0114689999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 125 VEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 125 ~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
..|-++|+|+.|.+. |.++...
T Consensus 307 rYDHqeRlTakEam~--HpyF~~~ 328 (338)
T KOG0668|consen 307 RYDHQERLTAKEAMA--HPYFAPV 328 (338)
T ss_pred hhccccccchHHHhc--CchHHHH
Confidence 999999999999998 6555543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-21 Score=143.87 Aligned_cols=140 Identities=22% Similarity=0.444 Sum_probs=103.1
Q ss_pred CCCCCCCCeEEcCCCC--ceEEecccCcccCccc--------ccccCCCCccceecccccccccccccccCCCCchhhHH
Q 029154 2 GKFMKEDNLLLTPDQK--SLKLADFGLAREETVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 71 (198)
Q Consensus 2 H~dlKp~NIll~~~~~--~~kl~DfGla~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvw 71 (198)
||||||+|||...-+. -+||+||-+......+ ....+.+|+..|||||+..-. .++...|+.+.|.|
T Consensus 199 HRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~f---v~qA~~YDKrCDlw 275 (463)
T KOG0607|consen 199 HRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVF---VDQATFYDKRCDLW 275 (463)
T ss_pred cccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhh---ccccccccccccHH
Confidence 9999999999975422 3799999887532211 113356899999999986432 22446788999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCcH-------------HHHHHHHHccCCCCCCCC----CcHHHHHHHHHhcccCCCCCCCH
Q 029154 72 SFGIVLWELLTNRLPFEGMSNL-------------QAAYAAAFKHARPGLPED----ISPDLAFIVQSCWVEDPNLRPSF 134 (198)
Q Consensus 72 s~G~~l~e~~~g~~p~~~~~~~-------------~~~~~~~~~~~~~~~p~~----~~~~~~~l~~~~l~~dp~~Rps~ 134 (198)
|+|+++|-|+.|.+||.|.... +..+...+......+|+. ++.+..+++..+|..|+.+|.++
T Consensus 276 SLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa 355 (463)
T KOG0607|consen 276 SLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSA 355 (463)
T ss_pred HHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhh
Confidence 9999999999999999764321 111223344555666643 78999999999999999999999
Q ss_pred HHHHHHHHHHHh
Q 029154 135 SQIIRMLNAFLF 146 (198)
Q Consensus 135 ~~~l~~l~~~~~ 146 (198)
.++++ +.|..
T Consensus 356 ~~vln--hPw~~ 365 (463)
T KOG0607|consen 356 AQVLN--HPWVQ 365 (463)
T ss_pred hhccC--Ccccc
Confidence 99988 55544
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.7e-21 Score=143.11 Aligned_cols=123 Identities=25% Similarity=0.498 Sum_probs=101.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|-||||-+|+||+.+ +++||.|+|+++... .....++.|||+.|.|||++.+ ..|+..+|+|++|++++|
T Consensus 373 iyrdlkldnvlldae-ghikltdygmcke~l~~gd~tstfcgtpnyiapeilrg--------eeygfsvdwwalgvlmfe 443 (593)
T KOG0695|consen 373 IYRDLKLDNVLLDAE-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG--------EEYGFSVDWWALGVLMFE 443 (593)
T ss_pred eeeeccccceEEccC-CceeecccchhhcCCCCCcccccccCCCcccchhhhcc--------cccCceehHHHHHHHHHH
Confidence 569999999999987 789999999998543 3344567899999999999965 678899999999999999
Q ss_pred HHcCCCCCC--CC----CcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC
Q 029154 80 LLTNRLPFE--GM----SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP 132 (198)
Q Consensus 80 ~~~g~~p~~--~~----~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp 132 (198)
|+.|+.||. ++ .+..+...+.+......+|..++..+..+++..|..||.+|.
T Consensus 444 mmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 444 MMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred HHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence 999999995 21 123344444555566678999999999999999999999995
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-21 Score=142.78 Aligned_cols=133 Identities=29% Similarity=0.396 Sum_probs=98.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc--ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||.|+|++.+ ..+||||||+++..... ...+..+-|.+|.|||++++ ...|+...||||.||++.
T Consensus 178 LHRDIKPGNLLVNSN-CvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMG-------aRhYs~AvDiWSVGCIFa 249 (449)
T KOG0664|consen 178 LHRDIKPGNLLVNSN-CILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMG-------ARRYTGAVDIWSVGCIFA 249 (449)
T ss_pred hhccCCCccEEeccC-ceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhc-------chhhcCccceehhhHHHH
Confidence 599999999999966 78999999999965432 22344567899999999986 578999999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHH--------------cc-------CC---CCC--------CCCCcHHHHHHHHHhccc
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAF--------------KH-------AR---PGL--------PEDISPDLAFIVQSCWVE 126 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~--------------~~-------~~---~~~--------p~~~~~~~~~l~~~~l~~ 126 (198)
|++..+..|+...+.++...+.. ++ .. +.+ +..-..+...++..++..
T Consensus 250 ELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~ 329 (449)
T KOG0664|consen 250 ELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHF 329 (449)
T ss_pred HHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCC
Confidence 99998888987776554422211 10 00 111 112234567788889999
Q ss_pred CCCCCCCHHHHHHHH
Q 029154 127 DPNLRPSFSQIIRML 141 (198)
Q Consensus 127 dp~~Rps~~~~l~~l 141 (198)
||.+|.+-.+.+.++
T Consensus 330 d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 330 DPDKRISVEEALQHR 344 (449)
T ss_pred CCcccccHhhhcccc
Confidence 999999888887754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.9e-22 Score=161.09 Aligned_cols=129 Identities=25% Similarity=0.390 Sum_probs=92.3
Q ss_pred CCCCCCCCCeEEcCC----CCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHH
Q 029154 1 MGKFMKEDNLLLTPD----QKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 72 (198)
Q Consensus 1 iH~dlKp~NIll~~~----~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws 72 (198)
|||||||.||||... ...++|+|||+++...... ...+..||-+|.|||++.. ..-+.++||+|
T Consensus 628 VHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~--------~~~~~avDiFs 699 (903)
T KOG1027|consen 628 VHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRE--------DRKTQAVDIFS 699 (903)
T ss_pred ccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhc--------cccCcccchhh
Confidence 799999999999862 2468999999998543221 1344578999999999864 33356899999
Q ss_pred HHHHHHHHHcC-CCCCCCCCcHHHHHHHHHccCCC-CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 73 FGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 73 ~G~~l~e~~~g-~~p~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+||++|.+++| ..||......+. .+....... .+-...+.++.+||.+|+..||..||++.+|+.
T Consensus 700 lGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 700 LGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred cCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 99999999875 789864332221 222111111 111122238999999999999999999999987
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.5e-21 Score=165.88 Aligned_cols=133 Identities=20% Similarity=0.305 Sum_probs=91.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+||+++.+ ...++. ||....... .....|+..|+|||++.+ ..++.++|||||||++||+
T Consensus 805 iH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~--------~~~~~~sDv~S~Gvvl~el 871 (968)
T PLN00113 805 VVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT---DTKCFISSAYVAPETRET--------KDITEKSDIYGFGLILIEL 871 (968)
T ss_pred ecCCCCHHhEEECCC-CceEEE-ecccccccc---CCCccccccccCcccccC--------CCCCcccchhhHHHHHHHH
Confidence 699999999999966 556665 665543221 123467899999999753 5688999999999999999
Q ss_pred HcCCCCCCCCCc----HHHHHHHHHc------cCCCCCCC------CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 81 LTNRLPFEGMSN----LQAAYAAAFK------HARPGLPE------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 81 ~~g~~p~~~~~~----~~~~~~~~~~------~~~~~~p~------~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
++|+.||..... .......... ...+.+.. ....++.+++.+||..||.+||++.++++.|+..
T Consensus 872 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 872 LTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred HhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 999999853221 1111110000 01111111 1123567899999999999999999999999876
Q ss_pred Hh
Q 029154 145 LF 146 (198)
Q Consensus 145 ~~ 146 (198)
..
T Consensus 952 ~~ 953 (968)
T PLN00113 952 SR 953 (968)
T ss_pred hc
Confidence 44
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-20 Score=152.78 Aligned_cols=136 Identities=27% Similarity=0.550 Sum_probs=110.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCC--ccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETG--TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~g--t~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||-..|+|+..- .++||.|||+++...... .+....| .+.|||-|.+. ...|+.++||||||+++
T Consensus 820 VHrdLaaRNVLVksP-~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~--------~~~~thqSDVWsfGVti 890 (1177)
T KOG1025|consen 820 VHRDLAARNVLVKSP-NHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIR--------IRKYTHQSDVWSFGVTI 890 (1177)
T ss_pred hhhhhhhhheeecCC-CeEEEEecchhhccCcccccccccccccCcHHHHHHHhh--------ccCCCchhhhhhhhhhH
Confidence 799999999999854 789999999998654322 2333333 56899999885 47899999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
||++| |..||.+... .........+.+...|+.++.++..++.+||..|+..||+|+++...+.....
T Consensus 891 WElmTFGa~Py~gi~~-~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 891 WELMTFGAKPYDGIPA-EEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HHHHhcCCCccCCCCH-HHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 99997 8899998664 33344455677788999999999999999999999999999999887766543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=129.24 Aligned_cols=131 Identities=27% Similarity=0.346 Sum_probs=100.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||.|+||+.+ +.+|++|||+++-.+... +++..+-|..|.+|.++.+ .+-|+...|+||-||++.|
T Consensus 123 lhrdlkpqnllin~n-gelkladfglarafgipvrcysaevvtlwyrppdvlfg-------akly~tsidmwsagcifae 194 (292)
T KOG0662|consen 123 LHRDLKPQNLLINRN-GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAE 194 (292)
T ss_pred hhccCCcceEEeccC-CcEEecccchhhhcCCceEeeeceeeeeeccCcceeee-------eehhccchHhhhcchHHHH
Confidence 599999999999987 789999999999766544 5667788999999999875 4678999999999999999
Q ss_pred HHc-CCCCCCCCCcHHHHHHHHHccCCC---------CCCC------------------CCcHHHHHHHHHhcccCCCCC
Q 029154 80 LLT-NRLPFEGMSNLQAAYAAAFKHARP---------GLPE------------------DISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 80 ~~~-g~~p~~~~~~~~~~~~~~~~~~~~---------~~p~------------------~~~~~~~~l~~~~l~~dp~~R 131 (198)
+.. |++.|.+.+-.++...+...-..+ .+|+ .++..-++++++++..+|.+|
T Consensus 195 lanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qr 274 (292)
T KOG0662|consen 195 LANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQR 274 (292)
T ss_pred HhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccc
Confidence 985 778888866544443332221111 1111 112345799999999999999
Q ss_pred CCHHHHHH
Q 029154 132 PSFSQIIR 139 (198)
Q Consensus 132 ps~~~~l~ 139 (198)
.++++.++
T Consensus 275 isaeaalq 282 (292)
T KOG0662|consen 275 ISAEAALQ 282 (292)
T ss_pred cCHHHHhc
Confidence 99999888
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.5e-20 Score=149.32 Aligned_cols=138 Identities=29% Similarity=0.462 Sum_probs=95.8
Q ss_pred CCCCCCCCCeEEcCCC-C--ceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQ-K--SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~-~--~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||.||++-... + .-||+|||.|+...++..+.+.+||..|++||.+.. .+.|+..+|.|||||++
T Consensus 142 vHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~-------q~~y~~tVDLWS~Gvtl 214 (732)
T KOG4250|consen 142 VHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYER-------QKKYTATVDLWSFGVTL 214 (732)
T ss_pred eeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhh-------ccCcCceeehhhhhhHH
Confidence 6999999999985321 2 359999999998888888888999999999999841 37889999999999999
Q ss_pred HHHHcCCCCCCCCCcHH----HHHHHHHcc------------C-C------CCCCCCCcH----HHHHHHHHhcccCCCC
Q 029154 78 WELLTNRLPFEGMSNLQ----AAYAAAFKH------------A-R------PGLPEDISP----DLAFIVQSCWVEDPNL 130 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~----~~~~~~~~~------------~-~------~~~p~~~~~----~~~~l~~~~l~~dp~~ 130 (198)
|+++||..||....... ..+...... . + .++|...+. .+..++..+|..+|.+
T Consensus 215 Y~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~ 294 (732)
T KOG4250|consen 215 YECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRK 294 (732)
T ss_pred HHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHH
Confidence 99999999985332221 111111110 0 0 112222332 3446777788888888
Q ss_pred CC--CHHHHHHHHHHHH
Q 029154 131 RP--SFSQIIRMLNAFL 145 (198)
Q Consensus 131 Rp--s~~~~l~~l~~~~ 145 (198)
|- .+.+....+.+++
T Consensus 295 ~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 295 RGHEGFDRFFAEVDDIL 311 (732)
T ss_pred hCCCCcchHHHHHHHHH
Confidence 87 5555555554444
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=146.91 Aligned_cols=142 Identities=18% Similarity=0.196 Sum_probs=92.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccC--CCCccceecccccccccccccc--------------cCCC
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTA--ETGTYRWMAPELYSTVTLRQGE--------------KKHY 64 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~--------------~~~~ 64 (198)
|||||||+|||++.+ +.+||+|||+++.......... ..+++.|++||.+......... ....
T Consensus 331 vHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~ 409 (507)
T PLN03224 331 VHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGR 409 (507)
T ss_pred ecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCC
Confidence 699999999999976 6799999999975432222222 2347899999987431100000 0011
Q ss_pred CchhhHHHHHHHHHHHHcCCC-CCCCCCcHHHHHH---------HHHccCC--CCCCCCCcHHHHHHHHHhcccCC---C
Q 029154 65 NNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYA---------AAFKHAR--PGLPEDISPDLAFIVQSCWVEDP---N 129 (198)
Q Consensus 65 ~~~~Dvws~G~~l~e~~~g~~-p~~~~~~~~~~~~---------~~~~~~~--~~~p~~~~~~~~~l~~~~l~~dp---~ 129 (198)
..+.|+||+||++++|++|.. ||.+......... ....... ....+..++..++|+.++|..+| .
T Consensus 410 ~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~ 489 (507)
T PLN03224 410 PDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANR 489 (507)
T ss_pred CCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcc
Confidence 235799999999999999875 6653221111100 0011111 22234578899999999999876 6
Q ss_pred CCCCHHHHHHHHHHHH
Q 029154 130 LRPSFSQIIRMLNAFL 145 (198)
Q Consensus 130 ~Rps~~~~l~~l~~~~ 145 (198)
+|+|++|+++ |.|+
T Consensus 490 ~RlSa~eaL~--Hp~f 503 (507)
T PLN03224 490 GRLSVGQALS--HRFF 503 (507)
T ss_pred cCCCHHHHhC--CCCc
Confidence 8999999999 6554
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.9e-19 Score=136.31 Aligned_cols=140 Identities=27% Similarity=0.569 Sum_probs=98.0
Q ss_pred CCCCCCCCeEEcCCCCceEEecccCcccCccc-----ccccCCCCccceecccccccccccccccCCC-C-chhhHHHHH
Q 029154 2 GKFMKEDNLLLTPDQKSLKLADFGLAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHY-N-NKVDVYSFG 74 (198)
Q Consensus 2 H~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~-~~~Dvws~G 74 (198)
|||||..|||+.++ +.+-|+|+|||...... ......+||..|||||++.... ....| + ..+||||||
T Consensus 339 HRDlKSKNILVKkn-~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdeti----n~~~Fesyk~ADIYafg 413 (513)
T KOG2052|consen 339 HRDLKSKNILVKKN-GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETI----NMKHFESYKRADIYAFG 413 (513)
T ss_pred ccccccccEEEccC-CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhc----ChhhhhhhhHHHHHHHH
Confidence 99999999999977 78999999999643221 2234568999999999986421 11112 1 359999999
Q ss_pred HHHHHHHc-----C-----CCCCCCCCcHHHHHHH-----HHccCCCCCCCCCc--H---HHHHHHHHhcccCCCCCCCH
Q 029154 75 IVLWELLT-----N-----RLPFEGMSNLQAAYAA-----AFKHARPGLPEDIS--P---DLAFIVQSCWVEDPNLRPSF 134 (198)
Q Consensus 75 ~~l~e~~~-----g-----~~p~~~~~~~~~~~~~-----~~~~~~~~~p~~~~--~---~~~~l~~~~l~~dp~~Rps~ 134 (198)
.++||++. | +.||.+..+.+..+.. .....+|.+|..+. + .+..+|+.||.-+|+-|-|+
T Consensus 414 LVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 414 LVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred HHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence 99999875 2 4688665433322222 22345555554432 3 35578999999999999999
Q ss_pred HHHHHHHHHHHh
Q 029154 135 SQIIRMLNAFLF 146 (198)
Q Consensus 135 ~~~l~~l~~~~~ 146 (198)
-.+-+.|..+..
T Consensus 494 LriKKtl~~l~~ 505 (513)
T KOG2052|consen 494 LRIKKTLAKLSN 505 (513)
T ss_pred HHHHHHHHHHhc
Confidence 888888877653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-18 Score=140.84 Aligned_cols=133 Identities=27% Similarity=0.405 Sum_probs=105.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc-ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
||||||-.|||+... +.+|++|||.+...+.... .+.++||++|||||+..-+ ..+.|...+|+|++|++..|
T Consensus 134 ~hRdiKGanilltd~-gDvklaDfgvsaqitati~KrksfiGtpywmapEvaave-----rkggynqlcdiwa~gitAie 207 (829)
T KOG0576|consen 134 IHRDIKGANILLTDE-GDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE-----RKGGYNQLCDIWALGITAIE 207 (829)
T ss_pred ccccccccceeeccc-CceeecccCchhhhhhhhhhhhcccCCccccchhHHHHH-----hcccccccccccccccchhh
Confidence 799999999999966 6799999999976554332 3467999999999986431 24678899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCC---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPG---LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+...++|.....+++..+.--.....++ -+..+++.+.+|++.++..+|.+||+++.+++
T Consensus 208 l~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 208 LGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred hhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 9999999877777766544332333322 24458899999999999999999999998876
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.3e-18 Score=132.43 Aligned_cols=143 Identities=28% Similarity=0.483 Sum_probs=96.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+|||||..|||+..| ..+.|+|||+|....... .....+||..|||||++-+..-++ ...--.+.||||+|.++
T Consensus 338 aHRDlkSkNVLvK~D-lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~--d~~Afkr~DvYamgLVL 414 (534)
T KOG3653|consen 338 AHRDLKSKNVLVKND-LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQ--DRDAFKRIDVYAMGLVL 414 (534)
T ss_pred ccccccccceEEccC-CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccc--cHHHHHHHHHHHHHHHH
Confidence 599999999999977 789999999997443221 122368999999999987643111 01111368999999999
Q ss_pred HHHHcCC------------CCCC---CCCcHHHHH--HHHHccCCCCCCCCC-----cHHHHHHHHHhcccCCCCCCCHH
Q 029154 78 WELLTNR------------LPFE---GMSNLQAAY--AAAFKHARPGLPEDI-----SPDLAFIVQSCWVEDPNLRPSFS 135 (198)
Q Consensus 78 ~e~~~g~------------~p~~---~~~~~~~~~--~~~~~~~~~~~p~~~-----~~~~~~l~~~~l~~dp~~Rps~~ 135 (198)
||+++.- .||+ |..+..... ....+..+|.+|..+ ..-+.+.+..||..|+.-|.|+.
T Consensus 415 WEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 415 WEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 9998731 2343 112111111 123345566666543 34477889999999999999988
Q ss_pred HHHHHHHHHHh
Q 029154 136 QIIRMLNAFLF 146 (198)
Q Consensus 136 ~~l~~l~~~~~ 146 (198)
=+.+.+..+..
T Consensus 495 Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 495 CVEERMAELMM 505 (534)
T ss_pred HHHHHHHHHhc
Confidence 77776655433
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=140.82 Aligned_cols=135 Identities=20% Similarity=0.240 Sum_probs=96.7
Q ss_pred CCCCCCC-CeEEcCCCCceEEecccCcccCccc---ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 2 GKFMKED-NLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 2 H~dlKp~-NIll~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|++.+|. |+++..+ ...++.|||.++..... ......+||+.|+|||++.+ ..++.++|||||||++
T Consensus 500 ~~~~~p~~~~~~~p~-~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~--------~~~~~~~DiwSlG~il 570 (669)
T cd05610 500 TQKPRPHGNLYQTPK-QVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLG--------KPHGPAVDWWALGVCL 570 (669)
T ss_pred CCCCCCCCceeECCc-cccccccCCCchhhhcccccccCCceeeCccccCHHHcCC--------CCCCcHHHHHHHHHHH
Confidence 3455666 4555544 45778899988653221 11234589999999999864 5578999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccC-CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|||++|+.||.+............... .+.....++..+.+++.+||..||.+||++.++++ +.|+..
T Consensus 571 ~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~~dP~~R~ta~e~l~--h~~~~~ 639 (669)
T cd05610 571 FEFLTGIPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQ--HPLFHG 639 (669)
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhHCcCHHHHHh--CHhhcC
Confidence 999999999987665443322222111 12223457888999999999999999999999999 666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.7e-18 Score=123.52 Aligned_cols=132 Identities=27% Similarity=0.380 Sum_probs=91.9
Q ss_pred CCCCCCCCCeEEc-CCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~-~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
||||||.+||||- .+...+||||||+.+..+... .....+..|.+||..... ..+.-...+.+|+|.||+++|.
T Consensus 143 VHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV--~~~~~~~~y~~pe~~~~~---~ne~~~~~ps~D~WqfGIi~f~ 217 (378)
T KOG1345|consen 143 VHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV--KYLEYVNNYHAPELCDTV---VNEKLVVNPSTDIWQFGIIFFY 217 (378)
T ss_pred hhcccccceEEEecCCccEEEeeecccccccCcee--hhhhhhcccCCcHHHhhc---cccceEecccccchheeeeeee
Confidence 7999999999994 344579999999987544322 122235578888875431 1122334678999999999999
Q ss_pred HHcCCCCCCCCCcHH---HHHHHHHccCCCCCCCC---CcHHHHHHHHHhcccCCCCCCCHHHH
Q 029154 80 LLTNRLPFEGMSNLQ---AAYAAAFKHARPGLPED---ISPDLAFIVQSCWVEDPNLRPSFSQI 137 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~p~~---~~~~~~~l~~~~l~~dp~~Rps~~~~ 137 (198)
+++|..||+.....+ ..+........+.+|.. +++.+..+.++-|..++.+|-..-++
T Consensus 218 cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 218 CLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred eecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHH
Confidence 999999998433222 23444444555555543 78899999999999999999444433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.7e-17 Score=123.46 Aligned_cols=143 Identities=25% Similarity=0.345 Sum_probs=103.2
Q ss_pred CCCCCCCCeEEcCCCC---ceEEecccCcccCcc-------cccccCCCCccceecccccccccccccccCCC-CchhhH
Q 029154 2 GKFMKEDNLLLTPDQK---SLKLADFGLAREETV-------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHY-NNKVDV 70 (198)
Q Consensus 2 H~dlKp~NIll~~~~~---~~kl~DfGla~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~Dv 70 (198)
|||||.+|||+.-++. .+.|+|||.+--... ....-..-|.-..||||+.... .+..... -.++|.
T Consensus 364 hRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~---PGp~avvny~kAD~ 440 (598)
T KOG4158|consen 364 HRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV---PGPNAVVNYEKADT 440 (598)
T ss_pred hhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC---CCCceeeccchhhh
Confidence 9999999999965432 468999998742111 1111223477889999987531 1111111 248999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 71 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 71 ws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|+.|.+.||++....||++............+...|.+|+.+++.+++++..+|..||++|++..=....|+-+++.
T Consensus 441 WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~ 517 (598)
T KOG4158|consen 441 WAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWR 517 (598)
T ss_pred hhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhc
Confidence 99999999999999999875443333344556677889999999999999999999999999977766666655553
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3e-17 Score=135.87 Aligned_cols=136 Identities=24% Similarity=0.390 Sum_probs=99.7
Q ss_pred CCCCCCCCeEEcCCCCceEEecccCcccCc---cc--ccccCCCCccceecccccccccccccccCCCC-chhhHHHHHH
Q 029154 2 GKFMKEDNLLLTPDQKSLKLADFGLAREET---VT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGI 75 (198)
Q Consensus 2 H~dlKp~NIll~~~~~~~kl~DfGla~~~~---~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~Dvws~G~ 75 (198)
|||||++|+++..+ +.+||+|||.+.... .. ......+|+..|+|||++.+ ..|+ ...||||.|+
T Consensus 443 hrdlK~enll~~~~-g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~--------~~ydpr~vDiwS~~i 513 (601)
T KOG0590|consen 443 HRDLKLENLLVTEN-GILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTG--------KEYDPRAVDVWSCGI 513 (601)
T ss_pred eccCccccEEEecC-CceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccc--------cccCcchhhhhhccc
Confidence 99999999999977 689999999986322 11 23455789999999999864 3444 4699999999
Q ss_pred HHHHHHcCCCCCCCCCcHHHHHHHH-------HccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 76 VLWELLTNRLPFEGMSNLQAAYAAA-------FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~~~~~~~~-------~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
+++.|.+|+.||.--...+..+... .......+...++.+.+.++.++|+.||.+|.+++++++ ..|+...
T Consensus 514 i~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~--d~W~~~i 591 (601)
T KOG0590|consen 514 IYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN--DEWIRSI 591 (601)
T ss_pred eEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh--ChHhhhc
Confidence 9999999999996433322211000 001111223346778899999999999999999999998 6676543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.1e-17 Score=129.36 Aligned_cols=123 Identities=29% Similarity=0.453 Sum_probs=86.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-------cccCCCCccceecccccccccccccccCCCCchhhHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 73 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~ 73 (198)
||||+||.||....+ ..+||+|||+........ ..+..+||..||+||.+.+ ..|+.++|||+|
T Consensus 378 ihrdlkp~nif~~~d-~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--------~~y~~kvdIyaL 448 (516)
T KOG1033|consen 378 IHRDLKPSNIFFSDD-DQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG--------QQYSEKVDIYAL 448 (516)
T ss_pred hhhhccccccccccc-hhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh--------hhhhhhcchhhH
Confidence 699999999999876 689999999986443222 2345689999999999975 789999999999
Q ss_pred HHHHHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHH
Q 029154 74 GIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 136 (198)
Q Consensus 74 G~~l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~ 136 (198)
|++++|++. -...+.......+ ...+..++....-.++-..|+.+++...|.+||++.+
T Consensus 449 Glil~EL~~~f~T~~er~~t~~d----~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 449 GLILAELLIQFSTQFERIATLTD----IRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred HHHHHHHHHHhccHHHHHHhhhh----hhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHH
Confidence 999999987 3334432222111 1111111111112345579999999999999995443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.4e-16 Score=132.02 Aligned_cols=136 Identities=25% Similarity=0.423 Sum_probs=98.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----------------cccCCCCccceecccccccccccccccCCC
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----------------MMTAETGTYRWMAPELYSTVTLRQGEKKHY 64 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 64 (198)
+|||+||+|.||..- +++|+.|||+++...... .-+..+||+.|.|||++.. +.|
T Consensus 165 vhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--------qgy 235 (1205)
T KOG0606|consen 165 VHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--------QGY 235 (1205)
T ss_pred ecCCCCCCcceeeec-ccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh--------hcc
Confidence 699999999999966 789999999987322110 0123489999999999863 778
Q ss_pred CchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHc--cCCCCCCCCCcHHHHHHHHHhcccCCCCC-CCHHHHHHHH
Q 029154 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK--HARPGLPEDISPDLAFIVQSCWVEDPNLR-PSFSQIIRML 141 (198)
Q Consensus 65 ~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~l~~~~l~~dp~~R-ps~~~~l~~l 141 (198)
+..+|+|++|+++||.+-|..||.+..+... +...+. ..-++-.+..++++++++.++|..+|..| -+..++.-.-
T Consensus 236 gkpvdwwamGiIlyeFLVgcvpffGdtpeel-fg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~ 314 (1205)
T KOG0606|consen 236 GKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQ 314 (1205)
T ss_pred CCCccHHHHHHHHHHHheeeeeccCCCHHHH-HhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhh
Confidence 9999999999999999999999998765332 221111 11112244578999999999999999999 3444333333
Q ss_pred HHHHh
Q 029154 142 NAFLF 146 (198)
Q Consensus 142 ~~~~~ 146 (198)
|.++.
T Consensus 315 h~ff~ 319 (1205)
T KOG0606|consen 315 HGFFQ 319 (1205)
T ss_pred cccee
Confidence 44443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.6e-16 Score=111.25 Aligned_cols=100 Identities=36% Similarity=0.645 Sum_probs=81.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||+|.||+++...+.++|+|||.+....... ......+...|++||.+.. ...++.+.|+|++|+++++
T Consensus 114 ~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~~D~~~lg~~~~~ 186 (215)
T cd00180 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG-------KGYYSEKSDIWSLGVILYE 186 (215)
T ss_pred eccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcc-------cCCCCchhhhHHHHHHHHH
Confidence 5999999999999723679999999987543321 1223457788999998753 1266789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 140 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~ 140 (198)
+ ..+.+++.+|+..+|++||++.++++.
T Consensus 187 l---------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 187 L---------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred H---------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 8 688999999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-16 Score=128.26 Aligned_cols=114 Identities=30% Similarity=0.508 Sum_probs=93.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
||||+|++||+++.+ |++++.|||+++....... .|||..|||||++. .....+|+||||++.+|+
T Consensus 119 iyrd~k~enilld~~-Ghi~~tdfglske~v~~~~---~cgt~eymApEI~~----------gh~~a~D~ws~gvl~fel 184 (612)
T KOG0603|consen 119 AYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKI---ACGTYEYRAPEIIN----------GHLSAADWWSFGVLAFEL 184 (612)
T ss_pred HHhcccccceeeccc-CccccCCchhhhHhHhhhh---cccchhhhhhHhhh----------ccCCcccchhhhhhHHHH
Confidence 589999999999987 7899999999986543322 28999999999984 356788999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 134 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~ 134 (198)
++|..||.+ . ....+....+..|..++..+.+++..++..+|..|.-.
T Consensus 185 ltg~~pf~~-----~-~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 185 LTGTLPFGG-----D-TMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhCCCCCch-----H-HHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 999999987 1 12222334566788899999999999999999999644
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.8e-16 Score=120.75 Aligned_cols=137 Identities=23% Similarity=0.334 Sum_probs=92.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc-cCcc-------c-------c------------------c------------
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR-EETV-------T-------E------------------M------------ 35 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~-~~~~-------~-------~------------------~------------ 35 (198)
|||||||+|+|.+...+.-.|.|||++. .... . . .
T Consensus 154 vHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~ 233 (418)
T KOG1167|consen 154 VHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSE 233 (418)
T ss_pred cccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccce
Confidence 7999999999998766667899999986 1000 0 0 0
Q ss_pred ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH--------------H-
Q 029154 36 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA--------------A- 100 (198)
Q Consensus 36 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~--------------~- 100 (198)
.....||++|.|||++.. ...-+++.|+||.|+++..++++..||............ .
T Consensus 234 ~anrAGT~GfRaPEvL~k-------~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l 306 (418)
T KOG1167|consen 234 RANRAGTPGFRAPEVLFR-------CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAAL 306 (418)
T ss_pred ecccCCCCCCCchHHHhh-------ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhc
Confidence 001258999999999864 345688999999999999999999998522111100000 0
Q ss_pred ------Hc---------------cC-----CC-CC--------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 101 ------FK---------------HA-----RP-GL--------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 101 ------~~---------------~~-----~~-~~--------p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
++ .. .. +. -+..+..+.+++.+|+..||.+|.++++.|+ |.++
T Consensus 307 ~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk--HpFF 384 (418)
T KOG1167|consen 307 PGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK--HPFF 384 (418)
T ss_pred CCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc--CcCC
Confidence 00 00 00 00 1123457889999999999999999999998 5554
Q ss_pred h
Q 029154 146 F 146 (198)
Q Consensus 146 ~ 146 (198)
.
T Consensus 385 ~ 385 (418)
T KOG1167|consen 385 D 385 (418)
T ss_pred c
Confidence 3
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.8e-16 Score=123.97 Aligned_cols=80 Identities=24% Similarity=0.467 Sum_probs=68.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
||||||-+|++++.+ +.+||+|||.+.+.. +..+.+++||..|+|||++.+ ..+.+...|||++|+++|.+
T Consensus 692 vhrdikdenvivd~~-g~~klidfgsaa~~k-sgpfd~f~gtv~~aapevl~g-------~~y~gk~qdiwalgillyti 762 (772)
T KOG1152|consen 692 VHRDIKDENVIVDSN-GFVKLIDFGSAAYTK-SGPFDVFVGTVDYAAPEVLGG-------EKYLGKPQDIWALGILLYTI 762 (772)
T ss_pred eecccccccEEEecC-CeEEEeeccchhhhc-CCCcceeeeeccccchhhhCC-------CccCCCcchhhhhhheeeEE
Confidence 799999999999977 789999999886533 344677899999999999865 34556779999999999999
Q ss_pred HcCCCCCCC
Q 029154 81 LTNRLPFEG 89 (198)
Q Consensus 81 ~~g~~p~~~ 89 (198)
+....||++
T Consensus 763 vykenpyyn 771 (772)
T KOG1152|consen 763 VYKENPYYN 771 (772)
T ss_pred EeccCCCcC
Confidence 999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.56 E-value=8.9e-15 Score=107.20 Aligned_cols=81 Identities=40% Similarity=0.621 Sum_probs=65.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||+|+||+++.+ ..++|+|||++....... ......++..|++||.+.. ...++.++|+|+||++++
T Consensus 120 ~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~~Dv~~lG~~~~ 191 (225)
T smart00221 120 VHRDLKPENILLGMD-GLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLG-------GKGYGEAVDIWSLGVILY 191 (225)
T ss_pred ecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcC-------CCCCCchhhHHHHHHHHH
Confidence 599999999999976 679999999987544322 2234567788999998731 356677999999999999
Q ss_pred HHHcCCCCCCC
Q 029154 79 ELLTNRLPFEG 89 (198)
Q Consensus 79 e~~~g~~p~~~ 89 (198)
++++|+.||..
T Consensus 192 ~l~~g~~pf~~ 202 (225)
T smart00221 192 ELLWGPEPFSG 202 (225)
T ss_pred HHHHCCCCccc
Confidence 99999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.9e-14 Score=107.24 Aligned_cols=135 Identities=30% Similarity=0.421 Sum_probs=96.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-------cccCCCCccceecccccccccccccccCCCCchhhHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 73 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~ 73 (198)
+|||+||+||+++.....++++|||+++...... ......|+..|++||.+.+.. ...+....|+|++
T Consensus 123 ~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~-----~~~~~~~~D~~s~ 197 (384)
T COG0515 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS-----LAYASSSSDIWSL 197 (384)
T ss_pred eccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCC-----CCCCCchHhHHHH
Confidence 6999999999999763369999999987433221 235678999999999875300 0467889999999
Q ss_pred HHHHHHHHcCCCCCCCCCc---HHHHHHHHHccCCC----CCCCCC----cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 029154 74 GIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARP----GLPEDI----SPDLAFIVQSCWVEDPNLRPSFSQIIRM 140 (198)
Q Consensus 74 G~~l~e~~~g~~p~~~~~~---~~~~~~~~~~~~~~----~~p~~~----~~~~~~l~~~~l~~dp~~Rps~~~~l~~ 140 (198)
|++++++++|..||..... .............+ ...... ...+.+++.+++..+|..|.+..+....
T Consensus 198 g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 198 GITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 9999999999999876653 22333332222222 111111 1578899999999999999988876663
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.5e-15 Score=114.46 Aligned_cols=121 Identities=23% Similarity=0.295 Sum_probs=74.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceeccccccccc-ccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT-LRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
||+||||+|++++.+ +.+.|+||+.....+..... ...+..|.+||...... +.. ....++.+.|.|++|+++|.
T Consensus 167 VHgdi~~~nfll~~~-G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~-~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 167 VHGDIKPENFLLDQD-GGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQ-NNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EEST-SGGGEEE-TT-S-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHH-SEEEE-HHHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCC-CCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCc-ccceeeeccCHHHHHHHHHH
Confidence 699999999999987 78999999877654432221 23457789999764310 000 12356889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
++++..||.......... ........+++.++.||.++|+.+|.+|
T Consensus 243 lWC~~lPf~~~~~~~~~~------~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPE------WDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSG------GGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCcccccc------ccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999999997544211110 0111222688899999999999999887
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.2e-14 Score=112.54 Aligned_cols=123 Identities=23% Similarity=0.319 Sum_probs=84.2
Q ss_pred CceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCC---CCC--
Q 029154 17 KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE---GMS-- 91 (198)
Q Consensus 17 ~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~---~~~-- 91 (198)
..+||+|||-|.... ..++..+-|..|.|||++.+ ..|++.+||||++|+++|++||...|. +..
T Consensus 391 i~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllG--------sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~ 460 (590)
T KOG1290|consen 391 IRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLG--------SGYSTSADIWSTACMAFELATGDYLFEPHSGENYS 460 (590)
T ss_pred eeEEEeeccchhhhh--hhhchhhhhhhccCcceeec--------CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCC
Confidence 469999999886432 22345567899999999976 678999999999999999999987663 221
Q ss_pred cHHHHHHH---HHccCCC--------------------------------------CCCCCCcHHHHHHHHHhcccCCCC
Q 029154 92 NLQAAYAA---AFKHARP--------------------------------------GLPEDISPDLAFIVQSCWVEDPNL 130 (198)
Q Consensus 92 ~~~~~~~~---~~~~~~~--------------------------------------~~p~~~~~~~~~l~~~~l~~dp~~ 130 (198)
...+-... +....+. .++..-..++.+|+.-||+.+|.+
T Consensus 461 rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeK 540 (590)
T KOG1290|consen 461 RDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEK 540 (590)
T ss_pred ccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccc
Confidence 11111111 1100000 001111345778999999999999
Q ss_pred CCCHHHHHHHHHHHHhhcCCC
Q 029154 131 RPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 131 Rps~~~~l~~l~~~~~~~~~~ 151 (198)
||||.+.++ +.|+.....+
T Consensus 541 R~tA~~cl~--hPwLn~~~~~ 559 (590)
T KOG1290|consen 541 RPTAAQCLK--HPWLNPVAGP 559 (590)
T ss_pred cccHHHHhc--CccccCCCCC
Confidence 999999998 8887755444
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.5e-13 Score=101.18 Aligned_cols=127 Identities=25% Similarity=0.533 Sum_probs=98.2
Q ss_pred CCCCCeEEcCCCCceEEe--cccCcccCcccccccCCCCccceecccccccccccccccCCC-CchhhHHHHHHHHHHHH
Q 029154 5 MKEDNLLLTPDQKSLKLA--DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY-NNKVDVYSFGIVLWELL 81 (198)
Q Consensus 5 lKp~NIll~~~~~~~kl~--DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~Dvws~G~~l~e~~ 81 (198)
|....++|+.+ ..++|. |--++-. ......++.||+||.+.. ..... -..+|+|||++++||+.
T Consensus 317 lns~hvmided-ltarismad~kfsfq------e~gr~y~pawmspealqr------kped~n~raadmwsfaillwel~ 383 (448)
T KOG0195|consen 317 LNSKHVMIDED-LTARISMADTKFSFQ------EVGRAYSPAWMSPEALQR------KPEDLNIRAADMWSFAILLWELN 383 (448)
T ss_pred cccceEEecch-hhhheecccceeeee------ccccccCcccCCHHHHhc------CchhcchhhhhHHHHHHHHHHhh
Confidence 45667777755 445443 3322211 123345789999998753 11111 24789999999999999
Q ss_pred cCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 82 TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 82 ~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
|...||....++..-.....++.++.+|+.++.....|+.-|+..||.+||.++.++..|+..
T Consensus 384 trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 384 TREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 999999998888877888889999999999999999999999999999999999999988764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.3e-12 Score=101.63 Aligned_cols=140 Identities=19% Similarity=0.253 Sum_probs=99.5
Q ss_pred CCCCCCCCCeEEcCCC----CceEEecccCcc--cCcccc-----c----ccCCCCccceecccccccccccccccCCCC
Q 029154 1 MGKFMKEDNLLLTPDQ----KSLKLADFGLAR--EETVTE-----M----MTAETGTYRWMAPELYSTVTLRQGEKKHYN 65 (198)
Q Consensus 1 iH~dlKp~NIll~~~~----~~~kl~DfGla~--~~~~~~-----~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 65 (198)
|||||||+|++++... ..+.|.|||+++ ...... . .....||..|+++.+..+ ...+
T Consensus 144 iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--------~e~~ 215 (322)
T KOG1164|consen 144 IHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--------IEQG 215 (322)
T ss_pred ccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--------CccC
Confidence 7999999999998653 458999999998 321111 1 123459999999997653 5678
Q ss_pred chhhHHHHHHHHHHHHcCCCCCCCCCcHHHH--HHHHHccCCCC-CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 66 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAA--YAAAFKHARPG-LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 66 ~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~--~~~~~~~~~~~-~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
.+.|+||++.++.++..|..||.+....... ........... .....+.++..+...+-..+...+|....+...|.
T Consensus 216 r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~ 295 (322)
T KOG1164|consen 216 RRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLK 295 (322)
T ss_pred CchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHH
Confidence 8999999999999999999999765532211 11111111111 23445677788888777789999999999999887
Q ss_pred HHHhhc
Q 029154 143 AFLFTL 148 (198)
Q Consensus 143 ~~~~~~ 148 (198)
......
T Consensus 296 ~~~~~~ 301 (322)
T KOG1164|consen 296 DVFDSE 301 (322)
T ss_pred HHHHhc
Confidence 766544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.9e-13 Score=116.26 Aligned_cols=135 Identities=22% Similarity=0.260 Sum_probs=87.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccC----ccccc----ccCCCCccceeccccccccc--ccccccCC-CCchhh
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREE----TVTEM----MTAETGTYRWMAPELYSTVT--LRQGEKKH-YNNKVD 69 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~----~~~~~----~~~~~gt~~y~aPE~~~~~~--~~~~~~~~-~~~~~D 69 (198)
.|+|||.|||||..= +.+.|+||...+.. .+... +.+...-.+|.|||.+.... ........ .+++.|
T Consensus 142 cHGDIKsENILiTSW-NW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMD 220 (1431)
T KOG1240|consen 142 CHGDIKSENILITSW-NWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMD 220 (1431)
T ss_pred cccccccceEEEeee-chhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhh
Confidence 499999999999865 35899999877621 11111 12233345899999986521 11111222 578999
Q ss_pred HHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHcc-CCCC-C-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 029154 70 VYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKH-ARPG-L-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 140 (198)
Q Consensus 70 vws~G~~l~e~~~-g~~p~~~~~~~~~~~~~~~~~-~~~~-~-p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~ 140 (198)
|||+||++.|+++ |+++|. ..+........ ..+. + -..-+..+++++..|++.||++|.++++.|+-
T Consensus 221 IFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 221 IFSAGCVIAELFLEGRPLFT----LSQLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hhhhhHHHHHHHhcCCCccc----HHHHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 9999999999986 788884 22221111110 0000 0 01124578999999999999999999999875
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.6e-13 Score=106.33 Aligned_cols=144 Identities=31% Similarity=0.453 Sum_probs=96.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc---ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
.|+.|+..|.+++.. +.+||.|||+....... .......-..-|.|||.+....... .....+.+.|+||||+++
T Consensus 71 ~hg~l~s~nClvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~-~~~~~~~~gdiYs~~ii~ 148 (484)
T KOG1023|consen 71 YHGALKSSNCLVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQS-LESALTQKGDIYSFGIIM 148 (484)
T ss_pred eeeeeccccceeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccc-ccccccccCCeehHHHHH
Confidence 499999999999966 89999999998654321 1111112345799999986521111 011246789999999999
Q ss_pred HHHHcCCCCCCCCCcHH---HHHHHHHc-cCCCCCCC-----CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLTNRLPFEGMSNLQ---AAYAAAFK-HARPGLPE-----DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~---~~~~~~~~-~~~~~~p~-----~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+|+++...||....... ........ ...+..|. ...+++..++..||..+|.+||+++++-..+.....
T Consensus 149 ~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 149 YEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred HHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99999999997532211 12222222 22222221 355679999999999999999999999887765543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=8.1e-11 Score=85.49 Aligned_cols=138 Identities=20% Similarity=0.272 Sum_probs=94.6
Q ss_pred CCCCCCCCCeEEcCCC--CceEEecccCcccCccccc--------ccCCCCccceecccccccccccccccCCCCchhhH
Q 029154 1 MGKFMKEDNLLLTPDQ--KSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 70 (198)
Q Consensus 1 iH~dlKp~NIll~~~~--~~~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dv 70 (198)
|||||||+|.|..-+. ..+-++|||+++...+... -....||..|++-....+ ..-+.+-|+
T Consensus 133 iHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--------~eqSRRDDm 204 (341)
T KOG1163|consen 133 IHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--------IEQSRRDDM 204 (341)
T ss_pred ccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhh--------hhhhhhhhh
Confidence 7999999999997542 3477999999985433221 123468999988665432 234667899
Q ss_pred HHHHHHHHHHHcCCCCCCCCCcHHHH-HHHHHccCCC-----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 71 YSFGIVLWELLTNRLPFEGMSNLQAA-YAAAFKHARP-----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 71 ws~G~~l~e~~~g~~p~~~~~~~~~~-~~~~~~~~~~-----~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
=|+|.++...-.|..||++....... ....+..... .+...++.++...+.-|-...-.+-|...-+.+...-+
T Consensus 205 eSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 205 ESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred hhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 99999999888999999987743322 1111222222 22345788888889888888888889887776655544
Q ss_pred Hh
Q 029154 145 LF 146 (198)
Q Consensus 145 ~~ 146 (198)
+.
T Consensus 285 fr 286 (341)
T KOG1163|consen 285 FR 286 (341)
T ss_pred Hh
Confidence 43
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.1e-11 Score=103.16 Aligned_cols=132 Identities=29% Similarity=0.329 Sum_probs=97.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc----cccccCCCC-ccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV----TEMMTAETG-TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~----~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
.|||+||+|.+++.++...++.|||++..... .......+| ++.|++||...+ ........|+||+|+
T Consensus 146 ~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~-------~~~~~~~~d~~S~g~ 218 (601)
T KOG0590|consen 146 THRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSG-------KAYRGPSVDVWSLGI 218 (601)
T ss_pred ccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccc-------hhhcCCCcccccccc
Confidence 49999999999997732799999999974433 222344678 999999998753 234567899999999
Q ss_pred HHHHHHcCCCCCCCCCcHHHHHHHHHccC---CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 76 VLWELLTNRLPFEGMSNLQAAYAAAFKHA---RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
++..+++|..|+.........+....... .......++....+++.+++..+|..|.+.+++..
T Consensus 219 ~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 219 VLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 99999999999865443332222222221 12335568889999999999999999999888766
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.1e-10 Score=83.48 Aligned_cols=139 Identities=20% Similarity=0.305 Sum_probs=96.9
Q ss_pred CCCCCCCCCeEEcCC----CCceEEecccCcccCccccc--------ccCCCCccceecccccccccccccccCCCCchh
Q 029154 1 MGKFMKEDNLLLTPD----QKSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 68 (198)
Q Consensus 1 iH~dlKp~NIll~~~----~~~~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 68 (198)
|-|||||+|.||..- ...+-++|||+++...+... .+...||..||+-....+ ..-+.+-
T Consensus 146 IYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--------rEQSRRD 217 (449)
T KOG1165|consen 146 IYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--------REQSRRD 217 (449)
T ss_pred eecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeecccc--------chhhhhh
Confidence 569999999999753 23578999999985543321 234569999999776653 4557788
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCcH--HHHHHHHHccCCC----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 69 DVYSFGIVLWELLTNRLPFEGMSNL--QAAYAAAFKHARP----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 69 Dvws~G~~l~e~~~g~~p~~~~~~~--~~~~~~~~~~~~~----~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
|+=++|=+++..+.|..||+|.... ...+...-+..+. .+.+.++.++..-+.-.-.++-.+-|..+-+...+.
T Consensus 218 DLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~ 297 (449)
T KOG1165|consen 218 DLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFD 297 (449)
T ss_pred hHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 9999999999999999999987632 2222222111111 223457778877777666777778899887777766
Q ss_pred HHHhh
Q 029154 143 AFLFT 147 (198)
Q Consensus 143 ~~~~~ 147 (198)
+++..
T Consensus 298 dvldr 302 (449)
T KOG1165|consen 298 DVLDR 302 (449)
T ss_pred HHHHh
Confidence 66643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=8e-10 Score=79.88 Aligned_cols=81 Identities=19% Similarity=0.122 Sum_probs=54.7
Q ss_pred CCCCC-CCCCeEEcCCCCceEEecccCcccCccccc-----c--------cC-CCCccceecccccccccccccccCCCC
Q 029154 1 MGKFM-KEDNLLLTPDQKSLKLADFGLAREETVTEM-----M--------TA-ETGTYRWMAPELYSTVTLRQGEKKHYN 65 (198)
Q Consensus 1 iH~dl-Kp~NIll~~~~~~~kl~DfGla~~~~~~~~-----~--------~~-~~gt~~y~aPE~~~~~~~~~~~~~~~~ 65 (198)
||||| ||+|||++.+ +.++|+|||++........ . +. ..+++.|+.|+.-.. -...+
T Consensus 113 vHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~-------l~~~~ 184 (218)
T PRK12274 113 AHNDLAKEANWLVQED-GSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRV-------LKRTS 184 (218)
T ss_pred ccCCCCCcceEEEcCC-CCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhh-------hccch
Confidence 79999 7999999866 6799999999974332210 0 00 125667777764321 11223
Q ss_pred -chhhHHHHHHHHHHHHcCCCCCCC
Q 029154 66 -NKVDVYSFGIVLWELLTNRLPFEG 89 (198)
Q Consensus 66 -~~~Dvws~G~~l~e~~~g~~p~~~ 89 (198)
...++++.|+-+|.++|+..++.+
T Consensus 185 ~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 185 WIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hHHHHHHHhcchHHHHHhccCCccc
Confidence 345667889999999999887644
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.86 E-value=6.1e-09 Score=89.68 Aligned_cols=127 Identities=18% Similarity=0.221 Sum_probs=86.5
Q ss_pred CCCCCCCCCeEEcCC------CCceEEecccCcccC---cccccccCCCCccceecccccccccccccccCCCCchhhHH
Q 029154 1 MGKFMKEDNLLLTPD------QKSLKLADFGLAREE---TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 71 (198)
Q Consensus 1 iH~dlKp~NIll~~~------~~~~kl~DfGla~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvw 71 (198)
||+||||+|.||... ...++|+|||-+..+ .+...+...++|-.+-++|... ++..++..|.|
T Consensus 816 IHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~--------grpWtYq~Dyf 887 (974)
T KOG1166|consen 816 IHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMRE--------GRPWTYQIDYF 887 (974)
T ss_pred ecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhc--------CCCCchhhhhH
Confidence 899999999999542 235899999998633 3344566678888999999875 47889999999
Q ss_pred HHHHHHHHHHcCCCC-CCCCCcHHHHHHHHHccCCCCCCCCCcHHHH-HHHHHhcccCCCCC--CCHHHHHHHHHHHHh
Q 029154 72 SFGIVLWELLTNRLP-FEGMSNLQAAYAAAFKHARPGLPEDISPDLA-FIVQSCWVEDPNLR--PSFSQIIRMLNAFLF 146 (198)
Q Consensus 72 s~G~~l~e~~~g~~p-~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~-~l~~~~l~~dp~~R--ps~~~~l~~l~~~~~ 146 (198)
.++.+++-|+.|+.- +.+.. .......++..+..+++ .++..+|. |+.+ |...++...++.++.
T Consensus 888 GlAa~~h~mLFG~y~q~~~g~---------~~~~~~~~~Ry~~~~~W~~~F~~lLN--~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 888 GLAATVHVMLFGKYMEVKNGS---------SWMVKTNFPRYWKRDMWNKFFDLLLN--PDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred HHHHHHHHHHHHHHHHhcCCc---------ceeccccchhhhhHHHHHHHHHHHhC--cCcccchhHHHHHHHHHHHHH
Confidence 999999999988532 11000 00111113444555555 46677776 4444 677777777766654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.7e-09 Score=84.93 Aligned_cols=52 Identities=23% Similarity=0.217 Sum_probs=39.4
Q ss_pred CCCCC-CCCCeEEcCCCCceEEecccCcccCcccc---------cccCCCCccceeccccccc
Q 029154 1 MGKFM-KEDNLLLTPDQKSLKLADFGLAREETVTE---------MMTAETGTYRWMAPELYST 53 (198)
Q Consensus 1 iH~dl-Kp~NIll~~~~~~~kl~DfGla~~~~~~~---------~~~~~~gt~~y~aPE~~~~ 53 (198)
||||| ||+|||++.+ +.+||+|||+++...... ......+++.|++||.+..
T Consensus 133 iHrDL~KP~NILv~~~-~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 133 THNDLAKPQNWLMGPD-GEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eeCCCCCcceEEEcCC-CCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 69999 9999999866 679999999998443221 1134467888999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=7e-09 Score=88.81 Aligned_cols=126 Identities=25% Similarity=0.330 Sum_probs=92.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-------c---c----------------------ccccCCCCccceecc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-------V---T----------------------EMMTAETGTYRWMAP 48 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-------~---~----------------------~~~~~~~gt~~y~aP 48 (198)
+|+|+||.|+|+..+ ++.++.|||...... . . .......||+.|.+|
T Consensus 926 ~h~~~~p~~~l~~~~-gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laP 1004 (1205)
T KOG0606|consen 926 KHRDLKPDSLLIAYD-GHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAP 1004 (1205)
T ss_pred hcccccccchhhccc-CCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCC
Confidence 599999999999976 789999998432100 0 0 001224689999999
Q ss_pred cccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCC-CCCCCCCcHHHHHHHHHhcccC
Q 029154 49 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR-PGLPEDISPDLAFIVQSCWVED 127 (198)
Q Consensus 49 E~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~l~~~~l~~d 127 (198)
|...+ ......+|+|++|++++|.++|.+||....+.+........... +.-+...+++.++++.+.+..+
T Consensus 1005 e~~lg--------~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~ 1076 (1205)
T KOG0606|consen 1005 EILLG--------RRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEE 1076 (1205)
T ss_pred ccccc--------ccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccC
Confidence 99865 45577889999999999999999999877664443222211122 2335668899999999999999
Q ss_pred CCCCCCHH
Q 029154 128 PNLRPSFS 135 (198)
Q Consensus 128 p~~Rps~~ 135 (198)
+.+|..+.
T Consensus 1077 ~~qr~~a~ 1084 (1205)
T KOG0606|consen 1077 PTQRLGAK 1084 (1205)
T ss_pred chhccCcc
Confidence 99996655
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.5e-09 Score=92.18 Aligned_cols=68 Identities=24% Similarity=0.272 Sum_probs=49.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.+ +.+||+|||+++...... .....++|+.|++||.... ...-...+++|++|+-
T Consensus 126 iHrDLKP~NILl~~~-g~vkL~DFGls~~~~~~~~~~~~~~~t~~~~~pe~~~~-------~~~~~~~s~~~s~g~~ 194 (669)
T cd05610 126 IHRDLKPDNMLISNE-GHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYS-------RTPGQVLSLISSLGFN 194 (669)
T ss_pred EeCCccHHHEEEcCC-CCEEEEeCCCCccccCCcccccccccCccccCcccccc-------CCCCceeeeeeecCcC
Confidence 699999999999976 689999999998543322 2334678999999997532 1222345677888743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.1e-09 Score=78.12 Aligned_cols=59 Identities=17% Similarity=0.281 Sum_probs=40.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|||+||+||+++.+ + ++|+|||..+......... . .+. ...|..++|+|+||+++.-.
T Consensus 157 ~H~Dikp~Nili~~~-g-i~liDfg~~~~~~e~~a~d------~-----~vl--------er~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 157 VSGDPHKGNFIVSKN-G-LRIIDLSGKRCTAQRKAKD------R-----IDL--------ERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred ccCCCChHHEEEeCC-C-EEEEECCCcccccchhhHH------H-----HHH--------HhHhcccccccceeEeehHH
Confidence 699999999999866 5 9999999876432211110 0 111 24456789999999877644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.52 E-value=8e-08 Score=77.83 Aligned_cols=128 Identities=23% Similarity=0.221 Sum_probs=87.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccc------cCCCCccceecccccccccccccccCCCCchhhHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMM------TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 74 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G 74 (198)
+|-|+||+||++..+....++.|||+.......... ...-|...|++||... .-++...|++++|
T Consensus 244 ~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~---------~l~~~~~di~sl~ 314 (524)
T KOG0601|consen 244 VHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN---------GLATFASDIFSLG 314 (524)
T ss_pred cccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc---------cccchHhhhcchh
Confidence 589999999999976467899999998755433211 1124667899999974 4678899999999
Q ss_pred HHHHHHHcCCCCCCCCCcHHHHHHHHHc-cCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 75 IVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 75 ~~l~e~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
.++.+..++...+....... +..... ..+.++....+..+...+..++..++..|++++.+..
T Consensus 315 ev~l~~~l~~~~~~~g~~~~--W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 315 EVILEAILGSHLPSVGKNSS--WSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred hhhHhhHhhcccccCCCCCC--ccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 99999988776554331100 000000 1222233345566777888999999999999887665
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=6.5e-08 Score=79.80 Aligned_cols=130 Identities=13% Similarity=0.266 Sum_probs=87.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccccc-----C-----CCCccceecccccccccccccccCCCCchhhH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMT-----A-----ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 70 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~-----~-----~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dv 70 (198)
||++|.|++|.++.+ +.+||+.|+++........+. . ..-...|.+||++.. ...+.++|+
T Consensus 122 VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~--------~~~~~~sd~ 192 (700)
T KOG2137|consen 122 VHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG--------TTNTPASDV 192 (700)
T ss_pred eecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc--------ccccccccc
Confidence 799999999999977 679999999886443321111 1 123457999999854 345789999
Q ss_pred HHHHHHHHHHH-cCCCCCCCCCcHHHH--HHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 71 YSFGIVLWELL-TNRLPFEGMSNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 71 ws~G~~l~e~~-~g~~p~~~~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+|+|+.+|.+. .|+.-+.+....... ...............++.++.+-+.+++..+..-||++..+..
T Consensus 193 fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 193 FSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred eeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 99999999988 455544433221110 0111111112234568899999999999999999997776655
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=4.4e-06 Score=66.07 Aligned_cols=141 Identities=19% Similarity=0.352 Sum_probs=90.4
Q ss_pred CCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHc
Q 029154 3 KFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 82 (198)
Q Consensus 3 ~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~ 82 (198)
+|+.++|+|+.++ ..+.|.|--......+...+...+|...|.+||...-.+ +....-+...|.|.+|+++++++.
T Consensus 141 GDVn~~~~lVsd~-~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~s---f~g~~r~~~hD~FGLavLiF~lL~ 216 (637)
T COG4248 141 GDVNQNSFLVSDD-SKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPS---FVGFERTANHDNFGLAVLIFHLLF 216 (637)
T ss_pred cccCccceeeecC-ceEEEEcccceeeccCCceEecccCccccCCHHHhcccc---ccccCCCccccchhHHHHHHHHHh
Confidence 7999999999966 568887643322223344455678999999999864211 122344678899999999999986
Q ss_pred C-CCCCCCCCc-------HH-HH------HHHHHc-cCCC---CCC-CCCcHHHHHHHHHhcccC--CCCCCCHHHHHHH
Q 029154 83 N-RLPFEGMSN-------LQ-AA------YAAAFK-HARP---GLP-EDISPDLAFIVQSCWVED--PNLRPSFSQIIRM 140 (198)
Q Consensus 83 g-~~p~~~~~~-------~~-~~------~~~~~~-~~~~---~~p-~~~~~~~~~l~~~~l~~d--p~~Rps~~~~l~~ 140 (198)
| +.||.|..- .. +. +..... +..+ ..| ..+++++..+..+|+... +.-||+++..+..
T Consensus 217 ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aA 296 (637)
T COG4248 217 GGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAA 296 (637)
T ss_pred cCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Confidence 5 899976431 11 00 000000 1111 112 236889999999998654 4589999987777
Q ss_pred HHHHHhh
Q 029154 141 LNAFLFT 147 (198)
Q Consensus 141 l~~~~~~ 147 (198)
|...-..
T Consensus 297 l~al~~~ 303 (637)
T COG4248 297 LDALRQQ 303 (637)
T ss_pred HHHHHHh
Confidence 6555443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.02 E-value=4e-06 Score=62.56 Aligned_cols=28 Identities=29% Similarity=0.392 Sum_probs=24.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLARE 29 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~ 29 (198)
+||||||+|||++.+ +.++|+|||.+..
T Consensus 164 ~HrDlkp~NILv~~~-~~v~LIDfg~~~~ 191 (239)
T PRK01723 164 YHADLNAHNILLDPD-GKFWLIDFDRGEL 191 (239)
T ss_pred CCCCCCchhEEEcCC-CCEEEEECCCccc
Confidence 699999999999876 5799999998754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.9e-06 Score=68.26 Aligned_cols=128 Identities=21% Similarity=0.177 Sum_probs=82.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCcccee-cccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+|+||+||++..+++..++.|||......... ....+.-.+. ..|.+. +...+..+.|+++||..+.+
T Consensus 388 ~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~--~~~~~~~r~~p~~~~~~-------e~~~~~~~~~~~sl~~~~~e 458 (524)
T KOG0601|consen 388 VHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS--GVFHHIDRLYPIAEILL-------EDYPHLSKADIFSLGLSVDE 458 (524)
T ss_pred hcccccccceeeccchhhhhccccccccccceec--ccccccccccccchhhc-------cccccccccccccccccccc
Confidence 6999999999999765668899999875322111 1112222333 244433 24566789999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
..++...-..... ......+..+..+... .++..+...+...++..||.+.++..+.+
T Consensus 459 ~~~~~~ls~~~~~----~~~i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 459 AITGSPLSESGVQ----SLTIRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred cccCcccCccccc----ceeeecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 9988653322121 1111222233333333 78888999999999999999988776544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=97.87 E-value=7.2e-06 Score=61.11 Aligned_cols=27 Identities=22% Similarity=0.279 Sum_probs=23.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLARE 29 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~ 29 (198)
+||||||+||+++ + +.++|+|||.+..
T Consensus 171 iH~Dikp~NIli~-~-~~i~LiDFg~a~~ 197 (237)
T smart00090 171 VHGDLSEYNILVH-D-GKVVIIDVSQSVE 197 (237)
T ss_pred EeCCCChhhEEEE-C-CCEEEEEChhhhc
Confidence 6999999999998 4 5799999998764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.77 E-value=1.2e-05 Score=58.76 Aligned_cols=27 Identities=15% Similarity=-0.057 Sum_probs=21.2
Q ss_pred CCCCCCCCCeEEcCC---CCceEEecccCc
Q 029154 1 MGKFMKEDNLLLTPD---QKSLKLADFGLA 27 (198)
Q Consensus 1 iH~dlKp~NIll~~~---~~~~kl~DfGla 27 (198)
|||||||+|||++.. ...++|+||+-+
T Consensus 127 vhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 127 VTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred eecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 699999999999743 236999995443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=97.62 E-value=2.5e-05 Score=65.06 Aligned_cols=27 Identities=30% Similarity=0.507 Sum_probs=23.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLARE 29 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~ 29 (198)
|||||||+|||++ + +.++|+|||+++.
T Consensus 450 iHrDlkp~NILl~-~-~~~~liDFGla~~ 476 (535)
T PRK09605 450 VHGDLTTSNFIVR-D-DRLYLIDFGLGKY 476 (535)
T ss_pred ccCCCChHHEEEE-C-CcEEEEeCccccc
Confidence 7999999999995 4 5699999999864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.56 E-value=5.8e-05 Score=54.97 Aligned_cols=27 Identities=30% Similarity=0.469 Sum_probs=23.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLARE 29 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~ 29 (198)
+|+|++|+|||++ + +.++|+|||+++.
T Consensus 117 ~H~Dl~p~Nil~~-~-~~~~liDf~~a~~ 143 (211)
T PRK14879 117 IHGDLTTSNMILS-G-GKIYLIDFGLAEF 143 (211)
T ss_pred ccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence 6999999999998 4 5699999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=97.54 E-value=6e-05 Score=54.40 Aligned_cols=27 Identities=30% Similarity=0.520 Sum_probs=23.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLARE 29 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~ 29 (198)
+|+|+||+||+++ + +.+++.|||+++.
T Consensus 112 ~H~Dl~~~Nil~~-~-~~~~liDfg~a~~ 138 (199)
T TIGR03724 112 VHGDLTTSNIIVR-D-DKLYLIDFGLGKY 138 (199)
T ss_pred ecCCCCcceEEEE-C-CcEEEEECCCCcC
Confidence 6999999999998 4 6799999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=97.48 E-value=8.8e-05 Score=51.97 Aligned_cols=26 Identities=31% Similarity=0.310 Sum_probs=22.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|++|.||+++ + +.++++|||.+.
T Consensus 110 ~HgD~~~~Nil~~-~-~~~~liDf~~a~ 135 (170)
T cd05151 110 CHNDLLPGNFLLD-D-GRLWLIDWEYAG 135 (170)
T ss_pred ecCCCCcCcEEEE-C-CeEEEEeccccc
Confidence 6999999999998 4 469999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0001 Score=59.84 Aligned_cols=30 Identities=17% Similarity=0.314 Sum_probs=25.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET 31 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~ 31 (198)
+|+|+||.||+++.+ +.++++|||++....
T Consensus 279 ~H~D~hPgNilv~~~-g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKD-GKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence 699999999999866 679999999986543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.00039 Score=53.55 Aligned_cols=126 Identities=15% Similarity=0.178 Sum_probs=72.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCccc-----CcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLARE-----ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~-----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
||+++...-|++..+ +-+|+.--..... ...........+-++|.+||.=. .-..+..+|||+||+
T Consensus 200 ihgnlTc~tifiq~n-gLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~--------~tn~~~a~dIy~fgm 270 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHN-GLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT--------TTNTTGASDIYKFGM 270 (458)
T ss_pred ccCCcchhheeecCC-ceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc--------ccccccchhhhhhhH
Confidence 699999999999865 5455542111110 00000111234567888888632 133467899999999
Q ss_pred HHHHHHcCCCC-CCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 029154 76 VLWELLTNRLP-FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 140 (198)
Q Consensus 76 ~l~e~~~g~~p-~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~ 140 (198)
+..+|..+..- -.+........... . ..-..-.+.-++++.+|+.-.|..||++.+++.+
T Consensus 271 cAlemailEiq~tnseS~~~~ee~ia--~---~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 271 CALEMAILEIQSTNSESKVEVEENIA--N---VIIGLENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHHHHHHheeccCCCcceeehhhhhh--h---heeeccCccccCcCcccccCCCCCCcchhhhhcC
Confidence 99999876542 22111111000000 0 0001112334678899999999999999988764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.00025 Score=58.80 Aligned_cols=31 Identities=19% Similarity=0.280 Sum_probs=25.8
Q ss_pred CCCCCCCCCeEEcCCC---CceEEecccCcccCc
Q 029154 1 MGKFMKEDNLLLTPDQ---KSLKLADFGLAREET 31 (198)
Q Consensus 1 iH~dlKp~NIll~~~~---~~~kl~DfGla~~~~ 31 (198)
+|+|+||.||+++.++ +.+++.|||+.....
T Consensus 282 fHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 282 FHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred eeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 6999999999998763 279999999987543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0006 Score=48.44 Aligned_cols=27 Identities=22% Similarity=0.400 Sum_probs=23.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLARE 29 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~ 29 (198)
||+||.++||++..+ .+.++|||++..
T Consensus 114 vHGDLTtsNiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 114 VHGDLTTSNIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred ecCCCccceEEEeCC--cEEEEECCcccc
Confidence 799999999999854 399999999863
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.00063 Score=48.37 Aligned_cols=29 Identities=31% Similarity=0.501 Sum_probs=24.4
Q ss_pred CCCCCCCCCeEEcCCCCce--EEecccCccc
Q 029154 1 MGKFMKEDNLLLTPDQKSL--KLADFGLARE 29 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~--kl~DfGla~~ 29 (198)
||+||..+||+|..++..+ -++|||++..
T Consensus 135 iHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 135 IHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ecccccccceEEecCCCcCceEEEeecchhc
Confidence 7999999999998776554 7999999753
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.0011 Score=60.79 Aligned_cols=78 Identities=14% Similarity=0.198 Sum_probs=62.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc-cCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|++||+-|.+|..+ ..+|++++|+.+ ........+...+++.|+.+++.+. -.++.++|+|..++.+|+
T Consensus 1362 v~~~Lkf~lpmIVtn-y~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~--------ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1362 VSKSLKFTLPMIVTN-YNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE--------IKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred hhhhhhhhccceecC-CcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH--------HhhhhHHHHHHHHHHHHH
Confidence 589999999999866 679999999998 3333344556678889999988642 456777999999999999
Q ss_pred HHcCCCCC
Q 029154 80 LLTNRLPF 87 (198)
Q Consensus 80 ~~~g~~p~ 87 (198)
...|..+|
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 88777665
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.0076 Score=45.81 Aligned_cols=28 Identities=18% Similarity=0.097 Sum_probs=23.1
Q ss_pred CCCCCCCCCeEEcC------CCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTP------DQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~------~~~~~kl~DfGla~ 28 (198)
+|+||++.|||++. +...+.++||+.++
T Consensus 160 ~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 160 NHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred ccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 69999999999974 13568999999774
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.0069 Score=43.49 Aligned_cols=27 Identities=26% Similarity=0.393 Sum_probs=20.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLARE 29 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~ 29 (198)
||+||.+.|||++.+ .+.|+|||-+..
T Consensus 129 vHGDLs~~NIlv~~~--~~~iIDf~qav~ 155 (188)
T PF01163_consen 129 VHGDLSEYNILVDDG--KVYIIDFGQAVD 155 (188)
T ss_dssp EESS-STTSEEEETT--CEEE--GTTEEE
T ss_pred eecCCChhhEEeecc--eEEEEecCccee
Confidence 699999999999955 599999997643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.012 Score=42.89 Aligned_cols=29 Identities=24% Similarity=0.317 Sum_probs=23.6
Q ss_pred CCCCCCCCCeEEcCCC--CceEEecccCccc
Q 029154 1 MGKFMKEDNLLLTPDQ--KSLKLADFGLARE 29 (198)
Q Consensus 1 iH~dlKp~NIll~~~~--~~~kl~DfGla~~ 29 (198)
+|+|+++.|||++.++ ..+.++||+-++.
T Consensus 140 ~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 140 YHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred CCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 6999999999999763 2588999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.011 Score=43.31 Aligned_cols=28 Identities=21% Similarity=0.366 Sum_probs=17.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
||+|+.|.|||++.+++.+-|+||+.+.
T Consensus 169 ~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 169 IHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp E-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred EEeccccccceeeeccceeEEEecccce
Confidence 6999999999999433555799998653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.02 Score=44.49 Aligned_cols=27 Identities=26% Similarity=0.296 Sum_probs=22.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
||+|+.+.|||++.+ ...-|+||+.+.
T Consensus 190 iHgD~~~~Nil~~~~-~~~~iIDf~~~~ 216 (319)
T PRK05231 190 IHADLFRDNVLFEGD-RLSGFIDFYFAC 216 (319)
T ss_pred CCCCCCCCcEEEECC-ceEEEEeccccc
Confidence 799999999999854 445799999764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.90 E-value=0.025 Score=41.84 Aligned_cols=28 Identities=18% Similarity=0.337 Sum_probs=23.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+.+.|||++.+++.+.++||-.+.
T Consensus 173 ~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 173 CHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 5999999999999622569999998664
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=94.89 E-value=0.023 Score=42.21 Aligned_cols=27 Identities=22% Similarity=0.289 Sum_probs=22.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+.+.|||++.+ +..-|+||+.+.
T Consensus 167 ~HGD~~~~Nvlv~~~-~i~giIDw~~a~ 193 (235)
T cd05155 167 FHGDLAPGNLLVQDG-RLSAVIDFGCLG 193 (235)
T ss_pred EeCCCCCCcEEEECC-CEEEEEeCcccC
Confidence 699999999999854 445699999763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.75 E-value=0.03 Score=40.09 Aligned_cols=27 Identities=22% Similarity=0.349 Sum_probs=22.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLARE 29 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~ 29 (198)
.|+|+.|+||++..+ + ++|+||+.+..
T Consensus 80 ~H~D~~~~N~~~~~~-~-~~lIDwe~a~~ 106 (188)
T PRK10271 80 LHMDVHAGNLVHSAS-G-LRLIDWEYAGD 106 (188)
T ss_pred ecCCCCCccEEEECC-C-EEEEeCCcccC
Confidence 599999999999855 4 89999998753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.53 E-value=0.032 Score=43.03 Aligned_cols=28 Identities=36% Similarity=0.425 Sum_probs=23.2
Q ss_pred CCCCCCCCCeEEcCC---CCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPD---QKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~---~~~~kl~DfGla~ 28 (198)
+|+|+.+.|||++.+ .+.+.++||..+.
T Consensus 182 cH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 182 CHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred EecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 599999999999863 2468999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=94.44 E-value=0.035 Score=41.35 Aligned_cols=27 Identities=19% Similarity=0.145 Sum_probs=22.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+.|.|||++.+ +.+.|+||+.+.
T Consensus 166 ~HgD~~~~Nil~~~~-~~~~iIDwe~a~ 192 (244)
T cd05150 166 THGDACLPNIIVDPG-KFSGFIDLGRLG 192 (244)
T ss_pred ECCCCCCccEEEeCC-cEEEEEEccccc
Confidence 699999999999965 557899998663
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.38 Score=40.86 Aligned_cols=72 Identities=14% Similarity=0.178 Sum_probs=47.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc-ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|++|.-+.|+++.+ +..||++|-++........ .....--..|..|+.+.. -.-..|.|.|||+++|
T Consensus 127 vHgNv~~~SVfVn~~-GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~----------s~~s~D~~~Lg~li~e 195 (690)
T KOG1243|consen 127 VHGNVCKDSVFVNES-GEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP----------SEWSIDSWGLGCLIEE 195 (690)
T ss_pred eeccEeeeeEEEcCC-CcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc----------cccchhhhhHHHHHHH
Confidence 699999999999977 7799999987653322111 111111223555654421 1134699999999999
Q ss_pred HHcC
Q 029154 80 LLTN 83 (198)
Q Consensus 80 ~~~g 83 (198)
++.|
T Consensus 196 l~ng 199 (690)
T KOG1243|consen 196 LFNG 199 (690)
T ss_pred HhCc
Confidence 9998
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.40 E-value=0.031 Score=42.70 Aligned_cols=28 Identities=18% Similarity=0.292 Sum_probs=22.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
||+|+.+.|||++.++...-|.||+.+.
T Consensus 188 vHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 188 VHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred EeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 6999999999998643345699999764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.27 E-value=0.034 Score=43.87 Aligned_cols=28 Identities=11% Similarity=0.358 Sum_probs=23.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
.|+|+++.|||++.+.+.+.++||..+.
T Consensus 203 cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 203 CHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred EeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 4999999999998644579999998765
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.22 E-value=0.045 Score=42.40 Aligned_cols=26 Identities=27% Similarity=0.304 Sum_probs=22.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLA 27 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla 27 (198)
+|+|+.+.||+++.+ +.+.|+||+.+
T Consensus 190 ~HgD~~~~Nvl~~~~-~~~~vIDfd~~ 215 (307)
T TIGR00938 190 IHADLFPDNVLFDGD-SVKGVIDFYFA 215 (307)
T ss_pred CCCCCCcCcEEEECC-ceEEEeecccc
Confidence 799999999999866 44679999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=94.18 E-value=0.033 Score=41.21 Aligned_cols=26 Identities=15% Similarity=0.079 Sum_probs=22.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+.|.||+++.+ + +.|+||+.+.
T Consensus 156 ~HgD~~~~Nii~~~~-~-~~iIDwe~a~ 181 (226)
T TIGR02172 156 LHGDFQIGNLITSGK-G-TYWIDLGDFG 181 (226)
T ss_pred EecCCCCCcEEEcCC-C-cEEEechhcC
Confidence 599999999999865 4 8999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=93.96 E-value=0.046 Score=41.11 Aligned_cols=26 Identities=35% Similarity=0.466 Sum_probs=22.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+.|.||+++.+ + +.|+||..+.
T Consensus 149 ~H~Dl~~~Nil~~~~-~-~~lIDwE~a~ 174 (256)
T TIGR02721 149 LHMDVHAYNLVVTPQ-G-LKLIDWEYAS 174 (256)
T ss_pred ecCCCCcCcEEEeCC-C-CEEEeccccC
Confidence 599999999999865 4 7899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.88 E-value=0.022 Score=47.99 Aligned_cols=73 Identities=22% Similarity=0.221 Sum_probs=55.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+| ||+... +..|..||+............+..+++.|++||+... ..+....|.|+.+.--.++
T Consensus 358 ~~~d----~~l~s~--~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~--------~~~~~~p~~~~~~~~~~~~ 423 (829)
T KOG0576|consen 358 VHRD----NILGSE--EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQE--------NTIDGCPDSGSLAVSAIQM 423 (829)
T ss_pred cCcc----cccccc--cccccccccCCcccCcccccccCCCCCCCCCchhhcc--------cccccCCCccCCCcchhhc
Confidence 3565 888874 4589999999876554444556789999999998753 5677888999999877777
Q ss_pred HcCCCCC
Q 029154 81 LTNRLPF 87 (198)
Q Consensus 81 ~~g~~p~ 87 (198)
.-|.+|-
T Consensus 424 ap~~pPr 430 (829)
T KOG0576|consen 424 APGLPPR 430 (829)
T ss_pred CCCCCCC
Confidence 7666654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=93.87 E-value=0.048 Score=41.87 Aligned_cols=27 Identities=26% Similarity=0.277 Sum_probs=22.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+.|.|||++.+ +.+.|.||+.+.
T Consensus 178 ~HgD~~~~Nil~~~~-~~~~iIDfe~a~ 204 (296)
T cd05153 178 IHADLFRDNVLFDGD-ELSGVIDFYFAC 204 (296)
T ss_pred CccCcCcccEEEeCC-ceEEEeehhhhc
Confidence 699999999999965 446799998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.77 E-value=0.05 Score=42.66 Aligned_cols=28 Identities=25% Similarity=0.304 Sum_probs=23.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
||+|+-|.||+++.+...+.+.||+-+.
T Consensus 200 IH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 200 IHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eecCCCccceeEcCCCCeeeEEEccccc
Confidence 7999999999999763347899999764
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.75 E-value=0.038 Score=40.27 Aligned_cols=27 Identities=26% Similarity=0.397 Sum_probs=16.8
Q ss_pred CCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 2 GKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 2 H~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
|.|+.+.|||++...+.++++||-.+.
T Consensus 147 HnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 147 HNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp -S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eccCccccEEeccCCCeEEEecHHHHh
Confidence 999999999993333679999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=92.94 E-value=0.089 Score=38.00 Aligned_cols=28 Identities=21% Similarity=0.347 Sum_probs=22.5
Q ss_pred CCCCCCCCCeEEcCCCC----ceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQK----SLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~----~~kl~DfGla~ 28 (198)
+|+|+.+.||++..++. .+.+.||..++
T Consensus 123 ~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 123 NHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 59999999999975422 58899998764
|
subfamily of choline kinases |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=92.41 E-value=0.11 Score=40.68 Aligned_cols=27 Identities=26% Similarity=0.374 Sum_probs=23.2
Q ss_pred CCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 2 GKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 2 H~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
|.|+-+.|||++.+++.++++||..|.
T Consensus 186 HnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 186 HNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred ECCCCcccEEEeCCCCcEEEEcccccC
Confidence 999999999997554679999998774
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=91.99 E-value=0.071 Score=43.50 Aligned_cols=15 Identities=27% Similarity=0.410 Sum_probs=13.3
Q ss_pred CCCCCCCCCeEEcCC
Q 029154 1 MGKFMKEDNLLLTPD 15 (198)
Q Consensus 1 iH~dlKp~NIll~~~ 15 (198)
||.||||+||||..+
T Consensus 210 IHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 210 IHTDLKPENVLLCST 224 (590)
T ss_pred cccCCCcceeeeecc
Confidence 799999999999754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=91.55 E-value=0.21 Score=36.89 Aligned_cols=26 Identities=15% Similarity=0.185 Sum_probs=22.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
.|+|..|.|+++..+ .+++.||+..+
T Consensus 157 ~HGD~hpgNFlv~~~--~i~iID~~~k~ 182 (229)
T PF06176_consen 157 YHGDPHPGNFLVSNN--GIRIIDTQGKR 182 (229)
T ss_pred ccCCCCcCcEEEECC--cEEEEECcccc
Confidence 599999999999854 49999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.09 E-value=0.16 Score=39.81 Aligned_cols=16 Identities=25% Similarity=0.362 Sum_probs=13.5
Q ss_pred CCCCCCCCCeEEcCCC
Q 029154 1 MGKFMKEDNLLLTPDQ 16 (198)
Q Consensus 1 iH~dlKp~NIll~~~~ 16 (198)
+|-||||+|||+-.+.
T Consensus 305 ~H~DLKPdNILiFds~ 320 (444)
T PHA03111 305 LHVDLKPDNILIFDSD 320 (444)
T ss_pred eeccCCCCcEEEecCC
Confidence 6999999999996553
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.78 E-value=0.19 Score=41.74 Aligned_cols=75 Identities=15% Similarity=0.134 Sum_probs=44.3
Q ss_pred CchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCC----------CCCCCCcHHHHHHHHHhcccCCCCCCCH
Q 029154 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP----------GLPEDISPDLAFIVQSCWVEDPNLRPSF 134 (198)
Q Consensus 65 ~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~----------~~p~~~~~~~~~l~~~~l~~dp~~Rps~ 134 (198)
.+|+||||+|.++.++.-|...+..................+ .+--.++.....+...|+-..|..||..
T Consensus 109 ~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~ 188 (725)
T KOG1093|consen 109 GPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP 188 (725)
T ss_pred CcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccch
Confidence 369999999999999988876664333222111110000000 0011245566778888998889888865
Q ss_pred HHHHH
Q 029154 135 SQIIR 139 (198)
Q Consensus 135 ~~~l~ 139 (198)
.++.+
T Consensus 189 ~~~~k 193 (725)
T KOG1093|consen 189 MELSK 193 (725)
T ss_pred hHHhc
Confidence 55443
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=90.78 E-value=0.18 Score=39.75 Aligned_cols=15 Identities=27% Similarity=0.366 Sum_probs=13.0
Q ss_pred CCCCCCCCCeEEcCC
Q 029154 1 MGKFMKEDNLLLTPD 15 (198)
Q Consensus 1 iH~dlKp~NIll~~~ 15 (198)
+|-||||+|||+-.+
T Consensus 301 ~H~DLKPdNILiFds 315 (434)
T PF05445_consen 301 LHVDLKPDNILIFDS 315 (434)
T ss_pred eecccCcCcEEEecC
Confidence 699999999999644
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.76 E-value=0.21 Score=38.96 Aligned_cols=28 Identities=21% Similarity=0.358 Sum_probs=24.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLARE 29 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~ 29 (198)
+|+|+.+.||+++.+ +-+-|.||+++..
T Consensus 201 vHGD~~~gNlii~~~-~~~gVlDwe~~~l 228 (321)
T COG3173 201 VHGDYRPGNLIIDPG-RPTGVLDWELATL 228 (321)
T ss_pred eeCCcccCCEEEeCC-CeeEEEecccccc
Confidence 699999999999976 4488999998864
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.71 E-value=0.22 Score=41.54 Aligned_cols=30 Identities=23% Similarity=0.344 Sum_probs=25.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET 31 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~ 31 (198)
+|.|..|.||+++.+ +.+.+.|||+.....
T Consensus 287 fHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~ 316 (517)
T COG0661 287 FHADPHPGNILVRSD-GRIVLLDFGIVGRLD 316 (517)
T ss_pred cccCCCccceEEecC-CcEEEEcCcceecCC
Confidence 599999999999977 679999999986443
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=90.50 E-value=0.22 Score=38.47 Aligned_cols=26 Identities=19% Similarity=0.253 Sum_probs=21.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+.+.||+++. +.+.|.||+.+.
T Consensus 190 iHgD~~~~Nil~~~--~~i~lIDfd~~~ 215 (313)
T TIGR02906 190 CHQDYAYHNILLKD--NEVYVIDFDYCT 215 (313)
T ss_pred EcCCCCcccEEEeC--CcEEEEECcccc
Confidence 69999999999985 347899998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=90.12 E-value=0.29 Score=37.27 Aligned_cols=27 Identities=33% Similarity=0.340 Sum_probs=23.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
.|.|+.|+|+|++.. +.++|+||--|.
T Consensus 156 cH~Dl~~~N~l~t~~-~~l~LIDWEyAg 182 (269)
T COG0510 156 CHNDLNPGNLLLTDK-GGLFLIDWEYAG 182 (269)
T ss_pred ecCCCCccceEEcCC-CcEEEEecccCC
Confidence 499999999999964 569999997665
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=90.11 E-value=0.23 Score=37.81 Aligned_cols=26 Identities=27% Similarity=0.318 Sum_probs=22.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLA 27 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla 27 (198)
||+|+.+=||+++.+ +.+.++||-=+
T Consensus 224 VHGDlSefNIlV~~d-g~~~vIDwPQ~ 249 (304)
T COG0478 224 VHGDLSEFNILVTED-GDIVVIDWPQA 249 (304)
T ss_pred cccCCchheEEEecC-CCEEEEeCccc
Confidence 799999999999977 56999999643
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=90.09 E-value=0.2 Score=39.92 Aligned_cols=26 Identities=31% Similarity=0.534 Sum_probs=23.9
Q ss_pred CCCCCCCCeEEcCCCCceEEecccCccc
Q 029154 2 GKFMKEDNLLLTPDQKSLKLADFGLARE 29 (198)
Q Consensus 2 H~dlKp~NIll~~~~~~~kl~DfGla~~ 29 (198)
|||+.-.||||+ + |++.|+||-++|.
T Consensus 345 hrnlt~~niLId-~-GnvtLIDfklsRl 370 (488)
T COG5072 345 HRNLTLDNILID-E-GNVTLIDFKLSRL 370 (488)
T ss_pred cccccccceeee-c-CceEEEEeeeeec
Confidence 999999999999 5 6799999999984
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=89.93 E-value=0.23 Score=40.03 Aligned_cols=26 Identities=15% Similarity=0.204 Sum_probs=22.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+.+.||++..+ .++++||-++.
T Consensus 226 ~HgDl~~gni~~~~~--~~~viD~E~a~ 251 (401)
T PRK09550 226 LHGDLHTGSIFVTEE--ETKVIDPEFAF 251 (401)
T ss_pred eeccCCcccEEeeCC--CcEEEeccccc
Confidence 699999999999855 48999997664
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=88.85 E-value=0.34 Score=43.93 Aligned_cols=28 Identities=29% Similarity=0.433 Sum_probs=22.4
Q ss_pred CCCCCCCCCeEEcCCC-Cce-EEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQ-KSL-KLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~-~~~-kl~DfGla~ 28 (198)
||.|+.+.|||++.+. +.+ -|+|||-+.
T Consensus 206 IHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 206 IHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred ECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 7999999999998653 134 499999875
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=88.68 E-value=0.25 Score=37.94 Aligned_cols=28 Identities=32% Similarity=0.401 Sum_probs=22.5
Q ss_pred CCCCCCCCCeEEcCCCC----ceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQK----SLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~----~~kl~DfGla~ 28 (198)
+|+|++..|||+..++. .+++.||-+++
T Consensus 218 ~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 218 CHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EcCccCHHhEeEccccccccccceeecccccc
Confidence 59999999999976532 48899998764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=87.99 E-value=0.32 Score=36.14 Aligned_cols=59 Identities=19% Similarity=0.103 Sum_probs=38.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+|..|+||+-++. +.+||.|=+.-.. .+..|..-| ....+.++.+-+|-..++++
T Consensus 165 lHGD~np~NiM~D~~-G~lKlVDP~~Ll~-----------~~V~~vN~~-----------Y~~lT~~aE~~~fv~s~l~~ 221 (308)
T PF07387_consen 165 LHGDCNPDNIMCDKF-GYLKLVDPVCLLE-----------NQVNMVNIE-----------YESLTQEAEVKVFVKSCLKL 221 (308)
T ss_pred ecCCCChhheeecCC-CCEEecChhhhhh-----------heeeEEeee-----------ccccChHHHHHHHHHHHHHH
Confidence 699999999999987 6699999663211 112233312 13346677777776666666
Q ss_pred Hc
Q 029154 81 LT 82 (198)
Q Consensus 81 ~~ 82 (198)
+.
T Consensus 222 v~ 223 (308)
T PF07387_consen 222 VE 223 (308)
T ss_pred HH
Confidence 54
|
The function of this family is unknown. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=87.61 E-value=0.52 Score=38.00 Aligned_cols=26 Identities=19% Similarity=0.203 Sum_probs=22.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
||+||.|.||+++.+ .+|++|.-++-
T Consensus 230 lHGDlHtGSI~v~~~--~~kvIDpEFAf 255 (409)
T PRK12396 230 IHGDLHTGSVFVKND--STKVIDPEFAF 255 (409)
T ss_pred ccCcCCCCCEEecCC--ceEEEcccccc
Confidence 799999999999965 48999977653
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=87.25 E-value=0.5 Score=42.73 Aligned_cols=28 Identities=21% Similarity=0.216 Sum_probs=22.2
Q ss_pred CCCCCCCCCeEEcCCC-C---ceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQ-K---SLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~-~---~~kl~DfGla~ 28 (198)
||.|+.+.|||++.+. + ..-|+|||-+.
T Consensus 211 IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 211 VHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred cCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 7999999999998652 1 23689999764
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=86.87 E-value=0.47 Score=37.77 Aligned_cols=26 Identities=12% Similarity=0.166 Sum_probs=21.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+||-+.||++..+ .++++|+.++.
T Consensus 195 lHGDl~~gNi~~~~~--~~~~iD~e~~~ 220 (370)
T TIGR01767 195 LHGDLHSGSIFVSEH--ETKVIDPEFAF 220 (370)
T ss_pred eeccCCcccEEEcCC--CCEEEcCcccc
Confidence 699999999999854 38899997664
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=85.78 E-value=0.5 Score=36.62 Aligned_cols=27 Identities=11% Similarity=0.118 Sum_probs=22.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+.+.|+|++.+ +.+.++||-.+.
T Consensus 199 cHgD~~~~Nvl~~~~-~~~~iIDfd~~~ 225 (309)
T TIGR02904 199 VHGKLSLSHFLYDET-RGGYFINFEKAS 225 (309)
T ss_pred eCCCCcHHhEEEcCC-CCEEEEEhhhcc
Confidence 699999999999866 458899997654
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=85.72 E-value=0.46 Score=37.21 Aligned_cols=25 Identities=24% Similarity=0.251 Sum_probs=21.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
||+|+-+.|||++ + + +.|+||+-+.
T Consensus 199 iHgD~h~~NvL~~-d-~-~~iIDFDd~~ 223 (325)
T PRK11768 199 LHGDCHPGNILWR-D-G-PHFVDLDDAR 223 (325)
T ss_pred eecCCCchhcccc-C-C-cEEEeCCCCC
Confidence 7999999999995 4 3 7799999764
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=83.10 E-value=0.95 Score=35.01 Aligned_cols=25 Identities=16% Similarity=0.242 Sum_probs=18.9
Q ss_pred CCCCCCCCCeEEcCC-CCceEEeccc
Q 029154 1 MGKFMKEDNLLLTPD-QKSLKLADFG 25 (198)
Q Consensus 1 iH~dlKp~NIll~~~-~~~~kl~DfG 25 (198)
+|+|+.+.||+++.+ +..+.|.|..
T Consensus 196 lHGDlw~gNvl~~~~~~~i~~liDPa 221 (297)
T PRK10593 196 VHGNFTLRSMLKDPRSDQLLAMLNPG 221 (297)
T ss_pred EeCCCCcccEEECCCCCceEEEECch
Confidence 699999999999854 2225677765
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=82.91 E-value=0.85 Score=40.53 Aligned_cols=28 Identities=21% Similarity=0.464 Sum_probs=22.4
Q ss_pred CCCCCCCCCeEEcCCC-CceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQ-KSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~-~~~kl~DfGla~ 28 (198)
||+|+++.|||++.++ ..+-|.||.++.
T Consensus 228 vHGD~~~~Nvl~~~~~~~v~aVLDWE~a~ 256 (822)
T PLN02876 228 VHGDFRIDNLVFHPTEDRVIGILDWELST 256 (822)
T ss_pred EecCcccccEEEcCCCCeEEEEEeeeccc
Confidence 6999999999998532 335689999875
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=82.33 E-value=1.5 Score=36.89 Aligned_cols=31 Identities=23% Similarity=0.308 Sum_probs=25.4
Q ss_pred CCCCCCCCCeEEcC---CCCceEEecccCcccCc
Q 029154 1 MGKFMKEDNLLLTP---DQKSLKLADFGLAREET 31 (198)
Q Consensus 1 iH~dlKp~NIll~~---~~~~~kl~DfGla~~~~ 31 (198)
+|.|-.|.||++.. .+..+.+.|||+.....
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 69999999999994 34678999999986543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 198 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-13 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-13 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-04 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-04 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-04 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-04 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-04 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 198 | |||
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-65 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 8e-63 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-62 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-62 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-60 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 5e-59 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-56 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-53 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-45 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 7e-44 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 8e-44 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-42 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 6e-41 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-38 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-37 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-30 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-30 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-28 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-28 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-27 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-27 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-27 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-27 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 5e-27 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 7e-27 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 4e-26 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 8e-26 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 9e-26 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-25 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-25 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-25 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-25 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-25 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-25 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-25 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-25 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-25 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 3e-25 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 6e-25 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 6e-25 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 7e-25 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 7e-25 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 8e-25 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 8e-25 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 8e-25 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-24 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-24 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-24 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-24 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-24 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-24 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-24 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-24 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-24 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-24 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 5e-24 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 5e-24 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 5e-24 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 5e-24 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-23 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-23 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-23 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-23 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-23 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-23 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-23 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-23 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-23 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-23 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-23 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 4e-23 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-23 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 5e-23 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 8e-23 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-22 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-22 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-22 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-22 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-22 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-22 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-22 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-22 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 8e-22 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-21 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-21 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 5e-21 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 9e-21 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-20 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-20 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-20 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-20 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-19 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 4e-19 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-18 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-18 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 3e-18 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-18 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 4e-18 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-18 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-18 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 6e-18 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 6e-18 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-17 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-17 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-17 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-17 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-17 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-17 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 4e-17 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-17 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 6e-17 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 6e-17 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 6e-17 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 6e-17 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 7e-17 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 8e-17 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-16 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-16 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-16 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-16 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-16 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-16 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-16 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 4e-16 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-16 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 5e-16 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 5e-16 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-16 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 9e-16 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-15 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-15 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-15 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-15 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 3e-15 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 4e-15 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 7e-15 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-14 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-14 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 4e-14 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 6e-14 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 7e-14 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 8e-14 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 8e-14 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-13 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-13 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-13 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-13 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-13 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-13 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-13 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-13 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-13 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-13 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-13 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-13 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-13 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-13 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 4e-13 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-13 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 4e-13 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 6e-13 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 6e-13 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 7e-13 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 7e-13 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-12 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-12 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-12 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-12 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 7e-12 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 9e-12 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-11 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-11 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-11 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-11 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-11 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 6e-11 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 7e-11 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 9e-11 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-10 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-10 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-10 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-10 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-10 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-10 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-10 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-10 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-10 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 4e-10 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-10 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 4e-10 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 4e-10 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 5e-10 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 5e-10 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 5e-10 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 5e-10 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 7e-10 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 8e-10 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 9e-10 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 9e-10 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-09 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-09 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-09 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-09 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-09 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-09 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-09 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-09 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-09 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-09 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-09 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-09 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 3e-09 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-09 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 5e-09 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 9e-09 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 3e-08 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 5e-08 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-06 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-06 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 3e-06 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 6e-06 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 8e-06 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-05 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-05 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-05 |
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-65
Identities = 52/148 (35%), Positives = 82/148 (55%), Gaps = 10/148 (6%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K NLL+ + ++K+ DFGL+R + T + GT WMAPE+ +
Sbjct: 165 LKSPNLLVD-KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL--------RDEP 215
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
N K DVYSFG++LWEL T + P+ ++ Q A FK R +P +++P +A I++ C
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGC 275
Query: 124 WVEDPNLRPSFSQIIRMLNAFLFTLRPP 151
W +P RPSF+ I+ +L + + PP
Sbjct: 276 WTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 8e-63
Identities = 44/145 (30%), Positives = 73/145 (50%), Gaps = 14/145 (9%)
Query: 6 KEDNLLLTPDQKS----LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+ N+ L ++ K+ADFGL+++ ++ G ++WMAPE E+
Sbjct: 151 RSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGNFQWMAPETIG------AEE 202
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA--FKHARPGLPEDISPDLAFI 119
+ Y K D YSF ++L+ +LT PF+ S + + + RP +PED P L +
Sbjct: 203 ESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNV 262
Query: 120 VQSCWVEDPNLRPSFSQIIRMLNAF 144
++ CW DP RP FS I++ L+
Sbjct: 263 IELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-62
Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 11/172 (6%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K NLLL LK+ DFG A + + MT G+ WMAPE++ E +Y
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNKGSAAWMAPEVF--------EGSNY 180
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
+ K DV+S+GI+LWE++T R PF+ + A RP L +++ + ++ C
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRC 240
Query: 124 WVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSNGAMTEFS 175
W +DP+ RPS +I++++ + + + +G + +
Sbjct: 241 WSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYV 292
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 3e-62
Identities = 52/146 (35%), Positives = 73/146 (50%), Gaps = 16/146 (10%)
Query: 5 MKEDNLLLT-------PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 57
+K N+L+ K LK+ DFGLARE T M+A G Y WMAPE+
Sbjct: 134 LKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAWMAPEVI------ 186
Query: 58 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 117
++ DV+S+G++LWELLT +PF G+ L AY A +P A
Sbjct: 187 --RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFA 244
Query: 118 FIVQSCWVEDPNLRPSFSQIIRMLNA 143
+++ CW DP+ RPSF+ I+ L
Sbjct: 245 KLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-60
Identities = 33/139 (23%), Positives = 65/139 (46%), Gaps = 10/139 (7%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
++++ + + +++ + W+APE L++ +
Sbjct: 140 NSRSVMID-EDMTARISMADVKFSFQ----SPGRMYAPAWVAPEA-----LQKKPEDTNR 189
Query: 66 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 125
D++SF ++LWEL+T +PF +SN++ A + RP +P ISP ++ +++ C
Sbjct: 190 RSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMN 249
Query: 126 EDPNLRPSFSQIIRMLNAF 144
EDP RP F I+ +L
Sbjct: 250 EDPAKRPKFDMIVPILEKM 268
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-59
Identities = 32/156 (20%), Positives = 66/156 (42%), Gaps = 11/156 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVT------EMMTAETGTYRWMAPELYSTVTL-R 57
+K N+ D + + DFGL V + + + G +APE+ ++
Sbjct: 156 LKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 58 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE-DISPDL 116
+ +K ++ DV++ G + +EL PF+ + +P L + + ++
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG-TGMKPNLSQIGMGKEI 272
Query: 117 AFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 152
+ I+ CW + RP+F++++ ML R S
Sbjct: 273 SDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS 308
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-56
Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 13/148 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEK 61
+K +N+ L + ++K+ DFGLA E++ +G+ WMAPE+ +R +
Sbjct: 146 LKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV-----IRMQDS 199
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA-AFKHARPGL---PEDISPDLA 117
Y+ + DVY+FGIVL+EL+T +LP+ ++N P L + +
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259
Query: 118 FIVQSCWVEDPNLRPSFSQIIRMLNAFL 145
++ C + + RPSF +I+ +
Sbjct: 260 RLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-45
Identities = 43/175 (24%), Positives = 63/175 (36%), Gaps = 28/175 (16%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEM---------------MTAETGTYRWMAPEL 50
N L+ + K++ +ADFGLAR + G WMAPE+
Sbjct: 135 NSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 51 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLP 109
+ + Y+ KVDV+SFGIVL E++ + + P
Sbjct: 194 -----ING---RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245
Query: 110 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL---RPPSPSVPESDTN 161
+ P I C DP RPSF ++ L L P P + + D
Sbjct: 246 PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRG 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-44
Identities = 36/167 (21%), Positives = 64/167 (38%), Gaps = 30/167 (17%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREE-----TVTEMMTAETGTYRWMAPE-LYSTVTLRQ 58
+K N+L+ + + +AD GLA + V GT R+M PE L ++
Sbjct: 168 LKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNH 226
Query: 59 GEKKHYNNKVDVYSFGIVLWELLT----------NRLPFEGMSNLQAAY-----AAAFKH 103
+ D+YSFG++LWE+ +LP+ + +Y K
Sbjct: 227 FQ---SYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK 283
Query: 104 ARPGLPE-----DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145
RP P + + ++ CW +P R + ++ + L
Sbjct: 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-44
Identities = 38/163 (23%), Positives = 68/163 (41%), Gaps = 28/163 (17%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMM-----TAETGTYRWMAPELYSTVTLRQG 59
+K N+L+ + +AD GLA + + GT R+MAPE+ Q
Sbjct: 139 LKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETI--QV 195
Query: 60 EKKHYNNKVDVYSFGIVLWELLT----------NRLPFEGMSNLQAAY-----AAAFKHA 104
+ +VD+++FG+VLWE+ + PF + ++
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ 255
Query: 105 RPGLPEDISPD-----LAFIVQSCWVEDPNLRPSFSQIIRMLN 142
RP +P D LA +++ CW ++P+ R + +I + L
Sbjct: 256 RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-41
Identities = 36/164 (21%), Positives = 68/164 (41%), Gaps = 30/164 (18%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREE-----TVTEMMTAETGTYRWMAPE-LYSTVTLRQ 58
+K N+L+ + + +AD GLA T+ GT R+MAPE L ++ ++
Sbjct: 173 LKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 231
Query: 59 GEKKHYNNKVDVYSFGIVLWELLT----------NRLPFEGMSNLQAAY-----AAAFKH 103
E + D+Y+ G+V WE+ +LP+ + + +
Sbjct: 232 FE---SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK 288
Query: 104 ARPGLPE-----DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142
RP +P + +A I++ CW + R + +I + L+
Sbjct: 289 LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 4e-38
Identities = 42/190 (22%), Positives = 71/190 (37%), Gaps = 37/190 (19%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEM---------MTAETGTYRWMAPE-LYSTVT 55
N+L+ D + ++DFGL+ T + +E GT R+MAPE L V
Sbjct: 147 NSRNVLVKND-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVN 205
Query: 56 LRQGEKKHYNNKVDVYSFGIVLWELL---TNRLPFEGMSNLQAAYAA------------- 99
LR E +VD+Y+ G++ WE+ T+ P E + Q A+
Sbjct: 206 LRDXE--SALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQV 263
Query: 100 --AFKHARPGLPEDISPD------LAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 151
+ + RP PE + L ++ CW +D R + + +
Sbjct: 264 LVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323
Query: 152 SPSVPESDTN 161
P + +
Sbjct: 324 KSVSPTAHHH 333
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-37
Identities = 41/163 (25%), Positives = 61/163 (37%), Gaps = 28/163 (17%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+K N+LL + + +ADFGLA + GT R+MAPE+ Q +
Sbjct: 157 IKSKNVLLKNN-LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRD- 214
Query: 62 KHYNNKVDVYSFGIVLWELLT-----------NRLPFEGM-----SNLQAAYAAAFKHAR 105
++D+Y+ G+VLWEL + LPFE S K R
Sbjct: 215 --AFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKR 272
Query: 106 PGLPEDISPD-----LAFIVQSCWVEDPNLRPSFSQIIRMLNA 143
P L + L ++ CW D R S + +
Sbjct: 273 PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-30
Identities = 34/132 (25%), Positives = 59/132 (44%), Gaps = 11/132 (8%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
K DN+ +T S+K+ D GLA + + GT +MAPE+Y ++ Y+
Sbjct: 158 KCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAPEMY---------EEKYD 207
Query: 66 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY-AAAFKHARPGLPEDISPDLAFIVQSCW 124
VDVY+FG+ + E+ T+ P+ N Y + P++ I++ C
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCI 267
Query: 125 VEDPNLRPSFSQ 136
++ + R S
Sbjct: 268 RQNKDERYSIKD 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-30
Identities = 36/138 (26%), Positives = 58/138 (42%), Gaps = 17/138 (12%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+ L ++ +K+ DFGL T GT R+M+PE + Y
Sbjct: 148 LKPSNIFLVDTKQ-VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQI--------SSQDY 198
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG-LPEDISPDLAFIVQSC 123
+VD+Y+ G++L ELL S F R G + + ++Q
Sbjct: 199 GKEVDLYALGLILAELLHVCDTAFETSKF-------FTDLRDGIISDIFDKKEKTLLQKL 251
Query: 124 WVEDPNLRPSFSQIIRML 141
+ P RP+ S+I+R L
Sbjct: 252 LSKKPEDRPNTSEILRTL 269
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-28
Identities = 41/161 (25%), Positives = 56/161 (34%), Gaps = 27/161 (16%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR-------------EETVTEMMTAETGTYRWMAPELY 51
+K N+ T D +K+ DFGL T + GT +M+PE
Sbjct: 144 LKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI 202
Query: 52 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 111
Y++KVD++S G++L+ELL PF P L
Sbjct: 203 --------HGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQ 251
Query: 112 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 152
P +VQ P RP II NA L P
Sbjct: 252 KYPCEYVMVQDMLSPSPMERPEAINIIE--NAVFEDLDFPG 290
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-28
Identities = 47/150 (31%), Positives = 71/150 (47%), Gaps = 24/150 (16%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT----YRWMAPELYSTVTLRQGEKKHY 64
N L+T ++ LK++DFG++REE A G +W APE L G Y
Sbjct: 243 NCLVT-EKNVLKISDFGMSREEADGVY-AASGGLRQVPVKWTAPE-----ALNYG---RY 292
Query: 65 NNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFI 119
+++ DV+SFGI+LWE + P+ +SN Q + G PE + +
Sbjct: 293 SSESDVWSFGILLWETFSLGASPYPNLSNQQT-----REFVEKGGRLPCPELCPDAVFRL 347
Query: 120 VQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149
++ CW +P RPSFS I + L + R
Sbjct: 348 MEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-27
Identities = 35/136 (25%), Positives = 54/136 (39%), Gaps = 13/136 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+ L P + KL DFGL E + G R+MAPEL L+ Y
Sbjct: 183 VKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL-----LQGS----Y 232
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
DV+S G+ + E+ N G Q + P +S +L ++
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ---GYLPPEFTAGLSSELRSVLVMML 289
Query: 125 VEDPNLRPSFSQIIRM 140
DP LR + ++ +
Sbjct: 290 EPDPKLRATAEALLAL 305
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-27
Identities = 38/165 (23%), Positives = 71/165 (43%), Gaps = 11/165 (6%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPEL---YSTVTLRQ 58
+K N L+ LKL DFG+A +T + + ++ G +M PE S+
Sbjct: 181 LKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENG 238
Query: 59 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHARPGLPEDISPDLA 117
K + K DV+S G +L+ + + PF+ + N + +A + P+ DL
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 298
Query: 118 FIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNE 162
+++ C DP R S +++ + ++ P + + T E
Sbjct: 299 DVLKCCLKRDPKQRISIPELLA--HPYVQIQTHPVNQMAKGTTEE 341
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-27
Identities = 42/137 (30%), Positives = 69/137 (50%), Gaps = 11/137 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K N+ LT D +++L DFG+AR + E+ A GT +++PE+ E K
Sbjct: 151 IKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC--------ENKP 201
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
YNNK D+++ G VL+EL T + FE +++ + P + S DL +V
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260
Query: 124 WVEDPNLRPSFSQIIRM 140
+ +P RPS + I+
Sbjct: 261 FKRNPRDRPSVNSILEK 277
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-27
Identities = 37/137 (27%), Positives = 56/137 (40%), Gaps = 11/137 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K N+ L Q ++KL DFGLAR T GT +M+PE +
Sbjct: 142 LKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM--------NRMS 192
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
YN K D++S G +L+EL PF + + + +P S +L I+
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFRRIPYRYSDELNEIITRM 251
Query: 124 WVEDPNLRPSFSQIIRM 140
RPS +I+
Sbjct: 252 LNLKDYHRPSVEEILEN 268
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-27
Identities = 39/165 (23%), Positives = 72/165 (43%), Gaps = 11/165 (6%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPEL---YSTVTLRQ 58
+K N L+ LKL DFG+A +T + + ++ GT +M PE S+
Sbjct: 153 LKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 210
Query: 59 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHARPGLPEDISPDLA 117
K + K DV+S G +L+ + + PF+ + N + +A + P+ DL
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 270
Query: 118 FIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNE 162
+++ C DP R S +++ + ++ P + + T E
Sbjct: 271 DVLKCCLKRDPKQRISIPELLA--HPYVQIQTHPVNQMAKGTTEE 313
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-27
Identities = 39/165 (23%), Positives = 72/165 (43%), Gaps = 11/165 (6%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPEL---YSTVTLRQ 58
+K N L+ LKL DFG+A +T + + ++ GT +M PE S+
Sbjct: 134 LKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 191
Query: 59 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHARPGLPEDISPDLA 117
K + K DV+S G +L+ + + PF+ + N + +A + P+ DL
Sbjct: 192 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 251
Query: 118 FIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNE 162
+++ C DP R S +++ + ++ P + + T E
Sbjct: 252 DVLKCCLKRDPKQRISIPELLA--HPYVQIQTHPVNQMAKGTTEE 294
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-26
Identities = 38/145 (26%), Positives = 67/145 (46%), Gaps = 27/145 (18%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 65
N+L++ + K++DFGL +E + + + +W APE LR+ ++
Sbjct: 147 NVLVS-EDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPE-----ALREK---KFS 192
Query: 66 NKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIV 120
K DV+SFGI+LWE+ + R+P+ + G P+ P + ++
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----VPRVEKGYKMDAPDGCPPAVYEVM 247
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFL 145
++CW D +RPSF Q+ L
Sbjct: 248 KNCWHLDAAMRPSFLQLREQLEHIK 272
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-26
Identities = 43/145 (29%), Positives = 73/145 (50%), Gaps = 22/145 (15%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 65
N+L+T + +K+ADFGLAR+ + T +WMAPE L Y
Sbjct: 233 NVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE-----ALFDRV---YT 283
Query: 66 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIV 120
++ DV+SFG+++WE+ T P+ G+ + FK + G P + + +L ++
Sbjct: 284 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-----FKLLKEGHRMDKPANCTNELYMMM 338
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFL 145
+ CW P+ RP+F Q++ L+ L
Sbjct: 339 RDCWHAVPSQRPTFKQLVEDLDRIL 363
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-26
Identities = 43/145 (29%), Positives = 73/145 (50%), Gaps = 22/145 (15%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 65
N+L+T + +K+ADFGLAR+ + T +WMAPE L Y
Sbjct: 187 NVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE-----ALFDRV---YT 237
Query: 66 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIV 120
++ DV+SFG+++WE+ T P+ G+ + FK + G P + + +L ++
Sbjct: 238 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-----FKLLKEGHRMDKPANCTNELYMMM 292
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFL 145
+ CW P+ RP+F Q++ L+ L
Sbjct: 293 RDCWHAVPSQRPTFKQLVEDLDRIL 317
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-25
Identities = 48/145 (33%), Positives = 75/145 (51%), Gaps = 23/145 (15%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 65
N+L++ D S K+ADFGLAR E TA G +W APE + G +
Sbjct: 139 NILVS-DTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPE-----AINYG---TFT 188
Query: 66 NKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIV 120
K DV+SFGI+L E++T+ R+P+ GM+N + ++ G P++ +L ++
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-----IQNLERGYRMVRPDNCPEELYQLM 243
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFL 145
+ CW E P RP+F + +L F
Sbjct: 244 RLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 37/145 (25%), Positives = 66/145 (45%), Gaps = 27/145 (18%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 65
N+L++ + K++DFGL +E + + + +W APE LR+ ++
Sbjct: 319 NVLVS-EDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPE-----ALREK---KFS 364
Query: 66 NKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIV 120
K DV+SFGI+LWE+ + R+P+ + G P+ P + ++
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----VPRVEKGYKMDAPDGCPPAVYDVM 419
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFL 145
++CW D RP+F Q+ L
Sbjct: 420 KNCWHLDAATRPTFLQLREQLEHIR 444
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-25
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 22/154 (14%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 65
N +L D ++ +ADFGL+R+ + + +W+A E +L Y
Sbjct: 167 NCMLAED-MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE-----SLADNL---YT 217
Query: 66 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIV 120
DV++FG+ +WE++T + P+ G+ N + + + G P + ++ ++
Sbjct: 218 VHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-----YNYLIGGNRLKQPPECMEEVYDLM 272
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS 154
CW DP RPSF+ + L L L S S
Sbjct: 273 YQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-25
Identities = 37/163 (22%), Positives = 64/163 (39%), Gaps = 23/163 (14%)
Query: 9 NLLLTPDQKSL--KLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKH 63
N LLT K+ DFG+AR+ +WM PE +G
Sbjct: 170 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE-----AFMEG---I 221
Query: 64 YNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAF 118
+ +K D +SFG++LWE+ + +P+ SN + + G P++ +
Sbjct: 222 FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-----LEFVTSGGRMDPPKNCPGPVYR 276
Query: 119 IVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTN 161
I+ CW P RP+F+ I+ + + ++P
Sbjct: 277 IMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGP 319
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-25
Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 18/158 (11%)
Query: 6 KEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
K DN+L+ LK++DFG ++ + TGT ++MAPE+ + Y
Sbjct: 149 KGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII------DKGPRGY 202
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK----HARPGLPEDISPDL-AFI 119
D++S G + E+ T + PF L AA FK P +PE +S + AFI
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPF---YELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259
Query: 120 VQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPE 157
++ C+ DP+ R + ++ + FL + P+
Sbjct: 260 LK-CFEPDPDKRACANDLLV--DEFLKVSSKKKKTQPK 294
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 2e-25
Identities = 37/148 (25%), Positives = 53/148 (35%), Gaps = 25/148 (16%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAR-------------EETVTEMMTAETGTYRWMAPELYS 52
K N+ T D +K+ DFGL T + GT +M+PE
Sbjct: 191 KPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE--- 246
Query: 53 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 112
Q +Y++KVD++S G++L+ELL F P L
Sbjct: 247 -----QIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQK 298
Query: 113 SPDLAFIVQSCWVEDPNLRPSFSQIIRM 140
P +VQ P RP + II
Sbjct: 299 YPQEHMMVQDMLSPSPTERPEATDIIEN 326
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-25
Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 22/148 (14%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 65
N +L D ++ +ADFGL+++ + +W+A E +L Y
Sbjct: 177 NCMLR-DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE-----SLADRV---YT 227
Query: 66 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIV 120
+K DV++FG+ +WE+ T P+ G+ N + + + G PED +L I+
Sbjct: 228 SKSDVWAFGVTMWEIATRGMTPYPGVQNHEM-----YDYLLHGHRLKQPEDCLDELYEIM 282
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFLFTL 148
SCW DP RP+FS + L L +L
Sbjct: 283 YSCWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-25
Identities = 42/158 (26%), Positives = 63/158 (39%), Gaps = 24/158 (15%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNN 66
N+L+ + K+ADFGLAR E + +W APE +
Sbjct: 310 NILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTI 360
Query: 67 KVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQ 121
K DV+SFGI+L EL T R+P+ GM N + G P + L ++
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQVERGYRMPCPPECPESLHDLMC 415
Query: 122 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESD 159
CW ++P RP+F + L + P +
Sbjct: 416 QCWRKEPEERPTFEYLQAFLEDY---FTSTEPQYQPGE 450
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-25
Identities = 37/163 (22%), Positives = 64/163 (39%), Gaps = 23/163 (14%)
Query: 9 NLLLTPDQKSL--KLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKH 63
N LLT K+ DFG+AR+ +WM PE +G
Sbjct: 211 NCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE-----AFMEGI--- 262
Query: 64 YNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAF 118
+ +K D +SFG++LWE+ + +P+ SN + + G P++ +
Sbjct: 263 FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-----LEFVTSGGRMDPPKNCPGPVYR 317
Query: 119 IVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTN 161
I+ CW P RP+F+ I+ + + ++P
Sbjct: 318 IMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGP 360
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-25
Identities = 44/145 (30%), Positives = 73/145 (50%), Gaps = 22/145 (15%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 65
N+L+T D +K+ADFGLAR+ + T +WMAPE L Y
Sbjct: 221 NVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE-----ALFDRI---YT 271
Query: 66 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIV 120
++ DV+SFG++LWE+ T P+ G+ + FK + G P + + +L ++
Sbjct: 272 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-----FKLLKEGHRMDKPSNCTNELYMMM 326
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFL 145
+ CW P+ RP+F Q++ L+ +
Sbjct: 327 RDCWHAVPSQRPTFKQLVEDLDRIV 351
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-25
Identities = 48/145 (33%), Positives = 69/145 (47%), Gaps = 23/145 (15%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 65
N+L++ K+ADFGLAR E TA G +W APE + +
Sbjct: 314 NILVS-ASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAIN--------FGSFT 363
Query: 66 NKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIV 120
K DV+SFGI+L E++T R+P+ GMSN + + G PE+ +L I+
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-----IRALERGYRMPRPENCPEELYNIM 418
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFL 145
CW P RP+F I +L+ F
Sbjct: 419 MRCWKNRPEERPTFEYIQSVLDDFY 443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-25
Identities = 40/145 (27%), Positives = 69/145 (47%), Gaps = 23/145 (15%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 65
N L+ + +K+ADFGL+R T + TA G +W APE +L ++
Sbjct: 141 NCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-----SLAYN---KFS 190
Query: 66 NKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIV 120
K DV++FG++LWE+ T P+ G+ Q ++ PE + ++
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----YELLEKDYRMERPEGCPEKVYELM 245
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFL 145
++CW +P+ RPSF++I +
Sbjct: 246 RACWQWNPSDRPSFAEIHQAFETMF 270
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 7e-25
Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 24/150 (16%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY-----RWMAPELYSTVTLRQGEKKH 63
N +L ++ ++K+ADFGLAR+ E + T +WMA E +L+ +
Sbjct: 158 NCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-----SLQTQK--- 208
Query: 64 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAF 118
+ K DV+SFG++LWEL+T P+ ++ + G PE L
Sbjct: 209 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----TVYLLQGRRLLQPEYCPDPLYE 263
Query: 119 IVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148
++ CW +RPSFS+++ ++A T
Sbjct: 264 VMLKCWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 7e-25
Identities = 42/158 (26%), Positives = 63/158 (39%), Gaps = 24/158 (15%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNN 66
N+L+ + K+ADFGLAR E + +W APE +
Sbjct: 393 NILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTI 443
Query: 67 KVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQ 121
K DV+SFGI+L EL T R+P+ GM N + G P + L ++
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQVERGYRMPCPPECPESLHDLMC 498
Query: 122 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESD 159
CW ++P RP+F + L + P +
Sbjct: 499 QCWRKEPEERPTFEYLQAFLEDY---FTSTEPQYQPGE 533
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 8e-25
Identities = 40/139 (28%), Positives = 62/139 (44%), Gaps = 12/139 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K N+ +T +KL D GL R + T + GT +M+PE +
Sbjct: 162 IKPANVFITATGV-VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI--------HENG 212
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKHARPGLPEDI-SPDLAFIVQ 121
YN K D++S G +L+E+ + PF G NL + + P LP D S +L +V
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVN 272
Query: 122 SCWVEDPNLRPSFSQIIRM 140
C DP RP + + +
Sbjct: 273 MCINPDPEKRPDVTYVYDV 291
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 8e-25
Identities = 32/152 (21%), Positives = 58/152 (38%), Gaps = 29/152 (19%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAR---------------EETVTEMMTAETGTYRWMAPEL 50
K N+ + + +K+ DFGLA+ ++ +T+ GT ++A E+
Sbjct: 143 KPMNIFIDESRN-VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV 201
Query: 51 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR---PG 107
HYN K+D+YS GI+ +E++ PF + P
Sbjct: 202 LD-------GTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPD 251
Query: 108 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139
++ I++ DPN RP ++
Sbjct: 252 FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 8e-25
Identities = 36/147 (24%), Positives = 65/147 (44%), Gaps = 26/147 (17%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPE--LYSTVTLRQGEKKH 63
N L+ +K+ DFG++R+ T+ T RWM PE +Y
Sbjct: 163 NCLVG-ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK---------- 211
Query: 64 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAF 118
+ + DV+SFG++LWE+ T + P+ +SN + + G P ++
Sbjct: 212 FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV-----IECITQGRVLERPRVCPKEVYD 266
Query: 119 IVQSCWVEDPNLRPSFSQIIRMLNAFL 145
++ CW +P R + +I ++L+A
Sbjct: 267 VMLGCWQREPQQRLNIKEIYKILHALG 293
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-24
Identities = 38/143 (26%), Positives = 67/143 (46%), Gaps = 18/143 (12%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKH 63
N+L+ + +K+ DFGLA+ E G +WMA E L+
Sbjct: 147 NVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI---------- 195
Query: 64 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
Y ++ DV+S+G+ +WEL+T P++G+ + + K R P + D+ I++
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPICTIDVYMIMRK 254
Query: 123 CWVEDPNLRPSFSQIIRMLNAFL 145
CW+ D + RP F ++I +
Sbjct: 255 CWMIDADSRPKFRELIIEFSKMA 277
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-24
Identities = 37/145 (25%), Positives = 71/145 (48%), Gaps = 22/145 (15%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 65
N+L+ + +K++DFGL+R+ + + +WMA E +L Y
Sbjct: 180 NILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE-----SLFDHI---YT 230
Query: 66 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIV 120
+ DV+SFG++LWE++T P+ G+ + F + G P++ S ++ ++
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERL-----FNLLKTGHRMERPDNCSEEMYRLM 285
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFL 145
CW ++P+ RP F+ I + L +
Sbjct: 286 LQCWKQEPDKRPVFADISKDLEKMM 310
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-24
Identities = 39/145 (26%), Positives = 64/145 (44%), Gaps = 22/145 (15%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYN 65
N L+ +K+ DFG++R+ T+ T RWM PE ++ + +
Sbjct: 188 NCLVGQG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE-----SILYRK---FT 238
Query: 66 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIV 120
+ DV+SFG+VLWE+ T + P+ +SN +A G P P++ I+
Sbjct: 239 TESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-----IDCITQGRELERPRACPPEVYAIM 293
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFL 145
+ CW +P R S + L A
Sbjct: 294 RGCWQREPQQRHSIKDVHARLQALA 318
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-24
Identities = 41/150 (27%), Positives = 67/150 (44%), Gaps = 24/150 (16%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY-----RWMAPELYSTVTLRQGEKKH 63
N +L + ++K+ADFGLAR+ E + + + +W A E +L+
Sbjct: 154 NCMLD-ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE-----SLQTYR--- 204
Query: 64 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAF 118
+ K DV+SFG++LWELLT P+ + G PE L
Sbjct: 205 FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL-----THFLAQGRRLPQPEYCPDSLYQ 259
Query: 119 IVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148
++Q CW DP +RP+F ++ + + L
Sbjct: 260 VMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-24
Identities = 38/147 (25%), Positives = 66/147 (44%), Gaps = 27/147 (18%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKH 63
N L+ +K++DFG+ R + + GT +W APE Y
Sbjct: 134 NCLVD-RDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFK---------- 181
Query: 64 YNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAF 118
Y++K DV++FGI++WE+ + ++P++ +N + G P S +
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-----VLKVSQGHRLYRPHLASDTIYQ 236
Query: 119 IVQSCWVEDPNLRPSFSQIIRMLNAFL 145
I+ SCW E P RP+F Q++ +
Sbjct: 237 IMYSCWHELPEKRPTFQQLLSSIEPLR 263
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-24
Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 24/150 (16%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY-----RWMAPELYSTVTLRQGEKKH 63
N +L ++ ++K+ADFGLAR+ E + T +WMA E +L+ +
Sbjct: 222 NCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE-----SLQTQK--- 272
Query: 64 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAF 118
+ K DV+SFG++LWEL+T P+ ++ + G PE L
Sbjct: 273 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----TVYLLQGRRLLQPEYCPDPLYE 327
Query: 119 IVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148
++ CW +RPSFS+++ ++A T
Sbjct: 328 VMLKCWHPKAEMRPSFSELVSRISAIFSTF 357
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-24
Identities = 42/147 (28%), Positives = 73/147 (49%), Gaps = 27/147 (18%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKH 63
N L+ + + +K++DFG+ R + T+ TGT +W +PE +S
Sbjct: 134 NCLVG-ENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSR---------- 181
Query: 64 YNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAF 118
Y++K DV+SFG+++WE+ + ++P+E SN + + G P S +
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDISTGFRLYKPRLASTHVYQ 236
Query: 119 IVQSCWVEDPNLRPSFSQIIRMLNAFL 145
I+ CW E P RP+FS+++R L
Sbjct: 237 IMNHCWRERPEDRPAFSRLLRQLAEIA 263
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-24
Identities = 41/147 (27%), Positives = 74/147 (50%), Gaps = 27/147 (18%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKH 63
N L+ DQ +K++DFGL+R E T+ G+ RW PE +YS
Sbjct: 150 NCLVN-DQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSK---------- 197
Query: 64 YNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAF 118
+++K D+++FG+++WE+ + ++P+E +N + +H GL P S +
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----AEHIAQGLRLYRPHLASEKVYT 252
Query: 119 IVQSCWVEDPNLRPSFSQIIRMLNAFL 145
I+ SCW E + RP+F ++ + +
Sbjct: 253 IMYSCWHEKADERPTFKILLSNILDVM 279
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 4e-24
Identities = 39/145 (26%), Positives = 68/145 (46%), Gaps = 23/145 (15%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 65
N L+ + +K+ADFGL+R T + TA G +W APE + ++
Sbjct: 348 NCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA--------YNKFS 397
Query: 66 NKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIV 120
K DV++FG++LWE+ T P+ G+ Q ++ PE + ++
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----YELLEKDYRMERPEGCPEKVYELM 452
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFL 145
++CW +P+ RPSF++I +
Sbjct: 453 RACWQWNPSDRPSFAEIHQAFETMF 477
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-24
Identities = 39/141 (27%), Positives = 68/141 (48%), Gaps = 13/141 (9%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 65
N+LL+ +K+ DFGLAR+ + +WMAPE T+ Y
Sbjct: 178 NILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE-----TIFDRV---YT 228
Query: 66 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
+ DV+SFG++LWE+ + P+ G+ + + R P+ +P++ + CW
Sbjct: 229 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW 288
Query: 125 VEDPNLRPSFSQIIRMLNAFL 145
+P+ RP+FS+++ L L
Sbjct: 289 HGEPSQRPTFSELVEHLGNLL 309
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-24
Identities = 33/148 (22%), Positives = 56/148 (37%), Gaps = 30/148 (20%)
Query: 7 EDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY----RWMAPE--LYSTVTLRQGE 60
+ T + +KL+D G++ W+ PE
Sbjct: 148 REEDRKTGNPPFIKLSDPGISIT-------VLPKDILQERIPWVPPECIENP-------- 192
Query: 61 KKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLA 117
K+ N D +SFG LWE+ + P + + + + LP + +LA
Sbjct: 193 -KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-----LQFYEDRHQLPAPKAAELA 246
Query: 118 FIVQSCWVEDPNLRPSFSQIIRMLNAFL 145
++ +C +P+ RPSF IIR LN+
Sbjct: 247 NLINNCMDYEPDHRPSFRAIIRDLNSLF 274
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 5e-24
Identities = 40/144 (27%), Positives = 67/144 (46%), Gaps = 21/144 (14%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNN 66
N+L++ +KL DFGL+R + A G +WMAPE ++ + +
Sbjct: 521 NVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-----SINFR---RFTS 571
Query: 67 KVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQ 121
DV+ FG+ +WE+L + PF+G+ N G +P + P L ++
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQGVKNNDV-----IGRIENGERLPMPPNCPPTLYSLMT 626
Query: 122 SCWVEDPNLRPSFSQIIRMLNAFL 145
CW DP+ RP F+++ L+ L
Sbjct: 627 KCWAYDPSRRPRFTELKAQLSTIL 650
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-24
Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 22/145 (15%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYN 65
N L+ + +K+ADFGL+R + A+ RWM PE ++ Y
Sbjct: 204 NCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE-----SIFYNR---YT 254
Query: 66 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIV 120
+ DV+++G+VLWE+ + P+ GM++ + + R G PE+ +L ++
Sbjct: 255 TESDVWAYGVVLWEIFSYGLQPYYGMAHEEV-----IYYVRDGNILACPENCPLELYNLM 309
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFL 145
+ CW + P RPSF I R+L
Sbjct: 310 RLCWSKLPADRPSFCSIHRILQRMC 334
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-24
Identities = 44/147 (29%), Positives = 72/147 (48%), Gaps = 29/147 (19%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKH 63
N+L+ + K+ADFGL+R + E+ +T RWMA E YS
Sbjct: 172 NILVGEN-YVAKIADFGLSRGQ---EVYVKKTMGRLPVRWMAIESLNYSV---------- 217
Query: 64 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAF 118
Y DV+S+G++LWE+++ P+ GM+ + ++ G P + ++
Sbjct: 218 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-----YEKLPQGYRLEKPLNCDDEVYD 272
Query: 119 IVQSCWVEDPNLRPSFSQIIRMLNAFL 145
+++ CW E P RPSF+QI+ LN L
Sbjct: 273 LMRQCWREKPYERPSFAQILVSLNRML 299
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-23
Identities = 40/144 (27%), Positives = 66/144 (45%), Gaps = 22/144 (15%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYN 65
N+L+ D+ ++K++D GL RE + + RWMAPE + G ++
Sbjct: 158 NVLVY-DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPE-----AIMYG---KFS 208
Query: 66 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIV 120
D++S+G+VLWE+ + P+ G SN + R P+D + ++
Sbjct: 209 IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV-----VEMIRNRQVLPCPDDCPAWVYALM 263
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAF 144
CW E P+ RP F I L A+
Sbjct: 264 IECWNEFPSRRPRFKDIHSRLRAW 287
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-23
Identities = 42/145 (28%), Positives = 71/145 (48%), Gaps = 22/145 (15%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYN 65
N ++ D ++K+ DFG+ R+ T+ RWM+PE +L+ G +
Sbjct: 168 NCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE-----SLKDGV---FT 218
Query: 66 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIV 120
DV+SFG+VLWE+ T P++G+SN Q + G P++ L ++
Sbjct: 219 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-----LRFVMEGGLLDKPDNCPDMLFELM 273
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFL 145
+ CW +P +RPSF +II + +
Sbjct: 274 RMCWQYNPKMRPSFLEIISSIKEEM 298
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-23
Identities = 35/156 (22%), Positives = 70/156 (44%), Gaps = 19/156 (12%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMM-TAETGT---YRWMAPE--LYSTVTLRQGEKK 62
N+LL ++ K++DFGL++ + TA + +W APE +
Sbjct: 140 NVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--------- 189
Query: 63 HYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQ 121
++++ DV+S+G+ +WE L+ + P++ M + A + R P + P+L ++
Sbjct: 190 -FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIEQGKRMECPPECPPELYALMS 247
Query: 122 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPE 157
CW+ RP F + + + A ++L
Sbjct: 248 DCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 283
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-23
Identities = 43/141 (30%), Positives = 68/141 (48%), Gaps = 13/141 (9%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 65
N+LLT + K+ DFGLAR+ + +WMAPE ++ Y
Sbjct: 175 NILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE-----SIFNCV---YT 225
Query: 66 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
+ DV+S+GI LWEL + P+ GM Y + R PE ++ I+++CW
Sbjct: 226 FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCW 285
Query: 125 VEDPNLRPSFSQIIRMLNAFL 145
DP RP+F QI++++ +
Sbjct: 286 DADPLKRPTFKQIVQLIEKQI 306
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-23
Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 25/146 (17%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPE--LYSTVTLRQGEKKHY 64
N+L++ +KL DFGL+R + A G +WMAPE + + +
Sbjct: 146 NVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF----------RRF 194
Query: 65 NNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFI 119
+ DV+ FG+ +WE+L + PF+G+ N G +P + P L +
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-----IGRIENGERLPMPPNCPPTLYSL 249
Query: 120 VQSCWVEDPNLRPSFSQIIRMLNAFL 145
+ CW DP+ RP F+++ L+ L
Sbjct: 250 MTKCWAYDPSRRPRFTELKAQLSTIL 275
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-23
Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 41/161 (25%)
Query: 20 KLADFGLARE-ETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSF 73
K++DFGL+R E E +G RW APE Y + + + DV+SF
Sbjct: 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY----------RKFTSASDVWSF 236
Query: 74 GIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDP 128
GIV+WE++T P+ +SN + K G P D + ++ CW ++
Sbjct: 237 GIVMWEVMTYGERPYWELSNHEV-----MKAINDGFRLPTPMDCPSAIYQLMMQCWQQER 291
Query: 129 NLRPSFSQIIRMLNAFL---------------FTLRPPSPS 154
RP F+ I+ +L+ + ++R PS S
Sbjct: 292 ARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTS 332
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-23
Identities = 33/135 (24%), Positives = 54/135 (40%), Gaps = 15/135 (11%)
Query: 6 KEDNLLLTPDQKSLKLADFG----LAREETVTEMMTAET--GTYRWMAPELYSTVTLRQG 59
K DN+LL+ D L DFG L + ++T + GT MAPE V + +
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE----VVMGKP 232
Query: 60 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA-AAFKHARPGLPEDISPDLAF 118
+ KVD++S ++ +L P+ A+ +P +P A
Sbjct: 233 ----CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ 288
Query: 119 IVQSCWVEDPNLRPS 133
+Q ++P R S
Sbjct: 289 AIQEGLRKEPVHRAS 303
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-23
Identities = 37/151 (24%), Positives = 64/151 (42%), Gaps = 27/151 (17%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMM-TAETGT---YRWMAPE--LYSTVTLRQGEKK 62
N+LL Q K++DFGL++ E A+T +W APE Y
Sbjct: 147 NVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--------- 196
Query: 63 HYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLA 117
+++K DV+SFG+++WE + + P+ GM + G P ++
Sbjct: 197 -FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-----TAMLEKGERMGCPAGCPREMY 250
Query: 118 FIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148
++ CW D RP F+ + L + + +
Sbjct: 251 DLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-23
Identities = 34/141 (24%), Positives = 62/141 (43%), Gaps = 14/141 (9%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 65
N+LL +++ADFG+A + + +WMA E Y
Sbjct: 145 NVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF--------GKYT 195
Query: 66 NKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
++ DV+S+G+ +WEL+T P+ G+ + K R P+ + D+ ++ CW
Sbjct: 196 HQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-PDLLEKGERLAQPQICTIDVYMVMVKCW 254
Query: 125 VEDPNLRPSFSQIIRMLNAFL 145
+ D N+RP+F ++
Sbjct: 255 MIDENIRPTFKELANEFTRMA 275
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 3e-23
Identities = 38/141 (26%), Positives = 67/141 (47%), Gaps = 13/141 (9%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 65
N+LL+ +K+ DFGLAR+ + +WMAPE + Y
Sbjct: 223 NILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE--------TIFDRVYT 273
Query: 66 NKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
+ DV+SFG++LWE+ + P+ G+ + + R P+ +P++ + CW
Sbjct: 274 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW 333
Query: 125 VEDPNLRPSFSQIIRMLNAFL 145
+P+ RP+FS+++ L L
Sbjct: 334 HGEPSQRPTFSELVEHLGNLL 354
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-23
Identities = 40/135 (29%), Positives = 61/135 (45%), Gaps = 22/135 (16%)
Query: 20 KLADFGLARE-ETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75
K++DFGL+R E + TG RW APE + +++ DV+SFG+
Sbjct: 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE-----AIAFR---TFSSASDVWSFGV 242
Query: 76 VLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNL 130
V+WE+L P+ M+N G P L ++ CW +D
Sbjct: 243 VMWEVLAYGERPYWNMTNRDV-----ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQ 297
Query: 131 RPSFSQIIRMLNAFL 145
RP FSQI+ +L+A +
Sbjct: 298 RPRFSQIVSVLDALI 312
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-23
Identities = 44/141 (31%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 65
N+L+T K +K+ DFGLAR+ +WMAPE +L +G Y
Sbjct: 202 NVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE-----SLFEGI---YT 252
Query: 66 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
K DV+S+GI+LWE+ + P+ G+ Y + P + ++ I+QSCW
Sbjct: 253 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCW 312
Query: 125 VEDPNLRPSFSQIIRMLNAFL 145
D RPSF + L L
Sbjct: 313 AFDSRKRPSFPNLTSFLGCQL 333
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 4e-23
Identities = 16/137 (11%), Positives = 44/137 (32%), Gaps = 13/137 (9%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL---YSTVTLRQGEKK 62
+ +++L + L F + + + + PEL +T++ + +
Sbjct: 233 RPVDIVLDQRGG-VFLTGFEHLVRDG---ARVVSSVSRGFEPPELEARRATISYHRDRRT 288
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
D ++ G+V++ + LP F+ ++I + +++
Sbjct: 289 LMTFSFDAWALGLVIYWIWCADLPITK-DAALGGSEWIFRS-----CKNIPQPVRALLEG 342
Query: 123 CWVEDPNLRPSFSQIIR 139
R Q +
Sbjct: 343 FLRYPKEDRLLPLQAME 359
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-23
Identities = 41/171 (23%), Positives = 71/171 (41%), Gaps = 30/171 (17%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKH 63
N+L+ + +K+ DFGLA+ E G +WMA E L+
Sbjct: 147 NVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI---------- 195
Query: 64 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
Y ++ DV+S+G+ +WEL+T P++G+ + + K R P + D+ I+
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPICTIDVYMIMVK 254
Query: 123 CWVEDPNLRPSFSQIIRMLNAFL------------FTLRPPSPSVPESDTN 161
CW+ D + RP F ++I + + PSP+
Sbjct: 255 CWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRA 305
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 8e-23
Identities = 33/135 (24%), Positives = 55/135 (40%), Gaps = 24/135 (17%)
Query: 20 KLADFGLAREETVTEMMTAETGTY--RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGI 75
KL DFGL+R + A +WM+PE + + DV+ F +
Sbjct: 153 KLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR----------FTTASDVWMFAV 202
Query: 76 VLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNL 130
+WE+L+ + PF + N G P+ P L ++ CW DP+
Sbjct: 203 CMWEILSFGKQPFFWLENKDV-----IGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSD 257
Query: 131 RPSFSQIIRMLNAFL 145
RP F++++ L+
Sbjct: 258 RPRFTELVCSLSDVY 272
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-22
Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 23/146 (15%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 65
N+LLT K+ DFGLAR+ + +WMAPE ++ Y
Sbjct: 194 NVLLTNG-HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE-----SIFDCV---YT 244
Query: 66 NKVDVYSFGIVLWELLT-NRLPFEG-MSNLQAAYAAAFKHARPGL----PEDISPDLAFI 119
+ DV+S+GI+LWE+ + P+ G + N + +K + G P ++ I
Sbjct: 245 VQSDVWSYGILLWEIFSLGLNPYPGILVNSKF-----YKLVKDGYQMAQPAFAPKNIYSI 299
Query: 120 VQSCWVEDPNLRPSFSQIIRMLNAFL 145
+Q+CW +P RP+F QI L
Sbjct: 300 MQACWALEPTHRPTFQQICSFLQEQA 325
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-22
Identities = 46/173 (26%), Positives = 71/173 (41%), Gaps = 37/173 (21%)
Query: 20 KLADFGLARE-ETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSF 73
K++DFGL R E E G RW +PE Y + + + DV+S+
Sbjct: 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY----------RKFTSASDVWSY 236
Query: 74 GIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDP 128
GIVLWE+++ P+ MSN K G P D L ++ CW +D
Sbjct: 237 GIVLWEVMSYGERPYWEMSNQDV-----IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDR 291
Query: 129 NLRPSFSQIIRMLNAFL-----------FTLRPPSPSVPESDTNEAAATSNGA 170
N RP F QI+ +L+ + RP + + +S+ + + G
Sbjct: 292 NNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGD 344
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-22
Identities = 37/140 (26%), Positives = 60/140 (42%), Gaps = 18/140 (12%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMM-TAETGT---YRWMAPE--LYSTVTLRQGEKK 62
NLLL + +K+ DFGL R + + + W APE T
Sbjct: 151 NLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT--------- 200
Query: 63 HYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQ 121
+++ D + FG+ LWE+ T + P+ G++ Q + + R PED D+ ++
Sbjct: 201 -FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMV 259
Query: 122 SCWVEDPNLRPSFSQIIRML 141
CW P RP+F + L
Sbjct: 260 QCWAHKPEDRPTFVALRDFL 279
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-22
Identities = 36/165 (21%), Positives = 66/165 (40%), Gaps = 21/165 (12%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVT----------EMMTAETGTYRWMAPELYSTV 54
+K N+LL D+ L D G + + + A+ T + APEL
Sbjct: 160 LKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL---F 215
Query: 55 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPEDIS 113
+++ + + DV+S G VL+ ++ P++ + + A A + S
Sbjct: 216 SVQSHCV--IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHS 273
Query: 114 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPES 158
L ++ S DP+ RP ++ L A L+PP+P +
Sbjct: 274 SALWQLLNSMMTVDPHQRPHIPLLLSQLEA----LQPPAPGQHTT 314
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-22
Identities = 42/171 (24%), Positives = 76/171 (44%), Gaps = 25/171 (14%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+K N+L+ + K+LK+ DFG+A+ E ++T+ GT ++ +PE Q +
Sbjct: 137 IKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNHV-LGTVQYFSPE--------QAKG 186
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR---PGLP----EDISP 114
+ + D+YS GIVL+E+L PF G + + A KH + P + +DI
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI----KHIQDSVPNVTTDVRKDIPQ 242
Query: 115 DLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFLFTLRPPSPSVPESDTNEAA 164
L+ ++ +D R + ++ L++ L R A
Sbjct: 243 SLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYELDKMKTIA 293
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-22
Identities = 37/171 (21%), Positives = 65/171 (38%), Gaps = 41/171 (23%)
Query: 9 NLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKK 62
N+LL + + +K+ DFGLA+ E W APE
Sbjct: 164 NVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK--------- 213
Query: 63 HYNNKVDVYSFGIVLWELLT---------------NRLPFEGMSNLQAAYAAAFKHARPG 107
+ DV+SFG+ L+ELLT + M+ L+ + G
Sbjct: 214 -FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL-----TELLERG 267
Query: 108 ----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS 154
P+ ++ ++++CW + + RP+F +I +L + +PS
Sbjct: 268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS 318
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 2e-22
Identities = 37/163 (22%), Positives = 71/163 (43%), Gaps = 22/163 (13%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMM-TAETGT---YRWMAPE--LYSTVTLRQGEKK 62
N+LL ++ K++DFGL++ + TA + +W APE +
Sbjct: 466 NVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--------- 515
Query: 63 HYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQ 121
++++ DV+S+G+ +WE L+ + P++ M + A + R P + P+L ++
Sbjct: 516 -FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIEQGKRMECPPECPPELYALMS 573
Query: 122 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAA 164
CW+ RP F + + + A + V E A
Sbjct: 574 DCWIYKWEDRPDFLTVEQRMRAC---YYSLASKVEGGSALEVA 613
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-22
Identities = 22/134 (16%), Positives = 48/134 (35%), Gaps = 14/134 (10%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
+ D ++ K+ D G T E G R++A E+ L+ E +
Sbjct: 160 EGDEDDWASNKVMFKIGDLGHV---TRISSPQVEEGDSRFLANEV-----LQ--ENYTHL 209
Query: 66 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 125
K D+++ + + + + P +P+ +S + +++
Sbjct: 210 PKADIFALALTVVCAAGAEPLPRNGD----QWHEIRQGRLPRIPQVLSQEFTELLKVMIH 265
Query: 126 EDPNLRPSFSQIIR 139
DP RPS +++
Sbjct: 266 PDPERRPSAMALVK 279
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 8e-22
Identities = 43/180 (23%), Positives = 81/180 (45%), Gaps = 25/180 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET----GTYRWMAPELYSTVTLRQGE 60
+K N++++ +K+ DFG+AR + +T GT ++++PE Q
Sbjct: 142 VKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE--------QAR 192
Query: 61 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR------PGLPEDISP 114
+ + DVYS G VL+E+LT PF G S + AY +H R E +S
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY----QHVREDPIPPSARHEGLSA 248
Query: 115 DLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFLFTLRPPSPS-VPESDTNEAAATSNGAMT 172
DL +V ++P R + +++ L P +P + +++ +++ G ++
Sbjct: 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTSLLSSAAGNLS 308
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-21
Identities = 35/163 (21%), Positives = 57/163 (34%), Gaps = 30/163 (18%)
Query: 5 MKEDNLLLTP---DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+K N++ Q KL DFG ARE E + GT ++ P++Y LR+ +
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQ 197
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ--------------AAYAAAFKHARPG 107
K Y VD++S G+ + T LPF + + + + A G
Sbjct: 198 KKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENG 257
Query: 108 -------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQI 137
L + L ++ + D F Q
Sbjct: 258 PIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 1e-21
Identities = 35/171 (20%), Positives = 57/171 (33%), Gaps = 30/171 (17%)
Query: 5 MKEDNLLLTPD---QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+K N++ Q KL DFG ARE E + GT ++ P++Y LR+ +
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQ 197
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-----------LQAAYAAAFKHARPG--- 107
K Y VD++S G+ + T LPF + + A +
Sbjct: 198 KKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENG 257
Query: 108 -------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145
L + L ++ + D F Q + L
Sbjct: 258 PIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 5e-21
Identities = 35/182 (19%), Positives = 68/182 (37%), Gaps = 28/182 (15%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVT-------------EMMTAETGTYRWMAPELY 51
+K +NLLL+ +Q ++KL DFG A + E T + PE+
Sbjct: 164 LKVENLLLS-NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222
Query: 52 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 111
+ K D+++ G +L+ L + PFE + L + + +P
Sbjct: 223 DLYS-----NFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------RIVNGKYSIPPH 271
Query: 112 --ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSNG 169
++++ +P R S ++++ L + R +P P ++ E
Sbjct: 272 DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE-IAAARNVNPKSPITELLEQNGGYGS 330
Query: 170 AM 171
A
Sbjct: 331 AT 332
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 87.8 bits (217), Expect = 9e-21
Identities = 16/158 (10%), Positives = 43/158 (27%), Gaps = 13/158 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
++ +++L + L F + + + A + Q
Sbjct: 237 LRPVDIVLDQRG-GVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPF---GQHHPT 292
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
D ++ G+ ++ + LP F+ ++I + +++
Sbjct: 293 LMTFAFDTWTLGLAIYWIWCADLPNTD-DAALGGSEWIFRS-----CKNIPQPVRALLEG 346
Query: 123 CWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDT 160
R Q + + S ++P T
Sbjct: 347 FLRYPKEDRLLPLQAMET-PEYEQLRTELSAALPLYQT 383
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-20
Identities = 38/162 (23%), Positives = 60/162 (37%), Gaps = 41/162 (25%)
Query: 9 NLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKK 62
N+L+ + +K+ DFGL + ET E T + W APE + S
Sbjct: 156 NVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK--------- 205
Query: 63 HYNNKVDVYSFGIVLWELLT---------------NRLPFEGMSNLQAAYAAAFKHARPG 107
+ DV+SFG+ L ELLT M+ + + G
Sbjct: 206 -FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL-----VNTLKEG 259
Query: 108 ----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145
P + ++ +++ CW P+ R SF +I A L
Sbjct: 260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-20
Identities = 33/163 (20%), Positives = 56/163 (34%), Gaps = 42/163 (25%)
Query: 9 NLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKK 62
N+L+ ++ +K+ DFGL + E + W APE S
Sbjct: 144 NILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK--------- 193
Query: 63 HYNNKVDVYSFGIVLWELLT----------------NRLPFEGMSNLQAAYAAAFKHARP 106
++ DV+SFG+VL+EL T M + +
Sbjct: 194 -FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL-----IELLKN 247
Query: 107 G----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145
P+ ++ I+ CW + N RPSF + ++
Sbjct: 248 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-20
Identities = 33/163 (20%), Positives = 56/163 (34%), Gaps = 42/163 (25%)
Query: 9 NLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKK 62
N+L+ ++ +K+ DFGL + E + W APE S
Sbjct: 175 NILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK--------- 224
Query: 63 HYNNKVDVYSFGIVLWELLT----------------NRLPFEGMSNLQAAYAAAFKHARP 106
++ DV+SFG+VL+EL T M + +
Sbjct: 225 -FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL-----IELLKN 278
Query: 107 G----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145
P+ ++ I+ CW + N RPSF + ++
Sbjct: 279 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 2e-20
Identities = 18/142 (12%), Positives = 39/142 (27%), Gaps = 16/142 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
DNL + PD L L D + A + + E +
Sbjct: 220 FTPDNLFIMPDG-RLMLGDVSALWKVG--TRGPASSVPVTYAPREF------LNASTATF 270
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE-------DISPDLA 117
+ ++ + G+ ++ + LPF ++ PG + +
Sbjct: 271 THALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVK 330
Query: 118 FIVQSCWVEDPNLRPSFSQIIR 139
++ D R + +
Sbjct: 331 TLIGRFLNFDRRRRLLPLEAME 352
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-19
Identities = 35/133 (26%), Positives = 57/133 (42%), Gaps = 6/133 (4%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
K N+LL ++ +KL DFG++ + G +MAPE + Y+
Sbjct: 152 KPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKP---DYD 207
Query: 66 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI--SPDLAFIVQSC 123
+ DV+S GI L EL T + P++ + P LP + S D V+ C
Sbjct: 208 IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDC 267
Query: 124 WVEDPNLRPSFSQ 136
+D RP +++
Sbjct: 268 LTKDHRKRPKYNK 280
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-19
Identities = 38/181 (20%), Positives = 62/181 (34%), Gaps = 43/181 (23%)
Query: 9 NLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKK 62
N+L+ + +K+ADFGLA+ + W APE +
Sbjct: 157 NILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI--------- 206
Query: 63 HYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGL------------- 108
++ + DV+SFG+VL+EL T A + R
Sbjct: 207 -FSRQSDVWSFGVVLYELFTYCDKSCSPS----AEFLRMMGCERDVPALSRLLELLEEGQ 261
Query: 109 ----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR----PPSPSVPESDT 160
P ++ +++ CW P RPSFS + L+ R + PE
Sbjct: 262 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKH 321
Query: 161 N 161
+
Sbjct: 322 H 322
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-18
Identities = 30/143 (20%), Positives = 54/143 (37%), Gaps = 15/143 (10%)
Query: 5 MKEDNLLLTPDQKS----LKLADFGLAR----EETVTEMMTAETGTYRWMAPELYSTVTL 56
+K N+L++ ++DFGL + + GT W+APE+ L
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM-----L 198
Query: 57 RQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYA-AAFKHARPGLPEDISP 114
+ K++ VD++S G V + +++ PF QA A +
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDV 258
Query: 115 DLAFIVQSCWVEDPNLRPSFSQI 137
+++ DP RPS +
Sbjct: 259 IARELIEKMIAMDPQKRPSAKHV 281
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-18
Identities = 31/132 (23%), Positives = 54/132 (40%), Gaps = 6/132 (4%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
K N+L+ +K+ DFG++ + G +MAPE + +K Y+
Sbjct: 137 KPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE----RINPELNQKGYS 191
Query: 66 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI-SPDLAFIVQSCW 124
K D++S GI + EL R P++ + P LP D S + C
Sbjct: 192 VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCL 251
Query: 125 VEDPNLRPSFSQ 136
++ RP++ +
Sbjct: 252 KKNSKERPTYPE 263
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-18
Identities = 38/138 (27%), Positives = 67/138 (48%), Gaps = 10/138 (7%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKH 63
K N+L+T + ++LADFG++ + T + ++ GT WMAPE+ V +
Sbjct: 144 KAGNVLMT-LEGDIRLADFGVSAKNLKT-LQKRDSFIGTPYWMAPEV---VMCETMKDTP 198
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQ 121
Y+ K D++S GI L E+ P ++ ++ A K P L P S + ++
Sbjct: 199 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSDPPTLLTPSKWSVEFRDFLK 257
Query: 122 SCWVEDPNLRPSFSQIIR 139
++P RPS +Q++
Sbjct: 258 IALDKNPETRPSAAQLLE 275
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-18
Identities = 34/138 (24%), Positives = 65/138 (47%), Gaps = 13/138 (9%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-GTYRWMAPELYSTVTLRQGEKKHY 64
K NLL+ + +K+ADFG++ E ++ + + T GT +MAPE S +K +
Sbjct: 164 KPSNLLVG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLS------ETRKIF 216
Query: 65 N-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQ 121
+ +DV++ G+ L+ + + PF + ++ K P+ DI+ DL ++
Sbjct: 217 SGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKI-KSQALEFPDQPDIAEDLKDLIT 274
Query: 122 SCWVEDPNLRPSFSQIIR 139
++P R +I
Sbjct: 275 RMLDKNPESRIVVPEIKL 292
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-18
Identities = 42/156 (26%), Positives = 61/156 (39%), Gaps = 31/156 (19%)
Query: 6 KEDNLLLTPDQK-SLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
K N+LL D+ K+ DFG+++ E T + T GT ++ PE +
Sbjct: 166 KSINILL--DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK-------- 215
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPF-----EGMSNLQAAYAAAFKHAR-------PGLP 109
K DVYSFG+VL+E+L R M NL A +A + P L
Sbjct: 216 GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL-AEWAVESHNNGQLEQIVDPNLA 274
Query: 110 EDISPDLAF----IVQSCWVEDPNLRPSFSQIIRML 141
+ I P+ C RPS ++ L
Sbjct: 275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 4e-18
Identities = 34/140 (24%), Positives = 53/140 (37%), Gaps = 27/140 (19%)
Query: 20 KLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76
K++DFGLAR + T M + GT +MAPE G K D+YSFG+V
Sbjct: 173 KISDFGLARASEKFAQTVMTSRIVGTTAYMAPE-ALR-----G---EITPKSDIYSFGVV 223
Query: 77 LWELLTNRLPFE---GMSNLQAAYAAAFKHARPGLPEDISPDL-----------AFIVQS 122
L E++T + L + + + I + +
Sbjct: 224 LLEIITGLPAVDEHREPQLL-LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQ 282
Query: 123 CWVEDPNLRPSFSQIIRMLN 142
C E N RP ++ ++L
Sbjct: 283 CLHEKKNKRPDIKKVQQLLQ 302
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-18
Identities = 37/163 (22%), Positives = 65/163 (39%), Gaps = 33/163 (20%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+K +N+L++ D L DFG+A +E +T++ GT +MAPE + +
Sbjct: 160 VKPENILVSADDF-AYLVDFGIASATTDEKLTQLGNT-VGTLYYMAPE--------RFSE 209
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH----------ARPGLPED 111
H + D+Y+ VL+E LT P++G + H RPG+P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPYQGDQ-----LSVMGAHINQAIPRPSTVRPGIP-- 262
Query: 112 ISPDLAFIVQSCWVEDPNLR-PSFSQIIRMLNAFLFTLRPPSP 153
++ ++P R + + +A L T
Sbjct: 263 --VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRA 303
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 80.1 bits (197), Expect = 6e-18
Identities = 34/137 (24%), Positives = 57/137 (41%), Gaps = 15/137 (10%)
Query: 5 MKEDNLLL--TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +N++L P + K+ D G A+E E+ T GT +++APEL E+K
Sbjct: 147 LKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL--------EQK 198
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSN--LQAAYAAAFKHARPGLPEDISPDLAFIV 120
Y VD +SFG + +E +T PF + + +D++ + F
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKF-- 256
Query: 121 QSCWVEDPNLRPSFSQI 137
S + PN
Sbjct: 257 -SSVLPTPNHLSGILAG 272
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-17
Identities = 38/137 (27%), Positives = 67/137 (48%), Gaps = 9/137 (6%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKH 63
K N+LLT + +KL DFG++ + T + T GT WMAPE+ + +
Sbjct: 156 KGQNVLLT-ENAEVKLVDFGVSAQLDRT-VGRRNTFIGTPYWMAPEV---IACDENPDAT 210
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL-PEDISPDLAFIVQS 122
Y+ K D++S GI E+ P M ++A + ++ P L + S ++S
Sbjct: 211 YDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-RNPAPRLKSKKWSKKFQSFIES 269
Query: 123 CWVEDPNLRPSFSQIIR 139
C V++ + RP+ Q+++
Sbjct: 270 CLVKNHSQRPATEQLMK 286
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-17
Identities = 41/130 (31%), Positives = 65/130 (50%), Gaps = 13/130 (10%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKH 63
K N+LL+ + +KLADFG+A + T T + T GT WMAPE V +
Sbjct: 146 KAANVLLS-EHGEVKLADFGVAGQLTDT-QIKRNTFVGTPFWMAPE----VIKQSA---- 195
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
Y++K D++S GI EL P + ++ + K+ P L + S L V++C
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEAC 254
Query: 124 WVEDPNLRPS 133
++P+ RP+
Sbjct: 255 LNKEPSFRPT 264
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-17
Identities = 32/137 (23%), Positives = 61/137 (44%), Gaps = 16/137 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K +NLLL + LK+ADFG + GT ++ PE+ E +
Sbjct: 135 IKPENLLLGSAGE-LKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMI--------EGR 182
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
++ KVD++S G++ +E L + PFE + Q Y + P+ ++ ++
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISR-VEFTFPDFVTEGARDLISR 240
Query: 123 CWVEDPNLRPSFSQIIR 139
+P+ RP +++
Sbjct: 241 LLKHNPSQRPMLREVLE 257
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-17
Identities = 27/154 (17%), Positives = 59/154 (38%), Gaps = 22/154 (14%)
Query: 5 MKEDNLLLTPDQKS------------LKLADFGLAR-----EETVTEMMTAETGTYRWMA 47
+K N+L++ + + ++DFGL + + + + +GT W A
Sbjct: 141 LKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRA 200
Query: 48 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAA---FKH 103
PEL Q K+ +D++S G V + +L+ + PF + ++
Sbjct: 201 PELLEESNNLQT-KRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDE 259
Query: 104 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 137
+ + + ++ DP RP+ ++
Sbjct: 260 MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-17
Identities = 36/132 (27%), Positives = 59/132 (44%), Gaps = 9/132 (6%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 68
N+LL ++KL DFG++ + + T + G +MAPE ++ Y+ +
Sbjct: 156 NILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE----RIDPSASRQGYDVRS 210
Query: 69 DVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI----SPDLAFIVQSCW 124
DV+S GI L+EL T R P+ +++ K P L SP V C
Sbjct: 211 DVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCL 270
Query: 125 VEDPNLRPSFSQ 136
+D + RP + +
Sbjct: 271 TKDESKRPKYKE 282
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-17
Identities = 48/155 (30%), Positives = 71/155 (45%), Gaps = 17/155 (10%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKH 63
K DN+LL S+KL DFG + T T GT WMAPE+ + +K
Sbjct: 143 KSDNILLG-MDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVVT--------RKA 192
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQ 121
Y KVD++S GI+ E++ P+ + L+A Y A + P L PE +S +
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLN 251
Query: 122 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 156
C D R S ++++ + FL +P S P
Sbjct: 252 RCLEMDVEKRGSAKELLQ--HQFLKIAKPLSSLTP 284
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-17
Identities = 30/135 (22%), Positives = 57/135 (42%), Gaps = 18/135 (13%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
K++N+L+ ++ LKL DFG T + GT + PE Y+
Sbjct: 176 KDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIR--------YHRYH 226
Query: 66 -NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
V+S GI+L++++ +PFE + + + +S + +++ C
Sbjct: 227 GRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQVFFRQRVSSECQHLIRWCL 278
Query: 125 VEDPNLRPSFSQIIR 139
P+ RP+F +I
Sbjct: 279 ALRPSDRPTFEEIQN 293
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 4e-17
Identities = 30/154 (19%), Positives = 48/154 (31%), Gaps = 25/154 (16%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K +N++LT +Q LKL D G + GT + APE+ T
Sbjct: 208 LKPENIMLTEEQ--LKLIDLGAVSRINSFGYLY---GTPGFQAPEIVRT---------GP 253
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE-DISPDLAFIVQSC 123
D+Y+ G L L + G P +++
Sbjct: 254 TVATDIYTVGRTLAALTLDLPTRNG---------RYVDGLPEDDPVLKTYDSYGRLLRRA 304
Query: 124 WVEDPNLRP-SFSQIIRMLNAFLFTLRPPSPSVP 156
DP R + ++ L L + VP
Sbjct: 305 IDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVP 338
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-17
Identities = 43/136 (31%), Positives = 70/136 (51%), Gaps = 12/136 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLA-REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K NL L + +K+ DFGLA + E E GT ++APE+ S KK
Sbjct: 141 LKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS--------KKG 191
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
++ +VDV+S G +++ LL + PFE S L+ Y K +P+ I+P A ++Q
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRI-KKNEYSIPKHINPVAASLIQKM 249
Query: 124 WVEDPNLRPSFSQIIR 139
DP RP+ ++++
Sbjct: 250 LQTDPTARPTINELLN 265
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-17
Identities = 29/149 (19%), Positives = 57/149 (38%), Gaps = 26/149 (17%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 68
N+L+ + +KL+DFG + ++ + GTY +M PE +S E + KV
Sbjct: 182 NILMDKN-GRVKLSDFGESEYMVDKKIKGSR-GTYEFMPPEFFS------NESSYNGAKV 233
Query: 69 DVYSFGIVLWELLTNRLPFEGMSNLQAAY------------------AAAFKHARPGLPE 110
D++S GI L+ + N +PF +L +
Sbjct: 234 DIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNN 293
Query: 111 DISPDLAFIVQSCWVEDPNLRPSFSQIIR 139
+S + ++ ++P R + ++
Sbjct: 294 FLSNEDIDFLKLFLRKNPAERITSEDALK 322
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-17
Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 15/161 (9%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
K +NLLL ++K+ADFG + E TV + A G + APEL+ K Y+
Sbjct: 141 KAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ--------GKKYD 191
Query: 66 -NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
+VDV+S G++L+ L++ LPF+G NL+ + +P +S D +++
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR-ERVLRGKYRIPFYMSTDCENLLKRFL 249
Query: 125 VEDPNLRPSFSQIIR---MLNAFLFTLRPPSPSVPESDTNE 162
V +P R + QI++ + P +++
Sbjct: 250 VLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQ 290
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-17
Identities = 39/153 (25%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
K +N+LL + K+ADFGL+ + E + G+ + APE+ S + Y
Sbjct: 138 KPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS--------GRLYA 188
Query: 66 -NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
+VD++S G++L+ LL LPF+ ++ + +PE ++ +A ++
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRG-GVFYIPEYLNRSVATLLMHML 246
Query: 125 VEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPE 157
DP R + I F PS PE
Sbjct: 247 QVDPLKRATIKDIREHE---WFKQDLPSYLFPE 276
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 7e-17
Identities = 33/140 (23%), Positives = 63/140 (45%), Gaps = 20/140 (14%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLA-REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+ NLLLT ++K+ADFGLA + + E GT +++PE+ + +
Sbjct: 138 LTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT--------RSA 188
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY----AAAFKHARPGLPEDISPDLAFI 119
+ + DV+S G + + LL R PF+ ++ A ++ +P +S + +
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPPFDT-DTVKNTLNKVVLADYE-----MPSFLSIEAKDL 242
Query: 120 VQSCWVEDPNLRPSFSQIIR 139
+ +P R S S ++
Sbjct: 243 IHQLLRRNPADRLSLSSVLD 262
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-17
Identities = 41/162 (25%), Positives = 65/162 (40%), Gaps = 14/162 (8%)
Query: 6 KEDNLLLTPDQKSLKLADFGLA---REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
K NLLLT +LK++ G+A + G+ + PE+ + G
Sbjct: 136 KPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN------GLDT 188
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
KVD++S G+ L+ + T PFEG N+ + K +P D P L+ +++
Sbjct: 189 FSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGK-GSYAIPGDCGPPLSDLLKG 246
Query: 123 CWVEDPNLRPSFSQIIRM--LNAFLFTLRPPSPSVPESDTNE 162
+P R S QI + P P P DT +
Sbjct: 247 MLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKD 288
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-16
Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 17/155 (10%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKH 63
K D++LLT +KL+DFG + + + ++ GT WMAPE+ S +
Sbjct: 168 KSDSILLT-LDGRVKLSDFGFCAQISKD-VPKRKSLVGTPYWMAPEVIS--------RSL 217
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQ 121
Y +VD++S GI++ E++ P+ S +QA P L +SP L ++
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR-DSPPPKLKNSHKVSPVLRDFLE 276
Query: 122 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 156
V DP R + +++ + FL P VP
Sbjct: 277 RMLVRDPQERATAQELLD--HPFLLQTGLPECLVP 309
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-16
Identities = 40/132 (30%), Positives = 60/132 (45%), Gaps = 15/132 (11%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKH 63
K N+LL + KLADFG+A + T T M T GT WMAPE+ +
Sbjct: 152 KAGNILLN-TEGHAKLADFGVAGQLTDT-MAKRNTVIGTPFWMAPEVIQ--------EIG 201
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQ 121
YN D++S GI E+ + P+ + ++A + + P PE S + V+
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP-TNPPPTFRKPELWSDNFTDFVK 260
Query: 122 SCWVEDPNLRPS 133
C V+ P R +
Sbjct: 261 QCLVKSPEQRAT 272
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-16
Identities = 43/136 (31%), Positives = 70/136 (51%), Gaps = 12/136 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLA-REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K NL L + +K+ DFGLA + E E GT ++APE+ S KK
Sbjct: 167 LKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS--------KKG 217
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
++ +VDV+S G +++ LL + PFE S L+ Y K +P+ I+P A ++Q
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRI-KKNEYSIPKHINPVAASLIQKM 275
Query: 124 WVEDPNLRPSFSQIIR 139
DP RP+ ++++
Sbjct: 276 LQTDPTARPTINELLN 291
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-16
Identities = 32/143 (22%), Positives = 61/143 (42%), Gaps = 16/143 (11%)
Query: 6 KEDNLLLTPDQKS-LKLADFGLAR-----EETVTEMMTAETGTYRWMAPELYSTVTLRQG 59
K +N L + ++ +KL DFGL++ MT + GT ++APE+ L
Sbjct: 195 KPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV-----LN-T 248
Query: 60 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISPDL 116
+ Y K D +S G++L LL +PF G+++ + P +SP
Sbjct: 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYN-VLSPLA 307
Query: 117 AFIVQSCWVEDPNLRPSFSQIIR 139
++ + + + R + ++
Sbjct: 308 RDLLSNLLNRNVDERFDAMRALQ 330
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-16
Identities = 33/130 (25%), Positives = 57/130 (43%), Gaps = 11/130 (8%)
Query: 5 MKEDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
MK DN+LL D+ + + DF +A +T GT +MAPE+ +
Sbjct: 141 MKPDNILL--DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEM-----FSSRKGAG 193
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMS--NLQAAYAAAFKHARPGLPEDISPDLAFIVQ 121
Y+ VD +S G+ +ELL R P+ S + + F+ P S ++ +++
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV-HTFETTVVTYPSAWSQEMVSLLK 252
Query: 122 SCWVEDPNLR 131
+P+ R
Sbjct: 253 KLLEPNPDQR 262
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-16
Identities = 33/135 (24%), Positives = 57/135 (42%), Gaps = 18/135 (13%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
K++N+L+ + KL DFG + GT + PE S + Y+
Sbjct: 166 KDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-GTRVYSPPEWIS--------RHQYH 216
Query: 66 -NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
V+S GI+L++++ +PFE + A P +SPD +++ C
Sbjct: 217 ALPATVWSLGILLYDMVCGDIPFERDQEI--------LEAELHFPAHVSPDCCALIRRCL 268
Query: 125 VEDPNLRPSFSQIIR 139
P+ RPS +I+
Sbjct: 269 APKPSSRPSLEEILL 283
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-16
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
K +NLLL D ++K+ADFGL+ T + G+ + APE+ + K Y
Sbjct: 135 KPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN--------GKLYA 185
Query: 66 -NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
+VDV+S GIVL+ +L RLPF+ + + +P+ +SP +++
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKV-NSCVYVMPDFLSPGAQSLIRRMI 243
Query: 125 VEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNE 162
V DP R + +I R F + P P +
Sbjct: 244 VADPMQRITIQEIRRDP---WFNVNLPDYLRPMEEVQG 278
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-16
Identities = 29/134 (21%), Positives = 52/134 (38%), Gaps = 12/134 (8%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
K +NLL+ + LK+ADFG + T GT ++ PE+ E K ++
Sbjct: 141 KPENLLMG-YKGELKIADFGWSVHAPSLRRRTM-CGTLDYLPPEMI--------EGKTHD 190
Query: 66 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 125
KVD++ G++ +E L PF+ + + P +S ++
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVN-VDLKFPPFLSDGSKDLISKLLR 248
Query: 126 EDPNLRPSFSQIIR 139
P R ++
Sbjct: 249 YHPPQRLPLKGVME 262
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-16
Identities = 36/143 (25%), Positives = 62/143 (43%), Gaps = 18/143 (12%)
Query: 6 KEDNLLLTPDQK--SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
K +N+LL+ ++ +K+ DFG ++ T +M GT ++APE+ L
Sbjct: 266 KPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV-----LVSVGTAG 320
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE----DISP---DL 116
YN VD +S G++L+ L+ PF Q + + ++S DL
Sbjct: 321 YNRAVDCWSLGVILFICLSGYPPFSE-HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDL 379
Query: 117 AFIVQSCWVEDPNLRPSFSQIIR 139
V+ V DP R + + +R
Sbjct: 380 ---VKKLLVVDPKARFTTEEALR 399
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 5e-16
Identities = 36/138 (26%), Positives = 64/138 (46%), Gaps = 15/138 (10%)
Query: 5 MKEDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +NLLL + ++ + +K+ DFGL+ + M GT ++APE+ +K
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL---------RK 212
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISPDLAFI 119
Y+ K DV+S G++L+ LL PF G ++ L+ + P ++S +
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK-NVSEGAKDL 271
Query: 120 VQSCWVEDPNLRPSFSQI 137
++ D R S Q
Sbjct: 272 IKQMLQFDSQRRISAQQA 289
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 7e-16
Identities = 33/138 (23%), Positives = 63/138 (45%), Gaps = 15/138 (10%)
Query: 5 MKEDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +NLLL + + + +++ DFGL+ ++ M + GT ++APE+
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL---------HG 202
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISPDLAFI 119
Y+ K DV+S G++L+ LL+ PF G + L+ + P +S +
Sbjct: 203 TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK-KVSESAKDL 261
Query: 120 VQSCWVEDPNLRPSFSQI 137
++ P++R S
Sbjct: 262 IRKMLTYVPSMRISARDA 279
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 9e-16
Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 5 MKEDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +N+LL + ++ +K+ DFGL+ M GT ++APE+ +
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL---------RG 197
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISPDLAFI 119
Y+ K DV+S G++L+ LL+ PF G + L+ + P IS D +
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR-TISDDAKDL 256
Query: 120 VQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSNGAMTEFSARAR 179
++ P+LR + +Q + + ++ +P++ + + E+A T+ + +F A +
Sbjct: 257 IRKMLTFHPSLRITATQCLE--HPWIQKYSSETPTISDLPSLESAMTN---IRQFQAEKK 311
Query: 180 GKFAFLR----QLFTAKRTKNLQ 198
A L +L T TK L
Sbjct: 312 LAQAALLYMASKLTTLDETKQLT 334
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-15
Identities = 43/131 (32%), Positives = 62/131 (47%), Gaps = 15/131 (11%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKH 63
K N+LL+ + +KL DFG A + M A + GT WMAPE+ + ++
Sbjct: 181 KAGNILLS-EPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEV-----ILAMDEGQ 229
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL-PEDISPDLAFIVQS 122
Y+ KVDV+S GI EL + P M+ + A Y A ++ P L S V S
Sbjct: 230 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPALQSGHWSEYFRNFVDS 288
Query: 123 CWVEDPNLRPS 133
C + P RP+
Sbjct: 289 CLQKIPQDRPT 299
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-15
Identities = 36/132 (27%), Positives = 65/132 (49%), Gaps = 13/132 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K +N+LL + + L DFGL++E E A GT +MAP++ +G
Sbjct: 185 IKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV------RGGDS 237
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK---HARPGLPEDISPDLAFI 119
++ VD +S G++++ELLT PF + + A + + P P+++S +
Sbjct: 238 GHDKAVDWWSLGVLMYELLTGASPFTV-DGEKNSQAEISRRILKSEPPYPQEMSALAKDL 296
Query: 120 VQSCWVEDPNLR 131
+Q ++DP R
Sbjct: 297 IQRLLMKDPKKR 308
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-15
Identities = 33/138 (23%), Positives = 62/138 (44%), Gaps = 15/138 (10%)
Query: 5 MKEDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +N+LL + +K+ DFGL+ + + GT ++APE+ KK
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL---------KK 222
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISPDLAFI 119
YN K DV+S G++++ LL PF G ++ ++ + +IS + +
Sbjct: 223 KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWK-NISDEAKEL 281
Query: 120 VQSCWVEDPNLRPSFSQI 137
++ D N R + +
Sbjct: 282 IKLMLTYDYNKRCTAEEA 299
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-15
Identities = 44/141 (31%), Positives = 66/141 (46%), Gaps = 22/141 (15%)
Query: 5 MKEDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +N+L S +K+ DFGLA E T GT +MAPE++ K+
Sbjct: 150 LKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF---------KR 200
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISP---DL 116
K D++S G+V++ LLT LPF G S Q A +A ++P DL
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE--CRPLTPQAVDL 258
Query: 117 AFIVQSCWVEDPNLRPSFSQI 137
++ +DP RPS +Q+
Sbjct: 259 ---LKQMLTKDPERRPSAAQV 276
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-15
Identities = 40/156 (25%), Positives = 64/156 (41%), Gaps = 28/156 (17%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K N+LL + ++ + DFGLA+ + T + TA GT +APE ST G
Sbjct: 160 VKAANILLDEEFEA-VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----G--- 210
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-----GLPEDISPDL- 116
+ K DV+ +G++L EL+T + F+ + L + DL
Sbjct: 211 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ 270
Query: 117 -----------AFIVQSCWVEDPNLRPSFSQIIRML 141
+ C P RP S+++RML
Sbjct: 271 GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-15
Identities = 38/143 (26%), Positives = 61/143 (42%), Gaps = 24/143 (16%)
Query: 6 KEDNLLLTPDQKSLKLADFG----LAREETVTEMMTAET--GTYRWMAPELYSTVTLRQG 59
K N+LL + S+++ADFG LA +T +T GT WMAPE+
Sbjct: 148 KAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME------- 199
Query: 60 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI------- 112
+ + Y+ K D++SFGI EL T P+ ++ ++ P L +
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-QNDPPSLETGVQDKEMLK 258
Query: 113 --SPDLAFIVQSCWVEDPNLRPS 133
++ C +DP RP+
Sbjct: 259 KYGKSFRKMISLCLQKDPEKRPT 281
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 7e-15
Identities = 37/161 (22%), Positives = 69/161 (42%), Gaps = 15/161 (9%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
K +N+LL + K+ADFGL+ + E + G+ + APE+ S + Y
Sbjct: 143 KPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS--------GRLYA 193
Query: 66 -NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
+VD++S G++L+ LL LPF+ ++ + P+ ++P + +++
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKI-CDGIFYTPQYLNPSVISLLKHML 251
Query: 125 VEDPNLRPSFSQIIR---MLNAFLFTLRPPSPSVPESDTNE 162
DP R + I L P PS + ++
Sbjct: 252 QVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDD 292
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-14
Identities = 36/143 (25%), Positives = 62/143 (43%), Gaps = 18/143 (12%)
Query: 6 KEDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
K +N+LL + ++ +K+ DFG ++ T +M GT ++APE+ L
Sbjct: 141 KPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV-----LVSVGTAG 195
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE----DISP---DL 116
YN VD +S G++L+ L+ PF Q + + ++S DL
Sbjct: 196 YNRAVDCWSLGVILFICLSGYPPFSE-HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDL 254
Query: 117 AFIVQSCWVEDPNLRPSFSQIIR 139
V+ V DP R + + +R
Sbjct: 255 ---VKKLLVVDPKARFTTEEALR 274
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-14
Identities = 39/139 (28%), Positives = 67/139 (48%), Gaps = 14/139 (10%)
Query: 6 KEDNLLLTPDQKSLKLADFGLA---REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
K +NLLL ++ +LK++DFGLA R ++ GT ++APEL ++
Sbjct: 132 KPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK--------RR 182
Query: 63 HYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIV 120
++ VDV+S GIVL +L LP++ S+ Y+ + P + I ++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 121 QSCWVEDPNLRPSFSQIIR 139
VE+P+ R + I +
Sbjct: 243 HKILVENPSARITIPDIKK 261
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-14
Identities = 29/135 (21%), Positives = 57/135 (42%), Gaps = 18/135 (13%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
K++N+++ + ++KL DFG A ++ GT + APE+ Y
Sbjct: 157 KDENIVIA-EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM--------GNPYR 207
Query: 66 -NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
+++++S G+ L+ L+ PF L+ AA P +S +L +V
Sbjct: 208 GPELEMWSLGVTLYTLVFEENPFC---ELEETVEAAIH-----PPYLVSKELMSLVSGLL 259
Query: 125 VEDPNLRPSFSQIIR 139
P R + +++
Sbjct: 260 QPVPERRTTLEKLVT 274
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 6e-14
Identities = 39/223 (17%), Positives = 66/223 (29%), Gaps = 68/223 (30%)
Query: 6 KEDNLLLTPDQKSLKLADFGLA--------REETVTEMMTAETGTYRWMAPELYSTVTLR 57
K ++L++ + L+ R+ V + W++PE+ L+
Sbjct: 155 KASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV-----LQ 208
Query: 58 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA---------------------- 95
Q + Y+ K D+YS GI EL +PF+ M Q
Sbjct: 209 Q-NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEE 267
Query: 96 ----------------------AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 133
+ SP V+ C +P+ RPS
Sbjct: 268 LTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327
Query: 134 ---------FSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATS 167
F QI R + L L P + + +++ S
Sbjct: 328 ASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHS 370
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 7e-14
Identities = 40/167 (23%), Positives = 72/167 (43%), Gaps = 17/167 (10%)
Query: 6 KEDNLLLTPDQKSLKLADFGLA---REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
K +NLLL ++ +LK++DFGLA R ++ GT ++APEL ++
Sbjct: 132 KPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK--------RR 182
Query: 63 HYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIV 120
++ VDV+S GIVL +L LP++ S+ Y+ + P + I ++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 121 QSCWVEDPNLRPSFSQIIR---MLNAFLFTLRPPSPSVPESDTNEAA 164
VE+P+ R + I + + P + + +
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG 289
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 8e-14
Identities = 34/142 (23%), Positives = 56/142 (39%), Gaps = 23/142 (16%)
Query: 5 MKEDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +N L T S LKL DFGLA +MM + GT +++P++ +
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL---------EG 182
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED----ISP---D 115
Y + D +S G++++ LL PF + PE +SP
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKI-REGTFTFPEKDWLNVSPQAES 240
Query: 116 LAFIVQSCWVEDPNLRPSFSQI 137
L ++ + P R + Q
Sbjct: 241 L---IRRLLTKSPKQRITSLQA 259
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 8e-14
Identities = 39/129 (30%), Positives = 70/129 (54%), Gaps = 14/129 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K +N+LL + +KL DFGL++E + A + GT +MAPE V R+G
Sbjct: 152 LKPENILLDEE-GHIKLTDFGLSKES-IDHEKKAYSFCGTVEYMAPE----VVNRRG--- 202
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
+ D +SFG++++E+LT LPF+G + + A+ G+P+ +SP+ +++
Sbjct: 203 -HTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETM-TMILKAKLGMPQFLSPEAQSLLRM 259
Query: 123 CWVEDPNLR 131
+ +P R
Sbjct: 260 LFKRNPANR 268
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-13
Identities = 31/92 (33%), Positives = 43/92 (46%), Gaps = 11/92 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAE--TGTYRWMAPELYSTVTLRQGEKK 62
+K NLLL P LKL DFG A+ E + + YR APEL T
Sbjct: 167 IKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--APELIFGAT------- 217
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
+Y +D++S G V+ EL+ + F G S +
Sbjct: 218 NYTTNIDIWSTGCVMAELMQGQPLFPGESGID 249
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-13
Identities = 41/172 (23%), Positives = 67/172 (38%), Gaps = 19/172 (11%)
Query: 6 KEDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
K +N LL LK+ DFG ++ + + GT ++APE+ ++ Y
Sbjct: 143 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--------RQEY 194
Query: 65 N-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG---LPED--ISPDLAF 118
+ DV+S G+ L+ +L PFE Y + +P+D ISP+
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFED-PEEPRDYRKTIQRILSVKYSIPDDIRISPECCH 253
Query: 119 IVQSCWVEDPNLRPSFSQIIR---MLNAFLFTLRPPSPSVPESDTNEAAATS 167
++ +V DP R S +I L L S + + E S
Sbjct: 254 LISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQS 305
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-13
Identities = 37/129 (28%), Positives = 61/129 (47%), Gaps = 14/129 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K DN+LL + KLADFG+ +E + +T T GT ++APE +
Sbjct: 150 LKLDNVLLDHE-GHCKLADFGMCKEG-ICNGVTTATFCGTPDYIAPE----ILQEML--- 200
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
Y VD ++ G++L+E+L PFE N + A + P + D I++S
Sbjct: 201 -YGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLF-EAILNDEVVYPTWLHEDATGILKS 257
Query: 123 CWVEDPNLR 131
++P +R
Sbjct: 258 FMTKNPTMR 266
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-13
Identities = 35/92 (38%), Positives = 45/92 (48%), Gaps = 11/92 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKK 62
+K NLLL PD LKL DFG A++ E + + YR APEL T
Sbjct: 182 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APELIFGAT------- 232
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
Y + +DV+S G VL ELL + F G S +
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-13
Identities = 32/136 (23%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K DN+LL + +KL D+G+ +E + T T GT ++APE + +
Sbjct: 179 LKLDNVLLDSE-GHIKLTDYGMCKEG-LRPGDTTSTFCGTPNYIAPE----ILRGED--- 229
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA-------AAFKHARPGLPEDISPD 115
Y VD ++ G++++E++ R PF+ + + + +P +S
Sbjct: 230 -YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 288
Query: 116 LAFIVQSCWVEDPNLR 131
A +++S +DP R
Sbjct: 289 AASVLKSFLNKDPKER 304
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-13
Identities = 21/92 (22%), Positives = 41/92 (44%), Gaps = 10/92 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM-APELYSTVTLRQGEKKH 63
+K N+++ + + L+L D+GLA + + R+ PEL +
Sbjct: 156 VKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFKGPELLVDY-------QM 207
Query: 64 YNNKVDVYSFGIVLWELLTNRLP-FEGMSNLQ 94
Y+ +D++S G +L ++ + P F G N
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 239
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-13
Identities = 32/136 (23%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K DN+LL + +KL D+G+ +E + T T GT ++APE + +
Sbjct: 136 LKLDNVLLDSE-GHIKLTDYGMCKEG-LRPGDTTSTFCGTPNYIAPE----ILRGED--- 186
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA-------AAFKHARPGLPEDISPD 115
Y VD ++ G++++E++ R PF+ + + + +P +S
Sbjct: 187 -YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 245
Query: 116 LAFIVQSCWVEDPNLR 131
A +++S +DP R
Sbjct: 246 AASVLKSFLNKDPKER 261
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 2e-13
Identities = 33/129 (25%), Positives = 60/129 (46%), Gaps = 14/129 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K +N++L +KL DFGL +E + + T GT +MAPE + +R G
Sbjct: 147 LKPENIMLNHQ-GHVKLTDFGLCKES-IHDGTVTHTFCGTIEYMAPE----ILMRSG--- 197
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
+N VD +S G +++++LT PF G N + + LP ++ + +++
Sbjct: 198 -HNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTI-DKILKCKLNLPPYLTQEARDLLKK 254
Query: 123 CWVEDPNLR 131
+ R
Sbjct: 255 LLKRNAASR 263
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 67.0 bits (163), Expect = 2e-13
Identities = 35/129 (27%), Positives = 65/129 (50%), Gaps = 14/129 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K DN++L + +K+ADFG+ +E + + +T +T GT ++APE + Q
Sbjct: 468 LKLDNVMLDSE-GHIKIADFGMCKEN-IWDGVTTKTFCGTPDYIAPE----IIAYQP--- 518
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
Y VD ++FG++L+E+L + PFEG + + + P+ +S + I +
Sbjct: 519 -YGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELF-QSIMEHNVAYPKSMSKEAVAICKG 575
Query: 123 CWVEDPNLR 131
+ P R
Sbjct: 576 LMTKHPGKR 584
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-13
Identities = 35/129 (27%), Positives = 61/129 (47%), Gaps = 14/129 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K +NL+L D +K+ DFGL +E +++ T +T GT ++APE V
Sbjct: 131 IKLENLMLDKD-GHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPE----VLEDND--- 181
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
Y VD + G+V++E++ RLPF + + + P +SP+ ++
Sbjct: 182 -YGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLF-ELILMEEIRFPRTLSPEAKSLLAG 238
Query: 123 CWVEDPNLR 131
+DP R
Sbjct: 239 LLKKDPKQR 247
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-13
Identities = 51/203 (25%), Positives = 81/203 (39%), Gaps = 31/203 (15%)
Query: 5 MKEDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +NLLL + + + +KLADFGLA E +E GT +++PE+ L+ K
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV-----LK---KD 205
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED----ISP---D 115
Y+ VD+++ G++L+ LL PF Q A K P ++P
Sbjct: 206 PYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQIKAGAYDYPSPEWDTVTPEAKS 263
Query: 116 LAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSNGAMTEFS 175
L + S +P R + Q L R S + +F+
Sbjct: 264 L---IDSMLTVNPKKRITADQA---LKVPWICNRERVASAIHRQDTVD------CLKKFN 311
Query: 176 ARARGKFAFLRQLFTAKRTKNLQ 198
AR + K A L + + NL
Sbjct: 312 ARRKLKGAILTTMIATRNLSNLG 334
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-13
Identities = 36/129 (27%), Positives = 65/129 (50%), Gaps = 14/129 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K DN+LL D +K+ADFG+ +E + T GT ++APE+ +
Sbjct: 144 LKLDNILLDKD-GHIKIADFGMCKEN-MLGDAKTNTFCGTPDYIAPEIL--------LGQ 193
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
YN+ VD +SFG++L+E+L + PF G + + + + + P P + + ++
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELF-HSIRMDNPFYPRWLEKEAKDLLVK 251
Query: 123 CWVEDPNLR 131
+V +P R
Sbjct: 252 LFVREPEKR 260
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 3e-13
Identities = 35/142 (24%), Positives = 63/142 (44%), Gaps = 23/142 (16%)
Query: 5 MKEDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +N+LL + ++ +K+ DFGL+ M GT ++APE+ +
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL---------RG 197
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED----ISP---D 115
Y+ K DV+S G++L+ LL+ PF G + + + + IS D
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 116 LAFIVQSCWVEDPNLRPSFSQI 137
L ++ P+LR + +Q
Sbjct: 256 L---IRKMLTFHPSLRITATQC 274
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-13
Identities = 35/129 (27%), Positives = 55/129 (42%), Gaps = 14/129 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K +N+LL + L DFGL +E + T T GT ++APE V +Q
Sbjct: 165 LKPENILLDSQ-GHIVLTDFGLCKEN-IEHNSTTSTFCGTPEYLAPE----VLHKQP--- 215
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
Y+ VD + G VL+E+L PF N Y + L +I+ +++
Sbjct: 216 -YDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMY-DNILNKPLQLKPNITNSARHLLEG 272
Query: 123 CWVEDPNLR 131
+D R
Sbjct: 273 LLQKDRTKR 281
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 4e-13
Identities = 34/129 (26%), Positives = 60/129 (46%), Gaps = 14/129 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K +NL+L D +K+ DFGL +E + + T +T GT ++APE+ E
Sbjct: 275 LKLENLMLDKD-GHIKITDFGLCKEG-IKDGATMKTFCGTPEYLAPEVL--------EDN 324
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
Y VD + G+V++E++ RLPF + + + P + P+ ++
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLF-ELILMEEIRFPRTLGPEAKSLLSG 382
Query: 123 CWVEDPNLR 131
+DP R
Sbjct: 383 LLKKDPKQR 391
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 4e-13
Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 11/91 (12%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKH 63
K NLL+ +LKL DFG A++ +E A + YR APEL T
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR--APELMLGAT-------E 218
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
Y +D++S G V EL+ + F G +++
Sbjct: 219 YTPSIDLWSIGCVFGELILGKPLFSGETSID 249
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 4e-13
Identities = 30/118 (25%), Positives = 53/118 (44%), Gaps = 13/118 (11%)
Query: 5 MKEDNLLLTPDQKS-LKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEK 61
+K DN+L+ D ++LADFG + + + GT +++PE+ + +G K
Sbjct: 201 IKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI---LQAMEGGK 255
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH----ARPGLPEDISPD 115
Y + D +S G+ ++E+L PF +L Y H P D+S +
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQVTDVSEN 312
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 6e-13
Identities = 35/129 (27%), Positives = 65/129 (50%), Gaps = 14/129 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K DN++L + +K+ADFG+ +E + + +T +T GT ++APE + Q
Sbjct: 147 LKLDNVMLDSE-GHIKIADFGMCKEN-IWDGVTTKTFCGTPDYIAPE----IIAYQP--- 197
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
Y VD ++FG++L+E+L + PFEG + + + P+ +S + I +
Sbjct: 198 -YGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELF-QSIMEHNVAYPKSMSKEAVAICKG 254
Query: 123 CWVEDPNLR 131
+ P R
Sbjct: 255 LMTKHPGKR 263
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 6e-13
Identities = 25/117 (21%), Positives = 48/117 (41%), Gaps = 9/117 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K DN+LL ++LADFG + + + GT +++PE+ V G
Sbjct: 188 IKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGS 246
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR----PGLPEDISPD 115
Y + D ++ G+ +E+ + PF + Y + P + E + +
Sbjct: 247 -YGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPLVDEGVPEE 301
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 7e-13
Identities = 17/111 (15%), Positives = 35/111 (31%), Gaps = 21/111 (18%)
Query: 5 MKEDNLLLTP----------DQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELY 51
+K DN +L L L D G + + + + TA+ T + E+
Sbjct: 198 IKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML 257
Query: 52 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 102
K +N ++D + ++ +L + F+
Sbjct: 258 --------SNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 7e-13
Identities = 26/87 (29%), Positives = 41/87 (47%), Gaps = 11/87 (12%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNN 66
N+L+ +LKL DFG A++ + +E A + YR APEL HY
Sbjct: 161 NVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYR--APELIFGNQ-------HYTT 211
Query: 67 KVDVYSFGIVLWELLTNRLPFEGMSNL 93
VD++S G + E++ F G ++
Sbjct: 212 AVDIWSVGCIFAEMMLGEPIFRGDNSA 238
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-12
Identities = 41/144 (28%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 5 MKEDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +NLL TP + LK+ADFGL++ +M GT + APE+ LR
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI-----LR---GC 225
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE----DISP---D 115
Y +VD++S GI+ + LL PF Q + + ++S D
Sbjct: 226 AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF-RRILNCEYYFISPWWDEVSLNAKD 284
Query: 116 LAFIVQSCWVEDPNLRPSFSQIIR 139
L V+ V DP R + Q ++
Sbjct: 285 L---VRKLIVLDPKKRLTTFQALQ 305
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-12
Identities = 28/130 (21%), Positives = 53/130 (40%), Gaps = 13/130 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K +N+LL D ++++D GLA + + GT +MAPE+ + + Y
Sbjct: 312 LKPENILL-DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--------KNERY 362
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK---HARPGLPEDISPDLAFIVQ 121
D ++ G +L+E++ + PF+ + + E SP +
Sbjct: 363 TFSPDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421
Query: 122 SCWVEDPNLR 131
+DP R
Sbjct: 422 QLLCKDPAER 431
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 3e-12
Identities = 32/132 (24%), Positives = 56/132 (42%), Gaps = 16/132 (12%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K +N+LL D +++++D GLA E + GT +MAPEL +
Sbjct: 315 LKPENVLLD-DDGNVRISDLGLAVEL-KAGQTKTKGYAGTPGFMAPELL--------LGE 364
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK---HARPGLPEDISPDLAFI 119
Y+ VD ++ G+ L+E++ R PF + + P+ SP
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRA-RGEKVENKELKQRVLEQAVTYPDKFSPASKDF 423
Query: 120 VQSCWVEDPNLR 131
++ +DP R
Sbjct: 424 CEALLQKDPEKR 435
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 3e-12
Identities = 40/142 (28%), Positives = 64/142 (45%), Gaps = 22/142 (15%)
Query: 5 MKEDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +NLLL + + + +KLADFGLA E +E GT +++PE+ L+ K
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV-----LK---KD 182
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED----ISP---D 115
Y+ VD+++ G++L+ LL PF Q A K P ++P
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240
Query: 116 LAFIVQSCWVEDPNLRPSFSQI 137
L + S +P R + Q
Sbjct: 241 L---IDSMLTVNPKKRITADQA 259
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 7e-12
Identities = 34/139 (24%), Positives = 53/139 (38%), Gaps = 15/139 (10%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65
K +N+LL D ++KL DFG + + E + GT ++APE+ Y
Sbjct: 151 KPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSM--NDNHPGYG 207
Query: 66 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE----DISP---DLAF 118
+VD++S G++++ LL PF Q D S DL
Sbjct: 208 KEVDMWSTGVIMYTLLAGSPPFWHRK--QMLMLRMIMSGNYQFGSPEWDDYSDTVKDL-- 263
Query: 119 IVQSCWVEDPNLRPSFSQI 137
V V P R + +
Sbjct: 264 -VSRFLVVQPQKRYTAEEA 281
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-12
Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 10/96 (10%)
Query: 5 MKEDNLLLTPDQKS-LKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEK 61
+K DN+LL D+ LKLADFG + M+ +T GT +++PE V QG
Sbjct: 194 VKPDNMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE----VLKSQGGD 247
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 97
+Y + D +S G+ L+E+L PF +L Y
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTY 282
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-11
Identities = 37/147 (25%), Positives = 64/147 (43%), Gaps = 25/147 (17%)
Query: 5 MKEDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +NLL + ++ + LKL DFG A+E T + T T ++APE V +
Sbjct: 154 VKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPE----VLGPEK--- 205
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE-------DISP- 114
Y+ D++S G++++ LL PF + QA + R G ++S
Sbjct: 206 -YDKSCDMWSLGVIMYILLCGFPPFYSNTG-QAISPGMKRRIRLGQYGFPNPEWSEVSED 263
Query: 115 --DLAFIVQSCWVEDPNLRPSFSQIIR 139
L ++ DP R + +Q +
Sbjct: 264 AKQL---IRLLLKTDPTERLTITQFMN 287
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-11
Identities = 33/141 (23%), Positives = 56/141 (39%), Gaps = 17/141 (12%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE-LYSTVTLRQGEKKH 63
+K +N+LL + ++L+DFG + E + GT ++APE L ++
Sbjct: 226 LKPENILLDDN-MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETH---PG 281
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE----DISP---DL 116
Y +VD+++ G++L+ LL PF Q + D S DL
Sbjct: 282 YGKEVDLWACGVILFTLLAGSPPFWHRR--QILMLRMIMEGQYQFSSPEWDDRSSTVKDL 339
Query: 117 AFIVQSCWVEDPNLRPSFSQI 137
+ DP R + Q
Sbjct: 340 ---ISRLLQVDPEARLTAEQA 357
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-11
Identities = 48/201 (23%), Positives = 80/201 (39%), Gaps = 32/201 (15%)
Query: 5 MKEDNLLL-TPDQKS-LKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+K +NLLL + + + +KLADFGLA E E + GT +++PE+ LR K
Sbjct: 136 LKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV-----LR---K 187
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED----ISP--- 114
Y VD+++ G++L+ LL PF Q K P ++P
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPPFWDED--QHRLYQQIKAGAYDFPSPEWDTVTPEAK 245
Query: 115 DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSNGAMTEF 174
DL + +P+ R + ++ L + R S + +F
Sbjct: 246 DL---INKMLTINPSKRITAAEA---LKHPWISHRSTVASCMHRQETVD------CLKKF 293
Query: 175 SARARGKFAFLRQLFTAKRTK 195
+AR + K A L + +
Sbjct: 294 NARRKLKGAILTVMLATRNFS 314
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 3e-11
Identities = 35/174 (20%), Positives = 59/174 (33%), Gaps = 54/174 (31%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR-QGEKKHY 64
K N+L+ + +KL DFG++ + + M + GT +M+PE R QG HY
Sbjct: 159 KPSNILVN-SRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-------RLQGT--HY 207
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR------------------- 105
+ + D++S G+ L E+ R P + +
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 106 ----------------------PGLPEDI-SPDLAFIVQSCWVEDPNLRPSFSQ 136
P LP + S + V C +++P R Q
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-11
Identities = 26/92 (28%), Positives = 40/92 (43%), Gaps = 12/92 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKK 62
+ N+LL + + + DF LARE+T T YR APEL + K
Sbjct: 160 LHPGNILLADNND-ITICDFNLAREDTADANKTHYVTHRWYR--APELV-------MQFK 209
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
+ VD++S G V+ E+ + F G +
Sbjct: 210 GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 6e-11
Identities = 31/129 (24%), Positives = 58/129 (44%), Gaps = 12/129 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+LL + ++++D GLA + + + + GT+ +MAPE+ + Y
Sbjct: 318 LKPANILLD-EHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ-------KGVAY 368
Query: 65 NNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
++ D +S G +L++LL PF + LP+ SP+L +++
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFSPELRSLLEG 427
Query: 123 CWVEDPNLR 131
D N R
Sbjct: 428 LLQRDVNRR 436
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 7e-11
Identities = 28/130 (21%), Positives = 55/130 (42%), Gaps = 14/130 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAET--GTYRWMAPELYSTVTLRQGEK 61
+K +N+LL + +++ DFG A+ ++ A + GT ++++PEL +
Sbjct: 156 LKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL--------TE 206
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQ 121
K D+++ G ++++L+ PF N + PE P +V+
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIF-QKIIKLEYDFPEKFFPKARDLVE 264
Query: 122 SCWVEDPNLR 131
V D R
Sbjct: 265 KLLVLDATKR 274
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 9e-11
Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 13/89 (14%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKK 62
+K N+++ D LK+ DFGLAR + MMT T YR APE+
Sbjct: 190 LKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRYYR--APEVILG--------M 238
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMS 91
Y VD++S G ++ E++ +++ F G
Sbjct: 239 GYKENVDIWSVGCIMGEMVRHKILFPGRD 267
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-10
Identities = 30/139 (21%), Positives = 61/139 (43%), Gaps = 19/139 (13%)
Query: 5 MKEDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K +N++ T S+K+ DFGLA + E++ T T + APE+ +++
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV--------DREP 226
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISP---DLA 117
D+++ G++ + LL+ PF G + LQ ++ +SP D
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS-SVSPEAKDF- 284
Query: 118 FIVQSCWVEDPNLRPSFSQ 136
+++ ++P R +
Sbjct: 285 --IKNLLQKEPRKRLTVHD 301
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-10
Identities = 37/138 (26%), Positives = 63/138 (45%), Gaps = 17/138 (12%)
Query: 5 MKEDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K +N+L D K +K+ DFGLAR E + GT ++APE+ +
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV-----VNY---DF 264
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISPDLA--F 118
+ D++S G++ + LL+ PF G ++ L A + DIS + A F
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQ-DIS-EEAKEF 322
Query: 119 IVQSCWVEDPNLRPSFSQ 136
I +++ + R S S+
Sbjct: 323 I-SKLLIKEKSWRISASE 339
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-10
Identities = 25/96 (26%), Positives = 42/96 (43%), Gaps = 15/96 (15%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGT--YRWMAPELYSTVTLRQ 58
+K NL + + LK+ DFGLAR + ++ T YR +P L
Sbjct: 146 LKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR--SPRLL------- 196
Query: 59 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
+Y +D+++ G + E+LT + F G L+
Sbjct: 197 LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 1e-10
Identities = 35/140 (25%), Positives = 56/140 (40%), Gaps = 21/140 (15%)
Query: 5 MKEDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K +N++ T LKL DFGL + + TGT + APE+ E K
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA--------EGKP 332
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED----ISP---DL 116
D++S G++ + LL+ PF G + K + + IS D
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPFGGEN--DDETLRNVKSCDWNMDDSAFSGISEDGKDF 390
Query: 117 AFIVQSCWVEDPNLRPSFSQ 136
++ + DPN R + Q
Sbjct: 391 ---IRKLLLADPNTRMTIHQ 407
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-10
Identities = 40/193 (20%), Positives = 70/193 (36%), Gaps = 26/193 (13%)
Query: 6 KEDNLLLT---PDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
K N+L + +S+++ DFG A++ ++ T ++APE V RQG
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE----VLERQG-- 196
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHARPGLPED----ISP-- 114
Y+ D++S G++L+ +LT PF + A + L +S
Sbjct: 197 --YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254
Query: 115 -DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSNGAMTE 173
DL V DP+ R + + + L P + +
Sbjct: 255 KDL---VSKMLHVDPHQRLTAALV---LRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAAT 308
Query: 174 FSARARGKFAFLR 186
+SA R + L
Sbjct: 309 YSALNRNQSPVLE 321
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-10
Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 11/88 (12%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM-APELYSTVTLRQGEKKH 63
+K N+++ D LK+ DFGLAR + MMT T R+ APE+
Sbjct: 153 LKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVT-RYYRAPEVILG--------MG 202
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMS 91
Y VD++S G ++ E++ + F G
Sbjct: 203 YKENVDIWSVGCIMGEMIKGGVLFPGTD 230
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-10
Identities = 37/193 (19%), Positives = 69/193 (35%), Gaps = 34/193 (17%)
Query: 5 MKEDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+K +N++L +KL DFGLA E GT ++APE+ +
Sbjct: 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-----VNY--- 192
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISP---D 115
+ + D++S G++ + LL+ PF G + L A ++ S D
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS-QTSELAKD 251
Query: 116 LAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP---SPSVPESDTNEAAATSNGAMT 172
++ V++ R + + LR P ++ + +
Sbjct: 252 F---IRKLLVKETRKRLTIQEA----------LRHPWITPVDTQQAMVRRESVVNLENFK 298
Query: 173 EFSARARGKFAFL 185
+ R R K +F
Sbjct: 299 KQYVRRRWKLSFS 311
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 57.5 bits (140), Expect = 2e-10
Identities = 35/129 (27%), Positives = 57/129 (44%), Gaps = 17/129 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKK 62
+K +N+LL + +K+ DFG A+ T GT ++APE V +
Sbjct: 132 LKPENILLDKN-GHIKITDFGFAKYVPDV----TYTLCGTPDYIAPE----VVSTKP--- 179
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
YN +D +SFGI+++E+L PF SN Y +A P + D+ ++
Sbjct: 180 -YNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTY-EKILNAELRFPPFFNEDVKDLLSR 236
Query: 123 CWVEDPNLR 131
D + R
Sbjct: 237 LITRDLSQR 245
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 4e-10
Identities = 30/93 (32%), Positives = 45/93 (48%), Gaps = 13/93 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYSTVTLRQGEK 61
+K +N+L+T +KL DFG AR T ++ E T YR +PEL +
Sbjct: 128 VKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SPELL----VGD--- 177
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
Y VDV++ G V ELL+ + G S++
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD 210
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-10
Identities = 43/193 (22%), Positives = 77/193 (39%), Gaps = 35/193 (18%)
Query: 5 MKEDNLLL-TPDQKS-LKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+K +LL + + + +KL FG+A + + GT +MAPE+ ++ +
Sbjct: 156 VKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV-----VK---R 207
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSN--LQAAYAAAFKHARPGLPEDISP---DL 116
+ Y VDV+ G++L+ LL+ LPF G + +K IS DL
Sbjct: 208 EPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWS-HISESAKDL 266
Query: 117 AFIVQSCWVEDPNLRPSFSQIIR---MLNAFLFTLRPPSPSVPESDTNEAAATSNGAMTE 173
V+ + DP R + + + + + + P E + +
Sbjct: 267 ---VRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQ------------LRK 311
Query: 174 FSARARGKFAFLR 186
F+AR + K A L
Sbjct: 312 FNARRKLKGAVLA 324
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 4e-10
Identities = 30/94 (31%), Positives = 42/94 (44%), Gaps = 14/94 (14%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYSTVTLRQGEK 61
+K NLL+ LKLA+FGLAR + +AE T YR P++ L
Sbjct: 127 LKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYR--PPDV-----LFGA-- 176
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLP-FEGMSNLQ 94
K Y+ +D++S G + EL P F G
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-10
Identities = 32/146 (21%), Positives = 60/146 (41%), Gaps = 22/146 (15%)
Query: 5 MKEDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +NLL + + LKL DFG A+E T +T T ++APE V +
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE----VLGPEK--- 239
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLPED----ISP-- 114
Y+ D++S G++++ LL PF + + + P +S
Sbjct: 240 -YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 298
Query: 115 -DLAFIVQSCWVEDPNLRPSFSQIIR 139
L +++ +P R + ++ +
Sbjct: 299 KML---IRNLLKTEPTQRMTITEFMN 321
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 5e-10
Identities = 19/103 (18%), Positives = 37/103 (35%), Gaps = 8/103 (7%)
Query: 69 DVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE------DISPDLAFIVQS 122
D+ G L+ LL NR P + +++ A A + E DI ++ +
Sbjct: 184 DIRGIGASLYALLVNRWPLPE-AGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAAR 242
Query: 123 CWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAA 165
D +R + S ++ ++ P + +AA
Sbjct: 243 SVQGDGGIRSA-STLLNLMQQATAVADRTEVLGPIDEAPVSAA 284
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 5e-10
Identities = 30/93 (32%), Positives = 45/93 (48%), Gaps = 13/93 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYSTVTLRQGEK 61
+K NLL+ + LK+ADFGLAR + T E T YR AP++ L
Sbjct: 126 LKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYR--APDV-----LMGS-- 175
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
K Y+ +D++S G + E++ F G+S
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 5e-10
Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 13/93 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYSTVTLRQGEK 61
+K NLL+ +LKLADFGLAR + T E T YR AP++ L G
Sbjct: 145 LKPQNLLIN-SDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--APDV-----L-MGS- 194
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
K Y+ VD++S G + E++T + F G+++
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 7e-10
Identities = 29/141 (20%), Positives = 56/141 (39%), Gaps = 21/141 (14%)
Query: 5 MKEDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+K +N++L +KL DFGLA E GT ++APE+ +
Sbjct: 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-----VNY--- 192
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISP---D 115
+ + D++S G++ + LL+ PF G + L + ++ S D
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS-HTSELAKD 251
Query: 116 LAFIVQSCWVEDPNLRPSFSQ 136
++ V++ R + +
Sbjct: 252 F---IRKLLVKETRKRLTIQE 269
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 8e-10
Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 23/97 (23%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPEL-----YSTVTLR 57
+K N+L+T +KLADFGLAR + +T+ T YR APE+ Y+T
Sbjct: 146 LKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYR--APEVLLQSSYAT---- 198
Query: 58 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
VD++S G + E+ + F G S++
Sbjct: 199 ---------PVDLWSVGCIFAEMFRRKPLFRGSSDVD 226
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 9e-10
Identities = 30/141 (21%), Positives = 58/141 (41%), Gaps = 21/141 (14%)
Query: 5 MKEDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+K +N++L + +K+ DFGLA + GT ++APE+ +
Sbjct: 140 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-----VNY--- 191
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISP---D 115
+ + D++S G++ + LL+ PF G + L A ++ + S D
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS-NTSALAKD 250
Query: 116 LAFIVQSCWVEDPNLRPSFSQ 136
++ V+DP R +
Sbjct: 251 F---IRRLLVKDPKKRMTIQD 268
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 9e-10
Identities = 26/140 (18%), Positives = 54/140 (38%), Gaps = 21/140 (15%)
Query: 5 MKEDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
++ +N++ T ++K+ +FG AR+ + + APE+ +
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV-----HQH---DV 179
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED----ISP---DL 116
+ D++S G +++ LL+ PF + +A E+ IS D
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAET--NQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 117 AFIVQSCWVEDPNLRPSFSQ 136
V V++ R + S+
Sbjct: 238 ---VDRLLVKERKSRMTASE 254
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-09
Identities = 34/91 (37%), Positives = 46/91 (50%), Gaps = 12/91 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW-MAPELYSTVTLRQGEKKH 63
+K NL + D + LK+ DFGLAR + MT T RW APE+ H
Sbjct: 158 LKPSNLAVNEDCE-LKILDFGLAR--HTADEMTGYVAT-RWYRAPEIMLNW-------MH 206
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
YN VD++S G ++ ELLT R F G ++
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHID 237
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-09
Identities = 38/190 (20%), Positives = 69/190 (36%), Gaps = 32/190 (16%)
Query: 5 MKEDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K N+LL + +K+ DFG++R+ + GT ++APE+ L
Sbjct: 157 LKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI-----LNY---D 208
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISP---DL 116
D+++ GI+ + LLT+ PF G N ++ +S D
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS-SVSQLATDF 267
Query: 117 AFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP--SPSVPESDTNEAAATSNGAMTEF 174
+QS V++P RP+ L E+ + +S+ +
Sbjct: 268 ---IQSLLVKNPEKRPTAEIC----------LSHSWLQQWDFENLFHPEETSSSSQTQDH 314
Query: 175 SARARGKFAF 184
S R+
Sbjct: 315 SVRSSEDKTS 324
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-09
Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 13/92 (14%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKK 62
+K +N+L+T ++KLADFGLAR + +T T YR APE+ L
Sbjct: 146 LKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYR--APEVL----L--QST- 195
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
Y VD++S G + E+ + F G S
Sbjct: 196 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-09
Identities = 33/128 (25%), Positives = 56/128 (43%), Gaps = 15/128 (11%)
Query: 5 MKEDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K +NLL+ DQ+ +++ DFG A+ V GT +APE + L +G
Sbjct: 167 LKPENLLI--DQQGYIQVTDFGFAKR--VKGRTWTLCGTPEALAPE----IILSKG---- 214
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
YN VD ++ G++++E+ PF Y + P S DL ++++
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIY-EKIVSGKVRFPSHFSSDLKDLLRNL 272
Query: 124 WVEDPNLR 131
D R
Sbjct: 273 LQVDLTKR 280
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-09
Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 13/93 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYSTVTLRQGEK 61
+K NLL+ + LKL DFGLAR + ++E T YR AP++ + G
Sbjct: 134 LKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR--APDVL----M--GS- 183
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
+ Y+ +D++S G +L E++T + F G ++ +
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE 216
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-09
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 13/93 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYSTVTLRQGEK 61
+K NLL+ ++ LKLADFGLAR +++ T+ E T YR P++ L
Sbjct: 126 LKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--PPDI-----LLGS-- 175
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
Y+ ++D++ G + +E+ T R F G + +
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-09
Identities = 33/91 (36%), Positives = 45/91 (49%), Gaps = 12/91 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW-MAPELYSTVTLRQGEKKH 63
+K NL + D + LK+ DFGLAR MT T RW APE+ H
Sbjct: 152 LKPGNLAVNEDCE-LKILDFGLAR--HADAEMTGYVVT-RWYRAPEVI-------LSWMH 200
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
YN VD++S G ++ E+LT + F+G L
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 231
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-09
Identities = 35/149 (23%), Positives = 59/149 (39%), Gaps = 26/149 (17%)
Query: 6 KEDNLLL-TPDQKS-LKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
K +NLL + +K+ DFG AR + + T + APEL L +
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL-----LN---QN 184
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA-----AFKHARPGLPED----IS 113
Y+ D++S G++L+ +L+ ++PF+ +A K + +S
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244
Query: 114 P---DLAFIVQSCWVEDPNLRPSFSQIIR 139
DL +Q DPN R S +
Sbjct: 245 QEAKDL---IQGLLTVDPNKRLKMSGLRY 270
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-09
Identities = 22/88 (25%), Positives = 41/88 (46%), Gaps = 11/88 (12%)
Query: 5 MKEDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+K +N++L +KL DFG+A + GT ++APE+ +
Sbjct: 134 LKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI-----VNY--- 185
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEG 89
+ + D++S G++ + LL+ PF G
Sbjct: 186 EPLGLEADMWSIGVITYILLSGASPFLG 213
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-09
Identities = 40/161 (24%), Positives = 64/161 (39%), Gaps = 30/161 (18%)
Query: 6 KEDNLLL-TPDQKS-LKLADFGLAR--------EETVTEMMTAETGTYRWMAPELYSTVT 55
K +N+L P+Q S +K+ DF L T + G+ +MAPE+ V
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV---VE 194
Query: 56 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLPEDI- 112
E Y+ + D++S G++L+ LL+ PF S+ A + L E I
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ 254
Query: 113 -------SPDLAFI-------VQSCWVEDPNLRPSFSQIIR 139
D A I + V D R S +Q+++
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-09
Identities = 37/185 (20%), Positives = 61/185 (32%), Gaps = 44/185 (23%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYSTVTLRQGEK 61
+K +N+L++ +KL DFG AR E+ E T YR APEL G+
Sbjct: 150 IKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYR--APELLV------GD- 199
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPF------------------------EGMSNLQAAY 97
Y VDV++ G ++ E+ F E +
Sbjct: 200 VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259
Query: 98 AAAFKHARPGLP-----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 152
+ P +S + + + C DP+ RP ++++ F
Sbjct: 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH--DFFQMDGFAE 317
Query: 153 PSVPE 157
E
Sbjct: 318 RFSQE 322
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-09
Identities = 34/96 (35%), Positives = 45/96 (46%), Gaps = 16/96 (16%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGT--YRWMAPELYSTVTLRQ 58
+K NLLL LK+ DFGLAR + T +T T YR APE+
Sbjct: 154 LKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYR--APEIM------- 203
Query: 59 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
K Y +D++S G +L E+L+NR F G L
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-09
Identities = 30/91 (32%), Positives = 44/91 (48%), Gaps = 12/91 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM-APELYSTVTLRQGEKKH 63
+K NL + D + LK+ DFGLAR MT T RW APE+
Sbjct: 154 LKPGNLAVNEDCE-LKILDFGLAR--QADSEMTGYVVT-RWYRAPEVI-------LNWMR 202
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
Y VD++S G ++ E++T + F+G +L
Sbjct: 203 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 233
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-09
Identities = 33/97 (34%), Positives = 45/97 (46%), Gaps = 16/97 (16%)
Query: 5 MKEDNLLLTPDQKS----LKLADFGLAREETV-TEMMTAETGT--YRWMAPELYSTVTLR 57
+K NLLL+ S LK+ DFGLAR + T E T YR PE+ L
Sbjct: 158 LKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR--PPEIL----L- 210
Query: 58 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
G +HY+ VD++S + E+L F G S +
Sbjct: 211 -GS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID 245
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-09
Identities = 31/97 (31%), Positives = 43/97 (44%), Gaps = 17/97 (17%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-----ETVTEMMTAETGT--YRWMAPELYSTVTLR 57
MK N+L+T LKLADFGLAR + T T YR PEL L
Sbjct: 150 MKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR--PPELL----L- 201
Query: 58 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
GE + Y +D++ G ++ E+ T +G +
Sbjct: 202 -GE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 236
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 9e-09
Identities = 34/93 (36%), Positives = 45/93 (48%), Gaps = 13/93 (13%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYSTVTLRQGEK 61
+K +NLLL + LKLADFGLA+ T + T YR APEL L
Sbjct: 138 LKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYR--APEL-----LFGA-- 187
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
+ Y VD+++ G +L ELL G S+L
Sbjct: 188 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 220
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-08
Identities = 29/96 (30%), Positives = 37/96 (38%), Gaps = 23/96 (23%)
Query: 9 NLLLTPDQKSLKLADFGLAR-----------EETVTEMMTAETGT--YRWMAPELYSTVT 55
NLL+ + LK+ DFGLAR M T YR APE+
Sbjct: 142 NLLINSNCD-LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR--APEVM---- 194
Query: 56 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 91
Y+ +DV+S G +L EL R F G
Sbjct: 195 ---LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 5e-08
Identities = 26/96 (27%), Positives = 41/96 (42%), Gaps = 18/96 (18%)
Query: 5 MKEDNLLLTPDQKS---LKLADFGLAREETV-TEMMTAETGT-----YRWMAPELYSTVT 55
+K N+L+ + +K+AD G AR + + YR APEL
Sbjct: 154 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR--APELL---- 207
Query: 56 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 91
L G +HY +D+++ G + ELLT+ F
Sbjct: 208 L--GA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-06
Identities = 22/90 (24%), Positives = 38/90 (42%), Gaps = 15/90 (16%)
Query: 5 MKEDNLLLTPDQKS-----LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 59
+K +N+L+ +K+AD G A + +T YR +PE V L
Sbjct: 158 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR--SPE----VLLGAP 211
Query: 60 EKKHYNNKVDVYSFGIVLWELLTNRLPFEG 89
+ D++S +++EL+T FE
Sbjct: 212 ----WGCGADIWSTACLIFELITGDFLFEP 237
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 2e-06
Identities = 36/220 (16%), Positives = 72/220 (32%), Gaps = 57/220 (25%)
Query: 8 DNLLLTPDQKSLKLADFGLAR---EETVTEMM-TAETGTYRWMAPELYSTVTLRQGEKKH 63
D+++++ D S L F EE V + + Y+++ + + +
Sbjct: 52 DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM 111
Query: 64 YN-------NKVDVYSFGIV------------LWELLTNR-LPFEGM-----SNLQAAYA 98
Y N V++ V L EL + + +G+ + +
Sbjct: 112 YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVC 171
Query: 99 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS--QIIRMLNAFLFTLRPPSPSVP 156
++K + F W+ NL+ S ++ ML L+ + P S
Sbjct: 172 LSYK------VQCKMDFKIF-----WL---NLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 157 ESDTNEAAATSNGAMTEFSARARGKFAFLRQLFTAKRTKN 196
+ +N S +A LR+L +K +N
Sbjct: 218 DHSSNIKLRIH-------SIQAE-----LRRLLKSKPYEN 245
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-06
Identities = 27/107 (25%), Positives = 42/107 (39%), Gaps = 34/107 (31%)
Query: 9 NLLLTPDQKSLKLADFGLAR----------------------EETVTEMMTAETGT--YR 44
N+LL + +K+ADFGL+R + ++T T YR
Sbjct: 139 NILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYR 197
Query: 45 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 91
APE+ Y +D++S G +L E+L + F G S
Sbjct: 198 --APEILLGS-------TKYTKGIDMWSLGCILGEILCGKPIFPGSS 235
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 3e-06
Identities = 23/82 (28%), Positives = 36/82 (43%), Gaps = 14/82 (17%)
Query: 15 DQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 72
++ +K+AD G A + TE + T YR + E V + G YN D++S
Sbjct: 231 EKLKVKIADLGNACWVHKHFTEDIQ--TRQYR--SLE----VLIGSG----YNTPADIWS 278
Query: 73 FGIVLWELLTNRLPFEGMSNLQ 94
+ +EL T FE S +
Sbjct: 279 TACMAFELATGDYLFEPHSGEE 300
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-06
Identities = 26/91 (28%), Positives = 39/91 (42%), Gaps = 11/91 (12%)
Query: 5 MKEDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K +N+LL + +K+ DFG + E ++ YR APE V L
Sbjct: 226 LKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR--APE----VILGAR---- 275
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
Y +D++S G +L ELLT G
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-06
Identities = 25/146 (17%), Positives = 49/146 (33%), Gaps = 43/146 (29%)
Query: 5 MKEDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +NLL + + LKL DFG A E +
Sbjct: 143 VKPENLLYTSKRPNAILKLTDFGFA--------------------KET---------TGE 173
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLPED----ISP-- 114
Y+ D++S G++++ LL PF + + + P +S
Sbjct: 174 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 233
Query: 115 -DLAFIVQSCWVEDPNLRPSFSQIIR 139
L +++ +P R + ++ +
Sbjct: 234 KML---IRNLLKTEPTQRMTITEFMN 256
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 1e-05
Identities = 26/103 (25%), Positives = 40/103 (38%), Gaps = 35/103 (33%)
Query: 9 NLLLTPDQKSLKLADFGLAR-----------------------EETVTEMMTAETGT--Y 43
N LL D +K+ DFGLAR + + + +T+ T Y
Sbjct: 159 NCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWY 217
Query: 44 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 86
R APEL +++Y +D++S G + ELL
Sbjct: 218 R--APELILL-------QENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-05
Identities = 24/91 (26%), Positives = 44/91 (48%), Gaps = 11/91 (12%)
Query: 5 MKEDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K +N+LL P + ++K+ DFG + + ++ YR +PE V L
Sbjct: 185 LKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPE----VLLGMP---- 234
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
Y+ +D++S G +L E+ T F G + +
Sbjct: 235 YDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-05
Identities = 43/190 (22%), Positives = 63/190 (33%), Gaps = 54/190 (28%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR----------------------------EETVTEMM 36
+K N L+ D S+K+ DFGLAR + + +
Sbjct: 182 LKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQL 240
Query: 37 TAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 94
T T YR APEL L Q ++Y +DV+S G + ELL
Sbjct: 241 TGHVVTRWYR--APEL----ILLQ---ENYTEAIDVWSIGCIFAELLNM----------I 281
Query: 95 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS 154
A P P L+ ++ + R + Q+ + N L PS
Sbjct: 282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFN----ILGTPSEE 337
Query: 155 VPESDTNEAA 164
E+ E A
Sbjct: 338 DIEALEKEDA 347
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 198 | |||
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.98 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.96 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.96 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.96 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.96 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.96 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.96 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.96 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.96 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.96 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.96 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.96 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.96 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.96 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.96 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.96 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.96 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.96 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.96 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.96 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.96 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.96 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.96 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.96 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.96 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.96 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.96 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.96 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.96 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.96 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.96 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.96 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.96 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.96 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.96 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.96 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.96 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.96 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.96 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.96 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.96 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.96 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.96 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.96 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.96 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.96 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.96 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.95 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.95 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.95 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.95 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.95 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.95 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.95 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.95 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.95 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.95 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.95 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.95 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.95 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.95 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.95 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.95 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.95 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.95 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.95 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.95 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.95 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.95 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.95 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.95 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.95 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.95 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.95 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.95 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.95 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.95 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.95 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.95 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.95 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.95 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.95 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.95 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.95 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.95 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.95 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.95 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.95 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.95 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.95 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.95 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.95 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.95 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.95 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.95 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.95 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.95 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.95 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.95 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.95 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.95 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.95 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.95 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.95 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.95 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.95 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.95 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.95 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.95 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.95 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.95 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.95 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.95 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.95 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.95 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.95 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.95 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.95 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.95 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.95 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.95 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.95 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.95 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.95 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.95 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.95 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.95 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.95 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.95 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.95 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.95 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.95 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.95 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.95 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.95 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.95 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.95 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.95 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.95 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.95 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.95 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.95 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.95 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.95 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.95 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.95 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.95 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.95 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.94 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.94 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.94 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.94 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.94 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.94 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.94 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.94 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.94 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.94 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.94 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.94 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.94 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.94 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.94 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.94 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.94 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.94 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.94 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.94 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.94 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.94 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.94 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.94 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.94 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.94 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.94 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.94 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.94 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.94 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.94 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.94 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.94 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.94 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.94 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.94 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.94 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.94 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.94 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.94 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.94 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.94 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.94 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.94 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.94 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.94 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.94 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.94 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.94 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.94 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.93 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.93 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.93 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.93 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.93 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.93 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.93 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.93 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.93 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.93 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.93 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.93 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.93 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.93 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.93 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.93 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.92 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.92 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.9 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.88 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.87 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.84 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.84 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.66 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.3 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 98.43 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 98.28 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 97.18 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.11 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 96.91 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 96.41 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 96.15 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.19 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.11 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 94.78 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 94.67 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 94.65 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 94.45 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 94.22 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 93.85 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 93.72 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 93.21 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 92.92 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 91.94 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 91.68 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 90.64 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 90.45 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 90.04 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 89.65 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 89.21 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 86.95 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.11 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.1 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 82.18 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 80.7 |
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=244.10 Aligned_cols=138 Identities=28% Similarity=0.560 Sum_probs=117.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+|+...... .....+||+.|||||++.+ ..|+.++|||||||++
T Consensus 207 iHRDLK~~NILl~~~-~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--------~~y~~ksDVwS~Gv~l 277 (353)
T 4ase_A 207 IHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLL 277 (353)
T ss_dssp CCSCCSGGGEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred ecCccCccceeeCCC-CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc--------CCCCCcccEeehHHHH
Confidence 799999999999976 689999999998543322 2234578999999999864 6789999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|||+| |..||.+...............++..|..+++++.+++.+||+.||.+|||+.+++++|+.++..
T Consensus 278 ~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 278 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 99998 89999887655555555566777888999999999999999999999999999999999988764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=235.10 Aligned_cols=140 Identities=28% Similarity=0.496 Sum_probs=108.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc---cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+||||+.+ +.+||+|||+|+.... .......+||+.|||||++.+. ....|+.++|||||||++
T Consensus 154 iHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~-----~~~~y~~ksDVwS~Gvvl 227 (307)
T 3omv_A 154 IHRDMKSNNIFLHEG-LTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ-----DNNPFSFQSDVYSYGIVL 227 (307)
T ss_dssp BCSCCCSSSEEEETT-EEEEECCCSSCBC------------CCCCTTSCCHHHHHCC-----SSCCCCHHHHHHHHHHHH
T ss_pred cCCccCHHHEEECCC-CcEEEeeccCceecccCCcceeecccccCCCccCHHHhhcc-----CCCCCCcHHHhHhHHHHH
Confidence 799999999999976 7899999999985432 2223456899999999998531 134689999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCC----CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHAR----PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~----~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|||++|+.||.+................ +..+..+++++.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus 228 ~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 228 YELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp HHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred HHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 9999999999987765554444333322 23456789999999999999999999999999999886643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=232.77 Aligned_cols=135 Identities=29% Similarity=0.458 Sum_probs=101.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+|+.........+.+||+.|||||++.+ ...++.++||||+||++|+|
T Consensus 134 iHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~-------~~y~~~~~DiwSlGvily~l 205 (275)
T 3hyh_A 134 VHRDLKPENLLLDEH-LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISG-------KLYAGPEVDVWSCGVILYVM 205 (275)
T ss_dssp CCCCCCTTTEEECTT-CCEEECCSSCC---------------CTTSCHHHHSS-------SSCCCTHHHHHHHHHHHHHH
T ss_pred ccccCChHHeEECCC-CCEEEeecCCCeecCCCCccCCeeECcccCChhhhcC-------CCCCCChhhhHHHHHHHHHH
Confidence 799999999999976 6899999999987655555567899999999999864 23346899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
++|+.||.+..... ... ......+.+|..+++++.+|+.+||+.||.+|||++|+++ |.|+..
T Consensus 206 ltg~~PF~~~~~~~-~~~-~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hpw~k~ 268 (275)
T 3hyh_A 206 LCRRLPFDDESIPV-LFK-NISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ--DDWFKV 268 (275)
T ss_dssp HHSSCSSCCSSHHH-HHH-HHHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--CHHHHT
T ss_pred HHCCCCCCCCCHHH-HHH-HHHcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc--Cccccc
Confidence 99999998765432 222 2334556778889999999999999999999999999999 777753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=235.94 Aligned_cols=134 Identities=28% Similarity=0.545 Sum_probs=109.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+||||+...+.+||+|||+|+.... ....+.+||+.|||||++. +.|+.++|||||||++|||
T Consensus 153 iHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~---------~~y~~~~DiwSlGvilyel 222 (290)
T 3fpq_A 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEM 222 (290)
T ss_dssp CCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHH
T ss_pred EecccChhheeEECCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHcC---------CCCCcHHHHHHHHHHHHHH
Confidence 79999999999985447899999999985433 2345678999999999874 3589999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCC-CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++|+.||.+................+ ..+..+++++.+|+.+||..||.+|||++|+++ |.|+.
T Consensus 223 ltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~--Hp~~~ 287 (290)
T 3fpq_A 223 ATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--HAFFQ 287 (290)
T ss_dssp HHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGC
T ss_pred HHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc--Ccccc
Confidence 99999998776655555544443332 345668899999999999999999999999998 66653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=240.04 Aligned_cols=138 Identities=30% Similarity=0.496 Sum_probs=112.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+||||+.+ +.+||+|||+|+.... .....+.+||+.|||||++.+ ..|+.++||||+||++||
T Consensus 192 iHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilye 262 (346)
T 4fih_A 192 IHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIE 262 (346)
T ss_dssp ECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHH
T ss_pred ccccCCHHHEEECCC-CCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCC--------CCCCcHHHHHHHHHHHHH
Confidence 799999999999977 6899999999986543 234566899999999999853 678999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC--CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
|++|..||.+....... ........+ ..+..+++++.+|+.+||..||.+|||+.|+++ |.|+....+
T Consensus 263 ml~G~~PF~~~~~~~~~-~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~--Hp~~~~~~~ 332 (346)
T 4fih_A 263 MVDGEPPYFNEPPLKAM-KMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGP 332 (346)
T ss_dssp HHHSSCTTTTSCHHHHH-HHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCCC
T ss_pred HHHCCCCCCCcCHHHHH-HHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhcCCCC
Confidence 99999999987654433 333333333 234568999999999999999999999999999 788775443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=236.16 Aligned_cols=134 Identities=28% Similarity=0.515 Sum_probs=113.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++...... .....+||+.|||||++.+ +.|+.++|||||||++
T Consensus 167 iHRDLK~~NILl~~~-~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--------~~~s~ksDVwSfGvvl 237 (308)
T 4gt4_A 167 VHKDLATRNVLVYDK-LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY--------GKFSIDSDIWSYGVVL 237 (308)
T ss_dssp CCSCCSGGGEEECGG-GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred CCCCccccceEECCC-CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC--------CCCCccchhhhHHHHH
Confidence 799999999999966 789999999998543322 2344679999999999854 6789999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
|||+| |..||.+..... ..........++.|..+++++.+|+.+||+.||.+||||.+|+++|+.+
T Consensus 238 ~El~t~g~~Pf~~~~~~~-~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 238 WEVFSYGLQPYCGYSNQD-VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHTTTCCTTTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 99998 899999876543 3444455666778899999999999999999999999999999999865
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=235.50 Aligned_cols=136 Identities=27% Similarity=0.523 Sum_probs=108.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+||||+.+ +.+||+|||+++...... .....+||+.|||||++.+ ..|+.++|||||||++
T Consensus 180 iHRDLKp~NILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--------~~~~~~sDvwS~Gvvl 250 (329)
T 4aoj_A 180 VHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--------RKFTTESDVWSFGVVL 250 (329)
T ss_dssp CCSCCCGGGEEEETT-TEEEECCCC----------------CCCCGGGCCHHHHTT--------CCCCHHHHHHHHHHHH
T ss_pred ecccccHhhEEECCC-CcEEEcccccceeccCCCcceecCcccccccccChhhhcC--------CCCCccccccchHHHH
Confidence 799999999999976 789999999998543322 2234679999999999853 6789999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|||+| |+.||.+...... ........+++.|..+++++.+|+.+||+.||.+|||+.|++++|+.+..
T Consensus 251 ~Ellt~G~~Pf~~~~~~~~-~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 251 WEIFTYGKQPWYQLSNTEA-IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHTTSCCTTCSSCHHHH-HHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCCCHHHH-HHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 99998 8999998775443 34444556778889999999999999999999999999999999998755
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=238.84 Aligned_cols=141 Identities=24% Similarity=0.246 Sum_probs=110.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc------cccCCCCccceecccccccccccccccCCCCchhhHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 74 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G 74 (198)
|||||||+||||+.++..+||+|||+|+...... .....+||+.|||||++.+ ..|+.++||||+|
T Consensus 172 iHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlG 243 (336)
T 4g3f_A 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG--------KPCDAKVDIWSSC 243 (336)
T ss_dssp ECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT--------CCCCTHHHHHHHH
T ss_pred eecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC--------CCCCcHHHHHHHH
Confidence 7999999999999774469999999998543221 1233589999999999864 6789999999999
Q ss_pred HHHHHHHcCCCCCCCCCcHHHHHHHHHccCC-CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 75 IVLWELLTNRLPFEGMSNLQAAYAAAFKHAR-PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 75 ~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
|++|||++|+.||.+...............+ ..+|..+++++.+|+.+||+.||.+|||+.|++++|...+....
T Consensus 244 vilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 244 CMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp HHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 9999999999999876543322222222221 24677899999999999999999999999999999988776543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=233.49 Aligned_cols=137 Identities=23% Similarity=0.472 Sum_probs=114.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+|+....... ....+||+.|||||++.+ ..|+.++|||||||++
T Consensus 150 iHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--------~~~~~k~DVwS~Gvvl 220 (299)
T 4asz_A 150 VHRDLATRNCLVGEN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSLGVVL 220 (299)
T ss_dssp CCSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred ccCccCHhhEEECCC-CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC--------CCCCchhhHHHHHHHH
Confidence 799999999999976 7899999999985432221 223468999999999864 6789999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|||+| |+.||.+..... ..........++.|..+++++.+|+.+||+.||.+|||+++++++|+.+...
T Consensus 221 ~Ellt~G~~Pf~~~~~~~-~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 221 WEIFTYGKQPWYQLSNNE-VIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHTTTCCTTTTSCHHH-HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCCCHHH-HHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 99998 899999876544 3344455666778899999999999999999999999999999999887654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=239.93 Aligned_cols=134 Identities=32% Similarity=0.493 Sum_probs=111.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+||||+.+ +.+||+|||+|+...... ...+.+||+.|||||++.+ ..|+.++||||+||++||
T Consensus 147 iHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~--------~~y~~~~DiwSlGvilye 217 (350)
T 4b9d_A 147 LHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN--------KPYNNKSDIWALGCVLYE 217 (350)
T ss_dssp EETTCCGGGEEECTT-CCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTT--------CCCCHHHHHHHHHHHHHH
T ss_pred eeccCCHHHEEECCC-CCEEEcccccceeecCCcccccccCCCccccCHHHHCC--------CCCCcHHHHHHHHHHHHH
Confidence 699999999999977 689999999998654432 2345689999999999854 678999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|++|+.||.+....... ........++.+..+++++.+|+.+||+.||.+|||+.|+++ +.|+.
T Consensus 218 mltG~~PF~~~~~~~~~-~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~--hp~~~ 281 (350)
T 4b9d_A 218 LCTLKHAFEAGSMKNLV-LKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE--KGFIA 281 (350)
T ss_dssp HHHSSCSCCCSSHHHHH-HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SHHHH
T ss_pred HHHCCCCCCCcCHHHHH-HHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc--CHHhh
Confidence 99999999987654433 333444555677889999999999999999999999999998 55553
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=240.30 Aligned_cols=138 Identities=30% Similarity=0.492 Sum_probs=112.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+||||+.+ +.+||+|||+|+.... .....+.+||+.|||||++.+ ..|+.++||||+||++||
T Consensus 269 iHRDiKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilye 339 (423)
T 4fie_A 269 IHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIE 339 (423)
T ss_dssp ECCCCSTTTEEECTT-CCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTT--------CCBCTHHHHHHHHHHHHH
T ss_pred ecccCCHHHEEEcCC-CCEEEecCccceECCCCCccccccccCcCcCCHHHHCC--------CCCCcHHHHHHHHHHHHH
Confidence 799999999999977 6899999999986543 233456799999999999853 678999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC--CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
|++|..||.+.......... .....+ ..+..+++++.+|+.+||..||.+|||+.|+++ |.|+....+
T Consensus 340 ml~G~~PF~~~~~~~~~~~i-~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~--Hp~~~~~~~ 409 (423)
T 4fie_A 340 MVDGEPPYFNEPPLKAMKMI-RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGP 409 (423)
T ss_dssp HHHSSCTTTTSCHHHHHHHH-HHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCCC
T ss_pred HHHCCCCCCCcCHHHHHHHH-HcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHHhcCCCC
Confidence 99999999987765443332 233322 345678999999999999999999999999999 788765443
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=230.34 Aligned_cols=133 Identities=29% Similarity=0.523 Sum_probs=107.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+|+.... .....+.+||+.|||||++.+ ..|+.++||||+||++||
T Consensus 148 iHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvilye 218 (304)
T 3ubd_A 148 IYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR--------RGHTQSADWWSFGVLMFE 218 (304)
T ss_dssp CCSSCCGGGEEECTT-SCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHH
T ss_pred cCCCCCHHHeEEcCC-CCEEecccccceeccCCCccccccccCcccCCHHHhcc--------CCCCCCCcccchHHHHHH
Confidence 799999999999977 6899999999985433 333456789999999999853 678999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH-----HHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-----SQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~-----~~~l~~l~~~~~ 146 (198)
|++|+.||.+.+........ ....+.+|..+++++.+|+.+||+.||.+|||+ +|+++ |.|+.
T Consensus 219 mltG~~PF~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~--Hp~f~ 286 (304)
T 3ubd_A 219 MLTGTLPFQGKDRKETMTMI--LKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR--HSFFS 286 (304)
T ss_dssp HHHSSCSSCCSSHHHHHHHH--HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT--SGGGT
T ss_pred HHhCCCCCCCcCHHHHHHHH--HcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc--Ccccc
Confidence 99999999987654433322 334567788899999999999999999999984 67776 56654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=230.82 Aligned_cols=128 Identities=21% Similarity=0.348 Sum_probs=106.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc---cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+||||+.+ +.+||+|||+|+.... .....+.+||+.|||||++.+ ..|+.++||||+||++
T Consensus 154 iHRDlKPeNILl~~~-g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvil 224 (311)
T 4aw0_A 154 IHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE--------KSACKSSDLWALGCII 224 (311)
T ss_dssp ECSCCSGGGEEECTT-SCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH--------SCBCHHHHHHHHHHHH
T ss_pred ccCCCCHHHeEEcCC-CCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC--------CCCCcHHHHHHHHHHH
Confidence 699999999999977 7899999999985432 223456799999999999864 6789999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
|||++|..||.+.+....... +....+.+|..+++++.+|+.+||..||.+|||++|++.
T Consensus 225 yeml~G~~PF~~~~~~~~~~~--i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 225 YQLVAGLPPFRAGNEGLIFAK--IIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HHHHHSSCSSCCSSHHHHHHH--HHHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred HHHHhCCCCCCCCCHHHHHHH--HHcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 999999999988664433222 233456778899999999999999999999999998643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=224.45 Aligned_cols=140 Identities=24% Similarity=0.348 Sum_probs=108.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-----cccccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
|||||||+|||++.+ +.+||+|||+++.... .....+.+||+.|+|||++.+ ...++.++||||+||
T Consensus 180 iHRDlKP~NIl~~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~-------~~~~~~~~DiWSlG~ 251 (398)
T 4b99_A 180 IHRDLKPSNLLVNEN-CELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLS-------LHEYTQAIDLWSVGC 251 (398)
T ss_dssp BCCCCCGGGEEECTT-CCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTT-------CSCCCTHHHHHHHHH
T ss_pred cCCCcCccccccCCC-CCEEEeecceeeecccCccccccccccceeChHhcCHHHhcC-------CCCCCChhheehhHH
Confidence 799999999999976 7899999999985432 123446799999999999764 356799999999999
Q ss_pred HHHHHHcCCCCCCCCCcHHHHHHHHHccCCC----------------------CC-------CCCCcHHHHHHHHHhccc
Q 029154 76 VLWELLTNRLPFEGMSNLQAAYAAAFKHARP----------------------GL-------PEDISPDLAFIVQSCWVE 126 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------~~-------p~~~~~~~~~l~~~~l~~ 126 (198)
++|||++|++||.+.+..............+ .. ...+++++.+|+.+||..
T Consensus 252 il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~ 331 (398)
T 4b99_A 252 IFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRF 331 (398)
T ss_dssp HHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCS
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcC
Confidence 9999999999999877655443322211111 01 124688999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 127 DPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 127 dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
||.+|||+.|+++ |.|+.....
T Consensus 332 dP~~R~ta~e~L~--Hp~f~~~~~ 353 (398)
T 4b99_A 332 EPSARISAAAALR--HPFLAKYHD 353 (398)
T ss_dssp STTTSCCHHHHTT--SGGGTTTCC
T ss_pred ChhHCcCHHHHhc--CHhhCcCCC
Confidence 9999999999999 888875543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=221.10 Aligned_cols=137 Identities=22% Similarity=0.313 Sum_probs=100.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-----------------------------ccccCCCCccceeccccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-----------------------------EMMTAETGTYRWMAPELY 51 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~ 51 (198)
|||||||+|||++.+.+.+||+|||+|+..... ....+.+||+.|+|||++
T Consensus 139 iHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 218 (361)
T 4f9c_A 139 VHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVL 218 (361)
T ss_dssp ECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHH
T ss_pred EeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence 699999999999876578999999999743211 112345899999999998
Q ss_pred ccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHc-----------------------------
Q 029154 52 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK----------------------------- 102 (198)
Q Consensus 52 ~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~----------------------------- 102 (198)
.+ ...|+.++||||+||++|||++|+.||...............
T Consensus 219 ~~-------~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~ 291 (361)
T 4f9c_A 219 TK-------CPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDL 291 (361)
T ss_dssp TT-------CSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCH
T ss_pred cC-------CCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhh
Confidence 64 346889999999999999999999999655432221111000
Q ss_pred --------c----------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 103 --------H----------------ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 103 --------~----------------~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
. ........+++++.+|+.+||..||.+|+|++|+++ |.|+.
T Consensus 292 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~--Hp~f~ 357 (361)
T 4f9c_A 292 RKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL--HPFFK 357 (361)
T ss_dssp HHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT--SGGGT
T ss_pred hHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc--CcccC
Confidence 0 000112457899999999999999999999999998 77764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=221.64 Aligned_cols=134 Identities=31% Similarity=0.443 Sum_probs=94.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-------------cccCCCCccceecccccccccccccccCCCCch
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 67 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 67 (198)
|||||||+|||++.+ +.+||+|||+|+...... ...+.+||+.|||||++.+ ..|+.+
T Consensus 140 iHRDlKp~NILl~~~-~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~ 210 (299)
T 4g31_A 140 MHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--------NSYSHK 210 (299)
T ss_dssp CCCCCCGGGEEECTT-CCEEECCCCCC--------------------------CCCTTSCHHHHTT--------CCCCTH
T ss_pred ccccCcHHHeEECCC-CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC--------CCCCCH
Confidence 799999999999977 689999999998543211 1234589999999999864 678999
Q ss_pred hhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 68 VDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 68 ~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
+||||+||++|||++ ||.+................++.+...++.+.+|+.+||+.||.+|||+.|+++ +.|+..
T Consensus 211 ~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~--h~~~~~ 285 (299)
T 4g31_A 211 VDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE--NAVFED 285 (299)
T ss_dssp HHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGCC
T ss_pred HHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhCC
Confidence 999999999999996 776433222222222222222222335677889999999999999999999998 666654
Q ss_pred c
Q 029154 148 L 148 (198)
Q Consensus 148 ~ 148 (198)
.
T Consensus 286 ~ 286 (299)
T 4g31_A 286 L 286 (299)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=219.08 Aligned_cols=143 Identities=22% Similarity=0.364 Sum_probs=98.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-----cccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
|||||||+||||+.+ +.+||+|||+++...... .....+||+.|||||++.+... .....++.++|||||||
T Consensus 130 iHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~--~~~~~~~~k~DVwS~Gv 206 (303)
T 3hmm_A 130 AHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN--MKHFESFKRADIYAMGL 206 (303)
T ss_dssp ECSCCCGGGEEECTT-SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSC--TTCHHHHHHHHHHHHHH
T ss_pred eeccCCcccEEECCC-CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhccccc--ccCCccChhHhhhhHHH
Confidence 699999999999977 789999999997433211 1224579999999999854110 00123577999999999
Q ss_pred HHHHHHcCCCCCC----------CCC----cHHHHHHHH-HccCCCCCCCC-----CcHHHHHHHHHhcccCCCCCCCHH
Q 029154 76 VLWELLTNRLPFE----------GMS----NLQAAYAAA-FKHARPGLPED-----ISPDLAFIVQSCWVEDPNLRPSFS 135 (198)
Q Consensus 76 ~l~e~~~g~~p~~----------~~~----~~~~~~~~~-~~~~~~~~p~~-----~~~~~~~l~~~~l~~dp~~Rps~~ 135 (198)
++|||++|.+||. +.. ......... ....++.+|.. .+..+.+|+.+||..||.+||||.
T Consensus 207 vl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 286 (303)
T 3hmm_A 207 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286 (303)
T ss_dssp HHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHH
T ss_pred HHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHH
Confidence 9999999976542 211 112222221 12334445433 234688999999999999999999
Q ss_pred HHHHHHHHHHh
Q 029154 136 QIIRMLNAFLF 146 (198)
Q Consensus 136 ~~l~~l~~~~~ 146 (198)
++++.|+.+..
T Consensus 287 ei~~~L~~l~~ 297 (303)
T 3hmm_A 287 RIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999988754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-33 Score=229.40 Aligned_cols=135 Identities=24% Similarity=0.396 Sum_probs=108.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+||||+.+ +++||+|||+|+...... ..+.+||+.|||||++.. ...|+.++|+||+||++|||
T Consensus 314 iHRDLKPeNILld~~-G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~-------~~~y~~~vDiWSLGvilYEm 384 (689)
T 3v5w_A 314 VYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKL 384 (689)
T ss_dssp ECCCCSGGGEEECTT-SCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHST-------TCCCCTHHHHHHHHHHHHHH
T ss_pred cccCCchHHeEEeCC-CCEEecccceeeecCCCC-CCCccCCcCccCHHHHhC-------CCCCCcHHHHHHHHHHHHHH
Confidence 799999999999977 789999999998654432 356799999999999852 24689999999999999999
Q ss_pred HcCCCCCCCCCcH-HHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNL-QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps-----~~~~l~~l~~~~~ 146 (198)
++|..||.+.... ............+.+|..+++++.+|+.+||..||.+|++ ++|+++ |.|+.
T Consensus 385 LtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~--HpfF~ 454 (689)
T 3v5w_A 385 LRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--SPFFR 454 (689)
T ss_dssp HHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT--SGGGT
T ss_pred HhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc--Ccccc
Confidence 9999999754321 1112223334566778899999999999999999999997 788888 66654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=223.43 Aligned_cols=138 Identities=25% Similarity=0.331 Sum_probs=111.1
Q ss_pred CCCCCCCCCeEEcCC-CCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~-~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ .+.+||+|||+++.........+.+||+.|||||++.+ ..|+.++||||+||++||
T Consensus 277 iHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~--------~~y~~~~DiWSlGvilye 348 (573)
T 3uto_A 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG--------KPVGYYTDMWSVGVLSYI 348 (573)
T ss_dssp ECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHH
T ss_pred eeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCC--------CCCCcHHHHHHHHHHHHH
Confidence 699999999999853 35799999999987665555566789999999999864 678999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCC--CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
|++|..||.+................ ...+..+++++.+|+.+||..||.+||++.|+++ |.|+...
T Consensus 349 ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~--Hpw~~~~ 417 (573)
T 3uto_A 349 LLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLTPG 417 (573)
T ss_dssp HHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTSCC
T ss_pred HHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcCcCCC
Confidence 99999999987765443333222222 1223568999999999999999999999999999 6776543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=203.04 Aligned_cols=142 Identities=37% Similarity=0.707 Sum_probs=107.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||+|+++|+
T Consensus 161 vH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 231 (309)
T 3p86_A 161 VHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD--------EPSNEKSDVYSFGVILWE 231 (309)
T ss_dssp CCTTCCGGGEEECTT-CCEEECCCC-----------------CCTTSCHHHHTT--------CCCCTTHHHHHHHHHHHH
T ss_pred ECCCCChhhEEEeCC-CcEEECCCCCCccccccccccccCCCCccccChhhhcC--------CCCCchhhHHHHHHHHHH
Confidence 799999999999976 689999999997543322 2234578999999999853 567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
+++|..||.+...................|..+++++.+++.+||..||.+||++.++++.|+.++....++
T Consensus 232 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 232 LATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp HHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred HHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 999999998877655444444455667778889999999999999999999999999999999988765444
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=201.22 Aligned_cols=137 Identities=30% Similarity=0.489 Sum_probs=111.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++...........+||+.|+|||++.+ ....+.++||||+||++|+|
T Consensus 136 vHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el 207 (328)
T 3fe3_A 136 VHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG-------KKYDGPEVDVWSLGVILYTL 207 (328)
T ss_dssp CCSCCCGGGEEECTT-SCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHT-------CCCCSHHHHHHHHHHHHHHH
T ss_pred eccCCCHHHEEEcCC-CCEEEeeccCceecCCCCccccccCCcceeCcccccC-------CCcCCchhhhhhhHHHHHHH
Confidence 799999999999976 6799999999986554445567789999999999864 23335799999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
++|..||.+....... ..........|..+++++.+++.+||..||.+|||+.++++ +.|+....
T Consensus 208 l~g~~pf~~~~~~~~~--~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~--h~~~~~~~ 272 (328)
T 3fe3_A 208 VSGSLPFDGQNLKELR--ERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK--DRWINAGH 272 (328)
T ss_dssp HHSSCSSCCSSHHHHH--HHHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT--CTTTTTTC
T ss_pred HhCCCCCCCCCHHHHH--HHHHhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc--CHhhcCCC
Confidence 9999999886643332 22334455678889999999999999999999999999999 77766443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-30 Score=203.68 Aligned_cols=140 Identities=27% Similarity=0.308 Sum_probs=108.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+++.+||+|||+++...........+||+.|+|||++.+ ...++.++||||+||++|||
T Consensus 178 vHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~el 250 (420)
T 1j1b_A 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG-------ATDYTSSIDVWSAGCVLAEL 250 (420)
T ss_dssp ECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTT-------CSSCCTHHHHHHHHHHHHHH
T ss_pred cccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcC-------CCCCCchhhhHHHHHHHHHH
Confidence 69999999999997656789999999986544444445689999999999753 24688999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccC---------------CCC------------CCCCCcHHHHHHHHHhcccCCCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHA---------------RPG------------LPEDISPDLAFIVQSCWVEDPNLRPS 133 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~---------------~~~------------~p~~~~~~~~~l~~~~l~~dp~~Rps 133 (198)
++|+.||.+............... ... ++..+++++.+|+.+||..||.+||+
T Consensus 251 l~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t 330 (420)
T 1j1b_A 251 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 330 (420)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC
Confidence 999999998765444332221100 001 23456899999999999999999999
Q ss_pred HHHHHHHHHHHHhhcC
Q 029154 134 FSQIIRMLNAFLFTLR 149 (198)
Q Consensus 134 ~~~~l~~l~~~~~~~~ 149 (198)
+.|+++ |.|+....
T Consensus 331 ~~e~l~--hp~f~~~~ 344 (420)
T 1j1b_A 331 PLEACA--HSFFDELR 344 (420)
T ss_dssp HHHHHT--SGGGGGGG
T ss_pred HHHHhC--CHhhcccc
Confidence 999998 77776544
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-30 Score=199.33 Aligned_cols=138 Identities=28% Similarity=0.560 Sum_probs=113.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++...... ......||..|+|||++.+ ..++.++||||||+++
T Consensus 215 vH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il 285 (359)
T 3vhe_A 215 IHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLL 285 (359)
T ss_dssp CCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred ccCCCChhhEEEcCC-CcEEEEeccceeeecccccchhccccCCCceeEChhhhcC--------CCCCchhhhhhHHHHH
Confidence 799999999999866 679999999997543221 2234567889999998853 5688999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|+|++ |..||.+...................+..+++++.+++.+||..||.+||++.+++++|+.++..
T Consensus 286 ~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 286 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 99998 99999887654554455555666777888999999999999999999999999999999988764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=199.81 Aligned_cols=139 Identities=24% Similarity=0.356 Sum_probs=104.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc----------------------cccccCCCCccceecccccccccccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV----------------------TEMMTAETGTYRWMAPELYSTVTLRQ 58 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 58 (198)
|||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|||++.+
T Consensus 131 vHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----- 204 (388)
T 3oz6_A 131 LHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG----- 204 (388)
T ss_dssp ECCCCCGGGEEECTT-CCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT-----
T ss_pred EeCCCCHHHeEEcCC-CCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC-----
Confidence 699999999999977 6899999999974321 112334689999999999853
Q ss_pred cccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCC--------------------------------
Q 029154 59 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-------------------------------- 106 (198)
Q Consensus 59 ~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------- 106 (198)
...++.++||||+||++|||++|.+||.+................+
T Consensus 205 --~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (388)
T 3oz6_A 205 --STKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKR 282 (388)
T ss_dssp --CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CC
T ss_pred --CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHH
Confidence 3568999999999999999999999998876544432221110100
Q ss_pred -------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 107 -------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 107 -------------~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
..+..+++++.+|+.+||..||.+|||+.++++ |.|+....
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~--Hp~~~~~~ 336 (388)
T 3oz6_A 283 DIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK--HPFVSIFH 336 (388)
T ss_dssp CCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTT--STTTTTTC
T ss_pred HhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhC--CHHHHHhc
Confidence 012257889999999999999999999999999 77766544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-30 Score=194.08 Aligned_cols=138 Identities=31% Similarity=0.485 Sum_probs=110.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||++...... ......+||+.|+|||++.+ ..++.++||||+|+++|+
T Consensus 138 ~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 208 (297)
T 3fxz_A 138 IHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIE 208 (297)
T ss_dssp ECCCCSGGGEEECTT-CCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHC--------SCBCTHHHHHHHHHHHHH
T ss_pred eeCCCCHHHEEECCC-CCEEEeeCCCceecCCcccccCCccCCcCccChhhhcC--------CCCCcHHHHHHHHHHHHH
Confidence 699999999999977 67999999998754332 22345689999999999853 568899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHc-cCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
|++|..||.+............. ......+..+++.+.+++.+||..||.+|||+.++++ +.|+....
T Consensus 209 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--h~~~~~~~ 277 (297)
T 3fxz_A 209 MIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HQFLKIAK 277 (297)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCC
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh--ChhhcccC
Confidence 99999999887765544333322 2233456678999999999999999999999999999 77766443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=197.95 Aligned_cols=138 Identities=29% Similarity=0.601 Sum_probs=112.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++...... ......+|+.|+|||++.+ ..++.++|||||||++
T Consensus 225 vHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DvwslG~il 295 (370)
T 2psq_A 225 IHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLM 295 (370)
T ss_dssp ECSCCCGGGEEECTT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT--------CCCCHHHHHHHHHHHH
T ss_pred eccccchhhEEECCC-CCEEEccccCCcccCcccceecccCCCcccceECHhHhcC--------CCCCcHHHHHHHHHHH
Confidence 699999999999976 689999999997543322 1223457889999998853 5689999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
|||++ |..||.+..... ..........+..|..+++++.+++.+||..||.+||++.++++.|+.++...
T Consensus 296 ~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 296 WEIFTLGGSPYPGIPVEE-LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHHTTSCCSSTTCCGGG-HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 99999 999998765432 33344455566778889999999999999999999999999999999987644
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=195.03 Aligned_cols=132 Identities=26% Similarity=0.483 Sum_probs=107.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++... ........+||+.|+|||++.+ ..++.++|+||+||++||
T Consensus 127 vHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 197 (337)
T 1o6l_A 127 VYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYE 197 (337)
T ss_dssp BCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS--------SCBCTTHHHHHHHHHHHH
T ss_pred ecCcCCHHHEEECCC-CCEEEeeccchhhcccCCCcccccccChhhCChhhhcC--------CCCCchhhcccchhHHHH
Confidence 699999999999977 689999999997532 2233456789999999999853 567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFL 145 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~~l~~~~ 145 (198)
|++|..||.+......... .......+|..+++++.+++.+||..||.+|| ++.++++ |.|+
T Consensus 198 ll~g~~Pf~~~~~~~~~~~--i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~--h~~f 264 (337)
T 1o6l_A 198 MMCGRLPFYNQDHERLFEL--ILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME--HRFF 264 (337)
T ss_dssp HHHSSCSSCCSSHHHHHHH--HHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT--SGGG
T ss_pred HhcCCCCCCCCCHHHHHHH--HHcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc--CCCc
Confidence 9999999987664332222 22345567888999999999999999999999 8999988 5554
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=199.18 Aligned_cols=141 Identities=26% Similarity=0.323 Sum_probs=110.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+.+.+||+|||+++...........+||+.|+|||++.+ ...++.++||||+||++|||
T Consensus 163 vHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~el 235 (394)
T 4e7w_A 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG-------ATNYTTNIDIWSTGCVMAEL 235 (394)
T ss_dssp ECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHH
T ss_pred cCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcC-------CCCCCcHHHHHHHHHHHHHH
Confidence 69999999999984447899999999986544444456688999999998753 34589999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCC------------------C---------CCCCCCcHHHHHHHHHhcccCCCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHAR------------------P---------GLPEDISPDLAFIVQSCWVEDPNLRPS 133 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~------------------~---------~~p~~~~~~~~~l~~~~l~~dp~~Rps 133 (198)
++|..||.+................ + .++..+++++.+|+.+||..||.+|||
T Consensus 236 l~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (394)
T 4e7w_A 236 MQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315 (394)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC
Confidence 9999999987755443322211000 0 023347899999999999999999999
Q ss_pred HHHHHHHHHHHHhhcCC
Q 029154 134 FSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 134 ~~~~l~~l~~~~~~~~~ 150 (198)
+.++++ |.|+.....
T Consensus 316 ~~e~l~--hp~f~~~~~ 330 (394)
T 4e7w_A 316 AIEALC--HPFFDELRT 330 (394)
T ss_dssp HHHHHT--SGGGSTTTS
T ss_pred HHHHhc--Chhhhhhcc
Confidence 999998 888776543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=199.81 Aligned_cols=135 Identities=24% Similarity=0.444 Sum_probs=106.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccC-cccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++.. .........+||+.|+|||++.+ ..++.++|+||+||++||
T Consensus 175 vHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~--------~~~~~~~DiwslGvllye 245 (396)
T 4dc2_A 175 IYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFE 245 (396)
T ss_dssp BCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHH
T ss_pred EeccCCHHHEEECCC-CCEEEeecceeeecccCCCccccccCCcccCCchhhcC--------CCCChHHHHHHHHHHHHH
Confidence 699999999999977 78999999999853 23334456789999999999854 568899999999999999
Q ss_pred HHcCCCCCCCCCcH-------HHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH------HHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNL-------QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF------SQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~------~~~l~~l~~~~~ 146 (198)
|++|..||...... ..............+|..+++++.+|+.+||..||.+|+++ .++++ |.|+.
T Consensus 246 ll~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~--Hpff~ 323 (396)
T 4dc2_A 246 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG--HPFFR 323 (396)
T ss_dssp HHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH--STTTT
T ss_pred HHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc--Ccccc
Confidence 99999999643211 11122333445667888899999999999999999999985 67776 55553
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=194.16 Aligned_cols=140 Identities=29% Similarity=0.520 Sum_probs=110.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.+ +.+||+|||+++...... ......+|..|+|||++.+ ..++.++||||||++
T Consensus 173 vH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~i 243 (325)
T 3kul_A 173 VHRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF--------RTFSSASDVWSFGVV 243 (325)
T ss_dssp ECSCCSGGGEEECTT-CCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHH--------CEECHHHHHHHHHHH
T ss_pred eCCCCCcceEEECCC-CCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcC--------CCCCcHHHHHHHHHH
Confidence 699999999999976 689999999997543221 1122346778999999853 567899999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
+|++++ |..||.+..... ...........+.+..+++++.+++.+||..||.+||++.++++.|+.++.....
T Consensus 244 l~ell~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 244 MWEVLAYGERPYWNMTNRD-VISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp HHHHHTTSCCTTTTSCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred HHHHHcCCCCCcccCCHHH-HHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 999998 999998766543 3344445556667788999999999999999999999999999999998765443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=198.52 Aligned_cols=142 Identities=18% Similarity=0.196 Sum_probs=106.9
Q ss_pred CCCCCCCCCeEEc--CCCCceEEecccCcccCccccc--------ccCCCCccceecccccccccccccccCCCCchhhH
Q 029154 1 MGKFMKEDNLLLT--PDQKSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 70 (198)
Q Consensus 1 iH~dlKp~NIll~--~~~~~~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dv 70 (198)
|||||||+|||++ .+ +.+||+|||+++....... ....+||+.|+|||++.+ ..++.++||
T Consensus 174 iHrDlkp~Nill~~~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di 244 (364)
T 3op5_A 174 VHGDIKASNLLLNYKNP-DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--------VAPSRRGDL 244 (364)
T ss_dssp ECCCCCGGGEEEESSCT-TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--------CCCCHHHHH
T ss_pred EEecCCHHHEEEecCCC-CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--------CCCCchhhH
Confidence 6999999999998 55 6799999999975432211 123459999999999853 568999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCC---------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 71 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG---------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 71 ws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
|||||++|||++|..||.+.................. .+..+++++.+++.+||..||.+||++.++++.|
T Consensus 245 ~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l 324 (364)
T 3op5_A 245 EILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDIL 324 (364)
T ss_dssp HHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Confidence 9999999999999999985332111111110000000 1246789999999999999999999999999999
Q ss_pred HHHHhhcCCC
Q 029154 142 NAFLFTLRPP 151 (198)
Q Consensus 142 ~~~~~~~~~~ 151 (198)
+.++......
T Consensus 325 ~~~~~~~~~~ 334 (364)
T 3op5_A 325 LQGLKAIGSK 334 (364)
T ss_dssp HHHHHHTTCC
T ss_pred HHHHHHcCCC
Confidence 9988766544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-29 Score=195.05 Aligned_cols=142 Identities=29% Similarity=0.577 Sum_probs=116.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++...... ......+|..|+|||++.+ ..++.++|||||||++
T Consensus 213 vH~Dlkp~NIll~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il 283 (382)
T 3tt0_A 213 IHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLL 283 (382)
T ss_dssp CCSCCCGGGEEECTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS--------CCCCHHHHHHHHHHHH
T ss_pred ecCCCCcceEEEcCC-CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC--------CCCCchhHHHHHHHHH
Confidence 799999999999976 679999999998543321 1233467889999999853 5688999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCC
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 152 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~ 152 (198)
|++++ |..||.+.... ..............+..+++++.+++.+||..||.+||++.+++++|+.++.......
T Consensus 284 ~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 284 WEIFTLGGSPYPGVPVE-ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HHHHTTSCCSSTTCCHH-HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 99999 99999876543 3344445556667788899999999999999999999999999999999987665443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=192.79 Aligned_cols=136 Identities=24% Similarity=0.319 Sum_probs=105.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++...........+||+.|+|||++.+ ..++.++||||+||++|+|
T Consensus 142 vH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~l 212 (308)
T 3g33_A 142 VHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ--------STYATPVDMWSVGCIFAEM 212 (308)
T ss_dssp CCSCCCTTTEEECTT-SCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHT--------SCCCSTHHHHHHHHHHHHT
T ss_pred ccCCCCHHHEEEcCC-CCEEEeeCccccccCCCcccCCccccccccCchHHcC--------CCCCchHHHHHHHHHHHHH
Confidence 799999999999976 6899999999986554444455678999999999853 5688999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCC-------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPG-------------------------LPEDISPDLAFIVQSCWVEDPNLRPSFS 135 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~p~~~~~~~~~l~~~~l~~dp~~Rps~~ 135 (198)
++|..||.+................+. ....+++.+.+|+.+||..||.+|||+.
T Consensus 213 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 292 (308)
T 3g33_A 213 FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292 (308)
T ss_dssp TTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHH
Confidence 999999988765444322221111000 1135788999999999999999999999
Q ss_pred HHHHHHHHHHhh
Q 029154 136 QIIRMLNAFLFT 147 (198)
Q Consensus 136 ~~l~~l~~~~~~ 147 (198)
++++ |.|+..
T Consensus 293 e~l~--h~~~~~ 302 (308)
T 3g33_A 293 RALQ--HSYLHK 302 (308)
T ss_dssp HHHT--STTC--
T ss_pred HHhc--CccccC
Confidence 9998 666543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=188.96 Aligned_cols=134 Identities=37% Similarity=0.750 Sum_probs=104.6
Q ss_pred CCCCCCCCCeEEcCC-------CCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHH
Q 029154 1 MGKFMKEDNLLLTPD-------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 73 (198)
Q Consensus 1 iH~dlKp~NIll~~~-------~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~ 73 (198)
+||||||+|||++.+ .+.+||+|||+++...... .....||+.|+|||.+.+ ..++.++|+||+
T Consensus 130 ~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~sl 200 (271)
T 3dtc_A 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRA--------SMFSKGSDVWSY 200 (271)
T ss_dssp CCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHH--------CCCSHHHHHHHH
T ss_pred eecCCchHHEEEecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhcc--------CCCCchhhHHHH
Confidence 599999999999852 3679999999997543322 224578999999999853 567899999999
Q ss_pred HHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 74 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 74 G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
|+++|++++|..||.+...................+..+++.+.+++.+||..||.+||++.+++++|+.
T Consensus 201 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 201 GVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 9999999999999998776555555554555566778899999999999999999999999999998864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-29 Score=193.67 Aligned_cols=142 Identities=27% Similarity=0.348 Sum_probs=108.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|||++.+ ...++.++||||+||++|+
T Consensus 134 vH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~e 205 (346)
T 1ua2_A 134 LHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCILAE 205 (346)
T ss_dssp CCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTT-------CSCCCHHHHHHHHHHHHHH
T ss_pred ECCCCCHHHEEEcCC-CCEEEEecccceeccCCcccCCcccccccccCchHhhC-------CCCCCchhhhHhHHHHHHH
Confidence 799999999999976 6899999999976533 223345678999999998753 3457899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC---C-----------------------CCCCCcHHHHHHHHHhcccCCCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP---G-----------------------LPEDISPDLAFIVQSCWVEDPNLRPS 133 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~---~-----------------------~p~~~~~~~~~l~~~~l~~dp~~Rps 133 (198)
|++|.+||.+................+ . ....+++++.+|+.+||..||.+|||
T Consensus 206 ll~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 285 (346)
T 1ua2_A 206 LLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 285 (346)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCC
Confidence 999999998876544433222211110 0 01345789999999999999999999
Q ss_pred HHHHHHHHHHHHhhcCCCC
Q 029154 134 FSQIIRMLNAFLFTLRPPS 152 (198)
Q Consensus 134 ~~~~l~~l~~~~~~~~~~~ 152 (198)
+.|+++ +.|+.....+.
T Consensus 286 ~~ell~--h~~f~~~~~~~ 302 (346)
T 1ua2_A 286 ATQALK--MKYFSNRPGPT 302 (346)
T ss_dssp HHHHHT--SGGGTSSSCCC
T ss_pred HHHHhc--ChhhhcCCCCC
Confidence 999999 77876554443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-29 Score=189.47 Aligned_cols=140 Identities=32% Similarity=0.663 Sum_probs=106.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.++..+||+|||++...... .....||+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 127 vH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el 196 (307)
T 2eva_A 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEG--------SNYSEKCDVFSWGIILWEV 196 (307)
T ss_dssp CCCCCSGGGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTC--------CCCCTHHHHHHHHHHHHHH
T ss_pred ecCCCChhHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCC--------CCCCcHHHHHHHHHHHHHH
Confidence 799999999999877445899999998754322 234568999999999853 5688999999999999999
Q ss_pred HcCCCCCCCCCcH-HHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 81 LTNRLPFEGMSNL-QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 81 ~~g~~p~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
++|..||...... ............+..+..+++.+.+++.+||..||.+||++.++++.|+.+......
T Consensus 197 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 197 ITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp HHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred HHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 9999999764332 222223334555666778999999999999999999999999999999988765543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-30 Score=198.19 Aligned_cols=135 Identities=29% Similarity=0.440 Sum_probs=108.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||++............+||+.|+|||++.+ ....+.++||||+|+++|+|
T Consensus 130 vH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l 201 (336)
T 3h4j_B 130 VHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-------KLYAGPEVDVWSCGIVLYVM 201 (336)
T ss_dssp CCCCCSTTTEEECTT-CCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCC-------SGGGCHHHHHHHHHHHHHHH
T ss_pred EecCCchhhEEEcCC-CCEEEEEeccceeccCCcccccccCCcCcCCHHHHcC-------CCCCCCccchhHHHHHHHHH
Confidence 799999999999976 6899999999986655555567789999999999854 22236899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
++|..||.+...... ...........|..+++++.+++.+||..||.+|||+.++++ +.|+..
T Consensus 202 l~g~~Pf~~~~~~~~--~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~~ 264 (336)
T 3h4j_B 202 LVGRLPFDDEFIPNL--FKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR--DPWFNV 264 (336)
T ss_dssp HHSSCSSBCSSSTTC--BCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT--CHHHHT
T ss_pred HhCCCCCCCccHHHH--HHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh--Chhhcc
Confidence 999999976442111 111123344567789999999999999999999999999999 777764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=195.46 Aligned_cols=143 Identities=20% Similarity=0.239 Sum_probs=110.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++...+.+||+|||+++............||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 153 vH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el 225 (360)
T 3e3p_A 153 CHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFG-------NQHYTTAVDIWSVGCIFAEM 225 (360)
T ss_dssp BCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHH
T ss_pred ecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcC-------CCCCCcHHHHHHHHHHHHHH
Confidence 69999999999996447899999999986655444456688999999998753 34578999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccC------------------------------CCCCCCCCcHHHHHHHHHhcccCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHA------------------------------RPGLPEDISPDLAFIVQSCWVEDPNL 130 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~------------------------------~~~~p~~~~~~~~~l~~~~l~~dp~~ 130 (198)
++|..||.+............... ....+...++++.+|+.+||+.||.+
T Consensus 226 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 305 (360)
T 3e3p_A 226 MLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEE 305 (360)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGG
T ss_pred HhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccc
Confidence 999999988765443322211100 01112235788999999999999999
Q ss_pred CCCHHHHHHHHHHHHhhcCCCC
Q 029154 131 RPSFSQIIRMLNAFLFTLRPPS 152 (198)
Q Consensus 131 Rps~~~~l~~l~~~~~~~~~~~ 152 (198)
|||+.++++ |.|+.....+.
T Consensus 306 Rpt~~e~l~--hp~f~~~~~~~ 325 (360)
T 3e3p_A 306 RMKPYEALC--HPYFDELHDPA 325 (360)
T ss_dssp SCCHHHHTT--SGGGGGGGCTT
T ss_pred cCCHHHHhc--CccccccCCcc
Confidence 999999999 88887665443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=198.06 Aligned_cols=133 Identities=28% Similarity=0.422 Sum_probs=103.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++... ........+||+.|+|||++.+ ..++.++|+||+||++||
T Consensus 146 vHrDlkp~NILl~~~-g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 216 (353)
T 3txo_A 146 IYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE--------MLYGPAVDWWAMGVLLYE 216 (353)
T ss_dssp BCCCCCGGGEEECTT-SCEEECCCTTCBCSCC---------CCGGGCCHHHHHH--------HHCTTHHHHHHHHHHHHH
T ss_pred cccCCCHHHEEECCC-CCEEEccccceeecccCCccccccCCCcCeEChhhcCC--------CCcCCccCCCcchHHHHH
Confidence 699999999999977 789999999997532 2233445689999999999854 567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH------HHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF------SQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~------~~~l~~l~~~~~ 146 (198)
|++|..||.+......... +.......|..+++++.+++.+||..||.+||++ .++++ |.|+.
T Consensus 217 ll~G~~Pf~~~~~~~~~~~--i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~--hp~f~ 285 (353)
T 3txo_A 217 MLCGHAPFEAENEDDLFEA--ILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR--HPFFK 285 (353)
T ss_dssp HHHSSCSSCCSSHHHHHHH--HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT--SGGGT
T ss_pred HHhCCCCCCCCCHHHHHHH--HHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh--CCccc
Confidence 9999999988765433222 2334556778899999999999999999999998 77887 55554
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=193.82 Aligned_cols=136 Identities=25% Similarity=0.516 Sum_probs=108.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++...... ......|+..|+|||++.+ ..++.++||||+|+++
T Consensus 137 vH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l 207 (325)
T 3kex_A 137 VHRNLAARNVLLKSP-SQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF--------GKYTHQSDVWSYGVTV 207 (325)
T ss_dssp CCSCCSSTTEEESSS-SCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred CCCccchheEEECCC-CeEEECCCCcccccCcccccccccCCCCcccccChHHhcc--------CCCChhhHhHHhHHHH
Confidence 799999999999876 679999999998543222 2234567889999999853 5689999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|++++ |..||.+...... ............+..++.++.+++.+||..||.+||++.+++++|+.+..
T Consensus 208 ~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 208 WELMTFGAEPYAGLRLAEV-PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp HHHHTTSCCTTTTSCTTHH-HHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHHHhCCCCCccccCHHHH-HHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 99999 9999987654332 23333444566677788999999999999999999999999999988754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-29 Score=188.54 Aligned_cols=135 Identities=33% Similarity=0.647 Sum_probs=107.5
Q ss_pred CCCCCCCCCeEEcCCCC----ceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQK----SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~----~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.++. .+||+|||+++.... ......||+.|+|||++.. ....++.++||||+|++
T Consensus 146 vH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~------~~~~~~~~~Di~slG~~ 217 (287)
T 4f0f_A 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGA------EEESYTEKADTYSFAMI 217 (287)
T ss_dssp BCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSC------SSCEECHHHHHHHHHHH
T ss_pred ecCCCCcceEEEeccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhcc------CCCCcCchhhHHHHHHH
Confidence 69999999999986521 299999999975433 2345679999999999743 23456889999999999
Q ss_pred HHHHHcCCCCCCCCCcHHH--HHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 77 LWELLTNRLPFEGMSNLQA--AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
+|++++|..||........ ..........+..+..+++++.+++.+||..||.+||++.++++.|+.
T Consensus 218 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 218 LYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 9999999999976553222 222333455667788899999999999999999999999999998864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-29 Score=197.85 Aligned_cols=139 Identities=22% Similarity=0.404 Sum_probs=100.1
Q ss_pred CCCCCCCCCeEEcCC--CCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~--~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ .+.+||+|||+++...........+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 183 vHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ 254 (400)
T 1nxk_A 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMY 254 (400)
T ss_dssp ECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCC--------CCSSSHHHHHHHHHHHH
T ss_pred cccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCC--------CCCCCcccHHHHHHHHH
Confidence 699999999999862 36799999999986554444456789999999999853 57889999999999999
Q ss_pred HHHcCCCCCCCCCcHH----HHHHHHHccCCCC--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 79 ELLTNRLPFEGMSNLQ----AAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~----~~~~~~~~~~~~~--~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
+|++|..||.+..... ............+ ....+++++.+|+.+||..||.+|||+.++++ +.|+....
T Consensus 255 ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~~~~ 329 (400)
T 1nxk_A 255 ILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQST 329 (400)
T ss_dssp HHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHHTTT
T ss_pred HHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--CccccCCC
Confidence 9999999997654211 1111111222221 22468999999999999999999999999999 77776433
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=188.25 Aligned_cols=137 Identities=23% Similarity=0.346 Sum_probs=104.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++..... .......||+.|+|||++.+.. ...++.++||||+|+++|+
T Consensus 159 vH~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~Di~slG~~l~~ 232 (298)
T 2zv2_A 159 IHRDIKPSNLLVGED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR-----KIFSGKALDVWAMGVTLYC 232 (298)
T ss_dssp ECCCCCGGGEEECTT-SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTC-----CCEESHHHHHHHHHHHHHH
T ss_pred eccCCCHHHEEECCC-CCEEEecCCCccccccccccccCCcCCccccChhhhccCC-----CCCCCchhhhHhHHHHHHH
Confidence 699999999999976 67999999999754332 2234568999999999985310 0113678999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
|++|..||.+.................+....+++++.+++.+||..||.+||++.++++ +.|+
T Consensus 233 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~--hp~~ 296 (298)
T 2zv2_A 233 FVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL--HPWV 296 (298)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT--CHHH
T ss_pred HHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc--Cccc
Confidence 999999998766433322222222233334568999999999999999999999999998 5554
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=200.63 Aligned_cols=138 Identities=33% Similarity=0.558 Sum_probs=112.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++....... .....++..|+|||++.. ..++.++||||||+++|
T Consensus 306 vHrDlkp~Nill~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~ 376 (454)
T 1qcf_A 306 IHRDLRAANILVSAS-LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLM 376 (454)
T ss_dssp CCSSCSGGGEEECTT-CCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHH
T ss_pred cCCCCCHHHEEECCC-CcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc--------CCCCcHHHHHhHHHHHH
Confidence 799999999999976 6899999999986543221 223456789999999853 56899999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
||++ |..||.+...... ..........+.|..+++++.+++.+||..||.+|||+.++++.|+.+....
T Consensus 377 el~t~g~~P~~~~~~~~~-~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 377 EIVTYGRIPYPGMSNPEV-IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp HHHTTSCCSSTTCCHHHH-HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred HHHhCCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 9999 9999988765433 3334445566678889999999999999999999999999999998875433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-29 Score=199.93 Aligned_cols=133 Identities=26% Similarity=0.472 Sum_probs=107.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++... ........+||+.|+|||++.+ ..++.++||||+||++||
T Consensus 271 iHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 341 (446)
T 4ejn_A 271 VYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYE 341 (446)
T ss_dssp CCCCCCGGGEEECSS-SCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHH
T ss_pred EECCCCHHHEEECCC-CCEEEccCCCceeccCCCcccccccCCccccCHhhcCC--------CCCCCccchhhhHHHHHH
Confidence 799999999999976 689999999997532 2233456789999999999853 678999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~~l~~~~~ 146 (198)
|++|..||.+.......... ......+|..+++++.+|+.+||..||.+|| ++.++++ |.|+.
T Consensus 342 ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~--hp~f~ 409 (446)
T 4ejn_A 342 MMCGRLPFYNQDHEKLFELI--LMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ--HRFFA 409 (446)
T ss_dssp HHHSSCSSCCSSHHHHHHHH--HHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT--SGGGT
T ss_pred HhhCCCCCCCCCHHHHHHHH--HhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh--Ccccc
Confidence 99999999876654333222 2344567788999999999999999999999 9999998 66654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=192.92 Aligned_cols=136 Identities=26% Similarity=0.508 Sum_probs=108.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++....... .....+|..|+|||++.+ ..++.++||||||+++
T Consensus 139 vH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il 209 (327)
T 3poz_A 139 VHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTV 209 (327)
T ss_dssp CCSCCCGGGEEEEET-TEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred eCCCCChheEEECCC-CCEEEccCcceeEccCCcccccccCCCccccccChHHhcc--------CCCCchhhhhhhHHHH
Confidence 799999999999976 6899999999974332211 223456889999999854 6689999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
||+++ |..||.+..... .............+..++.++.+++.+||..||.+||++.+++++|+.+..
T Consensus 210 ~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 210 WELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHTTSCCTTTTCCGGG-HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHhcCCCCccCCCHHH-HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99999 999998765433 223334445566777899999999999999999999999999999988754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-29 Score=193.74 Aligned_cols=132 Identities=27% Similarity=0.477 Sum_probs=106.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++... ........+||+.|+|||++.+ ..++.++|+||+||++||
T Consensus 143 vHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 213 (353)
T 2i0e_A 143 IYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYE 213 (353)
T ss_dssp BCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--------CCBSTHHHHHHHHHHHHH
T ss_pred EeccCCHHHEEEcCC-CcEEEEeCCcccccccCCcccccccCCccccChhhhcC--------CCcCCcccccchHHHHHH
Confidence 699999999999977 689999999997532 2233456789999999999853 567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFL 145 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps-----~~~~l~~l~~~~ 145 (198)
|++|..||.+....... .. +......+|..+++++.+|+.+||..||.+||+ +.++++ |.|+
T Consensus 214 ll~G~~Pf~~~~~~~~~-~~-i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~--h~~f 280 (353)
T 2i0e_A 214 MLAGQAPFEGEDEDELF-QS-IMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE--HAFF 280 (353)
T ss_dssp HHHSSCSSCCSSHHHHH-HH-HHHCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT--SGGG
T ss_pred HHcCCCCCCCCCHHHHH-HH-HHhCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc--Cccc
Confidence 99999999876643332 22 223455678889999999999999999999995 577777 4554
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-29 Score=192.93 Aligned_cols=136 Identities=29% Similarity=0.455 Sum_probs=108.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++..... ...+||+.|+|||++.+. ....++.++|||||||++|||
T Consensus 176 vH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~-----~~~~~~~~~DiwslG~il~el 246 (348)
T 1u5q_A 176 IHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIEL 246 (348)
T ss_dssp BCCCCSGGGEEEETT-TEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTT-----SSCCBCTHHHHHHHHHHHHHH
T ss_pred eeCCCCHHHEEECCC-CCEEEeeccCceecCCC---CcccCCcceeCHhhhccc-----cCCCCCcHHHHHHHHHHHHHH
Confidence 699999999999976 78999999999754432 346799999999987421 135678999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
++|..||.+...............+...+..+++.+.+++.+||..||.+||++.++++ +.|+..
T Consensus 247 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~--h~~~~~ 311 (348)
T 1u5q_A 247 AERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLR 311 (348)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--CHHHHS
T ss_pred HhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh--Chhhhc
Confidence 99999998877655544443333333445678999999999999999999999999999 666554
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=197.50 Aligned_cols=136 Identities=22% Similarity=0.348 Sum_probs=106.0
Q ss_pred CCCCCCCCCeEEcCC--CCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD--QKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~--~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ ++.+||+|||+++..... ......+||+.|+|||++.+ ..++.++||||+||++
T Consensus 132 vHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~DIwSlGvil 203 (444)
T 3soa_A 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK--------DPYGKPVDLWACGVIL 203 (444)
T ss_dssp BCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHH
T ss_pred cccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcC--------CCCCCccccHHHHHHH
Confidence 699999999999842 357999999999755432 22345689999999999853 5688999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCCCC--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|+|++|..||.+.................+ ....+++++.+|+.+||..||.+||++.++++ +.|+.
T Consensus 204 yell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~--hp~~~ 272 (444)
T 3soa_A 204 YILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK--HPWIS 272 (444)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SCTTH
T ss_pred HHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc--Ccccc
Confidence 999999999987665443333222222222 22468999999999999999999999999999 66654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=195.39 Aligned_cols=134 Identities=21% Similarity=0.300 Sum_probs=106.7
Q ss_pred CCCCCCCCCeEEcCCCC---ceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQK---SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~---~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.++. .+||+|||+++...........+||+.|+|||++.+ ..++.++|+||+||++
T Consensus 137 vHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil 208 (361)
T 2yab_A 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVIT 208 (361)
T ss_dssp ECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHH
T ss_pred ccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcC--------CCCCccccHHHHHHHH
Confidence 69999999999986632 699999999986655444556789999999999853 5688999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCCCCC----CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|+|++|..||.+........... .....+ +..+++++.+|+.+||..||.+|||+.++++ +.|+.
T Consensus 209 ~~ll~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~--hp~~~ 277 (361)
T 2yab_A 209 YILLSGASPFLGDTKQETLANIT--AVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR--HPWIT 277 (361)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHHH--TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--STTTS
T ss_pred HHHHhCCCCCCCCCHHHHHHHHH--hcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc--CcCcC
Confidence 99999999998866543322222 222222 2568899999999999999999999999998 55543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=188.87 Aligned_cols=139 Identities=31% Similarity=0.532 Sum_probs=112.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||+++....... .....||+.|+|||++.+ ..++.++||||+|+++
T Consensus 167 ~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 237 (313)
T 1t46_A 167 IHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGIFL 237 (313)
T ss_dssp CCSCCSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred ecCCCccceEEEcCC-CCEEEccccccccccccccceeccCCCCcceeeChHHhcC--------CCCChHHHHHHHHHHH
Confidence 699999999999976 7899999999975443221 223456788999998753 5688999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
|+|++ |..||.+...................+..++.++.+++.+||..||.+||++.+++++|+..+...
T Consensus 238 ~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 238 WELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 99998 999998766544444444445555667789999999999999999999999999999999887643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-29 Score=188.71 Aligned_cols=142 Identities=16% Similarity=0.224 Sum_probs=107.7
Q ss_pred CCCCCCCCCeEEcCCC----CceEEecccCcccCcccc--------cccCCCCccceecccccccccccccccCCCCchh
Q 029154 1 MGKFMKEDNLLLTPDQ----KSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 68 (198)
Q Consensus 1 iH~dlKp~NIll~~~~----~~~kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 68 (198)
|||||||+|||++.++ ..+||+|||+++...... ......||+.|+|||++.+ ..++.++
T Consensus 128 vH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~ 199 (298)
T 1csn_A 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--------REQSRRD 199 (298)
T ss_dssp ECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHH
T ss_pred ecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcC--------CCCChHH
Confidence 6999999999998552 239999999997543321 1234579999999999853 5679999
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCc--HHHHHHHHH----ccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 69 DVYSFGIVLWELLTNRLPFEGMSN--LQAAYAAAF----KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 69 Dvws~G~~l~e~~~g~~p~~~~~~--~~~~~~~~~----~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
||||||+++|+|++|..||.+... ......... ..........+++++.+++.+||..||.+||++.++++.|+
T Consensus 200 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~ 279 (298)
T 1csn_A 200 DLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 279 (298)
T ss_dssp HHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 999999999999999999987432 111111111 11112233468899999999999999999999999999999
Q ss_pred HHHhhcCC
Q 029154 143 AFLFTLRP 150 (198)
Q Consensus 143 ~~~~~~~~ 150 (198)
.++.....
T Consensus 280 ~~~~~~~~ 287 (298)
T 1csn_A 280 KVLERLNT 287 (298)
T ss_dssp HHHHHTTC
T ss_pred HHHHhcCC
Confidence 98876553
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-29 Score=194.41 Aligned_cols=137 Identities=24% Similarity=0.381 Sum_probs=107.2
Q ss_pred CCCCCCCCCeEEcCCC--CceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~--~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.++ ..+||+|||++............+||+.|+|||++.+ ..++.++||||+||++|
T Consensus 150 vH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ 221 (362)
T 2bdw_A 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILY 221 (362)
T ss_dssp BCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTT--------CCCCTHHHHHHHHHHHH
T ss_pred EeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHcc--------CCCCchhhHHHHHHHHH
Confidence 6999999999998542 3599999999986655444456789999999999853 56889999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCC--CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
+|++|..||.+.................+. ...+++++.+|+.+||..||.+||++.++++ +.|+..
T Consensus 222 ~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~~~~ 290 (362)
T 2bdw_A 222 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK--VPWICN 290 (362)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT--SHHHHT
T ss_pred HHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc--CcccCC
Confidence 999999999876654333222222222222 2357899999999999999999999999998 666653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=190.77 Aligned_cols=136 Identities=26% Similarity=0.516 Sum_probs=105.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++....... .....+|..|+|||++.+ ..++.++||||+|+++
T Consensus 139 vH~Dikp~NIl~~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il 209 (327)
T 3lzb_A 139 VHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTV 209 (327)
T ss_dssp CCSCCCGGGEEEEET-TEEEECCTTC----------------CCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred cCCCCCHHHEEEcCC-CCEEEccCcceeEccCccccccccCCCccccccCHHHHcC--------CCCChHHHHHHHHHHH
Confidence 799999999999866 6899999999975432221 223456788999999854 5688999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|++++ |..||.+...... ............+..++.++.+++.+||..||.+||++.++++.|+.+..
T Consensus 210 ~ell~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 210 WELMTFGSKPYDGIPASEI-SSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHTTSCCTTTTCCGGGH-HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHCCCCCCCCCCHHHH-HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 99999 9999987664332 23334455566778899999999999999999999999999999998864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.2e-29 Score=187.32 Aligned_cols=137 Identities=28% Similarity=0.578 Sum_probs=101.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+|||++.+ +.+||+|||+++....... .....+++.|+|||++.+ ..++.++|+||+|+++|
T Consensus 138 ~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ 208 (281)
T 1mp8_A 138 VHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMW 208 (281)
T ss_dssp CCSCCSGGGEEEEET-TEEEECC-------------------CCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHH
T ss_pred ecccccHHHEEECCC-CCEEECccccccccCcccccccccCCCcccccChhhccc--------CCCCCccCchHHHHHHH
Confidence 799999999999966 6899999999975543222 123356788999999853 56789999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
++++ |..||.+...... ............+..+++++.+++.+||..||.+||++.++++.|+.++..
T Consensus 209 ell~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 209 EILMHGVKPFQGVKNNDV-IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHTTSCCTTTTCCGGGH-HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCcCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 9996 9999987664332 233334455667788999999999999999999999999999999988654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=203.80 Aligned_cols=136 Identities=24% Similarity=0.398 Sum_probs=99.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++...........+||+.|+|||++.+ ..|+.++||||+||++|||
T Consensus 186 iHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el 256 (464)
T 3ttj_A 186 IHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEM 256 (464)
T ss_dssp CCCCCCGGGEEECTT-SCEEECCCCCC-----CCCC----CCCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHH
T ss_pred ccCCCChHhEEEeCC-CCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcC--------CCCCHHHHHHHHHHHHHHH
Confidence 799999999999976 6899999999986655444556789999999999864 5688999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCC--------------------CCC---------CCC-----------CcHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHAR--------------------PGL---------PED-----------ISPDLAFIV 120 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~--------------------~~~---------p~~-----------~~~~~~~l~ 120 (198)
++|+.||.+................ +.. +.. .++++.+|+
T Consensus 257 l~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 336 (464)
T 3ttj_A 257 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 336 (464)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHH
Confidence 9999999987654433222111000 000 000 156789999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 121 QSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 121 ~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
.+||..||.+|||++|+++ |.|+..
T Consensus 337 ~~mL~~dP~~R~ta~e~L~--Hp~~~~ 361 (464)
T 3ttj_A 337 SKMLVIDPAKRISVDDALQ--HPYINV 361 (464)
T ss_dssp HHHSCSSTTTSCCHHHHHT--STTTGG
T ss_pred HHHcCCChhhCCCHHHHhc--Chhhhh
Confidence 9999999999999999999 777653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=194.32 Aligned_cols=139 Identities=30% Similarity=0.509 Sum_probs=111.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++
T Consensus 194 vH~Dikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il 264 (344)
T 1rjb_A 194 VHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------GIYTIKSDVWSYGILL 264 (344)
T ss_dssp EETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred ccCCCChhhEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc--------CCCChhHhHHHHHHHH
Confidence 699999999999976 6899999999975432211 223456788999998753 5688999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
|+|++ |..||.+................+..+..+++++.+++.+||..||.+||++.+++++|+.++...
T Consensus 265 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 265 WEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 99998 999998766544444444555566677889999999999999999999999999999999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.7e-29 Score=189.97 Aligned_cols=139 Identities=27% Similarity=0.407 Sum_probs=104.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++..... ......+||+.|+|||++.+ ...++.++||||+||++|+
T Consensus 141 vH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ 212 (311)
T 3niz_A 141 LHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG-------SKKYSTSVDIWSIGCIFAE 212 (311)
T ss_dssp ECCCCCGGGEEECTT-CCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHH
T ss_pred ccCCCchHhEEECCC-CCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcC-------CCCCCchHHhHHHHHHHHH
Confidence 699999999999977 67999999999754322 22345678999999998753 3567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHH--HccCCCC--------------------------CCCCCcHHHHHHHHHhcccCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAA--FKHARPG--------------------------LPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~--~~~~~~~--------------------------~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
|++|..||.+........... .....+. ....+++++.+|+.+||..||.+|
T Consensus 213 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 292 (311)
T 3niz_A 213 MITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKR 292 (311)
T ss_dssp HHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTS
T ss_pred HHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHC
Confidence 999999998765433322211 1111110 113467899999999999999999
Q ss_pred CCHHHHHHHHHHHHhhcC
Q 029154 132 PSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~~ 149 (198)
||+.++++ +.|+....
T Consensus 293 pt~~ell~--hp~f~~~~ 308 (311)
T 3niz_A 293 ISARDAMN--HPYFKDLD 308 (311)
T ss_dssp CCHHHHHT--SGGGTTSC
T ss_pred CCHHHHhc--CcccccCC
Confidence 99999999 77766543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=189.87 Aligned_cols=141 Identities=23% Similarity=0.376 Sum_probs=107.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++..... ......+||+.|+|||++.+ ...++.++||||+||++|+
T Consensus 130 vH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~e 201 (317)
T 2pmi_A 130 LHRDLKPQNLLINKR-GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG-------SRTYSTSIDIWSCGCILAE 201 (317)
T ss_dssp ECCCCCGGGEEECTT-CCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHH
T ss_pred eeCCCChHHeEEcCC-CCEEECcCccceecCCCcccCCCCcccccccCchHhhC-------CCCCCcHHHHHHHHHHHHH
Confidence 699999999999976 67999999999754322 22345678999999999753 3467899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHH--ccCC------------------------------CCCCCCCcHHHHHHHHHhcccC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAF--KHAR------------------------------PGLPEDISPDLAFIVQSCWVED 127 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~--~~~~------------------------------~~~p~~~~~~~~~l~~~~l~~d 127 (198)
|++|..||.+............ .... +..+..+++++.+|+.+||..|
T Consensus 202 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 281 (317)
T 2pmi_A 202 MITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN 281 (317)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSS
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCC
Confidence 9999999988765443322211 0000 0112357889999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHhhcCCC
Q 029154 128 PNLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 128 p~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
|.+|||+.++++ +.|+......
T Consensus 282 P~~Rpt~~e~l~--hp~f~~~~~~ 303 (317)
T 2pmi_A 282 PDMRLSAKQALH--HPWFAEYYHH 303 (317)
T ss_dssp GGGSCCHHHHTT--SGGGGGGCC-
T ss_pred cccCCCHHHHhC--Chhhhcccch
Confidence 999999999999 7887765544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=194.41 Aligned_cols=133 Identities=27% Similarity=0.478 Sum_probs=107.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++... ........+||+.|+|||++.+ ..++.++|+||+||++||
T Consensus 140 vHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 210 (345)
T 1xjd_A 140 VYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG--------QKYNHSVDWWSFGVLLYE 210 (345)
T ss_dssp BCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHH
T ss_pred EeCCCChhhEEECCC-CCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcC--------CCCCChhhhHHHHHHHHH
Confidence 699999999999977 689999999997532 2223456789999999999853 568899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHH-HHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS-QIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~-~~l~~l~~~~~ 146 (198)
|++|..||.+......... .....+..|..+++++.+++.+||..||.+||++. ++++ |.|+.
T Consensus 211 ll~g~~Pf~~~~~~~~~~~--i~~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~--hp~f~ 274 (345)
T 1xjd_A 211 MLIGQSPFHGQDEEELFHS--IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ--HPLFR 274 (345)
T ss_dssp HHHSSCSSCCSSHHHHHHH--HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG--SGGGT
T ss_pred HhcCCCCCCCCCHHHHHHH--HHhCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc--Ccccc
Confidence 9999999987665333222 23345567788999999999999999999999997 7876 55543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=194.40 Aligned_cols=144 Identities=24% Similarity=0.426 Sum_probs=104.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccc---cccCCCCchhhHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNNKVDVYSFG 74 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~---~~~~~~~~~~Dvws~G 74 (198)
|||||||+|||++ + +.+||+|||+++...... .....+||+.|+|||++.+..... .....++.++||||||
T Consensus 177 vHrDlkp~NIll~-~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlG 254 (390)
T 2zmd_A 177 VHSDLKPANFLIV-D-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 254 (390)
T ss_dssp CCCCCCGGGEEES-S-SCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHH
T ss_pred eecCCCHHHEEEE-C-CeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHH
Confidence 7999999999996 4 579999999998553322 223567999999999975310000 0013578999999999
Q ss_pred HHHHHHHcCCCCCCCCCcHHHHHHHHHc-cCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 75 IVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 75 ~~l~e~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
|++|+|++|..||............... ......|...+.++.+|+.+||..||.+||++.++++ +.|+...
T Consensus 255 vil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~--hp~~~~~ 327 (390)
T 2zmd_A 255 CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQIQ 327 (390)
T ss_dssp HHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHSC
T ss_pred HHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh--CcCcccc
Confidence 9999999999999876544333333322 3344567778899999999999999999999999999 6666543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-29 Score=195.08 Aligned_cols=136 Identities=32% Similarity=0.545 Sum_probs=109.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccc---cCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++........ ....++..|+|||++.. ..++.++||||||+++
T Consensus 235 vHrDlkp~Nil~~~~-~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il 305 (377)
T 3cbl_A 235 IHRDLAARNCLVTEK-NVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY--------GRYSSESDVWSFGILL 305 (377)
T ss_dssp ECSCCSGGGEEECTT-CCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH--------CEEEHHHHHHHHHHHH
T ss_pred CCcccCHHHEEEcCC-CcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc--------CCCCchhhHHHHHHHH
Confidence 699999999999976 68999999999754332211 11235678999999853 4578899999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
||+++ |..||.+...... ..........+.|..+++++.+++.+||..||.+|||+.++++.|+.+..
T Consensus 306 ~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 306 WETFSLGASPYPNLSNQQT-REFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp HHHHTTSCCSSTTSCHHHH-HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 99998 9999988765433 33344555667788899999999999999999999999999999988754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-28 Score=197.13 Aligned_cols=136 Identities=24% Similarity=0.369 Sum_probs=110.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++...........+||+.|+|||++.+ ....+.++||||+||++|+|
T Consensus 138 vHrDLkp~NIll~~~-~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~el 209 (476)
T 2y94_A 138 VHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-------RLYAGPEVDIWSSGVILYAL 209 (476)
T ss_dssp ECSCCSGGGEEECTT-CCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTT-------CCBCSHHHHHHHHHHHHHHH
T ss_pred CcccccHHHEEEecC-CCeEEEeccchhhccccccccccCCCcCeEChhhccC-------CCCCCCcceehhhHHHHHHH
Confidence 699999999999976 6799999999986655445566789999999999854 22346899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
++|..||.+....... .. ........|..+++++.+|+.+||..||.+|||+.++++ +.|+...
T Consensus 210 ltG~~Pf~~~~~~~~~-~~-i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~--hp~~~~~ 273 (476)
T 2y94_A 210 LCGTLPFDDDHVPTLF-KK-ICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE--HEWFKQD 273 (476)
T ss_dssp HHSSCSSCCSSSHHHH-HH-HHTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT--CHHHHTT
T ss_pred hhCCCCCCCCCHHHHH-HH-HhcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh--CHHhhhc
Confidence 9999999876653332 22 223445667789999999999999999999999999999 6776643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-29 Score=189.72 Aligned_cols=139 Identities=27% Similarity=0.549 Sum_probs=112.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+||+++.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||+|+++
T Consensus 170 ~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il 240 (316)
T 2xir_A 170 IHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLL 240 (316)
T ss_dssp CCSCCSGGGEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred ccccCccceEEECCC-CCEEECCCccccccccCccceeccCCCcceeecCchhhcc--------ccccchhHHHHHHHHH
Confidence 799999999999866 679999999997543221 1223457889999999853 5688999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
|++++ |..||.+...................+..+++++.+++.+||..||.+||++.+++++|+.++...
T Consensus 241 ~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 241 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp HHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 99998 999998766444444444455566677889999999999999999999999999999999887643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-29 Score=192.42 Aligned_cols=135 Identities=24% Similarity=0.442 Sum_probs=105.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++... ........+||+.|+|||++.+ ..++.++|+||+||++||
T Consensus 132 vHrDlkp~NIll~~~-g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 202 (345)
T 3a8x_A 132 IYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFE 202 (345)
T ss_dssp BCCCCCGGGEEECTT-SCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHH
T ss_pred eecCCCHHHEEECCC-CCEEEEeccccccccCCCCcccccCCCccccCccccCC--------CCCChHHhHHHHHHHHHH
Confidence 699999999999976 689999999997532 2233456789999999999853 567899999999999999
Q ss_pred HHcCCCCCCCCCcH-------HHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH------HHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNL-------QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF------SQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~------~~~l~~l~~~~~ 146 (198)
|++|..||...... ..............+|..+++++.+++.+||..||.+||++ .++++ |.|+.
T Consensus 203 ll~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~--hp~f~ 280 (345)
T 3a8x_A 203 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG--HPFFR 280 (345)
T ss_dssp HHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT--SGGGT
T ss_pred HHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc--CCccC
Confidence 99999999652111 11122223345566788899999999999999999999985 67776 55554
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-29 Score=194.64 Aligned_cols=138 Identities=25% Similarity=0.495 Sum_probs=110.1
Q ss_pred CCCCCCCCCeEEcCCC--CceEEecccCcccCccc---ccccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQ--KSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~--~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
|||||||+|||++.++ ..+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||
T Consensus 203 vHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DvwslG~ 274 (367)
T 3l9p_A 203 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME--------GIFTSKTDTWSFGV 274 (367)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH--------CCCCHHHHHHHHHH
T ss_pred eCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC--------CCCCcHHHHHHHHH
Confidence 7999999999998442 35999999999743221 11223467889999999853 56899999999999
Q ss_pred HHHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 76 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 76 ~l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
++|||++ |..||.+..... .............+..+++.+.+|+.+||..||.+||++.+++++|+.+...
T Consensus 275 il~ellt~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 275 LLWEIFSLGYMPYPSKSNQE-VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHHHHTTSCCSSTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 9999998 999998766533 3344445555667788999999999999999999999999999999887653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.2e-29 Score=197.63 Aligned_cols=136 Identities=24% Similarity=0.273 Sum_probs=102.8
Q ss_pred CCCCCCCCCeEEcCCCCc--eEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKS--LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~--~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +. +||+|||+++.... .....+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 222 vHrDlKp~NILl~~~-~~~~vkL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ 290 (429)
T 3kvw_A 222 IHCDLKPENILLKQQ-GRSGIKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILG--------ARYGMPIDMWSLGCILA 290 (429)
T ss_dssp ECSCCSGGGEEESST-TSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHHT--------BCCCTHHHHHHHHHHHH
T ss_pred ecCCCCHHHeEEccC-CCcceEEeecccceecCC--cccccCCCCCccChHHHhC--------CCCCchHHHHhHHHHHH
Confidence 699999999999976 44 99999999975432 2345689999999999854 56899999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCC----------------------------------------------------
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARP---------------------------------------------------- 106 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------------------------------- 106 (198)
||++|..||.+................+
T Consensus 291 elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (429)
T 3kvw_A 291 ELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPES 370 (429)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccc
Confidence 9999999998876544332211100000
Q ss_pred -----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 107 -----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 107 -----~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
.++...++++.+|+.+||..||.+|||+.|+++ +.|+....
T Consensus 371 ~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~--Hpw~~~~~ 416 (429)
T 3kvw_A 371 REWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR--HPWLRRRL 416 (429)
T ss_dssp SCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT--STTTC---
T ss_pred hhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC--ChhhccCC
Confidence 011234788999999999999999999999999 77766543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=194.42 Aligned_cols=139 Identities=25% Similarity=0.341 Sum_probs=108.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|||++.+.+.+||+|||+++............||+.|+|||++.+ ...++.++||||+||++|+|
T Consensus 163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLG-------ATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTT-------CSSCCTHHHHHHHHHHHHHH
T ss_pred ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcC-------CCCCCcchhhhhHHHHHHHH
Confidence 69999999999985447899999999986554444456688999999998753 34589999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCC---------------------------CCCCCCcHHHHHHHHHhcccCCCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARP---------------------------GLPEDISPDLAFIVQSCWVEDPNLRPS 133 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~~~~l~~~~l~~dp~~Rps 133 (198)
++|..||.+................+ .++..+++++.+|+.+||..||.+|||
T Consensus 236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN 315 (383)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 99999999877655443322110100 134567899999999999999999999
Q ss_pred HHHHHHHHHHHHhhc
Q 029154 134 FSQIIRMLNAFLFTL 148 (198)
Q Consensus 134 ~~~~l~~l~~~~~~~ 148 (198)
+.|+++ |.|+...
T Consensus 316 ~~e~l~--hp~f~~~ 328 (383)
T 3eb0_A 316 PYEAMA--HPFFDHL 328 (383)
T ss_dssp HHHHHT--SGGGHHH
T ss_pred HHHHhc--CHHHHHH
Confidence 999998 6666543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=193.70 Aligned_cols=133 Identities=26% Similarity=0.423 Sum_probs=106.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++...........+||+.|+|||++... ....++.++|+||+||++|+|
T Consensus 137 vHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~~~~~DiwSlG~il~el 210 (384)
T 4fr4_A 137 IHRDMKPDNILLDEH-GHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR-----KGAGYSFAVDWWSLGVTAYEL 210 (384)
T ss_dssp ECCCCSGGGEEECTT-SCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCC-----SSCCBCTTHHHHHHHHHHHHH
T ss_pred eeccCcHHHeEECCC-CCEEEeccceeeeccCCCceeccCCCccccCCeeeccC-----CCCCCCccceeechHHHHHHH
Confidence 699999999999977 68999999999866555555677899999999998530 124578899999999999999
Q ss_pred HcCCCCCCCCCcH-HHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 029154 81 LTNRLPFEGMSNL-QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-FSQIIR 139 (198)
Q Consensus 81 ~~g~~p~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps-~~~~l~ 139 (198)
++|..||...... ...............|..+++++.+|+.+||..||.+||+ ++++++
T Consensus 211 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 211 LRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 9999999754321 1122223344556678889999999999999999999998 777776
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=186.83 Aligned_cols=141 Identities=18% Similarity=0.251 Sum_probs=107.2
Q ss_pred CCCCCCCCCeEE---cCCCCceEEecccCcccCcccc--------cccCCCCccceecccccccccccccccCCCCchhh
Q 029154 1 MGKFMKEDNLLL---TPDQKSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 69 (198)
Q Consensus 1 iH~dlKp~NIll---~~~~~~~kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~D 69 (198)
|||||||+|||+ +.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++|
T Consensus 127 vH~Dlkp~NIl~~~~~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~D 197 (296)
T 4hgt_A 127 IHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDD 197 (296)
T ss_dssp ECSCCSGGGEEECCGGGT-TCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--------CCCCHHHH
T ss_pred ecCCCCHHHeeeeccCCC-CeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcC--------CCCCchhH
Confidence 699999999999 544 679999999997543321 1234578999999999853 56889999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCcH------HHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 70 VYSFGIVLWELLTNRLPFEGMSNL------QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 70 vws~G~~l~e~~~g~~p~~~~~~~------~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
|||+||++|++++|..||.+.... ..................+++++.+++.+||..||.+||++.++++.|+.
T Consensus 198 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 198 LESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 999999999999999999764321 11111111111112235678999999999999999999999999999999
Q ss_pred HHhhcCC
Q 029154 144 FLFTLRP 150 (198)
Q Consensus 144 ~~~~~~~ 150 (198)
++.....
T Consensus 278 ~~~~~~~ 284 (296)
T 4hgt_A 278 LFHRQGF 284 (296)
T ss_dssp HHHHHTC
T ss_pred HHHHhCC
Confidence 8876653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=187.59 Aligned_cols=139 Identities=22% Similarity=0.325 Sum_probs=103.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++..... .......||+.|+|||++.+ ...++.++||||+||++|+
T Consensus 123 vH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ 194 (292)
T 3o0g_A 123 LHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAE 194 (292)
T ss_dssp ECCCCSGGGEEECTT-SCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCC-CCEEEeecccceecCCccccccCCccccCCcChHHHcC-------CCCcCchHHHHHHHHHHHH
Confidence 699999999999977 67999999999754322 23345678999999999853 3447899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHcc-CC---------------------------CCCCCCCcHHHHHHHHHhcccCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKH-AR---------------------------PGLPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~-~~---------------------------~~~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
|++|..||................ .. ......+++++.+|+.+||..||.+|
T Consensus 195 l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 274 (292)
T 3o0g_A 195 LANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQR 274 (292)
T ss_dssp HTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhC
Confidence 998887754444433332222110 00 01123478899999999999999999
Q ss_pred CCHHHHHHHHHHHHhhcC
Q 029154 132 PSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~~ 149 (198)
||++|+++ +.|+....
T Consensus 275 ~t~~e~l~--hp~f~~~~ 290 (292)
T 3o0g_A 275 ISAEEALQ--HPYFSDFC 290 (292)
T ss_dssp CCHHHHHT--SGGGTTC-
T ss_pred CCHHHHhc--CcccccCC
Confidence 99999999 77765433
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=189.00 Aligned_cols=139 Identities=27% Similarity=0.528 Sum_probs=106.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++....... .....+++.|+|||++.+ ..++.++||||+||++
T Consensus 159 vH~Dikp~NIli~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 229 (323)
T 3qup_A 159 IHRDLAARNCMLAED-MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD--------NLYTVHSDVWAFGVTM 229 (323)
T ss_dssp CCSCCSGGGEEECTT-SCEEECCCCC-----------------CCGGGCCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred ccCCCCcceEEEcCC-CCEEEeeccccccccccccccccccccCcccccCchhhcC--------CCCCCccchhhHHHHH
Confidence 799999999999976 6899999999975433221 123356788999999853 5688999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
|++++ |..||.+...... ............+..+++++.+++.+||..||.+||++.++++.|+.++....
T Consensus 230 ~ell~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 230 WEIMTRGQTPYAGIENAEI-YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp HHHHTTSCCTTTTCCGGGH-HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHhCCCCCccccChHHH-HHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 99999 8999987665433 33344455566778899999999999999999999999999999999876443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=186.54 Aligned_cols=142 Identities=18% Similarity=0.251 Sum_probs=107.2
Q ss_pred CCCCCCCCCeEEc--CCCCceEEecccCcccCccccc--------ccCCCCccceecccccccccccccccCCCCchhhH
Q 029154 1 MGKFMKEDNLLLT--PDQKSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 70 (198)
Q Consensus 1 iH~dlKp~NIll~--~~~~~~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dv 70 (198)
+||||||+|||++ .+++.+||+|||+++....... .....||+.|+|||++.+ ..++.++||
T Consensus 127 vH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di 198 (296)
T 3uzp_A 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDL 198 (296)
T ss_dssp ECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--------CCCCHHHHH
T ss_pred eeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcC--------CCCCcchhh
Confidence 6999999999994 2336799999999975433221 234578999999999853 568899999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCc------HHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 71 YSFGIVLWELLTNRLPFEGMSN------LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 71 ws~G~~l~e~~~g~~p~~~~~~------~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
||||+++|++++|..||.+... ................+..+++++.+++.+||..||.+||++.++++.|+.+
T Consensus 199 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 199 ESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 9999999999999999976432 1111111111111123356889999999999999999999999999999998
Q ss_pred HhhcCC
Q 029154 145 LFTLRP 150 (198)
Q Consensus 145 ~~~~~~ 150 (198)
......
T Consensus 279 ~~~~~~ 284 (296)
T 3uzp_A 279 FHRQGF 284 (296)
T ss_dssp HHHTTC
T ss_pred HHhcCC
Confidence 776554
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=206.47 Aligned_cols=133 Identities=26% Similarity=0.474 Sum_probs=108.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+||||+.+ +++||+|||+++... ........+||+.|+|||++.+ ..|+.++|+||||+++||
T Consensus 464 iHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~~DvwSlGvilye 534 (674)
T 3pfq_A 464 IYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYE 534 (674)
T ss_dssp ECCCCCSTTEEECSS-SCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTC--------CCBSTHHHHHHHHHHHHH
T ss_pred EeccCChhhEEEcCC-CcEEEeecceeeccccCCcccccccCCCcccCHhhhcC--------CCCCccceEechHHHHHH
Confidence 699999999999977 789999999998532 2333456789999999999853 678999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH-----HHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-----SQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~-----~~~l~~l~~~~~ 146 (198)
|++|..||.+....... . .+......+|..+++++.+|+.+||..||.+|+++ +++++ |.|+.
T Consensus 535 lltG~~Pf~~~~~~~~~-~-~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~--h~ff~ 602 (674)
T 3pfq_A 535 MLAGQAPFEGEDEDELF-Q-SIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE--HAFFR 602 (674)
T ss_dssp HHHSSCSSCCSSHHHHH-H-HHHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS--SGGGS
T ss_pred HHcCCCCCCCCCHHHHH-H-HHHhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc--Ccccc
Confidence 99999999986654332 2 23345567788899999999999999999999997 77776 55543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.2e-29 Score=187.53 Aligned_cols=140 Identities=21% Similarity=0.427 Sum_probs=99.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|||++.+ +.+||+|||+++............||+.|+|||++.... ....++.++|+||+|+++|++
T Consensus 132 ~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~~~~~Di~slG~il~~l 206 (290)
T 3fme_A 132 IHRDVKPSNVLINAL-GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPEL----NQKGYSVKSDIWSLGITMIEL 206 (290)
T ss_dssp CCCCCSGGGCEECTT-CCEEBCCC---------------CCCCCCSCHHHHSCCT----TC--CCHHHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEECCC-CCEEEeecCCcccccccccccccCCCccccChhhcChhh----cCcCCCcHHHHHHHHHHHHHH
Confidence 799999999999976 679999999997655444444457999999999963200 135678999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCC-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
++|..||..................+.. +..+++++.+++.+||..||.+|||+.++++ +.|+..
T Consensus 207 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~--hp~f~~ 272 (290)
T 3fme_A 207 AILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ--HPFFTL 272 (290)
T ss_dssp HHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--SHHHHH
T ss_pred HHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh--Cccccc
Confidence 9999999875544444444444444433 3568999999999999999999999999999 666654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-28 Score=184.23 Aligned_cols=141 Identities=29% Similarity=0.483 Sum_probs=111.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-----cccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
+||||||+|||++.+ +.+||+|||+++...... ......++..|+|||.+.+ ..++.++|+||+|+
T Consensus 146 ~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~ 216 (298)
T 3pls_A 146 VHRDLAARNCMLDES-FTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT--------YRFTTKSDVWSFGV 216 (298)
T ss_dssp CCSCCSGGGEEECTT-CCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT--------CCCCHHHHHHHHHH
T ss_pred ccCCCCcceEEEcCC-CcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc--------CCCChhhchhhHHH
Confidence 699999999999966 689999999997543221 1233467889999999853 56789999999999
Q ss_pred HHHHHHcCCCC-CCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCC
Q 029154 76 VLWELLTNRLP-FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 76 ~l~e~~~g~~p-~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
++|+|++|..| |..... ...............+..+++.+.+++.+||..||.+|||+.++++.|+.++......
T Consensus 217 il~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 217 LLWELLTRGAPPYRHIDP-FDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp HHHHHHHTSCCTTTTSCG-GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred HHHHHhhCCCCCCccCCH-HHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 99999995554 544333 3333444445556677889999999999999999999999999999999998876543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-29 Score=194.32 Aligned_cols=136 Identities=20% Similarity=0.256 Sum_probs=101.5
Q ss_pred CCCCCCCCCeEEcCCC-CceEEecccCcccCcccc--------cccCCCCccceecccccccccccccccCCCCchhhHH
Q 029154 1 MGKFMKEDNLLLTPDQ-KSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 71 (198)
Q Consensus 1 iH~dlKp~NIll~~~~-~~~kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvw 71 (198)
|||||||+|||++.++ +.+||+|||+++...... ......||..|+|||++.+ ..++.++|||
T Consensus 173 vH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~ 244 (345)
T 2v62_A 173 VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--------VALSRRSDVE 244 (345)
T ss_dssp ECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--------CCCCHHHHHH
T ss_pred eCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC--------CCCCchhhHH
Confidence 6999999999998652 279999999997543221 1134578999999999853 5689999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCC---------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 72 SFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP---------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 72 s~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p---------~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
||||++|||++|..||.+...................+ ..+++++.+++.+||..||.+||++.++++.|+
T Consensus 245 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 324 (345)
T 2v62_A 245 ILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILN 324 (345)
T ss_dssp HHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHC
T ss_pred HHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 99999999999999996532211111111111111112 268899999999999999999999999999887
Q ss_pred HH
Q 029154 143 AF 144 (198)
Q Consensus 143 ~~ 144 (198)
..
T Consensus 325 ~~ 326 (345)
T 2v62_A 325 PH 326 (345)
T ss_dssp TT
T ss_pred cc
Confidence 64
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=197.61 Aligned_cols=134 Identities=28% Similarity=0.566 Sum_probs=108.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++...... ....++..|+|||++.+ ..++.++||||||+++|||
T Consensus 311 vHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~--------~~~~~~sDvwslG~~l~el 379 (450)
T 1k9a_A 311 VHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEI 379 (450)
T ss_dssp ECSCCCGGGEEECTT-SCEEECCCTTCEECC--------CCCTTTSCHHHHHS--------SCCCHHHHHHHHHHHHHHH
T ss_pred eCCCCCHhhEEECCC-CCEEEeeCCCcccccccc--cCCCCCcceeCHHHhcC--------CCCCcHHHHHHHHHHHHHH
Confidence 699999999999976 689999999997543221 23357889999999853 5689999999999999999
Q ss_pred Hc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 81 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++ |..||.+...... ........+...|..+++++.+++.+||..||.+||++.++++.|+.+..
T Consensus 380 ~t~g~~P~~~~~~~~~-~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 380 YSFGRVPYPRIPLKDV-VPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp HTTTCCSSTTSCTTTH-HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCCHHHH-HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 98 9999987654332 23344556677788899999999999999999999999999999988754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=187.87 Aligned_cols=137 Identities=28% Similarity=0.446 Sum_probs=99.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.+ +.+||+|||+++...... .....+||+.|+|||++.+ ..++.++||||+|++
T Consensus 138 vH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~ 208 (311)
T 3ork_A 138 IHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG--------DSVDARSDVYSLGCV 208 (311)
T ss_dssp CCCCCCGGGEEEETT-SCEEECCCSCC------------------CCTTCCHHHHHT--------CCCCHHHHHHHHHHH
T ss_pred CcCCCCHHHEEEcCC-CCEEEeeccCcccccccccccccccccCcCcccCCHHHhcC--------CCCCchHhHHHHHHH
Confidence 799999999999976 679999999997543221 1233568999999999853 568899999999999
Q ss_pred HHHHHcCCCCCCCCCcHHHHHHHHHccCCCC--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 77 LWELLTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
+|+|++|..||.+................+. .+..+++++.+++.+||..||.+||++.+++. +.+....
T Consensus 209 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~--~~l~~~~ 280 (311)
T 3ork_A 209 LYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR--ADLVRVH 280 (311)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH--HHHHHHH
T ss_pred HHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH--HHHHHHh
Confidence 9999999999988776554444333322221 23558999999999999999999998777766 5554433
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-28 Score=201.28 Aligned_cols=141 Identities=24% Similarity=0.520 Sum_probs=112.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc----ccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.+ +.+||+|||+++....... .....+++.|+|||++.. ..++.++|||||||+
T Consensus 458 iHrDlkp~NILl~~~-~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~--------~~~~~~sDvwSlGv~ 528 (613)
T 2ozo_A 458 VHRNLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVT 528 (613)
T ss_dssp CCSCCSGGGEEEEET-TEEEECCCSTTTTCC--------------CCTTSCHHHHHH--------CCCCHHHHHHHHHHH
T ss_pred EcCcCCHHHEEEcCC-CcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcC--------CCCCcHHHHHHHHHH
Confidence 799999999999966 7899999999986432221 112345678999999853 578999999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCC
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
+|||++ |..||.+...... ........+...|..+++++.+++.+||..||.+||++.++++.|+.+.......
T Consensus 529 l~ellt~G~~Pf~~~~~~~~-~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 529 MWEALSYGQKPYKKMKGPEV-MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp HHHHHTTSCCTTTTCCSHHH-HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred HHHHHHCCCCCCCCCCHHHH-HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 999998 9999998776443 3344455666778889999999999999999999999999999999987766543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=197.13 Aligned_cols=140 Identities=30% Similarity=0.515 Sum_probs=109.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++....... .....++..|+|||++.. ..++.++||||||+++|
T Consensus 302 vHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwslG~~l~ 372 (452)
T 1fmk_A 302 VHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLT 372 (452)
T ss_dssp CCSCCSGGGEEECGG-GCEEECCCCTTC--------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHH
T ss_pred eCCCCChhhEEECCC-CCEEECCCccceecCCCceecccCCcccccccCHhHHhc--------CCCCccccHHhHHHHHH
Confidence 799999999999866 6799999999985433221 123456789999998853 56899999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
|+++ |..||.+...... ........+.+.|..+++.+.+++.+||..||.+|||+.++++.|+.+.....+
T Consensus 373 el~t~g~~P~~~~~~~~~-~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 373 ELTTKGRVPYPGMVNREV-LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp HHHTTTCCSSTTCCHHHH-HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred HHHhCCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 9999 9999988765433 334445556677888999999999999999999999999999999988655443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=186.93 Aligned_cols=136 Identities=25% Similarity=0.379 Sum_probs=100.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||+++.... ........||+.|+|||++.+ ...++.++|+||+||++|+
T Consensus 122 ~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ 193 (288)
T 1ob3_A 122 LHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG-------SKKYSTTIDIWSVGCIFAE 193 (288)
T ss_dssp CCSCCCGGGEEECTT-SCEEECCTTHHHHHCC---------CCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCC-CCEEEeECccccccCccccccccccccccccCchheeC-------CCCCCcHHHHHHHHHHHHH
Confidence 799999999999976 6799999999874332 122344578999999999753 3457899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC---------------------------CCCCCCcHHHHHHHHHhcccCCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP---------------------------GLPEDISPDLAFIVQSCWVEDPNLRP 132 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~~~~l~~~~l~~dp~~Rp 132 (198)
|++|..||.+................+ .....+++++.+++.+||..||.+||
T Consensus 194 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 273 (288)
T 1ob3_A 194 MVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI 273 (288)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCC
Confidence 999999998876544332221110000 01234789999999999999999999
Q ss_pred CHHHHHHHHHHHHh
Q 029154 133 SFSQIIRMLNAFLF 146 (198)
Q Consensus 133 s~~~~l~~l~~~~~ 146 (198)
|+.++++ +.|+.
T Consensus 274 t~~e~l~--hp~f~ 285 (288)
T 1ob3_A 274 TAKQALE--HAYFK 285 (288)
T ss_dssp CHHHHHT--SGGGG
T ss_pred CHHHHhc--Ccchh
Confidence 9999998 55543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=185.49 Aligned_cols=139 Identities=27% Similarity=0.557 Sum_probs=100.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc---cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||+++.... ........||+.|+|||++... ....++.++||||+|+++
T Consensus 142 ~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il 215 (289)
T 3og7_A 142 IHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ-----DSNPYSFQSDVYAFGIVL 215 (289)
T ss_dssp CCSCCCGGGEEEETT-TEEEECCCC------------------CCCTTCCHHHHC---------CCSCHHHHHHHHHHHH
T ss_pred ccccCccceEEECCC-CCEEEccceeccccccccccccccccCCCccccCchhhccc-----CCCCCCcccchHHHHHHH
Confidence 699999999999976 6899999999874332 2223345789999999987420 135678899999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCCC----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHARP----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~~----~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
|++++|..||.+................. ..+..+++++.+++.+||..||.+||++.++++.|+.+.
T Consensus 216 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 216 YELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 99999999998876655443333322221 234568899999999999999999999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-29 Score=191.28 Aligned_cols=129 Identities=26% Similarity=0.373 Sum_probs=98.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++............||+.|+|||++. +.++.++|||||||++||+
T Consensus 179 vH~Dikp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~el 248 (311)
T 3p1a_A 179 VHLDVKPANIFLGPR-GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ---------GSYGTAADVFSLGLTILEV 248 (311)
T ss_dssp ECCCCSGGGEEECGG-GCEEECCCTTCEECC------CCCCCGGGCCGGGGG---------TCCSTHHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEECCC-CCEEEccceeeeecccCCCCcccCCCccccCHhHhc---------CCCCchhhHHHHHHHHHHH
Confidence 699999999999876 679999999997655444445567999999999874 3578999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHc-cCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
++|..++.+.... ..... ...+..+..+++++.+++.+||..||.+||++.++++ +.|+
T Consensus 249 ~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~--hp~~ 308 (311)
T 3p1a_A 249 ACNMELPHGGEGW----QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA--LPVL 308 (311)
T ss_dssp HHTCCCCSSHHHH----HHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGG
T ss_pred HhCCCCCCCccHH----HHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh--Cccc
Confidence 9997776543221 11111 1222335668999999999999999999999999998 5554
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=192.76 Aligned_cols=136 Identities=24% Similarity=0.350 Sum_probs=106.9
Q ss_pred CCCCCCCCCeEEc-CCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~-~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||+. .+.+.+||+|||+++...........+||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 209 vH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 280 (373)
T 2x4f_A 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY--------DFVSFPTDMWSVGVIAYM 280 (373)
T ss_dssp ECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTT--------CBCCHHHHHHHHHHHHHH
T ss_pred ccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccC--------CCCCcHHhHHHHHHHHHH
Confidence 6999999999994 2336799999999986655444556689999999998853 567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC--CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|++|..||.+................. .....+++++.+|+.+||..||.+||++.++++ +.|+.
T Consensus 281 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~--hp~~~ 347 (373)
T 2x4f_A 281 LLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK--HPWLS 347 (373)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc--CcCcC
Confidence 999999998876544433332222221 123468999999999999999999999999999 56654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=182.40 Aligned_cols=136 Identities=29% Similarity=0.555 Sum_probs=110.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+||+++.+ +.+||+|||+++...... ......++..|+|||++.+ ..++.++|+||+|+++|
T Consensus 128 ~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ 198 (269)
T 4hcu_A 128 IHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMW 198 (269)
T ss_dssp CCSCCCGGGEEECGG-GCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHH
T ss_pred ecCCcchheEEEcCC-CCEEeccccccccccccccccccCcccccccCCHHHhcC--------CCCCchhhhHHHHHHHH
Confidence 699999999999866 679999999997543322 2233456788999999853 56889999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++++ |..||.+..... .............+...++++.+++.+||..||.+||++.+++++|+.+..
T Consensus 199 ~ll~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 199 EVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHTTSCCTTTTCCHHH-HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCCCCCHHH-HHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 9999 899998766433 334444455666677889999999999999999999999999999988764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-28 Score=195.25 Aligned_cols=140 Identities=26% Similarity=0.414 Sum_probs=108.3
Q ss_pred CCCCCCCCCeEEcCC--CCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~--~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.. .+.+||+|||+++...........+||+.|+|||++. +.++.++||||+||++|
T Consensus 143 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~ 213 (486)
T 3mwu_A 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR---------GTYDEKCDVWSAGVILY 213 (486)
T ss_dssp CCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGG---------SCCCHHHHHHHHHHHHH
T ss_pred EeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhC---------CCCCchhhHHHHHHHHH
Confidence 799999999999632 2469999999998655544455678999999999984 35889999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCCC--CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCC
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
+|++|..||.+...................+ ..+++++.+|+.+||..||.+|||+.++++ +.|+......
T Consensus 214 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~--hp~~~~~~~~ 286 (486)
T 3mwu_A 214 ILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQKYSSE 286 (486)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH--CHHHHHTCCC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc--CHhhccCccc
Confidence 9999999998876544433333222222222 457899999999999999999999999999 7787765433
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=191.15 Aligned_cols=137 Identities=26% Similarity=0.356 Sum_probs=98.1
Q ss_pred CCCCCCCCCeEEcC--CCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTP--DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~--~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++. +.+.+||+|||+++...........+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 170 vH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ 241 (349)
T 2w4o_A 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG--------CAYGPEVDMWSVGIITY 241 (349)
T ss_dssp CCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTT--------CCCCTHHHHHHHHHHHH
T ss_pred EecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcC--------CCCCcccchHHHHHHHH
Confidence 79999999999974 236799999999986554444455689999999999853 56889999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCC---CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHAR---PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
+|++|..||.+................ .+....++.++.+|+.+||..||.+||++.++++ +.|+..
T Consensus 242 ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~~ 311 (349)
T 2w4o_A 242 ILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ--HPWVTG 311 (349)
T ss_dssp HHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTTS
T ss_pred HHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc--CcccCC
Confidence 999999999876655434333333222 1223568899999999999999999999999999 666543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=189.12 Aligned_cols=143 Identities=24% Similarity=0.435 Sum_probs=103.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceeccccccccccccc---ccCCCCchhhHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQG---EKKHYNNKVDVYSFG 74 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~---~~~~~~~~~Dvws~G 74 (198)
|||||||+|||++ + +.+||+|||+++...... .....+||+.|+|||++.+...... ....++.++||||||
T Consensus 130 iHrDikp~NIll~-~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG 207 (343)
T 3dbq_A 130 VHSDLKPANFLIV-D-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 207 (343)
T ss_dssp CCCCCCGGGEEEE-T-TEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHH
T ss_pred ecCCCCcceEEEE-C-CcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHH
Confidence 7999999999997 4 579999999998553322 1234579999999999743110000 015678899999999
Q ss_pred HHHHHHHcCCCCCCCCCcHHHHHHHHH-ccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 75 IVLWELLTNRLPFEGMSNLQAAYAAAF-KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 75 ~~l~e~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|++|+|++|..||.............. .......|...+.++.+++.+||..||.+|||+.++++ +.|+..
T Consensus 208 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~--hp~~~~ 279 (343)
T 3dbq_A 208 CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQI 279 (343)
T ss_dssp HHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHS
T ss_pred HHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh--Cccccc
Confidence 999999999999987655433333332 23444667778899999999999999999999999999 666654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=187.04 Aligned_cols=137 Identities=26% Similarity=0.558 Sum_probs=110.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++...... ......+++.|+|||++.+ ..++.++||||+|+++
T Consensus 172 vH~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 242 (314)
T 2ivs_A 172 VHRDLAARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD--------HIYTTQSDVWSFGVLL 242 (314)
T ss_dssp ECCCCSGGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH--------CEECHHHHHHHHHHHH
T ss_pred cccccchheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcC--------CCcCchhhHHHHHHHH
Confidence 699999999999966 789999999997543221 1223457889999998853 4578999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|+|++ |..||.+..... .............+..+++++.+++.+||..||.+||++.+++++|+.++..
T Consensus 243 ~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 243 WEIVTLGGNPYPGIPPER-LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHHTTSCCSSTTCCGGG-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHhCCCCCCCCCCHHH-HHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 99999 999998766433 2333344455667788999999999999999999999999999999988653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-29 Score=191.89 Aligned_cols=137 Identities=18% Similarity=0.229 Sum_probs=107.2
Q ss_pred CCCCCCCCCeEEcCC-CCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~-~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ .+.+||+|||+++............||+.|+|||++.+ ..++.++|+||+|+++|+
T Consensus 124 vH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ 195 (321)
T 1tki_A 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH--------DVVSTATDMWSLGTLVYV 195 (321)
T ss_dssp ECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT--------CEECHHHHHHHHHHHHHH
T ss_pred CcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcC--------CCCCchhhHHHHHHHHHH
Confidence 699999999999862 36799999999986544444445678999999999853 457899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCC--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|++|..||.+.................. ....+++++.+++.+||..||.+|||+.++++ +.|+..
T Consensus 196 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~~~~ 263 (321)
T 1tki_A 196 LLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ--HPWLKQ 263 (321)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHHS
T ss_pred HHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc--Chhhcc
Confidence 9999999988665443322222222111 12468899999999999999999999999999 777764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=188.11 Aligned_cols=131 Identities=25% Similarity=0.414 Sum_probs=107.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|+||+||++|||
T Consensus 128 vHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 196 (318)
T 1fot_A 128 IYRDLKPENILLDKN-GHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST--------KPYNKSIDWWSFGILIYEM 196 (318)
T ss_dssp ECCCCCGGGEEECTT-SCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT--------CCBCTTHHHHHHHHHHHHH
T ss_pred cccCCChheEEEcCC-CCEEEeecCcceecCCc--cccccCCccccCHhHhcC--------CCCCcccchhhhHHHHHHH
Confidence 699999999999976 68999999999764432 245689999999999853 5678999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~~l~~~~~ 146 (198)
++|..||.+........... ......|..+++++.+++.+||..||.+|+ +++++++ |.|+.
T Consensus 197 l~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~--hp~f~ 263 (318)
T 1fot_A 197 LAGYTPFYDSNTMKTYEKIL--NAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN--HPWFK 263 (318)
T ss_dssp HHSSCTTCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT--SGGGS
T ss_pred HhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc--Ccccc
Confidence 99999998766543332222 334567788999999999999999999999 8999988 55553
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=189.99 Aligned_cols=136 Identities=20% Similarity=0.300 Sum_probs=105.7
Q ss_pred CCCCCCCCCeEEcCCCC---ceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQK---SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~---~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.++. .+||+|||+++...........+||+.|+|||++.+ ..++.++|+||+||++
T Consensus 136 vH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il 207 (326)
T 2y0a_A 136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVIT 207 (326)
T ss_dssp ECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT--------CCCCTHHHHHHHHHHH
T ss_pred EcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecC--------CCCCcHHHHHHHHHHH
Confidence 69999999999986531 699999999986554444456689999999999853 5688999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCCC--CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|+|++|..||.+................. ..+..+++.+.+|+.+||..||.+|||+.++++ +.|+.
T Consensus 208 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~ 276 (326)
T 2y0a_A 208 YILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ--HPWIK 276 (326)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--STTTS
T ss_pred HHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc--CCCcc
Confidence 99999999998766543332222111111 112467899999999999999999999999998 55543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=190.32 Aligned_cols=137 Identities=28% Similarity=0.510 Sum_probs=109.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++...... ......+|..|+|||++.+ ..++.++|+||||+++
T Consensus 196 vH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il 266 (343)
T 1luf_A 196 VHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVL 266 (343)
T ss_dssp CCSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred ecCCCCcceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhcc--------CCcCcccccHHHHHHH
Confidence 799999999999966 679999999987433221 1233567889999998853 5688999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|+|++ |..||.+...... ............+..+++++.+++.+||..||.+||++.+++++|+.+...
T Consensus 267 ~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 267 WEIFSYGLQPYYGMAHEEV-IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HHHHTTTCCTTTTSCHHHH-HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred HHHHhcCCCcCCCCChHHH-HHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 99998 9999987665333 333444555567788999999999999999999999999999999887543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=192.13 Aligned_cols=140 Identities=30% Similarity=0.531 Sum_probs=103.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc-----ccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
|||||||+|||++.+ +.+||+|||+++....... .....++..|+|||++.+ ..++.++||||||+
T Consensus 214 vHrDlkp~NIll~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~ 284 (373)
T 3c1x_A 214 VHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGV 284 (373)
T ss_dssp CCSCCCGGGEEECTT-CCEEECCC---------------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHH
T ss_pred ecCccchheEEECCC-CCEEEeeccccccccccccccccccCCCCCcccccChHHhcC--------CCCCcHHHHHHHHH
Confidence 799999999999976 6899999999975432211 123456788999999853 56889999999999
Q ss_pred HHHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 76 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 76 ~l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
++||+++ |.+||.+...... ............|..+++.+.+++.+||..||.+||++.++++.|+.++.....
T Consensus 285 il~ellt~~~~p~~~~~~~~~-~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 285 LLWELMTRGAPPYPDVNTFDI-TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp HHHHHHTTSCCSCTTSCSSCH-HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred HHHHHHhCcCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 9999999 6778876544322 223344455566788999999999999999999999999999999998876553
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=183.56 Aligned_cols=137 Identities=26% Similarity=0.501 Sum_probs=107.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+|||++.+ +.+||+|||++........ .....++..|+|||++.+ ..++.++|+||||+++|
T Consensus 135 ~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 205 (281)
T 3cc6_A 135 VHRDIAVRNILVASP-ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF--------RRFTTASDVWMFAVCMW 205 (281)
T ss_dssp CCCCCSGGGEEEEET-TEEEECCCCGGGCC---------CCCCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHH
T ss_pred ccCCCccceEEECCC-CcEEeCccCCCcccccccccccccCCCCcceeCchhhcc--------CCCCchhccHHHHHHHH
Confidence 699999999999966 6899999999975443221 223456889999998853 56889999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
++++ |..||........ ............+..+++.+.+++.+||..||.+||++.+++++|+.+...
T Consensus 206 ~llt~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 206 EILSFGKQPFFWLENKDV-IGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHTTTCCTTTTSCGGGH-HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCcccCChHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 9998 9999976554332 223333455566778999999999999999999999999999999887653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=191.58 Aligned_cols=124 Identities=23% Similarity=0.377 Sum_probs=101.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCc-ccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +++||+|||+++... ........+||+.|+|||++.+ ..++.++|+||+||++||
T Consensus 161 vHrDlkp~NIll~~~-g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 231 (373)
T 2r5t_A 161 VYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK--------QPYDRTVDWWCLGAVLYE 231 (373)
T ss_dssp CCCCCCGGGEEECTT-SCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTT--------CCCCTHHHHHHHHHHHHH
T ss_pred eecCCCHHHEEECCC-CCEEEeeCccccccccCCCccccccCCccccCHHHhCC--------CCCCchhhhHHHHHHHHH
Confidence 799999999999977 689999999997532 2233455689999999999853 568899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 135 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~ 135 (198)
|++|..||.+....... ... ......++..++.++.+++.+||..||.+||++.
T Consensus 232 ll~G~~Pf~~~~~~~~~-~~i-~~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 232 MLYGLPPFYSRNTAEMY-DNI-LNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHSSCTTCCSBHHHHH-HHH-HHSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred HHcCCCCCCCCCHHHHH-HHH-HhcccCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 99999999876543332 222 2344566778999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=190.42 Aligned_cols=138 Identities=29% Similarity=0.488 Sum_probs=111.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++....... .....||..|+|||++.+ ..++.++||||||+++
T Consensus 186 vH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 256 (333)
T 2i1m_A 186 IHRDVAARNVLLTNG-HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD--------CVYTVQSDVWSYGILL 256 (333)
T ss_dssp ECSCCSGGGCEEEGG-GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred ccCCcccceEEECCC-CeEEECccccccccccccceeecCCCCCCccccCHHHhcc--------CCCChHHHHHHHHHHH
Confidence 699999999999966 6899999999975432211 223456788999998753 5688999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|+|++ |..||.+...................+..+++++.+++.+||..||.+||++.+++++|+.....
T Consensus 257 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 257 WEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 99998 89999876654444444444555666777899999999999999999999999999999887653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=185.60 Aligned_cols=138 Identities=22% Similarity=0.407 Sum_probs=105.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.+ +.+||+|||+++...... ......++..|+|||++.+ ..++.++||||+|++
T Consensus 136 vH~Dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~ 206 (295)
T 3ugc_A 136 IHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE--------SKFSVASDVWSFGVV 206 (295)
T ss_dssp CCSCCSGGGEEEEET-TEEEECCCCSCC-------------CTTCGGGGCCHHHHHH--------CCCCHHHHHHHHHHH
T ss_pred ccCCCCHhhEEEcCC-CeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC--------CCCChHHHHHHHHHH
Confidence 799999999999976 789999999997543321 1223457788999999854 568999999999999
Q ss_pred HHHHHcCCCCCCCCCcH---------------HHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 77 LWELLTNRLPFEGMSNL---------------QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
+|++++|..|+...... .............+.+..+++++.+++.+||..||.+|||+.++++.|
T Consensus 207 l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L 286 (295)
T 3ugc_A 207 LYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286 (295)
T ss_dssp HHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 99999999887532110 011222334455667788999999999999999999999999999999
Q ss_pred HHHHhh
Q 029154 142 NAFLFT 147 (198)
Q Consensus 142 ~~~~~~ 147 (198)
+.+...
T Consensus 287 ~~l~~~ 292 (295)
T 3ugc_A 287 DQIRDN 292 (295)
T ss_dssp HHHHHC
T ss_pred HHHHHh
Confidence 987654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=189.36 Aligned_cols=138 Identities=25% Similarity=0.366 Sum_probs=107.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++..... ....+||+.|+|||++.+ ...++.++|+||+||++|||
T Consensus 150 vH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el 219 (367)
T 1cm8_A 150 IHRDLKPGNLAVNED-CELKILDFGLARQADSE--MTGYVVTRWYRAPEVILN-------WMRYTQTVDIWSVGCIMAEM 219 (367)
T ss_dssp ECCCCCGGGEEECTT-CCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHT-------TTCCCTTHHHHHHHHHHHHH
T ss_pred cccCcCHHHEEEcCC-CCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhC-------CCCCChhhhHHHHHHHHHHH
Confidence 699999999999976 67999999999864432 345688999999998753 25688999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCC-----------------------------CCCCCCCcHHHHHHHHHhcccCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHAR-----------------------------PGLPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
++|+.||.+................ .......++++.+|+.+||..||.+|
T Consensus 220 l~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R 299 (367)
T 1cm8_A 220 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 299 (367)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTS
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHC
Confidence 9999999887654433222111000 01234578999999999999999999
Q ss_pred CCHHHHHHHHHHHHhhcCC
Q 029154 132 PSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~~~ 150 (198)
||+.++++ |.|+.....
T Consensus 300 ~t~~e~l~--hp~f~~~~~ 316 (367)
T 1cm8_A 300 VTAGEALA--HPYFESLHD 316 (367)
T ss_dssp CCHHHHHH--SGGGTTTC-
T ss_pred CCHHHHhc--ChHHHhhcC
Confidence 99999999 777765543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-28 Score=187.33 Aligned_cols=135 Identities=30% Similarity=0.491 Sum_probs=106.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+|+++|+
T Consensus 163 vH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~il~e 233 (321)
T 2c30_A 163 IHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR--------SLYATEVDIWSLGIMVIE 233 (321)
T ss_dssp ECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEECCC-CcEEEeeeeeeeecccCccccccccCCccccCHhhhcC--------CCCCchhhHHHHHHHHHH
Confidence 699999999999976 67999999998754332 22345689999999999853 567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCC--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|++|..||.+....... ........+. .+..+++.+.+++.+||..||.+||++.++++ +.|+..
T Consensus 234 l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--hp~~~~ 300 (321)
T 2c30_A 234 MVDGEPPYFSDSPVQAM-KRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD--HPFLLQ 300 (321)
T ss_dssp HHHSSCTTTTSCHHHHH-HHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGGG
T ss_pred HHhCCCCCCCCCHHHHH-HHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc--Chhhcc
Confidence 99999999876654433 2222333222 23457899999999999999999999999999 666654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=189.45 Aligned_cols=139 Identities=31% Similarity=0.540 Sum_probs=110.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++............++..|+|||++.+ ..++.++||||+|+++|+|
T Consensus 164 vH~dlkp~NIl~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el 234 (327)
T 1fvr_A 164 IHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEI 234 (327)
T ss_dssp ECSCCSGGGEEECGG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH--------CEECHHHHHHHHHHHHHHH
T ss_pred cCCCCccceEEEcCC-CeEEEcccCcCccccccccccCCCCCccccChhhhcc--------ccCCchhcchHHHHHHHHH
Confidence 699999999999866 6799999999975443332334456889999999853 4578999999999999999
Q ss_pred Hc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 81 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 81 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
++ |..||.+..... .............+..+++++.+++.+||..||.+||++.+++++|+.++....
T Consensus 235 lt~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 235 VSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HTTSCCTTTTCCHHH-HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HcCCCCCCCCCcHHH-HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 98 999998766433 333333444556677899999999999999999999999999999999887554
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=186.10 Aligned_cols=139 Identities=30% Similarity=0.534 Sum_probs=107.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||+++...... ......+++.|+|||.+.+ ..++.++|+||||+++
T Consensus 169 vH~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 239 (313)
T 3brb_A 169 LHRDLAARNCMLRDD-MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--------RVYTSKSDVWAFGVTM 239 (313)
T ss_dssp CCCCCSGGGEEECTT-SCEEECSCSCC----------------CCGGGSCHHHHHS--------SCCCHHHHHHHHHHHH
T ss_pred ccCCCCcceEEEcCC-CcEEEeecCcceecccccccCcccccCCCccccCchhhcC--------CCccchhhhHHHHHHH
Confidence 799999999999976 679999999997543221 1223456889999999853 5688999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
|+|++ |..||.+...... .........+..+..+++++.+++.+||..||.+||++.+++++|+.++..++
T Consensus 240 ~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 240 WEIATRGMTPYPGVQNHEM-YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHHTTSCCSSTTCCGGGH-HHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHhcCCCCCccCCHHHH-HHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 99999 8899987654332 33344455667778899999999999999999999999999999999876543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=182.63 Aligned_cols=139 Identities=24% Similarity=0.369 Sum_probs=109.0
Q ss_pred CCCCCCCCCeEEcCCC--CceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~--~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+||+++.++ ..+||+|||++.............||+.|+|||++.+ ..++.++||||+|+++|
T Consensus 127 ~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ 198 (284)
T 3kk8_A 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILY 198 (284)
T ss_dssp ECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHH
T ss_pred CcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcC--------CCCCcccchHHHHHHHH
Confidence 6999999999997542 3499999999976555444455689999999999853 56789999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCC--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
++++|..||.+.................+ ....+++++.+++.+||..||.+||++.++++ +.|+....
T Consensus 199 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~~~ 269 (284)
T 3kk8_A 199 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK--VPWICNRE 269 (284)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT--SHHHHSCC
T ss_pred HHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc--CccccCCh
Confidence 99999999987665443333222222222 22468999999999999999999999999999 77776544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=190.39 Aligned_cols=131 Identities=23% Similarity=0.367 Sum_probs=107.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|+||+||++|+|
T Consensus 163 vHrDlkp~NIll~~~-g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 231 (350)
T 1rdq_E 163 IYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEM 231 (350)
T ss_dssp ECCCCSGGGEEECTT-SCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHH
T ss_pred ccccCccceEEECCC-CCEEEcccccceeccCC--cccccCCccccCHHHhcC--------CCCCCcCCEecccHhHhHH
Confidence 699999999999976 68999999999855432 235689999999999853 5678999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps-----~~~~l~~l~~~~~ 146 (198)
++|..||.+....... .. .......+|..+++++.+++.+||..||.+||+ +.++++ |.|+.
T Consensus 232 l~g~~Pf~~~~~~~~~-~~-i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~--h~~f~ 298 (350)
T 1rdq_E 232 AAGYPPFFADQPIQIY-EK-IVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN--HKWFA 298 (350)
T ss_dssp HHSSCSSCCSSHHHHH-HH-HHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT--SGGGT
T ss_pred hhCCCCCCCCCHHHHH-HH-HHcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh--CcCcC
Confidence 9999999876643332 22 223455678889999999999999999999998 888888 55554
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=189.06 Aligned_cols=139 Identities=24% Similarity=0.347 Sum_probs=105.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-----cccccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
|||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|||++.+ ...++.++||||+||
T Consensus 146 vH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~ 217 (351)
T 3mi9_A 146 LHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDLWGAGC 217 (351)
T ss_dssp ECCCCSGGGEEECTT-SCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT-------CCSCCTHHHHHHHHH
T ss_pred eCCCCCHHHEEEcCC-CCEEEccchhcccccccccccccccCCcccccCccCchhhcC-------CCCCCcHhHHHHHHH
Confidence 699999999999976 6899999999974331 122344578999999998753 355789999999999
Q ss_pred HHHHHHcCCCCCCCCCcHHHHHHH--HHccCCCCCCCC----------------------------CcHHHHHHHHHhcc
Q 029154 76 VLWELLTNRLPFEGMSNLQAAYAA--AFKHARPGLPED----------------------------ISPDLAFIVQSCWV 125 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~~~~~~~--~~~~~~~~~p~~----------------------------~~~~~~~l~~~~l~ 125 (198)
++|+|++|..||.+.......... ......+..... .++++.+|+.+||.
T Consensus 218 il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 297 (351)
T 3mi9_A 218 IMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV 297 (351)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSC
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhc
Confidence 999999999999887654433222 112222211111 26779999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 126 EDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 126 ~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
.||.+|||+.++++ +.|+....
T Consensus 298 ~dP~~R~t~~e~l~--hp~f~~~~ 319 (351)
T 3mi9_A 298 LDPAQRIDSDDALN--HDFFWSDP 319 (351)
T ss_dssp SSGGGSCCHHHHHT--SGGGGSSS
T ss_pred CChhhCCCHHHHhC--CCCcCCCC
Confidence 99999999999999 78876443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-28 Score=183.76 Aligned_cols=139 Identities=30% Similarity=0.534 Sum_probs=109.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc-----ccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
+||||||+|||++.+ +.+||+|||+++....... .....+|+.|+|||.+.+ ..++.++|+||+|+
T Consensus 150 ~H~dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~ 220 (298)
T 3f66_A 150 VHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGV 220 (298)
T ss_dssp CCSCCSGGGEEECTT-CCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH--------CCCCHHHHHHHHHH
T ss_pred cCCCCchheEEECCC-CCEEECcccccccccccchhccccccCCCCCccccChHHhcC--------CCCChHHHHHHHHH
Confidence 799999999999966 6899999999975433221 223457789999999853 56889999999999
Q ss_pred HHHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 76 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 76 ~l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
++|++++ |.+||.+..... .............+..+++.+.+++.+||..||.+||++.++++.|+.++....
T Consensus 221 il~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 221 LLWELMTRGAPPYPDVNTFD-ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp HHHHHHTTSCCSSTTSCTTT-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred HHHHHHhCCCCCCccCCHHH-HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 9999999 556666544332 233334455556677899999999999999999999999999999999877554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=202.80 Aligned_cols=137 Identities=27% Similarity=0.541 Sum_probs=110.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.+ +.+||+|||+++...... ......+|..|+|||++.. ..++.++|||||||+
T Consensus 491 iHrDLkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~--------~~~~~~sDvwSlGv~ 561 (635)
T 4fl3_A 491 VHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVL 561 (635)
T ss_dssp CCSCCSGGGEEEEET-TEEEECCTTHHHHTTC-------------CGGGSCHHHHHH--------CCCCHHHHHHHHHHH
T ss_pred eCCCCChHhEEEeCC-CCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcC--------CCCCcHHHHHHHHHH
Confidence 799999999999976 689999999997543222 1222356788999999853 578999999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
+|||++ |..||.+..... .............|..+++++.+++.+||..||.+||++.++++.|+.+...
T Consensus 562 l~ellt~G~~Pf~~~~~~~-~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 562 MWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp HHHHHTTTCCSSTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 999998 999998876543 3344445566777888999999999999999999999999999999988654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-28 Score=180.71 Aligned_cols=134 Identities=25% Similarity=0.516 Sum_probs=109.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|||++.+ +.++|+|||+..... .....||+.|+|||++.+. ....++.++||||+|+++|++
T Consensus 135 ~H~dikp~Nil~~~~-~~~~l~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el 204 (271)
T 3kmu_A 135 PRHALNSRSVMIDED-MTARISMADVKFSFQ----SPGRMYAPAWVAPEALQKK-----PEDTNRRSADMWSFAVLLWEL 204 (271)
T ss_dssp TTCCCSGGGEEECTT-SCEEEEGGGSCCTTS----CTTCBSCGGGSCHHHHHSC-----GGGSCHHHHHHHHHHHHHHHH
T ss_pred ecCCCccceEEEcCC-cceeEEeccceeeec----ccCccCCccccChhhhccC-----CCCCCCchhhHHHHHHHHHHH
Confidence 699999999999966 679999888865422 2345789999999998541 112334489999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
++|..||.+................+..+..+++++.+++.+||..||.+|||+.++++.|+.+
T Consensus 205 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 205 VTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp HHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 9999999887766555555556667778888999999999999999999999999999999876
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-28 Score=186.75 Aligned_cols=133 Identities=23% Similarity=0.399 Sum_probs=103.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|||++.+ ..++.++|+||+|+++|+
T Consensus 143 vH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 213 (327)
T 3a62_A 143 IYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR--------SGHNRAVDWWSLGALMYD 213 (327)
T ss_dssp CCCCCCTTTEEECTT-SCEEECCCSCC----------CTTSSCCTTSCHHHHTT--------SCCCTHHHHHHHHHHHHH
T ss_pred EcccCCHHHeEECCC-CcEEEEeCCcccccccCCccccccCCCcCccCHhhCcC--------CCCCCcccchhHHHHHHH
Confidence 799999999999976 6899999999975332 222345689999999999853 567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~~l~~~~~ 146 (198)
|++|..||.+......... .......+|..+++++.+++.+||..||.+|| ++.++++ |.|+.
T Consensus 214 l~~g~~pf~~~~~~~~~~~--i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~--hp~f~ 281 (327)
T 3a62_A 214 MLTGAPPFTGENRKKTIDK--ILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA--HPFFR 281 (327)
T ss_dssp HHHSSCSCCCSSHHHHHHH--HHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH--SGGGS
T ss_pred HHHCCCCCCCCCHHHHHHH--HHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc--CCccc
Confidence 9999999987665433222 22345567788999999999999999999999 7888888 56653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.6e-29 Score=202.76 Aligned_cols=135 Identities=21% Similarity=0.387 Sum_probs=109.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++...........+||+.|+|||++.+ ..++.++|+||+||++|||
T Consensus 308 vHrDLKPeNILld~~-g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~--------~~~~~~~DiwSLGvilyeL 378 (576)
T 2acx_A 308 VYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN--------ERYTFSPDWWALGCLLYEM 378 (576)
T ss_dssp ECCCCCGGGEEECTT-SCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTT--------CEESSHHHHHHHHHHHHHH
T ss_pred eccCCchheEEEeCC-CCeEEEecccceecccCccccccCCCccccCHHHHcC--------CCCCccchHHHHHHHHHHH
Confidence 699999999999976 6899999999986554444456789999999999853 5678999999999999999
Q ss_pred HcCCCCCCCCCc--HHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSN--LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~~l~~~~~ 146 (198)
++|..||.+... ................+..+++++.+|+.+||..||.+|| ++.++++ |.|+.
T Consensus 379 ltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~--HpfF~ 449 (576)
T 2acx_A 379 IAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE--HPLFK 449 (576)
T ss_dssp HHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT--SGGGT
T ss_pred HhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh--Chhhc
Confidence 999999986532 1122222333455667788999999999999999999999 7899988 66654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=191.60 Aligned_cols=137 Identities=29% Similarity=0.532 Sum_probs=100.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--c--cCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--M--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.+ +.+||+|||+++....... . ....++..|+|||++.+ ..++.++||||||++
T Consensus 169 vH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~SlG~i 239 (373)
T 2qol_A 169 VHRDLAARNILINSN-LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIV 239 (373)
T ss_dssp CCSCCCGGGEEECTT-CCEEECCC----------------------CTTSCHHHHHH--------CCCCHHHHHHHHHHH
T ss_pred eCCCCCcceEEEcCC-CCEEECcCccccccccCCccceeccCCCcCCCccChhhhcc--------CCcCchhcHHHHHHH
Confidence 799999999999976 6899999999975433211 1 11235678999999853 568899999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
+||+++ |..||.+..... ...........+.+..++..+.+++.+||..||.+||++.++++.|+.+...
T Consensus 240 l~ellt~g~~P~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 240 LWEVMSYGERPYWEMSNQD-VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHTTC-CTTTTCCHHH-HHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 999997 999998766533 3333344445556778999999999999999999999999999999988764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=183.46 Aligned_cols=143 Identities=24% Similarity=0.506 Sum_probs=115.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc----ccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+||||||+||+++.+ +.+||+|||+++....... .....+|..|+|||++.+ ..++.++|+||+|++
T Consensus 132 ~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~i 202 (287)
T 1u59_A 132 VHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVT 202 (287)
T ss_dssp ECCCCSGGGEEEEET-TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH--------CEECHHHHHHHHHHH
T ss_pred eeCCCchheEEEcCC-CCEEECcccceeeeccCcceeeccccccccccccCHHHhcc--------CCCCchhhHHHHHHH
Confidence 699999999999966 6899999999975432211 123456889999999853 457889999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCCC
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 153 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~~ 153 (198)
+|++++ |..||.+...... .........+..+..+++++.+++.+||..||.+||++.+++++|+.+......+..
T Consensus 203 l~ellt~g~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 203 MWEALSYGQKPYKKMKGPEV-MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp HHHHHTTSCCTTTTCCTHHH-HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred HHHHHcCCCCCcccCCHHHH-HHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 999998 9999987665433 333344555677888999999999999999999999999999999999887665543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.95 E-value=9.9e-28 Score=184.75 Aligned_cols=138 Identities=25% Similarity=0.329 Sum_probs=108.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|||++.+ +.+||+|||+++............|+..|+|||++.+ ..++.++||||+|+++|++
T Consensus 142 ~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l 212 (326)
T 1blx_A 142 VHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEM 212 (326)
T ss_dssp CCCCCCGGGEEECTT-CCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHH
T ss_pred eeccCCHHHeEEcCC-CCEEEecCcccccccCCCCccccccccceeCHHHHhc--------CCCCcchhHHHHHHHHHHH
Confidence 799999999999976 6799999999986554444456788999999999853 5678999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCC-------------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHAR-------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFS 135 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~ 135 (198)
++|..||.+................ ...+..+++.+.+|+.+||..||.+||++.
T Consensus 213 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 292 (326)
T 1blx_A 213 FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 292 (326)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHH
Confidence 9999999887654433222111000 012345789999999999999999999999
Q ss_pred HHHHHHHHHHhhcC
Q 029154 136 QIIRMLNAFLFTLR 149 (198)
Q Consensus 136 ~~l~~l~~~~~~~~ 149 (198)
++++ +.|+....
T Consensus 293 e~l~--hp~~~~~~ 304 (326)
T 1blx_A 293 SALS--HPYFQDLE 304 (326)
T ss_dssp HHHT--SGGGTTCC
T ss_pred HHhc--Cccccccc
Confidence 9998 77776554
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=189.06 Aligned_cols=137 Identities=27% Similarity=0.407 Sum_probs=105.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc---cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|||++.+ ...++.++||||+||++
T Consensus 127 vH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il 198 (323)
T 3tki_A 127 THRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVL 198 (323)
T ss_dssp ECSCCSGGGEEECTT-CCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHC-------SSBCHHHHHHHHHHHHH
T ss_pred cccccchHHEEEeCC-CCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhcc-------CCCCCCcccHHHHHHHH
Confidence 699999999999976 6799999999975432 222345689999999999853 23346789999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCC-CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHAR-PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|+|++|..||.+................ ......+++++.+|+.+||..||.+|||+.|+++ +.|+..
T Consensus 199 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~--h~~~~~ 267 (323)
T 3tki_A 199 TAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK--DRWYNK 267 (323)
T ss_dssp HHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTTTC
T ss_pred HHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh--Chhhcc
Confidence 9999999999865543333333222222 2223558899999999999999999999999999 667653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-28 Score=182.01 Aligned_cols=136 Identities=24% Similarity=0.487 Sum_probs=110.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+|||++.+ +.+||+|||+++...... ......+|+.|+|||++.+ ..++.++|+||+|+++|
T Consensus 142 ~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~ 212 (283)
T 3gen_A 142 LHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY--------SKFSSKSDIWAFGVLMW 212 (283)
T ss_dssp CCSSCSGGGEEECTT-SCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHH
T ss_pred cCCCCccceEEEcCC-CCEEEccccccccccccccccccCCccCcccCCHHHhcc--------CCCCchhhHHHHHHHHH
Confidence 699999999999976 679999999997543322 1223456788999999853 56789999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++++ |..||........ ............+...++.+.+++.+||..||.+||++.+++++|..++.
T Consensus 213 ~l~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 213 EIYSLGKMPYERFTNSET-AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp HHHTTTCCTTTTSCHHHH-HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhCCCCCccccChhHH-HHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 9998 9999987665433 33444455566677889999999999999999999999999999998765
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=193.16 Aligned_cols=138 Identities=20% Similarity=0.321 Sum_probs=107.8
Q ss_pred CCCCCCCCCeEEcCC-CCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~-~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ .+.+||+|||+++...........+||+.|+|||++.+ ..++.++||||+||++|+
T Consensus 171 vHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~e 242 (387)
T 1kob_A 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR--------EPVGFYTDMWAIGVLGYV 242 (387)
T ss_dssp ECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHH
T ss_pred eecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccC--------CCCCCcccEeeHhHHHHH
Confidence 699999999999743 35799999999986544433444579999999999853 567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccC--CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHA--RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
|++|..||.+............... ....+..+++++.+|+.+||..||.+||++.++++ +.|+...
T Consensus 243 lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~ 311 (387)
T 1kob_A 243 LLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE--HPWLKGD 311 (387)
T ss_dssp HHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT--STTTSSC
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh--CccccCC
Confidence 9999999988765443332222221 22334568999999999999999999999999999 6666543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-28 Score=182.03 Aligned_cols=141 Identities=30% Similarity=0.527 Sum_probs=111.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+||+++.+ +.+||+|||++....... ......++..|+|||++.+ ..++.++|+||+|+++|
T Consensus 131 ~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 201 (279)
T 1qpc_A 131 IHRDLRAANILVSDT-LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLT 201 (279)
T ss_dssp ECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH--------CEECHHHHHHHHHHHHH
T ss_pred eccCCCHhhEEEcCC-CCEEECCCcccccccCcccccccCCCCccCccChhhhcc--------CCCCchhhhHHHHHHHH
Confidence 699999999999966 679999999997544322 1223456788999999853 45788999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCC
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
+|++ |..||.+..... .............+..+++++.+++.+||..||.+||++.++++.|+.++......
T Consensus 202 el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 202 EIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp HHHTTTCCSSTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred HHHhCCCCCCcccCHHH-HHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 9999 899998766533 33334444555667789999999999999999999999999999999988765443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=189.03 Aligned_cols=139 Identities=19% Similarity=0.272 Sum_probs=90.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccc-------------cCCCCccceecccccccccccccccCCCCch
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMM-------------TAETGTYRWMAPELYSTVTLRQGEKKHYNNK 67 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~-------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 67 (198)
|||||||+|||++.+ +.+||+|||+++........ ....||+.|+|||++... ....++.+
T Consensus 160 vH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~~ 233 (337)
T 3ll6_A 160 IHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY-----SNFPIGEK 233 (337)
T ss_dssp BCCCCCGGGCEECTT-SCEEBCCCTTCBCCSSCC-------------------------------CC-----TTSCSSHH
T ss_pred EEccCCcccEEECCC-CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc-----ccCCCChH
Confidence 699999999999976 67999999999754332111 134689999999987320 13567889
Q ss_pred hhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 68 VDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 68 ~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
+||||||+++|+|++|..||........ .........+...+..+.+++.+||..||.+||++.+++++|+.+...
T Consensus 234 ~Dv~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 234 QDIWALGCILYLLCFRQHPFEDGAKLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp HHHHHHHHHHHHHHHSSCCC----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhHHHHHHHHHHHHhCCCCCcchhHHHh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999976443221 112223334556778899999999999999999999999999988775
Q ss_pred cC
Q 029154 148 LR 149 (198)
Q Consensus 148 ~~ 149 (198)
..
T Consensus 310 ~~ 311 (337)
T 3ll6_A 310 RN 311 (337)
T ss_dssp TT
T ss_pred cC
Confidence 44
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=196.84 Aligned_cols=138 Identities=22% Similarity=0.342 Sum_probs=105.5
Q ss_pred CCCCCCCCCeEE---cCCCCceEEecccCcccCccccc--------ccCCCCccceecccccccccccccccCCCCchhh
Q 029154 1 MGKFMKEDNLLL---TPDQKSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 69 (198)
Q Consensus 1 iH~dlKp~NIll---~~~~~~~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~D 69 (198)
|||||||+|||+ +.+ +.+||+|||+++....... ....+||..|++||++.+ ..++.++|
T Consensus 125 vHrDIKP~NILl~~~~~~-~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~~sD 195 (483)
T 3sv0_A 125 LHRDIKPDNFLMGLGRRA-NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG--------IEQSRRDD 195 (483)
T ss_dssp ECCCCCGGGEEECCGGGT-TCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHH
T ss_pred eecccCcceEEEecCCCC-CeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcC--------CCCChHHH
Confidence 699999999999 444 6799999999975433221 124679999999999854 56889999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCc--HHHHHHH----HHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 70 VYSFGIVLWELLTNRLPFEGMSN--LQAAYAA----AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 70 vws~G~~l~e~~~g~~p~~~~~~--~~~~~~~----~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
||||||++|||++|..||.+... ....+.. ........++..+++++.+++.+||..||.+||++.+|++.|+.
T Consensus 196 vwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 196 LESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp HHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 99999999999999999987543 1111111 11111112235678999999999999999999999999999988
Q ss_pred HHhh
Q 029154 144 FLFT 147 (198)
Q Consensus 144 ~~~~ 147 (198)
++..
T Consensus 276 l~~~ 279 (483)
T 3sv0_A 276 LFIR 279 (483)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-28 Score=186.85 Aligned_cols=141 Identities=25% Similarity=0.376 Sum_probs=106.1
Q ss_pred CCCCCCCCCeEEcCCC-CceEEecccCcccCccc---c--cccCCCCccceecccccccccccccccCCCCchhhHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQ-KSLKLADFGLAREETVT---E--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 74 (198)
Q Consensus 1 iH~dlKp~NIll~~~~-~~~kl~DfGla~~~~~~---~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G 74 (198)
|||||||+|||++.++ ..+||+|||+++..... . ......||+.|+|||++.+ ....++.++||||||
T Consensus 190 vH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~DiwslG 263 (345)
T 3hko_A 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT------TNESYGPKCDAWSAG 263 (345)
T ss_dssp ECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC------SSSCCCTHHHHHHHH
T ss_pred cccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc------CCCCCCcHHHHHHHH
Confidence 6999999999998652 27999999999743221 1 1234579999999999853 235688999999999
Q ss_pred HHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCC--CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 75 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 75 ~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
+++|+|++|..||.+...................+ ..+++++.+++.+||..||.+||++.++++ +.|+....
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~--hp~~~~~~ 338 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ--HPWISQFS 338 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH--SHHHHTTS
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc--ChhhccCh
Confidence 99999999999998877655444333333222222 237899999999999999999999999999 77776543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=188.33 Aligned_cols=138 Identities=23% Similarity=0.356 Sum_probs=104.9
Q ss_pred CCCCCCCCCeEEcC--CCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTP--DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~--~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++. +.+.+||+|||+++............||+.|+|||++.+ ..++.++|+||+|+++|
T Consensus 153 vH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ 224 (327)
T 3lm5_A 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY--------DPITTATDMWNIGIIAY 224 (327)
T ss_dssp ECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHH
T ss_pred ecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecC--------CCCCchhhHHHHHHHHH
Confidence 69999999999986 136799999999986554444455689999999999853 56889999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHcc--CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKH--ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
+|++|..||.+.............. .....+..+++.+.+++.+||..||.+||++.++++ +.|+...
T Consensus 225 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~--h~~~~~~ 294 (327)
T 3lm5_A 225 MLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS--HSWLQQW 294 (327)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--CGGGCCC
T ss_pred HHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC--CHhhccc
Confidence 9999999998876544433322222 222334568999999999999999999999999998 7776543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=188.16 Aligned_cols=141 Identities=26% Similarity=0.496 Sum_probs=99.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc-----ccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
|||||||+|||++.+ +.+||+|||+++....... ....+||+.|+|||++.+.... ....++.++||||||+
T Consensus 135 vH~Dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~DvwslG~ 211 (301)
T 3q4u_A 135 AHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV--DCFDSYKRVDIWAFGL 211 (301)
T ss_dssp ECSCCCGGGEEECTT-SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCT--TCHHHHHHHHHHHHHH
T ss_pred ecCCCChHhEEEcCC-CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCC--CcccCCchhhHHHHHH
Confidence 699999999999976 6899999999974322111 2334799999999998541000 0003446899999999
Q ss_pred HHHHHHcC----------CCCCCCCCc----HHHHHHHH-HccCCCCCCC-----CCcHHHHHHHHHhcccCCCCCCCHH
Q 029154 76 VLWELLTN----------RLPFEGMSN----LQAAYAAA-FKHARPGLPE-----DISPDLAFIVQSCWVEDPNLRPSFS 135 (198)
Q Consensus 76 ~l~e~~~g----------~~p~~~~~~----~~~~~~~~-~~~~~~~~p~-----~~~~~~~~l~~~~l~~dp~~Rps~~ 135 (198)
++|||++| ..||..... ........ .....+..+. ..++++.+++.+||..||.+|||+.
T Consensus 212 il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 291 (301)
T 3q4u_A 212 VLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291 (301)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHH
Confidence 99999999 888864321 12221111 1222233332 2457899999999999999999999
Q ss_pred HHHHHHHHH
Q 029154 136 QIIRMLNAF 144 (198)
Q Consensus 136 ~~l~~l~~~ 144 (198)
++++.|+.+
T Consensus 292 ~i~~~L~~i 300 (301)
T 3q4u_A 292 RIKKTLTKI 300 (301)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHhcc
Confidence 999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-28 Score=184.19 Aligned_cols=137 Identities=26% Similarity=0.418 Sum_probs=102.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+|||++.+ +.+||+|||+++...... .....+||+.|+|||++.+ ..++.++|+||+|+++|
T Consensus 133 ~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ 203 (294)
T 4eqm_A 133 VHRDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG--------EATDECTDIYSIGIVLY 203 (294)
T ss_dssp CCCCCCGGGEEECTT-SCEEECCCSSSTTC-------------CCSSCCHHHHHT--------CCCCTTHHHHHHHHHHH
T ss_pred ccCCCCHHHEEECCC-CCEEEEeCCCccccccccccccCccccCccccCHhHhcC--------CCCCchHhHHHHHHHHH
Confidence 799999999999976 679999999997544322 1234578999999999853 56788999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCC---CCCCCCcHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHh
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARP---GLPEDISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFLF 146 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~l~~~~l~~dp~~Rp-s~~~~l~~l~~~~~ 146 (198)
+|++|..||.+................. ..+..+++.+.+++.+||..||.+|| +++++.+.|..++.
T Consensus 204 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 204 EMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred HHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 9999999998877554433333222211 23466889999999999999999998 88888888776544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=187.42 Aligned_cols=141 Identities=23% Similarity=0.354 Sum_probs=103.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++..... ......+||+.|+|||++.+ ...++.++||||+||++|+
T Consensus 122 vH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ 193 (324)
T 3mtl_A 122 LHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLG-------STDYSTQIDMWGVGCIFYE 193 (324)
T ss_dssp EESSCCGGGEEECTT-CCEEECSSSEEECC------------CGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHH
T ss_pred cCCCcCHHHEEECCC-CCEEEccCcccccccCCccccccccCcccccChhhhcC-------CCCCCcHHHHHHHHHHHHH
Confidence 699999999999977 67999999999754322 22344578999999998753 3567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC--C--------------------------CCCCCcHHHHHHHHHhcccCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP--G--------------------------LPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~--~--------------------------~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
|++|..||.+................+ . ....+++++.+|+.+||..||.+|
T Consensus 194 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 273 (324)
T 3mtl_A 194 MATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNR 273 (324)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccC
Confidence 999999998876544332221111100 0 012467899999999999999999
Q ss_pred CCHHHHHHHHHHHHhhcCCC
Q 029154 132 PSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~~~~ 151 (198)
||+.|+++ +.|+......
T Consensus 274 ~t~~e~l~--hp~f~~~~~~ 291 (324)
T 3mtl_A 274 ISAEDAMK--HPFFLSLGER 291 (324)
T ss_dssp CCHHHHTT--SGGGGGGCST
T ss_pred CCHHHHhc--Chhhhhcccc
Confidence 99999999 8888766544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-28 Score=188.72 Aligned_cols=136 Identities=25% Similarity=0.478 Sum_probs=92.1
Q ss_pred CCCCCCCCCeEEcCCC-CceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCc-hhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQ-KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNN-KVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~-~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-~~Dvws~G~~l~ 78 (198)
|||||||+|||++.++ ..+||+|||+++...........+||+.|+|||++.+ ..++. ++||||+||++|
T Consensus 138 vH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~ 209 (361)
T 3uc3_A 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--------QEYDGKIADVWSCGVTLY 209 (361)
T ss_dssp CSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHC--------SSCCHHHHHHHHHHHHHH
T ss_pred ccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcC--------CCCCCCeeeeehhHHHHH
Confidence 7999999999998652 2499999999975443333445679999999999853 34444 489999999999
Q ss_pred HHHcCCCCCCCCCc---HHHHHHHHHccCCCCCC--CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 79 ELLTNRLPFEGMSN---LQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 79 e~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~p--~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
+|++|..||.+... ....... ........| ..+++++.+|+.+||..||.+|||+.++++ |.|+..
T Consensus 210 ell~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~--hp~f~~ 280 (361)
T 3uc3_A 210 VMLVGAYPFEDPEEPRDYRKTIQR-ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT--HSWFLK 280 (361)
T ss_dssp HHHHSSCSCC----CCCHHHHHHH-HHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT--SHHHHT
T ss_pred HHHhCCCCCCCCccHHHHHHHHHH-HhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh--Ccchhc
Confidence 99999999976432 1111111 122222333 357999999999999999999999999999 777654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=184.57 Aligned_cols=138 Identities=28% Similarity=0.520 Sum_probs=105.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc----ccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+||||||+|||++.+ +.+||+|||+++....... .....++..|+|||++.+ ..++.++||||||++
T Consensus 169 vH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~i 239 (333)
T 1mqb_A 169 VHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIV 239 (333)
T ss_dssp CCSCCCGGGEEECTT-CCEEECCCCC-----------------CCCGGGSCHHHHHS--------CCCCHHHHHHHHHHH
T ss_pred eCCCCChheEEECCC-CcEEECCCCcchhhccccccccccCCCCccccccCchhccc--------CCCCchhhhHHHHHH
Confidence 799999999999976 6899999999975432211 112345788999999853 568899999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
+|++++ |..||.+..... .............+..+++.+.+++.+||..||.+||++.++++.|+.++...
T Consensus 240 l~ellt~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 240 MWEVMTYGERPYWELSNHE-VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp HHHHHTTSCCTTTTCCHHH-HHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHcCCCCCcccCCHHH-HHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 999998 999998766433 33334444556667789999999999999999999999999999999887643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-28 Score=193.94 Aligned_cols=140 Identities=26% Similarity=0.366 Sum_probs=97.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc----------------------------ccccCCCCccceecccccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT----------------------------EMMTAETGTYRWMAPELYS 52 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~ 52 (198)
|||||||+|||++.+ +.+||+|||+++..... ......+||+.|+|||++.
T Consensus 178 iHrDlKp~NILl~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 256 (458)
T 3rp9_A 178 LHRDLKPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL 256 (458)
T ss_dssp BCCCCCGGGEEECTT-CCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred CCCCCChhhEEECCC-CCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence 799999999999977 68999999999854311 1233457899999999864
Q ss_pred cccccccccCCCCchhhHHHHHHHHHHHHc-----------CCCCCCCCCcH--------------------HHHHHH--
Q 029154 53 TVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----------NRLPFEGMSNL--------------------QAAYAA-- 99 (198)
Q Consensus 53 ~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~-----------g~~p~~~~~~~--------------------~~~~~~-- 99 (198)
. ...++.++||||+||++|||++ |.++|.+.... ......
T Consensus 257 ~-------~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~ 329 (458)
T 3rp9_A 257 L-------QENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFN 329 (458)
T ss_dssp T-------CCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHH
T ss_pred C-------CCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHH
Confidence 2 3568999999999999999998 66677654310 000000
Q ss_pred HH--------------------ccCCC-------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 100 AF--------------------KHARP-------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 100 ~~--------------------~~~~~-------~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
.. ..... ......++++.+|+.+||..||.+|||++|+++ |.|+.....
T Consensus 330 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~--Hp~f~~~~~ 405 (458)
T 3rp9_A 330 ILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA--HPFFKEVRI 405 (458)
T ss_dssp HHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGTTTCC
T ss_pred HcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc--CHhhhhcCC
Confidence 00 00000 012346899999999999999999999999999 888876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=195.62 Aligned_cols=140 Identities=24% Similarity=0.317 Sum_probs=106.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++...... ...+.+||+.|+|||++.... ....++.++|+||+||++|
T Consensus 190 vHrDLKp~NILl~~~-g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~----~~~~~~~~~DiwSlGvily 264 (410)
T 3v8s_A 190 IHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG----GDGYYGRECDWWSVGVFLY 264 (410)
T ss_dssp ECCCCSGGGEEECTT-SCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTT----TTCEEETHHHHHHHHHHHH
T ss_pred EeccCCHHHeeECCC-CCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccC----CCcCCCCcceEecchHHHH
Confidence 699999999999977 689999999997544322 234678999999999985300 0112678999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHcc--CCCCCCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHHHHHHHHhh
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKH--ARPGLPEDISPDLAFIVQSCWVEDPNL--RPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~l~~~~l~~dp~~--Rps~~~~l~~l~~~~~~ 147 (198)
||++|..||.+.............. ...+....+++++.+|+.+||..+|.+ |++++++++ |.|+..
T Consensus 265 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~--Hp~f~~ 335 (410)
T 3v8s_A 265 EMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR--HLFFKN 335 (410)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT--SGGGCC
T ss_pred HHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc--CccccC
Confidence 9999999998866544332222211 222333468999999999999998888 999999999 667653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=189.90 Aligned_cols=149 Identities=21% Similarity=0.390 Sum_probs=102.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc---------ccccCCCCccceecccccccccccccccCCCCchhhHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT---------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 71 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvw 71 (198)
|||||||+|||++.+ +.+||+|||+++..... ......+||+.|+|||++.+..... ....++.++|||
T Consensus 142 vH~Dikp~Nill~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~~Diw 219 (336)
T 3g2f_A 142 SHRDLNSRNVLVKND-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR-DXESALKQVDMY 219 (336)
T ss_dssp ECSSCSGGGEEECTT-SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGG-GHHHHHHHHHHH
T ss_pred eecccccceEEEcCC-CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccc-cccccccccchH
Confidence 699999999999976 68999999999754321 1122457999999999985311000 012456789999
Q ss_pred HHHHHHHHHHcCCCCCCCCCc-----------------HHHHH-HHHHccCCCCCCCC------CcHHHHHHHHHhcccC
Q 029154 72 SFGIVLWELLTNRLPFEGMSN-----------------LQAAY-AAAFKHARPGLPED------ISPDLAFIVQSCWVED 127 (198)
Q Consensus 72 s~G~~l~e~~~g~~p~~~~~~-----------------~~~~~-~~~~~~~~~~~p~~------~~~~~~~l~~~~l~~d 127 (198)
||||++|||++|..||..... ..... ........+.+|.. +++++.+++.+||..|
T Consensus 220 slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (336)
T 3g2f_A 220 ALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299 (336)
T ss_dssp HHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSS
T ss_pred HHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCC
Confidence 999999999999766532111 01111 11112233344443 3457999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHhhcCCC
Q 029154 128 PNLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 128 p~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
|.+|||+.++++.|+.++......
T Consensus 300 P~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 300 AEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp GGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred hhhCcchHHHHHHHHHHHHHHHhc
Confidence 999999999999999988755543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=197.49 Aligned_cols=141 Identities=20% Similarity=0.344 Sum_probs=106.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++...... .....+||+.|+|||++.... .....++.++||||+||++|
T Consensus 197 iHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~~~~~~DvwSlGvil~ 272 (437)
T 4aw2_A 197 VHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME---GGKGRYGPECDWWSLGVCMY 272 (437)
T ss_dssp ECCCCSGGGEEECTT-SCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHH---TSCCEECTHHHHHHHHHHHH
T ss_pred EecccCHHHeeEcCC-CCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcc---cCCCCCCCcCeeHHHHHHHH
Confidence 699999999999977 689999999997543322 233468999999999975200 01245789999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHcc---CCCCCCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHHHHHHHHhh
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKH---ARPGLPEDISPDLAFIVQSCWVEDPNL--RPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~p~~~~~~~~~l~~~~l~~dp~~--Rps~~~~l~~l~~~~~~ 147 (198)
||++|..||.+.............. ..+..+..+++++.+|+.+||..+|.+ |++++++++ |.|+..
T Consensus 273 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~--Hpff~~ 344 (437)
T 4aw2_A 273 EMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK--HPFFSG 344 (437)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT--SGGGTT
T ss_pred HHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC--CCccCC
Confidence 9999999998876544332222111 122233458999999999999888888 899999999 777754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-28 Score=182.93 Aligned_cols=138 Identities=27% Similarity=0.538 Sum_probs=110.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc----ccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+||||||+|||++.+ +.+||+|||++........ .....++..|+|||++.+ ..++.++|+||+|++
T Consensus 139 ~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~i 209 (291)
T 1xbb_A 139 VHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVL 209 (291)
T ss_dssp ECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH--------CEEEHHHHHHHHHHH
T ss_pred EcCCCCcceEEEeCC-CcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhcc--------CCCChhhhHHHHHHH
Confidence 699999999999966 6899999999975432211 122346788999999853 456889999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
+|++++ |..||.+..... ..........+..+..+++++.+++.+||..||.+||++.++++.|+.++...
T Consensus 210 l~~l~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 210 MWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HHHHHTTTCCSSTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 999999 999998766533 33334445556677889999999999999999999999999999999987654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=8e-28 Score=181.64 Aligned_cols=137 Identities=22% Similarity=0.433 Sum_probs=108.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|||++.+ +.+||+|||++....... .....|+..|+|||.+.+ ..++.++|+||+|+++|+|
T Consensus 131 ~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l 200 (279)
T 3fdn_A 131 IHRDIKPENLLLGSA-GELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEG--------RMHDEKVDLWSLGVLCYEF 200 (279)
T ss_dssp EECCCCGGGEEECTT-SCEEECSCCEESCC---------CCCCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHH
T ss_pred ecccCChHhEEEcCC-CCEEEEeccccccCCccc-ccccCCCCCccCHhHhcc--------CCCCccchhHhHHHHHHHH
Confidence 699999999999976 679999999986443322 234578999999999853 5678899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
++|..||.+....... ..........|..+++++.+++.+||..||.+||++.++++ +.|+......
T Consensus 201 ~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~--h~~~~~~~~~ 267 (279)
T 3fdn_A 201 LVGKPPFEANTYQETY--KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITANSSK 267 (279)
T ss_dssp HHSSCTTCCSSHHHHH--HHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH--CHHHHHHCSS
T ss_pred HHCCCCCCCCcHHHHH--HHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh--CccccCCccC
Confidence 9999999876643332 22334555677889999999999999999999999999999 7887765543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-29 Score=196.89 Aligned_cols=136 Identities=13% Similarity=0.167 Sum_probs=101.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++...... ....+|+.|+|||++.+ ....++.++|||||||++|+|
T Consensus 216 vHrDikp~NIll~~~-~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~------~~~~~~~~~DiwSlG~il~el 286 (371)
T 3q60_A 216 VHGHFTPDNLFIMPD-GRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNA------STATFTHALNAWQLGLSIYRV 286 (371)
T ss_dssp EETTCSGGGEEECTT-SCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTC------SEEECCHHHHHHHHHHHHHHH
T ss_pred ccCcCCHHHEEECCC-CCEEEEecceeeecCCCc--cCccCCcCCcChhhccC------CCCCcCccccHHHHHHHHHHH
Confidence 699999999999976 689999999998654322 13456799999999853 125679999999999999999
Q ss_pred HcCCCCCCCCCcHHHH-HH----HHHc--cCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 81 LTNRLPFEGMSNLQAA-YA----AAFK--HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~-~~----~~~~--~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
++|..||.+....... +. .... ....+.+..+++++.+|+.+||..||.+||++.++++ +.|+..
T Consensus 287 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~f~~ 358 (371)
T 3q60_A 287 WCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME--TPEFLQ 358 (371)
T ss_dssp HHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT--SHHHHH
T ss_pred HhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc--CHHHHH
Confidence 9999999765321100 00 0000 1111223468999999999999999999999999998 566543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-28 Score=185.77 Aligned_cols=140 Identities=29% Similarity=0.586 Sum_probs=112.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++...... ......+++.|+|||++.+ ..++.++||||+|+++
T Consensus 179 vH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 249 (334)
T 2pvf_A 179 IHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLM 249 (334)
T ss_dssp ECSCCSGGGEEECTT-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHH
T ss_pred eCCCCccceEEEcCC-CCEEEccccccccccccccccccCCCCcccceeChHHhcC--------CCcChHHHHHHHHHHH
Confidence 699999999999976 679999999997543322 1223456789999998753 4578999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
|++++ |..||.+.... ..............+..++.++.+++.+||..||.+||++.++++.|+.++.....
T Consensus 250 ~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 250 WEIFTLGGSPYPGIPVE-ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHTTSCCSSTTCCHH-HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHhCCCCCcCcCCHH-HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 99999 99999876543 33334444555667788999999999999999999999999999999998876543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=186.16 Aligned_cols=141 Identities=17% Similarity=0.246 Sum_probs=107.9
Q ss_pred CCCCCCCCCeEEcCCCC--ceEEecccCcccCccccc--------ccCCCCccceecccccccccccccccCCCCchhhH
Q 029154 1 MGKFMKEDNLLLTPDQK--SLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 70 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~--~~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dv 70 (198)
|||||||+|||++.+ + .+||+|||+++....... .....||+.|+|||++.+ ..++.++||
T Consensus 181 vH~Dikp~NIl~~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di 251 (352)
T 2jii_A 181 VHGNVTAENIFVDPE-DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--------CGPSRRSDL 251 (352)
T ss_dssp BCSCCCGGGEEEETT-EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--------CCCCHHHHH
T ss_pred cCCCCCHHHEEEcCC-CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--------CCCCchhhH
Confidence 699999999999976 5 799999999975433211 133478999999999853 568899999
Q ss_pred HHHHHHHHHHHcCCCCCCCCC-cHHHHHHH--HHccCCCCCC------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 71 YSFGIVLWELLTNRLPFEGMS-NLQAAYAA--AFKHARPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 71 ws~G~~l~e~~~g~~p~~~~~-~~~~~~~~--~~~~~~~~~p------~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
||||+++|+|++|..||.+.. ........ ........++ ..+++++.+++.+||..||.+||++.++++.|
T Consensus 252 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 331 (352)
T 2jii_A 252 QSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL 331 (352)
T ss_dssp HHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence 999999999999999998654 22222111 1122222222 24689999999999999999999999999999
Q ss_pred HHHHhhcCC
Q 029154 142 NAFLFTLRP 150 (198)
Q Consensus 142 ~~~~~~~~~ 150 (198)
+.++.....
T Consensus 332 ~~~~~~~~~ 340 (352)
T 2jii_A 332 EALLQDLRV 340 (352)
T ss_dssp HHHHHHTTC
T ss_pred HHHHHhcCC
Confidence 998876653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-29 Score=190.16 Aligned_cols=138 Identities=29% Similarity=0.435 Sum_probs=104.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---------------ccCCCCccceecccccccccccccccCCCC
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---------------MTAETGTYRWMAPELYSTVTLRQGEKKHYN 65 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 65 (198)
|||||||+|||++.+ +.+||+|||+++....... ....+||+.|+|||++.+ ..++
T Consensus 130 vH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~ 200 (310)
T 3s95_A 130 IHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--------RSYD 200 (310)
T ss_dssp ECSCCSTTSEEECTT-SCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT--------CCCC
T ss_pred cCCCCCcCeEEECCC-CCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC--------CCCC
Confidence 699999999999976 6799999999975432211 114579999999999853 6688
Q ss_pred chhhHHHHHHHHHHHHcCCCCCCCCCcHHH----HHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 66 NKVDVYSFGIVLWELLTNRLPFEGMSNLQA----AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 66 ~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~----~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
.++||||||+++|++++|..|+........ ...... ....+..+++.+.+++.+||..||.+||++.++++.|
T Consensus 201 ~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L 277 (310)
T 3s95_A 201 EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL---DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277 (310)
T ss_dssp THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH---HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc---cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 999999999999999999988764321100 001111 1123566888999999999999999999999999999
Q ss_pred HHHHhhcCC
Q 029154 142 NAFLFTLRP 150 (198)
Q Consensus 142 ~~~~~~~~~ 150 (198)
+.+......
T Consensus 278 ~~l~~~~~~ 286 (310)
T 3s95_A 278 ETLRMHLAG 286 (310)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHhccC
Confidence 988665443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=189.80 Aligned_cols=128 Identities=21% Similarity=0.370 Sum_probs=103.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++...........+||+.|+|||++.+ ...++.++||||+|+++|+|
T Consensus 152 vH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el 223 (335)
T 3dls_A 152 IHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG-------NPYRGPELEMWSLGVTLYTL 223 (335)
T ss_dssp ECSCCSGGGEEECTT-SCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTT-------CCBCSHHHHHHHHHHHHHHH
T ss_pred EEeccCHHHEEEcCC-CcEEEeecccceECCCCCceeccCCCccccChhhhcC-------CCCCCCcccchhHHHHHHHH
Confidence 699999999999976 6899999999986554444445679999999999854 22347899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++|..||..... ........|..+++++.+|+.+||..||.+||++.++++ +.|+.
T Consensus 224 ~~g~~pf~~~~~--------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~--hp~~~ 279 (335)
T 3dls_A 224 VFEENPFCELEE--------TVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT--DPWVT 279 (335)
T ss_dssp HHSSCSCSSGGG--------GTTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH--CTTTT
T ss_pred HhCCCchhhHHH--------HHhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc--Ccccc
Confidence 999999975332 112233456678999999999999999999999999999 66654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-28 Score=186.98 Aligned_cols=139 Identities=17% Similarity=0.281 Sum_probs=105.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.++..+||+|||+++............|+..|+|||++.+ ...++.++||||+||++|+|
T Consensus 152 vH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l 224 (330)
T 3nsz_A 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASM 224 (330)
T ss_dssp ECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHH
T ss_pred eeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcC-------CCcCCchhhHHHHHHHHHHH
Confidence 69999999999997755899999999986554444556789999999999753 35688999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHH------------ccCC------------------------CCCCCCCcHHHHHHHHHhc
Q 029154 81 LTNRLPFEGMSNLQAAYAAAF------------KHAR------------------------PGLPEDISPDLAFIVQSCW 124 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~------------~~~~------------------------~~~p~~~~~~~~~l~~~~l 124 (198)
++|..||.............. .... ...+..+++++.+|+.+||
T Consensus 225 l~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 304 (330)
T 3nsz_A 225 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 304 (330)
T ss_dssp HHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTS
T ss_pred HhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHh
Confidence 999999855443222111100 0000 1112227899999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 125 VEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 125 ~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
..||.+|||++++++ +.|+...
T Consensus 305 ~~dP~~Rpta~e~l~--hp~f~~~ 326 (330)
T 3nsz_A 305 RYDHQSRLTAREAME--HPYFYTV 326 (330)
T ss_dssp CSSGGGSCCHHHHHT--SGGGTTC
T ss_pred cCCcccCCCHHHHhc--CccHhhh
Confidence 999999999999999 6666543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-28 Score=186.83 Aligned_cols=139 Identities=20% Similarity=0.291 Sum_probs=104.4
Q ss_pred CCCCCCCCCeEEcCCCCc-----eEEecccCcccCccccc--------ccCCCCccceecccccccccccccccCCCCch
Q 029154 1 MGKFMKEDNLLLTPDQKS-----LKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 67 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~-----~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 67 (198)
|||||||+|||++.+ +. +||+|||+++....... ....+||+.|+|||++.+ ..++.+
T Consensus 127 iHrDlkp~Nill~~~-~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~ 197 (330)
T 2izr_A 127 IYRDVKPENFLIGRP-GNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--------KEQSRR 197 (330)
T ss_dssp ECCCCCGGGEEECCG-GGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHH
T ss_pred eccCCCHHHeeeccC-CCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC--------CCCCch
Confidence 699999999999866 44 99999999985432211 235679999999999853 568899
Q ss_pred hhHHHHHHHHHHHHcCCCCCCCCCc--HHHHHHHHHc---cCCC-CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 68 VDVYSFGIVLWELLTNRLPFEGMSN--LQAAYAAAFK---HARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 68 ~Dvws~G~~l~e~~~g~~p~~~~~~--~~~~~~~~~~---~~~~-~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
+||||||+++|||++|..||.+... .......... .... .....++ ++.+++.+||..||.+||++.++.+.|
T Consensus 198 ~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l 276 (330)
T 2izr_A 198 DDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLF 276 (330)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHH
Confidence 9999999999999999999987532 2221111111 1111 1122344 999999999999999999999999999
Q ss_pred HHHHhhcC
Q 029154 142 NAFLFTLR 149 (198)
Q Consensus 142 ~~~~~~~~ 149 (198)
+.+.....
T Consensus 277 ~~~~~~~~ 284 (330)
T 2izr_A 277 TDLFDRKG 284 (330)
T ss_dssp HHHHHHTT
T ss_pred HHHHHHcC
Confidence 98876543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=191.62 Aligned_cols=135 Identities=24% Similarity=0.405 Sum_probs=94.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++...........+||+.|+|||++.+ ..++.++||||+||++|+|
T Consensus 149 vH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 219 (371)
T 2xrw_A 149 IHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEM 219 (371)
T ss_dssp CCSCCCGGGEEECTT-SCEEECCCCC----------------CTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHH
T ss_pred ecccCCHHHEEEcCC-CCEEEEEeecccccccccccCCceecCCccCHHHhcC--------CCCCchHhHHHHHHHHHHH
Confidence 799999999999976 6799999999986554444455689999999999853 5688999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCC---------------------CCC--------------CCC------CcHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHAR---------------------PGL--------------PED------ISPDLAFI 119 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~---------------------~~~--------------p~~------~~~~~~~l 119 (198)
++|..||.+......... ...... +.. |.. .++++.+|
T Consensus 220 ~~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (371)
T 2xrw_A 220 IKGGVLFPGTDHIDQWNK-VIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 298 (371)
T ss_dssp HHSSCSSCCSSHHHHHHH-HHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHH-HHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHH
Confidence 999999988765433222 111110 000 000 15678999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 120 VQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 120 ~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
+.+||..||.+|||++++++ +.|+..
T Consensus 299 i~~mL~~dP~~R~t~~e~l~--hp~~~~ 324 (371)
T 2xrw_A 299 LSKMLVIDASKRISVDEALQ--HPYINV 324 (371)
T ss_dssp HHHHSCSSGGGSCCHHHHHH--SHHHHT
T ss_pred HHHHCcCChhhCCCHHHHhC--Ccchhh
Confidence 99999999999999999999 777653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=181.52 Aligned_cols=135 Identities=30% Similarity=0.477 Sum_probs=98.5
Q ss_pred CCCCCCCCCeEEcCC--CCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~--~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ .+.+||+|||+++............||+.|+|||++. ..++.++|+||+|+++|
T Consensus 146 vH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~il~ 216 (285)
T 3is5_A 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK---------RDVTFKCDIWSAGVVMY 216 (285)
T ss_dssp CCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT---------TCCCHHHHHHHHHHHHH
T ss_pred EECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc---------cCCCcccCeehHHHHHH
Confidence 799999999999532 2569999999997654444445567999999999873 45789999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCC-CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+|++|..||.+................. .....+++++.+++.+||..||.+||++.++++ +.|+.
T Consensus 217 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~f~ 283 (285)
T 3is5_A 217 FLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH--HEWFK 283 (285)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT--SGGGG
T ss_pred HHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc--CHHhh
Confidence 9999999998866443332222222221 122347899999999999999999999999998 55543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-28 Score=188.96 Aligned_cols=140 Identities=21% Similarity=0.339 Sum_probs=106.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+|||++.+ +.+||+|||++............+||+.|+|||++.+... .....++.++|||||||++|+|
T Consensus 222 ~H~Dlkp~NIl~~~~-~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~~Di~slG~il~el 298 (365)
T 2y7j_A 222 VHRDLKPENILLDDN-MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMD--ETHPGYGKEVDLWACGVILFTL 298 (365)
T ss_dssp ECSCCSGGGEEECTT-CCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTC--TTSCCBCTTHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEECCC-CCEEEEecCcccccCCCcccccCCCCCCccChhhcccccc--ccCcCCCchhhHHhHHHHHHHH
Confidence 699999999999976 6899999999976554444556789999999998753110 0123578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCC--CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
++|..||.+................... ...++..+.+++.+||..||.+||++.++++ +.|+
T Consensus 299 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~--hp~f 363 (365)
T 2y7j_A 299 LAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ--HPFF 363 (365)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGG
T ss_pred HHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--Cccc
Confidence 9999999876644333222222222211 2457889999999999999999999999998 5554
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-28 Score=183.41 Aligned_cols=136 Identities=28% Similarity=0.543 Sum_probs=106.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+|+||||+||+++.+ +.+||+|||+++...... ......++..|+|||++.+ ..++.++|+||+|++
T Consensus 143 ~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~i 213 (291)
T 1u46_A 143 IHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--------RTFSHASDTWMFGVT 213 (291)
T ss_dssp ECSCCCGGGEEEEET-TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH--------CEEEHHHHHHHHHHH
T ss_pred ccCCCchheEEEcCC-CCEEEccccccccccccccchhhhccCCCCceeeCchhhcC--------CCCCchhhHHHHHHH
Confidence 699999999999866 689999999987543221 1223457788999999853 456889999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
+|++++ |..||.+...................+..++.++.+++.+||..||.+||++.+++++|+...
T Consensus 214 l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 214 LWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 999999 999998876544433333334455566789999999999999999999999999999988753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-28 Score=198.33 Aligned_cols=139 Identities=29% Similarity=0.501 Sum_probs=112.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++....... .....++..|+|||++.. ..++.++||||||+++|
T Consensus 385 vHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwSlGv~l~ 455 (535)
T 2h8h_A 385 VHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLT 455 (535)
T ss_dssp CCSCCSGGGEEECGG-GCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHH
T ss_pred eCCCCCHhhEEEcCC-CcEEEcccccceecCCCceecccCCcCcccccCHHHhcc--------CCCCchhhHHHHHHHHH
Confidence 799999999999866 6799999999986543221 223456789999998853 56899999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
||++ |..||.+..... .........+...+..+++++.+||.+||..||.+||++.++++.|+.++....
T Consensus 456 el~t~g~~P~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 456 ELTTKGRVPYPGMVNRE-VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp HHTTTTCCSSTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred HHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 9999 899998876543 333444555666778899999999999999999999999999999998765443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=189.24 Aligned_cols=143 Identities=26% Similarity=0.381 Sum_probs=101.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++...... .....+||+.|+|||++.+... ....++.++|||||||++
T Consensus 153 vH~Dlkp~Nill~~~-~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwslG~il 228 (322)
T 3soc_A 153 SHRDIKSKNVLLKNN-LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAIN---FQRDAFLRIDMYAMGLVL 228 (322)
T ss_dssp ECSCCSGGGEEECTT-CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCC---CCHHHHHHHHHHHHHHHH
T ss_pred EeCCCChHhEEECCC-CeEEEccCCcccccccccCccccccCccCccccCHhhcccccc---cCcCCCccchhHHHHHHH
Confidence 699999999999976 689999999997433221 1233579999999999853110 012345688999999999
Q ss_pred HHHHcCCCCCCCCCc---------------HHHHHHHHH-ccCCCCCCCC-----CcHHHHHHHHHhcccCCCCCCCHHH
Q 029154 78 WELLTNRLPFEGMSN---------------LQAAYAAAF-KHARPGLPED-----ISPDLAFIVQSCWVEDPNLRPSFSQ 136 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~---------------~~~~~~~~~-~~~~~~~p~~-----~~~~~~~l~~~~l~~dp~~Rps~~~ 136 (198)
|||++|..||.+... ......... ....+..+.. .+.++.+++.+||..||.+|||+.+
T Consensus 229 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 308 (322)
T 3soc_A 229 WELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308 (322)
T ss_dssp HHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHH
Confidence 999999999865321 111111111 1122222221 2456999999999999999999999
Q ss_pred HHHHHHHHHhh
Q 029154 137 IIRMLNAFLFT 147 (198)
Q Consensus 137 ~l~~l~~~~~~ 147 (198)
+++.|+.+...
T Consensus 309 ll~~L~~l~~~ 319 (322)
T 3soc_A 309 VGERITQMQRL 319 (322)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999987553
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=180.79 Aligned_cols=140 Identities=26% Similarity=0.403 Sum_probs=109.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc---cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||++..... ........|+..|+|||++.+ ....++.++||||+|+++
T Consensus 131 ~H~dlkp~NIl~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Di~slG~il 203 (305)
T 2wtk_C 131 VHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG------LDTFSGFKVDIWSAGVTL 203 (305)
T ss_dssp ECSCCSGGGEEECTT-CCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTC------CSCEESHHHHHHHHHHHH
T ss_pred eecCCCcccEEEcCC-CcEEeeccccccccCccccccccccCCCCCCCcChhhccC------cccCCcchhhHHHHHHHH
Confidence 699999999999976 6799999999975431 222345678999999998753 112346799999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCC
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
|++++|..||.+....... ..........+..+++.+.+++.+||..||.+||++.++++ +.|+....++
T Consensus 204 ~~l~~g~~p~~~~~~~~~~--~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~~~~~~~~~~ 273 (305)
T 2wtk_C 204 YNITTGLYPFEGDNIYKLF--ENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ--HSWFRKKHPP 273 (305)
T ss_dssp HHHHHSSCSCCCSSHHHHH--HHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH--SHHHHSCCCC
T ss_pred HHHHhCCCCCCCchHHHHH--HHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc--CcccccCCCC
Confidence 9999999999876543322 22233455677789999999999999999999999999999 7777655443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=186.92 Aligned_cols=135 Identities=25% Similarity=0.392 Sum_probs=103.6
Q ss_pred CCCCCCCCCeEEcCCC--CceEEecccCcccCccccc-ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQ--KSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~--~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.++ ..+||+|||+++....... ....+||+.|+|||++.+ ..++.++||||+||++
T Consensus 152 vHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il 223 (351)
T 3c0i_A 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR--------EPYGKPVDVWGCGVIL 223 (351)
T ss_dssp ECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHH
T ss_pred eeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcC--------CCCCchHhhHHHHHHH
Confidence 6999999999997542 3499999999976543322 345689999999999853 5678999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCCCC---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHARPG---LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|+|++|..||.+... ............. ....+++++.+|+.+||..||.+||++.++++ +.|+..
T Consensus 224 ~~ll~g~~pf~~~~~--~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~--hp~~~~ 292 (351)
T 3c0i_A 224 FILLSGCLPFYGTKE--RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN--HPWLKE 292 (351)
T ss_dssp HHHHHSSCSSCSSHH--HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHT
T ss_pred HHHHHCCCCCCCcHH--HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--ChhhcC
Confidence 999999999987432 2222222221111 12468899999999999999999999999998 666654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-28 Score=181.41 Aligned_cols=135 Identities=27% Similarity=0.531 Sum_probs=108.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+|||++.+ +.+||+|||++........ .....++..|+|||++.+ ..++.++|+||+|+++|
T Consensus 126 ~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 196 (268)
T 3sxs_A 126 IHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY--------FKYSSKSDVWAFGILMW 196 (268)
T ss_dssp EESSCSGGGEEECTT-CCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHH--------SEEETTHHHHHHHHHHH
T ss_pred ecCCcCcceEEECCC-CCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhc--------cCCchhhhhHHHHHHHH
Confidence 699999999999976 6799999999975433221 223456778999999853 45788999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
++++ |..||........ ............+...++.+.+++.+||..||.+|||+.+++++|+.+.
T Consensus 197 ~l~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 197 EVFSLGKMPYDLYTNSEV-VLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp HHHTTTCCTTTTSCHHHH-HHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred HHHcCCCCCccccChHHH-HHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 9998 9999987665433 3334445555667778999999999999999999999999999997763
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-28 Score=186.92 Aligned_cols=140 Identities=27% Similarity=0.432 Sum_probs=107.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.+ +.+||+|||+++...... ......||..|+|||++.+ ..++.++||||+|++
T Consensus 149 vH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~i 219 (327)
T 3lxl_A 149 VHRDLAARNILVESE-AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD--------NIFSRQSDVWSFGVV 219 (327)
T ss_dssp ECSCCSGGGEEEEET-TEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH--------CEEEHHHHHHHHHHH
T ss_pred cCCCCChhhEEECCC-CCEEEcccccceecccCCccceeeccCCccccccCHHHhcc--------CCCChHHhHHHHHHH
Confidence 699999999999866 689999999997543221 2233467889999999854 457889999999999
Q ss_pred HHHHHcCCCCCCCCCc--------------HHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 77 LWELLTNRLPFEGMSN--------------LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~--------------~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
+|++++|..||..... ................+..+++++.+++.+||..||.+||++.+++++|+
T Consensus 220 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 299 (327)
T 3lxl_A 220 LYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299 (327)
T ss_dssp HHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999999999854221 11222333344556677889999999999999999999999999999999
Q ss_pred HHHhhcC
Q 029154 143 AFLFTLR 149 (198)
Q Consensus 143 ~~~~~~~ 149 (198)
.+.....
T Consensus 300 ~~~~~~~ 306 (327)
T 3lxl_A 300 MLWSGSR 306 (327)
T ss_dssp HC-----
T ss_pred HHHhhhc
Confidence 8765443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=194.17 Aligned_cols=135 Identities=25% Similarity=0.376 Sum_probs=106.6
Q ss_pred CCCCCCCCCeEEcCC--CCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~--~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.. .+.+||+|||+++...........+||+.|+|||++. ..++.++||||+||++|
T Consensus 158 vH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~DiwslG~il~ 228 (494)
T 3lij_A 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR---------KKYDEKCDVWSIGVILF 228 (494)
T ss_dssp ECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT---------TCBCTHHHHHHHHHHHH
T ss_pred eeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc---------ccCCCchhHHHHHHHHH
Confidence 699999999999753 2459999999998665545556678999999999874 35789999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCC--CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+|++|..||.+................... ...+++++.+|+.+||..||.+|||+.++++ +.|+.
T Consensus 229 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~--hp~~~ 296 (494)
T 3lij_A 229 ILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE--HPWIK 296 (494)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--CHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc--Ccccc
Confidence 999999999887654433333222222222 2458999999999999999999999999998 55554
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=183.27 Aligned_cols=140 Identities=26% Similarity=0.474 Sum_probs=99.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|||++.+ +.+||+|||++.............|++.|+|||++..... ....++.++||||+|+++|+|
T Consensus 147 ~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Di~slG~il~~l 222 (318)
T 2dyl_A 147 IHRDVKPSNILLDER-GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDP---TKPDYDIRADVWSLGISLVEL 222 (318)
T ss_dssp CCCCCCGGGEEECTT-SCEEECCCTTC--------------CCTTCCHHHHC-----------CCTHHHHHHHHHHHHHH
T ss_pred EeCCCCHHHEEECCC-CCEEEEECCCchhccCCccccccCCCccccChhhcccccc---cccCCccccchhhHHHHHHHH
Confidence 699999999999976 6799999999975544333445678999999999742100 124578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCC--CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++|..||..................+..+ ..+++++.+++.+||..||.+||++.++++ +.++.
T Consensus 223 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~ 288 (318)
T 2dyl_A 223 ATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE--HSFIK 288 (318)
T ss_dssp HHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT--SHHHH
T ss_pred HhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh--CHHHH
Confidence 99999998755544444444444444444 357999999999999999999999999998 55554
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=8.9e-28 Score=185.70 Aligned_cols=139 Identities=24% Similarity=0.494 Sum_probs=100.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc-----ccCCCCccceecccccccccccccccCCCCc------hhh
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNN------KVD 69 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~------~~D 69 (198)
|||||||+|||++.+ +.+||+|||+++....... ....+||+.|+|||++.+ ..+.. ++|
T Consensus 164 vH~Dikp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~~~~~~D 234 (337)
T 3mdy_A 164 AHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--------SLNRNHFQSYIMAD 234 (337)
T ss_dssp ECSCCCGGGEEECTT-SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT--------CCCTTCTHHHHHHH
T ss_pred EecccchHHEEECCC-CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc--------ccCCccccCccccc
Confidence 699999999999976 6899999999974432211 124579999999999854 22223 499
Q ss_pred HHHHHHHHHHHHcC----------CCCCCCCCc----HHHHHHH-HHccCCCCCCC-----CCcHHHHHHHHHhcccCCC
Q 029154 70 VYSFGIVLWELLTN----------RLPFEGMSN----LQAAYAA-AFKHARPGLPE-----DISPDLAFIVQSCWVEDPN 129 (198)
Q Consensus 70 vws~G~~l~e~~~g----------~~p~~~~~~----~~~~~~~-~~~~~~~~~p~-----~~~~~~~~l~~~~l~~dp~ 129 (198)
||||||++|||++| ..||..... ....... ......+..+. .+++++.+++.+||..||.
T Consensus 235 iwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 314 (337)
T 3mdy_A 235 MYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPA 314 (337)
T ss_dssp HHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGG
T ss_pred hHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChh
Confidence 99999999999999 777754321 1111111 11222333332 3567799999999999999
Q ss_pred CCCCHHHHHHHHHHHHhhc
Q 029154 130 LRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 130 ~Rps~~~~l~~l~~~~~~~ 148 (198)
+||++.+++++|+.+....
T Consensus 315 ~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 315 SRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp GSCCHHHHHHHHHHHHHTT
T ss_pred hCCCHHHHHHHHHHHHhhc
Confidence 9999999999999887644
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=197.69 Aligned_cols=135 Identities=29% Similarity=0.542 Sum_probs=109.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++....... .....++..|+|||++.. ..++.++||||||+++|
T Consensus 340 vHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwSlG~~l~ 410 (495)
T 1opk_A 340 IHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLW 410 (495)
T ss_dssp ECSCCSGGGEEECGG-GCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHH
T ss_pred ccCCCChhhEEECCC-CcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhc--------CCCCcHHhHHhHHHHHH
Confidence 699999999999866 6799999999986533221 223456789999999853 56789999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
||++ |..||.+..... .........+...|..+++++.+|+.+||..||.+||++.++++.|+.++
T Consensus 411 el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 411 EIATYGMSPYPGIDLSQ-VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHHTTSCCSSTTCCGGG-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 9998 999998766433 23344455566778889999999999999999999999999999988653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=189.81 Aligned_cols=139 Identities=28% Similarity=0.379 Sum_probs=97.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++..... ....+||..|+|||++.+ ...++.++||||+||++|+|
T Consensus 154 vH~Dlkp~NIll~~~-~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el 223 (367)
T 2fst_X 154 IHRDLKPSNLAVNED-CELKILDFGLARHTADE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAEL 223 (367)
T ss_dssp CCCCCCGGGEEECTT-CCEEECC-----------------CCCTTCCHHHHTT-------CCSCCTTHHHHHHHHHHHHH
T ss_pred eeCCCCHhhEEECCC-CCEEEeecccccccccc--CCCcCcCcCccChHHHcC-------CcCCCchhhHHHHHHHHHHH
Confidence 799999999999976 68999999999754322 345678999999998753 35678999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCC---------------------CC--------CCCCCcHHHHHHHHHhcccCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHAR---------------------PG--------LPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~---------------------~~--------~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
++|+.||.+................ +. .....++++.+|+.+||..||.+|
T Consensus 224 l~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R 303 (367)
T 2fst_X 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 303 (367)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccC
Confidence 9999999887654433222110000 00 013467899999999999999999
Q ss_pred CCHHHHHHHHHHHHhhcCCC
Q 029154 132 PSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~~~~ 151 (198)
||+.++++ +.|+.....+
T Consensus 304 ~t~~e~L~--hp~~~~~~~~ 321 (367)
T 2fst_X 304 ITAAQALA--HAYFAQYHDP 321 (367)
T ss_dssp CCHHHHHT--SGGGTTTCCG
T ss_pred cCHHHHhc--ChhhhhccCC
Confidence 99999999 7787655433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=197.81 Aligned_cols=134 Identities=25% Similarity=0.421 Sum_probs=105.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc-ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++....... ....+||+.|+|||++.+ ..++.++|+||+||++||
T Consensus 311 vHrDLKP~NILl~~~-g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~~DiwSlGvilye 381 (543)
T 3c4z_A 311 IYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG--------EEYDFSVDYFALGVTLYE 381 (543)
T ss_dssp ECCCCCGGGEEECTT-SCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTT--------CCBCTHHHHHHHHHHHHH
T ss_pred cccCCChHHEEEeCC-CCEEEeecceeeeccCCCcccccccCCccccChhhhcC--------CCCChHHhcCcchHHHHH
Confidence 699999999999977 6899999999986543322 334589999999999853 568899999999999999
Q ss_pred HHcCCCCCCCCCc---HHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH-----HHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-----SQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~-----~~~l~~l~~~~~ 146 (198)
|++|..||.+... ..... ..........|..+++++.+++.+||..||.+||++ .++++ |.|+.
T Consensus 382 lltG~~PF~~~~~~~~~~~~~-~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~--Hpff~ 453 (543)
T 3c4z_A 382 MIAARGPFRARGEKVENKELK-QRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT--HPLFR 453 (543)
T ss_dssp HHHSSCSSCCTTCCCCHHHHH-HHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT--SGGGT
T ss_pred HHhCCCCCCCCccchhHHHHH-HHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc--Ccccc
Confidence 9999999976532 22222 222334556778899999999999999999999965 67776 55554
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=193.58 Aligned_cols=134 Identities=11% Similarity=0.146 Sum_probs=97.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceeccccccccc---ccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT---LRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++.... .....+| +.|+|||++.+.. ........++.++|||||||++
T Consensus 228 vHrDikp~NIll~~~-~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 228 VHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp ECSCCCGGGEEECTT-CCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCC-CCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 699999999999977 6899999999985433 2345678 9999999986410 0000002688999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|||++|..||.+....... ......+..+++++.+++.+||..||.+||++.++++ +.|+.
T Consensus 304 ~elltg~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~f~ 364 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGS------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME--TPEYE 364 (377)
T ss_dssp HHHHHSSCCC------CCS------GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT--SHHHH
T ss_pred HHHHHCCCCCcccccccch------hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh--ChHHH
Confidence 9999999999754421110 0111223568999999999999999999999999998 55544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=181.58 Aligned_cols=133 Identities=28% Similarity=0.541 Sum_probs=105.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|||++.+.+.+||+|||++...... ......||+.|+|||++. ..++.++|+||+|+++|+|
T Consensus 153 ~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~~l~~l 222 (290)
T 1t4h_A 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEM 222 (290)
T ss_dssp CCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHH
T ss_pred EECCCCHHHEEEECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHh---------ccCCCcchHHHHHHHHHHH
Confidence 799999999999844478999999999654332 223457899999999874 3578999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCC-CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHAR-PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
++|..||.+................ ...+...++++.+++.+||..||.+||++.++++ +.|+
T Consensus 223 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--h~~f 286 (290)
T 1t4h_A 223 ATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--HAFF 286 (290)
T ss_dssp HHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGG
T ss_pred HhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh--Cccc
Confidence 9999999886665555444433322 2345567899999999999999999999999998 5554
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-28 Score=196.44 Aligned_cols=139 Identities=24% Similarity=0.426 Sum_probs=109.1
Q ss_pred CCCCCCCCCeEEcC--CCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTP--DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~--~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++. ..+.+||+|||+++...........+||+.|+|||++. +.++.++||||+||++|
T Consensus 148 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~ 218 (484)
T 3nyv_A 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH---------GTYDEKCDVWSTGVILY 218 (484)
T ss_dssp CCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHH---------TCCCTHHHHHHHHHHHH
T ss_pred eeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeec---------CCCCCcceeHHHHHHHH
Confidence 79999999999952 23679999999997554443344567999999999974 35789999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCCC--CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
+|++|..||.+...................+ ..+++++.+|+.+||..||.+|||+.++++ |.|+.....
T Consensus 219 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~--h~~~~~~~~ 290 (484)
T 3nyv_A 219 ILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD--HEWIQTYTK 290 (484)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SHHHHHHTC
T ss_pred HHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh--Chhhccccc
Confidence 9999999999876544433333322222222 458899999999999999999999999999 778776543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-28 Score=183.73 Aligned_cols=136 Identities=24% Similarity=0.413 Sum_probs=107.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+||||||+|||++.+ +.+||+|||++....... ......||..|+|||++.+ ..++.++|+||+|++
T Consensus 148 ~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~i 218 (302)
T 4e5w_A 148 VHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ--------SKFYIASDVWSFGVT 218 (302)
T ss_dssp ECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH--------CEEEHHHHHHHHHHH
T ss_pred ccCCCchheEEEcCC-CCEEECcccccccccCCCcceeccCCCCCCccccCCeeecC--------CCCCcchhHHHHHHH
Confidence 699999999999876 689999999997543322 2234568889999998854 456789999999999
Q ss_pred HHHHHcCCCCCCC--------------CCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 77 LWELLTNRLPFEG--------------MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 77 l~e~~~g~~p~~~--------------~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
+|++++|..|+.. ...................+..+++++.+++.+||..||.+|||+.++++.|+
T Consensus 219 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 298 (302)
T 4e5w_A 219 LHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298 (302)
T ss_dssp HHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 9999999887532 11222223334445566677889999999999999999999999999999998
Q ss_pred HHH
Q 029154 143 AFL 145 (198)
Q Consensus 143 ~~~ 145 (198)
.++
T Consensus 299 ~ll 301 (302)
T 4e5w_A 299 ALL 301 (302)
T ss_dssp HHH
T ss_pred HHh
Confidence 875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-28 Score=187.58 Aligned_cols=139 Identities=27% Similarity=0.550 Sum_probs=84.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|||++.+ +.+||+|||+++............||..|+|||++.... ....++.++||||||+++|+|
T Consensus 148 vH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~~Di~slG~il~~l 222 (327)
T 3aln_A 148 IHRDIKPSNILLDRS-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA----SRQGYDVRSDVWSLGITLYEL 222 (327)
T ss_dssp CCSCCCGGGEEEETT-TEEEECCCSSSCC----------------------------------CCSHHHHHHHHHHHHHH
T ss_pred eECCCCHHHEEEcCC-CCEEEccCCCceecccccccccCCCCccccCceeecccc----CcCCCCchhhHHHHHHHHHHH
Confidence 799999999999976 789999999997654443334457899999999973210 124578999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCC----CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++|..||.+................+.++ ..+++++.+++.+||..||.+||++.++++ +.|+.
T Consensus 223 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--hp~~~ 290 (327)
T 3aln_A 223 ATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK--HPFIL 290 (327)
T ss_dssp HHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT--SHHHH
T ss_pred HHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh--ChHHH
Confidence 99999998654322221111122222222 358899999999999999999999999998 55554
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=178.15 Aligned_cols=136 Identities=29% Similarity=0.555 Sum_probs=109.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+||+++.+ +.+||+|||++....... ......++..|+|||++.+ ..++.++|+||+|+++|
T Consensus 126 ~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 196 (267)
T 3t9t_A 126 IHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMW 196 (267)
T ss_dssp CCSSCCGGGEEECGG-GCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHH
T ss_pred ccCCCchheEEECCC-CCEEEcccccccccccccccccccccccccccChhhhcC--------CCccchhchhhhHHHHH
Confidence 699999999999866 679999999997543321 1233457789999999853 56789999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++++ |..||.+..... .............+..+++.+.+++.+||..||.+||++.+++++|+.+..
T Consensus 197 ~l~~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 197 EVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHTTSCCTTTTCCHHH-HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccCCCCCCCCCHHH-HHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999 899998765433 333344444556677789999999999999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=187.17 Aligned_cols=143 Identities=23% Similarity=0.429 Sum_probs=109.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.+ +.+||+|||++....... ......++..|+|||++.+ ..++.++||||+|++
T Consensus 156 vH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~i 226 (318)
T 3lxp_A 156 IHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE--------YKFYYASDVWSFGVT 226 (318)
T ss_dssp ECSCCSGGGEEECTT-CCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH--------CEEEHHHHHHHHHHH
T ss_pred cCCCCchheEEEcCC-CCEEECCccccccccccccccccccCCCCCceeeChHHhcC--------CCCCcHHHHHHHHHH
Confidence 699999999999976 679999999997543321 1233467889999999853 456789999999999
Q ss_pred HHHHHcCCCCCCCCCcH--------------HHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 77 LWELLTNRLPFEGMSNL--------------QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~--------------~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
+|++++|..||...... ...............+..+++++.+++.+||..||.+||++.++++.|+
T Consensus 227 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 306 (318)
T 3lxp_A 227 LYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306 (318)
T ss_dssp HHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 99999999998642211 0111222334455667889999999999999999999999999999999
Q ss_pred HHHhhcCCCC
Q 029154 143 AFLFTLRPPS 152 (198)
Q Consensus 143 ~~~~~~~~~~ 152 (198)
.+......+.
T Consensus 307 ~l~~~~~~~~ 316 (318)
T 3lxp_A 307 TVHEKYQGQA 316 (318)
T ss_dssp HHHHHHHC--
T ss_pred HHHHhhccCC
Confidence 9887665543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=193.46 Aligned_cols=142 Identities=20% Similarity=0.316 Sum_probs=103.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +++||+|||+++....... ....+||+.|+|||++...... .....++.++|+||+||++|
T Consensus 184 iHrDLKp~NILld~~-g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~-~~~~~~~~~~DiwSlGvily 261 (412)
T 2vd5_A 184 VHRDIKPDNILLDRC-GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG-PGTGSYGPECDWWALGVFAY 261 (412)
T ss_dssp ECCCCSGGGEEECTT-SCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTC-TTCSEECTHHHHHHHHHHHH
T ss_pred eecccCHHHeeecCC-CCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccC-cCCCCCChHHhhhHHhHHHH
Confidence 699999999999976 7899999999975433222 2346899999999998520000 00245789999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHc---cCCCCCCCCCcHHHHHHHHHhcccCCCCC---CCHHHHHHHHHHHHhh
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFK---HARPGLPEDISPDLAFIVQSCWVEDPNLR---PSFSQIIRMLNAFLFT 147 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~p~~~~~~~~~l~~~~l~~dp~~R---ps~~~~l~~l~~~~~~ 147 (198)
||++|..||.+............. ...+..+..+++++.+|+.+||. +|.+| ++++++++ |.|+..
T Consensus 262 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~--Hpff~~ 333 (412)
T 2vd5_A 262 EMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT--HPFFFG 333 (412)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT--SGGGTT
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc--CCCcCC
Confidence 999999999886654433222211 11222346799999999999999 99998 58999988 777653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=183.68 Aligned_cols=135 Identities=29% Similarity=0.550 Sum_probs=108.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||+++...... ......+|+.|+|||++.+ ..++.++||||+|+++
T Consensus 160 ~H~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 230 (322)
T 1p4o_A 160 VHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVL 230 (322)
T ss_dssp BCSCCSGGGEEECTT-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred ccCCCccceEEEcCC-CeEEECcCccccccccccccccccCCCCCCCccChhhhcc--------CCCCchhhHHHHHHHH
Confidence 699999999999976 689999999997543322 1223456889999999753 5678999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
|++++ |..||.+..... .............+..+++.+.+++.+||..||.+||++.+++++|+..+
T Consensus 231 ~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 231 WEIATLAEQPYQGLSNEQ-VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHHHTSCCTTTTSCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHhcCCCccccCCHHH-HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 99999 889998766433 33334444555667789999999999999999999999999999987653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-28 Score=185.83 Aligned_cols=143 Identities=22% Similarity=0.369 Sum_probs=103.1
Q ss_pred CCCCCCCCCeEE----cCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLL----TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll----~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||+ +.+ +.+||+|||+++............||..|+|||++............++.++||||+||+
T Consensus 134 vH~Dlkp~NIll~~~~~~~-~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~i 212 (319)
T 4euu_A 134 VHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212 (319)
T ss_dssp ECSCCSGGGEEEEECTTSC-EEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHH
T ss_pred ecCCCCHHHEEEeccCCCC-ceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHH
Confidence 699999999998 544 569999999998665544455678999999999875311111113567899999999999
Q ss_pred HHHHHcCCCCCCCCCc---HHHHHHHHHccCCC------------------------CCCCCCcHHHHHHHHHhcccCCC
Q 029154 77 LWELLTNRLPFEGMSN---LQAAYAAAFKHARP------------------------GLPEDISPDLAFIVQSCWVEDPN 129 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~---~~~~~~~~~~~~~~------------------------~~p~~~~~~~~~l~~~~l~~dp~ 129 (198)
+|||++|..||..... ............+. .++..++..+.+++.+||..||.
T Consensus 213 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 292 (319)
T 4euu_A 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292 (319)
T ss_dssp HHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTT
T ss_pred HHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChh
Confidence 9999999999964332 11222222222211 11122456788999999999999
Q ss_pred CCCCHHHHHHHHHHH
Q 029154 130 LRPSFSQIIRMLNAF 144 (198)
Q Consensus 130 ~Rps~~~~l~~l~~~ 144 (198)
+||+++|++++..+-
T Consensus 293 ~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 293 KCWGFDQFFAETSDI 307 (319)
T ss_dssp TSCCHHHHHHHHHHH
T ss_pred hhccHHHhhhccHHH
Confidence 999999999987654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-27 Score=183.77 Aligned_cols=141 Identities=28% Similarity=0.356 Sum_probs=105.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-----------cccCCCCccceecccccccccccccccCCCCchhh
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-----------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 69 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~D 69 (198)
|||||||+|||++.+ +.+||+|||+++...... .....+||+.|+|||++.. ...++.++|
T Consensus 134 vH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~D 205 (353)
T 2b9h_A 134 IHRDLKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT-------SAKYSRAMD 205 (353)
T ss_dssp ECSCCCGGGEEECTT-CCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHS-------CCCCCHHHH
T ss_pred ecCCCCHHHeEEcCC-CcEEEEecccccccccccccccCccccccchhhccccccccCCeeecc-------CCCccchhh
Confidence 699999999999976 679999999997543211 1223478999999998743 356789999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCC------------------------------CCCCCCcHHHHHH
Q 029154 70 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP------------------------------GLPEDISPDLAFI 119 (198)
Q Consensus 70 vws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------~~p~~~~~~~~~l 119 (198)
+||+||++|+|++|..||.+................+ ..+..+++++.++
T Consensus 206 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (353)
T 2b9h_A 206 VWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDL 285 (353)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHH
Confidence 9999999999999999998766433322111100000 0123578899999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHhhcCCC
Q 029154 120 VQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 120 ~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
+.+||..||.+|||+.++++ +.|+.....+
T Consensus 286 i~~~L~~dP~~Rpt~~ell~--hp~~~~~~~~ 315 (353)
T 2b9h_A 286 LQRMLVFDPAKRITAKEALE--HPYLQTYHDP 315 (353)
T ss_dssp HHHHSCSSGGGSCCHHHHHT--SGGGTTTCCT
T ss_pred HHHhcCcCcccCCCHHHHhc--CccccccCCc
Confidence 99999999999999999999 7887765544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-28 Score=190.34 Aligned_cols=139 Identities=20% Similarity=0.288 Sum_probs=95.8
Q ss_pred CCCCCCCCCeEE----cCCCCceEEecccCcccCccc----ccccCCCCccceecccccccccccccccCCCCchhhHHH
Q 029154 1 MGKFMKEDNLLL----TPDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 72 (198)
Q Consensus 1 iH~dlKp~NIll----~~~~~~~kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws 72 (198)
|||||||+|||+ +.+ +.+||+|||+++..... ......+||+.|+|||++.+ ...++.++||||
T Consensus 150 vH~Dlkp~NIll~~~~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwS 221 (405)
T 3rgf_A 150 LHRDLKPANILVMGEGPER-GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWA 221 (405)
T ss_dssp CCCCCCGGGEEECCSSTTT-TCEEECCTTCCC----------------CCCTTCCHHHHTT-------CCSCCHHHHHHH
T ss_pred eCCCcCHHHeEEecCCCCC-CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcC-------CCcccchhhhHH
Confidence 799999999999 433 67999999999754322 22344678999999999853 245889999999
Q ss_pred HHHHHHHHHcCCCCCCCCCcH---------HHHHHH--HHccCCCC----------------------------------
Q 029154 73 FGIVLWELLTNRLPFEGMSNL---------QAAYAA--AFKHARPG---------------------------------- 107 (198)
Q Consensus 73 ~G~~l~e~~~g~~p~~~~~~~---------~~~~~~--~~~~~~~~---------------------------------- 107 (198)
+||++|+|++|..||.+.... ...... ........
T Consensus 222 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (405)
T 3rgf_A 222 IGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEK 301 (405)
T ss_dssp HHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhh
Confidence 999999999999999765431 111111 11100000
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 108 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 108 ~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
.....++++.+|+.+||..||.+|||+.|+++ |.|+....
T Consensus 302 ~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~--hp~f~~~~ 341 (405)
T 3rgf_A 302 HKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ--DPYFLEDP 341 (405)
T ss_dssp TTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTSSS
T ss_pred cCCCCCHHHHHHHHHHccCCcccCCCHHHHhc--ChhhccCC
Confidence 00112678899999999999999999999999 88876544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=187.39 Aligned_cols=138 Identities=26% Similarity=0.342 Sum_probs=105.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc----ccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.+ +.+||+|||+++....... ....+||+.|+|||++.. ...++.++||||+||+
T Consensus 150 vH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~i 221 (364)
T 3qyz_A 150 LHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCI 221 (364)
T ss_dssp ECCCCCGGGEEECTT-CCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHT-------BCSCSTHHHHHHHHHH
T ss_pred ecCCCChHhEEECCC-CCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcC-------CCCCCcchhHHHHHHH
Confidence 699999999999976 6799999999975443221 234589999999998643 3457899999999999
Q ss_pred HHHHHcCCCCCCCCCcHHHHHHHHHc----------------------cCC--CC-----CCCCCcHHHHHHHHHhcccC
Q 029154 77 LWELLTNRLPFEGMSNLQAAYAAAFK----------------------HAR--PG-----LPEDISPDLAFIVQSCWVED 127 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~~~~~~~~~~----------------------~~~--~~-----~p~~~~~~~~~l~~~~l~~d 127 (198)
+|+|++|..||.+............. ... .. ....+++++.+|+.+||..|
T Consensus 222 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 301 (364)
T 3qyz_A 222 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN 301 (364)
T ss_dssp HHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSS
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCC
Confidence 99999999999876543332211100 000 00 12457889999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHhhc
Q 029154 128 PNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 128 p~~Rps~~~~l~~l~~~~~~~ 148 (198)
|.+|||+.++++ +.|+...
T Consensus 302 P~~R~t~~e~l~--hp~~~~~ 320 (364)
T 3qyz_A 302 PHKRIEVEQALA--HPYLEQY 320 (364)
T ss_dssp TTTSCCHHHHHT--SGGGTTT
T ss_pred hhhCCCHHHHhc--Ccchhhc
Confidence 999999999999 7777654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=190.43 Aligned_cols=141 Identities=28% Similarity=0.336 Sum_probs=99.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-----------------------cccCCCCccceeccccccccccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-----------------------MMTAETGTYRWMAPELYSTVTLR 57 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~ 57 (198)
|||||||+|||++.+ +.+||+|||+++...... .....+||+.|+|||++..
T Consensus 151 vHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---- 225 (432)
T 3n9x_A 151 IHRDLKPANCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL---- 225 (432)
T ss_dssp ECCCCCGGGEEECTT-CCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTT----
T ss_pred CCCCCCHHHeEECCC-CCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc----
Confidence 699999999999977 689999999998543221 2355789999999998643
Q ss_pred ccccCCCCchhhHHHHHHHHHHHHcC-----------CCCCCCCCc-----------------HHHHHH-----------
Q 029154 58 QGEKKHYNNKVDVYSFGIVLWELLTN-----------RLPFEGMSN-----------------LQAAYA----------- 98 (198)
Q Consensus 58 ~~~~~~~~~~~Dvws~G~~l~e~~~g-----------~~p~~~~~~-----------------~~~~~~----------- 98 (198)
...++.++||||+||++|||++| .++|.+... ......
T Consensus 226 ---~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~ 302 (432)
T 3n9x_A 226 ---QENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTED 302 (432)
T ss_dssp ---CSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHH
T ss_pred ---CCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHH
Confidence 35689999999999999999974 444444321 000000
Q ss_pred -----------HHHccCCCCC-------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCC
Q 029154 99 -----------AAFKHARPGL-------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 99 -----------~~~~~~~~~~-------p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
.......... ...+++++.+|+.+||..||.+|||++|+++ |.|+.....+
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~~~~~~ 371 (432)
T 3n9x_A 303 DLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD--HPYLKDVRKK 371 (432)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--CGGGTTTCCT
T ss_pred HHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc--ChhhhhccCc
Confidence 0001111111 1357899999999999999999999999999 8888765543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.94 E-value=9.5e-28 Score=191.23 Aligned_cols=138 Identities=25% Similarity=0.383 Sum_probs=96.5
Q ss_pred CCCCCCCCCeEEcCCC--CceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~--~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.++ ..+||+|||+++...........+||+.|+|||++.+. ....++.++|+||+||++|
T Consensus 261 vHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~DiwslG~il~ 335 (419)
T 3i6u_A 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV-----GTAGYNRAVDCWSLGVILF 335 (419)
T ss_dssp CCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC---------CTTHHHHHHHHHHHHHH
T ss_pred cccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecC-----CCCCCCchhhhHhHHHHHH
Confidence 7999999999997432 35999999999876655545567899999999997421 1256788999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCC---CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARP---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
+|++|..||.+................. ..+..+++.+.+++.+||..||.+||++.++++ +.|+
T Consensus 336 ~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~~ 403 (419)
T 3i6u_A 336 ICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR--HPWL 403 (419)
T ss_dssp HHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGG
T ss_pred HHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC--Cccc
Confidence 9999999997654322222222222211 122458899999999999999999999999998 5554
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=178.94 Aligned_cols=134 Identities=29% Similarity=0.573 Sum_probs=103.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+ +.+||+|||++...... .....++..|+|||++.+ ..++.++|+||+|+++|++
T Consensus 139 ~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l 207 (278)
T 1byg_A 139 VHRDLAARNVLVSED-NVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEI 207 (278)
T ss_dssp CCSCCSGGGEEECTT-SCEEECCCCC--------------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHH
T ss_pred cccCCCcceEEEeCC-CcEEEeecccccccccc--ccCCCccccccCHHHhCC--------CCCCchhcHHHHHHHHHHH
Confidence 699999999999976 67999999998754332 123457889999999853 5678999999999999999
Q ss_pred Hc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 81 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++ |..||....... .............+..+++.+.+++.+||..||.+||++.++++.|+.+..
T Consensus 208 ~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 208 YSFGRVPYPRIPLKD-VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp HTTSCCSCTTSCGGG-HHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCCHHH-HHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 98 999998765432 223333444566778899999999999999999999999999999988754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=180.57 Aligned_cols=133 Identities=24% Similarity=0.436 Sum_probs=105.5
Q ss_pred CCCCCCCCCeEE---cCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll---~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||+ +.+ +.+||+|||++.............||+.|+|||++. +.++.++|+||+|+++
T Consensus 128 ~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~~l 197 (277)
T 3f3z_A 128 AHRDLKPENFLFLTDSPD-SPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE---------GLYGPECDEWSAGVMM 197 (277)
T ss_dssp ECCCCSGGGEEESSSSTT-CCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT---------TCBCTTHHHHHHHHHH
T ss_pred cCCCCCHHHEEEecCCCC-CcEEEEecccceeccCccchhccCCCCCccChHHhc---------ccCCchhhehhHHHHH
Confidence 699999999999 544 679999999997655444455668999999999874 3478999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCCCCCC----CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|++++|..||.+........... ......+ ..+++++.+++.+||..||.+||++.++++ +.|+..
T Consensus 198 ~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~--h~~~~~ 267 (277)
T 3f3z_A 198 YVLLCGYPPFSAPTDSEVMLKIR--EGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE--HEWFEK 267 (277)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT--SHHHHH
T ss_pred HHHHHCCCCCCCCCHHHHHHHHH--hCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc--CHHHhc
Confidence 99999999998766544332222 2222333 258899999999999999999999999998 666654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-27 Score=177.81 Aligned_cols=136 Identities=21% Similarity=0.336 Sum_probs=109.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+ +.+||+|||++...... ......|+..|+|||++.+ ..++.++|+||+|+++|++
T Consensus 136 ~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l 205 (284)
T 2vgo_A 136 IHRDIKPENLLMGYK-GELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEG--------KTHDEKVDLWCAGVLCYEF 205 (284)
T ss_dssp ECCCCSGGGEEECTT-CCEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTT--------CCBCTTHHHHHHHHHHHHH
T ss_pred eecCCCHHHEEEcCC-CCEEEecccccccCccc-ccccccCCCCcCCHHHhcc--------CCCCcccchhhHHHHHHHH
Confidence 699999999999976 67999999998654322 2234678999999999853 5678899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
++|..||.......... .........|..++.++.+++.+||..||.+||++.++++ +.|+.....
T Consensus 206 ~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--h~~~~~~~~ 271 (284)
T 2vgo_A 206 LVGMPPFDSPSHTETHR--RIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME--HPWVKANSR 271 (284)
T ss_dssp HHSSCTTCCSSHHHHHH--HHHTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--CHHHHHHCC
T ss_pred HHCCCCCCCCCHhHHHH--HHhccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh--CHHHHhhcc
Confidence 99999998766433322 2233455677889999999999999999999999999999 677765443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=180.30 Aligned_cols=137 Identities=28% Similarity=0.523 Sum_probs=110.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+||+++.+ +.+||+|||++....... ......+++.|+|||++.+ ..++.++|+||+|+++|
T Consensus 133 ~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 203 (288)
T 3kfa_A 133 IHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLW 203 (288)
T ss_dssp CCSCCSGGGEEECGG-GCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHH
T ss_pred cCCCCCcceEEEcCC-CCEEEccCccceeccCCccccccCCccccCcCChhhhcc--------CCCCchhhHHHHHHHHH
Confidence 799999999999866 679999999997544322 1223346778999999853 56889999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
++++ |..||.+..... .............+..+++++.+++.+||..||.+||++.++++.|+.++..
T Consensus 204 ~ll~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 204 EIATYGMSPYPGIDLSQ-VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHTTSCCSSTTCCGGG-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHH-HHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 9999 999998765433 2333444555667788999999999999999999999999999999887653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.8e-28 Score=189.30 Aligned_cols=140 Identities=21% Similarity=0.422 Sum_probs=100.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc--------ccccCCCCccceecccccccccccccccCCCCchhhHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 72 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws 72 (198)
|||||||+|||++.+ +.+||+|||++...... ......+||+.|+|||++.+ ....++.++||||
T Consensus 150 vHrDlkp~NIll~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~Diws 222 (389)
T 3gni_B 150 VHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ------NLQGYDAKSDIYS 222 (389)
T ss_dssp ECCCCSGGGEEECTT-CCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHST------TSSCBCTHHHHHH
T ss_pred ecCCCCHHHEEEcCC-CCEEEcccccceeeccccccccccccccccccccccccCHHHHhc------cCCCCCcHhHHHH
Confidence 699999999999976 68999999988633211 11223478999999999853 1256889999999
Q ss_pred HHHHHHHHHcCCCCCCCCCcHHHHHHHHHcc--------------------------------------------CCCCC
Q 029154 73 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKH--------------------------------------------ARPGL 108 (198)
Q Consensus 73 ~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~ 108 (198)
+||++|+|++|..||.+.............. ...+.
T Consensus 223 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (389)
T 3gni_B 223 VGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPY 302 (389)
T ss_dssp HHHHHHHHHHSSCTTTTCCSTTHHHHC-----------------------------------------------------
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcc
Confidence 9999999999999997654432221111000 00123
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 109 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 109 p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
+..+++++.+|+.+||..||.+|||+.++++ +.|+....
T Consensus 303 ~~~~s~~~~~li~~~L~~dP~~Rpta~ell~--hp~f~~~~ 341 (389)
T 3gni_B 303 HRTFSPHFHHFVEQCLQRNPDARPSASTLLN--HSFFKQIK 341 (389)
T ss_dssp ---CCHHHHHHHHHHTCSCTTTSCCHHHHTT--SGGGGGC-
T ss_pred ccccCHHHHHHHHHHhhcCcccCCCHHHHhc--CHHHHHHh
Confidence 4557889999999999999999999999998 77766544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=177.62 Aligned_cols=135 Identities=24% Similarity=0.412 Sum_probs=99.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.+ +.+||+|||++.............|++.|+|||++.+ ....+.++|+||+|+++|++
T Consensus 133 ~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l 204 (276)
T 2h6d_A 133 VHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-------RLYAGPEVDIWSCGVILYAL 204 (276)
T ss_dssp SCCCCCGGGEEECTT-SCEEECCCCGGGCCCC-------------CCTGGGTT-------SCCCHHHHHHHHHHHHHHHH
T ss_pred ccCCCChhhEEECCC-CCEEEeecccccccCCCcceecccCCccccCHHHHcC-------CCCCCccchHHHHHHHHHHH
Confidence 699999999999976 6799999999986554443445678999999999853 22336799999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
++|..||........ .. .........|..++..+.+++.+||..||.+||++.++++ +.|+..
T Consensus 205 ~~g~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~--h~~~~~ 267 (276)
T 2h6d_A 205 LCGTLPFDDEHVPTL-FK-KIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE--HEWFKQ 267 (276)
T ss_dssp HHSSCSSCCSSHHHH-HH-HHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHHT
T ss_pred HhCCCCCCCCcHHHH-HH-HhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh--Chhhcc
Confidence 999999987654332 22 2233445567788999999999999999999999999999 677654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=183.83 Aligned_cols=133 Identities=21% Similarity=0.307 Sum_probs=105.2
Q ss_pred CCCCCCCCCeEEcCCCC---ceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQK---SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~---~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.++. .+||+|||+++............||+.|+|||++.+ ..++.++|+||+|+++
T Consensus 137 vH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il 208 (321)
T 2a2a_A 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVIT 208 (321)
T ss_dssp ECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHH
T ss_pred ecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccC--------CCCCCccccHHHHHHH
Confidence 69999999999986632 699999999986554444455679999999999853 5678999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCCCCC----CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
|+|++|..||.+.......... ....... +..+++.+.+++.+||..||.+||++.++++ +.|+
T Consensus 209 ~~l~~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~--hp~~ 276 (321)
T 2a2a_A 209 YILLSGASPFLGDTKQETLANI--TSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR--HPWI 276 (321)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHH--HTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH--STTT
T ss_pred HHHHHCCCCCCCCCHHHHHHHH--HhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc--Cccc
Confidence 9999999999876643332222 2222222 2568899999999999999999999999998 5554
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=187.07 Aligned_cols=136 Identities=27% Similarity=0.433 Sum_probs=103.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc--ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++..... ......+||+.|+|||++.+ ....++.++|||||||++|
T Consensus 181 vH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~DvwslG~il~ 253 (355)
T 1vzo_A 181 IYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG------GDSGHDKAVDWWSLGVLMY 253 (355)
T ss_dssp CCCCCCGGGEEECTT-SCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTT------CC---CTHHHHHHHHHHHH
T ss_pred ccCCCCHHHEEECCC-CcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcC------CCCCCCchhhHHHHHHHHH
Confidence 799999999999976 68999999999754322 22234579999999999853 1245788999999999999
Q ss_pred HHHcCCCCCCCCCc--HHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHH
Q 029154 79 ELLTNRLPFEGMSN--LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFL 145 (198)
Q Consensus 79 e~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~~l~~~~ 145 (198)
+|++|..||..... .............+..+..++..+.+|+.+||..||.+|| ++.++++ +.|+
T Consensus 254 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~--h~~f 325 (355)
T 1vzo_A 254 ELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE--HLFF 325 (355)
T ss_dssp HHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT--SGGG
T ss_pred HHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc--Ccch
Confidence 99999999964321 1122222223345667788999999999999999999999 9999998 4444
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-28 Score=189.86 Aligned_cols=134 Identities=19% Similarity=0.273 Sum_probs=100.0
Q ss_pred CCCCCCCCCeEEcC-CCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTP-DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~-~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++. +.+.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++||
T Consensus 181 vHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~e 250 (382)
T 2vx3_A 181 IHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLG--------MPYDLAIDMWSLGCILVE 250 (382)
T ss_dssp ECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHH
T ss_pred EcCCCCcccEEEecCCCCcEEEEeccCceecccc--cccccCCccccChHHHcC--------CCCCcHHHHHHHHHHHHH
Confidence 69999999999953 2367999999999765432 345689999999999854 568899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCC----------------CCC------------------C--------------
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPG----------------LPE------------------D-------------- 111 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------~p~------------------~-------------- 111 (198)
|++|..||.+................++ ++. .
T Consensus 251 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 330 (382)
T 2vx3_A 251 MHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGG 330 (382)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTS
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccC
Confidence 9999999998765443322211100000 000 0
Q ss_pred --------------CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 112 --------------ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 112 --------------~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
..+++.+|+.+||..||.+|||+.++++ +.|+.
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~--hp~f~ 377 (382)
T 2vx3_A 331 PGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQ--HSFFK 377 (382)
T ss_dssp GGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTT--SGGGC
T ss_pred CCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhc--Ccccc
Confidence 0147899999999999999999999998 66654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-28 Score=186.70 Aligned_cols=139 Identities=24% Similarity=0.376 Sum_probs=102.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc---cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+|||++.+ +.+||+|||+++.... ........||+.|+|||++.+ ..++.++||||||+++
T Consensus 161 vH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il 231 (321)
T 2qkw_B 161 IHRDVKSINILLDEN-FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK--------GRLTEKSDVYSFGVVL 231 (321)
T ss_dssp ECSCCCSTTEEECTT-CCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH--------CBCCTHHHHHHHHHHH
T ss_pred ecCCCCHHHEEECCC-CCEEEeecccccccccccccccccccCCCccccCHHHhcC--------CCCCcccchHhHHHHH
Confidence 699999999999976 6899999999974322 111233468999999999853 5678999999999999
Q ss_pred HHHHcCCCCCCCCCcHH-----HHHHHHHccC------CCC----CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 78 WELLTNRLPFEGMSNLQ-----AAYAAAFKHA------RPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~-----~~~~~~~~~~------~~~----~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
|++++|+.||.+..... .......... .+. .+...+..+.+++.+||..||.+||++.+++++|+
T Consensus 232 ~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 232 FEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp HHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 99999999986543211 1000011000 111 12224567889999999999999999999999999
Q ss_pred HHHhhc
Q 029154 143 AFLFTL 148 (198)
Q Consensus 143 ~~~~~~ 148 (198)
..+...
T Consensus 312 ~~l~~~ 317 (321)
T 2qkw_B 312 YALRLQ 317 (321)
T ss_dssp HHHHSS
T ss_pred HHhhcc
Confidence 887643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.6e-28 Score=185.46 Aligned_cols=138 Identities=24% Similarity=0.327 Sum_probs=98.4
Q ss_pred CCCCCCCCCeEEcCC----CCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD----QKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~----~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
|||||||+|||++.+ .+.+||+|||+++..... ......+||..|+|||++.+ ...++.++||||+||
T Consensus 154 vH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~ 226 (329)
T 3gbz_A 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG-------SRHYSTSVDIWSIAC 226 (329)
T ss_dssp CCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTT-------CCCCCTHHHHHHHHH
T ss_pred ECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcC-------CCCCCcHHHHHHHHH
Confidence 799999999999532 245999999999744322 22344578999999999853 345799999999999
Q ss_pred HHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCC----------------------------CCCCcHHHHHHHHHhcccC
Q 029154 76 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL----------------------------PEDISPDLAFIVQSCWVED 127 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------------p~~~~~~~~~l~~~~l~~d 127 (198)
++|+|++|..||.+................+.. +..+++++.+|+.+||..|
T Consensus 227 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 306 (329)
T 3gbz_A 227 IWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMD 306 (329)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSS
T ss_pred HHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCC
Confidence 999999999999887765444333221111100 0116789999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHhh
Q 029154 128 PNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 128 p~~Rps~~~~l~~l~~~~~~ 147 (198)
|.+|||+.++++ +.|+..
T Consensus 307 P~~R~t~~e~l~--hp~f~~ 324 (329)
T 3gbz_A 307 PVKRISAKNALE--HPYFSH 324 (329)
T ss_dssp GGGSCCHHHHHT--SGGGSS
T ss_pred hhhCCCHHHHhC--CcccCC
Confidence 999999999998 666543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=180.19 Aligned_cols=143 Identities=26% Similarity=0.380 Sum_probs=98.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+||+++.+ +.+||+|||++....... ......|+..|+|||++.+ ..++.++|+||||+++|+
T Consensus 158 ~H~dl~p~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~ 228 (310)
T 2wqm_A 158 MHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYE 228 (310)
T ss_dssp CCCCCCGGGEEECTT-SCEEECCC------------------CCSSCCHHHHTT--------CCCCHHHHHHHHHHHHHH
T ss_pred eCCCCcHHHEEEcCC-CCEEEEeccceeeecCCCccccccCCCeeEeChHHhCC--------CCCCchhhHHHHHHHHHH
Confidence 699999999999976 679999999987543322 2234578999999998753 567899999999999999
Q ss_pred HHcCCCCCCCCCc-HHHHHHHHHccCCCCC-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCC
Q 029154 80 LLTNRLPFEGMSN-LQAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 152 (198)
Q Consensus 80 ~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~-p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~ 152 (198)
+++|..||.+... .............+.. +..+++++.+++.+||..||.+||++.++++.|+.+......+.
T Consensus 229 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 229 MAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp HHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred HHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 9999999976432 2222222222222222 35689999999999999999999999999999999988776553
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-27 Score=192.83 Aligned_cols=138 Identities=23% Similarity=0.354 Sum_probs=108.8
Q ss_pred CCCCCCCCCeEEcCCCC--ceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQK--SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~--~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.++. .+||+|||+++...........+||+.|+|||++. ..++.++||||+||++|
T Consensus 168 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~ 238 (504)
T 3q5i_A 168 VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK---------KKYNEKCDVWSCGVIMY 238 (504)
T ss_dssp ECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT---------TCBCTHHHHHHHHHHHH
T ss_pred EeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc---------cCCCchHHHHHHHHHHH
Confidence 69999999999986532 59999999998665544455678999999999874 35789999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCC--CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
+|++|..||.+................... ...+++++.+|+.+||..||.+|||+.++++ +.|+....
T Consensus 239 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~~~~ 309 (504)
T 3q5i_A 239 ILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN--SRWIKKYA 309 (504)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHHTC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc--CHhhhhch
Confidence 999999999887654433222222211111 2568999999999999999999999999999 77776544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=186.15 Aligned_cols=137 Identities=30% Similarity=0.397 Sum_probs=102.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++..... ....+||+.|+|||++.+ ...++.++||||+||++|+|
T Consensus 166 vH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el 235 (371)
T 4exu_A 166 VHRDLKPGNLAVNED-CELKILDFGLARHADAE--MTGYVVTRWYRAPEVILS-------WMHYNQTVDIWSVGCIMAEM 235 (371)
T ss_dssp CCSCCCGGGEEECTT-CCEEECSTTCC----------CTTCCCTTSCHHHHSC-------CSCCCTTHHHHHHHHHHHHH
T ss_pred cCCCcCHHHeEECCC-CCEEEEecCcccccccC--cCCcccCccccCHHHhcC-------CCCCCcHHhHHHHHHHHHHH
Confidence 799999999999976 67999999999754322 345678999999998753 35678999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCC---------------------C--------CCCCCCcHHHHHHHHHhcccCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHAR---------------------P--------GLPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~---------------------~--------~~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
++|..||.+................ + ..+..+++++.+|+.+||..||.+|
T Consensus 236 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 315 (371)
T 4exu_A 236 LTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR 315 (371)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTS
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhc
Confidence 9999999886654433222110000 0 0123568999999999999999999
Q ss_pred CCHHHHHHHHHHHHhhcC
Q 029154 132 PSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~~ 149 (198)
||+.++++ +.|+....
T Consensus 316 pt~~ell~--hp~f~~~~ 331 (371)
T 4exu_A 316 LTAAQALT--HPFFEPFR 331 (371)
T ss_dssp CCHHHHHT--SGGGTTTC
T ss_pred CCHHHHhc--CcccccCC
Confidence 99999999 78876544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=186.17 Aligned_cols=135 Identities=21% Similarity=0.407 Sum_probs=102.6
Q ss_pred CCCCCCCCCeEEcCCCC---ceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQK---SLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~---~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||+..+.+ .+||+|||+++.... .......+||+.|+|||++.+ ..++.++|+||+||+
T Consensus 138 vHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~i 209 (342)
T 2qr7_A 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER--------QGYDAACDIWSLGVL 209 (342)
T ss_dssp ECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHH--------HHHHHHHHHHHHHHH
T ss_pred EeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcC--------CCCCCccCeeeHhHH
Confidence 69999999999854322 499999999975432 223445689999999999853 447889999999999
Q ss_pred HHHHHcCCCCCCCCC--cHHHHHHHHHccCCC----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 77 LWELLTNRLPFEGMS--NLQAAYAAAFKHARP----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 77 l~e~~~g~~p~~~~~--~~~~~~~~~~~~~~~----~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+|+|++|..||.+.. .......... .... ..+..+++++.+|+.+||..||.+||++.++++ +.|+.
T Consensus 210 l~ell~g~~Pf~~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~--hp~~~ 282 (342)
T 2qr7_A 210 LYTMLTGYTPFANGPDDTPEEILARIG-SGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR--HPWIV 282 (342)
T ss_dssp HHHHHHSSCSSCSSTTSCHHHHHHHHH-HCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT--SHHHH
T ss_pred HHHHhcCCCCCCCCCcCCHHHHHHHHc-cCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--CCeec
Confidence 999999999997632 2222222222 2222 223568999999999999999999999999999 66664
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.4e-28 Score=187.71 Aligned_cols=132 Identities=26% Similarity=0.313 Sum_probs=98.4
Q ss_pred CCCCCCCCCeEEcC------------------------CCCceEEecccCcccCcccccccCCCCccceecccccccccc
Q 029154 1 MGKFMKEDNLLLTP------------------------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 56 (198)
Q Consensus 1 iH~dlKp~NIll~~------------------------~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 56 (198)
|||||||+|||++. ..+.+||+|||+++..... ....+||+.|+|||++.+
T Consensus 159 vHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~--- 233 (360)
T 3llt_A 159 THTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILN--- 233 (360)
T ss_dssp ECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTT---
T ss_pred eeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcC---
Confidence 69999999999974 1367999999999754332 245679999999999853
Q ss_pred cccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCC------------------------CCC---
Q 029154 57 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP------------------------GLP--- 109 (198)
Q Consensus 57 ~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------~~p--- 109 (198)
..++.++||||+||++|+|++|..||.+................. ..|
T Consensus 234 -----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 308 (360)
T 3llt_A 234 -----LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENA 308 (360)
T ss_dssp -----CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTC
T ss_pred -----CCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccc
Confidence 568999999999999999999999998766443322111100000 001
Q ss_pred -----------------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 110 -----------------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 110 -----------------~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
...++.+.+|+.+||+.||.+|||+.++++ +.|
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~--hp~ 358 (360)
T 3llt_A 309 SSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK--HKF 358 (360)
T ss_dssp SCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT--SGG
T ss_pred cchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc--Ccc
Confidence 112367889999999999999999999998 444
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-27 Score=197.17 Aligned_cols=137 Identities=28% Similarity=0.579 Sum_probs=109.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccc--cCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++........ ....+++.|+|||++.+ ..++.++||||||+++|
T Consensus 513 vHrDikp~NILl~~~-~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ 583 (656)
T 2j0j_A 513 VHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMW 583 (656)
T ss_dssp CCSCCSGGGEEEEET-TEEEECCCCCCCSCCC----------CCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHH
T ss_pred cccccchHhEEEeCC-CCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcC--------CCCCchhhHHHHHHHHH
Confidence 799999999999976 78999999999865433221 22456789999999853 56899999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
||++ |..||.+...... .........+..|..+++.+.+++.+||..||.+||++.++++.|+.++..
T Consensus 584 ellt~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 584 EILMHGVKPFQGVKNNDV-IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHTTSCCTTTTCCHHHH-HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCCHHHH-HHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 9997 9999988665433 333344555667888999999999999999999999999999999987653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=182.58 Aligned_cols=139 Identities=27% Similarity=0.397 Sum_probs=100.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||++...... ......+||..|+|||++.+ ...++.++|+||+|+++|+
T Consensus 124 vH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~ 195 (311)
T 4agu_A 124 IHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG-------DTQYGPPVDVWAIGCVFAE 195 (311)
T ss_dssp ECCCCSGGGEEECTT-SCEEECCCTTCEECC------------GGGCCHHHHHT-------CSCCCTHHHHHHHHHHHHH
T ss_pred cCCCCChhhEEEcCC-CCEEEeeCCCchhccCcccccCCCcCCccccChHHHhc-------CCCCCcchhhHHHHHHHHH
Confidence 699999999999976 68999999999754422 22345678999999998753 3567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHc-------------------cCCCCC----------CCCCcHHHHHHHHHhcccCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFK-------------------HARPGL----------PEDISPDLAFIVQSCWVEDPNL 130 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~-------------------~~~~~~----------p~~~~~~~~~l~~~~l~~dp~~ 130 (198)
+++|..||.+............. ....+. ...+++++.+++.+||..||.+
T Consensus 196 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 275 (311)
T 4agu_A 196 LLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTE 275 (311)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTT
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhh
Confidence 99999999887654433221110 000011 1347888999999999999999
Q ss_pred CCCHHHHHHHHHHHHhhcC
Q 029154 131 RPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 131 Rps~~~~l~~l~~~~~~~~ 149 (198)
|||++++++ +.|+....
T Consensus 276 Rpt~~ell~--hp~f~~~~ 292 (311)
T 4agu_A 276 RLTCEQLLH--HPYFENIR 292 (311)
T ss_dssp SCCHHHHHT--SGGGTTCC
T ss_pred cCCHHHHhc--ChHHHhcc
Confidence 999999999 77776544
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=181.50 Aligned_cols=140 Identities=26% Similarity=0.424 Sum_probs=100.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+|||++.+ +.+||+|||++...... .......|++.|+|||++.... .....++.++||||||+++|+
T Consensus 151 vH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~ 226 (326)
T 2x7f_A 151 IHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDFKSDLWSLGITAIE 226 (326)
T ss_dssp CCCCCSGGGEEECTT-CCEEECCCTTTC-------------CCGGGCCHHHHC-----------CCTTHHHHHHHHHHHH
T ss_pred cccCCcHHHEEEcCC-CCEEEeeCcCceecCcCccccccccCCccccChhhhcccc---ccCcCCCccchHHHHHHHHHH
Confidence 699999999999966 67999999998754322 1223457899999999975210 012467889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+++|..||.+...................+..++..+.+++.+||..||.+||++.++++ +.|+.
T Consensus 227 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--hp~~~ 291 (326)
T 2x7f_A 227 MAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK--HPFIR 291 (326)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT--SHHHH
T ss_pred HHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh--ChHHh
Confidence 999999998776554443333322333335668999999999999999999999999999 66665
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=180.73 Aligned_cols=139 Identities=27% Similarity=0.506 Sum_probs=107.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++...+.+||+|||++...... .......|+..|+|||++.+ ....++.++|+||||+++|+
T Consensus 144 ~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Di~slG~il~~ 217 (295)
T 2clq_A 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK------GPRGYGKAADIWSLGCTIIE 217 (295)
T ss_dssp ECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHH------GGGGCSHHHHHHHHHHHHHH
T ss_pred EccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcC------CCCCCCcHHHHHHHHHHHHH
Confidence 699999999999874478999999999754322 22344678999999999753 12347889999999999999
Q ss_pred HHcCCCCCCCCCcHHHH-HHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 80 LLTNRLPFEGMSNLQAA-YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|++|..||......... .........+.++..+++++.+++.+||..||.+||++.++++ +.|+..
T Consensus 218 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--~~~~~~ 284 (295)
T 2clq_A 218 MATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV--DEFLKV 284 (295)
T ss_dssp HHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT--SGGGCC
T ss_pred HHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc--Chhhhh
Confidence 99999999765443322 2223334556778889999999999999999999999999998 666553
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=186.45 Aligned_cols=139 Identities=22% Similarity=0.290 Sum_probs=98.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++............||+.|+|||++.+ ...++.++||||+||++|++
T Consensus 156 vH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l 227 (362)
T 3pg1_A 156 VHRDLHPGNILLADN-NDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQ-------FKGFTKLVDMWSAGCVMAEM 227 (362)
T ss_dssp CCCCCCGGGEEECTT-CCEEECCTTC---------------CGGGCCHHHHTT-------CTTCCTHHHHHHHHHHHHHH
T ss_pred EecCCChHHEEEcCC-CCEEEEecCcccccccccccceecccceecCcHHhcC-------CCCCCcHhHHHhHHHHHHHH
Confidence 799999999999976 6799999999975544444455678999999998753 35678999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccC----------------------CCC--------CCCCCcHHHHHHHHHhcccCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHA----------------------RPG--------LPEDISPDLAFIVQSCWVEDPNL 130 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~----------------------~~~--------~p~~~~~~~~~l~~~~l~~dp~~ 130 (198)
++|..||.+............... ... .+...++.+.+|+.+||..||.+
T Consensus 228 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 307 (362)
T 3pg1_A 228 FNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307 (362)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGG
T ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhh
Confidence 999999987664333222111000 001 12346888999999999999999
Q ss_pred CCCHHHHHHHHHHHHhhcC
Q 029154 131 RPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 131 Rps~~~~l~~l~~~~~~~~ 149 (198)
|||+.++++ +.|+....
T Consensus 308 Rpt~~ell~--hp~f~~~~ 324 (362)
T 3pg1_A 308 RISTEQALR--HPYFESLF 324 (362)
T ss_dssp SCCHHHHHT--SGGGTTTC
T ss_pred CCCHHHHHc--Cchhhhcc
Confidence 999999999 77876554
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-27 Score=182.17 Aligned_cols=137 Identities=29% Similarity=0.374 Sum_probs=102.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|||++.+ +.+||+|||+++..... .....||+.|+|||++.+ ...++.++|+||+|+++|+|
T Consensus 148 vH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el 217 (353)
T 3coi_A 148 VHRDLKPGNLAVNED-CELKILDFGLARHADAE--MTGYVVTRWYRAPEVILS-------WMHYNQTVDIWSVGCIMAEM 217 (353)
T ss_dssp CCSSCCGGGEEECTT-CCEEECSTTCTTC----------CCSBCCSCHHHHSC-------CSCCCTTHHHHHHHHHHHHH
T ss_pred ccCCCCHHHEeECCC-CcEEEeecccccCCCCC--ccccccCcCcCCHHHHhC-------cCCCCchhhHHHHHHHHHHH
Confidence 799999999999976 67999999999754322 234578999999998753 25678999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHc----------------------c-------CCCCCCCCCcHHHHHHHHHhcccCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFK----------------------H-------ARPGLPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~----------------------~-------~~~~~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
++|..||.+............. . .....+..+++++.+++.+||..||.+|
T Consensus 218 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 297 (353)
T 3coi_A 218 LTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR 297 (353)
T ss_dssp HHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTS
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccC
Confidence 9999999876644332211110 0 0012234578999999999999999999
Q ss_pred CCHHHHHHHHHHHHhhcC
Q 029154 132 PSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~~ 149 (198)
|++.++++ +.|+....
T Consensus 298 pt~~e~l~--hp~f~~~~ 313 (353)
T 3coi_A 298 LTAAQALT--HPFFEPFR 313 (353)
T ss_dssp CCHHHHHT--SGGGTTTC
T ss_pred CCHHHHhc--Ccchhhcc
Confidence 99999998 77776443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-27 Score=182.59 Aligned_cols=136 Identities=29% Similarity=0.481 Sum_probs=109.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||++..... ........||..|+|||++.+ ..++.++||||||+++|+
T Consensus 163 vH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ 233 (335)
T 2owb_A 163 IHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK--------KGHSFEVDVWSIGCIMYT 233 (335)
T ss_dssp ECSCCCGGGEEECTT-CCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHT--------SCBCTHHHHHHHHHHHHH
T ss_pred EecCCCchhEEEcCC-CCEEEeeccCceecccCcccccccCCCccccCHHHhcc--------CCCCchhhHHHHHHHHHH
Confidence 699999999999976 6799999999975432 222344678999999999853 567889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
|++|..||........... .......++..+++++.+++.+||..||.+||++.++++ +.|+....
T Consensus 234 l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--~~~~~~~~ 299 (335)
T 2owb_A 234 LLVGKPPFETSCLKETYLR--IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN--DEFFTSGY 299 (335)
T ss_dssp HHHSSCTTCCSSHHHHHHH--HHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHTSC
T ss_pred HHHCcCCCCCCCHHHHHHH--HhcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc--CccccCCC
Confidence 9999999987654333222 223445667789999999999999999999999999999 77766543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.9e-28 Score=190.80 Aligned_cols=129 Identities=12% Similarity=0.153 Sum_probs=96.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceeccccccccccc--ccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR--QGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++..... ....+| +.|+|||++.+.... ......++.++|||||||++|
T Consensus 233 iHrDiKp~NILl~~~-~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp ECSCCCGGGEEECTT-CCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecC-CeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 699999999999977 67999999998765433 345678 999999998321000 001245788999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
||++|+.||.+....... . ........+++++.+|+.+||..||.+||++.++++
T Consensus 309 elltg~~Pf~~~~~~~~~-~-----~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGS-E-----WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSCS-G-----GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhhH-H-----HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999765432110 0 011122357899999999999999999999877765
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=178.54 Aligned_cols=132 Identities=27% Similarity=0.396 Sum_probs=105.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+|||++.+ +.+||+|||++.............|++.|+|||++.+ ..++.++|+||+|+++|+|
T Consensus 144 ~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l 214 (284)
T 2a19_B 144 INRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS--------QDYGKEVDLYALGLILAEL 214 (284)
T ss_dssp ECSCCSGGGEEEEET-TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHC--------SCCCTHHHHHHHHHHHHHH
T ss_pred eeccCCHHHEEEcCC-CCEEECcchhheeccccccccccCCcccccChhhhcc--------CCCcchhhhHHHHHHHHHH
Confidence 699999999999966 6899999999976554443445679999999999853 5678999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
++|..|+.... ....... ....+..++.++.+++.+||..||.+||++.+++++|..+...
T Consensus 215 ~~~~~~~~~~~---~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 215 LHVCDTAFETS---KFFTDLR---DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HSCCSSHHHHH---HHHHHHH---TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HhcCCcchhHH---HHHHHhh---cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 99998874211 1111111 2234567899999999999999999999999999999877543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-27 Score=179.84 Aligned_cols=145 Identities=21% Similarity=0.421 Sum_probs=102.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc------cccccCCCCccceecccccccccccc-cccCCCCchhhHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV------TEMMTAETGTYRWMAPELYSTVTLRQ-GEKKHYNNKVDVYSF 73 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~~~Dvws~ 73 (198)
+||||||+|||++ + +.+||+|||+++.... ........|+..|+|||++....... .....++.++|||||
T Consensus 152 ~H~dlkp~NIl~~-~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~sl 229 (319)
T 2y4i_B 152 LHKDLKSKNVFYD-N-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229 (319)
T ss_dssp CCCCCCSTTEEEC----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHH
T ss_pred cccCCChhhEEEe-C-CCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHH
Confidence 7999999999998 4 5799999999864321 11223346899999999875311000 012457889999999
Q ss_pred HHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCC-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 74 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 74 G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
|+++|++++|..||.+........ .......+.. +..++.++.+++.+||..||.+||++.++++.|+.+....
T Consensus 230 G~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 230 GTIWYELHAREWPFKTQPAEAIIW-QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHHHHHHHHSSCSSSSCCHHHHHH-HHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHH-HhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 999999999999998766543332 2223333332 3457889999999999999999999999999998765543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=181.63 Aligned_cols=132 Identities=28% Similarity=0.492 Sum_probs=101.4
Q ss_pred CCCCCCCCCeEEcCCCCc--------eEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHH
Q 029154 1 MGKFMKEDNLLLTPDQKS--------LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 72 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~--------~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws 72 (198)
|||||||+|||++.+ +. +||+|||++....... ...|+..|+|||++.+ ...++.++||||
T Consensus 135 vH~Dlkp~NIll~~~-~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~y~aPE~~~~-------~~~~~~~~Diws 203 (289)
T 4fvq_A 135 IHGNVCAKNILLIRE-EDRKTGNPPFIKLSDPGISITVLPKD---ILQERIPWVPPECIEN-------PKNLNLATDKWS 203 (289)
T ss_dssp CCCCCCGGGEEEEEC-CBGGGTBCCEEEECCCCSCTTTSCHH---HHHHTTTTSCHHHHHC-------GGGCCHHHHHHH
T ss_pred ECCCcCcceEEEecC-CcccccccceeeeccCcccccccCcc---ccCCcCcccCHHHhCC-------CCCCCchhHHHH
Confidence 799999999999866 44 9999999987543322 2346788999998753 255789999999
Q ss_pred HHHHHHHHHcCC-CCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 73 FGIVLWELLTNR-LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 73 ~G~~l~e~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+|+++|+|++|. +||..... ...... .......+...++++.+++.+||..||.+|||+.+++++|+.++.
T Consensus 204 lG~il~el~~g~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 204 FGTTLWEICSGGDKPLSALDS-QRKLQF--YEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHHHHHHTTTCCTTTTSCH-HHHHHH--HHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHHHHHHHHcCCCCCccccch-HHHHHH--hhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 999999999955 45554443 222222 223455666778899999999999999999999999999987655
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-27 Score=177.80 Aligned_cols=136 Identities=29% Similarity=0.481 Sum_probs=109.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||++..... ........|++.|+|||++.+ ..++.++|+||+|+++|+
T Consensus 137 ~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ 207 (294)
T 2rku_A 137 IHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK--------KGHSFEVDVWSIGCIMYT 207 (294)
T ss_dssp ECCCCCGGGEEECTT-CCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTT--------SCBCTHHHHHHHHHHHHH
T ss_pred cccCCChHhEEEcCC-CCEEEEeccCceecccCccccccccCCCCcCCcchhcc--------CCCCchhhHHHHHHHHHH
Confidence 699999999999976 6799999999975432 222344578999999999853 557889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
|++|..||.......... .........|..+++.+.+++.+||..||.+||++.++++ +.++....
T Consensus 208 l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--~~~~~~~~ 273 (294)
T 2rku_A 208 LLVGKPPFETSCLKETYL--RIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN--DEFFTSGY 273 (294)
T ss_dssp HHHSSCTTCCSSHHHHHH--HHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHTSC
T ss_pred HHhCCCCCCCCCHHHHHH--HHhhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhh--ChheecCC
Confidence 999999998766433322 2233445667889999999999999999999999999999 67766443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=183.84 Aligned_cols=138 Identities=25% Similarity=0.440 Sum_probs=87.2
Q ss_pred CCCCCCCCCeEEcCCC--CceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQ--KSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~--~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.++ ..+||+|||+++.... .......+||+.|+|||++.+ ..++.++||||+|+++
T Consensus 128 vH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il 199 (325)
T 3kn6_A 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ--------NGYDESCDLWSLGVIL 199 (325)
T ss_dssp ECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------------CCCCHHHHHHHHHHHH
T ss_pred eecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcC--------CCCCCccchHHHHHHH
Confidence 6999999999998552 2699999999975432 223345678999999999853 5688999999999999
Q ss_pred HHHHcCCCCCCCCCcH------HHHHHHHHccCCCCCC----CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLTNRLPFEGMSNL------QAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~------~~~~~~~~~~~~~~~p----~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|+|++|..||.+.... ..... .........+ ..+++++.+|+.+||..||.+||++.++++ +.|+..
T Consensus 200 ~~ll~g~~pf~~~~~~~~~~~~~~~~~-~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--h~w~~~ 276 (325)
T 3kn6_A 200 YTMLSGQVPFQSHDRSLTCTSAVEIMK-KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY--NEWLQD 276 (325)
T ss_dssp HHHHHSSCTTC-------CCCHHHHHH-HHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT--CGGGCT
T ss_pred HHHHhCCCCCCCCccccccccHHHHHH-HHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc--Chhhcc
Confidence 9999999999764321 12222 2222222222 347899999999999999999999999998 777764
Q ss_pred cC
Q 029154 148 LR 149 (198)
Q Consensus 148 ~~ 149 (198)
..
T Consensus 277 ~~ 278 (325)
T 3kn6_A 277 GS 278 (325)
T ss_dssp TC
T ss_pred Cc
Confidence 43
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=5.9e-27 Score=182.96 Aligned_cols=137 Identities=26% Similarity=0.449 Sum_probs=102.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||++...... ......||+.|+|||++.+ ..++.++||||+|+++|+|
T Consensus 154 ~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l 223 (360)
T 3eqc_A 154 MHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEM 223 (360)
T ss_dssp CCSCCSGGGEEECTT-CCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTT--------CCCSHHHHHHHHHHHHHHH
T ss_pred EcCCccHHHEEECCC-CCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcC--------CCCCchhhHHHHHHHHHHH
Confidence 699999999999976 67999999998643222 2334578999999999853 5688999999999999999
Q ss_pred HcCCCCCCCCCcHHHHH-----------------------------------------HHHHccCCCCCC-CCCcHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAY-----------------------------------------AAAFKHARPGLP-EDISPDLAF 118 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~p-~~~~~~~~~ 118 (198)
++|..||.......... ........+..+ ..++.++.+
T Consensus 224 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (360)
T 3eqc_A 224 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 303 (360)
T ss_dssp HHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHH
Confidence 99999997655322110 111112222222 347889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 119 IVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 119 l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
|+.+||..||.+|||+.++++ |.|+....
T Consensus 304 li~~~L~~dP~~Rpt~~ell~--hp~~~~~~ 332 (360)
T 3eqc_A 304 FVNKCLIKNPAERADLKQLMV--HAFIKRSD 332 (360)
T ss_dssp HHHHHHCSSTTTSCCHHHHHT--SHHHHHHH
T ss_pred HHHHHhhcChhhCCCHHHHhh--ChHhhcch
Confidence 999999999999999999999 67765443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=183.51 Aligned_cols=136 Identities=26% Similarity=0.438 Sum_probs=99.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++.... ........|+..|+|||++.+ ...++.++||||+||++|+
T Consensus 146 vH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~ 217 (331)
T 4aaa_A 146 IHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG-------DVKYGKAVDVWAIGCLVTE 217 (331)
T ss_dssp CCCCCCGGGEEECTT-SCEEECCCTTC------------CCCCCTTCCHHHHTT-------CTTCCTHHHHHHHHHHHHH
T ss_pred EccCcChheEEEcCC-CcEEEEeCCCceeecCCccccCCCcCCccccCcccccC-------CCCcchHHHHHHHHHHHHH
Confidence 799999999999976 6899999999975433 222345678999999999853 2467899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCC-----------------CCC------------CCCCcHHHHHHHHHhcccCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHAR-----------------PGL------------PEDISPDLAFIVQSCWVEDPNL 130 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------~~~------------p~~~~~~~~~l~~~~l~~dp~~ 130 (198)
|++|..||.+................ ... ...+++.+.+|+.+||..||.+
T Consensus 218 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 297 (331)
T 4aaa_A 218 MFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDK 297 (331)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGG
T ss_pred HHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCccc
Confidence 99999999887654433222111000 000 1246889999999999999999
Q ss_pred CCCHHHHHHHHHHHHh
Q 029154 131 RPSFSQIIRMLNAFLF 146 (198)
Q Consensus 131 Rps~~~~l~~l~~~~~ 146 (198)
||++.++++ +.|+.
T Consensus 298 Rpt~~ell~--hp~f~ 311 (331)
T 4aaa_A 298 RPFCAELLH--HDFFQ 311 (331)
T ss_dssp SCCGGGGGG--SHHHH
T ss_pred CCCHHHHhc--Cchhc
Confidence 999999998 66654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-28 Score=186.54 Aligned_cols=127 Identities=28% Similarity=0.407 Sum_probs=94.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-------------ccccCCCCccceecccccccccccccccCCCCch
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 67 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 67 (198)
|||||||+|||++.+ +.+||+|||+++..... ......+||+.|+|||++.+ ..++.+
T Consensus 186 vH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~ 256 (332)
T 3qd2_B 186 MHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG--------NNYSHK 256 (332)
T ss_dssp ECCCCCGGGEEECTT-CCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHC--------CCCCTH
T ss_pred eecCCCcccEEEeCC-CCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcC--------CCCcch
Confidence 699999999999976 68999999999754332 12234579999999999853 568999
Q ss_pred hhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 68 VDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 68 ~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+||||+|+++|+|++|..|+.. .............+..+...++++.+++.+||..||.+||++.++++
T Consensus 257 ~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 257 VDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 9999999999999998776521 11112222222222222345678899999999999999999999998
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=180.39 Aligned_cols=130 Identities=28% Similarity=0.387 Sum_probs=103.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||+++...... ......|+..|+|||++.+ ..++.++|+||+|+++|+
T Consensus 138 vH~dl~p~NIl~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ 208 (279)
T 2w5a_A 138 LHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR--------MSYNEKSDIWSLGCLLYE 208 (279)
T ss_dssp CCCCCSGGGEEECSS-SCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHC--------C-CCHHHHHHHHHHHHHH
T ss_pred EEeccchhhEEEcCC-CCEEEecCchheeeccccccccccCCCccccChHHhcc--------CCCCchhhHHHHHHHHHH
Confidence 799999999999976 679999999987543221 1223468899999999853 567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 140 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~ 140 (198)
+++|..||....... ............++..+++++.+++.+||..||.+||++.+++++
T Consensus 209 l~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 209 LCALMPPFTAFSQKE-LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp HHHSSCSSCCSSHHH-HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHCCCCCcccCHHH-HHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 999999998765433 233333444556777899999999999999999999999999983
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-27 Score=179.85 Aligned_cols=139 Identities=24% Similarity=0.344 Sum_probs=97.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+||||||+|||++.+ +.+||+|||++....... ......|+..|+|||++.+ ..++.++|+||||+++|
T Consensus 156 ~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 226 (309)
T 2h34_A 156 THRDVKPENILVSAD-DFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE--------SHATYRADIYALTCVLY 226 (309)
T ss_dssp CCSCCCGGGEEECTT-SCEEECSCCC----------------CCGGGCCGGGTCC------------CCCHHHHHHHHHH
T ss_pred CcCCCChHHEEEcCC-CCEEEecCccCccccccccccccccCCCcCccCHHHHcC--------CCCCchHhHHHHHHHHH
Confidence 699999999999976 679999999987543321 2234578999999999853 56788999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCC--CCCCCCCcHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHhhcC
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~l~~~~l~~dp~~Rp-s~~~~l~~l~~~~~~~~ 149 (198)
++++|..||.+.... ........... ...+..+++++.+++.+||..||.+|| +++++++.|+.++....
T Consensus 227 ~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 227 ECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp HHHHSSCSSCSCHHH-HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred HHHHCCCCCCCchHH-HHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 999999999875432 22222222211 134566889999999999999999999 99999999988765443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.9e-27 Score=179.75 Aligned_cols=137 Identities=26% Similarity=0.498 Sum_probs=107.7
Q ss_pred CCCCCCCCCeEEcCC--CCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD--QKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~--~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
+||||||+|||++.+ +..+||+|||+++...... ......|++.|+|||++.+ ..++.++||||||+
T Consensus 162 ~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~ 233 (327)
T 2yfx_A 162 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME--------GIFTSKTDTWSFGV 233 (327)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH--------CCCCHHHHHHHHHH
T ss_pred ecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC--------CCCCchhhHHHHHH
Confidence 699999999999843 2469999999986332211 1223457889999998853 56789999999999
Q ss_pred HHHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 76 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 76 ~l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++|++++ |..||.+..... .............+..+++.+.+++.+||..||.+||++.+++++|..+..
T Consensus 234 il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 234 LLWEIFSLGYMPYPSKSNQE-VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHHHHTTSCCSSTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCcCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 9999998 899998765433 333344445566677899999999999999999999999999999987755
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-27 Score=180.03 Aligned_cols=142 Identities=21% Similarity=0.326 Sum_probs=104.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc----ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+||||||+|||++.+++.+||+|||+++..... .......++..|+|||++.. ...++.++|+||||++
T Consensus 142 ~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~i 214 (320)
T 2i6l_A 142 LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS-------PNNYTKAIDMWAAGCI 214 (320)
T ss_dssp BCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC-------TTCCCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcC-------cccCCchhhhHhHHHH
Confidence 699999999999865578999999999754321 11223457889999998743 3567899999999999
Q ss_pred HHHHHcCCCCCCCCCcHHHHHHHHHccC-----------------------CC-----CCCCCCcHHHHHHHHHhcccCC
Q 029154 77 LWELLTNRLPFEGMSNLQAAYAAAFKHA-----------------------RP-----GLPEDISPDLAFIVQSCWVEDP 128 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------~~-----~~p~~~~~~~~~l~~~~l~~dp 128 (198)
+|++++|..||.+............... .+ ..+..++.++.+++.+||..||
T Consensus 215 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 294 (320)
T 2i6l_A 215 FAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294 (320)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSG
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCc
Confidence 9999999999988765433222111100 00 1124578999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCC
Q 029154 129 NLRPSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 129 ~~Rps~~~~l~~l~~~~~~~~~~ 151 (198)
.+||++.++++ +.|+.....+
T Consensus 295 ~~Rpt~~ell~--hp~~~~~~~p 315 (320)
T 2i6l_A 295 MDRLTAEEALS--HPYMSIYSFP 315 (320)
T ss_dssp GGSCCHHHHHT--SHHHHTTCC-
T ss_pred cccCCHHHHhC--CcccccccCc
Confidence 99999999999 7787755443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=177.16 Aligned_cols=136 Identities=24% Similarity=0.351 Sum_probs=104.8
Q ss_pred CCCCCCCCCeEE---cCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll---~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+||++ +.+ +.+||+|||+++..... ......|++.|+|||++.+ ..++.++|+||+|+++
T Consensus 128 ~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 197 (304)
T 2jam_A 128 VHRDLKPENLLYLTPEEN-SKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQ--------KPYSKAVDCWSIGVIT 197 (304)
T ss_dssp CCCSCCGGGCEESSSSTT-CCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSS--------CSCCHHHHHHHHHHHH
T ss_pred cccCCCHHHEEEecCCCC-CCEEEccCCcceecCCC-ccccccCCCCccChHHhcc--------CCCCchhhHHHHHHHH
Confidence 699999999999 434 67999999998754322 1223468999999999853 5678999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccC--CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHA--RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
|++++|..||.+............... ....+..+++++.+++.+||..||.+||++.++++ +.|+...
T Consensus 198 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~~ 268 (304)
T 2jam_A 198 YILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS--HPWIDGN 268 (304)
T ss_dssp HHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT--SHHHHSS
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CccccCC
Confidence 999999999987664333222222211 22334568999999999999999999999999999 7776643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=177.03 Aligned_cols=135 Identities=30% Similarity=0.517 Sum_probs=108.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++....... ......|++.|+|||++.+ ..++.++|+||||+++|+
T Consensus 141 ~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ 211 (303)
T 3a7i_A 141 IHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--------SAYDSKADIWSLGITAIE 211 (303)
T ss_dssp ECCCCSGGGEEECTT-SCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHH
T ss_pred ccCCCChheEEECCC-CCEEEeecccceecCccccccCccCCCcCccCHHHHhc--------CCCCchhhhHHHHHHHHH
Confidence 699999999999976 679999999997544322 2344678999999999853 567889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
+++|..||......... ........+..+..++..+.+++.+||..||.+||++.++++ +.++..
T Consensus 212 l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~~~~~~ 276 (303)
T 3a7i_A 212 LARGEPPHSELHPMKVL-FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK--HKFILR 276 (303)
T ss_dssp HHHSSCTTTTSCHHHHH-HHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT--CHHHHH
T ss_pred HccCCCCCCCcCHHHHH-HHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh--Chhhhc
Confidence 99999999876654333 233344555667789999999999999999999999999999 555543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-27 Score=183.21 Aligned_cols=144 Identities=23% Similarity=0.442 Sum_probs=102.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-----cccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
|||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||++.+.... ....++.++||||||+
T Consensus 169 vH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~Di~slG~ 245 (342)
T 1b6c_B 169 AHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM--KHFESFKRADIYAMGL 245 (342)
T ss_dssp ECSCCSGGGEEECTT-SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT--TCHHHHHHHHHHHHHH
T ss_pred eeCCCCHHHEEECCC-CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccc--cccccCCcccHHHHHH
Confidence 699999999999976 689999999997433221 22445799999999998541000 0002236899999999
Q ss_pred HHHHHHcC----------CCCCCCCCc----HHHHHHHHH-ccCCCCCCC-----CCcHHHHHHHHHhcccCCCCCCCHH
Q 029154 76 VLWELLTN----------RLPFEGMSN----LQAAYAAAF-KHARPGLPE-----DISPDLAFIVQSCWVEDPNLRPSFS 135 (198)
Q Consensus 76 ~l~e~~~g----------~~p~~~~~~----~~~~~~~~~-~~~~~~~p~-----~~~~~~~~l~~~~l~~dp~~Rps~~ 135 (198)
++|||++| ..||..... ......... ....+.++. ..+..+.+++.+||..||.+||++.
T Consensus 246 il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 325 (342)
T 1b6c_B 246 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325 (342)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHH
Confidence 99999999 778865421 222222221 222333332 2346789999999999999999999
Q ss_pred HHHHHHHHHHhh
Q 029154 136 QIIRMLNAFLFT 147 (198)
Q Consensus 136 ~~l~~l~~~~~~ 147 (198)
+++++|+.+...
T Consensus 326 ~i~~~L~~i~~~ 337 (342)
T 1b6c_B 326 RIKKTLSQLSQQ 337 (342)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHHHHHHHHHH
Confidence 999999988654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=177.28 Aligned_cols=145 Identities=24% Similarity=0.425 Sum_probs=102.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccc---cccCCCCchhhHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNNKVDVYSFG 74 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~---~~~~~~~~~~Dvws~G 74 (198)
+||||||+|||++ + +.+||+|||+++...... ......|++.|+|||++.+..... .....++.++||||||
T Consensus 149 vH~dlkp~NIl~~-~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG 226 (313)
T 3cek_A 149 VHSDLKPANFLIV-D-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226 (313)
T ss_dssp CCCCCCGGGEEEE-T-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHH
T ss_pred eecCCCcccEEEE-C-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHH
Confidence 6999999999997 4 679999999997543321 123457899999999975310000 0013678899999999
Q ss_pred HHHHHHHcCCCCCCCCCcHHHHHHHHH-ccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 75 IVLWELLTNRLPFEGMSNLQAAYAAAF-KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 75 ~~l~e~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
+++|+|++|..||.............. .......+...+.++.+++.+||..||.+||++.++++ +.|+....
T Consensus 227 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--h~~~~~~~ 300 (313)
T 3cek_A 227 CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQIQT 300 (313)
T ss_dssp HHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHCC-
T ss_pred HHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc--CccccCCC
Confidence 999999999999987654433333322 23334566778899999999999999999999999999 66765433
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-27 Score=177.68 Aligned_cols=136 Identities=21% Similarity=0.333 Sum_probs=102.1
Q ss_pred CCCCCCCCCeEEcCCCC---ceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQK---SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~---~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+||+++.++. .+||+|||++.............|++.|+|||++.+ ..++.++|+||+|+++
T Consensus 130 ~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 201 (283)
T 3bhy_A 130 AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVIT 201 (283)
T ss_dssp ECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHH
T ss_pred cCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecC--------CCCCcchhhhhHHHHH
Confidence 69999999999986531 699999999976544444445678999999998853 5678999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCCCCC----CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
|++++|..||.+........... ...... +..+++.+.+++.+||..||.+||++.++++ +.|+...
T Consensus 202 ~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~~ 272 (283)
T 3bhy_A 202 YILLSGASPFLGETKQETLTNIS--AVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE--HSWIKAI 272 (283)
T ss_dssp HHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH--CHHHHHH
T ss_pred HHHHHCCCCCCCcchHHHHHHhH--hcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh--CHHHHHH
Confidence 99999999998766443322221 222222 2467889999999999999999999999998 6665544
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-27 Score=175.97 Aligned_cols=136 Identities=27% Similarity=0.411 Sum_probs=102.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc---ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+|+||||+||+++.+ +.+||+|||++...... .......|+..|+|||++.+ ...++.++|+||+|+++
T Consensus 127 ~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il 198 (276)
T 2yex_A 127 THRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVL 198 (276)
T ss_dssp ECSCCSGGGEEECTT-CCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTC-------SSBCHHHHHHHHHHHHH
T ss_pred eccCCChHHEEEccC-CCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhc-------CCCCCCcchHHHHHHHH
Confidence 699999999999976 67999999998754321 22345678999999999853 22346789999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCC-CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHAR-PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|++++|..||.................. ......+++.+.+++.+||..||.+||++.++++ +.|+.
T Consensus 199 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~ 266 (276)
T 2yex_A 199 TAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK--DRWYN 266 (276)
T ss_dssp HHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTTT
T ss_pred HHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc--Ccccc
Confidence 9999999999765543222222222211 1223458899999999999999999999999998 55543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-27 Score=180.84 Aligned_cols=136 Identities=19% Similarity=0.228 Sum_probs=101.4
Q ss_pred CCCCCCCCCeEEcCC------------------CCceEEecccCcccCcccccccCCCCccceecccccccccccccccC
Q 029154 1 MGKFMKEDNLLLTPD------------------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62 (198)
Q Consensus 1 iH~dlKp~NIll~~~------------------~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 62 (198)
|||||||+|||++.+ .+.+||+|||+++..... .....||+.|+|||++.+ .
T Consensus 140 vH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~ 209 (339)
T 1z57_A 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILA--------L 209 (339)
T ss_dssp ECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTT--------S
T ss_pred cCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhC--------C
Confidence 699999999999863 246999999999754322 245678999999999853 5
Q ss_pred CCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH--HHccCC-----------------------------------
Q 029154 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA--AFKHAR----------------------------------- 105 (198)
Q Consensus 63 ~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~--~~~~~~----------------------------------- 105 (198)
.++.++||||+||++||+++|..||.+.......... .....+
T Consensus 210 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (339)
T 1z57_A 210 GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK 289 (339)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC
T ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCc
Confidence 6889999999999999999999999876643322111 110000
Q ss_pred -----CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 106 -----PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 106 -----~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
...+...++++.+|+.+||..||.+|||+.|+++ +.|+...
T Consensus 290 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~ 335 (339)
T 1z57_A 290 PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK--HPFFDLL 335 (339)
T ss_dssp CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT--SGGGGGG
T ss_pred chhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc--CHHHHHH
Confidence 0011223577899999999999999999999998 6666543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-27 Score=180.15 Aligned_cols=134 Identities=29% Similarity=0.438 Sum_probs=97.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc--cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++.... ........||+.|+|||++.+ ..++.++||||+|+++|
T Consensus 156 vH~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 226 (326)
T 3uim_A 156 IHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--------GKSSEKTDVFGYGVMLL 226 (326)
T ss_dssp ECCCCSGGGEEECTT-CCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH--------SEECHHHHHHHHHHHHH
T ss_pred EeCCCchhhEEECCC-CCEEeccCccccccCcccccccccccCCcCccCHHHhcc--------CCCCccccchhHHHHHH
Confidence 699999999999976 6899999999975432 222334569999999999853 45789999999999999
Q ss_pred HHHcCCCCCCCC-------CcHHHHHHHHHccCC----------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 79 ELLTNRLPFEGM-------SNLQAAYAAAFKHAR----------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 79 e~~~g~~p~~~~-------~~~~~~~~~~~~~~~----------~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
+|++|..||... ............... ...+...+..+.+++.+||..||.+|||+.+++++|
T Consensus 227 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 227 ELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp HHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred HHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 999999999511 011110000000000 011112346789999999999999999999999999
Q ss_pred HH
Q 029154 142 NA 143 (198)
Q Consensus 142 ~~ 143 (198)
+.
T Consensus 307 ~~ 308 (326)
T 3uim_A 307 EG 308 (326)
T ss_dssp HT
T ss_pred cC
Confidence 75
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=187.33 Aligned_cols=116 Identities=20% Similarity=0.232 Sum_probs=83.7
Q ss_pred ceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCc-----
Q 029154 18 SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN----- 92 (198)
Q Consensus 18 ~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~----- 92 (198)
.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...
T Consensus 234 ~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 303 (397)
T 1wak_A 234 KVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIG--------SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTR 303 (397)
T ss_dssp CEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCH
T ss_pred ceEecccccccccccc--CccCCCCCcccCChhhcC--------CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCc
Confidence 6999999999754432 345679999999999854 5688999999999999999999999975432
Q ss_pred HHHHHHH---HHccCC--------------------------------------CCCCCCCcHHHHHHHHHhcccCCCCC
Q 029154 93 LQAAYAA---AFKHAR--------------------------------------PGLPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 93 ~~~~~~~---~~~~~~--------------------------------------~~~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
....... .....+ ...+...+..+.+|+.+||..||.+|
T Consensus 304 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 383 (397)
T 1wak_A 304 DEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR 383 (397)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGS
T ss_pred hHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhc
Confidence 1111111 100000 01122234678899999999999999
Q ss_pred CCHHHHHHHHHHHH
Q 029154 132 PSFSQIIRMLNAFL 145 (198)
Q Consensus 132 ps~~~~l~~l~~~~ 145 (198)
||+.++++ +.|+
T Consensus 384 pt~~e~l~--hp~~ 395 (397)
T 1wak_A 384 ATAAECLR--HPWL 395 (397)
T ss_dssp CCHHHHHT--SGGG
T ss_pred CCHHHHhh--Cccc
Confidence 99999998 5554
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=175.83 Aligned_cols=137 Identities=26% Similarity=0.425 Sum_probs=104.6
Q ss_pred CCCCCCCCCeEEcCCC--CceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~--~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
+|+||||+||+++.++ ..+||+|||++.............|++.|+|||++. +.++.++|+||+|+++|
T Consensus 143 ~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~Di~slG~~l~ 213 (287)
T 2wei_A 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR---------GTYDEKCDVWSAGVILY 213 (287)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHT---------TCCCTHHHHHHHHHHHH
T ss_pred eccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhc---------CCCCCchhhHhHHHHHH
Confidence 6999999999997542 369999999987554433333446889999999874 34789999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCCC--CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
++++|..||.+...................+ ..+++++.+++.+||..||.+||++.++++ +.|+...
T Consensus 214 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--hp~~~~~ 283 (287)
T 2wei_A 214 ILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQKY 283 (287)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc--CHHHhcc
Confidence 9999999998766543332222222222222 468899999999999999999999999998 5665543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=176.70 Aligned_cols=136 Identities=29% Similarity=0.480 Sum_probs=106.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+|+||||+||+++.+ +.+||+|||++...... .......|+..|+|||++.+ ..++.++|+||+|+++|+
T Consensus 147 ~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ 217 (314)
T 3com_A 147 IHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE--------IGYNCVADIWSLGITAIE 217 (314)
T ss_dssp ECCCCSGGGEEECTT-CCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSS--------SCBCTTHHHHHHHHHHHH
T ss_pred cCCCcCHHHEEECCC-CCEEEeecccchhhhhhccccCccCCCCCccChhhcCC--------CCCCccccHHHHHHHHHH
Confidence 699999999999976 67999999999754332 22334578999999999853 567889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCC--CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
+++|..||............. .... ...+..++..+.+++.+||..||.+||++.++++ +.|+...
T Consensus 218 l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~--~~~~~~~ 285 (314)
T 3com_A 218 MAEGKPPYADIHPMRAIFMIP-TNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ--HPFVRSA 285 (314)
T ss_dssp HHHSSCTTTTSCHHHHHHHHH-HSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT--SHHHHTC
T ss_pred HHhCCCCCCCCChHHHHHHHh-cCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh--CHHHhcC
Confidence 999999998766544433222 2222 2235567899999999999999999999999999 6776543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-27 Score=180.23 Aligned_cols=142 Identities=23% Similarity=0.405 Sum_probs=98.2
Q ss_pred CCCCCCCCCeEEcCCCC--ceEEecccCcccCccc--------ccccCCCCccceecccccccccccccccCCCCchhhH
Q 029154 1 MGKFMKEDNLLLTPDQK--SLKLADFGLAREETVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 70 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~--~~kl~DfGla~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dv 70 (198)
|||||||+|||++.++. .+||+|||+++..... ......+||+.|+|||++..... ....++.++||
T Consensus 133 vH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~Di 209 (316)
T 2ac3_A 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE---EASIYDKRCDL 209 (316)
T ss_dssp CCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSH---HHHHHTTTHHH
T ss_pred eeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccc---cccCCCccccc
Confidence 79999999999986532 3999999998743211 11223469999999998742000 01346789999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCcH-------------HHHHHHHHccCCCCCC----CCCcHHHHHHHHHhcccCCCCCCC
Q 029154 71 YSFGIVLWELLTNRLPFEGMSNL-------------QAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPS 133 (198)
Q Consensus 71 ws~G~~l~e~~~g~~p~~~~~~~-------------~~~~~~~~~~~~~~~p----~~~~~~~~~l~~~~l~~dp~~Rps 133 (198)
||+||++|+|++|..||.+.... ...............| ..+++++.+|+.+||..||.+||+
T Consensus 210 wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps 289 (316)
T 2ac3_A 210 WSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS 289 (316)
T ss_dssp HHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCC
Confidence 99999999999999999765321 1111122222333333 357899999999999999999999
Q ss_pred HHHHHHHHHHHHhh
Q 029154 134 FSQIIRMLNAFLFT 147 (198)
Q Consensus 134 ~~~~l~~l~~~~~~ 147 (198)
+.++++ +.|+..
T Consensus 290 ~~e~l~--hp~~~~ 301 (316)
T 2ac3_A 290 AAQVLQ--HPWVQG 301 (316)
T ss_dssp HHHHHH--STTCC-
T ss_pred HHHHhc--ChhhcC
Confidence 999999 666554
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=180.79 Aligned_cols=137 Identities=20% Similarity=0.242 Sum_probs=101.1
Q ss_pred CCCCCCCCCeEEcC------------------CCCceEEecccCcccCcccccccCCCCccceecccccccccccccccC
Q 029154 1 MGKFMKEDNLLLTP------------------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62 (198)
Q Consensus 1 iH~dlKp~NIll~~------------------~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 62 (198)
|||||||+|||+.. ..+.+||+|||+++..... .....||+.|+|||++.+ .
T Consensus 145 vH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~ 214 (355)
T 2eu9_A 145 THTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILE--------L 214 (355)
T ss_dssp ECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTT--------C
T ss_pred ccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeec--------C
Confidence 69999999999932 2367999999999754322 245679999999999853 5
Q ss_pred CCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHH-ccCCC-----------------------------------
Q 029154 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF-KHARP----------------------------------- 106 (198)
Q Consensus 63 ~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~-~~~~~----------------------------------- 106 (198)
.++.++||||+||++|||++|..||.+............ ....+
T Consensus 215 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (355)
T 2eu9_A 215 GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK 294 (355)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC
T ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCC
Confidence 688999999999999999999999987664432211111 00000
Q ss_pred ------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 107 ------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 107 ------~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
......+.++.+|+.+||..||.+|||+.++++ +.|+....
T Consensus 295 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~--hp~f~~~~ 341 (355)
T 2eu9_A 295 PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL--HPFFAGLT 341 (355)
T ss_dssp CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT--SGGGGGCC
T ss_pred cccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc--ChhhcCCC
Confidence 000112457889999999999999999999998 77776543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-27 Score=180.09 Aligned_cols=128 Identities=23% Similarity=0.433 Sum_probs=101.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+.+.+||+|||+++..... ......||+.|+|||++.+ ...++.++||||||+++|++
T Consensus 171 vH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el 242 (320)
T 3a99_A 171 LHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYDM 242 (320)
T ss_dssp ECCCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHH-------SCBCHHHHHHHHHHHHHHHH
T ss_pred EeCCCCHHHEEEeCCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhcc-------CCCCCccchHHhHHHHHHHH
Confidence 699999999999854478999999999765432 2345679999999998753 23346789999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++|..||..... . .......+..+++++.+++.+||..||.+||++.++++ +.|+.
T Consensus 243 ~~g~~pf~~~~~---~-----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--hp~~~ 298 (320)
T 3a99_A 243 VCGDIPFEHDEE---I-----IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQ 298 (320)
T ss_dssp HHSSCSCCSHHH---H-----HHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGS
T ss_pred HHCCCCCCChhh---h-----hcccccccccCCHHHHHHHHHHccCChhhCcCHHHHhc--CHhhc
Confidence 999999975321 1 12234456778999999999999999999999999998 55544
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=176.13 Aligned_cols=141 Identities=24% Similarity=0.391 Sum_probs=106.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+|+||||+||+++.+ +.+||+|||++.............|++.|+|||++.+... .....++.++|+||+|+++|++
T Consensus 146 ~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~~Di~slG~~l~~l 222 (298)
T 1phk_A 146 VHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN--DNHPGYGKEVDMWSTGVIMYTL 222 (298)
T ss_dssp ECSCCSGGGEEECTT-CCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHC--TTSCCBCTHHHHHHHHHHHHHH
T ss_pred ccCCCCcceEEEcCC-CcEEEecccchhhcCCCcccccccCCccccCHHHhccccc--cccccCCcccccHhHHHHHHHH
Confidence 699999999999976 6799999999976554444455679999999998742110 0124578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCC--CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++|..||.+...................+ ..++..+.+++.+||..||.+||++.++++ +.|+.
T Consensus 223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~ 288 (298)
T 1phk_A 223 LAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA--HPFFQ 288 (298)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT--SGGGC
T ss_pred HHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh--ChHhh
Confidence 99999998766543332222222222222 357899999999999999999999999998 66654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.93 E-value=8e-27 Score=182.76 Aligned_cols=136 Identities=18% Similarity=0.250 Sum_probs=98.1
Q ss_pred CCCCCCCCCeEEcCC-----CCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD-----QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~-----~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
|||||||+|||++.+ ...+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||
T Consensus 154 vH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~ 223 (373)
T 1q8y_A 154 IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG--------APWGCGADIWSTAC 223 (373)
T ss_dssp ECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT--------CCCCTHHHHHHHHH
T ss_pred EecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhC--------CCCCchHhHHHHHH
Confidence 699999999999532 236999999999754432 345678999999999853 56889999999999
Q ss_pred HHHHHHcCCCCCCCCCcH-----HHHHHHHH---cc--------------------------------------CCCCCC
Q 029154 76 VLWELLTNRLPFEGMSNL-----QAAYAAAF---KH--------------------------------------ARPGLP 109 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~-----~~~~~~~~---~~--------------------------------------~~~~~p 109 (198)
++|+|++|..||.+.... ........ .. .....+
T Consensus 224 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (373)
T 1q8y_A 224 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 303 (373)
T ss_dssp HHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCC
T ss_pred HHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCC
Confidence 999999999999754311 11111110 00 011223
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 110 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 110 ~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
..++.++.+|+.+||..||.+|||+.++++ +.|+...
T Consensus 304 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~ 340 (373)
T 1q8y_A 304 KDEAKEISDFLSPMLQLDPRKRADAGGLVN--HPWLKDT 340 (373)
T ss_dssp HHHHHHHHHHHGGGGCSSTTTCBCHHHHHT--CGGGTTC
T ss_pred cchHHHHHHHHHHHhccCccccCCHHHHhh--Chhhhcc
Confidence 345678899999999999999999999999 7777654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.3e-27 Score=179.63 Aligned_cols=138 Identities=22% Similarity=0.397 Sum_probs=105.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc----ccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
+||||||+|||++.+ +.+||+|||+++....... .....++..|+|||++.+ ..++.++||||+|++
T Consensus 167 vH~dikp~NIli~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~i 237 (326)
T 2w1i_A 167 IHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE--------SKFSVASDVWSFGVV 237 (326)
T ss_dssp ECSCCCGGGEEEEET-TEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH--------CEEEHHHHHHHHHHH
T ss_pred eccCCCcceEEEcCC-CcEEEecCcchhhccccccccccccCCCCceeEECchhhcC--------CCCCchhhHHHHHHH
Confidence 699999999999966 6899999999975433221 223456788999999853 456889999999999
Q ss_pred HHHHHcCCCCCCCCCcH---------------HHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 029154 77 LWELLTNRLPFEGMSNL---------------QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 141 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l 141 (198)
+|++++|..|+...... .............+.+..+++++.+++.+||..||.+||++.++++.|
T Consensus 238 l~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L 317 (326)
T 2w1i_A 238 LYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317 (326)
T ss_dssp HHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999887532100 011122223344566778999999999999999999999999999999
Q ss_pred HHHHhh
Q 029154 142 NAFLFT 147 (198)
Q Consensus 142 ~~~~~~ 147 (198)
+.+...
T Consensus 318 ~~l~~~ 323 (326)
T 2w1i_A 318 DQIRDQ 323 (326)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-27 Score=186.41 Aligned_cols=146 Identities=23% Similarity=0.384 Sum_probs=104.5
Q ss_pred CCCCCCCCCeEE----cCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLL----TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll----~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||+ +.+ +.+||+|||+++...........+||..|+|||++............++.++|||||||+
T Consensus 134 vH~Dlkp~NIll~~~~~~~-~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~i 212 (396)
T 4eut_A 134 VHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212 (396)
T ss_dssp ECCCCCGGGEEEEECTTSC-EEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHH
T ss_pred EECCcCHHHEEEeecCCCc-eeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHH
Confidence 699999999998 533 569999999998665555555678999999999874311100001346789999999999
Q ss_pred HHHHHcCCCCCCCCCc---HHHHHHHHHccCCCC------------------------CCCCCcHHHHHHHHHhcccCCC
Q 029154 77 LWELLTNRLPFEGMSN---LQAAYAAAFKHARPG------------------------LPEDISPDLAFIVQSCWVEDPN 129 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~---~~~~~~~~~~~~~~~------------------------~p~~~~~~~~~l~~~~l~~dp~ 129 (198)
+|||++|..||..... ............+.. ++..++..+.+++.+||..||.
T Consensus 213 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~ 292 (396)
T 4eut_A 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292 (396)
T ss_dssp HHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTT
T ss_pred HHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChh
Confidence 9999999999964221 112222222222211 1122456788999999999999
Q ss_pred CCCCHHHHHHHHHHHHhh
Q 029154 130 LRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 130 ~Rps~~~~l~~l~~~~~~ 147 (198)
+||++.++++.+..++..
T Consensus 293 ~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 293 KCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TSCCHHHHHHHHHHHHTC
T ss_pred hhccHHHHHHHHHHHhhc
Confidence 999999999999888764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8e-27 Score=175.98 Aligned_cols=133 Identities=26% Similarity=0.390 Sum_probs=85.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+||+++.+ +.+||+|||++...... .......||+.|+|||++.+ ..++.++|+||+|+++|+
T Consensus 134 ~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ 204 (278)
T 3cok_A 134 LHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR--------SAHGLESDVWSLGCMFYT 204 (278)
T ss_dssp ECSSCCGGGEEECTT-CCEEECCCTTCEECC------------------------------------CTHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCC-CCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcC--------CCCCchhhHHHHHHHHHH
Confidence 699999999999976 67999999999754322 22234578999999998853 557889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+++|..||......... ..........|..++.++.+++.+||..||.+||++.++++ +.|+.
T Consensus 205 l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~ 267 (278)
T 3cok_A 205 LLIGRPPFDTDTVKNTL--NKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD--HPFMS 267 (278)
T ss_dssp HHHSSCSSCCCSCC-------CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--STTTC
T ss_pred HHhCCCCCCChhHHHHH--HHHhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc--Ccccc
Confidence 99999999765432211 11122334557778999999999999999999999999998 55543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5e-27 Score=180.80 Aligned_cols=134 Identities=25% Similarity=0.371 Sum_probs=99.7
Q ss_pred CCCCCCCCCeEEcCCC--CceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~--~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.++ ..+||+|||+++............||+.|+|||++... ....++.++||||||+++|
T Consensus 136 vH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~ 210 (322)
T 2ycf_A 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV-----GTAGYNRAVDCWSLGVILF 210 (322)
T ss_dssp ECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHT-----TTTTCTTHHHHHHHHHHHH
T ss_pred eccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccC-----CCCCCCchhhHHHHHHHHH
Confidence 6999999999998652 24999999999865443333345689999999986320 1356789999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCC---CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARP---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
++++|..||................... ..+..+++++.+++.+||..||.+||++.++++
T Consensus 211 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 211 ICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 9999999997654321111111111111 123467899999999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.1e-27 Score=178.32 Aligned_cols=135 Identities=26% Similarity=0.380 Sum_probs=100.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc---ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
+||||||+||+++.+ +.+||+|||+++..... .......||+.|+|||++.+ .++.++|+||||+++
T Consensus 155 ~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---------~~~~~~Dv~slG~il 224 (307)
T 2nru_A 155 IHRDIKSANILLDEA-FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG---------EITPKSDIYSFGVVL 224 (307)
T ss_dssp ECSCCCGGGEEECTT-CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT---------EECTHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCC-CcEEEeecccccccccccccccccccCCCcCcCChHHhcC---------CCCccchhHHHHHHH
Confidence 699999999999966 68999999998754321 11234578999999998742 468899999999999
Q ss_pred HHHHcCCCCCCCCCcHH---HHHHHHHc----------cCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 78 WELLTNRLPFEGMSNLQ---AAYAAAFK----------HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~---~~~~~~~~----------~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
|++++|..||.+..... ........ ......+...+..+.+++.+||..||.+||++.+++++|+.+
T Consensus 225 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 225 LEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 99999999997643211 11111110 111112233456789999999999999999999999999876
Q ss_pred H
Q 029154 145 L 145 (198)
Q Consensus 145 ~ 145 (198)
.
T Consensus 305 ~ 305 (307)
T 2nru_A 305 T 305 (307)
T ss_dssp C
T ss_pred h
Confidence 3
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=178.01 Aligned_cols=134 Identities=25% Similarity=0.440 Sum_probs=104.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCc-hhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNN-KVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||++...... ......|+..|+|||++.+ ...++. ++|+||+|+++|+
T Consensus 174 ~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~~Di~slG~il~~ 244 (348)
T 2pml_X 174 CHRDVKPSNILMDKN-GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSN-------ESSYNGAKVDIWSLGICLYV 244 (348)
T ss_dssp ECCCCCGGGEEECTT-SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSS-------CCCEEHHHHHHHHHHHHHHH
T ss_pred eecCCChHhEEEcCC-CcEEEeccccccccccc-cccCCCCCcCccCchhhcC-------CCCCCcchhhHHHHHHHHHH
Confidence 699999999999976 68999999999754332 3345678999999999854 124555 9999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCC-------------------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLP-------------------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 140 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p-------------------~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~ 140 (198)
+++|..||............ ........| ..+++++.+++.+||..||.+||++.++++
T Consensus 245 l~~g~~pf~~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~- 322 (348)
T 2pml_X 245 MFYNVVPFSLKISLVELFNN-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK- 322 (348)
T ss_dssp HHHSSCSSCCSSCSHHHHHH-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT-
T ss_pred HHhCCCCCCCCCcHHHHHHH-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc-
Confidence 99999999876652333222 223333344 568899999999999999999999999998
Q ss_pred HHHHHh
Q 029154 141 LNAFLF 146 (198)
Q Consensus 141 l~~~~~ 146 (198)
+.|+.
T Consensus 323 -hp~f~ 327 (348)
T 2pml_X 323 -HEWLA 327 (348)
T ss_dssp -SGGGT
T ss_pred -Ccccc
Confidence 55543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=176.51 Aligned_cols=129 Identities=26% Similarity=0.464 Sum_probs=102.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
+||||||+||+++.+.+.+||+|||+++..... ......|+..|+|||++.+ ....+.++||||+|+++|++
T Consensus 161 ~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l 232 (312)
T 2iwi_A 161 VHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISR-------HQYHALPATVWSLGILLYDM 232 (312)
T ss_dssp ECCCCSGGGEEEETTTTEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHH-------SCBCHHHHHHHHHHHHHHHH
T ss_pred eecCCChhhEEEeCCCCeEEEEEcchhhhcccC-cccccCCcccccCceeeec-------CCCCCccchHHHHHHHHHHH
Confidence 699999999999844478999999999755432 2345678999999998753 22334589999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
++|..||..... ........+..+++++.+++.+||..||.+||++.++++ +.|+..
T Consensus 233 ~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~--~~~~~~ 289 (312)
T 2iwi_A 233 VCGDIPFERDQE--------ILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL--DPWMQT 289 (312)
T ss_dssp HHSSCSCCSHHH--------HHHTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH--STTTCC
T ss_pred HHCCCCCCChHH--------HhhhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc--ChhhcC
Confidence 999999975221 112344567789999999999999999999999999998 666543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=179.37 Aligned_cols=137 Identities=23% Similarity=0.363 Sum_probs=83.9
Q ss_pred CCCCCCCCCeEEcCC--CCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~--~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ .+.+||+|||+++..... .....+||+.|+|||++.+ ..++.++||||+|+++|
T Consensus 150 vH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 220 (336)
T 3fhr_A 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMY 220 (336)
T ss_dssp ECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------------------------------CHHHHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCC--------CCCCchhhHHHHHHHHH
Confidence 699999999999753 245999999999754432 2345678999999999843 55788999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHH--HHHH----ccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 79 ELLTNRLPFEGMSNLQAAY--AAAF----KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~--~~~~----~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
++++|..||.+........ .... ..........+++++.+|+.+||..||.+|||+.++++ +.|+...
T Consensus 221 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~ 294 (336)
T 3fhr_A 221 ILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN--HPWINQS 294 (336)
T ss_dssp HHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH--SHHHHTG
T ss_pred HHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc--Ccccccc
Confidence 9999999997654322110 0101 11112223568999999999999999999999999999 7777643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=173.15 Aligned_cols=130 Identities=16% Similarity=0.283 Sum_probs=101.1
Q ss_pred CCCCCCCCCeEEcCC------------------CCceEEecccCcccCcccccccCCCCccceecccccccccccccccC
Q 029154 1 MGKFMKEDNLLLTPD------------------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62 (198)
Q Consensus 1 iH~dlKp~NIll~~~------------------~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 62 (198)
|||||||+|||++.+ ...+||+|||++...... ....||..|+|||++.+ ..
T Consensus 137 vH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~-------~~ 206 (289)
T 1x8b_A 137 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQE-------NY 206 (289)
T ss_dssp ECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTT-------CC
T ss_pred eecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcC-------CC
Confidence 699999999999843 236899999998755432 23468999999999853 23
Q ss_pred CCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 63 ~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
.++.++||||+|+++|++++|.+++..... .........+..+..+++++.+++.+||..||.+||++.++++ +
T Consensus 207 ~~~~~~Di~slG~il~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--h 280 (289)
T 1x8b_A 207 THLPKADIFALALTVVCAAGAEPLPRNGDQ----WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK--H 280 (289)
T ss_dssp TTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT--C
T ss_pred CCCchhhHHHHHHHHHHHhcCCCCCcchhH----HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh--C
Confidence 556799999999999999999887754322 2333445556778889999999999999999999999999998 5
Q ss_pred HHHh
Q 029154 143 AFLF 146 (198)
Q Consensus 143 ~~~~ 146 (198)
.|+.
T Consensus 281 ~~~~ 284 (289)
T 1x8b_A 281 SVLL 284 (289)
T ss_dssp TTC-
T ss_pred hHhh
Confidence 5543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=176.38 Aligned_cols=139 Identities=27% Similarity=0.457 Sum_probs=101.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
+||||||+|||++.+ +.+||+|||++..... ........|+..|+|||++..... ....++.++|+||+|+++|+
T Consensus 139 ~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Di~slG~il~~ 214 (302)
T 2j7t_A 139 IHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM---KDTPYDYKADIWSLGITLIE 214 (302)
T ss_dssp CCCCCSGGGEEECTT-SCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHT---TSTTTTTHHHHHHHHHHHHH
T ss_pred ccCCCCHHHEEECCC-CCEEEEECCCCccccccccccccccCChhhcCCeeeccccC---CCCCCchhhhHHHHHHHHHH
Confidence 699999999999976 6799999998753221 112234578999999998732100 13567889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC--CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|++|..||............. ....+ ..+..++.++.+++.+||..||.+||++.++++ +.|+.
T Consensus 215 l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~ 280 (302)
T 2j7t_A 215 MAQIEPPHHELNPMRVLLKIA-KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE--HPFVS 280 (302)
T ss_dssp HHHSSCTTTTSCHHHHHHHHH-HSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT--STTTT
T ss_pred HhcCCCCCccCCHHHHHHHHh-ccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc--ChHHh
Confidence 999999998766544333222 22222 234568899999999999999999999999988 55543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.6e-27 Score=178.66 Aligned_cols=138 Identities=22% Similarity=0.311 Sum_probs=100.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----------cccCCCCccceecccccccccccccccCCCCchhhH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 70 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dv 70 (198)
+||||||+|||++.+ +.+||+|||++....... ......||+.|+|||++.+. ....++.++||
T Consensus 156 vH~dlkp~NIl~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di 229 (317)
T 2buj_A 156 AHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ-----SHCVIDERTDV 229 (317)
T ss_dssp ECCCCCGGGEEECTT-SCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC-----SEEEECTHHHH
T ss_pred ccCCCCHHHEEEcCC-CCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccC-----CCcCCCchhhH
Confidence 699999999999876 679999999987432211 01123578999999987531 01236789999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCcHH-HHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 71 YSFGIVLWELLTNRLPFEGMSNLQ-AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 71 ws~G~~l~e~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
||||+++|++++|..||....... ............+.+..+++++.+++.+||..||.+||++.+++++|+.+
T Consensus 230 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 230 WSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp HHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 999999999999999985311000 01111222333344556899999999999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=179.12 Aligned_cols=134 Identities=16% Similarity=0.111 Sum_probs=101.4
Q ss_pred CCCCCCCCCeEEcCC----------CCceEEecccCcccC---cccccccCCCCccceecccccccccccccccCCCCch
Q 029154 1 MGKFMKEDNLLLTPD----------QKSLKLADFGLAREE---TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 67 (198)
Q Consensus 1 iH~dlKp~NIll~~~----------~~~~kl~DfGla~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 67 (198)
|||||||+|||++.+ .+.+||+|||+++.. .........+||+.|+|||++.+ ..++.+
T Consensus 194 vHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~ 265 (365)
T 3e7e_A 194 IHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN--------KPWNYQ 265 (365)
T ss_dssp ECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT--------CCBSTH
T ss_pred ecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC--------CCCCcc
Confidence 699999999999861 367999999999643 22333456789999999999854 568999
Q ss_pred hhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHHHh
Q 029154 68 VDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR-PSFSQIIRMLNAFLF 146 (198)
Q Consensus 68 ~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~R-ps~~~~l~~l~~~~~ 146 (198)
+|||||||++|||++|+.||....... ............++...+++.+||..+|.+| |++.++.+.|+.++.
T Consensus 266 ~DiwslG~il~elltg~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 266 IDYFGVAATVYCMLFGTYMKVKNEGGE------CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp HHHHHHHHHHHHHHHSSCCCEEEETTE------EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhCCCccccCCCCc------eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 999999999999999999985432200 0000111111246778899999999999999 688999999988876
Q ss_pred hc
Q 029154 147 TL 148 (198)
Q Consensus 147 ~~ 148 (198)
..
T Consensus 340 ~~ 341 (365)
T 3e7e_A 340 QH 341 (365)
T ss_dssp HH
T ss_pred Hh
Confidence 53
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=182.13 Aligned_cols=132 Identities=23% Similarity=0.357 Sum_probs=91.9
Q ss_pred CCCCCCCCCeEEcCC----CCceEEecccCcccCccc----ccccCCCCccceecccccccccccccccCCCCchhhHHH
Q 029154 1 MGKFMKEDNLLLTPD----QKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 72 (198)
Q Consensus 1 iH~dlKp~NIll~~~----~~~~kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws 72 (198)
|||||||+|||++.+ ...+||+|||+++..... ......+||+.|+|||++... ....++.++||||
T Consensus 140 vHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~t~~~DiwS 214 (432)
T 3p23_A 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED-----CKENPTYTVDIFS 214 (432)
T ss_dssp CCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC--------CCCTHHHHHH
T ss_pred EeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcc-----cccCCCcHHHHHH
Confidence 799999999999532 135789999999754322 123346799999999998531 1245678999999
Q ss_pred HHHHHHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCC---CCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 73 FGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGL---PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 73 ~G~~l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~---p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
+||++|||++ |..||......... .......... +...+..+.+|+.+||..||.+||++.++++
T Consensus 215 lG~il~ellt~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 215 AGCVFYYVISEGSHPFGKSLQRQAN--ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHHHHHHHTTSCBTTBSTTTHHHH--HHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCCCCcchhhHHHHH--HHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 9999999999 88998654433222 2222211111 1224566889999999999999999999996
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=175.63 Aligned_cols=135 Identities=27% Similarity=0.513 Sum_probs=99.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc------ccccCCCCccceecccccccccccccccCCCCchhhHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 74 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G 74 (198)
+||||||+||+++.+ +.+||+|||++...... .......||+.|+|||++.+ ...++.++|+||+|
T Consensus 143 ~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG 214 (303)
T 2vwi_A 143 IHRDVKAGNILLGED-GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ-------VRGYDFKADIWSFG 214 (303)
T ss_dssp CCCCCSGGGEEECTT-CCEEECCCHHHHHCC---------------CCCTTCCHHHHHH-------HHCCCTHHHHHHHH
T ss_pred CCCCCChhhEEEcCC-CCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcc-------ccCCCchhhHHHHH
Confidence 699999999999976 67999999998643221 11234578999999998743 24578999999999
Q ss_pred HHHHHHHcCCCCCCCCCcHHHHHHHHHccCCC---------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 75 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARP---------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 75 ~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~---------~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
+++|+|++|..||............ .....+ .....++.++.+++.+||..||.+||++.++++ +.|+
T Consensus 215 ~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--h~~~ 291 (303)
T 2vwi_A 215 ITAIELATGAAPYHKYPPMKVLMLT-LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR--HKFF 291 (303)
T ss_dssp HHHHHHHHSSCTTTTSCGGGHHHHH-HTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT--STTC
T ss_pred HHHHHHHhCCCCCccCchhhHHHHH-hccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh--Chhh
Confidence 9999999999999876654333222 222221 123457889999999999999999999999998 5554
Q ss_pred h
Q 029154 146 F 146 (198)
Q Consensus 146 ~ 146 (198)
.
T Consensus 292 ~ 292 (303)
T 2vwi_A 292 Q 292 (303)
T ss_dssp -
T ss_pred h
Confidence 4
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.7e-26 Score=181.33 Aligned_cols=136 Identities=20% Similarity=0.390 Sum_probs=93.6
Q ss_pred CCCCCCCCCeEEcCC------------CCceEEecccCcccCcccc-----cccCCCCccceecccccccccccccccCC
Q 029154 1 MGKFMKEDNLLLTPD------------QKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKH 63 (198)
Q Consensus 1 iH~dlKp~NIll~~~------------~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 63 (198)
|||||||+|||++.+ ...+||+|||+++...... .....+||+.|+|||++.+.... .....
T Consensus 137 vHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~ 215 (434)
T 2rio_A 137 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL-QTKRR 215 (434)
T ss_dssp ECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTT-SCCCC
T ss_pred cccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccccc-ccccC
Confidence 699999999999743 2479999999998543321 12345799999999998531100 01256
Q ss_pred CCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHccCCCC-CC----CCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 029154 64 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG-LP----EDISPDLAFIVQSCWVEDPNLRPSFSQI 137 (198)
Q Consensus 64 ~~~~~Dvws~G~~l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~-~p----~~~~~~~~~l~~~~l~~dp~~Rps~~~~ 137 (198)
++.++||||+||++|||++ |..||......... ......... .+ ..+++++.+++.+||..||.+||++.++
T Consensus 216 ~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~--i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei 293 (434)
T 2rio_A 216 LTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN--IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293 (434)
T ss_dssp CCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHH--HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHH--HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHH
Confidence 7899999999999999998 89999765543322 111111111 11 1245789999999999999999999999
Q ss_pred HH
Q 029154 138 IR 139 (198)
Q Consensus 138 l~ 139 (198)
++
T Consensus 294 l~ 295 (434)
T 2rio_A 294 LR 295 (434)
T ss_dssp HT
T ss_pred Hh
Confidence 87
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-26 Score=172.01 Aligned_cols=132 Identities=25% Similarity=0.458 Sum_probs=92.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc---------------ccccCCCCccceecccccccccccccccCCCC
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT---------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 65 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 65 (198)
+||||||+|||++.+ +.+||+|||++...... .......|+..|+|||++.+ ...++
T Consensus 138 ~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~ 209 (303)
T 1zy4_A 138 IHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG-------TGHYN 209 (303)
T ss_dssp CCSCCCGGGEEECTT-SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTS-------CSCCC
T ss_pred ecccCCHHhEEEcCC-CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC-------CCCCc
Confidence 699999999999976 67999999998754321 12234568999999999753 24678
Q ss_pred chhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHc---cCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 66 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK---HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 66 ~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
.++|+||+|+++|+|++ ||............... ..++..+...++.+.+++.+||..||.+||++.++++ +
T Consensus 210 ~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--h 284 (303)
T 1zy4_A 210 EKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN--S 284 (303)
T ss_dssp THHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH--S
T ss_pred chhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC--C
Confidence 99999999999999998 55432222222222211 1223344557788999999999999999999999998 4
Q ss_pred HHH
Q 029154 143 AFL 145 (198)
Q Consensus 143 ~~~ 145 (198)
.|+
T Consensus 285 ~~~ 287 (303)
T 1zy4_A 285 GWL 287 (303)
T ss_dssp SCS
T ss_pred CCc
Confidence 443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=174.96 Aligned_cols=130 Identities=25% Similarity=0.299 Sum_probs=93.5
Q ss_pred CCCCCCCCCeEEcCCCC--ceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQK--SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~--~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.++. .+||+|||++.............||..|+|||++.+ ..++.++||||+|+++|
T Consensus 143 VHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~s~ksDIwSLGviLy 214 (676)
T 3qa8_A 143 IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ--------KKYTVTVDYWSFGTLAF 214 (676)
T ss_dssp CCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCC--------SCCSTTHHHHHHHHHHH
T ss_pred ccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhcc--------CCCCchhHHHHHHHHHH
Confidence 79999999999986532 389999999986655444556789999999999853 67889999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHH--------HH-HHc---------cCCC----CCCCCCcHHHHHHHHHhcccCCCCCCCHHH
Q 029154 79 ELLTNRLPFEGMSNLQAAY--------AA-AFK---------HARP----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 136 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~--------~~-~~~---------~~~~----~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~ 136 (198)
++++|..||.+........ .. ... .... .+...+++.+.+++.+||..||.+||++.+
T Consensus 215 eLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 215 ECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp HHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred HHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 9999999997643221100 00 000 0000 112235688999999999999999999988
Q ss_pred HH
Q 029154 137 II 138 (198)
Q Consensus 137 ~l 138 (198)
++
T Consensus 295 lL 296 (676)
T 3qa8_A 295 NP 296 (676)
T ss_dssp CC
T ss_pred Hh
Confidence 43
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.9e-23 Score=156.99 Aligned_cols=118 Identities=23% Similarity=0.495 Sum_probs=85.1
Q ss_pred CCCCCCCCCeEEcCC--CCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~--~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ .+.+||+|||++.... ...++.++|+||+||++|
T Consensus 139 ~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-----------------------------~~~~~~~~DiwslG~il~ 189 (299)
T 3m2w_A 139 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-----------------------------GEKYDKSCDMWSLGVIMY 189 (299)
T ss_dssp ECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-----------------------------TCGGGGHHHHHHHHHHHH
T ss_pred ccCCCCHHHEEEecCCCCCcEEEeccccccccc-----------------------------cccCCchhhHHHHHHHHH
Confidence 699999999999862 3679999999885321 123578899999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHH--HHHccCCCCCC----CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 79 ELLTNRLPFEGMSNLQAAYA--AAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~--~~~~~~~~~~p----~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
+|++|..||.+......... ..........+ ..+++++.+++.+||..||.+||++.++++ +.|+....
T Consensus 190 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~--hp~~~~~~ 264 (299)
T 3m2w_A 190 ILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQST 264 (299)
T ss_dssp HHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHTGG
T ss_pred HHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc--Chhhcccc
Confidence 99999999976443221100 00001111222 457899999999999999999999999999 77776543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-22 Score=170.70 Aligned_cols=122 Identities=21% Similarity=0.190 Sum_probs=91.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ .+||+|||+++..... ...+||+.|+|||++.+ .++.++|||||||++|+|
T Consensus 204 iHrDlkp~NIll~~~--~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~---------~~~~~sDi~slG~~l~~l 269 (681)
T 2pzi_A 204 VYNDLKPENIMLTEE--QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRT---------GPTVATDIYTVGRTLAAL 269 (681)
T ss_dssp ECCCCSGGGEEECSS--CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHH---------CSCHHHHHHHHHHHHHHH
T ss_pred eecccChHHeEEeCC--cEEEEecccchhcccC---CccCCCccccCHHHHcC---------CCCCceehhhhHHHHHHH
Confidence 699999999999854 6999999999765432 45679999999998753 348899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCC-CCCCcHHHHHHHHHhcccCCCCCCC-HHHHHHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPS-FSQIIRMLNAFL 145 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~l~~~~l~~dp~~Rps-~~~~l~~l~~~~ 145 (198)
++|..||.+.... ...... ....++.+.+++.+||..||.+||+ ++++...|..++
T Consensus 270 ~~g~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 270 TLDLPTRNGRYVD---------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HSCCCEETTEECS---------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HhCCCCCcccccc---------cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 9999887642110 000000 0113578899999999999999985 566666665544
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.84 E-value=2.3e-22 Score=155.60 Aligned_cols=121 Identities=13% Similarity=0.105 Sum_probs=85.6
Q ss_pred CCCCCCCCCeEEcCCC-------------------CceEEecccCcccCcccccccCCCCccceeccccccccccccccc
Q 029154 1 MGKFMKEDNLLLTPDQ-------------------KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61 (198)
Q Consensus 1 iH~dlKp~NIll~~~~-------------------~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 61 (198)
|||||||+|||++.++ ..+||+|||+++..... ..+||+.|+|||++.+
T Consensus 184 vHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g-------- 251 (336)
T 2vuw_A 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG-------- 251 (336)
T ss_dssp BCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC--------
T ss_pred eECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC--------
Confidence 7999999999999663 17999999999854432 3478999999999854
Q ss_pred CCCCchhhHHHHHHH-HHHHHcCCCCCCCCCcHHHHHHHHHccCC--CC----CCCCCcHHHHHHHHHhcccCCCCCCCH
Q 029154 62 KHYNNKVDVYSFGIV-LWELLTNRLPFEGMSNLQAAYAAAFKHAR--PG----LPEDISPDLAFIVQSCWVEDPNLRPSF 134 (198)
Q Consensus 62 ~~~~~~~Dvws~G~~-l~e~~~g~~p~~~~~~~~~~~~~~~~~~~--~~----~p~~~~~~~~~l~~~~l~~dp~~Rps~ 134 (198)
..+.++||||++++ .++++.|..||.+................ .. .+..+++++.+|+.+||..| |+
T Consensus 252 -~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa 325 (336)
T 2vuw_A 252 -DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SA 325 (336)
T ss_dssp -CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SH
T ss_pred -CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CH
Confidence 23789999998776 77788899998532111111112221111 11 12236788999999999976 89
Q ss_pred HHHH-H
Q 029154 135 SQII-R 139 (198)
Q Consensus 135 ~~~l-~ 139 (198)
.|++ +
T Consensus 326 ~e~l~~ 331 (336)
T 2vuw_A 326 TDLLCQ 331 (336)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 9998 6
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.84 E-value=8.9e-22 Score=149.31 Aligned_cols=113 Identities=17% Similarity=0.177 Sum_probs=82.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+++|. ++ .++.++|||||||++|+|
T Consensus 151 vH~Dikp~NIll~~~-g~~kl~~~~~-------------------~~---------------~~~~~~Di~slG~il~el 195 (286)
T 3uqc_A 151 ALSIDHPSRVRVSID-GDVVLAYPAT-------------------MP---------------DANPQDDIRGIGASLYAL 195 (286)
T ss_dssp CCCCCSGGGEEEETT-SCEEECSCCC-------------------CT---------------TCCHHHHHHHHHHHHHHH
T ss_pred ccCCCCcccEEEcCC-CCEEEEeccc-------------------cC---------------CCCchhHHHHHHHHHHHH
Confidence 799999999999976 6788885432 21 257899999999999999
Q ss_pred HcCCCCCCCCCcHHHH---HHHHHccCCC--CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 81 LTNRLPFEGMSNLQAA---YAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~---~~~~~~~~~~--~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
++|+.||.+....... .......... ..+..+++++.+++.+||+.||.+| |+.++++.|+.......
T Consensus 196 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 196 LVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 9999999875532110 0000000000 1235688999999999999999999 99999999998765443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=3.2e-18 Score=140.91 Aligned_cols=73 Identities=14% Similarity=0.085 Sum_probs=44.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+||||+.+ +.+||+|||+++..... ....+.+||+.|++||++.+ .+...+|+||+|++.++
T Consensus 361 IHRDIKPeNILL~~d-g~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g---------~~~~~~d~~s~g~~~~~ 430 (569)
T 4azs_A 361 WHDDVRPWNVMVDAR-QHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE---------NKSWNGFWRSAPVHPFN 430 (569)
T ss_dssp EESCCCGGGEEECTT-SCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC--------------------------CC
T ss_pred eeccCchHhEEECCC-CCEEEeecccCeeCCCCCccccCceechhhccHHHhCC---------CCCCcccccccccchhh
Confidence 699999999999977 68999999999865432 22345689999999999853 45678999999998776
Q ss_pred HHcC
Q 029154 80 LLTN 83 (198)
Q Consensus 80 ~~~g 83 (198)
+.++
T Consensus 431 l~~~ 434 (569)
T 4azs_A 431 LPQP 434 (569)
T ss_dssp CCTT
T ss_pred hccc
Confidence 5443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=9.2e-14 Score=113.83 Aligned_cols=79 Identities=18% Similarity=0.250 Sum_probs=61.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--------ccCCCCccceecccccccccccccccCCCCchhhHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 72 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws 72 (198)
|||||||+|||++. .+||+|||+++....... ....+||+.|+|||++... ...|+..+|+|+
T Consensus 453 iHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~------~~~Y~~~~d~ws 523 (540)
T 3en9_A 453 IHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERF------LEGYKSVYDRWE 523 (540)
T ss_dssp ECTTCCTTSEEESS---SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHH------HHHHHHHCTTHH
T ss_pred ccCCCCHHHEEECC---eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHH------HHHHHHHHhHHH
Confidence 69999999999995 699999999986543221 1345799999999998531 134667789999
Q ss_pred HHHHHHHHHcCCCCCC
Q 029154 73 FGIVLWELLTNRLPFE 88 (198)
Q Consensus 73 ~G~~l~e~~~g~~p~~ 88 (198)
..+-..+.+.++.+|.
T Consensus 524 ~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 524 IILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHTCSCCC
T ss_pred HHHHHHHHHHhccccC
Confidence 9988888877766663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=7.6e-08 Score=72.45 Aligned_cols=37 Identities=16% Similarity=0.152 Sum_probs=30.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceeccccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY 51 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~ 51 (198)
|||||||+|||++ + +.+||+|||+++. +..++|||.+
T Consensus 215 iHrDlkp~NILl~-~-~~vkl~DFG~a~~------------~~~~~a~e~l 251 (282)
T 1zar_A 215 VHGDLSQYNVLVS-E-EGIWIIDFPQSVE------------VGEEGWREIL 251 (282)
T ss_dssp ECSCCSTTSEEEE-T-TEEEECCCTTCEE------------TTSTTHHHHH
T ss_pred EeCCCCHHHEEEE-C-CcEEEEECCCCeE------------CCCCCHHHHH
Confidence 6999999999999 5 7899999999863 2345777765
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=2.7e-07 Score=68.45 Aligned_cols=26 Identities=19% Similarity=0.254 Sum_probs=23.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLARE 29 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~ 29 (198)
|||||||+|||++. .++|+|||++..
T Consensus 193 vHrDlkp~NILl~~---~~~liDFG~a~~ 218 (258)
T 1zth_A 193 VHADLSEYNIMYID---KVYFIDMGQAVT 218 (258)
T ss_dssp ECSSCSTTSEEESS---SEEECCCTTCEE
T ss_pred EeCCCCHHHEEEcC---cEEEEECccccc
Confidence 69999999999985 699999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=97.18 E-value=8.6e-05 Score=58.21 Aligned_cols=28 Identities=14% Similarity=0.182 Sum_probs=22.2
Q ss_pred CCCCCCCCCeEEcCCCC---------ceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQK---------SLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~---------~~kl~DfGla~ 28 (198)
|||||||.|||++.++. .+.|+||+=+.
T Consensus 227 VHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 227 IHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp ECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred cCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence 79999999999986531 37899998554
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.11 E-value=6.5e-05 Score=56.78 Aligned_cols=86 Identities=15% Similarity=0.192 Sum_probs=45.6
Q ss_pred CCCCCCCCCeEEcCC-CCceEEecccCcccCcccccccCCCCccceeccccccccccccccc-------CCCCchhhHHH
Q 029154 1 MGKFMKEDNLLLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK-------KHYNNKVDVYS 72 (198)
Q Consensus 1 iH~dlKp~NIll~~~-~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-------~~~~~~~Dvws 72 (198)
+|+|+++.||+++.+ +..+.|+||+.+.................-..++.... .+..+.. .......+.|+
T Consensus 194 ~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~-~l~~Y~~~~~~~~~~r~~~~~~~~~ 272 (304)
T 3sg8_A 194 IHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSK-ILNHYKHKDIPTVLEKYRMKEKYWS 272 (304)
T ss_dssp ECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHH-HHHHHTCSCHHHHHHHHHHHHHHHH
T ss_pred EeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHH-HHHHcCCCCcHHHHHHHHHHHHHHH
Confidence 599999999999964 35678999998763211100000000000011111000 0000000 00112357899
Q ss_pred HHHHHHHHHcCCCCC
Q 029154 73 FGIVLWELLTNRLPF 87 (198)
Q Consensus 73 ~G~~l~e~~~g~~p~ 87 (198)
++.++|.+.+|..+|
T Consensus 273 l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 273 FEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHcCCHHH
Confidence 999999999998776
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.91 E-value=0.00026 Score=51.80 Aligned_cols=27 Identities=11% Similarity=-0.001 Sum_probs=22.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|++|.|||++.+ +.+.|+|||.+.
T Consensus 187 ~HgDl~~~Nil~~~~-~~~~liD~~~a~ 213 (264)
T 1nd4_A 187 THGDACLPNIMVENG-RFSGFIDCGRLG 213 (264)
T ss_dssp ECSSCCGGGEEEETT-EEEEECCCTTCE
T ss_pred ECCCCCCCcEEEECC-cEEEEEcchhcc
Confidence 699999999999854 446799999763
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0014 Score=48.19 Aligned_cols=26 Identities=15% Similarity=0.243 Sum_probs=21.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLA 27 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla 27 (198)
+|+|+++.|||++.+ ..+.|+||+.+
T Consensus 186 ~HgDl~~~Nil~~~~-~~~~lIDwe~a 211 (263)
T 3tm0_A 186 SHGDLGDSNIFVKDG-KVSGFIDLGRS 211 (263)
T ss_dssp ECSSCCTTSEEEETT-EEEEECCCTTC
T ss_pred ECCCCCcCcEEEECC-cEEEEEEchhc
Confidence 699999999999843 44679999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=96.15 E-value=0.002 Score=49.73 Aligned_cols=29 Identities=24% Similarity=0.378 Sum_probs=23.6
Q ss_pred CCCCCCCCCeEEcCCCC-ceEEecccCccc
Q 029154 1 MGKFMKEDNLLLTPDQK-SLKLADFGLARE 29 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~-~~kl~DfGla~~ 29 (198)
||+|+++.|||++.++. .+.|+||+.+..
T Consensus 219 vHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 219 VHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp ECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred EeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 69999999999986532 358999998753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.19 E-value=0.0074 Score=45.82 Aligned_cols=27 Identities=15% Similarity=0.145 Sum_probs=22.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+++.|||++.+ +.+.|+||+.+.
T Consensus 225 ~HgD~~~~Nil~~~~-~~~~lIDfe~a~ 251 (346)
T 2q83_A 225 CHQDYGTGNTLLGEN-EQIWVIDLDTVS 251 (346)
T ss_dssp ECSSCSTTSEEECGG-GCEEECCCTTCE
T ss_pred ecCCCCcccEEEeCC-CcEEEEehhhcc
Confidence 699999999999755 568999998763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.11 E-value=0.0079 Score=47.47 Aligned_cols=27 Identities=11% Similarity=0.148 Sum_probs=23.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCccc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLARE 29 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~ 29 (198)
+|+|+++.|||++.+ + ++|+||+.+..
T Consensus 235 iHGDl~~~Nil~~~~-~-~~lID~e~a~~ 261 (420)
T 2pyw_A 235 IHGDLHTGSVMVTQD-S-TQVIDPEFSFY 261 (420)
T ss_dssp ECSCCSGGGEEECSS-C-EEECCCTTCEE
T ss_pred EecCCCCCcEEEeCC-C-CEEEeCccccc
Confidence 699999999999865 4 99999998753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=94.78 E-value=0.013 Score=42.97 Aligned_cols=27 Identities=22% Similarity=0.212 Sum_probs=22.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+.+.|||++.+ +.+-|+||+.+.
T Consensus 196 ~HGDl~~~Nil~~~~-~~~~viDwe~a~ 222 (272)
T 4gkh_A 196 THGDFSLDNLIFDEG-KLIGCIDVGRVG 222 (272)
T ss_dssp ECSCCCTTSEEEETT-EEEEECCCTTCE
T ss_pred EcCCCCCCeEEEECC-eEEEEEECcccc
Confidence 699999999999854 556699998763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=94.65 E-value=0.014 Score=44.09 Aligned_cols=28 Identities=21% Similarity=0.247 Sum_probs=22.6
Q ss_pred CCCCCCCCCeEEcC---CCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTP---DQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~---~~~~~kl~DfGla~ 28 (198)
+|+|+++.|||++. ++..+.|+||+.+.
T Consensus 193 ~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 193 IHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp ECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred EeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 69999999999986 33445899999764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.22 E-value=0.015 Score=43.92 Aligned_cols=27 Identities=26% Similarity=0.279 Sum_probs=22.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
||+|+.+.|||++.+ ..+.|+||+.+.
T Consensus 190 iHgDl~~~Nil~~~~-~~~~lIDf~~a~ 216 (322)
T 2ppq_A 190 IHADLFQDNVFFLGD-ELSGLIDFYFAC 216 (322)
T ss_dssp ECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred CCCCCCccCEEEeCC-ceEEEecchhcc
Confidence 699999999999854 445799998763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=93.85 E-value=0.018 Score=44.22 Aligned_cols=27 Identities=11% Similarity=0.165 Sum_probs=22.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
||+|+.+.|||++. +..+.|+||+.+.
T Consensus 225 ~HgDl~~~Nil~~~-~~~~~vIDwe~a~ 251 (357)
T 3ats_A 225 LWGDARVGNVLYRD-FQPVAVLDWEMVA 251 (357)
T ss_dssp ECSSCSGGGEEEET-TEEEEECCGGGCE
T ss_pred EeCCCCCCeEEEeC-CcEEEEEcccccc
Confidence 69999999999984 3457899998763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.72 E-value=0.031 Score=42.29 Aligned_cols=25 Identities=24% Similarity=0.251 Sum_probs=21.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+++.|||++ + .+.|+||+.+.
T Consensus 198 ~HgD~~~~Nil~~-~--~~~lIDfe~a~ 222 (328)
T 1zyl_A 198 LHGDCHAGNILWR-D--GPMFVDLDDAR 222 (328)
T ss_dssp CCSSCSGGGEEES-S--SEEECCCTTCC
T ss_pred eeCCCCcccEeEc-C--CCEEEECCCCC
Confidence 6999999999998 4 58999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=93.21 E-value=0.03 Score=42.56 Aligned_cols=28 Identities=25% Similarity=0.393 Sum_probs=23.2
Q ss_pred CCCCCCCCCeEEcCC---CCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPD---QKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~---~~~~kl~DfGla~ 28 (198)
||+|+.+.||+++.+ ...+.|+||+.+.
T Consensus 186 vHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 186 VHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp ECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred EeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 699999999999853 1458999999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=92.92 E-value=0.43 Score=34.26 Aligned_cols=72 Identities=17% Similarity=0.222 Sum_probs=46.2
Q ss_pred ceecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHh
Q 029154 44 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123 (198)
Q Consensus 44 ~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~ 123 (198)
.+.+||... ...+.+.-|||+|+++|..+--..| ...+..+++++..|+..|
T Consensus 102 ~~~~pe~~~---------~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~M 153 (229)
T 2yle_A 102 PPVAGKLGY---------SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHM 153 (229)
T ss_dssp -----CCSS---------SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHH
T ss_pred CCCChhhcc---------ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHH
Confidence 456777642 2335788899999999988753322 122345888999999888
Q ss_pred ccc-------------------------CCCCCCCHHHHHHHHHH
Q 029154 124 WVE-------------------------DPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 124 l~~-------------------------dp~~Rps~~~~l~~l~~ 143 (198)
... .+..|.++++|++.-..
T Consensus 154 t~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 154 ANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp TTCCC--------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred HhcccccccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 755 24577888888876554
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=91.94 E-value=0.063 Score=41.81 Aligned_cols=26 Identities=12% Similarity=0.120 Sum_probs=22.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+.+.||+++.+ .+++.||..+.
T Consensus 230 ~HGDl~~~Nil~~~~--~~~lID~e~a~ 255 (397)
T 2olc_A 230 IHGDLHTGSIFASEH--ETKVIDPEFAF 255 (397)
T ss_dssp ECSCCSGGGEEECSS--CEEECCCTTCE
T ss_pred eeCCCCcCcEEEeCC--CeEEEeCcccc
Confidence 599999999999854 38999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=91.68 E-value=0.071 Score=41.11 Aligned_cols=26 Identities=27% Similarity=0.432 Sum_probs=21.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+.+.|||++.+ .+.|+||..+.
T Consensus 215 ~HgDl~~~Nil~~~~--~~~lID~e~a~ 240 (369)
T 3c5i_A 215 CHNDLQENNIINTNK--CLRLIDFEYSG 240 (369)
T ss_dssp ECSCCCGGGEEECC---CEEECCCTTCE
T ss_pred EeCCCCcccEEecCC--cEEEEEecCCC
Confidence 599999999999844 38999998765
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=90.64 E-value=0.075 Score=40.62 Aligned_cols=27 Identities=15% Similarity=0.235 Sum_probs=23.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+.+.||+++.+ +.+.|+||+.+.
T Consensus 209 ~HgD~~~~N~l~~~~-~~~~~iD~e~~~ 235 (339)
T 3i1a_A 209 CHSDIHAGNVLVGNE-ESIYIIDWDEPM 235 (339)
T ss_dssp ECSCCCGGGEEECGG-GCEEECCCSSCE
T ss_pred EeCCCCcCCEEEeCC-CeEEEEECCCCe
Confidence 599999999999854 468999998765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=90.45 E-value=0.097 Score=41.46 Aligned_cols=15 Identities=27% Similarity=0.352 Sum_probs=12.9
Q ss_pred CCCCCCCCCeEEcCC
Q 029154 1 MGKFMKEDNLLLTPD 15 (198)
Q Consensus 1 iH~dlKp~NIll~~~ 15 (198)
+|+|+.+.|||++.+
T Consensus 252 ~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 252 CHNDLQEGNILLPKA 266 (429)
T ss_dssp ECSCCCGGGEEEEC-
T ss_pred EeCCCCCCeEEeeCC
Confidence 599999999999864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=90.04 E-value=0.12 Score=38.59 Aligned_cols=26 Identities=15% Similarity=0.064 Sum_probs=21.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+.+.||+.+ + +.+.|+||..+.
T Consensus 176 ~HgDl~~~Nil~~-~-~~~~lID~e~a~ 201 (301)
T 3dxq_A 176 CHCDPLCENFLDT-G-ERMWIVDWEYSG 201 (301)
T ss_dssp ECSCCCGGGEEEC-S-SCEEECCCTTCE
T ss_pred eccCCCcCCEEEC-C-CCEEEEeccccc
Confidence 5999999999954 4 458999998765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=89.65 E-value=0.15 Score=40.79 Aligned_cols=13 Identities=15% Similarity=0.020 Sum_probs=12.2
Q ss_pred CCCCCCCCCeEEc
Q 029154 1 MGKFMKEDNLLLT 13 (198)
Q Consensus 1 iH~dlKp~NIll~ 13 (198)
+|+|+.+.|||++
T Consensus 293 cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 293 CHCDLLSSNIINT 305 (458)
T ss_dssp ECSCCCGGGEEEC
T ss_pred EecCCCCCcEEee
Confidence 5999999999998
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=89.21 E-value=0.17 Score=39.46 Aligned_cols=28 Identities=32% Similarity=0.466 Sum_probs=23.0
Q ss_pred CCCCCCCCCeEEcCC---CCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPD---QKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~---~~~~kl~DfGla~ 28 (198)
+|+|+.+.|||++.+ .+.+.|+||..+.
T Consensus 223 ~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 223 CHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp ECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 599999999999865 2468999998775
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.10 E-value=0.35 Score=37.79 Aligned_cols=28 Identities=29% Similarity=0.412 Sum_probs=22.6
Q ss_pred CCCCCCCCCeEEcC-----CCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTP-----DQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~-----~~~~~kl~DfGla~ 28 (198)
.|+|+.+.|||+.. +...+.++||-.|.
T Consensus 247 cHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 247 CHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp ECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred EEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 49999999999942 33568999998875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=82.18 E-value=0.55 Score=37.14 Aligned_cols=26 Identities=19% Similarity=0.460 Sum_probs=21.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+.+.||+ +.+ +.+.|+||..+.
T Consensus 265 ~H~D~~~~N~l-~~~-~~~~~IDwe~a~ 290 (424)
T 3mes_A 265 AHNDLQENNLL-QTQ-NNIRMIDYEYSA 290 (424)
T ss_dssp ECSCCCGGGEE-ECS-SCEEECCCTTCE
T ss_pred ECCCCCcccee-cCC-CcEEEEecccCC
Confidence 59999999999 534 679999998875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=80.70 E-value=0.5 Score=34.90 Aligned_cols=21 Identities=19% Similarity=0.167 Sum_probs=17.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEec
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLAD 23 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~D 23 (198)
||+|+.+.||+++.+ + ..+.|
T Consensus 191 vHGDlw~gNvl~~~~-g-~~~iD 211 (288)
T 3f7w_A 191 IHGDLWNGNVLWQDD-G-AVVID 211 (288)
T ss_dssp ECSCCSGGGEEEETT-E-EEECS
T ss_pred eecCCCCCcEEEcCC-C-eEEEe
Confidence 699999999999976 3 55666
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 198 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-32 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-32 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-32 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-31 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-31 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-31 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-31 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-31 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-31 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-30 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-30 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-30 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-30 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-30 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-29 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-29 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-29 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-29 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-29 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-29 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-28 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-27 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-26 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-26 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-26 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-25 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-25 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-25 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-25 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-25 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-25 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-25 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-24 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-23 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-23 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-22 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-22 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-22 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-21 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-21 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-20 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-20 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-19 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-19 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-18 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-17 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-17 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-17 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-16 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-16 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-16 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-15 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-13 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-10 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-10 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 7e-38
Identities = 40/151 (26%), Positives = 73/151 (48%), Gaps = 13/151 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+K +N+ L D ++K+ DFGLA + + +G+ WMAPE+ +R +K
Sbjct: 130 LKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV-----IRMQDK 183
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR----PGLPEDISPDLA 117
Y+ + DVY+FGIVL+EL+T +LP+ ++N + + + +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 118 FIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148
++ C + + RP F QI+ + +L
Sbjct: 244 RLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 8e-36
Identities = 36/136 (26%), Positives = 64/136 (47%), Gaps = 11/136 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K DN+ +T S+K+ D GLA + A GT +MAPE+Y ++ Y
Sbjct: 140 LKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMY---------EEKY 189
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG-LPEDISPDLAFIVQSC 123
+ VDVY+FG+ + E+ T+ P+ N Y +P + P++ I++ C
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 249
Query: 124 WVEDPNLRPSFSQIIR 139
++ + R S ++
Sbjct: 250 IRQNKDERYSIKDLLN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 5e-33
Identities = 42/146 (28%), Positives = 62/146 (42%), Gaps = 14/146 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTYRWMAPELYSTVTLRQG 59
+ N +L +K+ADFGLAR E T +WMA E T
Sbjct: 156 LAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT------ 208
Query: 60 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 119
+ + K DV+SFG++LWEL+T P N + R PE L +
Sbjct: 209 --QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266
Query: 120 VQSCWVEDPNLRPSFSQIIRMLNAFL 145
+ CW +RPSFS+++ ++A
Sbjct: 267 MLKCWHPKAEMRPSFSELVSRISAIF 292
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 1e-32
Identities = 37/149 (24%), Positives = 59/149 (39%), Gaps = 11/149 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
++ N+L+ + K+ADFGLAR E+ +W APE
Sbjct: 139 LRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------G 189
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
+ K DV+SFGI+L EL T + + R P + L ++
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249
Query: 123 CWVEDPNLRPSFSQIIRMLNAFLFTLRPP 151
CW ++P RP+F + L + + P
Sbjct: 250 CWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-32
Identities = 39/136 (28%), Positives = 57/136 (41%), Gaps = 11/136 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K N+ L Q ++KL DFGLAR T A GT +M+PE +
Sbjct: 140 LKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR--------MS 190
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
YN K D++S G +L+EL PF S + + +P S +L I+
Sbjct: 191 YNEKSDIWSLGCLLYELCALMPPFTAFSQKE-LAGKIREGKFRRIPYRYSDELNEIITRM 249
Query: 124 WVEDPNLRPSFSQIIR 139
RPS +I+
Sbjct: 250 LNLKDYHRPSVEEILE 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 4e-32
Identities = 30/135 (22%), Positives = 59/135 (43%), Gaps = 12/135 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K +NLLL LK+ADFG + + T GT ++ PE+ + +
Sbjct: 132 IKPENLLLGSA-GELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEG--------RMH 181
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
+ KVD++S G++ +E L + PFE + + P+ ++ ++
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLL 239
Query: 125 VEDPNLRPSFSQIIR 139
+P+ RP +++
Sbjct: 240 KHNPSQRPMLREVLE 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-31
Identities = 36/145 (24%), Positives = 63/145 (43%), Gaps = 13/145 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTYRWMAPELYSTVTLRQGE 60
+ N+L+ + K++DFGL+R + T + RW APE S
Sbjct: 136 LAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY------- 187
Query: 61 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 120
+ + + DV+SFGIV+WE++T + A R P D + ++
Sbjct: 188 -RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLM 246
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFL 145
CW ++ RP F+ I+ +L+ +
Sbjct: 247 MQCWQQERARRPKFADIVSILDKLI 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-31
Identities = 34/149 (22%), Positives = 71/149 (47%), Gaps = 15/149 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTYRWMAPELYSTVTLRQGE 60
+ N+LL K++DFGL++ +++ +A +W APE +
Sbjct: 135 LAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF------- 186
Query: 61 KKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 119
+ ++++ DV+S+G+ +WE L+ + P++ M + A + R P + P+L +
Sbjct: 187 -RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPELYAL 244
Query: 120 VQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148
+ CW+ RP F + + + A ++L
Sbjct: 245 MSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (286), Expect = 1e-31
Identities = 43/152 (28%), Positives = 66/152 (43%), Gaps = 11/152 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+LL+ +KL DFG A GT WMAPE+ + ++ Y
Sbjct: 141 VKAGNILLSEPGL-VKLGDFGSASIMAPANSFV---GTPYWMAPEV-----ILAMDEGQY 191
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
+ KVDV+S GI EL + P M+ + A Y A + S V SC
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251
Query: 125 VEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 156
+ P RP+ +++ + F+ RPP+ +
Sbjct: 252 QKIPQDRPTSEVLLK--HRFVLRERPPTVIMD 281
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 4e-31
Identities = 37/137 (27%), Positives = 62/137 (45%), Gaps = 11/137 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+ N+L++ D K++DFGL +E + +W APE K +
Sbjct: 129 LAARNVLVSEDNV-AKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALRE--------KKF 177
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
+ K DV+SFGI+LWE+ + L+ K + P+ P + ++++CW
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 237
Query: 125 VEDPNLRPSFSQIIRML 141
D +RPSF Q+ L
Sbjct: 238 HLDAAMRPSFLQLREQL 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 6e-31
Identities = 37/147 (25%), Positives = 66/147 (44%), Gaps = 15/147 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTYRWMAPELYSTVTLRQGE 60
+ N+LL K++DFGL++ +E + T +W APE +
Sbjct: 133 LAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY------- 184
Query: 61 KKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 119
+++K DV+SFG+++WE + + P+ GM + A K R G P ++ +
Sbjct: 185 -YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREMYDL 242
Query: 120 VQSCWVEDPNLRPSFSQIIRMLNAFLF 146
+ CW D RP F+ + L + +
Sbjct: 243 MNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 6e-31
Identities = 34/140 (24%), Positives = 66/140 (47%), Gaps = 13/140 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+ N L+ +K++DFGL+R + RW PE+
Sbjct: 126 LAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY--------S 176
Query: 63 HYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQ 121
+++K D+++FG+++WE+ + ++P+E +N + A A + R P S + I+
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIMY 235
Query: 122 SCWVEDPNLRPSFSQIIRML 141
SCW E + RP+F ++ +
Sbjct: 236 SCWHEKADERPTFKILLSNI 255
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-30
Identities = 35/139 (25%), Positives = 63/139 (45%), Gaps = 11/139 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+ N L+ + + +K++DFG+ R + T +W +PE++S
Sbjct: 127 LAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF--------S 177
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
Y++K DV+SFG+++WE+ + + R P S + I+
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237
Query: 123 CWVEDPNLRPSFSQIIRML 141
CW E P RP+FS+++R L
Sbjct: 238 CWKERPEDRPAFSRLLRQL 256
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 2e-30
Identities = 46/154 (29%), Positives = 70/154 (45%), Gaps = 13/154 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K DN+LL D S+KL DFG + T + + GT WMAPE+ + K
Sbjct: 142 IKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KA 192
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQS 122
Y KVD++S GI+ E++ P+ + L+A Y A PE +S +
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 123 CWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 156
C D R S ++++ + FL +P S P
Sbjct: 253 CLDMDVEKRGSAKELLQ--HQFLKIAKPLSSLTP 284
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 3e-30
Identities = 39/143 (27%), Positives = 63/143 (44%), Gaps = 11/143 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
++ N+L+ D S K+ADFGLAR E+ +W APE +
Sbjct: 135 LRAANILV-SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY--------G 185
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
+ K DV+SFGI+L E++T+ + R P++ +L +++
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245
Query: 123 CWVEDPNLRPSFSQIIRMLNAFL 145
CW E P RP+F + +L F
Sbjct: 246 CWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 3e-30
Identities = 38/142 (26%), Positives = 61/142 (42%), Gaps = 14/142 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTYRWMAPELYSTVTLRQGE 60
+ NLLL +K+ DFGL R + M + W APE T
Sbjct: 137 LAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT------- 188
Query: 61 KKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 119
+ +++ D + FG+ LWE+ T + P+ G++ Q + + R PED D+ +
Sbjct: 189 -RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 120 VQSCWVEDPNLRPSFSQIIRML 141
+ CW P RP+F + L
Sbjct: 248 MVQCWAHKPEDRPTFVALRDFL 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 3e-30
Identities = 38/137 (27%), Positives = 67/137 (48%), Gaps = 6/137 (4%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K N+L T D +KLADFG++ + T T + + GT WMAPE+ T + +
Sbjct: 136 LKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD---RP 191
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA-AAFKHARPGLPEDISPDLAFIVQS 122
Y+ K DV+S GI L E+ P ++ ++ A + P S + ++
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 251
Query: 123 CWVEDPNLRPSFSQIIR 139
C ++ + R + SQ+++
Sbjct: 252 CLEKNVDARWTTSQLLQ 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 4e-30
Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 11/142 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+ N+L+ + K+ADFGL+R + V T RWMA E + Y
Sbjct: 153 LAARNILVGENYV-AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVY 203
Query: 65 NNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
DV+S+G++LWE+++ P+ GM Y + R P + ++ +++ C
Sbjct: 204 TTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQC 262
Query: 124 WVEDPNLRPSFSQIIRMLNAFL 145
W E P RPSF+QI+ LN L
Sbjct: 263 WREKPYERPSFAQILVSLNRML 284
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (271), Expect = 2e-29
Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 14/143 (9%)
Query: 3 KFMKEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQG 59
+ + N L+ + +K+ADFGL+R + + RWM PE
Sbjct: 164 RDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY------ 216
Query: 60 EKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 118
Y + DV+++G+VLWE+ + P+ GM++ + Y PE+ +L
Sbjct: 217 --NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYN 273
Query: 119 IVQSCWVEDPNLRPSFSQIIRML 141
+++ CW + P RPSF I R+L
Sbjct: 274 LMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 108 bits (270), Expect = 2e-29
Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 17/148 (11%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR------EETVTEMMTAETGTYRWMAPELYSTVTLRQ 58
+ N+L+ + K++DFGL+R + RW APE
Sbjct: 154 LAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY----- 207
Query: 59 GEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 117
+ + + DV+S+GIV+WE+++ P+ M+N Q A + R P D L
Sbjct: 208 ---RKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQDYRLPPPMDCPSALH 263
Query: 118 FIVQSCWVEDPNLRPSFSQIIRMLNAFL 145
++ CW +D N RP F QI+ L+ +
Sbjct: 264 QLMLDCWQKDRNHRPKFGQIVNTLDKMI 291
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 2e-29
Identities = 42/145 (28%), Positives = 64/145 (44%), Gaps = 13/145 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+ N+L+T K +K+ DFGLAR ++ + +WMAPE
Sbjct: 190 LAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-------- 240
Query: 62 KHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 120
Y K DV+S+GI+LWE+ + P+ G+ Y + P + ++ I+
Sbjct: 241 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIM 300
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFL 145
QSCW D RPSF + L L
Sbjct: 301 QSCWAFDSRKRPSFPNLTSFLGCQL 325
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-29
Identities = 35/143 (24%), Positives = 64/143 (44%), Gaps = 11/143 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+ N+L++ +KL DFGL+R E++ + +WMAPE + +
Sbjct: 134 IAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--------R 184
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
+ + DV+ FG+ +WE+L + + R +P + P L ++
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 244
Query: 123 CWVEDPNLRPSFSQIIRMLNAFL 145
CW DP+ RP F+++ L+ L
Sbjct: 245 CWAYDPSRRPRFTELKAQLSTIL 267
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 106 bits (266), Expect = 5e-29
Identities = 34/137 (24%), Positives = 59/137 (43%), Gaps = 5/137 (3%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K +N+LL D +KL DFG + + E + GT ++APE+ Y
Sbjct: 136 LKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC--SMNDNHPGY 192
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQS 122
+VD++S G++++ LL PF + + + G PE D S + +V
Sbjct: 193 GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR 252
Query: 123 CWVEDPNLRPSFSQIIR 139
V P R + + +
Sbjct: 253 FLVVQPQKRYTAEEALA 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 6e-29
Identities = 40/169 (23%), Positives = 69/169 (40%), Gaps = 15/169 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+ N+L+ + +K+ DFGLA+ E +WMA E
Sbjct: 137 LAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-------- 187
Query: 62 KHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 120
+ Y ++ DV+S+G+ +WEL+T P++G+ + K R P + D+ I+
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGERLPQPPICTIDVYMIM 246
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFLFTL-RPPSPSVPESDTNEAAATSN 168
CW+ D + RP F ++I + R E + SN
Sbjct: 247 VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSN 295
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 104 bits (261), Expect = 3e-28
Identities = 36/143 (25%), Positives = 63/143 (44%), Gaps = 11/143 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+ N L+ + +K+ADFGL+R +W APE +
Sbjct: 141 LAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------N 191
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 122
++ K DV++FG++LWE+ T + +L Y K R PE + ++++
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251
Query: 123 CWVEDPNLRPSFSQIIRMLNAFL 145
CW +P+ RPSF++I +
Sbjct: 252 CWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 8e-28
Identities = 38/138 (27%), Positives = 62/138 (44%), Gaps = 12/138 (8%)
Query: 6 KEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
K +NLLL +LK++DFGLA ++ GT ++APEL ++
Sbjct: 130 KPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-------RE 181
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA-FKHARPGLPEDISPDLAFIVQ 121
+ VDV+S GIVL +L LP++ S+ Y+ K + I ++
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 122 SCWVEDPNLRPSFSQIIR 139
VE+P+ R + I +
Sbjct: 242 KILVENPSARITIPDIKK 259
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 3e-27
Identities = 29/132 (21%), Positives = 57/132 (43%), Gaps = 16/132 (12%)
Query: 8 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 67
+N+L+ ++ LKL DFG T + T GT + PE +++
Sbjct: 139 ENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRY-------HRYHGRS 190
Query: 68 VDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVED 127
V+S GI+L++++ +PFE + + + +S + +++ C
Sbjct: 191 AAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQVFFRQRVSSECQHLIRWCLALR 242
Query: 128 PNLRPSFSQIIR 139
P+ RP+F +I
Sbjct: 243 PSDRPTFEEIQN 254
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 6e-27
Identities = 34/163 (20%), Positives = 63/163 (38%), Gaps = 28/163 (17%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTYRWMAPELYSTVTLRQG 59
+K N+L+ + + +AD GLA +T+ GT R+MAPE+ +
Sbjct: 134 LKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 192
Query: 60 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY---------------AAAFKHA 104
+ + D+Y+ G+V WE+ + Q Y +
Sbjct: 193 FE--SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 250
Query: 105 RPGLPE-----DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142
RP +P + +A I++ CW + R + +I + L+
Sbjct: 251 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 3e-26
Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 13/145 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+ N+LL+ +K+ DFGLAR ++ +WMAPE
Sbjct: 160 LAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-------- 210
Query: 62 KHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 120
+ Y + DV+SFG++LWE+ + P+ G+ + + R P+ +P++ +
Sbjct: 211 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM 270
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFL 145
CW +P+ RP+FS+++ L L
Sbjct: 271 LDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 100 bits (249), Expect = 5e-26
Identities = 33/138 (23%), Positives = 59/138 (42%), Gaps = 11/138 (7%)
Query: 5 MKEDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K +N++ T + + LKL DFGL + + TGT + APE+ K
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG--------KP 201
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA--AAFKHARPGLPEDISPDLAFIVQ 121
D++S G++ + LL+ PF G ++ + + + IS D ++
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261
Query: 122 SCWVEDPNLRPSFSQIIR 139
+ DPN R + Q +
Sbjct: 262 KLLLADPNTRMTIHQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.5 bits (245), Expect = 8e-26
Identities = 28/136 (20%), Positives = 55/136 (40%), Gaps = 14/136 (10%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+K +N+LL D +++ DFG A+ E+ + GT ++++PEL +
Sbjct: 134 LKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-------- 184
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQ 121
K D+++ G ++++L+ PF + PE P +V+
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFFPKARDLVE 242
Query: 122 SCWVEDPNLRPSFSQI 137
V D R ++
Sbjct: 243 KLLVLDATKRLGCEEM 258
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 1e-25
Identities = 25/135 (18%), Positives = 55/135 (40%), Gaps = 11/135 (8%)
Query: 8 DNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNN 66
+N++ + S +K+ +FG AR+ + + APE++ + +
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH--------QHDVVST 182
Query: 67 KVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCW 124
D++S G +++ LL+ PF +N Q ++IS + V
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLL 242
Query: 125 VEDPNLRPSFSQIIR 139
V++ R + S+ ++
Sbjct: 243 VKERKSRMTASEALQ 257
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 97.8 bits (243), Expect = 2e-25
Identities = 28/133 (21%), Positives = 56/133 (42%), Gaps = 10/133 (7%)
Query: 9 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 68
+ + ++DFGL++ E +++ GT ++APE+ + K Y+ V
Sbjct: 139 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ--------KPYSKAV 190
Query: 69 DVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVE 126
D +S G++ + LL PF ++ + P +DIS ++ +
Sbjct: 191 DCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEK 250
Query: 127 DPNLRPSFSQIIR 139
DP R + Q ++
Sbjct: 251 DPEKRFTCEQALQ 263
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 2e-25
Identities = 37/136 (27%), Positives = 63/136 (46%), Gaps = 12/136 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K DN+LL D K+ADFG+ +E GT ++APE+ +
Sbjct: 129 LKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG--------QK 179
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
YN+ VD +SFG++L+E+L + PF G + + + + P P + + ++
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH--SIRMDNPFYPRWLEKEAKDLLVKL 237
Query: 124 WVEDPNLRPSFSQIIR 139
+V +P R IR
Sbjct: 238 FVREPEKRLGVRGDIR 253
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 97.8 bits (243), Expect = 3e-25
Identities = 27/138 (19%), Positives = 60/138 (43%), Gaps = 11/138 (7%)
Query: 5 MKEDNLLLTPDQK-SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K +N++ + S+K+ DFGLA + E++ T T + APE+ +++
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV--------DREP 204
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQ 121
D+++ G++ + LL+ PF G +L+ +SP+ ++
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264
Query: 122 SCWVEDPNLRPSFSQIIR 139
+ ++P R + +
Sbjct: 265 NLLQKEPRKRLTVHDALE 282
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 4e-25
Identities = 27/137 (19%), Positives = 54/137 (39%), Gaps = 13/137 (9%)
Query: 8 DNLLLTPD---QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+N++L + +K+ DFGLA + GT ++APE+ +
Sbjct: 142 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV--------NYEPL 193
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA--AAFKHARPGLPEDISPDLAFIVQS 122
+ D++S G++ + LL+ PF G + + A + S ++
Sbjct: 194 GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 253
Query: 123 CWVEDPNLRPSFSQIIR 139
V+DP R + ++
Sbjct: 254 LLVKDPKKRMTIQDSLQ 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.9 bits (240), Expect = 5e-25
Identities = 39/141 (27%), Positives = 64/141 (45%), Gaps = 14/141 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+ N ++ D ++K+ DFG+ R E RWM+PE
Sbjct: 159 LAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-------- 209
Query: 62 KHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 120
+ DV+SFG+VLWE+ T P++G+SN Q + P++ L ++
Sbjct: 210 GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-LRFVMEGGLLDKPDNCPDMLFELM 268
Query: 121 QSCWVEDPNLRPSFSQIIRML 141
+ CW +P +RPSF +II +
Sbjct: 269 RMCWQYNPKMRPSFLEIISSI 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 6e-25
Identities = 41/145 (28%), Positives = 72/145 (49%), Gaps = 14/145 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+ N+L+T D K+ADFGLAR + T +WMAPE
Sbjct: 161 LAARNVLVTEDNVM-KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-------- 211
Query: 62 KHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 120
+ Y ++ DV+SFG++LWE+ T P+ G+ ++ + + R P + + +L ++
Sbjct: 212 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMM 270
Query: 121 QSCWVEDPNLRPSFSQIIRMLNAFL 145
+ CW P+ RP+F Q++ L+ +
Sbjct: 271 RDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.4 bits (234), Expect = 5e-24
Identities = 32/177 (18%), Positives = 57/177 (32%), Gaps = 52/177 (29%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+L+ + +KL DFG++ + + M + GT +M+PE HY
Sbjct: 131 VKPSNILVNSRGE-IKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQG--------THY 180
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSN-------------------------------- 92
+ + D++S G+ L E+ R P
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 93 ---------LQAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIR 139
+ P LP S + V C +++P R Q++
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 92.6 bits (229), Expect = 2e-23
Identities = 22/163 (13%), Positives = 49/163 (30%), Gaps = 26/163 (15%)
Query: 5 MKEDNLLLT----PDQKSLKLADFGLAR--------EETVTEMMTAETGTYRWMAPELYS 52
+K DN L+ + + + DFG+ + + +GT R+M+ +
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH- 185
Query: 53 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA------AAFKHARP 106
+ + + D+ + G V L LP++G+
Sbjct: 186 -------LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 107 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149
L + + + P + + + + L L
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 90.9 bits (225), Expect = 9e-23
Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K +N+LL + +K+ DFG A+ V ++ GT ++APE+ ST K Y
Sbjct: 130 LKPENILLDKN-GHIKITDFGFAKY--VPDVTYTLCGTPDYIAPEVVST--------KPY 178
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
N +D +SFGI+++E+L PF + ++ +A P + D+ ++
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE--KILNAELRFPPFFNEDVKDLLSRLI 236
Query: 125 VEDPNLRPSFSQ 136
D + R Q
Sbjct: 237 TRDLSQRLGNLQ 248
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (224), Expect = 1e-22
Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 13/141 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+ N+LLT + + K+ DFGLAR ++ + +WMAPE
Sbjct: 171 LAARNILLTHGRIT-KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-------- 221
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLP-FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 120
Y + DV+S+GI LWEL + + GM Y + R PE ++ I+
Sbjct: 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIM 281
Query: 121 QSCWVEDPNLRPSFSQIIRML 141
++CW DP RP+F QI++++
Sbjct: 282 KTCWDADPLKRPTFKQIVQLI 302
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.5 bits (224), Expect = 2e-22
Identities = 37/200 (18%), Positives = 78/200 (39%), Gaps = 17/200 (8%)
Query: 5 MKEDNLLLT--PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +NLL T LKL DFG A+E T +T T ++APE+ +
Sbjct: 137 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG--------PE 188
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA--AAFKHARPGLPE----DISPDL 116
Y+ D++S G++++ LL PF L + + + P ++S ++
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248
Query: 117 AFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSNGAMTEFSA 176
++++ +P R + ++ + + + + P + S + + E
Sbjct: 249 KMLIRNLLKTEPTQRMTITEFMNH-PWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMT 307
Query: 177 RARGKFAFLRQLFTAKRTKN 196
A + K+ ++
Sbjct: 308 SALATMRVDYEQIKIKKIED 327
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.7 bits (219), Expect = 7e-22
Identities = 33/130 (25%), Positives = 56/130 (43%), Gaps = 12/130 (9%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K +NL+L D +K+ DFGL +E + M GT ++APE+
Sbjct: 131 IKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------ND 181
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
Y VD + G+V++E++ RLPF + + P +SP+ ++
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAKSLLAGL 239
Query: 124 WVEDPNLRPS 133
+DP R
Sbjct: 240 LKKDPKQRLG 249
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 87.1 bits (215), Expect = 3e-21
Identities = 40/172 (23%), Positives = 68/172 (39%), Gaps = 21/172 (12%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+LL + ++++D GLA + + A GT+ +MAPE+ Y
Sbjct: 133 LKPANILLD-EHGHVRISDLGLACD-FSKKKPHASVGTHGYMAPEVLQK-------GVAY 183
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAAFKHARPGLPEDISPDLAFIVQSC 123
++ D +S G +L++LL PF + LP+ SP+L +++
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 243
Query: 124 WVEDPNLRPSFSQI----------IRMLN-AFLFTLRPPSPSVPESDTNEAA 164
D N R R L+ +F + P P +P AA
Sbjct: 244 LQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAA 295
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 85.6 bits (211), Expect = 5e-21
Identities = 33/140 (23%), Positives = 55/140 (39%), Gaps = 13/140 (9%)
Query: 5 MKEDNLLLTPDQK---SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+K N++++ +A A GT ++++PE
Sbjct: 137 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-------- 188
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFI 119
+ + DVYS G VL+E+LT PF G S + AY + P E +S DL +
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV 248
Query: 120 VQSCWVEDPNLRPSFSQIIR 139
V ++P R + +R
Sbjct: 249 VLKALAKNPENRYQTAAEMR 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 84.9 bits (209), Expect = 1e-20
Identities = 27/162 (16%), Positives = 53/162 (32%), Gaps = 24/162 (14%)
Query: 3 KFMKEDNLLLTPDQKSLKL--ADFGLAR--------EETVTEMMTAETGTYRWMAPELYS 52
+ +K DN L+ +K + DFGLA+ + TGT R+ + +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 53 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR------P 106
+ + D+ S G VL LP++G+ +
Sbjct: 187 G--------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238
Query: 107 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148
L + + A + C + +P +S + ++
Sbjct: 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.4 bits (205), Expect = 5e-20
Identities = 38/136 (27%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+K +N+LL + + L DFGL++E TE GT +MAP++ +G
Sbjct: 155 IKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV------RGGDS 207
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMS--NLQAAYAAAFKHARPGLPEDISPDLAFIV 120
++ VD +S G++++ELLT PF N QA + + P P+++S ++
Sbjct: 208 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLI 267
Query: 121 QSCWVEDPNLRPSFSQ 136
Q ++DP R
Sbjct: 268 QRLLMKDPKKRLGCGP 283
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.4 bits (200), Expect = 2e-19
Identities = 41/177 (23%), Positives = 65/177 (36%), Gaps = 37/177 (20%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K +NLLL + LKLADFGLA+ T + T + APEL +
Sbjct: 126 LKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG-------ARM 177
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE------------- 110
Y VD+++ G +L ELL G S+L P +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 111 -------------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS 154
DL ++Q ++ +P R + +Q ++M + P+P
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSNRPGPTPG 292
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 4e-19
Identities = 35/160 (21%), Positives = 55/160 (34%), Gaps = 34/160 (21%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+L+T +KLADFGLAR + +T+ T + APE+ Y
Sbjct: 142 LKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSY 192
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG----------------- 107
VD++S G + E+ + F G S++ PG
Sbjct: 193 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS 252
Query: 108 --------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139
DI ++ C +P R S +
Sbjct: 253 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.4 bits (192), Expect = 3e-18
Identities = 43/179 (24%), Positives = 68/179 (37%), Gaps = 38/179 (21%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K NLL+ + ++KLADFGLAR V T E T + APE+ K+
Sbjct: 128 LKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL-------GCKY 179
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA----------------AAFKHARPG 107
Y+ VD++S G + E++T R F G S + + + +P
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 108 LPE-----------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSV 155
P+ + D ++ DPN R S + F + P P +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH--PFFQDVTKPVPHL 296
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.1 bits (189), Expect = 1e-17
Identities = 41/179 (22%), Positives = 62/179 (34%), Gaps = 36/179 (20%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K NLLL PD LKL DFG A++ E + + + APEL Y
Sbjct: 148 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF-------GATDY 200
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA---------------AAFKHARPGLP 109
+ +DV+S G VL ELL + F G S + + P
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 260
Query: 110 E------------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 156
+ P+ + P R + + ++F LR P+ +P
Sbjct: 261 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA--HSFFDELRDPNVKLP 317
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.1 bits (186), Expect = 2e-17
Identities = 34/181 (18%), Positives = 59/181 (32%), Gaps = 45/181 (24%)
Query: 8 DNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
N+L+T D LKLADFGLAR + + T T + PEL ++
Sbjct: 146 ANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ER 197
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA-------------------------AY 97
Y +D++ G ++ E+ T +G +
Sbjct: 198 DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEK 257
Query: 98 AAAFKHARPGLPEDI-----SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 152
K + + + + P ++ V DP R + + F ++ PS
Sbjct: 258 LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--HDFFWSDPMPS 315
Query: 153 P 153
Sbjct: 316 D 316
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 75.6 bits (185), Expect = 4e-17
Identities = 23/173 (13%), Positives = 52/173 (30%), Gaps = 43/173 (24%)
Query: 3 KFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 62
+ +K N+++ + + L+L D+GLA + + + PEL + +
Sbjct: 153 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV-------DYQ 205
Query: 63 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-------------------- 102
Y+ +D++S G +L ++ + PF + K
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265
Query: 103 ----------------HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139
+SP+ + D R + + +
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 74.1 bits (181), Expect = 2e-16
Identities = 31/140 (22%), Positives = 56/140 (40%), Gaps = 18/140 (12%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K +NLL+ +++ DFG A+ GT +APE+ + K Y
Sbjct: 167 LKPENLLIDQQ-GYIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILS--------KGY 215
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
N VD ++ G++++E+ PF +Q + P S DL ++++
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE--KIVSGKVRFPSHFSSDLKDLLRNLL 273
Query: 125 VEDP-----NLRPSFSQIIR 139
D NL+ + I
Sbjct: 274 QVDLTKRFGNLKNGVNDIKN 293
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.3 bits (176), Expect = 4e-16
Identities = 31/176 (17%), Positives = 63/176 (35%), Gaps = 39/176 (22%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKH 63
+K NLL+ + + KLA+FGLAR + +AE T + P++ K
Sbjct: 127 LKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKL 178
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK--------------------- 102
Y+ +D++S G + EL P +++ F+
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 103 -------HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 151
+ + ++ ++Q+ +P R S + ++ + + PP
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ--HPYFSDFCPP 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 71.8 bits (175), Expect = 6e-16
Identities = 33/163 (20%), Positives = 54/163 (33%), Gaps = 36/163 (22%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW-MAPELYSTVTLRQGEKKH 63
+K NLL+ + LK+ADFGLAR + W AP++ K
Sbjct: 126 LKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM-------GSKK 177
Query: 64 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ-----------------------AAYAAA 100
Y+ +D++S G + E++ F G+S Y
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 101 FKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139
F P + + ++ DPN R + Q +
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.4 bits (174), Expect = 2e-15
Identities = 37/168 (22%), Positives = 55/168 (32%), Gaps = 41/168 (24%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTYRWMAPELYSTVTLRQGE 60
+K NLLL LK+ DFGLAR + T +T T + APE+
Sbjct: 135 LKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN------- 186
Query: 61 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG------------- 107
K Y +D++S G +L E+L+NR F G L P
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 108 ----------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139
L + ++ +P+ R Q +
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.7 bits (154), Expect = 7e-13
Identities = 41/188 (21%), Positives = 70/188 (37%), Gaps = 43/188 (22%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K NL + D + K+ DFGLAR+ MT T + APE+ Y
Sbjct: 147 LKPGNLAVNEDCEL-KILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL-------NWMRY 196
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY------------------AAAFKHARP 106
VD++S G ++ E++T + F+G +L + K+
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256
Query: 107 GLPE-----------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS--P 153
GLPE + SP +++ V D R + + + + +L P
Sbjct: 257 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH--PYFESLHDTEDEP 314
Query: 154 SVPESDTN 161
V + D +
Sbjct: 315 QVQKYDDS 322
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (135), Expect = 2e-10
Identities = 40/178 (22%), Positives = 66/178 (37%), Gaps = 41/178 (23%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K NL + LK+ DFGLAR + MT T + APE+ HY
Sbjct: 147 LKPSNLA-VNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIML-------NWMHY 196
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY---------------------AAAFKH 103
N VD++S G ++ ELLT R F G ++ A +
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 104 ARPGLPE--------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 153
+ +P+ +P +++ V D + R + +Q + +A+ P
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--HAYFAQYHDPDD 312
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.7 bits (133), Expect = 4e-10
Identities = 28/135 (20%), Positives = 53/135 (39%), Gaps = 10/135 (7%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 64
+K N+++ D K+ DFGLAR + MMT T + APE+ Y
Sbjct: 145 LKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL--------GMGY 195
Query: 65 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 124
VD++S G ++ E++ +++ F G + + + PE + +
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 125 VEDPNLRPSFSQIIR 139
+F ++
Sbjct: 255 NRPKYAGLTFPKLFP 269
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 52.3 bits (124), Expect = 6e-09
Identities = 23/184 (12%), Positives = 49/184 (26%), Gaps = 57/184 (30%)
Query: 5 MKEDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 61
+K +N+L+ L +A E T T + +PE+
Sbjct: 152 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG-------- 203
Query: 62 KHYNNKVDVYSFGIVLWELLTNRLPFEG-------------------------------- 89
+ D++S +++EL+T FE
Sbjct: 204 APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGK 263
Query: 90 --------------MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 135
+S L+ + +D + +++ + DP R
Sbjct: 264 YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323
Query: 136 QIIR 139
++
Sbjct: 324 GLVN 327
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 198 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.98 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.98 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.97 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.97 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.97 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.97 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.97 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.96 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.96 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.96 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.96 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.96 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.95 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.95 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.93 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 98.57 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.68 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 94.28 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 94.11 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 92.65 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.37 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 81.89 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-36 Score=224.79 Aligned_cols=141 Identities=27% Similarity=0.499 Sum_probs=109.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc---ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++..... .......||+.|+|||++.+. ....|+.++|||||||++
T Consensus 126 vHrDlKp~NiLl~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~~~sDiwS~Gv~l 199 (276)
T d1uwha_ 126 IHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ-----DKNPYSFQSDVYAFGIVL 199 (276)
T ss_dssp CCSCCCGGGEEEETT-SSEEECCCCCSCC------------CCCCGGGCCHHHHTTC-----SSCCCCHHHHHHHHHHHH
T ss_pred eccccCHHHEEEcCC-CCEEEccccceeeccccCCcccccccccCcccCCHHHHhcc-----cCCCCCchhhhhhhHHHH
Confidence 799999999999976 78999999999754322 223456899999999998531 124578999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCCC----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHARP----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~~----~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|||++|+.||.+................. ..+..+++++.+|+.+||..||.+|||+.+++++|+.+...
T Consensus 200 ~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 200 YELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 99999999999877655544443333222 34567899999999999999999999999999999877654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-36 Score=227.27 Aligned_cols=138 Identities=28% Similarity=0.548 Sum_probs=109.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc---ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++
T Consensus 156 vHrDlKp~NILl~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDiwS~Gvil 226 (299)
T d1ywna1 156 IHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLL 226 (299)
T ss_dssp CCSCCCGGGEEECGG-GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred cCCcCCccceeECCC-CcEEEccCcchhhccccccccccCceeeCccccchhHhhc--------CCCCcccceeehHHHH
Confidence 799999999999966 68999999999854322 12334679999999999854 6789999999999999
Q ss_pred HHHHcC-CCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|||++| .+||.+................+..|..+++++.+++.+||..||.+|||+.+++++|+.++..
T Consensus 227 ~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 227 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 999986 5678776655555555566677888889999999999999999999999999999999988653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-36 Score=221.82 Aligned_cols=133 Identities=23% Similarity=0.457 Sum_probs=110.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++...... ....+||+.|+|||++.+ ..++.++||||+||++|||
T Consensus 128 vHrDiKp~Nill~~~-~~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~~--------~~~~~~~DiwSlGvilyel 197 (263)
T d2j4za1 128 IHRDIKPENLLLGSA-GELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEG--------RMHDEKVDLWSLGVLCYEF 197 (263)
T ss_dssp CCCCCCGGGEEECTT-SCEEECCCCSCSCCCCCC-CEETTEEGGGCCHHHHTT--------CCCCTTHHHHHHHHHHHHH
T ss_pred eeeeeccccceecCC-CCEeecccceeeecCCCc-ccccCCCCcccCHHHHcC--------CCCCchhhhhhHhHHHHHH
Confidence 799999999999976 679999999997654332 345689999999999864 5689999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
++|+.||.+....... .......+.+|..+++++.+|+.+||..||.+|||++|+++ |.|+..
T Consensus 198 l~G~~Pf~~~~~~~~~--~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~--hp~~~~ 260 (263)
T d2j4za1 198 LVGKPPFEANTYQETY--KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITA 260 (263)
T ss_dssp HHSSCTTCCSSHHHHH--HHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT--CHHHHH
T ss_pred hcCCCCCCCCCHHHHH--HHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc--CcCcCC
Confidence 9999999876643322 22334556778889999999999999999999999999998 666643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-35 Score=222.24 Aligned_cols=138 Identities=28% Similarity=0.410 Sum_probs=113.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||++.. ..++.++|||||||++|
T Consensus 131 vHrDiKp~NIll~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~~sDvwS~Gvvl~ 201 (272)
T d1qpca_ 131 IHRDLRAANILVSDT-LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLT 201 (272)
T ss_dssp ECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH--------CEECHHHHHHHHHHHHH
T ss_pred ccCccchhheeeecc-cceeeccccceEEccCCccccccccCCcccccChHHHhC--------CCCCchhhhhhhHHHHH
Confidence 699999999999976 789999999998654322 2334578999999999853 56889999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
||++|..|+.................++..|..+++++.+|+.+||..||.+|||++++++.|++++..
T Consensus 202 ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 202 EIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999966555444444555555566677778889999999999999999999999999999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-35 Score=220.87 Aligned_cols=137 Identities=26% Similarity=0.443 Sum_probs=107.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||+
T Consensus 132 iHrDlKp~NILl~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~sDI~S~Gvi 202 (283)
T d1mqba_ 132 VHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIV 202 (283)
T ss_dssp CCSCCCGGGEEECTT-CCEEECCCCC-----------------CCCGGGSCHHHHHS--------CCCCHHHHHHHHHHH
T ss_pred ccCccccceEEECCC-CeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHcc--------CCCCCcccccccHHH
Confidence 799999999999977 789999999998543321 1223468999999998853 678999999999999
Q ss_pred HHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 77 LWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+|||+++..|+.................+++.|..++.++.+|+.+||..||.+||++.++++.|+.+..
T Consensus 203 l~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 203 MWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 9999997666555455555556666677778888899999999999999999999999999999988765
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-36 Score=229.71 Aligned_cols=133 Identities=31% Similarity=0.546 Sum_probs=112.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+|+...... ...+..||+.|+|||++.+ ..++.++|||||||++
T Consensus 186 iHRDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~DiwS~Gvil 256 (325)
T d1rjba_ 186 VHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------GIYTIKSDVWSYGILL 256 (325)
T ss_dssp EETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred eeccCchhccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC--------CCCCcceeccchhHHH
Confidence 699999999999977 789999999998543322 2234567999999999853 6789999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
|||++ |..||.+...............+++.|..+++++.+|+.+||+.||++|||++||+++|.
T Consensus 257 ~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 257 WEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 99997 899998876555555555566677888899999999999999999999999999999885
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-35 Score=221.64 Aligned_cols=133 Identities=29% Similarity=0.559 Sum_probs=107.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+.+.+||+|||+++..... .....+||+.|+|||++. +.++.++||||+||++|||
T Consensus 136 iHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~---------~~~~~~~DIwSlGvilyel 205 (270)
T d1t4ha_ 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEM 205 (270)
T ss_dssp CCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHH
T ss_pred EeCCcChhhceeeCCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhC---------CCCCCcCchhhHHHHHHHH
Confidence 799999999999754468999999999754332 234568999999999874 3589999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCC-CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
++|+.||.+................+ .++...++++.+|+.+||..||.+|||++|+++ |.|+
T Consensus 206 ~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~--Hp~f 269 (270)
T d1t4ha_ 206 ATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--HAFF 269 (270)
T ss_dssp HHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGG
T ss_pred HHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC--Cccc
Confidence 99999998776655554444433332 345668899999999999999999999999998 5443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-36 Score=223.67 Aligned_cols=129 Identities=29% Similarity=0.401 Sum_probs=99.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++..... ......+||+.|+|||++.+ ..|+.++|||||||++||
T Consensus 136 iHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~DIwSlGvilye 206 (269)
T d2java1 136 LHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR--------MSYNEKSDIWSLGCLLYE 206 (269)
T ss_dssp ----CCGGGEEECTT-SCEEECCHHHHHHC-----------CCCSCCCHHHHTT--------CCCCHHHHHHHHHHHHHH
T ss_pred EeCcCchhhcCcCCC-CcEEEeeccceeecccCCCccccCCCCcccCCHHHHcC--------CCCChHHHHHhhCHHHHH
Confidence 799999999999977 68999999999865432 23345789999999999853 678999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
|++|+.||.+..... ............+|..+++++.+|+.+||..||.+|||++|+++
T Consensus 207 l~tg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 207 LCALMPPFTAFSQKE-LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHSSCSCCCSSHHH-HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhhCCCCCCCCCHHH-HHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 999999998866543 33333444555678889999999999999999999999999987
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-35 Score=218.66 Aligned_cols=136 Identities=27% Similarity=0.541 Sum_probs=102.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++....... .....||+.|+|||++.+ ..|+.++|||||||++|
T Consensus 123 iHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~k~DVwS~Gvil~ 193 (263)
T d1sm2a_ 123 IHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMW 193 (263)
T ss_dssp CCTTCSGGGEEECGG-GCEEECSCC------------------CTTSCCHHHHTT--------CCCCHHHHHHHHHHHHH
T ss_pred eecccchhheeecCC-CCeEecccchheeccCCCceeecceecCcccCChHHhcC--------CCCCchhhhcchHHHHH
Confidence 799999999999976 6899999999985443222 223578999999999853 57899999999999999
Q ss_pred HHHcC-CCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 79 ELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 79 e~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
||+++ .+||... .............++..|..+++++.+++.+||..||.+|||+++++++|+.+..
T Consensus 194 el~t~~~~~~~~~-~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 194 EVFSEGKIPYENR-SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHTTSCCTTCSC-CHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHCCCCCCCCC-CHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 99995 5555544 4444444555566677788899999999999999999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-35 Score=222.38 Aligned_cols=136 Identities=32% Similarity=0.483 Sum_probs=111.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|||++.+ ..|+.++||||+||++|+
T Consensus 138 iHrDiKp~NILl~~~-~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~~DiwSlGvilye 208 (293)
T d1yhwa1 138 IHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIE 208 (293)
T ss_dssp ECCCCSGGGEEECTT-CCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSS--------SCBCTHHHHHHHHHHHHH
T ss_pred cccCCcHHHeEECCC-CcEeeccchhheeeccccccccccccCCCccChhhhcC--------CCCCchhceehHhHHHHH
Confidence 699999999999976 6899999999986433 233455689999999999853 568999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHcc-CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKH-ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|++|..||.+.............. .....+..+++++.+|+.+||..||.+|||+.|+++ |.|+..
T Consensus 209 mltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--Hp~~~~ 275 (293)
T d1yhwa1 209 MIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLKI 275 (293)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT--CGGGGG
T ss_pred HhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhCC
Confidence 999999998877655544433332 233456778999999999999999999999999998 777653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-35 Score=222.30 Aligned_cols=136 Identities=29% Similarity=0.455 Sum_probs=110.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++..... ...+||+.|+|||++.+. ....|+.++|||||||++|||
T Consensus 137 iHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~~~---~~~~GT~~Y~APE~~~~~-----~~~~y~~~~DiwSlGvilyel 207 (309)
T d1u5ra_ 137 IHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIEL 207 (309)
T ss_dssp BCCCCSGGGEEEETT-TEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHTTT-----TSCCBCTHHHHHHHHHHHHHH
T ss_pred eccCCCcceEEECCC-CCEEEeecccccccCCC---CccccCccccCHHHHhcc-----CCCCcCchhhhhhHHHHHHHH
Confidence 699999999999976 78999999999864432 356899999999998531 134688999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
++|..||.+...............+...+..+++++.+|+.+||..||.+|||++++++ |.|+..
T Consensus 208 ~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--Hp~~~~ 272 (309)
T d1u5ra_ 208 AERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLR 272 (309)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--CHHHHS
T ss_pred HHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh--CHHhcC
Confidence 99999998877655544444433334445568999999999999999999999999999 677654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-34 Score=219.78 Aligned_cols=136 Identities=29% Similarity=0.525 Sum_probs=104.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccc------cCCCCccceecccccccccccccccCCCCchhhHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMM------TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 74 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G 74 (198)
|||||||+|||++.+ +.+||+|||+++........ ....||+.|+|||.+.. ..++.++||||||
T Consensus 150 iHrDlKp~NILl~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~sDvwS~G 220 (299)
T d1jpaa_ 150 VHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--------RKFTSASDVWSYG 220 (299)
T ss_dssp CCSCCCGGGEEECTT-CCEEECCC-----------------------CGGGSCHHHHHS--------CCCCHHHHHHHHH
T ss_pred ccCccccceEEECCC-CcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc--------CCCCcccccccch
Confidence 799999999999976 78999999999854332211 12357899999999853 6789999999999
Q ss_pred HHHHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 75 IVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 75 ~~l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|++|||++ |..||.+..... .........+++.|..++.++.+|+.+||+.||.+|||+.++++.|+.++.
T Consensus 221 vvl~el~t~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 221 IVMWEVMSYGERPYWDMTNQD-VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHHHHHHTTSCCTTTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 99999998 899998876543 334445566677788899999999999999999999999999999998765
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.9e-35 Score=219.74 Aligned_cols=136 Identities=27% Similarity=0.480 Sum_probs=112.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++....... .....|++.|+|||++.+ ..|+.++|||||||++|
T Consensus 137 iHrDlKp~NILl~~~-~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~k~DiwS~Gv~l~ 207 (287)
T d1opja_ 137 IHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLW 207 (287)
T ss_dssp CCSCCSGGGEEECGG-GCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHH--------CCCSHHHHHHHHHHHHH
T ss_pred ccCccccCeEEECCC-CcEEEccccceeecCCCCceeeccccccccccChHHHcC--------CCCCchhhhhhHHHHHH
Confidence 799999999999976 6899999999986543222 223357889999999854 67899999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
||++|..||..................+..|..+++++.+|+.+||..||.+|||++++++.|+.+.
T Consensus 208 ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 208 EIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 9999777665555555555555566777888899999999999999999999999999999888763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=217.19 Aligned_cols=136 Identities=27% Similarity=0.541 Sum_probs=111.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||++.. ..++.++|||||||+
T Consensus 129 iHrDlKp~Nill~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDiwS~Gv~ 199 (277)
T d1xbba_ 129 VHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVL 199 (277)
T ss_dssp ECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH--------CEEEHHHHHHHHHHH
T ss_pred ccCCCcchhhccccc-CcccccchhhhhhccccccccccccccCCCceecCchhhcC--------CCCCchhhhccchhh
Confidence 699999999999976 789999999998543221 1223568999999999854 567899999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
+|||++ |..||.+.... ..........+++.|..+++++.+|+.+||..||.+|||++++++.|+.+..
T Consensus 200 l~ellt~g~~Pf~~~~~~-~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 200 MWEAFSYGQKPYRGMKGS-EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHTTTCCSSTTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred hhHHhhCCCCCCCCCCHH-HHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 999997 89999887654 3334445566778888999999999999999999999999999999987653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-34 Score=217.22 Aligned_cols=138 Identities=25% Similarity=0.531 Sum_probs=113.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||++.. ..++.++|||||||+
T Consensus 131 iHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDVwS~Gv~ 201 (285)
T d1u59a_ 131 VHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVT 201 (285)
T ss_dssp ECCCCSGGGEEEEET-TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH--------CEECHHHHHHHHHHH
T ss_pred ecCcCchhheeeccC-CceeeccchhhhcccccccccccccccccCccccChHHHhC--------CCCCccchhhcchHH
Confidence 699999999999976 789999999998543221 1234568999999999854 568999999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
+|||++ |..||.+..... .........+++.|..+++++.+|+.+||..||.+||++.++++.|+......
T Consensus 202 l~E~lt~G~~Pf~~~~~~~-~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 202 MWEALSYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp HHHHHTTSCCTTTTCCTHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999998 899998876543 33444556677888999999999999999999999999999999998765543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-34 Score=218.95 Aligned_cols=134 Identities=28% Similarity=0.526 Sum_probs=109.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc---ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++..... ....+..|++.|+|||.+.+ ..|+.++|||||||++
T Consensus 162 vHrDlKp~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~t~ksDVwS~Gvvl 232 (301)
T d1lufa_ 162 VHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVL 232 (301)
T ss_dssp CCSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred EeeEEcccceEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc--------CCCChhhhhccchhhH
Confidence 799999999999976 68999999999743222 12234678899999999864 6789999999999999
Q ss_pred HHHHcCC-CCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 78 WELLTNR-LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 78 ~e~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
|||++|. +||.+.... ...........+..|..+++++.+|+.+||..||++||||.+|++.|+.+
T Consensus 233 ~ell~~~~~p~~~~~~~-e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 233 WEIFSYGLQPYYGMAHE-EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HHHHTTTCCTTTTSCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHHccCCCCCCCCCHH-HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 9999986 577766544 34445556667778889999999999999999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-35 Score=217.70 Aligned_cols=136 Identities=27% Similarity=0.410 Sum_probs=104.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc---cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+|+.... .......+||+.|+|||++.+ ...++.++||||+||++
T Consensus 125 iHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-------~~~~~~~~DiwSlGvil 196 (271)
T d1nvra_ 125 THRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVL 196 (271)
T ss_dssp ECSCCCGGGEEECTT-CCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHC-------SSBCHHHHHHHHHHHHH
T ss_pred ccCcccHHHEEECCC-CCEEEccchhheeeccCCccccccceeeCcCccCHhHhcC-------CCCCCCceeeeHhHHHH
Confidence 699999999999976 6799999999985432 222445789999999999853 22346789999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCC-CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHAR-PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|||++|+.||.................. ...+..+++++.+|+.+||..||.+|||++|+++ |.|+.
T Consensus 197 yeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~--hpwf~ 264 (271)
T d1nvra_ 197 TAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK--DRWYN 264 (271)
T ss_dssp HHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTTT
T ss_pred HHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhC
Confidence 9999999999765543333333322222 2223568999999999999999999999999988 66653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-34 Score=219.31 Aligned_cols=137 Identities=23% Similarity=0.367 Sum_probs=96.9
Q ss_pred CCCCCCCCCeEEcC--CCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTP--DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~--~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||+.. +++.+||+|||+++.........+.+||+.|+|||++.+ ..|+.++||||+||++|
T Consensus 129 iHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~--------~~~~~~~DiwSlGvily 200 (307)
T d1a06a_ 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ--------KPYSKAVDCWSIGVIAY 200 (307)
T ss_dssp CCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTT--------CCCCTHHHHHHHHHHHH
T ss_pred eeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcC--------CCCCcHHHhhhhhHHHH
Confidence 79999999999953 236799999999986655555566789999999999853 56899999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCC--CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
||++|..||.+................. +.+..+++++.+|+.+||..||.+|||++|+++ |.|+..
T Consensus 201 ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~~ 269 (307)
T d1a06a_ 201 ILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ--HPWIAG 269 (307)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--STTTTS
T ss_pred HHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc--CHhhCC
Confidence 9999999998876544333333222222 334678999999999999999999999999999 666643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-34 Score=220.07 Aligned_cols=135 Identities=26% Similarity=0.464 Sum_probs=102.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+|+..... ...+.+||+.|+|||++.+ ..|+.++||||+||++|||
T Consensus 127 iHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~--------~~y~~~~DiWSlGvil~el 196 (322)
T d1s9ja_ 127 MHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEM 196 (322)
T ss_dssp CCSCCSGGGEEECTT-CCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHC--------SCCCTTHHHHHHHHHHHHH
T ss_pred EccccCHHHeeECCC-CCEEEeeCCCccccCCC-ccccccCCccccCchHHcC--------CCCCcHHHHHHHHHHHHHH
Confidence 799999999999976 68999999999854332 2345789999999999864 5789999999999999999
Q ss_pred HcCCCCCCCCCcHHHHH-----------------------------------------HHHHccCCCCCCC-CCcHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAY-----------------------------------------AAAFKHARPGLPE-DISPDLAF 118 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~p~-~~~~~~~~ 118 (198)
++|+.||.+........ ........+..+. .++.++.+
T Consensus 197 l~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 276 (322)
T d1s9ja_ 197 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 276 (322)
T ss_dssp HHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHH
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHH
Confidence 99999997654321110 0111112222222 36789999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 119 IVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 119 l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|+.+||..||.+|||++|+++ |.|+..
T Consensus 277 li~~~L~~dP~~R~ta~e~L~--Hpf~~~ 303 (322)
T d1s9ja_ 277 FVNKCLIKNPAERADLKQLMV--HAFIKR 303 (322)
T ss_dssp HHHHHTCSSTTTSCCHHHHHT--SHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHhh--CHhhCc
Confidence 999999999999999999999 677654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-34 Score=214.36 Aligned_cols=140 Identities=26% Similarity=0.370 Sum_probs=109.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||++.. ..++.++|||||||++|
T Consensus 135 vH~DlKp~NIll~~~-~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDI~S~Giil~ 205 (285)
T d1fmka3 135 VHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLT 205 (285)
T ss_dssp CCSCCSGGGEEECGG-GCEEECCCCTTC--------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHH
T ss_pred ecccccceEEEECCC-CcEEEcccchhhhccCCCceeeccccccccccChHHHhC--------CCCCcHHhhhcchHHHH
Confidence 799999999999976 689999999998543322 2233578999999999853 67899999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 79 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
||++|..|+..................++.+..+++++.+++.+||+.||++||++++|+++|+.++....
T Consensus 206 el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 206 ELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 99997666554454454455555566677888999999999999999999999999999999999876554
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-34 Score=217.81 Aligned_cols=128 Identities=21% Similarity=0.365 Sum_probs=103.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc---cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|||++.+ ..|+.++||||+||++
T Consensus 130 iHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~~~~~DiwSlGvil 200 (288)
T d1uu3a_ 130 IHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE--------KSACKSSDLWALGCII 200 (288)
T ss_dssp ECSCCSGGGEEECTT-SCEEECCCTTCEECC----------CCCCGGGCCHHHHHT--------CCCCHHHHHHHHHHHH
T ss_pred EcCcCCccccccCCC-ceEEecccccceecccCCcccccccccCCccccCceeecc--------CCCCcccceehhhHHH
Confidence 699999999999976 6799999999985432 222345689999999999854 6789999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 139 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~ 139 (198)
|||++|..||.+....... .. .....+.+|..+++++.+|+.+||+.||.+|||++|+++
T Consensus 201 yell~g~~Pf~~~~~~~~~-~~-i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 201 YQLVAGLPPFRAGNEYLIF-QK-IIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHHHHSSCSSCCSSHHHHH-HH-HHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHHhhCCCCCCCcCHHHHH-HH-HHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 9999999999886644332 22 234456778889999999999999999999999999755
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-34 Score=213.43 Aligned_cols=137 Identities=28% Similarity=0.575 Sum_probs=104.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc--cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+||+++.+ +.+||+|||+++...... ......||+.|+|||++.. ..++.++|||||||++|
T Consensus 130 iHrDlKp~NIll~~~-~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~--------~~~~~~~DiwSlGvil~ 200 (273)
T d1mp8a_ 130 VHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMW 200 (273)
T ss_dssp CCSCCSGGGEEEEET-TEEEECC-------------------CCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHH
T ss_pred eccccchhheeecCC-CcEEEccchhheeccCCcceeccceecCcccchhhHhcc--------CCCCCccccccchHHHH
Confidence 799999999999976 689999999998643322 2234568899999999853 67899999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
||++ |.+||.+...... .........++.|..+++++.+|+.+||..||.+|||+.++++.|+.++..
T Consensus 201 e~lt~g~~P~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 201 EILMHGVKPFQGVKNNDV-IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHTTSCCTTTTCCGGGH-HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9997 8899987665433 334455666778889999999999999999999999999999999887653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-33 Score=217.28 Aligned_cols=132 Identities=26% Similarity=0.495 Sum_probs=109.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+|+.... .......+||+.|+|||++.+ ..|+.++|+||+||++||
T Consensus 127 iHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~--------~~y~~~~DiwSlGvilye 197 (337)
T d1o6la_ 127 VYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYE 197 (337)
T ss_dssp BCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS--------SCBCTTHHHHHHHHHHHH
T ss_pred cccccCHHHeEecCC-CCEEEeecccccccccCCcccccceeCHHHhhhhhccC--------CCCChhhcccchhhHHHH
Confidence 799999999999977 6899999999985433 334456789999999999854 678999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFL 145 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps-----~~~~l~~l~~~~ 145 (198)
|++|+.||.+....... .......+.+|..+++++.+|+.+||+.||.+|++ +.++++ |.|+
T Consensus 198 ml~G~~pf~~~~~~~~~--~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~--Hp~f 264 (337)
T d1o6la_ 198 MMCGRLPFYNQDHERLF--ELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME--HRFF 264 (337)
T ss_dssp HHHSSCSSCCSSHHHHH--HHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT--SGGG
T ss_pred HHHCCCCCCCcCHHHHH--HHHhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc--Cccc
Confidence 99999999987654332 23334556788899999999999999999999994 888888 5554
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-34 Score=217.38 Aligned_cols=139 Identities=28% Similarity=0.455 Sum_probs=108.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++..... ....+.+||+.|+|||++.... .....|+.++||||+||++||
T Consensus 132 vHrDiKp~NIll~~~-~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~---~~~~~y~~k~DiwSlGvilye 207 (288)
T d2jfla1 132 IHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET---SKDRPYDYKADVWSLGITLIE 207 (288)
T ss_dssp ECCCCSGGGEEECTT-SCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCS---TTTSSTTTHHHHHHHHHHHHH
T ss_pred EEeecChhheeECCC-CCEEEEechhhhccCCCcccccccccccccCCHHHHhhcc---cCCCCCChhhhHHHHHHHHHH
Confidence 699999999999977 67999999999754332 2234678999999999974311 123568899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccC-CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
|++|..||.+............... ....+..+++++.+|+.+||+.||.+|||++|+++ |.|+
T Consensus 208 mltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~--hp~~ 272 (288)
T d2jfla1 208 MAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ--HPFV 272 (288)
T ss_dssp HHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--SGGG
T ss_pred HhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc--Cccc
Confidence 9999999988776544433332221 22345678999999999999999999999999998 5665
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-33 Score=212.75 Aligned_cols=141 Identities=28% Similarity=0.364 Sum_probs=108.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++..... ......+||+.|+|||++.. ...|+.++||||+||++||
T Consensus 122 iHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~e 193 (299)
T d1ua2a_ 122 LHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCILAE 193 (299)
T ss_dssp CCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTT-------CSCCCHHHHHHHHHHHHHH
T ss_pred ecccCCcceEEecCC-CccccccCccccccCCCcccccceecChhhccHHHHcc-------CCCCChhhhhhhcchHHHH
Confidence 799999999999976 68999999999755432 23345689999999998753 3567999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC---------------------C-----CCCCCcHHHHHHHHHhcccCCCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP---------------------G-----LPEDISPDLAFIVQSCWVEDPNLRPS 133 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------~-----~p~~~~~~~~~l~~~~l~~dp~~Rps 133 (198)
|++|..||.+................+ . ....+++++.+|+.+||..||++|||
T Consensus 194 l~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s 273 (299)
T d1ua2a_ 194 LLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 273 (299)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC
T ss_pred HHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcC
Confidence 999999998877655433222110000 0 01246789999999999999999999
Q ss_pred HHHHHHHHHHHHhhcCCC
Q 029154 134 FSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 134 ~~~~l~~l~~~~~~~~~~ 151 (198)
++|+++ |.|+.....+
T Consensus 274 a~e~L~--Hp~f~~~p~p 289 (299)
T d1ua2a_ 274 ATQALK--MKYFSNRPGP 289 (299)
T ss_dssp HHHHHT--SGGGTSSSCC
T ss_pred HHHHhC--CHhhCCCCCC
Confidence 999999 7887654433
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-33 Score=212.70 Aligned_cols=137 Identities=25% Similarity=0.330 Sum_probs=110.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++...........+||+.|+|||++.+ ..|+.++||||+||++|||
T Consensus 138 vHrDiKp~NILi~~~-~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~--------~~y~~~~DiwSlG~il~el 208 (305)
T d1blxa_ 138 VHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEM 208 (305)
T ss_dssp CCCCCCGGGEEECTT-CCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHH
T ss_pred EecCCCccEEEEcCC-CCeeecchhhhhhhcccccCCCcccChhhcCcchhcC--------CCCChhehhhchHHHHHHH
Confidence 799999999999966 6899999999987666566667899999999999854 6789999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCC-------------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHAR-------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFS 135 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~ 135 (198)
++|+.||.+................ ...+..+++.+.+|+.+||..||.+|||+.
T Consensus 209 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~ 288 (305)
T d1blxa_ 209 FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288 (305)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence 9999999887654433322111000 012345789999999999999999999999
Q ss_pred HHHHHHHHHHhhc
Q 029154 136 QIIRMLNAFLFTL 148 (198)
Q Consensus 136 ~~l~~l~~~~~~~ 148 (198)
|+++ |.|+...
T Consensus 289 e~L~--Hpff~~i 299 (305)
T d1blxa_ 289 SALS--HPYFQDL 299 (305)
T ss_dssp HHHT--SGGGTTC
T ss_pred HHhc--ChhhcCc
Confidence 9999 7776544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-33 Score=207.91 Aligned_cols=133 Identities=25% Similarity=0.505 Sum_probs=110.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc--ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++....... .....||+.|+|||.+.. ..++.++|||||||++|
T Consensus 122 iH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~ksDiwS~G~~l~ 192 (258)
T d1k2pa_ 122 LHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY--------SKFSSKSDIWAFGVLMW 192 (258)
T ss_dssp CCSCCSGGGEEECTT-CCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHH
T ss_pred ccccccceeEEEcCC-CcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcC--------CCCCcceeecccchhhH
Confidence 799999999999976 6899999999975433222 223578999999999854 56899999999999999
Q ss_pred HHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 79 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 79 e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
||++ |+.||.+..... .........++..|..+++++.+|+.+||+.||.+|||+++++++|.+
T Consensus 193 el~t~g~~Pf~~~~~~~-~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 193 EIYSLGKMPYERFTNSE-TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHTTSCCTTTTSCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred hHHhcCCCCCCCCCHHH-HHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 9998 899998877543 344445566777888899999999999999999999999999998854
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-33 Score=218.71 Aligned_cols=135 Identities=24% Similarity=0.396 Sum_probs=108.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+|+...... ....+||+.|+|||++.. ...|+.++||||+||++|||
T Consensus 129 iHrDlKP~NILl~~~-g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~-------~~~~~~~~DiwSlGvilyem 199 (364)
T d1omwa3 129 VYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKL 199 (364)
T ss_dssp ECCCCSGGGEEECSS-SCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHST-------TCCCCTHHHHHHHHHHHHHH
T ss_pred cceeeccceeEEcCC-CcEEEeeeceeeecCCCc-ccccccccccchhHHhhc-------CCCCCcccchhHHHHHHHHH
Confidence 699999999999976 689999999998654432 345689999999999853 35689999999999999999
Q ss_pred HcCCCCCCCCCcHHH-HHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQA-AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps-----~~~~l~~l~~~~~ 146 (198)
++|+.||.+...... .............|..+++++.+|+.+||..||.+||+ ++++++ |.|+.
T Consensus 200 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~--Hp~f~ 269 (364)
T d1omwa3 200 LRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--SPFFR 269 (364)
T ss_dssp HHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT--SGGGT
T ss_pred HhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc--Ccccc
Confidence 999999976543221 22223344556677889999999999999999999999 788988 66654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-33 Score=217.39 Aligned_cols=131 Identities=23% Similarity=0.360 Sum_probs=107.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++..... ..+.+||+.|||||++.+ ..++.++||||+||++|||
T Consensus 163 iHRDIKP~NILl~~~-g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~--------~~~~~~~DiwSlGvilyem 231 (350)
T d1rdqe_ 163 IYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEM 231 (350)
T ss_dssp ECCCCSGGGEEECTT-SCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHH
T ss_pred ecCcCCHHHcccCCC-CCEEeeeceeeeecccc--cccccCccccCCHHHHcC--------CCCCccccccchhHHHHHH
Confidence 699999999999977 68999999999865432 345689999999999864 6689999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~~l~~~~~ 146 (198)
++|..||.+......... .....+..|..+++++.+|+.+||..||.+|+ +++++++ |.|+.
T Consensus 232 ltG~~Pf~~~~~~~~~~~--i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~--Hp~f~ 298 (350)
T d1rdqe_ 232 AAGYPPFFADQPIQIYEK--IVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN--HKWFA 298 (350)
T ss_dssp HHSSCSSCCSSHHHHHHH--HHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT--SGGGT
T ss_pred HhCCCCCCCcCHHHHHHH--HhcCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc--Ccccc
Confidence 999999988765433322 23345567788999999999999999999994 8999998 55543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-33 Score=213.95 Aligned_cols=131 Identities=25% Similarity=0.411 Sum_probs=108.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++..... ..+.+||+.|+|||++.+ ..|+.++||||+||++|+|
T Consensus 126 iHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~--------~~y~~~~DiwSlGvilyem 194 (316)
T d1fota_ 126 IYRDLKPENILLDKN-GHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST--------KPYNKSIDWWSFGILIYEM 194 (316)
T ss_dssp ECCCCCGGGEEECTT-SCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT--------CCBCTTHHHHHHHHHHHHH
T ss_pred EccccCchheeEcCC-CCEEEecCccceEeccc--cccccCcccccCHHHHcC--------CCCCchhhccccchhHHHH
Confidence 699999999999976 68999999999865432 345789999999999853 5688999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~~l~~~~~ 146 (198)
++|+.||.+.......... .......|..+++++.+++.+||..||.+|+ +++++++ |.|+.
T Consensus 195 ltG~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~--Hp~f~ 261 (316)
T d1fota_ 195 LAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN--HPWFK 261 (316)
T ss_dssp HHSSCTTCCSSHHHHHHHH--HHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT--SGGGS
T ss_pred HhCCCCCCCcCHHHHHHHH--HcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc--Ccccc
Confidence 9999999887654433322 2344567788999999999999999999996 8999988 55543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-33 Score=214.59 Aligned_cols=139 Identities=31% Similarity=0.530 Sum_probs=112.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++............||..|+|||.+.. ..++.++|||||||++|||
T Consensus 149 iHrDlkp~NIL~~~~-~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~sDvwSfGvil~el 219 (309)
T d1fvra_ 149 IHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEI 219 (309)
T ss_dssp ECSCCSGGGEEECGG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH--------CEECHHHHHHHHHHHHHHH
T ss_pred cccccccceEEEcCC-CceEEccccccccccccccccceecCCcccchHHhcc--------CCCCccceeehhHHHHHHH
Confidence 699999999999977 6899999999986554433345578999999999854 5689999999999999999
Q ss_pred HcCC-CCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q 029154 81 LTNR-LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 81 ~~g~-~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 149 (198)
++|. +||.+... ...........++..|..+++++.+|+.+||..||++|||+.+++++|+.++....
T Consensus 220 l~~~~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 220 VSLGGTPYCGMTC-AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp HTTSCCTTTTCCH-HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HhcCCCCCCCCCH-HHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 9975 56766543 44444455667778888999999999999999999999999999999999876443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-33 Score=215.21 Aligned_cols=136 Identities=26% Similarity=0.508 Sum_probs=109.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccccc---ccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++....... .....||+.|+|||++.+ +.|+.++|||||||++
T Consensus 133 iHrDlKp~NIll~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDvwS~Gvil 203 (317)
T d1xkka_ 133 VHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTV 203 (317)
T ss_dssp CCSCCCGGGEEEEET-TEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred ccCcchhhcceeCCC-CCeEeeccccceecccccccccccccccCccccChHHHhc--------CCCChhhhhhhHHHHH
Confidence 799999999999976 7899999999985433221 223468999999999854 5789999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|||++ |..||.+..... .........+++.|..+++++.+|+.+||..||.+|||+.+++++|..+..
T Consensus 204 ~el~t~g~~p~~~~~~~~-~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 204 WELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHTTSCCTTTTSCGGG-HHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHH-HHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 99998 788888765433 334445566677888899999999999999999999999999999877643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-33 Score=209.32 Aligned_cols=137 Identities=30% Similarity=0.615 Sum_probs=114.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++...... ......|++.|+|||.+.+ +.|+.++||||||+++
T Consensus 157 vHrDiKp~NiLl~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--------~~y~~k~DiwS~Gvvl 227 (299)
T d1fgka_ 157 IHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLL 227 (299)
T ss_dssp CCSCCSGGGEEECTT-CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred EeeeecccceeecCC-CCeEeccchhhccccccccccccccCCCChhhhhhhHhcC--------CCCCchhhhHHhHHHH
Confidence 799999999999977 679999999998543322 2234578999999999853 6789999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|||++ |.+||.+... ............+..|..+++++.+|+.+||+.||.+|||+.|+++.|+.+++.
T Consensus 228 ~ell~~g~~p~~~~~~-~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 228 WEIFTLGGSPYPGVPV-EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHTTSCCSSTTCCH-HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhccCCCCCCCCCCH-HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 99998 6888876554 344455556677788889999999999999999999999999999999988764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-33 Score=211.60 Aligned_cols=138 Identities=31% Similarity=0.480 Sum_probs=111.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-----cccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
|||||||+|||++.+ +.+||+|||+++...... ......||..|+|||.+.. ..++.++||||||+
T Consensus 152 iHrDLK~~NILl~~~-~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDI~SfGi 222 (311)
T d1r0pa_ 152 VHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGV 222 (311)
T ss_dssp CCSCCSGGGEEECTT-CCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH--------CCCCHHHHHHHHHH
T ss_pred ccCCccHHhEeECCC-CCEEEecccchhhccccccccceecccccccccccChHHHhc--------CCCCChhHhhhhHH
Confidence 799999999999966 789999999998543321 1223468999999998753 67899999999999
Q ss_pred HHHHHHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 76 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
++|||++|..||.................++..|..+++++.+|+.+||..||.+||++.|++++|+.+...
T Consensus 223 vl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 223 LLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 999999988777655544444445556677778888999999999999999999999999999999988764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-33 Score=217.27 Aligned_cols=138 Identities=25% Similarity=0.327 Sum_probs=109.0
Q ss_pred CCCCCCCCCeEEcCC-CCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~-~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ .+.+||+|||+++.........+.+||+.|+|||++.+ ..++.++||||+||++|+
T Consensus 146 iHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~--------~~~~~~~DiwSlGvilye 217 (350)
T d1koaa2 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG--------KPVGYYTDMWSVGVLSYI 217 (350)
T ss_dssp ECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHT--------CCBCHHHHHHHHHHHHHH
T ss_pred eeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcC--------CCCChhHhhhhhhHHHHH
Confidence 699999999999642 36799999999986655454556789999999999853 568899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC--CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
|++|..||.+................. ..+..+++++.+|+.+||..||.+|||++|+++ |.|+...
T Consensus 218 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~--hp~~~~~ 286 (350)
T d1koaa2 218 LLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLTPG 286 (350)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH--STTTSCT
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccCCC
Confidence 999999998776544333332222221 222458899999999999999999999999999 6776543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-33 Score=210.09 Aligned_cols=134 Identities=28% Similarity=0.560 Sum_probs=108.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.+ +.+||+|||+++...... ......|+..|+|||++.+ ..++.++||||||++
T Consensus 133 iHrDikp~NIll~~~-~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~S~Gvi 203 (273)
T d1u46a_ 133 IHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--------RTFSHASDTWMFGVT 203 (273)
T ss_dssp ECSCCCGGGEEEEET-TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH--------CEEEHHHHHHHHHHH
T ss_pred eeeeecHHHhccccc-cceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC--------CCCCcchhhhhhHHH
Confidence 699999999999977 689999999998543221 1223467889999999864 567899999999999
Q ss_pred HHHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 029154 77 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 143 (198)
Q Consensus 77 l~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~ 143 (198)
+|||++ |..||.+................++.+..+++++.+|+.+||..||.+||||.++++.|..
T Consensus 204 l~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 204 LWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 999998 8999998776655444444556677788899999999999999999999999999998865
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.98 E-value=2.5e-33 Score=216.55 Aligned_cols=137 Identities=20% Similarity=0.335 Sum_probs=110.2
Q ss_pred CCCCCCCCCeEEcC-CCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTP-DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~-~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++. +.+.+||+|||+++............||+.|+|||++.+ ..++.++||||+||++|+
T Consensus 149 iHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvilye 220 (352)
T d1koba_ 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR--------EPVGFYTDMWAIGVLGYV 220 (352)
T ss_dssp ECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHH
T ss_pred eecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcC--------CCCCCccchHHHHHHHHH
Confidence 69999999999973 336799999999987655554556789999999999853 678999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCC--CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|++|..||.+................ ...+..+++++.+|+.+||..||.+|||+.|+++ |.|+..
T Consensus 221 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~--Hp~~~~ 288 (352)
T d1koba_ 221 LLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE--HPWLKG 288 (352)
T ss_dssp HHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT--STTTSS
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhCC
Confidence 99999999987765443333322222 2334568999999999999999999999999998 666653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.5e-33 Score=211.02 Aligned_cols=128 Identities=23% Similarity=0.437 Sum_probs=104.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+.+.+||+|||+++..... ...+.+||+.|+|||++.+ ...++.++||||+||++|||
T Consensus 132 iHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~-------~~~~~~~~DiwSlGvilyel 203 (273)
T d1xwsa_ 132 LHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYDM 203 (273)
T ss_dssp ECSCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHH-------SCBCHHHHHHHHHHHHHHHH
T ss_pred ccccCcccceEEecCCCeEEECccccceecccc-cccccccCCCcCCHHHHcC-------CCCCCcccccccceeeehhH
Confidence 699999999999876578999999999754432 3456789999999999854 23346779999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
++|+.||.+... ........+..+++++.+|+.+||..||.+|||++|+++ +.|+.
T Consensus 204 l~g~~Pf~~~~~--------i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~--hp~~~ 259 (273)
T d1xwsa_ 204 VCGDIPFEHDEE--------IIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQ 259 (273)
T ss_dssp HHSSCSCCSHHH--------HHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGS
T ss_pred hhCCCCCCCchH--------HhhcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc--CHhhC
Confidence 999999975321 112344567789999999999999999999999999998 66654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.4e-32 Score=208.02 Aligned_cols=138 Identities=31% Similarity=0.550 Sum_probs=113.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+|++|||+++...... .....+||+.|+|||++.. ..++.++|||||||++
T Consensus 167 vHrDLKp~NIl~~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DIwS~G~~l 237 (311)
T d1t46a_ 167 IHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGIFL 237 (311)
T ss_dssp CCSCCSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred eeccccccccccccc-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcC--------CCCCCcccccchHHHH
Confidence 799999999999976 789999999998554322 2234578999999999853 6789999999999999
Q ss_pred HHHHc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 78 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 78 ~e~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
|||++ |.+||.+...............++..|..+++++.+|+.+||+.||.+|||+++++++|+..+..
T Consensus 238 ~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 238 WELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 99998 66667665554444445555677777888999999999999999999999999999999887654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.9e-33 Score=209.10 Aligned_cols=136 Identities=20% Similarity=0.300 Sum_probs=108.3
Q ss_pred CCCCCCCCCeEEcCCCC---ceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQK---SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~---~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.++. .+||+|||+++............||+.|+|||++.+ ..++.++||||+||++
T Consensus 135 vHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~--------~~~~~~~DiwSlGvil 206 (293)
T d1jksa_ 135 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVIT 206 (293)
T ss_dssp ECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT--------CCBCTHHHHHHHHHHH
T ss_pred eecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcC--------CCCCCcccchhhhHHH
Confidence 69999999999986632 599999999987655555566789999999999853 5689999999999999
Q ss_pred HHHHcCCCCCCCCCcHHHHHHHHHccCCC--CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 78 WELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 78 ~e~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|||++|..||.+................. ..+..+++++.+|+.+||..||.+|||++|+++ |.|+.
T Consensus 207 yell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~ 275 (293)
T d1jksa_ 207 YILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ--HPWIK 275 (293)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTC
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccC
Confidence 99999999999876544333222211111 223568999999999999999999999999998 66664
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.97 E-value=1.6e-32 Score=205.64 Aligned_cols=140 Identities=24% Similarity=0.367 Sum_probs=110.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++...........+||+.|++||.+.+.... ....++.++||||+||++|+|
T Consensus 132 vHrDlkp~Nill~~~-~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~--~~~~~~~~~DiwslGvilyem 208 (277)
T d1phka_ 132 VHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND--NHPGYGKEVDMWSTGVIMYTL 208 (277)
T ss_dssp ECSCCSGGGEEECTT-CCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCT--TSCCBCTHHHHHHHHHHHHHH
T ss_pred cccccccceEEEcCC-CCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccc--cCCCCCchheEcccchhhhhh
Confidence 699999999999976 78999999999866554445567899999999998642211 234578899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCCCC--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
++|+.||.+................+. ....+++++.+|+.+||..||.+|||++|+++ |.|+
T Consensus 209 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~--h~~~ 273 (277)
T d1phka_ 209 LAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA--HPFF 273 (277)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT--SGGG
T ss_pred ccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc--CHHH
Confidence 999999998776554433333333322 23468999999999999999999999999988 5554
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.5e-32 Score=209.73 Aligned_cols=137 Identities=23% Similarity=0.477 Sum_probs=105.1
Q ss_pred CCCCCCCCCeEEcCC--CCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~--~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ .+.+||+|||+++...........+||+.|+|||++.+ ..|+.++||||+||++|
T Consensus 133 iHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~y~~~~DiwSlGvily 204 (335)
T d2ozaa1 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMY 204 (335)
T ss_dssp ECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCG--------GGGSHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcC--------CCCCHHHHHHhhchhHH
Confidence 699999999999853 24699999999986655555566789999999999854 56899999999999999
Q ss_pred HHHcCCCCCCCCCcHHHHH--HHHHccCCCCCC----CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 79 ELLTNRLPFEGMSNLQAAY--AAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 79 e~~~g~~p~~~~~~~~~~~--~~~~~~~~~~~p----~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
+|++|+.||.+........ ..........+| ..+++++.+|+.+||..||++|||+.|+++ |.|+..
T Consensus 205 ~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~~ 277 (335)
T d2ozaa1 205 ILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQ 277 (335)
T ss_dssp HHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SHHHHT
T ss_pred HHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc--CHHhhC
Confidence 9999999997654322211 111111222233 247899999999999999999999999998 676643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=5.4e-32 Score=202.94 Aligned_cols=135 Identities=28% Similarity=0.455 Sum_probs=101.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc----ccccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.+ +..+|+|||+++..... ......+||+.|+|||++.+ ..++.++||||+||+
T Consensus 133 iHrDiKP~NIll~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~~~~~DiwSlGvi 203 (277)
T d1o6ya_ 133 IHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG--------DSVDARSDVYSLGCV 203 (277)
T ss_dssp ECCCCSGGGEEEETT-SCEEECCCTTCEECC----------------TTCCHHHHTT--------CCCCHHHHHHHHHHH
T ss_pred cCccccCcccccCcc-ccceeehhhhhhhhccccccccccccccCcccccCHHHHcC--------CCCCcceecccchHH
Confidence 699999999999976 67999999998643221 12344689999999999853 568999999999999
Q ss_pred HHHHHcCCCCCCCCCcHHHHHHHHHccCCC--CCCCCCcHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHH
Q 029154 77 LWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAF 144 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~l~~~~l~~dp~~Rp-s~~~~l~~l~~~ 144 (198)
+|||++|+.||.+................+ .....+++++.+++.+||+.||.+|| ++++++..|..+
T Consensus 204 lyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 204 LYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 999999999999877655544444333332 23456899999999999999999998 899988877654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.9e-32 Score=209.09 Aligned_cols=132 Identities=27% Similarity=0.503 Sum_probs=108.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|||++.+ ..++.++||||+||++||
T Consensus 125 iHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvilye 195 (320)
T d1xjda_ 125 VYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG--------QKYNHSVDWWSFGVLLYE 195 (320)
T ss_dssp BCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHH
T ss_pred eeccCcccceeecCC-CceeccccchhhhcccccccccccCCCCCcCCHHHHcC--------CCCCchhhhhhhhHHHHH
Confidence 799999999999976 6899999999985433 233445689999999999864 678999999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHH-HHHHHHHHHH
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS-QIIRMLNAFL 145 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~-~~l~~l~~~~ 145 (198)
|++|+.||.+......... .....+..|..+++++.+|+.+||..||.+||++. ++++ |.|+
T Consensus 196 mltG~~PF~~~~~~~~~~~--i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~--hpff 258 (320)
T d1xjda_ 196 MLIGQSPFHGQDEEELFHS--IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ--HPLF 258 (320)
T ss_dssp HHHSSCSSCCSSHHHHHHH--HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG--SGGG
T ss_pred HHhCCCCCCCCCHHHHHHH--HHcCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh--Cchh
Confidence 9999999998765433222 23455677888999999999999999999999995 7876 4444
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.3e-32 Score=205.83 Aligned_cols=134 Identities=28% Similarity=0.531 Sum_probs=109.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc---cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 77 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l 77 (198)
|||||||+|||++.+ +.+||+|||+++...... ......||+.|++||.+.+ ..++.++||||||+++
T Consensus 155 vHrDlk~~NiLld~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~--------~~~~~~~Dv~S~G~il 225 (308)
T d1p4oa_ 155 VHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVL 225 (308)
T ss_dssp BCSCCSGGGEEECTT-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred eeceEcCCceeecCC-ceEEEeecccceeccCCcceeeccceecccccCCHHHHcc--------CCCCcccccccHHHHH
Confidence 699999999999976 789999999998543322 2234568999999999854 6688999999999999
Q ss_pred HHHHcCC-CCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 78 WELLTNR-LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 78 ~e~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
|||++|. .||.+.... ...........+..|..+++.+.+++.+||+.||.+|||+.+++++|+..
T Consensus 226 ~El~t~~~~p~~~~~~~-~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 226 WEIATLAEQPYQGLSNE-QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHHTSCCTTTTSCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHhCCCCCCCCCCHH-HHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 9999985 677765543 33444556667778888999999999999999999999999999988654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.2e-32 Score=200.87 Aligned_cols=133 Identities=29% Similarity=0.583 Sum_probs=104.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+||+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||
T Consensus 125 vH~dlkp~Nil~~~~-~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~--------~~~t~~sDIwSfG~il~el 193 (262)
T d1byga_ 125 VHRDLAARNVLVSED-NVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEI 193 (262)
T ss_dssp CCSCCSGGGEEECTT-SCEEECCCCC--------------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHH
T ss_pred eccccchHhheecCC-CCEeecccccceecCCC--CccccccccCCChHHHhC--------CCCChHHHHHhHHHHHHHH
Confidence 799999999999977 67999999999854332 234567899999999853 5789999999999999999
Q ss_pred Hc-CCCCCCCCCcHHHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 029154 81 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 145 (198)
Q Consensus 81 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~ 145 (198)
++ |.+||.+..... .........+++.|..+++++.+|+.+||..||.+|||+.+++++|+.+.
T Consensus 194 ~t~~~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 194 YSFGRVPYPRIPLKD-VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp HTTSCCSCTTSCGGG-HHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHCCCCCCCCCCHHH-HHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 98 688887765433 33444556778888999999999999999999999999999999998763
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-31 Score=206.75 Aligned_cols=142 Identities=28% Similarity=0.331 Sum_probs=111.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.++..+||+|||+++.........+.+||..|+|||.+.+ ...++.++||||+||++|||
T Consensus 144 iHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DIwSlG~il~el 216 (350)
T d1q5ka_ 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG-------ATDYTSSIDVWSAGCVLAEL 216 (350)
T ss_dssp ECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTT-------CSSCCTHHHHHHHHHHHHHH
T ss_pred cccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhc-------ccCCCcceeecccceEEEeh
Confidence 69999999999997756799999999986655555566789999999998753 35689999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHcc------------------CCC---------CCCCCCcHHHHHHHHHhcccCCCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKH------------------ARP---------GLPEDISPDLAFIVQSCWVEDPNLRPS 133 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~------------------~~~---------~~p~~~~~~~~~l~~~~l~~dp~~Rps 133 (198)
++|..||.+.............. ..+ ......++++.+|+.+||..||.+|||
T Consensus 217 ~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 296 (350)
T d1q5ka_ 217 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296 (350)
T ss_dssp HHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred hhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC
Confidence 99999998776544332221100 000 012347899999999999999999999
Q ss_pred HHHHHHHHHHHHhhcCCC
Q 029154 134 FSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 134 ~~~~l~~l~~~~~~~~~~ 151 (198)
+.|+++ |.|+.....+
T Consensus 297 a~e~L~--Hp~f~~~~~~ 312 (350)
T d1q5ka_ 297 PLEACA--HSFFDELRDP 312 (350)
T ss_dssp HHHHHT--SGGGGGGGCT
T ss_pred HHHHhc--CHhhccccCC
Confidence 999998 7777665443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1e-31 Score=203.39 Aligned_cols=142 Identities=29% Similarity=0.420 Sum_probs=108.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc-cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|||++.. ...++.++|+||+||++|+
T Consensus 124 iHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~-------~~~~~~~~DiwSlGvily~ 195 (298)
T d1gz8a_ 124 LHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-------CKYYSTAVDIWSLGCIFAE 195 (298)
T ss_dssp CCSCCCGGGEEECTT-SCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTT-------CSSCCTHHHHHHHHHHHHH
T ss_pred EccccCchheeeccc-CcceeccCCcceeccCCcccceeecccceeeehhhhcc-------ccCCCccccccccchhhhH
Confidence 799999999999977 6899999999975432 233445689999999998753 3456889999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC----------------CC-----------CCCCcHHHHHHHHHhcccCCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP----------------GL-----------PEDISPDLAFIVQSCWVEDPNLRP 132 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------~~-----------p~~~~~~~~~l~~~~l~~dp~~Rp 132 (198)
|++|+.||.+................+ .. ...+++++.+|+.+||..||.+||
T Consensus 196 m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 275 (298)
T d1gz8a_ 196 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 275 (298)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSC
T ss_pred HhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCc
Confidence 999999998876554433322111110 00 123578899999999999999999
Q ss_pred CHHHHHHHHHHHHhhcCCCC
Q 029154 133 SFSQIIRMLNAFLFTLRPPS 152 (198)
Q Consensus 133 s~~~~l~~l~~~~~~~~~~~ 152 (198)
|+.|+++ |.|+.....|.
T Consensus 276 t~~ell~--H~ff~~~~~p~ 293 (298)
T d1gz8a_ 276 SAKAALA--HPFFQDVTKPV 293 (298)
T ss_dssp CHHHHHT--SGGGTTCCCCC
T ss_pred CHHHHhC--CHhhccCCCCC
Confidence 9999999 78876655543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=3.6e-31 Score=200.44 Aligned_cols=140 Identities=19% Similarity=0.252 Sum_probs=104.6
Q ss_pred CCCCCCCCCeEEcCC--CCceEEecccCcccCcccc--------cccCCCCccceecccccccccccccccCCCCchhhH
Q 029154 1 MGKFMKEDNLLLTPD--QKSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 70 (198)
Q Consensus 1 iH~dlKp~NIll~~~--~~~~kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dv 70 (198)
|||||||+|||++.. +..+||+|||+++...... .....+||+.|+|||++.+ ..++.++||
T Consensus 125 iHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di 196 (299)
T d1ckia_ 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDL 196 (299)
T ss_dssp ECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--------BCCCHHHHH
T ss_pred eeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhC--------CCCCChhhE
Confidence 699999999998642 2469999999998543221 1234579999999999853 568999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCcHHHHHH------HHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 029154 71 YSFGIVLWELLTNRLPFEGMSNLQAAYA------AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 144 (198)
Q Consensus 71 ws~G~~l~e~~~g~~p~~~~~~~~~~~~------~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~ 144 (198)
|||||++|||++|..||.+......... ..........+..+++++.+++.+||..||.+||+++++.+.|+.+
T Consensus 197 wSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 197 ESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred EecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 9999999999999999976553322111 1111111223457899999999999999999999999999999887
Q ss_pred Hhhc
Q 029154 145 LFTL 148 (198)
Q Consensus 145 ~~~~ 148 (198)
....
T Consensus 277 ~~~~ 280 (299)
T d1ckia_ 277 FHRQ 280 (299)
T ss_dssp HHHH
T ss_pred HHHc
Confidence 6543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-30 Score=199.28 Aligned_cols=138 Identities=25% Similarity=0.346 Sum_probs=104.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCccc-----ccccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
|||||||+|||++.+ +.+||+|||+++..... ......+||+.|+|||++.+ ...++.++||||+||
T Consensus 139 vHrDlKp~NILl~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-------~~~~~~k~DiwSlGv 210 (318)
T d3blha1 139 LHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDLWGAGC 210 (318)
T ss_dssp ECCCCCGGGEEECTT-SCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTT-------CSSCCTHHHHHHHHH
T ss_pred EecCcCchheeecCC-CcEEeeecceeeecccccccccccccceecCHHHhhHHHHcC-------CCCCCcHHHcccCCc
Confidence 699999999999977 67999999999743321 12234579999999999753 356889999999999
Q ss_pred HHHHHHcCCCCCCCCCcHHHHHHHH--HccCCCCCCC----------------------------CCcHHHHHHHHHhcc
Q 029154 76 VLWELLTNRLPFEGMSNLQAAYAAA--FKHARPGLPE----------------------------DISPDLAFIVQSCWV 125 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~~~~~~~~--~~~~~~~~p~----------------------------~~~~~~~~l~~~~l~ 125 (198)
++|||++|+.||.+........... .......... ..++++.+|+.+||.
T Consensus 211 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~ 290 (318)
T d3blha1 211 IMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV 290 (318)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSC
T ss_pred eeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCc
Confidence 9999999999998876544332221 1111111100 125678899999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHhhc
Q 029154 126 EDPNLRPSFSQIIRMLNAFLFTL 148 (198)
Q Consensus 126 ~dp~~Rps~~~~l~~l~~~~~~~ 148 (198)
.||.+|||++|+++ |.|+...
T Consensus 291 ~dP~~R~sa~elL~--Hpff~~~ 311 (318)
T d3blha1 291 LDPAQRIDSDDALN--HDFFWSD 311 (318)
T ss_dssp SSTTTSCCHHHHHH--SGGGSSS
T ss_pred CChhHCcCHHHHHc--ChhhccC
Confidence 99999999999999 8887643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=5.7e-31 Score=198.16 Aligned_cols=135 Identities=24% Similarity=0.365 Sum_probs=100.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||++....... ......|++.|++||.+.. ...++.++|+||+||++||
T Consensus 122 vHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~-------~~~~~~~~DiwslGv~l~e 193 (286)
T d1ob3a_ 122 LHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG-------SKKYSTTIDIWSVGCIFAE 193 (286)
T ss_dssp CCSCCCGGGEEECTT-SCEEECCTTHHHHHCC---------CCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHH
T ss_pred EecCCCCceeeEcCC-CCEEecccccceecccCccccceecccchhhhHHHHhC-------CCCCCcceeehhcCcHHHH
Confidence 799999999999977 689999999997543322 2234578999999999853 3567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCC---------------------------CCCCCCCcHHHHHHHHHhcccCCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHAR---------------------------PGLPEDISPDLAFIVQSCWVEDPNLRP 132 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------------~~~p~~~~~~~~~l~~~~l~~dp~~Rp 132 (198)
|++|+.||.+................ ...+..+++++.+|+.+||..||.+||
T Consensus 194 l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ 273 (286)
T d1ob3a_ 194 MVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI 273 (286)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCc
Confidence 99999999887654443322111000 012345688999999999999999999
Q ss_pred CHHHHHHHHHHHH
Q 029154 133 SFSQIIRMLNAFL 145 (198)
Q Consensus 133 s~~~~l~~l~~~~ 145 (198)
|++|+++ |.|+
T Consensus 274 s~~ell~--Hp~f 284 (286)
T d1ob3a_ 274 TAKQALE--HAYF 284 (286)
T ss_dssp CHHHHHT--SGGG
T ss_pred CHHHHhc--Cccc
Confidence 9999998 5554
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3e-31 Score=201.18 Aligned_cols=145 Identities=21% Similarity=0.340 Sum_probs=100.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-----cccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
|||||||+|||++.+ +.+||+|||+++...... .....+||+.|+|||++...... ....++.++|||||||
T Consensus 130 vHrDlKp~NILl~~~-~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~k~Di~S~Gv 206 (303)
T d1vjya_ 130 AHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM--KHFESFKRADIYAMGL 206 (303)
T ss_dssp ECSCCCGGGEEECTT-SCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCT--TCHHHHHHHHHHHHHH
T ss_pred eccccCccceEEcCC-CCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccc--cCCCcCcchhhhhhHH
Confidence 699999999999977 789999999997443211 22346899999999987531100 0112567899999999
Q ss_pred HHHHHHcCCCCCCCCC--------------cHHHHHHHH-HccCCCCCCCC-----CcHHHHHHHHHhcccCCCCCCCHH
Q 029154 76 VLWELLTNRLPFEGMS--------------NLQAAYAAA-FKHARPGLPED-----ISPDLAFIVQSCWVEDPNLRPSFS 135 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~--------------~~~~~~~~~-~~~~~~~~p~~-----~~~~~~~l~~~~l~~dp~~Rps~~ 135 (198)
++|||++|..||.... ......... ....++.+|.. ....+.+|+.+||+.||.+|||+.
T Consensus 207 vl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 286 (303)
T d1vjya_ 207 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286 (303)
T ss_dssp HHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHH
T ss_pred HHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHH
Confidence 9999999987653211 111111111 12233344332 224588999999999999999999
Q ss_pred HHHHHHHHHHhhc
Q 029154 136 QIIRMLNAFLFTL 148 (198)
Q Consensus 136 ~~l~~l~~~~~~~ 148 (198)
|+++.|+.+....
T Consensus 287 ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 287 RIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhc
Confidence 9999999876543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.5e-31 Score=203.03 Aligned_cols=136 Identities=18% Similarity=0.228 Sum_probs=107.4
Q ss_pred CCCCCCCCCeEEcCC-CCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~-~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ ...+||+|||+++...........+||+.|++||.+.+ ..|+.++||||+||++|+
T Consensus 124 iHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~--------~~~~~~~DiWSlGvily~ 195 (321)
T d1tkia_ 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH--------DVVSTATDMWSLGTLVYV 195 (321)
T ss_dssp ECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT--------CEECHHHHHHHHHHHHHH
T ss_pred CcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccC--------CCCCchhhcccHHHHHHH
Confidence 699999999999754 24699999999986655444455678999999998753 567899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHccCCC--CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
|++|..||.+................. ..+..+++++.+|+.+||..||.+|||+.|+++ |.|+.
T Consensus 196 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~--hp~~~ 262 (321)
T d1tkia_ 196 LLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ--HPWLK 262 (321)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhc
Confidence 999999998877544433333222221 112468999999999999999999999999998 66664
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.1e-30 Score=199.85 Aligned_cols=140 Identities=26% Similarity=0.338 Sum_probs=105.7
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc----cccCCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 76 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~ 76 (198)
|||||||+|||++.+ +.+||+|||+++...... .....+||+.|+|||++.. ...++.++||||+||+
T Consensus 131 iHRDIKp~NILl~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DiwSlG~i 202 (345)
T d1pmea_ 131 LHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCI 202 (345)
T ss_dssp ECCCCCGGGEEECTT-CCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTT-------BCSCSTHHHHHHHHHH
T ss_pred cCCCCCcceEEECCC-CCEEEcccCceeeccCCCccceeeccccccceechHHHhhc-------CCCCCchhhhhccCce
Confidence 699999999999976 689999999997543221 2345679999999999753 3567889999999999
Q ss_pred HHHHHcCCCCCCCCCcHHHHHHHHHcc----------------------CCC-------CCCCCCcHHHHHHHHHhcccC
Q 029154 77 LWELLTNRLPFEGMSNLQAAYAAAFKH----------------------ARP-------GLPEDISPDLAFIVQSCWVED 127 (198)
Q Consensus 77 l~e~~~g~~p~~~~~~~~~~~~~~~~~----------------------~~~-------~~p~~~~~~~~~l~~~~l~~d 127 (198)
+|+|++|+.||.+.............. ... .....+++++.+|+.+||..|
T Consensus 203 l~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 282 (345)
T d1pmea_ 203 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN 282 (345)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSS
T ss_pred ehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCC
Confidence 999999999998766433322211100 000 012356789999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHhhcCC
Q 029154 128 PNLRPSFSQIIRMLNAFLFTLRP 150 (198)
Q Consensus 128 p~~Rps~~~~l~~l~~~~~~~~~ 150 (198)
|.+|||+.++++ +.|+.....
T Consensus 283 P~~R~ta~e~L~--hpf~~~~~~ 303 (345)
T d1pmea_ 283 PHKRIEVEQALA--HPYLEQYYD 303 (345)
T ss_dssp TTTSCCHHHHHT--SGGGTTTCC
T ss_pred hhHCcCHHHHhc--CHhhccCCC
Confidence 999999999999 777664433
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.5e-30 Score=198.69 Aligned_cols=137 Identities=25% Similarity=0.370 Sum_probs=107.3
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+|++|||+++..... .+..+||+.|+|||++.+ ...++.++||||+||++|+|
T Consensus 143 iHrDiKp~NIL~~~~-~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~el 212 (346)
T d1cm8a_ 143 IHRDLKPGNLAVNED-CELKILDFGLARQADSE--MTGYVVTRWYRAPEVILN-------WMRYTQTVDIWSVGCIMAEM 212 (346)
T ss_dssp ECCCCCGGGEEECTT-CCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHT-------TTCCCTTHHHHHHHHHHHHH
T ss_pred cccccCcchhhcccc-cccccccccceeccCCc--cccccccccccCHHHHcC-------CCCCCccchhhcchHHHHHH
Confidence 699999999999977 68999999999865432 345789999999999853 35678999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCC-----------------------------CCCCCCCcHHHHHHHHHhcccCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHAR-----------------------------PGLPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
++|..||.+................ ......+++++.+|+.+||..||.+|
T Consensus 213 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R 292 (346)
T d1cm8a_ 213 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 292 (346)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTS
T ss_pred HHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHC
Confidence 9999999887654433221110000 01234578999999999999999999
Q ss_pred CCHHHHHHHHHHHHhhcC
Q 029154 132 PSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~~ 149 (198)
||+.|+++ |.|+....
T Consensus 293 ~ta~eiL~--Hp~f~~~~ 308 (346)
T d1cm8a_ 293 VTAGEALA--HPYFESLH 308 (346)
T ss_dssp CCHHHHHH--SGGGTTTC
T ss_pred cCHHHHhc--ChhhCcCC
Confidence 99999999 77876544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.96 E-value=4.3e-30 Score=193.97 Aligned_cols=141 Identities=16% Similarity=0.240 Sum_probs=106.9
Q ss_pred CCCCCCCCCeEEcCC----CCceEEecccCcccCccc--------ccccCCCCccceecccccccccccccccCCCCchh
Q 029154 1 MGKFMKEDNLLLTPD----QKSLKLADFGLAREETVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 68 (198)
Q Consensus 1 iH~dlKp~NIll~~~----~~~~kl~DfGla~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 68 (198)
|||||||+|||++.+ .+.+||+|||+++..... ......+||+.|||||++.+ ..++.++
T Consensus 123 iHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--------~~~~~~~ 194 (293)
T d1csna_ 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--------REQSRRD 194 (293)
T ss_dssp ECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHH
T ss_pred eeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC--------CCCChHH
Confidence 699999999999742 356999999999854321 12234579999999999853 6789999
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCcH--HHHHHH----HHccCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 029154 69 DVYSFGIVLWELLTNRLPFEGMSNL--QAAYAA----AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 142 (198)
Q Consensus 69 Dvws~G~~l~e~~~g~~p~~~~~~~--~~~~~~----~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~ 142 (198)
||||+|+++|||++|..||.+.... ...... ........++..+++++.+++..|+..+|++||+++.+.+.|+
T Consensus 195 DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 195 DLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp HHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred HHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 9999999999999999999765421 111111 1111112234568899999999999999999999999999998
Q ss_pred HHHhhcC
Q 029154 143 AFLFTLR 149 (198)
Q Consensus 143 ~~~~~~~ 149 (198)
+++....
T Consensus 275 ~~~~~~~ 281 (293)
T d1csna_ 275 KVLERLN 281 (293)
T ss_dssp HHHHHTT
T ss_pred HHHHHcC
Confidence 8876554
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.96 E-value=2.5e-30 Score=198.20 Aligned_cols=138 Identities=18% Similarity=0.292 Sum_probs=106.2
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.++..+||+|||+++...........+||+.|+|||.+.+ ...++.++|+||+||++|++
T Consensus 151 vHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~e~ 223 (328)
T d3bqca1 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASM 223 (328)
T ss_dssp ECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHH
T ss_pred ccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccC-------CCCCCcccchhhhhhhhHHh
Confidence 69999999999997656799999999986655555567789999999999754 34578999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHc------------c------------------------CCCCCCCCCcHHHHHHHHHhc
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFK------------H------------------------ARPGLPEDISPDLAFIVQSCW 124 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~------------~------------------------~~~~~p~~~~~~~~~l~~~~l 124 (198)
++|..||............... . ........+++++.+|+.+||
T Consensus 224 ~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL 303 (328)
T d3bqca1 224 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303 (328)
T ss_dssp HHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHS
T ss_pred ccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHc
Confidence 9999999765543322111000 0 000112336889999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHHhh
Q 029154 125 VEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 125 ~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
..||.+|||++|+++ |.|+..
T Consensus 304 ~~dP~~R~ta~e~L~--Hp~F~~ 324 (328)
T d3bqca1 304 RYDHQSRLTAREAME--HPYFYT 324 (328)
T ss_dssp CSSGGGSCCHHHHHT--SGGGTT
T ss_pred cCChhHCcCHHHHhc--CcccCC
Confidence 999999999999998 777654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.7e-30 Score=198.43 Aligned_cols=136 Identities=28% Similarity=0.439 Sum_probs=104.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcc--cccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETV--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 78 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~ 78 (198)
|||||||+|||++.+ +.+||+|||+++.... .....+..|++.|++||.+.+ ....++.++||||+||++|
T Consensus 151 vHrDiKp~Nill~~~-~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~------~~~~~~~ksDIWSlG~iLy 223 (322)
T d1vzoa_ 151 IYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG------GDSGHDKAVDWWSLGVLMY 223 (322)
T ss_dssp CCCCCCGGGEEECTT-SCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTT------CC---CTHHHHHHHHHHHH
T ss_pred EeccCCccceeecCC-CCEEEeeccchhhhcccccccccccccccccchhHHhhc------CCcCCCchhhhHHHHHHHH
Confidence 799999999999977 6799999999975432 222344678999999999854 2345788999999999999
Q ss_pred HHHcCCCCCCCCCcH--HHHHHHHHccCCCCCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHH
Q 029154 79 ELLTNRLPFEGMSNL--QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFL 145 (198)
Q Consensus 79 e~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~l~~~~l~~dp~~Rp-----s~~~~l~~l~~~~ 145 (198)
+|++|..||.+.... ............+..|..+++++.+|+.+||..||.+|| +++|+++ |.|+
T Consensus 224 elltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~--Hpff 295 (322)
T d1vzoa_ 224 ELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE--HLFF 295 (322)
T ss_dssp HHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT--SGGG
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc--CHhh
Confidence 999999999765421 122222233455667788999999999999999999998 4788887 5554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.1e-29 Score=189.95 Aligned_cols=139 Identities=22% Similarity=0.318 Sum_probs=104.4
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccc-cccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 79 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e 79 (198)
|||||||+|||++.+ +.+||+|||.++...... ......++..|++||++.. ...++.++||||+||++||
T Consensus 123 vHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~~DiwSlG~il~e 194 (292)
T d1unla_ 123 LHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAE 194 (292)
T ss_dssp ECCCCSGGGEEECTT-CCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHH
T ss_pred eeecccCcccccccC-CceeeeecchhhcccCCCccceeeccccchhhhhHhcc-------CCCCCchhhccccchHHHH
Confidence 699999999999976 679999999998654332 2334567889999998753 3457899999999999999
Q ss_pred HHcCCCCCCCCCcHHHHHHHHHc--c--------------------------CCCCCCCCCcHHHHHHHHHhcccCCCCC
Q 029154 80 LLTNRLPFEGMSNLQAAYAAAFK--H--------------------------ARPGLPEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 80 ~~~g~~p~~~~~~~~~~~~~~~~--~--------------------------~~~~~p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
|++|+.||............... . .....+..+++.+.+|+.+||+.||.+|
T Consensus 195 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R 274 (292)
T d1unla_ 195 LANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQR 274 (292)
T ss_dssp HTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHC
Confidence 99999987655544433322211 0 0011234568899999999999999999
Q ss_pred CCHHHHHHHHHHHHhhcC
Q 029154 132 PSFSQIIRMLNAFLFTLR 149 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~~ 149 (198)
||++|+++ |.|+....
T Consensus 275 ~sa~e~L~--Hp~f~~~~ 290 (292)
T d1unla_ 275 ISAEEALQ--HPYFSDFC 290 (292)
T ss_dssp CCHHHHTT--SGGGSSCS
T ss_pred cCHHHHhc--ChhhcCCC
Confidence 99999999 67765433
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=8.1e-29 Score=191.09 Aligned_cols=139 Identities=28% Similarity=0.380 Sum_probs=103.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+|++|||++...... ..+..|++.|+|||++.+ ...++.++|+||+||++|+|
T Consensus 143 iHrDiKp~NILi~~~-~~~kl~dfg~a~~~~~~--~~~~~g~~~y~apE~~~~-------~~~~~~~~DiwSlGv~l~~l 212 (348)
T d2gfsa1 143 IHRDLKPSNLAVNED-CELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAEL 212 (348)
T ss_dssp CCCCCCGGGEEECTT-CCEEECCC----CCTGG--GSSSCHHHHTSCHHHHTT-------CSCCCTTHHHHHHHHHHHHH
T ss_pred cccccCCcccccccc-ccccccccchhcccCcc--cccccccccccCchhhcC-------CccCCcccchhhhhHHHHHH
Confidence 799999999999977 67999999998754432 345689999999998653 34568899999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHHccCC---------------------CCC--------CCCCcHHHHHHHHHhcccCCCCC
Q 029154 81 LTNRLPFEGMSNLQAAYAAAFKHAR---------------------PGL--------PEDISPDLAFIVQSCWVEDPNLR 131 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~~~~~---------------------~~~--------p~~~~~~~~~l~~~~l~~dp~~R 131 (198)
++|..||.+................ ... ...+++++.+|+.+||..||.+|
T Consensus 213 l~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R 292 (348)
T d2gfsa1 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 292 (348)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhC
Confidence 9999999887654433222111111 001 13478899999999999999999
Q ss_pred CCHHHHHHHHHHHHhhcCCC
Q 029154 132 PSFSQIIRMLNAFLFTLRPP 151 (198)
Q Consensus 132 ps~~~~l~~l~~~~~~~~~~ 151 (198)
||+.|+++ |.|+.....+
T Consensus 293 ~ta~elL~--Hp~f~~~~~~ 310 (348)
T d2gfsa1 293 ITAAQALA--HAYFAQYHDP 310 (348)
T ss_dssp CCHHHHHT--SGGGTTTCCT
T ss_pred cCHHHHhc--CHhhCCCCCC
Confidence 99999999 7887765443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.2e-28 Score=190.71 Aligned_cols=136 Identities=24% Similarity=0.363 Sum_probs=95.0
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 80 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~~l~e~ 80 (198)
|||||||+|||++.+ +.+|++|||+++...........+||+.|+|||++.+ ..++.++||||+||++++|
T Consensus 141 iHrDlKP~Nil~~~~-~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~--------~~~~~~~DiwSlG~~l~el 211 (355)
T d2b1pa1 141 IHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEM 211 (355)
T ss_dssp CCSCCCGGGEEECTT-CCEEECCCCC---------------CCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHH
T ss_pred ccccCCccccccccc-cceeeechhhhhccccccccccccccccccChhhhcC--------CCCCCCcccccccchHHHH
Confidence 799999999999977 6799999999886665555566789999999999854 5788999999999999999
Q ss_pred HcCCCCCCCCCcHHHHHHHHH---------------------ccCCCC-------------CC------CCCcHHHHHHH
Q 029154 81 LTNRLPFEGMSNLQAAYAAAF---------------------KHARPG-------------LP------EDISPDLAFIV 120 (198)
Q Consensus 81 ~~g~~p~~~~~~~~~~~~~~~---------------------~~~~~~-------------~p------~~~~~~~~~l~ 120 (198)
++|+.||.+............ ...... .+ ...++++.+|+
T Consensus 212 l~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll 291 (355)
T d2b1pa1 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291 (355)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHH
T ss_pred hhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHH
Confidence 999999987664333221110 000000 00 01356789999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHhh
Q 029154 121 QSCWVEDPNLRPSFSQIIRMLNAFLFT 147 (198)
Q Consensus 121 ~~~l~~dp~~Rps~~~~l~~l~~~~~~ 147 (198)
.+||..||++|||++|+++ |.|+..
T Consensus 292 ~~mL~~dP~~R~ta~elL~--Hpw~~~ 316 (355)
T d2b1pa1 292 SKMLVIDPAKRISVDDALQ--HPYINV 316 (355)
T ss_dssp HHHSCSSTTTSCCHHHHHT--STTTGG
T ss_pred HHHCcCChhHCcCHHHHhc--CcccCC
Confidence 9999999999999999999 777764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.93 E-value=2.8e-27 Score=183.14 Aligned_cols=134 Identities=19% Similarity=0.268 Sum_probs=96.2
Q ss_pred CCCCCCCCCeEEcCCCC-----ceEEecccCcccCcccccccCCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 029154 1 MGKFMKEDNLLLTPDQK-----SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 75 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~-----~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws~G~ 75 (198)
|||||||+|||++.++. .++++|||.+...... ....+||+.|+|||++.. ..++.++|+||+||
T Consensus 148 vHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~ 217 (362)
T d1q8ya_ 148 IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG--------APWGCGADIWSTAC 217 (362)
T ss_dssp ECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT--------CCCCTHHHHHHHHH
T ss_pred ccccCChhHeeeeccCcccccceeeEeecccccccccc--cccccccccccChhhccc--------cCCCccccccchHH
Confidence 69999999999985532 3899999998754432 345689999999998853 56899999999999
Q ss_pred HHHHHHcCCCCCCCCCcHH-----HHHHH---HHcc-----------------------C---------------CCCCC
Q 029154 76 VLWELLTNRLPFEGMSNLQ-----AAYAA---AFKH-----------------------A---------------RPGLP 109 (198)
Q Consensus 76 ~l~e~~~g~~p~~~~~~~~-----~~~~~---~~~~-----------------------~---------------~~~~p 109 (198)
++++|++|+.||....... ..... .... . ....+
T Consensus 218 il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (362)
T d1q8ya_ 218 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 297 (362)
T ss_dssp HHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCC
T ss_pred HHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccC
Confidence 9999999999996533211 00000 0000 0 00111
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 029154 110 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 146 (198)
Q Consensus 110 ~~~~~~~~~l~~~~l~~dp~~Rps~~~~l~~l~~~~~ 146 (198)
...++++.+|+.+||..||.+|||++|+++ |.|+.
T Consensus 298 ~~~~~~~~dll~~mL~~dP~~Rpta~e~L~--Hp~f~ 332 (362)
T d1q8ya_ 298 KDEAKEISDFLSPMLQLDPRKRADAGGLVN--HPWLK 332 (362)
T ss_dssp HHHHHHHHHHHGGGGCSSTTTCBCHHHHHT--CGGGT
T ss_pred cccCHHHHHHHHHHCCCChhHCcCHHHHhc--CcccC
Confidence 223577899999999999999999999998 77776
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=98.57 E-value=9.6e-09 Score=71.18 Aligned_cols=28 Identities=18% Similarity=0.270 Sum_probs=24.1
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcccC
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAREE 30 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~~~ 30 (198)
|||||||+|||++.+ .++|+|||.++..
T Consensus 125 iHrDiKP~NILv~~~--~~~liDFG~a~~~ 152 (191)
T d1zara2 125 VHGDLSQYNVLVSEE--GIWIIDFPQSVEV 152 (191)
T ss_dssp ECSCCSTTSEEEETT--EEEECCCTTCEET
T ss_pred EEccCChhheeeeCC--CEEEEECCCcccC
Confidence 699999999999954 4999999998654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.68 E-value=0.0048 Score=44.81 Aligned_cols=27 Identities=26% Similarity=0.279 Sum_probs=22.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
||+|+.++||+++.+ ...-|.||+.+.
T Consensus 186 IHgDl~~dNvl~~~~-~v~gvIDF~~~~ 212 (316)
T d2ppqa1 186 IHADLFQDNVFFLGD-ELSGLIDFYFAC 212 (316)
T ss_dssp ECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred ccCCcchhhhhcccc-cceeEecccccc
Confidence 799999999999965 445799999763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=94.28 E-value=0.0069 Score=42.30 Aligned_cols=26 Identities=12% Similarity=0.011 Sum_probs=21.8
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLA 27 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla 27 (198)
||+|+.|.|||++.+ ..+-|+||+.+
T Consensus 178 iHgD~~~~Nvl~~~~-~~~~iID~~~~ 203 (255)
T d1nd4a_ 178 THGDACLPNIMVENG-RFSGFIDCGRL 203 (255)
T ss_dssp ECSSCCGGGEEEETT-EEEEECCCTTC
T ss_pred EeCCCCCcceEEeCC-ceEEEEEchhc
Confidence 699999999999854 45679999865
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=94.11 E-value=0.011 Score=41.42 Aligned_cols=27 Identities=15% Similarity=0.222 Sum_probs=21.9
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+.|.|||++.+ +.+-|.||+.+.
T Consensus 186 ~HgD~~~~Nil~~~~-~~~~lIDwe~a~ 212 (263)
T d1j7la_ 186 SHGDLGDSNIFVKDG-KVSGFIDLGRSG 212 (263)
T ss_dssp ECSCCCTTSEEEETT-EEEEECCCTTCE
T ss_pred EEeeccCcceeecCC-ceEEEeechhcc
Confidence 599999999999854 445699998763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=92.65 E-value=0.022 Score=42.71 Aligned_cols=26 Identities=12% Similarity=0.120 Sum_probs=22.5
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
+|+|+.+.|||++.+ .++|+||..+.
T Consensus 226 iHGDl~~gNIlv~~~--~~~vID~E~a~ 251 (392)
T d2pula1 226 IHGDLHTGSIFASEH--ETKVIDPEFAF 251 (392)
T ss_dssp ECSCCCGGGEEECSS--CEEECCCTTCE
T ss_pred eccCCcCCceeEcCC--ceEEechhhcc
Confidence 699999999999855 48999998775
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.37 E-value=0.03 Score=40.72 Aligned_cols=25 Identities=24% Similarity=0.231 Sum_probs=20.6
Q ss_pred CCCCCCCCCeEEcCCCCceEEecccCcc
Q 029154 1 MGKFMKEDNLLLTPDQKSLKLADFGLAR 28 (198)
Q Consensus 1 iH~dlKp~NIll~~~~~~~kl~DfGla~ 28 (198)
||+|+.+.|||++ + + ..+.||+-+.
T Consensus 195 iHgDlh~~NvL~~-~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWR-D-G-PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEES-S-S-EEECCCTTCC
T ss_pred ecCCCCcccEEEe-C-C-ceEEechhcc
Confidence 7999999999997 3 3 4589998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=81.89 E-value=0.29 Score=36.24 Aligned_cols=13 Identities=31% Similarity=0.437 Sum_probs=11.8
Q ss_pred CCCCCCCCeEEcC
Q 029154 2 GKFMKEDNLLLTP 14 (198)
Q Consensus 2 H~dlKp~NIll~~ 14 (198)
|.|+.+.|||+..
T Consensus 222 HnDL~~~NiL~~~ 234 (395)
T d1nw1a_ 222 HNDLQEGNILLPK 234 (395)
T ss_dssp CSCCCGGGEEEEC
T ss_pred ecCCCcccEeecc
Confidence 9999999999854
|